<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/site/component/osmap/?view=xsl&amp;format=xsl&amp;layout=standard&amp;id=1&amp;Itemid=490"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc><![CDATA[https://www.onconews.com.br/site/institucional.html]]></loc><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/publieditoriais.html]]></loc><lastmod>2023-11-03T18:03:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/publieditoriais/anvisa-e-cmed-aprovam-tratamento-inovador-com-177lu-psma-617-para-cancer-de-prostata.html]]></loc><lastmod>2025-02-03T11:44:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/publieditoriais/destiny-lung02-trastuzumabe%20deruxtecana-no-cpcnp-com-mutação-her2.html]]></loc><lastmod>2024-05-16T15:22:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/publieditoriais/anvisa-aprova-trastuzumabe-deruxtecana-em-segunda-linha-no-cancer-gastrico-e-ou-de-juncao-gastroesofagica-her2.html]]></loc><lastmod>2023-12-11T21:32:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/publieditoriais/daiichi-sankyo-brasil-investe-na-oncologia.html]]></loc><lastmod>2024-05-22T23:24:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/institucional/conselho-cientifico.html]]></loc><lastmod>2018-07-22T13:54:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/home-page/nosso-projeto.html]]></loc><lastmod>2021-11-08T20:28:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/home-page/quem-somos.html]]></loc><lastmod>2023-10-17T19:53:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/home-page/expediente.html]]></loc><lastmod>2025-01-27T14:40:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/videos-editoriais.html]]></loc><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/san-antonio-2025/t-dxd-confirma-beneficio-versus-t-dm1-no-cancer-de-mama-de-alto-risco.html]]></loc><lastmod>2025-12-15T20:37:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/anvisa-aprova-indicacao-de-durvalumabe-perioperatorio-no-cancer-de-pulmao-ressecavel.html]]></loc><lastmod>2025-12-03T16:14:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-durvalumabe-perioperatoria-em-combinacao-com-flot-no-tratamento-do-cancer-gastrico-e-de-juncao-gastroesofagica.html]]></loc><lastmod>2025-11-28T12:41:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/libertas-atualiza-resultados-e-confirma-resposta-de-psa-com-apa-adt-intermitente-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2025-11-11T15:55:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comissao-lancet-oncology-analisa-a-crise-humana-no-tratamento-do-cancer.html]]></loc><lastmod>2025-11-03T14:34:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-breast09-combinacao-de-trastuzumabe-deruxtecana-e-pertuzumabe-pode-ser-novo-padrao-de-primeira-linha-no-cancer-de-mama-metastatico-her2.html]]></loc><lastmod>2025-10-30T10:07:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/flaura2-analise-mostra-beneficio-de-sobrevida-global-em-subgrupos-de-pior-prognostico-no-cpcnp-avancado-com-mutacao-de-egfr.html]]></loc><lastmod>2025-10-18T10:22:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/destiny-breast05-confirma-beneficio-de-t-dxd-pos-neoadjuvante-no-cancer-de-mama-her2.html]]></loc><lastmod>2025-10-18T12:05:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iarc-destaca-o-consumo-de-alcool-como-causa-evitavel-de-cancer.html]]></loc><lastmod>2025-10-09T16:41:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-denunciou-publicidade-ilegal-de-tabaco-e-nicotina-nas-midias-sociais.html]]></loc><lastmod>2025-10-07T17:52:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sus-garante-acesso-a-mamografia-a-partir-dos-40-anos.html]]></loc><lastmod>2025-09-24T19:05:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/programa-brasileiro-de-vacinacao-contra-o-hpv-ja-mostra-impacto-na-reducao-da-incidencia-do-cancer-cervical.html]]></loc><lastmod>2025-09-22T16:27:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-nova-indicacao-de-t-dxd-para-tratamento-de-cancer-de-mama-com-expressao-ultrabaixa-de-her2.html]]></loc><lastmod>2025-09-16T19:22:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tropion-lung01-dato-dxd-mostra-atividade-intracraniana-em-pacientes-com-cpcnp-e-metastases-cerebrais.html]]></loc><lastmod>2025-09-08T18:04:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ideate-lung01-ifinatamab-deruxtecana-mostra-eficacia-no-cancer-de-pulmao-de-celulas-pequenas-em-estagio-extenso.html]]></loc><lastmod>2025-09-08T18:36:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-indicacao-de-durvalumabe-perioperatorio-no-cancer-de-pulmao-ressecavel.html]]></loc><lastmod>2025-09-04T16:48:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/duart-estudo-sugere-eficacia-de-durvalumabe-apos-rt-no-cpcnp-irressecavel-estagio-iii-inelegivel-a-quimioterapia.html]]></loc><lastmod>2025-08-27T12:38:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-papel-do-status-menopausal-na-relacao-entre-sedentarismo-e-risco-de-cancer-de-mama.html]]></loc><lastmod>2025-08-21T15:34:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ensaios-clinicos-sobre-cancer-devem-capturar-o-status-do-tabagismo.html]]></loc><lastmod>2025-08-06T15:30:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/beneficio-de-sobrevida-da-ooforectomia-paliativa-em-pacientes-com-cancer-gastrico-e-metastase-ovariana.html]]></loc><lastmod>2025-08-01T16:41:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacina-experimental-de-mrna-e-nova-promessa-contra-o-cancer.html]]></loc><lastmod>2025-07-24T21:28:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-envolvendo-171-paises-analisa-disparidades-globais-e-carga-do-cancer.html]]></loc><lastmod>2025-07-24T19:07:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-da-iarc-revela-que-infeccao-pelo-virus-epstein-barr-pode-aumentar-o-risco-de-amplo-espectro-de-tipos-de-cancer.html]]></loc><lastmod>2025-07-17T16:31:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-projeta-estimativas-globais-de-cancer-gastrico-em-185-paises.html]]></loc><lastmod>2025-07-08T18:51:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iarc-e-acs-lancam-o-atlas-do-cancer-4a-edicao.html]]></loc><lastmod>2025-06-30T12:04:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-lanca-versao-2-0-da-escala-de-magnitude-de-beneficio-clinico.html]]></loc><lastmod>2025-06-26T16:08:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-aprovacao-acelerada-para-datopotamab-deruxtecan-no-cpcnp-com-mutacao-do-egfr.html]]></loc><lastmod>2025-06-24T13:04:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cemiplimabe-e-a-primeira-terapia-sistemica-a-reduzir-recorrencia-do-cec-de-alto-risco.html]]></loc><lastmod>2025-10-09T19:59:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/combinacao-de-t-dxd-e-pertuzumabe-pode-ser-novo-padrao-de-1l-no-cancer-de-mama-avancado-her2-positivo.html]]></loc><lastmod>2025-06-02T12:36:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/matterhorn-tratamento-perioperatorio-com-durvalumabe-e-qt-flot-pode-reduzir-o-risco-de-recorrencia-em-pacientes-com-cancer-gastrico.html]]></loc><lastmod>2025-06-02T11:11:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/adium-lanca-trabectedina-para-o-tratamento-de-sarcoma-avancado-de-partes-moles.html]]></loc><lastmod>2025-05-29T20:01:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-que-esperar-da-pesquisa-em-cancer.html]]></loc><lastmod>2025-05-08T15:42:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/progressos-e-armadilhas-da-aprovacao-acelerada.html]]></loc><lastmod>2025-04-22T21:23:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-adesao-a-terapia-endocrina-no-tratamento-do-cancer-de-mama-no-brasil.html]]></loc><lastmod>2025-04-21T21:09:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-diretrizes-para-biopsia-do-linfonodo-sentinela-no-cancer-de-mama-inicial.html]]></loc><lastmod>2025-04-17T16:35:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metanalise-conclui-que-radioterapia-moderadamente-hipofracionada-isodose-deve-ser-padrao-no-cancer-de-prostata.html]]></loc><lastmod>2025-04-14T16:24:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/barcode1-escore-de-risco-poligenico-mostra-resultados-no-rastreamento-do-cancer-de-prostata.html]]></loc><lastmod>2025-04-10T15:30:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-mostra-custos-sobrevida-e-qualidade-do-tratamento-de-cpcnp-na-saude-privada.html]]></loc><lastmod>2025-04-01T13:18:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/krocus-fulzerasib-mais-cetuximabe-no-cpcnp-kras-g12c.html]]></loc><lastmod>2025-03-27T16:26:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/orchard-combinacao-de-osi-dato-dxd-mostra-eficacia-promissora-no-cpcnp.html]]></loc><lastmod>2025-03-26T15:18:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cadonot-revisao-compara-abordagem-axilar-na-cirurgia-do-cancer-de-mama.html]]></loc><lastmod>2025-03-24T15:58:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-avalia-resultados-oncologicos-da-cirurgia-conservadora-da-mama-versus-mastectomia-apos-qt-neo.html]]></loc><lastmod>2025-03-20T13:14:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-genetico-da-linha-germinativa-no-cancer-de-mama-disparidades-e-utilizacao-no-brasil.html]]></loc><lastmod>2025-03-10T17:38:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-analisa-sobrevida-e-impacto-economico-do-cancer-de-mama-triplo-negativo-na-saude-publica-brasileira.html]]></loc><lastmod>2025-03-09T15:24:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iarc-alerta-para-aumento-global-de-casos-de-cancer-de-mama-e-mortes-pela-doenca.html]]></loc><lastmod>2025-02-24T21:29:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/niagara-durvalumabe-perioperatorio-melhora-os-resultados-no-cancer-de-bexiga.html]]></loc><lastmod>2025-11-17T15:06:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacina-neoantigena-gera-imunidade-antitumoral-no-carcinoma-de-celulas-renais.html]]></loc><lastmod>2025-02-10T13:58:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-t-dxd-no-cancer-de-mama-metastatico-rh-her2-low-ultralow-apos-terapia-endocrina.html]]></loc><lastmod>2025-01-28T17:46:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-da-oms-sobre-circunferencia-da-cintura-atividade-fisica-e-risco-de-cancer.html]]></loc><lastmod>2025-03-17T00:03:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/os-destaques-do-simposio-asco-gu-2025.html]]></loc><lastmod>2025-01-27T10:56:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esopec-pesquisa-mostra-beneficio-de-sg-da-qt-perioperatoria-com-flot-no-cancer-de-esofago-localmente-avancado.html]]></loc><lastmod>2025-02-05T17:43:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-a-datopotamab-deruxtecan-no-cpcnp-avancado-egfr-mutado-previamente-tratado.html]]></loc><lastmod>2025-01-13T17:55:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-zolbetuximabe-para-o-tratamento-do-cancer-gastrico-e-de-juncao-gastroesofagica-cldn-18-2.html]]></loc><lastmod>2024-12-18T17:17:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/olympia-olaparibe-mostra-beneficio-de-sobrevida-a-longo-prazo-para-pacientes-com-cancer-de-mama-de-alto-risco-e-positivo-para-brca.html]]></loc><lastmod>2024-12-11T12:20:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/destiny-breast06-mostra-beneficio-clinico-de-t-dxd-no-cancer-de-mama-metastatico-rh-her2-low-ultralow-apos-terapia-endocrina.html]]></loc><lastmod>2024-12-10T21:12:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/transplante-autologo-nao-mostra-beneficio-no-linfoma-de-celulas-do-manto-em-primeira-remissao-completa-com-doenca-residual-minima-indetectavel.html]]></loc><lastmod>2024-12-10T16:18:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-durvalumabe-apos-quimiorradioterapia-no-cancer-de-pulmao-de-celulas-pequenas-em-estagio-limitado.html]]></loc><lastmod>2024-12-02T20:58:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-de-nivo-ipi-aumenta-slp-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2024-12-02T15:36:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-descreve-incidencia-de-cancer-apos-15-sintomas-frequentes-na-atencao-primaria.html]]></loc><lastmod>2024-11-29T13:48:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consorcio-internacional-mostra-associacao-entre-prolactina-e-risco-de-cancer-de-mama-na-pos-menopausa.html]]></loc><lastmod>2024-11-28T21:36:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/colangiocarcinoma-na-america-latina-estudo-multicentrico-alerta-sobre-disparidades-etnicas.html]]></loc><lastmod>2024-11-27T19:03:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-indicacao-agnostica-de-t-dxd-para-tumores-solidos-her2-irressecaveis-ou-metastaticos.html]]></loc><lastmod>2024-11-26T21:37:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-mostra-barreiras-que-limitam-a-implementacao-de-testes-genomicos-para-cancer-de-pulmao-no-brasil.html]]></loc><lastmod>2024-11-25T13:47:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/horse-mito-18-resultados-de-sobrevida-nao-apoiam-hipec-na-citorreducao-secundaria-do-cancer-de-ovario.html]]></loc><lastmod>2024-11-26T17:43:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-associacao-do-status-de-hiv-com-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2024-11-21T21:48:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/review-de-t-dxd-em-2024-asco-esmo-breast-e-esmo.html]]></loc><lastmod>2024-11-13T16:02:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fosp-publica-serie-historica-e-mostra-que-um-terco-dos-casos-de-cancer-de-prostata-em-sp-tem-diagnostico-tardio.html]]></loc><lastmod>2024-11-13T15:10:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-solucoes-de-telessaude-para-integrar-suporte-psicossocial-nutricao-e-atividade-fisica-na-jornada-contra-o-cancer.html]]></loc><lastmod>2024-11-12T22:10:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-mostra-eficacia-e-seguranca-dos-inibidores-de-pd-1-pd-l1-em-pacientes-com-carcinoma-de-celulas-de-merkel.html]]></loc><lastmod>2024-11-11T18:40:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-epidemiologica-multinacional-avalia-incidencia-de-hpv-oral-em-homens.html]]></loc><lastmod>2024-11-06T19:12:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-caso-pioneiro-mostra-beneficio-de-t-dxd-em-paciente-com-cancer-de-prostata-avancado.html]]></loc><lastmod>2024-11-05T22:17:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dados-do-mundo-real-revelam-padroes-de-tratamento-do-cancer-cervical-e-utilizacao-de-recursos-no-sistema-publico-de-saude-brasileiro.html]]></loc><lastmod>2024-11-05T14:20:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-impacto-da-farmacogenomica-na-prescricao-do-tratamento-do-cancer-e-na-seguranca-do-paciente.html]]></loc><lastmod>2024-11-05T14:11:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-sobre-prioridades-para-as-monografias-da-iarc-de-2025-a-2029.html]]></loc><lastmod>2024-11-04T21:01:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-de-sobrevida-mostram-valor-da-intervencao-precoce-para-parar-de-fumar-apos-diagnostico-de-cancer.html]]></loc><lastmod>2024-11-01T14:10:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-canceres-de-mama-her2-low-e-er-low-e-os-novos-paradigmas-de-diagnostico-e-tratamento.html]]></loc><lastmod>2024-10-30T17:58:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-compara-desfechos-de-longo-prazo-com-terapia-focal-no-cancer-de-prostata.html]]></loc><lastmod>2024-10-29T16:08:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sugere-que-ngs-identifica-mais-mutacoes-egfr-acionaveis-no-cancer-de-pulmao-que-pcr-em-tempo-real.html]]></loc><lastmod>2024-10-28T15:23:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/9a-classificacao-tnm-para-cancer-de-nasofaringe-melhora-precisao-prognostica-e-aplicacao-clinica.html]]></loc><lastmod>2024-10-21T18:19:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-importancia-de-melhorar-o-acesso-global-a-radioterapia-para-enfrentar-o-desafio-do-controle-do-cancer.html]]></loc><lastmod>2024-10-17T12:04:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recistt-estudo-detalha-toxicidade-da-radioquimioterapia-com-cisplatina-no-carcinoma-espinocelular-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-10-16T16:04:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-analisa-epidemia-de-diagnosticos-do-cancer-de-tireoide-em-63-paises-nos-5-continentes.html]]></loc><lastmod>2024-10-24T15:06:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-aponta-biomarcadores-de-resposta-a-imatinibe-na-lmc.html]]></loc><lastmod>2024-10-15T18:36:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-destaca-colaboracao-global-no-enfrentamento-do-cancer-de-pulmao.html]]></loc><lastmod>2024-10-14T16:57:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-descreve-desfechos-substitutos-e-limitacoes-no-tratamento-do-cancer.html]]></loc><lastmod>2024-10-11T16:48:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sbm-mostra-grandes-divergencias-entre-cirurgioes-brasileiros-na-marcacao-mamaria-e-axilar-no-cenario-neoadjuvante-do-cancer-de-mama.html]]></loc><lastmod>2024-10-09T15:43:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/micrornas-da-linguagem-secreta-das-celulas-ao-premio-nobel-de-medicina-2024.html]]></loc><lastmod>2024-10-08T16:41:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/swog-s1011-mostra-que-linfadenectomia-estendida-aumenta-risco-de-complicacoes-e-morte-no-cancer-de-bexiga-musculo-invasivo.html]]></loc><lastmod>2024-10-03T16:29:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-de-um-programa-de-triagem-baseado-em-sorologia-do-virus-epstein-barr-na-mortalidade-do-carcinoma-de-nasofaringe.html]]></loc><lastmod>2024-10-02T22:08:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbiota-mostra-impacto-na-deteccao-do-cancer-colorretal.html]]></loc><lastmod>2024-10-01T17:51:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-da-iaslc-recomenda-cautela-na-rt-hipofracionada-no-cpcnp-localmente-avancado.html]]></loc><lastmod>2024-09-30T18:37:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-com-presenca-brasileira-discute-disparidades-no-acesso-ao-diagnostico-e-tratamento-do-cancer-de-mama-entre-minorias.html]]></loc><lastmod>2024-09-26T16:15:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/programa-com-kit-de-coleta-de-linfonodos-e-protocolo-de-disseccao-macroscopica-aumenta-a-sobrevida-global-no-cancer-de-pulmao.html]]></loc><lastmod>2024-09-24T20:46:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/com-resultados-decepcionantes-msd-descontinua-ensaios-keynote-867-e-keynote-630-com-keytruda-r.html]]></loc><lastmod>2024-09-23T21:43:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rano-propoe-algoritmo-para-definir-pros-e-contras-da-cirurgia-oncologica-supramaxima-no-glioma-difuso-recem-diagnosticado.html]]></loc><lastmod>2024-09-23T21:17:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lustre-ensaio-randomizado-fornece-dados-prospectivos-de-sbrt-no-cancer-de-pulmao-clinicamente-inoperavel.html]]></loc><lastmod>2024-09-20T19:13:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-poluicao-ambiental-e-o-impacto-das-guerras.html]]></loc><lastmod>2024-09-19T19:09:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/niagara-durvalumabe-perioperatorio-mostra-beneficio-de-sobrevida-global-no-cancer-de-bexiga-operavel.html]]></loc><lastmod>2025-11-17T14:43:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/destiny-breast06-t-dxd-mostra-beneficio-apos-terapia-endocrina-no-cancer-de-mama-rh-metastatico.html]]></loc><lastmod>2024-09-15T20:37:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/adriatic-durvalumabe-de-consolidacao-no-cpcp-em-estagio-limitado-confirma-beneficio-em-subgrupos-pre-especificados-qrt-previa-e-irradiacao-craniana-profilatica.html]]></loc><lastmod>2024-09-13T12:25:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/modelo-utiliza-expressao-de-trop2-para-prever-resposta-a-dato-dxd-no-cpcnp.html]]></loc><lastmod>2024-09-09T13:16:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-agrupada-mostra-beneficio-de-t-dxd-em-pacientes-com-cancer-de-mama-metastatico-her2-com-metastases-cerebrais.html]]></loc><lastmod>2024-09-04T21:43:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-descreve-fenotipos-associados-ao-risco-de-diabetes-induzido-por-inibidores-de-checkpoint-imune.html]]></loc><lastmod>2024-09-03T19:58:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-indica-nova-regiao-genomica-que-pode-estar-associada-ao-risco-de-cancer-pancreatico-e-consumo-de-alcool.html]]></loc><lastmod>2024-09-03T19:50:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-testes-de-dna-de-hpv-de-segunda-geracao-e-destaca-a-necessidade-de-consenso-para-validar-uso-no-rastreamento-do-cancer-cervical.html]]></loc><lastmod>2024-09-02T19:11:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-para-preservacao-da-fertilidade-no-cancer-ginecologico.html]]></loc><lastmod>2024-08-30T19:57:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iarc-aponta-43-tipos-de-cancer-por-agentes-infecciosos-e-alerta-para-maior-risco-em-imunossuprimidos.html]]></loc><lastmod>2024-08-30T19:48:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biobanco-do-hcor-aposta-na-pesquisa-com-celulas-tumorais-circulantes.html]]></loc><lastmod>2024-08-17T16:14:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-publica-diretriz-de-manejo-do-cancer-retal-localmente-avancado.html]]></loc><lastmod>2024-08-15T20:16:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atlas-de-celulas-mamarias-normais-oferece-nova-ferramenta-para-entender-a-origem-do-cancer-de-mama.html]]></loc><lastmod>2024-08-13T22:03:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/insight-2-mostra-atividade-clinica-da-combinacao-de-tepotinib-e-osimertinibe-no-cpcnp.html]]></loc><lastmod>2024-08-07T21:56:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/a-proxima-onda-players-da-saude-preparam-expansao-e-apostam-na-oncologia.html]]></loc><lastmod>2024-08-07T00:35:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-estratificadas-por-recursos-orientam-estrategias-de-controle-do-cancer-em-paises-de-baixa-e-media-renda.html]]></loc><lastmod>2024-08-06T20:21:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-crc02-estudo-apoia-5-4-mg-kg-de-t-dxd-como-dose-ideal-no-cancer-colorretal-metastatico-her2-positivo-pre-tratado.html]]></loc><lastmod>2024-08-06T20:13:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/projecoes-para-2050-estimam-impacto-economico-do-cancer-doenca-cardiaca-demencia-e-avc.html]]></loc><lastmod>2024-08-11T23:49:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dreamm-7-belantamab-mafodotin-mostra-beneficio-na-combinacao-com-terapias-padrao-no-mieloma-multiplo-recidivado.html]]></loc><lastmod>2024-08-02T15:49:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inca-investiga-como-as-celulas-de-defesa-do-corpo-humano-afetam-o-desenvolvimento-de-tumores.html]]></loc><lastmod>2024-08-01T18:20:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-alta-taxa-de-mortalidade-por-pancreaticoduodenectomia-no-brasil.html]]></loc><lastmod>2024-07-30T22:33:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caminhos-e-desafios-para-a-eliminacao-do-cancer-cervical-no-brasil.html]]></loc><lastmod>2024-07-30T19:03:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/promriine-ressonancia-pre-operatoria-e-resultados-cirurgicos-no-cancer-de-mama.html]]></loc><lastmod>2024-07-29T21:02:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-de-vida-e-desfechos-na-pesquisa-em-cancer.html]]></loc><lastmod>2024-07-29T20:49:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mortalidade-por-cancer-entre-trabalhadores-da-industria-de-energia-expostos-ao-amianto.html]]></loc><lastmod>2024-07-25T14:16:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-que-triagem-com-sigmoidoscopia-flexivel-reduziu-incidencia-e-mortalidade-por-cancer-colorretal.html]]></loc><lastmod>2024-07-25T13:24:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-diretriz-de-tratamento-do-cpcnp-estagio-iii.html]]></loc><lastmod>2024-07-24T21:05:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/discordancias-entre-o-diagnostico-inicial-de-sarcomas.html]]></loc><lastmod>2024-07-24T20:30:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/documentos-vazados-sugerem-que-gigante-do-tabaco-financiou-pesquisas-e-academicos-para-influenciar-politicas-de-saude.html]]></loc><lastmod>2024-07-15T14:08:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/internacoes-hospitalares-nao-planejadas-em-pacientes-com-tumores-solidos-no-brasil.html]]></loc><lastmod>2024-07-12T21:14:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/suresh-ramalingam-apresenta-o-estudo-laura-em-video-para-o-onconews.html]]></loc><lastmod>2024-07-12T18:23:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exposicao-a-ozonio-e-risco-de-cancer-no-brasil.html]]></loc><lastmod>2024-07-11T01:01:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mayo-clinic-faz-relato-historico-do-primeiro-transplante-total-de-laringe-no-condrossarcoma-de-laringe.html]]></loc><lastmod>2024-07-11T00:17:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-traz-novos-dados-sobre-risco-genetico-no-cancer-de-prostata.html]]></loc><lastmod>2024-07-08T18:37:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iarc-publica-novo-volume-sobre-prevencao-do-cancer.html]]></loc><lastmod>2024-07-04T16:00:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-com-radioligante-no-cancer-de-prostata-e-destaque-em-congresso-internacional.html]]></loc><lastmod>2024-07-03T22:22:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-revela-perfil-molecular-do-cancer-de-pulmao-em-pacientes-brasileiros-que-nunca-fumaram.html]]></loc><lastmod>2024-07-15T20:41:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-mudancas-moleculares-e-clinicopatologicas-no-cancer-de-mama-her2-low-e-her2-0-apos-terapia-neoadjuvante.html]]></loc><lastmod>2024-07-06T15:26:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nrg-oncology-rtog-0617-apoia-uso-padrao-da-imrt-no-cancer-de-pulmao-irressecavel.html]]></loc><lastmod>2024-07-15T23:09:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/canceres-gi-de-inicio-precoce-uma-preocupacao-crescente.html]]></loc><lastmod>2024-06-27T20:53:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/netter-2-analise-de-subgrupo-avalia-eficacia-de-radioligante-em-gep-nets-por-grau-e-origem-do-tumor.html]]></loc><lastmod>2024-07-15T19:26:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assinatura-sanguinea-baseada-em-ia-mostra-especificidade-na-deteccao-precoce-do-chc.html]]></loc><lastmod>2024-06-26T17:22:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-do-cancer-de-pulmao-20-anos-de-progresso.html]]></loc><lastmod>2024-06-25T00:18:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-do-status-do-receptor-hormonal-e-dos-subtipos-no-cancer-de-mama-em-jovens-com-mutacao-brca.html]]></loc><lastmod>2024-06-21T20:27:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/icesp-descreve-experiencia-com-fechamento-abdominal-temporario-em-pacientes-oncologicos.html]]></loc><lastmod>2024-06-21T14:48:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/premio-internacional-reconhece-tres-projetos-de-destaque-na-pesquisa-oncologica-brasileira.html]]></loc><lastmod>2024-06-20T23:29:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/duo-o-adicao-de-durvalumabe-e-olaparibe-mostra-beneficio-historico-de-slp-no-cancer-de-ovario.html]]></loc><lastmod>2024-06-23T15:59:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rede-com-especialistas-de-diversos-paises-europeus-discute-manejo-de-tumores-ginecologicos-raros.html]]></loc><lastmod>2024-06-20T14:25:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/epcoritamabe-em-monoterapia-induz-respostas-profundas-no-linfoma-folicular.html]]></loc><lastmod>2024-06-23T18:31:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-publica-diretrizes-para-comunicacao-com-pacientes-em-tratamento-de-cancer.html]]></loc><lastmod>2024-06-23T19:06:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-descreve-experiencia-brasileira-de-transplante-de-figado-de-doador-vivo-no-tratamento-do-colangiocarcinoma-intra-hepatico.html]]></loc><lastmod>2024-06-13T14:04:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/onco-jornada-evento-discute-papel-da-inovacao-no-percurso-do-paciente-com-cancer.html]]></loc><lastmod>2024-06-14T17:43:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-critica-apresenta-graus-de-recomendacao-para-biopsia-do-linfonodo-sentinela-no-cancer-de-mama.html]]></loc><lastmod>2024-06-18T23:42:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lacc-analise-final-de-sobrevida-mostra-que-cirurgia-aberta-deve-ser-o-padrao-na-histerectomia-para-cancer-cervical.html]]></loc><lastmod>2024-06-11T21:16:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/us-doppler-pode-prever-resposta-a-quimioterapia-neoadjuvante-no-cancer-de-mama.html]]></loc><lastmod>2024-06-11T20:44:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/descontinuacao-de-tkis-na-leucemia-mieloide-cronica-a-experiencia-do-sus.html]]></loc><lastmod>2024-06-11T13:00:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/colaboracao-e-caminho-para-acesso-a-medicamentos-essenciais-no-tratamento-do-cancer.html]]></loc><lastmod>2024-05-30T15:55:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-atualiza-recomendacoes-para-ngs-no-cancer-avancado.html]]></loc><lastmod>2024-05-28T17:30:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-delphi-internacional-padroniza-definicoes-e-terminologia-de-resseccoes-pancreaticas-do-lado-esquerdo.html]]></loc><lastmod>2024-05-24T15:53:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guia-propoe-recomendacoes-para-a-pesquisa-de-patologia-tumoral-baseada-em-evidencias.html]]></loc><lastmod>2024-05-21T21:51:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-base-populacional-explora-fatores-e-tendencias-associados-ao-lugar-da-morte-por-cancer-no-brasil.html]]></loc><lastmod>2024-05-16T16:44:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diagnostico-e-tratamento-do-cancer-de-mama-localmente-avançado-na-america-latina.html]]></loc><lastmod>2024-05-16T17:56:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-breast02-dados-de-qualidade-de-vida-reforçam-benefício-de-trastuzumabe-deruxtecana.html]]></loc><lastmod>2024-05-13T22:30:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trastuzumabe-deruxtecana-mostra-resultados-no-cenário-pan-tumoral.html]]></loc><lastmod>2024-05-14T19:52:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variação-geográfica-de-exposições-mutagênicas-em-genomas-de-câncer-renal.html]]></loc><lastmod>2024-05-14T01:15:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-breast03-analise-exploratoria-mostra-superioridade-de-t-dxd-versus-t-dm1.html]]></loc><lastmod>2024-05-15T16:30:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-enzalutamida-no-cancer-de-prostata-com-recidiva-bioquimica-de-alto-risco.html]]></loc><lastmod>2024-05-14T13:51:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-osimertinibe-qt-no-cpcnp-avancado-com-mutacao-de-egfr.html]]></loc><lastmod>2024-05-14T14:02:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-breast06-t-dxd-melhora-slp-no-cancer-de-mama-metastatico-her2-baixo-e-her2-ultrabaixo.html]]></loc><lastmod>2024-05-14T14:12:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-mostra-resultados-de-celulas-car-t-no-tratamento-de-leucemia-e-linfoma.html]]></loc><lastmod>2024-05-14T14:26:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tropion-pantumor01-dato-dxd-em-tumores-de-mama-fortemente-pre-tratados.html]]></loc><lastmod>2024-05-14T14:58:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-deve-superar-3-milhoes-de-novos-casos-por-ano-ate-2040.html]]></loc><lastmod>2024-05-14T20:24:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-mantem-proibicao-do-cigarro-eletronico.html]]></loc><lastmod>2024-05-14T20:45:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-latino-americano-para-o-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-05-14T23:36:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pembrolizumabe-made-in-brazil.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024/azd1390-com-imrt-mostra-perfil-de-seguranca-gerenciavel-e-eficacia-preliminar-no-glioblastoma.html]]></loc><lastmod>2024-05-06T01:46:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024/abordagem-proteomica-para-quantificar-escores-de-stemness-e-revelar-alvos-drogaveis.html]]></loc><lastmod>2024-05-06T02:10:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024/compassion-15-anti-pd-1-ctla4-mostra-resultados-de-fase-3-no-cancer-gastrico-e-gej.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024/menos-da-metade-dos-medicamentos-contra-o-cancer-com-aprovacao-acelerada-mostrou-beneficios-clinicos-em-ensaios-confirmatorios.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-trastuzumabe-deruxtecana-em-tumores-solidos-her2-irressecaveis-ou-metastaticos.html]]></loc><lastmod>2024-04-11T20:30:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/senomac-e-seguro-omitir-a-disseccao-axilar-no-cancer-de-mama-com-metastases-de-linfonodo-sentinela.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ministerio-da-saude-adota-esquema-de-vacinacao-em-dose-unica-contra-o-hpv.html]]></loc><lastmod>2024-04-12T19:51:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/status-her2-em-metastases-cerebrais-do-cancer-de-mama-e-oportunidades-de-tratamento.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/accent-idea-analise-agrupada-avalia-qt-adjuvante-com-oxaliplatina-no-idoso-com-cancer-de-colon-sp-535.html]]></loc><lastmod>2024-04-18T16:54:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iaslc-incorpora-nova-medida-histologica-na-9-classificacao-tnm-do-cancer-de-pulmao.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-lung01-trastuzumabe-deruxtecana-no-cpcnp-metastatico-com-superexpressao-de-her2.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-descreve-15-anos-de-qt-neoadjuvante-com-docetaxel-no-adenocarcinoma-esofagico.html]]></loc><lastmod>2024-04-08T21:13:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/elcc-2024/flaura-2-osimertinibe-mostra-tendencia-de-sg-no-cpcnp-pos-progressao.html]]></loc><lastmod>2024-03-22T15:09:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/natalee-ribociclibe-mais-terapia-endocrina-mostra-resultados-no-cancer-de-mama-inicial.html]]></loc><lastmod>2024-03-21T16:02:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-publica-diretriz-sobre-vacinacao-de-adultos-com-cancer.html]]></loc><lastmod>2024-03-20T15:53:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-do-duo-e-reforcam-beneficios-clinicos-de-durvalumabe-e-olaparibe-no-cancer-de-endometrio.html]]></loc><lastmod>2024-03-24T21:50:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hipofracionamento-de-rt-pos-prostatectomia.html]]></loc><lastmod>2024-03-28T14:27:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-mostra-resultados-no-rastreamento-do-cancer-colorretal.html]]></loc><lastmod>2024-03-18T14:59:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-de-lazer-e-cancer-de-mama-na-pre-menopausa.html]]></loc><lastmod>2024-03-13T19:18:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-do-ensaio-flaura-na-pratica-clinica-de-rotina.html]]></loc><lastmod>2024-03-12T17:31:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/venice-1-venetoclax-em-pacientes-com-llc-recidivante-ou-refrataria.html]]></loc><lastmod>2024-03-11T13:42:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sus-incorpora-teste-de-dna-hpv-para-rastreamento-do-cancer-do-colo-do-utero.html]]></loc><lastmod>2024-03-09T00:35:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/histerectomia-simples-nao-e-inferior-a-cirurgia-radical-no-cancer-cervical-de-baixo-risco.html]]></loc><lastmod>2024-03-06T16:56:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/infeccao-por-h-pylori-aumenta-incidencia-e-mortalidade-de-cancer-colorretal.html]]></loc><lastmod>2024-03-08T16:56:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-diretrizes-para-terapias-de-resgate-no-cancer-de-prostata.html]]></loc><lastmod>2024-03-23T01:13:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-microambiente-imune-do-hepatocarcinoma-associado-a-esteatose-hepatica-nao-alcoolica.html]]></loc><lastmod>2024-03-18T18:58:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rusfertide-no-controle-da-eritrocitose-em-pacientes-com-policitemia-vera.html]]></loc><lastmod>2024-02-27T21:31:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-epcoritamabe-no-linfoma-folicular-recidivante-ou-refratario-dificil-de-tratar.html]]></loc><lastmod>2024-02-27T21:18:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tapur-olaparibe-mostra-eficacia-no-cancer-de-pancreas-com-mutacao-brca1-2.html]]></loc><lastmod>2024-03-01T16:26:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-tratamento-inovador-com-lu-177-para-cancer-de-prostata.html]]></loc><lastmod>2024-02-23T16:30:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qt-neo-a-base-de-platina-e-linfadenectomia-no-cancer-de-penis.html]]></loc><lastmod>2024-02-22T17:19:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/himalaya-analise-mostra-beneficio-de-longo-prazo-de-tremelimumabe-mais-durvalumabe-no-carcinoma-hepatocelular.html]]></loc><lastmod>2024-02-29T16:21:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pout-confirma-beneficio-da-qt-adjuvante-no-cancer-urotelial.html]]></loc><lastmod>2024-03-01T18:55:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-osimertinibe-qt-no-cpcnp-avancado-com-mutacao-de-egfr.html]]></loc><lastmod>2024-02-20T17:31:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/folfirinox-neoadjuvante-nao-aumenta-sobrevida-no-cancer-de-pancreas.html]]></loc><lastmod>2024-02-20T17:36:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exposicao-a-doxorrubicina-e-risco-de-cancer-de-mama-subsequente.html]]></loc><lastmod>2024-03-11T22:22:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atomic-meso-pegargiminase-qt-na-primeira-linha-do-mesotelioma-pleural-nao-epitelioide.html]]></loc><lastmod>2024-02-29T16:26:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/os-avancos-no-tratamento-do-cancer-de-mama-em-2023.html]]></loc><lastmod>2024-02-15T16:01:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-pode-superar-mecanismo-de-resistencia-imunologica-no-cancer-de-pulmao.html]]></loc><lastmod>2024-02-14T19:57:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ans-abre-consulta-publica-para-incorporacao-de-osimertinibe-adjuvante-no-cancer-de-pulmao.html]]></loc><lastmod>2024-02-14T16:46:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/coloxis-machine-learning-e-preditivo-do-beneficio-da-oxaliplatina-no-cancer-colorretal-inicial.html]]></loc><lastmod>2024-02-14T16:47:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-do-dreamm-7-suportam-potencial-padrao-de-cuidados-no-mieloma-multiplo.html]]></loc><lastmod>2024-02-06T19:35:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-confirma-beneficio-de-t-dxd-em-metastases-cerebrais-do-cancer-de-mama.html]]></loc><lastmod>2024-02-18T23:52:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-europeu-publica-recomendacoes-para-o-diagnostico-e-tratamento-do-cancer-de-ovario.html]]></loc><lastmod>2024-02-09T20:52:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/olympia-analise-mostra-resultados-relatados-pelos-pacientes.html]]></loc><lastmod>2024-02-05T17:02:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relatorio-da-oms-revela-impacto-socioeconomico-nas-desigualdades-do-cancer.html]]></loc><lastmod>2024-02-01T19:34:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/danos-e-beneficios-do-rastreamento-mamografico-no-brasil.html]]></loc><lastmod>2024-02-01T14:00:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-propoe-recomendacoes-para-avaliacao-e-tratamento-do-cancer-urotelial-avancado.html]]></loc><lastmod>2024-02-01T16:26:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretriz-asco-para-testes-de-linhagem-germinativa-em-pacientes-com-cancer-de-mama.html]]></loc><lastmod>2024-02-01T13:24:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-t-dxd-em-tumores-solidos-metastaticos-her2.html]]></loc><lastmod>2024-01-30T16:22:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sugere-ganho-de-slp-com-sbrt-no-cancer-de-pulmao-oligometastatico.html]]></loc><lastmod>2024-02-21T13:48:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/readministracao-de-egfr-tki-e-segura-e-eficaz-no-cpcnp-apos-dpi.html]]></loc><lastmod>2024-02-17T13:11:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-guiado-por-drm-na-llc.html]]></loc><lastmod>2024-02-08T20:23:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/medida-de-qualidade-de-vida-relacionada-a-saude-centrada-no-paciente-no-ccrm.html]]></loc><lastmod>2024-01-27T16:47:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-erdafitinibe-no-cancer-urotelial.html]]></loc><lastmod>2024-01-22T15:33:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/repotrectinib-e-nova-promessa-no-cpcnp-com-fusao-ros1.html]]></loc><lastmod>2024-01-24T20:18:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-para-cancer-de-mama-metastatico-em-cenarios-com-recursos-limitados.html]]></loc><lastmod>2024-01-22T15:04:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/emerald-1-pode-estabelecer-novo-padrao-no-carcinoma-hepatocelular.html]]></loc><lastmod>2024-01-22T12:32:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/netter-2-177lu-lu-dota-tate-mostra-resultados-no-tratamento-de-primeira-linha-de-gep-nets.html]]></loc><lastmod>2024-01-20T17:56:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/tendencias-de-sobrevida-no-cancer-gastrico-no-brasil.html]]></loc><lastmod>2024-01-18T19:14:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/metanalise-mostra-beneficio-de-zolbetuximabe-no-cancer-gastrico-ou-gej-cldn-18-2.html]]></loc><lastmod>2024-01-18T21:25:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/destiny-gastric-03-trastuzumabe-deruxtecana-no-cancer-gastrico-her2-e-her2-low.html]]></loc><lastmod>2024-01-17T12:17:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/estrategia-watch-and-wait-e-risco-de-metastases-a-distancia-no-cancer-de-reto.html]]></loc><lastmod>2024-01-17T13:22:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-cemiplimabe-qt-no-cpcnp-avancado.html]]></loc><lastmod>2023-12-21T14:59:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-epcoritamabe-para-tratamento-do-ldgcb-recidivante-ou-refratario.html]]></loc><lastmod>2024-01-03T16:47:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/tratamento-guiado-por-doenca-residual-mensuravel-mostra-resultados-na-llc.html]]></loc><lastmod>2023-12-13T23:52:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/sympatico-venetoclax-ibrutinibe-no-linfoma-de-celulas-do-manto-recidivante-refratario.html]]></loc><lastmod>2023-12-12T17:30:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/erg-e-um-novo-gene-de-predisposicao-para-insuficiencia-da-medula-ossea-e-malignidade-hematologica.html]]></loc><lastmod>2023-12-12T17:28:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/resultados-de-longo-prazo-e-fatores-de-risco-em-adultos-com-lla-t-na-america-latina.html]]></loc><lastmod>2023-12-11T18:56:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/loyal-epidemiologia-padroes-de-tratamento-e-resultados-de-pacientes-latino-americanos-com-lma-recem-diagnosticada.html]]></loc><lastmod>2023-12-11T13:55:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/iskia-adicao-de-isatuximab-a-inducao-e-consolidacao-com-krd-mostra-beneficio-no-mm.html]]></loc><lastmod>2023-12-11T11:04:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/epcore-nhl-5-epcoritamab-subcutaneo-mais-lenalidomida-no-linfoma-difuso-de-grandes-celulas-b-recidivante-e-ou-refratario.html]]></loc><lastmod>2024-01-03T14:55:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/esquema-triplo-mostra-beneficio-de-slp-no-cancer-de-mama-her2-hr.html]]></loc><lastmod>2023-12-14T16:41:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/regime-neodjuvante-de-nivolumabe-e-quimioterapia-mostra-resultados-no-tnbc.html]]></loc><lastmod>2023-12-14T16:46:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/estudo-natalee-mostra-analise-final-de-sobrevida-livre-de-doenca-invasiva.html]]></loc><lastmod>2023-12-14T16:50:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/estudo-nao-apoia-alnd-de-rotina-em-linfonodos-positivos-adicionais-pos-qt-neoadjuvante.html]]></loc><lastmod>2023-12-14T16:43:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/tropion-breast01-resultados-apoiam-dato-dxd-no-cancer-de-mama-hr-her2.html]]></loc><lastmod>2023-12-14T16:40:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/positive-preservacao-da-fertilidade-e-tecnicas-de-reproducao-assistida-nao-aumentam-risco-de-recorrencia-no-cancer-de-mama-hr.html]]></loc><lastmod>2024-05-09T08:54:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/preferable-effect-atividade-fisica-melhora-qualidade-de-vida-de-pacientes-com-cancer-de-mama-metastatico.html]]></loc><lastmod>2023-12-14T16:49:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/aprovacao-de-t-dxd-e-novo-status-de-her2-mostram-impacto-positivo-no-tratamento-do-cancer-de-mama-no-brasil.html]]></loc><lastmod>2023-12-14T16:42:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/confident-b-inteligencia-artificial-valoriza-custo-beneficio-na-patologia-mamaria.html]]></loc><lastmod>2023-12-14T16:44:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/amber-padrao-de-sono-e-qualidade-de-vida-em-pacientes-com-cancer-de-mama-recem-diagnosticado.html]]></loc><lastmod>2023-12-14T16:45:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/analise-agrupada-da-serie-monaleesa-confirma-beneficio-de-ribociclibe-em-pacientes-idosos.html]]></loc><lastmod>2023-12-14T16:43:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/epidemiologista-e-premiado-no-sabcs-2023.html]]></loc><lastmod>2023-12-14T16:44:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iarc-destaca-importancia-da-prevencao-do-cancer-oral.html]]></loc><lastmod>2023-11-29T19:06:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-alerta-para-malignidades-secundarias-apos-tratamento-com-car-t-cells.html]]></loc><lastmod>2023-11-29T13:57:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/doenca-residual-minima-orienta-estrategias-de-consolidacao-no-lcm.html]]></loc><lastmod>2023-11-27T19:08:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-de-mundo-real-mostra-eficacia-e-seguranca-de-amivantamabe-no-cpcnp-com-mutacao-egfr.html]]></loc><lastmod>2023-11-27T19:00:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nejm-estudo-demonstra-beneficio-de-osimertinibe-qt-no-cpcnp-avancado.html]]></loc><lastmod>2023-11-23T14:57:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-pulmao-em-nunca-fumantes-da-epidemiologia-ao-panorama-genomico-e-diretrizes-de-rastreio.html]]></loc><lastmod>2023-11-22T18:46:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-discute-consenso-de-oligometastase-no-cancer-de-pancreas.html]]></loc><lastmod>2023-11-30T11:27:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-relatados-pelos-pacientes-marcadores-tumorais-e-sobrevida-no-cancer-gastrointestinal-avancado.html]]></loc><lastmod>2023-11-27T18:41:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vigitel-confirma-importancia-de-combater-o-cigarro-eletronico.html]]></loc><lastmod>2023-11-20T21:56:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consulta-publica-ajude-a-coibir-o-cigarro-eletronico-no-brasil.html]]></loc><lastmod>2023-11-17T20:40:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/censo-sboc-e-o-perfil-do-oncologista-brasileiro.html]]></loc><lastmod>2023-11-16T20:33:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-combinacao-de-tremelimumabe-durvalumabe-e-quimioterapia-como-primeira-linha-no-cpcnpm.html]]></loc><lastmod>2023-11-14T18:36:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-para-o-monitoramento-proativo-diagnostico-precoce-e-manejo-de-dpi-induzida-por-t-dxd-no-cancer-de-mama.html]]></loc><lastmod>2023-11-14T15:23:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/poseidon-pacientes-relatam-qualidade-de-vida-com-vantagens-do-esquema-triplo-vs-qt.html]]></loc><lastmod>2023-11-14T18:38:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/flaura2-osimertinibe-com-ou-sem-quimioterapia-no-cpcnp-avancado-com-mutacao-de-egfr.html]]></loc><lastmod>2023-11-13T21:31:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-trastuzumabe-deruxtecana-no-cancer-gastrico-e-ou-jeg-her2.html]]></loc><lastmod>2023-11-07T13:07:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/edge-gastric-duplo-bloqueio-e-nova-promessa-no-cancer-gastrico-avancado.html]]></loc><lastmod>2023-11-06T22:26:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/multiplos-haplotipos-tp53-p-r337h-e-implicacoes-para-suscetibilidade-tumoral.html]]></loc><lastmod>2023-11-01T18:02:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-de-final-da-vida-na-assistencia-oncologica.html]]></loc><lastmod>2023-10-31T14:26:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iarc-e-opas-lancam-a-1-edicao-do-codigo-contra-o-cancer-da-america-latina-e-do-caribe.html]]></loc><lastmod>2023-10-25T22:47:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/psmafore-lu-psma-617-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2023-10-24T14:49:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/destiny-breast04-t-dxd-confirma-beneficio-no-cancer-de-mama-her2-low.html]]></loc><lastmod>2023-10-24T14:58:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/ev-302-novo-padrao-de-tratamento-no-carcinoma-urotelial-localmente-avancado-ou-metastatico.html]]></loc><lastmod>2023-10-24T15:39:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/interlace-quimio-de-inducao-quimiorradiacao-no-cancer-de-colo-do-utero-localmente-avancado.html]]></loc><lastmod>2023-10-24T19:11:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/destiny-pantumor01-apresenta-resultados-da-analise-primaria.html]]></loc><lastmod>2023-10-23T11:48:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/libretto-431-selpercatinib-mostra-ganho-de-slp-no-cpcnp-ret.html]]></loc><lastmod>2023-10-21T18:59:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/cemiplimabe-neoadjuvante-mostra-resultados-de-sobrevida-no-carcinoma-espinocelular-cutaneo-estagio-ii-iv.html]]></loc><lastmod>2023-10-22T17:48:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/osimertinibe-mostra-eficacia-e-seguranca-em-metastases-do-snc-do-cpcnp-egfr-mutado.html]]></loc><lastmod>2023-10-24T16:27:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/tropion-lung05-dato-dxd-mostra-atividade-promissora-no-cpcnp-avancado.html]]></loc><lastmod>2023-10-21T10:34:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/estudo-do-icesp-alerta-para-malignidades-induzidas-por-rt-na-sindrome-de-li-fraumeni.html]]></loc><lastmod>2023-10-21T14:56:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/matterhorn-analise-interina-de-durvalumabe-mais-flot-no-cancer-gastrico-e-jeg-ressecavel.html]]></loc><lastmod>2023-10-20T19:33:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/lupsma-enza-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2023-10-24T11:28:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/jejum-de-curta-duracao-e-qualidade-de-vida-durante-a-quimioterapia.html]]></loc><lastmod>2023-10-20T17:45:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/sano-qrt-neo-seguida-de-cirurgia-versus-vigilancia-ativa-no-cancer-de-esofago.html]]></loc><lastmod>2023-10-24T17:43:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/embark-enzalutamida-mostra-resultados-no-cancer-de-prostata-com-recorrencia-bioquimica.html]]></loc><lastmod>2023-10-19T11:11:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-destaca-era-da-medicina-personalizada-no-cpcnp.html]]></loc><lastmod>2023-10-18T13:17:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-diretrizes-para-cppc.html]]></loc><lastmod>2023-10-13T19:55:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/a-carga-global-do-cancer-de-pulmao.html]]></loc><lastmod>2023-10-13T14:45:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-atualiza-diretrizes-para-diagnostico-e-tratamento-da-lla-b.html]]></loc><lastmod>2023-10-11T19:23:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-nao-recomenda-ipinivocabo-no-cancer-renal-metastatico.html]]></loc><lastmod>2023-10-11T18:57:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/conjugado-mostra-atividade-e-estabelece-her3-como-novo-alvo-no-cancer-de-mama.html]]></loc><lastmod>2023-10-09T20:05:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacientes-com-cancer-obesos-e-dose-ideal-de-terapias-alvo.html]]></loc><lastmod>2023-10-06T19:27:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/parar-de-fumar-melhora-a-sobrevida-em-dois-anos-apos-o-diagnostico-de-cancer-de-pulmao.html]]></loc><lastmod>2023-10-06T19:49:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/olaparibe-em-manutencao-mostra-ganho-de-slp-no-cancer-de-ovario.html]]></loc><lastmod>2023-10-05T18:14:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/heterogeneidade-e-panorama-atual-do-tratamento-do-cancer-de-ovario.html]]></loc><lastmod>2023-10-04T19:45:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/validacao-internacional-da-biopsia-immunoscore-em-pacientes-com-cancer-retal.html]]></loc><lastmod>2023-10-04T12:46:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hipofracionamento-pode-reduzir-a-carga-do-cancer-de-cabeca-e-pescoco-em-paises-de-baixa-e-media-renda.html]]></loc><lastmod>2023-10-04T19:33:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brazil-tnt-terapia-neoadjuvante-total-no-cancer-retal.html]]></loc><lastmod>2023-10-03T18:32:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pace-b-eficacia-da-sbrt-no-cancer-de-prostata-localizado.html]]></loc><lastmod>2023-10-06T17:22:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/saude-bucal-e-sobrevida-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2023-10-02T19:27:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-descreve-status-mutacional-do-egfr-em-pacientes-brasileiros-com-cpcnp.html]]></loc><lastmod>2023-10-01T22:32:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/escolhas-cirurgicas-e-complicacoes-em-mulheres-idosas.html]]></loc><lastmod>2023-09-29T12:37:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacific-brazil-pesquisa-brasileira-inicia-inscricao-de-pacientes.html]]></loc><lastmod>2023-09-28T19:14:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/especialistas-criticam-rastreio-mamografico-a-partir-dos-40-anos.html]]></loc><lastmod>2023-09-27T12:54:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/omissao-da-cirurgia-axilar-vs-biopsia-do-linfonodo-sentinela.html]]></loc><lastmod>2023-09-27T18:33:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/icesp-investiga-nova-estrategia-no-cancer-vulvar.html]]></loc><lastmod>2023-09-27T12:57:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/expressao-her2-low-em-tumores-solidos-avancados-ou-metastaticos.html]]></loc><lastmod>2023-10-01T22:44:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-reduz-a-inflamacao-em-pacientes-com-sindrome-de-lynch.html]]></loc><lastmod>2023-09-20T17:01:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neo-aegis-terapia-trimodal-vs-qt-perioperatoria-no-cancer-de-esofago-e-jeg.html]]></loc><lastmod>2023-10-01T20:48:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desafios-da-aprovacao-acelerada-de-medicamentos-contra-o-cancer.html]]></loc><lastmod>2023-09-18T12:45:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/krd-mostra-slp-na-leucemia-primaria-de-celulas-plasmaticas.html]]></loc><lastmod>2023-09-19T18:28:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ribociclibe-adjuvante-mantem-qualidade-de-vida-no-cancer-de-mama.html]]></loc><lastmod>2023-10-01T22:43:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relatorio-da-aacr-destaca-avancos-e-desafios-na-pesquisa-e-tratamento-do-cancer.html]]></loc><lastmod>2023-09-14T11:46:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/propel-analise-final-de-sobrevida-global.html]]></loc><lastmod>2023-09-15T16:21:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/destiny-lung02-analise-primaria-de-trastuzumabe-deruxtecana-no-cpcnp-com-mutacao-her2.html]]></loc><lastmod>2023-09-12T22:42:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/osimertinibe-mostra-beneficio-de-slp-no-cancer-de-pulmao-avancado.html]]></loc><lastmod>2023-09-13T21:36:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/investigacao-em-larga-escala-apoia-sistema-de-classificacao-modificado-para-adenocarcinomas-pulmonares.html]]></loc><lastmod>2023-09-12T20:06:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/mars-decorticacao-e-quimioterapia-sao-associadas-a-piores-resultados-no-mesotelioma-inicial.html]]></loc><lastmod>2023-09-12T21:03:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/durvalumabe-mostra-resultados-de-acesso-expandido-em-pacientes-com-cpcnp.html]]></loc><lastmod>2023-09-09T13:04:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/nova-analise-de-dato-dxd-mostra-resultados-encorajadores-no-cancer-de-pulmao.html]]></loc><lastmod>2023-09-14T23:34:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-entre-adultos-mais-jovens-aumenta-79-1-em-quase-30-anos.html]]></loc><lastmod>2023-09-10T13:24:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/medicamentos-essenciais-e-beneficio-clinico-no-tratamento-do-cancer.html]]></loc><lastmod>2023-09-05T18:03:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-biomarcador-para-rastreamento-do-cancer-de-nasofaringe.html]]></loc><lastmod>2023-09-01T16:23:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/duracao-da-abstinencia-do-tabagismo-antes-do-diagnostico-e-sobrevida-no-cpcnp.html]]></loc><lastmod>2023-08-26T21:00:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estimativas-globais-e-regionais-da-prevalencia-do-hpv-genital-em-homens.html]]></loc><lastmod>2023-08-22T19:35:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-atualiza-diretrizes-de-pratica-clinica-para-o-cancer-de-ovario.html]]></loc><lastmod>2023-08-26T17:12:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ribociclibe-melhora-resultados-na-progressao-do-cancer-de-mama-metastatico-hr-her2.html]]></loc><lastmod>2023-08-26T18:16:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microangiopatia-trombotica-e-novos-agentes-anticancer.html]]></loc><lastmod>2023-08-17T20:31:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/omissao-da-radioterapia-apos-cirurgia-conservadora-no-cancer-de-mama-luminal-a.html]]></loc><lastmod>2023-08-27T21:38:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cemiplimabe-confirma-beneficio-de-sobrevida-no-cpcnp.html]]></loc><lastmod>2023-08-21T13:52:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perspectivas-e-desafios-do-cuidado-de-adolescentes-e-jovens-adultos-com-cancer-no-brasil.html]]></loc><lastmod>2023-08-17T18:14:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bacterias-modificadas-detectam-cancer-colorretal-em-modelos-pre-clinicos.html]]></loc><lastmod>2023-08-14T14:27:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cemiplimabe-neoadjuvante-e-sobrevida-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2023-08-10T13:35:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/daisy-expressao-her2-e-sensibilidade-a-t-dxd-no-cancer-de-mama.html]]></loc><lastmod>2023-08-26T15:16:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/timectomia-e-risco-de-cancer.html]]></loc><lastmod>2023-08-15T16:02:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recursos-de-radioterapia-no-brasil-e-projecoes-para-2030.html]]></loc><lastmod>2023-08-03T18:35:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-melhora-disfuncao-sexual-causada-pelo-tratamento-do-cancer-de-prostata.html]]></loc><lastmod>2023-08-01T21:49:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-apoia-seguranca-de-t-dxd-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2023-08-02T20:49:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-promissores-de-ensaio-nao-invasivo-de-metilacao-do-dna-para-deteccao-precoce-de-multiplos-tumores-gastrointestinais.html]]></loc><lastmod>2023-08-03T13:42:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oms-ampla-lista-de-medicamentos-essenciais.html]]></loc><lastmod>2023-07-28T15:41:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/primeira-paciente-tratada-com-car-t-cell-desenvolvida-pelo-albert-einstein-alcanca-remissao-completa.html]]></loc><lastmod>2023-07-28T12:46:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desfechos-que-realmente-importam-no-tratamento-do-cancer.html]]></loc><lastmod>2023-08-01T16:10:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-de-manutencao-com-selinexor-amplia-sobrevida-livre-de-progressao-no-cancer-de-endometrio.html]]></loc><lastmod>2023-08-03T12:38:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mulheres-tratadas-para-cancer-de-mama-tem-envelhecimento-biologico-mais-acelerado.html]]></loc><lastmod>2023-07-20T13:31:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-diretrizes-para-avaliacao-e-manejo-de-idosos-com-cancer-em-tratamento-sistemico.html]]></loc><lastmod>2023-07-18T23:50:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/valor-prognostico-do-status-her2-low-no-cancer-de-mama.html]]></loc><lastmod>2023-07-18T02:24:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oms-e-iarc-classificam-aspartame-como-possivelmente-carcinogenico.html]]></loc><lastmod>2023-07-17T12:05:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibicao-de-braf-mek-mostra-resposta-sem-precedentes-no-craniofaringioma-papilar.html]]></loc><lastmod>2023-07-14T15:03:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nivolumabe-como-tratamento-perioperatorio-aumenta-sobrevida-no-cpcnp.html]]></loc><lastmod>2023-07-16T17:33:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-de-vida-e-recuperacao-funcional-do-idoso-apos-cirurgia-oncologica.html]]></loc><lastmod>2023-07-03T16:26:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atlas-genomico-aumenta-compreensao-sobre-a-biologia-mamaria.html]]></loc><lastmod>2023-07-03T15:56:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esgo-estro-esp-atualizam-diretrizes-para-o-manejo-de-pacientes-com-cancer-do-colo-do-utero.html]]></loc><lastmod>2023-07-10T14:02:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fire-4-5-bevacizumabe-deve-ser-o-agente-de-escolha-no-cancer-colorretal-metastatico-brafv600e.html]]></loc><lastmod>2023-07-26T14:11:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-pele-nao-melanoma-do-diagnostico-ao-tratamento-sistemico.html]]></loc><lastmod>2023-06-21T13:20:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-gastric02-trastuzumabe-deruxtecana-em-segunda-linha-no-cancer-gastrico-avancado-ou-da-jge-her2-positivo.html]]></loc><lastmod>2023-06-20T17:20:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-diretriz-de-conduta-para-o-teste-de-her2-no-cancer-de-mama.html]]></loc><lastmod>2023-06-15T14:42:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/capivasertibe-e-o-primeiro-inibidor-de-akt-revisado-no-projeto-orbis.html]]></loc><lastmod>2023-06-13T16:10:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/destiny-pantumor02-trastuzumabe-deruxtecana-mostra-eficacia-em-diferentes-tumores-que-expressam-her2.html]]></loc><lastmod>2023-06-06T13:58:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/adaura-osimertinibe-adjuvante-aumenta-sobrevida-global-no-cpcnp.html]]></loc><lastmod>2023-07-05T19:23:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/vorasidenib-atrasa-a-progressao-da-doenca-ou-morte-em-glioma-de-grau-2-com-mutacao-idh.html]]></loc><lastmod>2023-06-05T00:47:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/prospect-radiacao-pode-ser-omitida-com-seguranca-em-pacientes-selecionados-com-cancer-de-reto-localmente-avancado.html]]></loc><lastmod>2023-06-04T21:54:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/swog-s1826-nivolumabe-reduz-risco-de-progressao-da-doenca-ou-morte-no-linfoma-de-hodgkin-nao-tratado-em-comparacao-com-brentuximabe.html]]></loc><lastmod>2023-06-05T19:04:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/conquer-cancer-premia-pesquisadores-brasileiros-no-asco-2023.html]]></loc><lastmod>2023-06-04T02:43:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/combinacao-de-durvalumabe-e-olaparibe-aumenta-sobrevida-no-cancer-epitelial-de-ovario-avancado.html]]></loc><lastmod>2023-06-04T22:04:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/natalee-ribociclibe-adjuvante-melhora-resultados-no-cancer-de-mama-inicial.html]]></loc><lastmod>2023-10-01T22:41:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/himalaya-tremelimumabe-e-durvalumabe-no-carcinoma-hepatocelular-irressecavel.html]]></loc><lastmod>2023-06-07T02:27:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/shape-histerectomia-simples-e-opcao-segura-para-pacientes-com-cancer-de-colo-do-utero-estagio-inicial-de-baixo-risco.html]]></loc><lastmod>2023-06-04T23:29:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/norpact-1-folfirinox-neoadjuvante-nao-mostra-beneficio-no-cancer-pancreatico-ressecavel.html]]></loc><lastmod>2023-06-07T03:57:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-durvalumabe-e-tremelimumabe-no-tratamento-do-cancer-de-figado.html]]></loc><lastmod>2023-05-25T12:51:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-breast02-eficacia-e-seguranca-de-trastuzumabe-deruxtecana-no-cancer-de-mama-metastatico-her2.html]]></loc><lastmod>2023-05-23T12:24:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sabr-ou-radioterapia-estereotatica-ablativa-em-oligometastases-pulmonares.html]]></loc><lastmod>2023-05-22T15:04:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/determinantes-sociais-da-saude-obesidade-e-mortalidade-por-cancer.html]]></loc><lastmod>2023-05-10T23:44:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/embark-enzalutamida-mais-leuprolida-reduz-risco-de-metastase-no-cancer-de-prostata-hormonio-sensivel-nao-metastatico.html]]></loc><lastmod>2023-05-08T19:02:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quantum-first-quizartinib-mostra-resultados-em-pacientes-com-leucemia-mieloide-aguda-flt3-itd-positivo-recem-diagnosticados.html]]></loc><lastmod>2023-05-08T15:46:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/evolucao-das-metastases-de-cancer-de-pulmao-de-celulas-nao-pequenas-no-estudo-tracerx.html]]></loc><lastmod>2023-04-27T15:10:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/tapestry-sequenciamento-do-exoma-e-diretrizes-de-triagem.html]]></loc><lastmod>2023-04-19T16:58:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/score-stemness-baseado-em-proteomica-desdiferenciacao-oncogenica-e-identificacao-de-alvos-para-medicamentos.html]]></loc><lastmod>2023-04-18T20:16:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/novo-anticorpo-biespecifico-demonstra-atividade-clinica-em-pacientes-com-mieloma-multiplo.html]]></loc><lastmod>2023-04-17T13:22:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/aegean-durvalumabe-pre-e-pos-cirurgia-melhora-resultados-no-cpcnp-ressecavel.html]]></loc><lastmod>2023-04-16T16:06:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/biopsia-liquida-e-diagnostico-precoce-em-12-tipos-de-cancer.html]]></loc><lastmod>2023-04-16T16:36:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esquema-alternativo-de-exemestano-mostra-nao-inferioridade-no-cancer-de-mama.html]]></loc><lastmod>2023-04-02T12:00:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/h-pylori-genes-de-recombinacao-homologa-e-cancer-gastrico.html]]></loc><lastmod>2023-03-31T15:44:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023/esmo-reforca-alerta-para-controle-da-poluicao-do-ar-na-prevencao-do-cancer-de-pulmao.html]]></loc><lastmod>2023-03-30T21:30:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023/empower-lung-3-resultados-de-longo-prazo-confirmam-beneficio-de-sobrevida-com-cemiplimabe-no-cancer-de-pulmao.html]]></loc><lastmod>2023-04-02T11:51:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023/anticorpo-biespecifico-egfr-met-mostra-atividade-sustentada-no-cpcnp-2.html]]></loc><lastmod>2023-03-30T16:00:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023/osimertinibe-diminui-o-risco-de-progressao-cerebral-do-cpcnp.html]]></loc><lastmod>2023-03-29T16:10:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/enzamet-mostra-analise-planejada-de-sg-com-enzalutamida.html]]></loc><lastmod>2023-04-02T23:50:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ruby-estudo-mostra-resultados-da-imunoterapia-no-cancer-de-endometrio.html]]></loc><lastmod>2023-04-02T20:52:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/protect-vigilancia-ativa-e-tratamento-radical-conferem-resultados-semelhantes-no-cancer-de-prostata-localizado.html]]></loc><lastmod>2023-03-24T20:13:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/glow-zolbetuximab-capox-na-primeira-linha-do-cancer-gastrico-ou-de-juncao-gastroesofagica.html]]></loc><lastmod>2023-03-23T18:00:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-celular-mostra-beneficio-de-sobrevida-no-mieloma-multiplo-avancado.html]]></loc><lastmod>2023-03-29T13:10:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/axitinibe-e-avelumabe-no-carcinoma-adenoide-cistico.html]]></loc><lastmod>2023-03-16T11:30:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custo-global-dos-tumores-mais-prevalentes-entre-2020-a-2050.html]]></loc><lastmod>2023-03-15T12:12:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-de-sequelas-da-covid-19-e-maior-em-pacientes-de-cancer-nao-vacinados.html]]></loc><lastmod>2023-03-09T20:37:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-pantumor02-trastuzumabe-deruxtecana-mostra-resultados-em-multiplos-tumores-com-expressao-de-her2.html]]></loc><lastmod>2023-03-06T17:38:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ans-abre-contribuicoes-para-atualizacao-do-rol.html]]></loc><lastmod>2023-03-06T15:45:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dieta-mediterranea-e-resposta-aos-inibidores-de-checkpoint.html]]></loc><lastmod>2023-03-03T00:39:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imrt-hiperfracionada-no-carcinoma-nasofaringeo-recorrente-localmente-avancado.html]]></loc><lastmod>2023-03-06T13:46:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/propel-resultados-de-sobrevida-global-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2023-02-26T15:18:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/talazoparib-e-enzalutamida-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2023-02-26T17:35:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/rucaparib-no-cancer-de-prostata-metastatico-resistente-a-castracao-com-mutacao-brca-1-2-ou-atm.html]]></loc><lastmod>2023-02-26T15:26:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/inteligencia-artificial-e-biomarcador-prognostico-no-cancer-de-prostata.html]]></loc><lastmod>2023-02-16T16:12:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/dieta-rica-em-vegetais-e-menor-risco-de-progressao-e-recorrencia-do-cancer-de-prostata.html]]></loc><lastmod>2023-02-16T16:14:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/projecao-de-mortes-prematuras-aponta-reducao-de-mortalidade-por-cancer-no-brasil.html]]></loc><lastmod>2023-02-15T19:56:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-sacituzumabe-govitecana-no-cancer-de-mama-metastatico-hr-her2-negativo-pre-tratado.html]]></loc><lastmod>2023-02-06T17:26:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-de-fim-de-vida-em-pacientes-com-carcinoma-de-celulas-renais-metastatico.html]]></loc><lastmod>2023-02-06T02:18:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-alimentos-ultraprocessados-aumenta-o-risco-de-cancer-de-ovario.html]]></loc><lastmod>2023-02-02T13:35:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-pre-operatoria-no-cancer-de-colon-ressecavel.html]]></loc><lastmod>2023-01-31T17:37:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uniao-europeia-aprova-t-dxd-no-cancer-de-mama-metastatico-her2-low.html]]></loc><lastmod>2023-01-26T19:30:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-publica-diretrizes-de-pratica-clinica-no-cpnpc.html]]></loc><lastmod>2023-02-06T02:47:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/sunlight-resultados-apoiam-ftd-tpi-bev-no-cancer-colorretal-avancado.html]]></loc><lastmod>2023-01-22T16:29:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/radioterapia-paliativa-mostra-beneficio-no-carcinoma-hepatocelular.html]]></loc><lastmod>2023-01-23T13:13:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/her2-low-e-perfil-imune-no-cancer-gastroesofagico.html]]></loc><lastmod>2023-01-23T13:09:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resposta-imune-e-assinaturas-genomicas-de-tumores-gi-com-mss.html]]></loc><lastmod>2023-01-26T15:59:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-de-mama-contralateral-e-variantes-patogenicas-germinativas.html]]></loc><lastmod>2023-02-15T15:37:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/spotlight-zolbetuximabe-na-primeira-linha-do-cancer-gastrico-ou-de-juncao-gastroesofagica.html]]></loc><lastmod>2024-06-26T13:17:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alliance-dose-ideal-de-radioterapia-no-cppc.html]]></loc><lastmod>2023-02-05T13:53:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncologicos-dose-ideal-e-desenvolvimento-clinico.html]]></loc><lastmod>2023-02-05T15:44:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-gi-2023-e-os-destaques-do-programa-cientifico.html]]></loc><lastmod>2023-01-10T22:57:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-diretrizes-no-cancer-gastroesofagico.html]]></loc><lastmod>2023-02-05T15:05:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-publica-novas-diretrizes-de-pratica-clinica-no-cpcnp-avancado.html]]></loc><lastmod>2023-02-06T02:44:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/blinatumomabe-mostra-ganho-de-sobrevida-global-na-lla-e-e-novo-padrao-de-tratamento.html]]></loc><lastmod>2022-12-13T17:38:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/matrix-apresenta-resultados-no-linfoma-primario-do-sistema-nervoso-central.html]]></loc><lastmod>2022-12-13T17:01:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/alpine-zanubrutinib-e-superior-a-ibrutinibe-na-leucemia-linfocitica-cronica-recidivada-refrataria.html]]></loc><lastmod>2022-12-14T12:26:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/isatuximabe-mostra-resultados-no-mieloma-multiplo-de-alto-risco.html]]></loc><lastmod>2022-12-13T01:08:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/zuma-5-analise-de-acompanhamento-de-3-anos-de-axi-cel-no-linfoma-nao-hodgkin-indolente.html]]></loc><lastmod>2022-12-14T01:46:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/exposicao-ao-venetoclax-eficacia-e-seguranca-no-mieloma-multiplo-recidivado-refratario.html]]></loc><lastmod>2022-12-12T18:45:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/epcoritamab-mostra-eficacia-e-seguranca-no-linfoma-de-grandes-celulas-b.html]]></loc><lastmod>2022-12-12T15:07:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/zuma-7-nova-analise-com-terapia-celular-axi-cell-informa-decisoes-de-tratamento-no-lbcl.html]]></loc><lastmod>2022-12-12T11:15:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/acosog-z11102-terapia-conservadora-da-mama-e-recorrencia-local-em-pacientes-com-multiplas-lesoes-mamarias.html]]></loc><lastmod>2022-12-11T17:58:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/interrupcao-da-terapia-endocrina-para-gravidez-nao-aumenta-taxa-de-recorrencia-em-curto-prazo.html]]></loc><lastmod>2022-12-11T15:11:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/capitello-291-capivasertib-fulvestranto-melhora-sobrevida-livre-de-progressao-no-cancer-de-mama-avancado-hr.html]]></loc><lastmod>2022-12-09T03:08:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/serena-2-camizestrant-mostra-superioridade-em-comparacao-com-fulvestranto-em-pacientes-com-cancer-de-mama-hr-her2-negativo.html]]></loc><lastmod>2025-05-27T21:15:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/destiny-breast03-dados-atualizados-de-t-dxd-em-comparacao-com-t-dm1-no-cancer-de-mama-metastatico-her2-positivo.html]]></loc><lastmod>2022-12-08T14:04:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/t-dxd-mostra-superioridade-em-comparacao-com-a-quimioterapia-em-pacientes-previamente-tratados-com-t-dm1.html]]></loc><lastmod>2022-12-08T14:05:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/trastuzumabe-deruxtecana-neoadjuvante-mostra-atividade-clinica-em-pacientes-com-cancer-de-mama-her2-low.html]]></loc><lastmod>2022-12-08T16:57:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/right-choice-ribociclibe-e-terapia-endocrina-na-primeira-linha-do-cancer-de-mama-agressivo-hr-her2-negativo.html]]></loc><lastmod>2022-12-06T18:41:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-de-saude-relacionados-a-radioterapia-estereotatica-pulmonar-no-brasil.html]]></loc><lastmod>2022-11-29T19:20:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metanalise-mostra-5-anos-de-sabr-no-carcinoma-de-celulas-renais.html]]></loc><lastmod>2022-12-02T15:18:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estimativas-inca-704-mil-novos-casos-de-cancer-por-ano-no-brasil-ate-2025.html]]></loc><lastmod>2022-11-28T12:45:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-gastric01-mostra-evidencias-preliminares-da-atividade-de-trastuzumabe-deruxtecana-no-cancer-gastrico-her2-low.html]]></loc><lastmod>2022-11-23T15:18:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/amaros-estudo-mostra-analise-de-qualidade-de-vida-e-resultados-de-longo-prazo.html]]></loc><lastmod>2022-11-23T14:51:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perspectiva-da-iarc-sobre-prevencao-do-cancer-bucal.html]]></loc><lastmod>2024-08-01T15:36:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-guideline-de-tratamento-do-cancer-colorretal-metastatico.html]]></loc><lastmod>2022-11-15T20:01:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/keynote-042-follow-up-de-5-anos-continua-a-mostrar-beneficio-de-pembrolizumabe-no-cpcnp-com-expressao-de-pd-l1.html]]></loc><lastmod>2022-11-15T23:41:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-italiano-confirma-beneficio-da-quimioterapia-com-dose-densa-sem-flurouracil-no-cancer-de-mama-inicial.html]]></loc><lastmod>2022-11-16T00:11:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-cemiplimabe-em-combinacao-com-quimioterapia-no-cpcnp.html]]></loc><lastmod>2022-11-09T15:45:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-em-pacientes-com-cancer-de-mama.html]]></loc><lastmod>2022-11-09T15:41:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sindrome-hereditaria-do-cancer-de-mama-e-ovario-guideline-traz-recomendacoes-para-rastreamento-e-aconselhamento-genetico.html]]></loc><lastmod>2022-11-07T12:19:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cemiplimabe-neoadjuvante-mostra-resposta-patologica-completa-no-carcinoma-espinocelular-cutaneo-ressecavel.html]]></loc><lastmod>2022-11-07T12:21:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/beneficio-de-sobrevida-global-com-a-adicao-de-sbrt-a-terapia-sistemica-no-carci-noma-hepatocelular.html]]></loc><lastmod>2022-11-07T11:45:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/accent-idea-nova-analise-avalia-impacto-nos-resultados-do-cancer-de-colon.html]]></loc><lastmod>2022-11-15T19:18:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variante-germline-rara-em-atm-influencia-o-desenvolvimento-de-llc.html]]></loc><lastmod>2022-11-03T12:08:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-trastuzumabe-deruxtecana-no-cancer-de-mama-her2-low.html]]></loc><lastmod>2022-10-31T14:36:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-terapia-celular-axi-cel-no-tratamento-de-linfoma-de-grandes-celulas-b-e-linfoma-folicular-recidivado-ou-refratario.html]]></loc><lastmod>2022-10-26T18:58:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-em-mulheres-soropositivas-com-cancer-de-mama-atendidas-no-inca.html]]></loc><lastmod>2022-10-26T14:17:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-sacituzumabe-govitecana-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2022-10-31T14:33:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diversidade-na-pesquisa-clinica.html]]></loc><lastmod>2022-10-19T14:17:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/de-escalonamento-no-seminoma-estagio-iia-ou-iib.html]]></loc><lastmod>2022-10-31T18:22:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-paliativos-como-prioridade-global-para-o-cuidado-oncologico.html]]></loc><lastmod>2022-10-19T13:07:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-do-programa-de-avaliacao-biopsicossocial-nas-internacoes-hospitalares.html]]></loc><lastmod>2022-10-11T18:15:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/machine-learning-e-prognostico-de-pacientes-com-cpcnp-metastatico.html]]></loc><lastmod>2022-10-03T17:36:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/grupo-frances-compara-sequenciamento-molecular-por-tecido-versus-ctdna.html]]></loc><lastmod>2022-09-27T18:31:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-traz-dados-sobre-cancer-renal-de-celulas-nao-claras.html]]></loc><lastmod>2022-09-26T19:47:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-sistemica-e-selecao-de-dose.html]]></loc><lastmod>2022-09-21T23:50:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/laparoscopia-vs-cirurgia-aberta-no-cancer-do-reto-inferior.html]]></loc><lastmod>2022-09-21T23:24:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/efeito-da-microbiota-no-tratamento-do-cancer.html]]></loc><lastmod>2022-09-21T00:28:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gemcitabina-intravesical-e-docetaxel-no-cancer-de-bexiga.html]]></loc><lastmod>2022-09-21T00:16:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/adaura-resultados-atualizados-de-osimertinibe-adjuvante-no-cpcnp-estagio-ib-iiia-egfrm-ressecado.html]]></loc><lastmod>2022-09-15T21:05:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/alteracoes-na-microbiota-intestinal-conforme-o-tratamento-no-carcinoma-de-celulas-renais-metastatico.html]]></loc><lastmod>2022-09-15T20:54:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/duracao-da-terapia-de-privacao-androgenica-com-radioterapia-pos-operatoria-no-cancer-de-prostata.html]]></loc><lastmod>2022-09-15T13:52:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/niche-2-resultados-da-imunoterapia-neoadjuvante-no-cancer-de-colon-localmente-avancado-com-dmmr.html]]></loc><lastmod>2022-09-13T17:46:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/immotion010-atezolizumabe-adjuvante-no-carcinoma-de-celulas-renais-com-risco-aumentado-de-recorrencia-apos-resseccao.html]]></loc><lastmod>2022-09-13T14:54:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/cemiplimabe-neoadjuvante-no-cancer-de-pele-mostra-resposta-patologica-sem-precedentes-em-tumores-solidos.html]]></loc><lastmod>2022-09-12T19:46:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/poseidon-atualizacao-mostra-beneficio-de-sobrevida-global-apos-4-anos-de-follow-up.html]]></loc><lastmod>2022-09-11T20:37:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/pathfinder-primeiro-estudo-prospectivo-a-demonstrar-a-eficacia-da-biopsia-liquida-para-deteccao-precoce-de-multiplos-tumores.html]]></loc><lastmod>2022-09-11T17:18:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/tratamento-com-linfocitos-infiltrantes-tumorais-tils-melhora-sobrevida-livre-de-progressao-no-melanoma-avancado.html]]></loc><lastmod>2022-09-18T16:11:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/estudo-revela-associacao-entre-poluicao-do-ar-e-cancer-de-pulmao-em-nao-fumantes.html]]></loc><lastmod>2022-09-10T22:20:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/defi-novo-inibidor-oral-da-gama-secretase-nirogacestat-mostra-resultados-em-tumores-desmoides.html]]></loc><lastmod>2022-09-11T19:39:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/solo1-sobrevida-global-em-7-anos-de-olaparibe-de-manutencao-no-cancer-de-ovario-avancado-brca-mutado-recem-diagnosticado.html]]></loc><lastmod>2022-09-11T19:01:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/paola-1-apresenta-resultados-finais-de-sobrevida-global.html]]></loc><lastmod>2022-09-11T18:53:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/rationale-301-analise-final-mostra-tislelizumabe-como-primeira-linha-no-carcinoma-hepatocelular-irressecavel.html]]></loc><lastmod>2022-09-14T15:27:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/tropics-02-resultados-de-sobrevida-global-de-sacituzumabe-govitecana-no-cancer-de-mama-metastatico-hr-her2-negativo.html]]></loc><lastmod>2022-09-10T22:19:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/empower-cervical-1-sobrevida-em-longo-prazo-de-cemiplimabe-no-cancer-de-colo-do-utero-recorrente-ou-metastatico.html]]></loc><lastmod>2022-09-10T22:19:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/idosos-e-desigualdades-no-acesso-ao-tratamento-de-cancer.html]]></loc><lastmod>2022-09-01T20:55:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/frequencia-global-e-perfil-epidemiologico-de-usuarios-de-cigarro-eletronico.html]]></loc><lastmod>2022-09-01T18:12:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carga-global-de-cancer-atribuivel-a-fatores-de-risco-entre-2010-e-2019.html]]></loc><lastmod>2022-08-29T16:27:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-lobular-invasivo-do-diagnostico-ao-tratamento-sistemico.html]]></loc><lastmod>2022-08-24T13:55:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preservacao-de-orgao-no-cancer-retal.html]]></loc><lastmod>2022-08-24T13:49:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/choosing-wisely-para-oncologia-no-brasil-recomendacoes-para-cuidados-baseados-em-evidencias.html]]></loc><lastmod>2022-08-22T15:10:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-consenso-de-especialistas-para-sobreviventes-de-cancer.html]]></loc><lastmod>2022-08-22T19:43:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/panorama-de-variantes-germinativas-patogenicas-em-pacientes-com-cancer-de-pulmao.html]]></loc><lastmod>2022-08-21T20:42:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tuxedo-1-trastuzumabe-deruxtecana-mostra-atividade-em-metastases-cerebrais-do-cancer-de-mama.html]]></loc><lastmod>2022-08-21T23:11:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-aprovacao-acelerada-para-trastuzumabe-deruxtecana-no-cpcnp-metastatico-her2-mutado.html]]></loc><lastmod>2022-08-12T17:52:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/wclc-2022/calgb-140503-resseccao-sublobar-nao-e-inferior-a-lobectomia-no-cancer-de-pulmao-de-celulas-nao-pequenas-periferico.html]]></loc><lastmod>2022-08-15T17:41:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/downstaging-e-transplante-no-carcinoma-hepatocelular-10-anos-da-experiencia-norte-americana.html]]></loc><lastmod>2022-08-16T17:05:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/wclc-2022/poseidon-associacao-entre-mutacoes-kras-stk11-keap1-e-resultados-de-sobrevida.html]]></loc><lastmod>2022-08-10T19:23:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-trastuzumabe-deruxtecana-no-cancer-de-mama-her2-low.html]]></loc><lastmod>2022-08-08T17:31:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/empower-cervical-1-qualidade-de-vida-com-cemiplimabe-no-cancer-do-colo-do-utero-recorrente.html]]></loc><lastmod>2022-08-08T22:06:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-hereditario-de-mama-e-ovario-estudo-analisa-prevalencia-de-variantes-germinativas-em-latino-americanos-e-hispanicos-dos-eua.html]]></loc><lastmod>2022-08-01T02:55:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/licoes-do-plano-de-expansao-da-radioterapia-brasileira.html]]></loc><lastmod>2022-08-01T02:54:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tendencias-temporais-e-projecao-de-epidemia-de-obesidade-em-adultos-brasileiros-entre-2006-e-2030.html]]></loc><lastmod>2022-08-01T02:54:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metastasectomia-no-cancer-renal-metastatico-tem-impacto-na-sobrevida.html]]></loc><lastmod>2022-08-02T20:16:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-prognosticos-no-adenocarcinoma-de-pulmao-estagio-i-com-intencao-curativa.html]]></loc><lastmod>2022-07-21T13:14:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-olaparibe-no-tratamento-adjuvante-do-cancer-de-mama-her2-negativo.html]]></loc><lastmod>2022-07-21T16:37:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mfolfirinox-neoadjuvante-mostra-resultados-no-cancer-de-pancreas-boderline-ressecavel.html]]></loc><lastmod>2022-07-20T17:53:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/significancia-prognostica-e-biologica-de-her2-low-no-cancer-de-mama-estagio-inicial.html]]></loc><lastmod>2022-07-14T13:37:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/padroes-de-atividade-fisica-e-mortalidade.html]]></loc><lastmod>2022-07-13T18:07:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disseminacao-metastatica-do-cancer-de-mama-e-maior-durante-o-sono.html]]></loc><lastmod>2022-07-13T00:13:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-isatuximabe-em-nova-combinacao-no-tratamento-do-mieloma-multiplo-recidivado-e-refratario.html]]></loc><lastmod>2022-07-11T20:24:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/himalaya-durvalumabe-e-tremelimumabe-no-carcinoma-hepatocelular.html]]></loc><lastmod>2022-07-03T23:38:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/rationale-306-tislelizumabe-mais-quimioterapia-na-primeira-linha-do-cancer-de-esofago-avancado-ou-metastatico.html]]></loc><lastmod>2022-07-03T16:56:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/topaz-1-durvalumabe-gemcis-no-cancer-do-trato-biliar-avancado.html]]></loc><lastmod>2022-07-03T17:23:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/pemigatinibe-no-colangiocarcinoma-avancado-com-fusao-de-fgfr2.html]]></loc><lastmod>2022-07-03T19:39:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-ampliacao-de-indicacao-de-trastuzumabe-deruxtecana-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2022-07-13T00:23:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-cemiplimabe-no-cancer-de-colo-de-utero-recorrente.html]]></loc><lastmod>2022-06-27T21:27:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/primeira-aprovacao-agnostica-para-tumores-com-mutacao-braf-v600e.html]]></loc><lastmod>2022-06-27T19:00:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/isatuximabe-atualiza-resultados-com-beneficio-historico-de-sobrevida-no-mieloma-multiplo.html]]></loc><lastmod>2022-06-13T12:19:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/stampede-analise-final-confirma-beneficio-da-rt-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2022-06-15T16:11:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/desintensificacao-terapeutica-no-cancer-de-mama-luminal.html]]></loc><lastmod>2022-06-07T12:03:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/panitumumab-na-primeira-linha-do-cancer-colorretal-metastatico.html]]></loc><lastmod>2022-06-07T18:28:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/bloqueio-de-pd-1-no-cancer-de-reto-localmente-avancado-com-deficiencia-no-mismatch-repair-mostra-resposta-completa.html]]></loc><lastmod>2022-06-08T01:50:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/destiny-breast04-trastuzumabe-deruxtecana-mostra-ganho-de-sobrevida-global-no-cancer-de-mama-her2-low.html]]></loc><lastmod>2022-06-06T02:20:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/enzalutamida-confirma-beneficio-de-sobrevida-no-cancer-de-prostata-metastatico-hormonio-sensivel.html]]></loc><lastmod>2022-06-05T22:32:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/dynamic-trial-quimioterapia-adjuvante-guiada-por-ctdna-no-cancer-de-colon-estadio-ii.html]]></loc><lastmod>2022-06-05T15:50:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/docetaxel-como-radiossensibilizador-no-carcinoma-espinocelular-de-cabeca-e-pescoco-localmente-avancado.html]]></loc><lastmod>2022-06-04T00:44:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/everolimus-na-adjuvancia-do-carcinoma-de-celulas-renais-de-alto-risco.html]]></loc><lastmod>2022-06-03T17:08:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/brentuximabe-vedotina-no-linfoma-de-hodgkin-classico.html]]></loc><lastmod>2022-06-04T03:43:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/adagrasibe-e-promessa-no-cancer-de-pulmao-com-mutacao-krasg12c.html]]></loc><lastmod>2022-06-04T04:17:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-expandindo-o-espectro-de-her2-no-cancer-de-mama.html]]></loc><lastmod>2022-06-02T16:52:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/unicancer-avalia-adicao-de-qt-a-terapia-endocrina-adjuvante-no-cancer-de-mama-de-acordo-com-indice-genomico.html]]></loc><lastmod>2022-06-07T11:42:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/conquer-cancer-premia-oncologistas-brasileiros-na-asco-2022.html]]></loc><lastmod>2022-05-28T16:09:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/desigualdades-no-uso-da-telemedicina-para-o-tratamento-do-cancer.html]]></loc><lastmod>2022-05-30T17:08:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/superando-barreiras-na-pesquisa-clinica-em-cancer.html]]></loc><lastmod>2022-05-26T22:26:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/negras-norte-americanas-com-cancer-de-mama-metastatico-tem-menos-oportunidade-de-participar-de-ensaios-clinicos.html]]></loc><lastmod>2022-05-26T22:22:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-asiatico-mostra-nao-inferioridade-entre-3-e-6-meses-de-adjuvancia-no-cancer-de-colon.html]]></loc><lastmod>2022-05-23T20:16:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/segmentectomia-como-novo-padrao-de-cuidados-no-cancer-de-pulmao-inicial.html]]></loc><lastmod>2022-05-17T18:32:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/astro-atualiza-diretrizes-clinicas-de-radioterapia-em-metastases-cerebrais.html]]></loc><lastmod>2022-05-23T11:08:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-desenvolve-criterios-para-orientar-a-pesquisa-sobre-a-desintensificacao-do-tratamento-oncologico.html]]></loc><lastmod>2022-05-11T21:57:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-trastuzumabe-deruxtecana-no-cancer-de-mama-metastatico-her2-positivo-em-pacientes-previamente-tratados-com-agente-anti-her2.html]]></loc><lastmod>2022-05-05T23:25:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-breast-2022/monaleesa-3-apresenta-resultados-atualizados-de-sobrevida-global-na-primeira-linha.html]]></loc><lastmod>2022-05-05T14:23:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/highlights-da-asco-2022.html]]></loc><lastmod>2022-05-04T20:57:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-breast-2022/tuxedo-1-trastuzumabe-deruxtecana-em-pacientes-com-cancer-de-mama-her2-com-metastases-cerebrais-ativas.html]]></loc><lastmod>2022-05-04T16:21:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prioridades-para-a-pesquisa-em-cancer-em-paises-de-baixa-e-media-renda.html]]></loc><lastmod>2022-05-02T15:05:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/oncologista-brasileira-recebe-o-asco-merit-award-2022.html]]></loc><lastmod>2022-05-01T19:08:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/opra-preservacao-de-orgao-em-pacientes-com-cancer-de-reto-tratados-com-terapia-neoadjuvante-total.html]]></loc><lastmod>2022-05-01T18:37:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ivosidenib-mostra-resultados-na-leucemia-mieloide-aguda.html]]></loc><lastmod>2022-05-01T21:46:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-atualiza-diretrizes-sobre-testes-genomicos-no-cancer-de-mama.html]]></loc><lastmod>2022-05-01T21:23:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisador-brasileiro-e-premiado-pela-aacr.html]]></loc><lastmod>2022-04-17T01:25:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/car-t-cell-e-nova-promessa-em-tumores-solidos.html]]></loc><lastmod>2022-04-18T01:21:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variante-do-gene-ctla-4-associada-a-doenca-autoimune-e-resposta-a-imunoterapia-no-cpcnp.html]]></loc><lastmod>2022-04-17T13:13:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/linfocitos-infiltrantes-de-tumor-estromal-e-valor-prognostico-no-cancer-de-mama-precoce.html]]></loc><lastmod>2022-04-18T01:20:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-e-selecao-de-tratamento-no-cancer-renal.html]]></loc><lastmod>2022-04-17T14:06:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/angelita-habr-gama-e-reconhecida-como-uma-das-cientistas-mais-influentes-do-mundo.html]]></loc><lastmod>2022-04-18T01:30:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-atualiza-diretrizes-para-diagnostico-e-tratamento-de-seminomas.html]]></loc><lastmod>2022-04-04T13:08:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-impacto-psicologico-do-cancer.html]]></loc><lastmod>2022-03-30T18:05:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-breast03-novo-paradigma-no-tratamento-do-cancer-de-mama-metastatico-her2-positivo.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alchemist-study-tratamento-subotimo-em-protocolo-de-pesquisa.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cenario-da-radioterapia-no-brasil-mostra-vazios-de-assistencia.html]]></loc><lastmod>2022-03-16T13:18:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/competicao-nao-afetou-preco-dos-medicamentos-contra-o-cancer-nos-eua-sp-675.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ribociclibe-mostra-analise-final-de-sobrevida-global-no-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-diretrizes-para-o-tratamento-de-pacientes-com-cancer-do-colo-do-utero-recorrente-ou-metastatico-sp-806.html]]></loc><lastmod>2022-03-20T15:40:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hola-covid-19-o-impacto-da-covid-19-na-prestacao-de-cuidados-em-cancer-na-america-latina-sp-671.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lei-obriga-acesso-a-quimioterapia-oral-na-cobertura-dos-planos-de-saude-sp-264.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-diretrizes-para-bisfosfonatos-no-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/axi-cel-no-linfoma-de-grandes-celulas-b-recidivado-ou-refratario.html]]></loc><lastmod>2022-02-24T12:21:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/magnitude-niraparibe-e-abiraterona-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2022-02-19T20:59:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/propel-olaparibe-e-abiraterona-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/preside-mostra-beneficios-do-uso-continuo-de-enzalutamida-no-cancer-de-prostata.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/neoadjuvancia-no-cancer-renal.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/empower-cervical-1-sobrevida-com-cemiplimabe-no-cancer-cervical-recorrente.html]]></loc><lastmod>2022-02-14T15:52:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/congresso-aprova-mp-dos-planos-de-saude-e-agiliza-a-incorporacao-de-medicamentos-oncologicos-de-uso-oral.html]]></loc><lastmod>2022-02-14T15:52:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/seguranca-da-vacina-de-mrna-contra-a-covid-19-em-pacientes-com-cancer.html]]></loc><lastmod>2022-02-09T11:50:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caracteristicas-dos-ensaios-clinicos-que-avaliam-biossimilares-no-tratamento-do-cancer-sp-869.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidores-de-aromatase-e-recorrencia-do-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teravolt-estudo-identifica-sete-fatores-que-aumentam-o-risco-de-mortalidade-em-pacientes-com-cancer-de-pulmao-e-covid-19.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uniao-europeia-estima-359-mil-mortes-por-cancer-em-2022.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lenvatinibe-mais-pembrolizumabe-no-cancer-de-endometrio-avancado-sp-932.html]]></loc><lastmod>2022-01-26T16:54:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/himalaya-combinacao-de-imunoterapias-melhora-sobrevida-no-cancer-de-figado-avancado.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/topaz-1-imunoterapia-mostra-resultados-no-tratamento-de-primeira-linha-do-cancer-do-trato-biliar-avancado.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-combinacao-mostra-resultados-no-melanoma-avancado-sp-660.html]]></loc><lastmod>2022-01-27T14:19:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/asco-gi-e-os-avancos-da-oncologia-gastrointestinal.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-europeu-discute-hipofracionamento-no-cancer-de-mama-inicial.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-em-lla-quase-dobra-em-20-anos.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidado-domiciliar-versus-terapia-ambulatorial-no-tratamento-do-cancer-sp-123.html]]></loc><lastmod>2022-01-13T18:00:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-padrao-no-carcinossarcoma-ginecologico.html]]></loc><lastmod>2022-01-14T19:04:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dieta-estilo-de-vida-e-modelos-preditivos-de-recorrencia-e-morte-em-pacientes-com-cancer-de-colon-sp-282.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carga-global-do-cancer-entre-2010-e-2019-sp-627.html]]></loc><lastmod>2022-02-08T19:11:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cmed-define-preco-para-trastuzumabe-deruxtecana-no-tratamento-do-cancer-de-mama-sp-662.html]]></loc><lastmod>2022-01-10T21:46:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/polarix-resultados-no-linfoma-difuso-de-grandes-celulas-b.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/zuma-7-mostra-beneficio-de-axi-cel-no-tratamento-de-linfoma-de-grandes-celulas-b-recorrente-ou-refratario.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/gmmg-hd7-isatuximabe-de-inducao-no-mieloma-multiplo-recem-diagnosticado-elegivel-para-transplante.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/monaleesa-analise-agrupada-de-sobrevida-global-por-subtipo-intrinseco.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/destiny-breast03-analise-de-subgrupo-mostra-superioridade-de-trastuzumabe-deruxtecana-versus-t-dm1.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/safir02-breast-utilidade-clinica-do-perfil-molecular-em-pacientes-com-cancer-de-mama-metastatico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/pirotinibe-e-quimioterapia-em-pacientes-com-cancer-de-mama-her2-positivo-previamente-tratados.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/nova-diretoria-da-sboc-pretende-ampliar-acesso-e-fomentar-pesquisa-clinica-em-oncologia.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimorradioterapia-quimioterapia-de-inducao-ou-consolidacao-como-terapia-neoadjuvante-total-no-cancer-retal-localmente-avancado.html]]></loc><lastmod>2021-11-28T23:22:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-avalia-resultados-de-pacientes-com-cancer-de-pulmao-de-celulas-nao-pequenas-estagio-iiia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-e-resistencia-androgenica-no-cancer-de-prostata.html]]></loc><lastmod>2021-11-27T18:43:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/conjugados-anticorpo-droga-em-diversas-histologias-tumorais.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-de-mutacao-germline-de-suscetibilidade-ao-cancer-hepatobiliar-em-pacientes-nao-selecionados-sp-375.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dreamseq-estudo-avalia-sequencia-de-tratamento-ideal-no-melanoma-avancado-braf-mutado-sp-398.html]]></loc><lastmod>2021-11-22T12:57:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/monitoramento-digital-de-sintomas-utilizando-dados-relatados-pelo-paciente-sp-584.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/testes-de-psa-tem-tendencia-de-alta-nos-eua-sp-869.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/centralizacao-e-abordagem-multidisciplinar-tem-impacto-no-tratamento-do-cancer-de-bexiga-musculo-invasivo.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/checkmate-214-sobrevida-livre-de-tratamento-apos-imunoterapia-no-carcinoma-de-celulas-renais-avancado.html]]></loc><lastmod>2021-11-16T11:20:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-com-inibidores-de-checkpoint-imune-em-pacientes-com-cancer-avancado-inelegiveis-para-ensaios-clinicos-sp-888.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sus-incorpora-inibidores-de-ciclinas-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2021-11-27T20:08:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-do-espectro-da-sindrome-de-li-fraumeni.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/controle-do-cancer-na-america-latina-e-caribe.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fusobacterium-nucleatum-como-preditor-do-risco-de-metastases-no-cancer-de-esofago-sp-930.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/a-nova-geracao-de-oncologicos-quando-menos-e-mais.html]]></loc><lastmod>2021-11-08T16:34:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/solo1-mostra-resultados-de-longo-prazo-de-olaparibe-no-cancer-de-ovario-avancado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adt-radioterapia-escalonada-nao-aumenta-sobrevida-global-no-cancer-de-prostata-de-risco-intermediario.html]]></loc><lastmod>2021-11-08T19:55:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-transoral-e-imrt-adjuvante-de-baixa-intensidade-mostram-resultados-no-cancer-de-orofaringe.html]]></loc><lastmod>2021-11-07T20:38:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/astro-2021-estudo-mostra-resultados-da-radioterapia-hipofracionada-pos-prostatectomia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dieta-e-microambiente-tumoral-sp-432.html]]></loc><lastmod>2021-10-24T22:15:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sars-cov-2-mieloma-multiplo-e-resposta-vacinal-sp-596.html]]></loc><lastmod>2021-10-25T02:14:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-atualiza-guideline-para-cancer-de-mama-metastatico.html]]></loc><lastmod>2021-10-20T17:59:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bacterias-comensais-pro-inflamatorias-associadas-ao-cancer-colorretal-sp-154.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-analise-combinada-reforca-beneficio-de-inibidores-de-ciclinas-no-cancer-de-mama.html]]></loc><lastmod>2021-10-19T14:41:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nivolumabe-mostra-eficacia-no-mesotelioma-recidivado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-perinatais-da-primeira-gravidez-apos-quimioterapia-para-neoplasia-trofoblastica-gestacional-sp-670.html]]></loc><lastmod>2021-10-18T18:20:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-populacional-discute-diagnostico-de-cancer-de-mama-e-mortalidade.html]]></loc><lastmod>2021-10-14T13:06:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aacr-destaca-avancos-na-pesquisa-e-tratamento-do-cancer-sp-867.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/medicamentos-representam-a-maior-pressao-de-custos-no-tratamento-do-cancer.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-abemaciclibe-adjuvante-no-cancer-de-mama-precoce-hr-her2-negativo-de-alto-risco.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/a-qualidade-do-cuidado-podemos-avancar-sp-258.html]]></loc><lastmod>2021-10-13T12:11:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/toxicidade-financeira-na-gestao-dos-sintomas-do-cancer.html]]></loc><lastmod>2021-10-05T11:52:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-trastumabe-deruxtecana-no-tratamento-do-cancer-de-mama-avancado.html]]></loc><lastmod>2021-10-19T11:25:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oms-prioriza-acesso-a-tratamentos-de-cancer-e-diabetes-em-nova-lista-de-medicamentos-essenciais.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radiofarmaco-mostra-eficacia-e-seguranca-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sabr-mostra-resultados-de-longo-prazo-no-cancer-de-pulmao-inicial-sp-848.html]]></loc><lastmod>2021-09-27T17:10:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acesso-e-prioridades-na-oncologia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/destiny-gastric02-trastuzumabe-deruxtecan-demonstra-resultados-no-cancer-gastrico-avancado-her2-positivo.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/novo-regime-e-alternativa-no-tratamento-neoadjuvate-do-cancer-retal.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/cemiplimabe-mostra-resultados-de-sobrevida-na-primeira-linha-do-cancer-de-pulmao-sp-107.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/ribociclibe-mostra-beneficio-de-sobrevida-global-no-cancer-de-mama-avancado-sp-882.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/arches-analise-final-de-sg-confirma-beneficio-de-enza-no-cancer-de-prostata-metastatico-hormonio-sensivel.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/destiny-lung01-trastuzumabe-deruxtecana-no-cancer-de-pulmao-de-celulas-nao-pequenas-her2-mutado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/tratamento-adjuvante-estendido-com-letrozol-em-pacientes-com-cancer-de-mama-na-pos-menopausa.html]]></loc><lastmod>2021-09-19T20:44:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/trastuzumabe-deruxtecan-marca-novo-paradigma-no-tratamento-do-cancer-de-mama-metastatico-her2.html]]></loc><lastmod>2021-09-19T23:07:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/grupo-alemao-aio-apresenta-resultados-encorajadores-no-cancer-do-trato-biliar-avancado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/epik-p1-alpelisibe-demonstra-beneficio-clinico-em-pacientes-com-espectro-de-crescimento-excessivo-relacionado-a-pik3ca-pros.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/solar-1-tratamento-pos-progressao-no-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/esmo-inicia-mais-um-encontro-e-fortalece-a-pesquisa-em-cancer.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/carga-glicolitica-tumoral-no-cpcnp-pode-prever-beneficio-da-imunoterapia-sp-141.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/wclc-2021/poseidon-durvalumabe-e-tremelimumabe-melhoraram-sobrevida-no-cancer-de-pulmao-metastatico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/ribociclibe-apresenta-resultados-de-sobrevida-e-qualidade-de-vida-no-cancer-de-mama-avancado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/estudo-de-mundo-real-compara-regimes-de-tratamento-no-carcinoma-anal-de-celulas-escamosas-localizado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mastectomia-redutora-de-risco-tendencias-temporais-e-fatores-de-adesao.html]]></loc><lastmod>2021-09-28T21:47:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/wclc-2021/vulnerabilidade-social-e-fator-de-risco-em-pacientes-submetidos-a-tratamento-cirurgico-de-cancer-de-pulmao.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/wclc-2021/estadiamento-nodal-de-resseccoes-pulmonares-abertas-videotoracoscopicas-e-roboticas-de-cpcnp.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/prevalencia-e-impacto-das-sequelas-de-covid-19-em-pacientes-com-cancer.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/estimativas-de-longo-prazo-de-incidencia-e-mortalidade-por-cancer-na-europa.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/oncologista-brasileiro-e-premiado-com-o-esmo-research-fellowship.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-eano-esmo-enfoca-metastases-cerebrais-de-tumores-solidos.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-mostra-resultados-dos-principais-registros-de-cancer-e-covid-19-sp-520.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacinacao-contra-hpv-reduz-risco-de-cancer-de-orofaringe-sp-339.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-materna-e-risco-futuro-de-cancer-colorretal-em-nascidos-vivos-sp-343.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nccn-recomenda-terceira-dose-de-vacina-de-mrna-contra-a-covid-19-para-pacientes-com-cancer-sp-403.html]]></loc><lastmod>2021-08-31T21:03:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-no-cancer-renal-sp-895.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relevancia-clinica-do-subtipo-morfologico-do-carcinoma-neuroendocrino-extrapulmonar.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avancos-na-radioterapia-em-metastases-osseas-no-contexto-de-novas-terapias-alvo-e-alternativas-ablativas.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/manejo-da-leucemia-linfocitica-cronica-em-paises-com-recursos-limitados.html]]></loc><lastmod>2021-08-29T14:31:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-e-funcao-cognitiva-no-tratamento-do-cancer-sp-954.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-discute-riscos-e-beneficios-da-tomografia-computadorizada-de-torax-na-triagem-do-cancer-de-pulmao-sp-124.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-publica-novas-diretrizes-para-a-pesquisa-em-cancer-de-prostata-sp-355.html]]></loc><lastmod>2021-08-15T23:14:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-personalizada-orientada-por-genomica-sp-938.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-e-terapia-sistemica-no-cancer-ginecologico.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/duracao-da-terapia-com-inibidor-de-aromatase-adjuvante-no-cancer-de-mama-na-pos-menopausa.html]]></loc><lastmod>2021-08-01T16:17:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consorcio-internacional-identifica-22-novos-loci-de-suscetibilidade-associados-ao-cancer-testicular-hereditario-sp-321.html]]></loc><lastmod>2021-08-02T18:31:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/governo-veta-pl-da-quimioterapia-oral.html]]></loc><lastmod>2021-07-27T14:53:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gravidez-apos-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/her2-low-analise-agrupada-amplia-compreensao-dos-subtipos-em-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-e-consumo-de-alcool.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acido-folinico-de-resgate-na-neoplasia-trofoblastica-gestacional-de-baixo-risco-sp-561.html]]></loc><lastmod>2021-07-18T18:38:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/panorama-genetico-do-cancer-de-mama-masculino.html]]></loc><lastmod>2021-07-18T18:01:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/associacao-de-fadiga-e-resultados-no-cancer-avancado-sp-761.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mri-no-rastreamento-do-cancer-de-prostata.html]]></loc><lastmod>2021-07-19T00:13:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-e-fatores-prognosticos-de-pacientes-hospitalizados-com-covid-19-e-cancer.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oms-atualiza-recomendacoes-para-triagem-e-tratamento-do-cancer-cervical-sp-594.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-do-cancer-de-prostata-avancado-e-funcao-cognitiva-sp-145.html]]></loc><lastmod>2021-07-07T01:19:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/destiny-gastric01-biomarcadores-de-trastuzumabe-deruxtecana-no-cancer-gastrico-avancado-her2.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/apact-mostra-resultados-de-sg-em-5-anos.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/biopsia-liquida-e-sequenciamento-do-exoma-total-mostram-valor-preditivo-e-prognostico-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variacao-no-risco-de-cancer-colorretal-em-familias-com-sindrome-de-lynch-2-sp-115.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/estudo-mostra-pratica-de-oncologistas-brasileiros-na-prescricao-de-bolus-de-5-fu.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/pnets-resultados-pos-cirurgicos-e-fatores-prognosticos-de-pacientes-brasileiros.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neoplasia-trofoblastica-gestacional-e-o-tratamento-em-pacientes-de-alto-risco-sp-192.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resistencia-a-inibidores-de-krasg12c.html]]></loc><lastmod>2021-07-01T17:10:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-tepotinibe-no-cpcnp-com-mutacao-metex14.html]]></loc><lastmod>2021-06-28T17:06:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ctcs-de-pacientes-com-cancer-de-reto-localmente-avancado-e-resistencia-a-quimiorradioterapia-neoadjuvante.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/implicacoes-terapeuticas-do-teste-da-linhagem-germinativa-em-pacientes-com-cancer-avancado-sp-484.html]]></loc><lastmod>2021-06-23T16:45:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/ecog-acrin-platina-vs-capecitabina-no-cancer-de-mama-triplo-negativo-subtipo-basal.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/checkmate-649-nivolumabe-mais-quimioterapia-em-tumores-gastrointestinais-do-trato-alto.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/breast-cancer-index-e-beneficio-da-terapia-estendida-com-inibidor-de-aromatase.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/sotorasibe-no-cancer-de-pulmao-com-mutacao-kras-p-g12c.html]]></loc><lastmod>2021-06-04T23:46:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/classificador-de-risco-genomico-no-cancer-de-prostata.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/olympia-inibidor-de-parp-adjuvante-pos-qt-neo-adjuvante-no-cancer-de-mama-brca-mutado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/jupiter-02-imunoterapia-no-tratamento-de-primeira-linha-do-carcinoma-de-nasofaringe-avancado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/quimioterapia-adjuvante-nao-oferece-beneficio-de-sobrevida-para-pacientes-com-cancer-cervical-localmente-avancado.html]]></loc><lastmod>2021-06-05T00:26:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/pembrolizumabe-e-nova-opcao-para-tratamento-adjuvante-do-cancer-renal-sp-911.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/vision-lupsma-mostra-resultados-no-mcrpc-previamente-tratado.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bevacizumabe-biossimilar-mostra-eficacia-e-seguranca-no-cancer-de-pulmao-sp-377.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uspstf-atualiza-recomendacoes-para-rastreamento-do-cancer-colorretal.html]]></loc><lastmod>2021-05-24T20:01:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/painel-revisa-criterios-de-endpoints-na-pesquisa-clinica-em-cancer-de-mama.html]]></loc><lastmod>2021-05-24T01:29:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tax3503-privacao-androgenica-docetaxel-em-pacientes-com-recorrencia-bioquimica-de-alto-risco-apos-prostatectomia-sp-312.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acesso-a-radioterapia-de-alta-tecnologia-no-tratamento-do-cancer-de-pulmao-no-brasil.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-nao-mostra-beneficio-da-cardioprotecao-no-tratamento-adjuvante-do-cancer-de-mama.html]]></loc><lastmod>2021-05-17T21:14:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/enfortumabe-vedotina-no-cancer-urotelial.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-virtual-plenary-destaca-imunoterapia-no-cancer-cervical-sp-283.html]]></loc><lastmod>2021-05-24T01:59:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-breast-cancer-2021/nova-promessa-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/regime-ideal-na-primeira-linha-de-tratamento-de-idosas-vulneraveis-com-cancer-de-ovario.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mesotelioma-em-paises-em-desenvolvimento-e-o-longo-caminho-do-paciente.html]]></loc><lastmod>2021-05-10T03:01:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pop-brasil-eficacia-do-programa-de-vacinacao-universal-contra-hpv-em-jovens-brasileiras-sp-619.html]]></loc><lastmod>2021-05-09T22:14:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-covid-19-na-pesquisa-clinica-em-oncologia-na-america-latina-sp-128.html]]></loc><lastmod>2021-05-09T22:09:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-l-brain-imunoterapia-como-tratamento-isolado-para-pacientes-com-metastases-cerebrais-de-cpcnp.html]]></loc><lastmod>2021-05-09T21:03:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimiorradioterapia-neoadjuvante-mais-cirurgia-para-cancer-de-esofago---resultados-de-longo-prazo-do-estudo-cross.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-breast-cancer-2021/assinatura-molecular-prediz-beneficio-da-terapia-endocrina-no-cancer-de-mama-pre-menopausa.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-breast-cancer-2021/monaleesa-7-sobrevida-global-por-subgrupo-etario.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-breast-cancer-2021/acompanhamento-personalizado-em-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacinacao-contra-hpv-em-jovens-adultos-nos-eua.html]]></loc><lastmod>2021-05-03T15:07:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destaques-do-programa-cientifico-do-asco-2021.html]]></loc><lastmod>2021-04-29T21:57:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/linfadenectomia-no-cancer-de-prostata-localizado-qual-a-evidencia-sp-449.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/manejo-dos-efeitos-colaterais-da-terapia-endocrina-adjuvante-no-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/smarca4-e-alteracoes-genomicas-swi-snf-no-cpcnp.html]]></loc><lastmod>2021-04-25T22:52:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/1-em-cada-6-pacientes-tem-predisposicao-hereditaria-ao-cancer-colorretal-sp-973.html]]></loc><lastmod>2021-04-25T22:29:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-revisa-escala-de-beneficio-clinico-e-aponta-vies-na-pesquisa-em-cancer-sp-385.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ascent-sacituzumabe-govitecan-no-cancer-de-mama-triplo-negativo-metastatico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-mostra-resultados-de-5-anos-em-pacientes-com-alta-expressao-de-pd-l1.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-de-aspirina-e-risco-de-cancer-colorretal-em-idosos-sp-356.html]]></loc><lastmod>2021-04-25T23:14:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tislelizumab-quimioterapia-na-primeira-linha-do-cancer-de-pulmao-de-celulas-nao-pequenas-nao-escamoso.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estimativas-reconfiguram-o-mapa-do-cancer-nos-eua-sp-502.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/olaparibe-mostra-analise-de-qualidade-de-vida-no-cancer-de-ovario.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/unicancer-prodige-23-nova-abordagem-no-cancer-retal-localmente-avancado.html]]></loc><lastmod>2021-04-25T22:16:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pembrolizumabe-adjuvante-mostra-qualidade-de-vida-no-melanoma-de-alto-risco.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/aacr-2021/classificacao-de-risco-no-cancer-de-mama-resultados-da-us-lacrn.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brasil-tem-15-vezes-mais-casos-de-cancer-adrenocortical-pediatrico-que-a-media-mundial.html]]></loc><lastmod>2021-04-12T02:41:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/aacr-2021/chronos-3-combinacao-de-copanlisibe-e-rituximabe-demonstra-resultados-no-linfoma-nao-hodgkin-sp-703.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/aacr-2021/biopsia-liquida-para-decisao-terapeutica-em-tumores-solidos-avancados-sp-497.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/aacr-2021/aneuploidia-do-cancer-pode-predizer-resposta-a-imunoterapia-no-cancer-de-pulmao.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-e-custos-do-cancer-no-sus-sp-344.html]]></loc><lastmod>2021-04-07T15:21:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-mutacional-no-cancer-de-pulmao-sp-695.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-cervical-e-risco-genetico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-e-sobrevida-em-pacientes-com-cancer-sp-110.html]]></loc><lastmod>2021-04-05T04:25:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-adjuvante-no-cancer-de-esofago-ou-juncao-gastroesofagica-ressecado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-isatuximabe-no-mieloma-multiplo.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comissao-europeia-aprova-combinacao-de-cabozantinibe-e-nivolumabe-no-cancer-renal-avancado.html]]></loc><lastmod>2021-04-01T18:31:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/kit-de-coleta-de-linfonodos-e-resultados-de-sobrevida-no-cancer-de-pulmao.html]]></loc><lastmod>2021-03-29T03:43:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-de-manutencao-no-cancer-de-ovario-revidivado-brcam---analise-final-do-solo2.html]]></loc><lastmod>2021-03-28T20:40:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eficacia-dos-inibidores-de-checkpoint-em-idosos-com-cancer-renal-metastatico.html]]></loc><lastmod>2021-03-28T15:37:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/sgo-2021/lesser-histerectomia-radical-simples-versus-modificada-em-cancer-cervical.html]]></loc><lastmod>2021-03-24T02:08:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-japones-compara-duas-geracoes-de-tratamento-no-cancer-de-pulmao.html]]></loc><lastmod>2021-03-23T16:04:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ccc19-fatores-clinicos-tratamento-oncologico-e-gravidade-da-covid-19-em-pacientes-com-cancer.html]]></loc><lastmod>2021-03-29T03:33:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreio-de-metastases-pulmonares-na-neoplasia-trofoblastica-gestacional.html]]></loc><lastmod>2021-03-17T15:39:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tendencias-na-incidencia-do-cancer-de-tireoide-em-25-paises.html]]></loc><lastmod>2021-03-22T19:30:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ferramenta-calcula-impacto-da-covid-19-na-mortalidade-por-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2021-03-14T19:54:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-neoadjuvante-em-gestantes-com-cancer-cervical.html]]></loc><lastmod>2021-03-14T17:48:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estrategias-para-mitigar-o-impacto-da-covid-19-no-tratamento-do-cancer.html]]></loc><lastmod>2021-03-15T06:18:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uspstf-atualiza-recomendacoes-para-rastreamento-de-cancer-de-pulmao.html]]></loc><lastmod>2021-03-15T02:39:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inca-reporta-resultados-da-primeira-coorte-de-cancer-e-covid-19.html]]></loc><lastmod>2021-03-08T13:30:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/transposicao-uterina-para-canceres-ginecologicos.html]]></loc><lastmod>2021-03-09T16:15:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carga-metastatica-e-beneficio-da-radioterapia-no-cancer-de-prostata.html]]></loc><lastmod>2021-03-15T03:43:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biossimilares-no-cancer-de-mama-her2-implicacoes-e-promessas.html]]></loc><lastmod>2021-03-03T15:17:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-finais-de-imatinibe-adjuvante-no-gist-localizado.html]]></loc><lastmod>2021-03-01T00:45:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avancos-na-pesquisa-em-cancer-promessa-ou-realidade.html]]></loc><lastmod>2021-02-25T21:56:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-androgenica-bipolar-no-cancer-de-prostata.html]]></loc><lastmod>2021-02-28T18:18:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analises-genomicas-de-sars-cov-2-em-pacientes-com-cancer.html]]></loc><lastmod>2021-02-24T14:07:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cemiplimabe-na-primeira-linha-do-cpcnp-avancado-com-alta-expressao-de-pd-l1.html]]></loc><lastmod>2021-02-22T21:26:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-tratamento-do-cpcnp-estadio-iv-com-alteracoes-driver.html]]></loc><lastmod>2021-02-23T13:41:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diferencas-na-mortalidade-de-pacientes-oncologicos-com-covid-19.html]]></loc><lastmod>2021-02-22T18:48:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/swog-1500-cabozantinibe-mostra-resultados-no-carcinoma-papilar-de-celulas-renais-metastatico.html]]></loc><lastmod>2021-02-15T01:39:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/lupsma-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2021-02-15T01:40:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/titan-analise-final-confirma-ganho-de-sobrevida-global.html]]></loc><lastmod>2021-02-11T16:02:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/acis-apalutamida-reduz-risco-de-progressao-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2021-02-11T15:08:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/enfortumabe-vedotina-e-novo-padrao-no-cancer-urotelial-metastatico.html]]></loc><lastmod>2021-02-15T01:38:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/asco-gu-2021-destaques-do-programa-cientifico.html]]></loc><lastmod>2021-02-11T11:41:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-de-covid-19-em-pacientes-com-cancer-assintomaticos-em-tratamento-sistemico-ativo.html]]></loc><lastmod>2021-02-05T19:39:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-molecular-em-tumores-gastrointestinais-o-avanco-do-ano.html]]></loc><lastmod>2021-02-04T23:27:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hipofracionamento-no-cancer-de-bexiga-localmente-avancado.html]]></loc><lastmod>2021-02-08T15:04:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cresce-demanda-global-por-cirurgia-em-cancer.html]]></loc><lastmod>2021-02-03T17:55:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-pelvica-no-cancer-de-prostata-de-alto-risco.html]]></loc><lastmod>2021-01-31T17:55:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-identificam-quatro-subtipos-moleculares-no-cancer-de-pulmao-pequenas-celulas.html]]></loc><lastmod>2021-02-08T13:57:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-por-transmissao-materno-infantil.html]]></loc><lastmod>2021-01-31T19:06:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nejm-reporta-novos-dados-sobre-cancer-de-mama-e-variantes-patogenicas.html]]></loc><lastmod>2021-01-29T16:46:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prodige-7-resultados-finais-nao-mostram-beneficio-da-hipec.html]]></loc><lastmod>2021-01-31T19:47:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uniao-europeia-aprova-trastuzumab-deruxtecan-no-cancer-de-mama-metastatico-her2.html]]></loc><lastmod>2021-01-20T20:41:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-individual-e-rastreamento-do-cancer-oral.html]]></loc><lastmod>2021-01-27T15:23:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/fight-bemarituzumabe-mfolfox6-mostra-resultados-no-cancer-gastrico.html]]></loc><lastmod>2021-01-18T23:54:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/nacre-radioterapia-versus-radioquimioterapia-no-paciente-idoso-com-cancer-retal.html]]></loc><lastmod>2021-01-18T23:55:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/s-1-mais-docetaxel-adjuvante-no-cancer-gastrico-estagio-iii.html]]></loc><lastmod>2021-01-18T19:03:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/ivosidenib-mostra-eficacia-no-colangiocarcinoma-avancado-com-mutacao-idh1.html]]></loc><lastmod>2021-01-17T19:59:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/biopsia-liquida-e-risco-de-recorrencia-no-cancer-colorretal.html]]></loc><lastmod>2021-01-16T19:52:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/cabozantinibe-no-carcinoma-hepatocelular-avancado-uma-experiencia-de-mundo-real.html]]></loc><lastmod>2021-01-15T18:54:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/paclitaxel-intraperitoneal-e-xelox-no-cancer-gastrico-com-metastases-peritoneais.html]]></loc><lastmod>2021-01-15T18:49:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metformina-associada-a-irinotecano-no-cancer-colorretal-refratario.html]]></loc><lastmod>2021-01-12T14:28:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-hipofracionada-de-leito-prostatico.html]]></loc><lastmod>2021-01-11T00:46:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-avelumabe-no-carcinoma-urotelial.html]]></loc><lastmod>2020-12-28T21:44:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/oncologia-mamaria-renova-apostas-na-medicina-de-precisao.html]]></loc><lastmod>2020-12-26T18:04:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/destaques-de-2020-no-panorama-gastrointestinal.html]]></loc><lastmod>2020-12-26T17:32:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/oncoginecologia-consolida-conceitos.html]]></loc><lastmod>2021-01-18T15:21:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/oncologia-gu-da-pesquisa-a-assistencia.html]]></loc><lastmod>2021-01-05T13:35:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-osimertinibe-adjuvante-no-cpcnp-egfr-mutado.html]]></loc><lastmod>2020-12-28T20:22:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assinatura-br-bcsc-celulas-tronco-metastases-cerebrais-e-prognostico-no-cancer-de-mama-linfonodo-positivo.html]]></loc><lastmod>2020-12-23T21:59:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-livre-de-recorrencia-e-resposta-completa-por-watch-and-wait-no-cancer-retal.html]]></loc><lastmod>2020-12-13T16:12:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/bylieve-alpelisibe-letrozol-no-cancer-de-mama-avancado-hr-her2-com-mutacao-pik3ca.html]]></loc><lastmod>2020-12-13T00:25:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/rxponder-escore-de-recorrencia-status-menopausal-e-quimioterapia-no-cancer-de-mama.html]]></loc><lastmod>2020-12-13T23:42:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/monarche-dados-de-longo-prazo-confirmam-beneficio-do-abemaciclibe.html]]></loc><lastmod>2020-12-11T12:40:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/monaleesa-7-ribociclibe-apresenta-resultados-atualizados-de-sobrevida-global.html]]></loc><lastmod>2020-12-23T22:29:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/destiny-breast01-trastuzumabe-deruxtecan-no-cancer-de-mama-metastatico-her2-positivo.html]]></loc><lastmod>2020-12-09T11:38:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-destaca-atividade-antitumoral-do-propolis.html]]></loc><lastmod>2020-12-08T14:30:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacientes-com-covid-19-apos-terapia-imunossupressora-para-cancer-podem-ser-contagiosos-por-periodo-estendido.html]]></loc><lastmod>2020-12-03T21:39:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/estro-2020/influencia-do-tempo-entre-a-cirurgia-e-a-radioterapia-pos-operatoria-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2020-12-03T16:15:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/estro-2020/radioterapia-de-campo-envolvido-no-tratamento-de-adenocarcinomas-pancreaticos-localmente-avancados.html]]></loc><lastmod>2020-12-03T16:53:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/estro-2020/impacto-da-infeccao-por-hiv-na-radioterapia-de-consolidacao-do-linfoma-difuso-de-grandes-celulas-b.html]]></loc><lastmod>2020-12-02T14:22:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desafios-da-enfermagem-oncologica.html]]></loc><lastmod>2020-11-30T02:09:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preditores-clinico-patologicos-de-doenca-residual-apos-quimio-neoadjuvante-no-cancer-de-mama.html]]></loc><lastmod>2020-11-27T13:25:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/poetic-ki67-e-valor-preditivo-no-cancer-de-mama.html]]></loc><lastmod>2020-11-30T02:43:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/genomica-de-super-respondedores-ao-tratamento-do-cancer.html]]></loc><lastmod>2020-11-29T23:13:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-prognosticos-em-adenocarcinomas-endocervicais-estagio-ib-figo-2018.html]]></loc><lastmod>2020-11-23T22:07:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oms-lanca-compromisso-global-para-erradicacao-do-cancer-de-colo-do-utero.html]]></loc><lastmod>2020-11-24T19:36:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-de-consolidacao-nao-impacta-sobrevida-no-linfoma-de-hodgkin-avancado.html]]></loc><lastmod>2020-11-19T20:26:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/celulas-tumorais-circulantes-como-potencial-biomarcador-no-cancer-de-mama.html]]></loc><lastmod>2020-11-29T18:32:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/last-trial-descontinuacao-de-tkis-em-lmc-e-segura-e-melhora-qualidade-de-vida.html]]></loc><lastmod>2020-11-15T22:56:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/panorama-do-cancer-ginecologico-no-brasil.html]]></loc><lastmod>2020-11-15T23:34:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-emocional-associada-ao-covid-19.html]]></loc><lastmod>2020-11-16T01:00:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/osimertinibe-no-cpcnp-egfr-mutado-ressecado.html]]></loc><lastmod>2020-11-25T16:11:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atraso-no-tratamento-do-cancer-e-mortalidade.html]]></loc><lastmod>2020-11-16T01:13:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-genetico-universal-vs-teste-direcionado-para-pacientes-com-sindrome-do-cancer-hereditario.html]]></loc><lastmod>2020-11-09T20:40:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/patologia-status-mutacional-e-triagem-em-pacientes-com-cancer-colorretal.html]]></loc><lastmod>2020-11-09T11:22:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/astro-2020/radioterapia-os-destaques-da-astro-2020.html]]></loc><lastmod>2020-10-29T18:34:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/astro-2020/celulas-tumorais-circulantes-como-potenciais-biomarcadores-do-controle-de-metastases-cerebrais-em-pacientes-com-cancer-de-mama.html]]></loc><lastmod>2020-10-29T12:34:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-quimioterapia-adjuvante-e-terapia-alvo-no-cancer-de-mama-inicial.html]]></loc><lastmod>2020-11-03T18:28:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-publica-recomendacoes-para-preservar-a-fertilidade-no-tratamento-do-cancer.html]]></loc><lastmod>2020-11-06T17:26:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/star-cap-sistema-de-estadiamento-prognostico-do-cancer-de-prostata-nao-metastatico.html]]></loc><lastmod>2020-10-24T22:30:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/astro-atualiza-diretrizes-para-o-tratamento-de-radioterapia-no-cancer-retal.html]]></loc><lastmod>2020-10-22T01:11:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-do-cancer-colorretal-no-hospital-de-cancer-de-barretos.html]]></loc><lastmod>2020-10-18T17:21:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nci-match-novas-evidencias-na-oncologia-de-precisao.html]]></loc><lastmod>2020-10-19T03:03:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/portec-3-classificacao-molecular-e-valor-prognostico.html]]></loc><lastmod>2020-10-09T15:53:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/premio-nobel-de-quimica-vai-para-descoberta-da-crispr-cas9.html]]></loc><lastmod>2020-10-07T18:08:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nobel-de-medicina-reconhece-pesquisadores-pela-descoberta-do-virus-da-hepatite-c.html]]></loc><lastmod>2020-10-05T20:57:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacinacao-contra-hpv-e-risco-de-cancer-do-colo-do-utero-invasivo.html]]></loc><lastmod>2020-10-05T02:41:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-perioperatorios-durante-a-pandemia-da-covid-19.html]]></loc><lastmod>2020-10-01T03:00:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-adjuvante-versus-radioterapia-de-resgate-no-cancer-de-prostata.html]]></loc><lastmod>2020-10-05T01:50:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radicals-rt-nao-apoia-radioterapia-adjuvante-no-cancer-de-prostata-inicial-de-alto-risco.html]]></loc><lastmod>2020-09-30T01:54:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/medo-de-recidiva-em-sobreviventes-de-cancer-renal.html]]></loc><lastmod>2020-09-28T13:22:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-descobertas-sobre-a-caquexia-associada-ao-cancer-de-pancreas.html]]></loc><lastmod>2020-09-25T16:00:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relatorio-anual-da-aacr-destaca-avancos-na-pesquisa-e-tratamento-do-cancer.html]]></loc><lastmod>2020-09-24T19:18:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/imunoterapia-e-nova-opcao-no-cancer-gastrico.html]]></loc><lastmod>2020-09-21T17:21:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/inibicao-de-krasg12c-em-tumores-solidos-avancados.html]]></loc><lastmod>2020-09-22T01:03:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/custo-do-cancer-na-europa-atingiu-eur-199-bilhoes-em-2018.html]]></loc><lastmod>2020-09-21T16:17:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/lung-art-radioterapia-pos-operatoria-nao-mostra-beneficio-no-cancer-de-pulmao-com-envolvimento-mediastinal-n2.html]]></loc><lastmod>2020-09-21T04:59:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/adaura-osimertinibe-melhora-controle-de-recorrencia-no-snc.html]]></loc><lastmod>2020-09-20T16:22:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/olaparibe-apresenta-resultados-de-sobrevida-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2020-09-21T16:37:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/nova-opcao-de-tratamento-de-primeira-linha-para-cancer-renal-metastatico.html]]></loc><lastmod>2020-09-20T01:10:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/avelumabe-no-tratamento-de-manutencao-do-cancer-urotelial-avancado.html]]></loc><lastmod>2020-09-20T22:28:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/pacific-atualiza-resultados-de-sobrevida.html]]></loc><lastmod>2020-09-20T01:17:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/stampede-abiraterona-mostra-dados-de-longo-prazo-em-pacientes-m1.html]]></loc><lastmod>2020-09-20T01:08:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/mutacoes-germinativas-brca2-no-cancer-de-prostata.html]]></loc><lastmod>2020-09-20T01:09:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/esmo-avalia-reflexos-da-pandemia-em-profissionais-de-oncologia.html]]></loc><lastmod>2020-09-14T22:13:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/covid-19-e-os-cuidados-em-cancer.html]]></loc><lastmod>2020-09-19T19:33:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/repensando-a-pesquisa-clinica-em-oncologia-pos-covid-19.html]]></loc><lastmod>2020-09-06T21:19:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-e-radioterapia-novos-dados-no-cancer-de-pulmao.html]]></loc><lastmod>2020-09-06T21:15:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-atualiza-recomendacoes-sobre-neurotoxicidade-induzida-por-terapia-sistemica.html]]></loc><lastmod>2020-09-06T21:42:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-diretrizes-para-sequenciamento-de-proxima-geracao-em-tumores-metastaticos.html]]></loc><lastmod>2020-09-07T00:04:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/caminhos-da-assistencia-da-pesquisa-clinica-ao-custo-do-acesso.html]]></loc><lastmod>2020-08-31T12:11:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-metronomica-paliativa-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2020-08-31T12:18:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ablacao-guiada-por-ultrassom-endoscopico-em-tumores-pancreaticos.html]]></loc><lastmod>2020-08-24T00:44:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/20-anos-de-pesquisa-sobre-a-mutacao-r337h-do-gene-tp53.html]]></loc><lastmod>2020-08-24T18:28:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-inibidores-da-parp-no-tratamento-do-cancer-de-ovario.html]]></loc><lastmod>2020-08-24T19:03:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-de-resgate-com-preservacao-de-orgao-apos-vigilancia-no-cancer-retal.html]]></loc><lastmod>2024-11-18T14:39:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mindfulness-e-reducao-de-ansiedade-no-tratamento-do-cancer.html]]></loc><lastmod>2020-08-24T19:24:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ki-67-e-decisao-terapeutica-no-cancer-de-mama-inicial.html]]></loc><lastmod>2020-08-19T21:19:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/doenca-periodontal-e-precursores-do-cancer-colorretal.html]]></loc><lastmod>2020-08-12T19:55:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acs-atualiza-diretrizes-de-rastreio-do-cancer-do-colo-do-utero.html]]></loc><lastmod>2020-08-19T21:21:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-em-sobreviventes-com-mamas-densas.html]]></loc><lastmod>2020-08-05T13:17:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sustentabilidade-na-pesquisa-e-desenvolvimento-de-oncologicos.html]]></loc><lastmod>2020-08-05T12:55:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-e-estresse-oxidativo.html]]></loc><lastmod>2020-07-27T13:14:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nrg1-e-resistencia-a-terapia-antiandrogenica-no-cancer-de-prostata.html]]></loc><lastmod>2020-07-23T01:35:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fast-resultados-de-10-anos-no-cancer-de-mama-inicial.html]]></loc><lastmod>2020-07-20T15:06:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sinais-de-alerta-e-diagnostico-de-cancer.html]]></loc><lastmod>2020-07-26T17:26:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbiota-e-progressao-tumoral.html]]></loc><lastmod>2020-08-16T15:04:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-publica-guideline-para-o-tratamento-do-cancer-de-esofago.html]]></loc><lastmod>2020-07-13T02:54:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cabozantinibe-no-carcinoma-urotelial-metastatico-refratario-a-platina.html]]></loc><lastmod>2020-07-11T19:04:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/esmo-gi-nalirifox-no-cancer-de-pancreas.html]]></loc><lastmod>2020-07-08T17:22:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/polo-olaparibe-de-manutencao-em-idosos-com-cancer-de-pancreas-metastatico.html]]></loc><lastmod>2020-07-02T22:29:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/nomograma-prognostico-no-cancer-de-pancreas.html]]></loc><lastmod>2020-07-02T22:20:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/dispositivo-de-braquiterapia-mostra-resultados-no-cancer-de-pancreas.html]]></loc><lastmod>2020-07-03T18:54:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/implicacoes-e-desafios-da-pan-genomica-2.html]]></loc><lastmod>2020-07-01T21:12:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutagenese-e-evolucao-do-cancer.html]]></loc><lastmod>2020-06-28T22:39:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variante-xaf1-em-combinacao-com-o-gene-p53-e-aumento-do-risco-de-cancer.html]]></loc><lastmod>2020-07-14T14:19:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aacr-biopsia-liquida-no-cancer-renal-inicial-e-em-tumores-do-snc.html]]></loc><lastmod>2020-06-24T16:28:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-atualiza-diretrizes-em-neoplasias-neuroendocrinas-gastroenteropancreaticas.html]]></loc><lastmod>2020-06-30T15:34:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-e-cancer-o-que-sabemos.html]]></loc><lastmod>2020-06-28T21:13:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-genomico-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2020-06-22T20:42:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lacc-qualidade-de-vida-em-pacientes-com-cancer-de-colo-de-utero-apos-histerectomia.html]]></loc><lastmod>2020-06-19T15:09:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/asco-2020-teravolt-e-o-impacto-da-covid-19-na-oncologia.html]]></loc><lastmod>2020-06-15T15:06:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/asco-2020-terapia-de-manutencao-no-cancer-de-ovario-recidivado-brca-mutado.html]]></loc><lastmod>2020-06-09T00:31:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/asco-2020-tratamento-e-manejo-do-cancer-retal.html]]></loc><lastmod>2020-06-08T22:23:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/tv-onconews-cancer-renal-e-tumores-uroteliais-na-asco-2020.html]]></loc><lastmod>2020-06-09T02:00:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/trastuzumab-deruxtecan-no-cancer-gastrico-her2.html]]></loc><lastmod>2020-06-05T13:12:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/cirurgia-citorredutora-no-cancer-de-ovario-recidivado.html]]></loc><lastmod>2020-06-18T17:43:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/tapur-olaparibe-mostra-resultados-no-cancer-de-prostata-e-pancreas-brca-mutado.html]]></loc><lastmod>2020-06-19T20:14:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/savoir-estudo-mostra-resultados-de-inibidor-de-met-no-cancer-renal-papilar.html]]></loc><lastmod>2020-06-03T21:10:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/idea-resultados-finais-sobre-adjuvancia-no-cancer-de-colon.html]]></loc><lastmod>2020-06-19T20:11:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/quimioterapia-e-risco-de-morte-em-pacientes-com-covid-19.html]]></loc><lastmod>2020-06-11T14:38:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/consorcio-global-mostra-resultados-sobre-cancer-e-covid-19.html]]></loc><lastmod>2020-06-04T00:34:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/javelin-bladder-100-mostra-ganho-de-sobrevida-no-cancer-urotelial.html]]></loc><lastmod>2020-12-09T00:41:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/osimertinibe-adjuvante-mostra-reducao-de-83-no-risco-de-recorrencia-ou-morte-no-cpcnp.html]]></loc><lastmod>2020-06-03T23:56:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/baixa-adesao-aos-cuidados-de-suporte-para-aliviar-a-fadiga-em-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2020-05-27T16:21:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-olaparibe-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2020-05-25T01:20:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/terapia-de-manutencao-com-olaparibe-aumenta-a-sobrevida-no-cancer-de-ovario-recidivado-brca-mutado.html]]></loc><lastmod>2020-06-04T00:28:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/cessacao-do-tabagismo-e-beneficio-de-sobrevida-em-pacientes-com-cancer-de-pulmao.html]]></loc><lastmod>2020-06-04T00:28:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/abordagem-integrada-entre-geriatras-e-oncologistas-melhora-resultados-de-idosos-com-cancer.html]]></loc><lastmod>2020-06-04T00:29:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/videoconferencia-reduz-ansiedade-e-distress-de-cuidadores-a-distancia.html]]></loc><lastmod>2020-06-04T00:29:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-diagnostico-e-manejo-do-carcinoma-espinocelular-de-cabeca-e-pescoco-de-primario-desconhecido.html]]></loc><lastmod>2020-05-11T00:41:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-repete-resultados-do-cleopatra-trial.html]]></loc><lastmod>2020-05-11T12:52:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alteracoes-de-cdk12-e-cancer-de-prostata.html]]></loc><lastmod>2020-05-06T00:00:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/memoria-marcos-moraes-1936-2020.html]]></loc><lastmod>2020-05-11T00:50:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/ultra-hipofracionamento-de-radioterapia-em-cancer-de-mama---uma-nova-tendencia.html]]></loc><lastmod>2020-05-05T12:48:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/aacr-2020/aacr-mostra-resultados-de-olaparibe-e-durvalumabe-no-cancer-de-mama.html]]></loc><lastmod>2020-05-01T19:48:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/asco-2020-covid-19-medicina-de-precisao-e-acesso-sao-destaques-do-programa-cientifico.html]]></loc><lastmod>2020-06-04T00:30:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/controversias-no-tratamento-e-manejo-do-cancer-retal.html]]></loc><lastmod>2020-06-04T00:33:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/crowdsourcing-covid-19-e-oncologia.html]]></loc><lastmod>2020-04-26T18:57:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relatorio-analisa-prognostico-de-pacientes-com-cancer-e-covid-19-nos-eua.html]]></loc><lastmod>2020-04-25T01:07:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/elevate-tn-acalabrutinibe-no-tratamento-de-primeira-linha-da-leucemia-linfocitica-cronica.html]]></loc><lastmod>2020-05-11T13:27:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caracteristicas-demograficas-clinicas-e-patologicas-de-pacientes-com-melanoma-cutaneo.html]]></loc><lastmod>2020-04-25T00:38:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/covid-19-oncologia-toracica-anuncia-registro-global.html]]></loc><lastmod>2020-04-26T19:20:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-discute-cancer-e-covid-19.html]]></loc><lastmod>2020-04-13T02:31:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-microbiota-e-implicacoes-terapeuticas.html]]></loc><lastmod>2020-04-12T21:07:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-promete-detectar-com-precisao-mais-de-50-tipos-de-cancer.html]]></loc><lastmod>2020-04-14T00:20:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-manejo-do-cancer-de-mama-hereditario.html]]></loc><lastmod>2024-05-04T20:06:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-para-cancer-durante-a-pandemia-de-covid-19.html]]></loc><lastmod>2020-04-06T12:44:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/covid-19-e-as-consequencias-para-a-oncologia-global.html]]></loc><lastmod>2020-04-02T18:15:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-prostata-familial-ou-hereditario.html]]></loc><lastmod>2020-04-24T16:13:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-adjuvante-no-cancer-urotelial.html]]></loc><lastmod>2020-03-30T03:46:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/geparocto-neoadjuvancia-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2020-04-13T01:11:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carboplatina-e-pemetrexede-seguido-de-manutencao-com-pemetrexede-em-idosos-com-cpnpc-avancado.html]]></loc><lastmod>2020-03-30T04:49:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-recomendacoes-de-cuidados-durante-a-pandemia-de-coronavirus.html]]></loc><lastmod>2020-03-19T18:44:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/covid-19-em-pacientes-de-cancer-a-experiencia-chinesa.html]]></loc><lastmod>2020-03-31T02:31:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-recomendacoes-para-uso-de-placebo-em-ensaios-de-cirurgia.html]]></loc><lastmod>2020-03-18T14:21:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/explorando-o-receptor-de-folato-a-em-oncologia.html]]></loc><lastmod>2020-03-15T22:02:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aspirina-e-carcinoma-hepatocelular.html]]></loc><lastmod>2020-03-12T12:15:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-brasileiro-publica-recomendacoes-para-prevencao-e-tratamento-do-cancer-hereditario.html]]></loc><lastmod>2020-03-11T16:09:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bio-manguinhos-fiocruz-incorpora-rituximabe-biossimilar-ao-seu-portfolio.html]]></loc><lastmod>2020-03-09T20:38:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-reduz-risco-de-cancer-invasivo-em-mulheres-na-pos-menopausa.html]]></loc><lastmod>2020-03-16T02:39:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/letrozol-neoadjuvante-no-cdis.html]]></loc><lastmod>2020-04-26T21:40:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-discute-ancestralidade-no-cancer-colorretal.html]]></loc><lastmod>2020-03-05T16:03:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pancan-e-os-resultados-do-registro-know-your-tumor.html]]></loc><lastmod>2020-03-04T21:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbiota-como-fator-prognostico-de-sobrevida.html]]></loc><lastmod>2020-03-02T03:17:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/conitec-avalia-incorporacao-de-tratamento-para-mielofibrose-no-sus.html]]></loc><lastmod>2020-02-26T12:55:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assinatura-genica-risco-e-adjuvancia-no-cancer-de-mama.html]]></loc><lastmod>2020-03-01T15:46:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidor-de-met-e-de-vegfr2-no-osteossarcoma-e-no-sarcoma-de-ewing.html]]></loc><lastmod>2020-03-02T02:12:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-bariatrica-e-cancer-de-colon.html]]></loc><lastmod>2020-03-02T02:23:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/video-klotz-e-denis.html]]></loc><lastmod>2020-02-16T01:19:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/video-fabio-e-ana-paula.html]]></loc><lastmod>2020-02-16T01:21:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/video-neeraj.html]]></loc><lastmod>2020-02-16T01:33:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/video-morbeck-ana-e-fay.html]]></loc><lastmod>2020-02-15T02:50:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/video-ariel-e-flavio.html]]></loc><lastmod>2020-02-15T16:09:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/imunoterapia-e-quimioterapia-neoadjuvante-no-cancer-de-bexiga-musculo-invasivo.html]]></loc><lastmod>2020-02-14T23:20:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-apalutamida-no-cancer-de-prostata-metastatico-sensivel-a-castracao.html]]></loc><lastmod>2020-02-14T07:42:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/video-denis-murilo-e-flavio.html]]></loc><lastmod>2020-02-14T16:10:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/stomp-resultados-de-longo-prazo-no-cancer-de-prostata-oligometastatico.html]]></loc><lastmod>2020-02-16T02:13:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/novos-testes-prometem-predizer-diagnostico-e-risco-no-cancer-de-prostata.html]]></loc><lastmod>2020-02-15T00:09:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-gastrico-familiar-a-infeccao-por-h-pylori.html]]></loc><lastmod>2020-02-10T12:09:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-esmo-tratamento-de-doencas-cardiovasculares-em-pacientes-com-cancer.html]]></loc><lastmod>2020-02-09T23:43:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-neoadjuvante-e-morbidade-pos-operatoria-no-adenocarcinoma-de-pancreas.html]]></loc><lastmod>2020-02-09T23:45:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estimativas-inca-625-mil-novos-casos-de-cancer-por-ano-entre-2020-e-2022.html]]></loc><lastmod>2020-02-05T20:28:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nelson-trial-e-triagem-para-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T16:51:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oms-reforca-importancia-da-vacina-contra-hpv-na-prevencao-do-cancer-cervical.html]]></loc><lastmod>2020-02-09T23:01:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/melanoma-biomarcadores-e-resposta-a-terapia-alvo.html]]></loc><lastmod>2020-02-07T12:39:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diferencas-e-semelhancas-da-recorrencia-intra-abdominal-do-cancer-colorretal.html]]></loc><lastmod>2020-02-09T18:51:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gi-2020/oncologia-personalizada-idade-e-resultados-clinicos-no-cancer-colorretal.html]]></loc><lastmod>2020-01-27T02:04:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gi-2020/lavagem-peritoneal-nao-reduz-risco-de-recorrencia-no-cancer-gastrico.html]]></loc><lastmod>2020-01-24T23:53:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gi-2020/biopsia-liquida-em-tumores-gastrointestinais-dificeis-de-detectar.html]]></loc><lastmod>2020-01-27T00:07:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-guideline-para-uso-de-imagem-no-cancer-de-prostata-avancado.html]]></loc><lastmod>2020-01-22T18:33:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inteligencia-artificial-e-discordancia-diagnosticas-em-polipos-colorretais.html]]></loc><lastmod>2020-01-21T12:38:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imrt-no-cancer-de-bexiga-linfonodo-positivo.html]]></loc><lastmod>2020-01-22T21:26:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-estereotatica-para-tratamento-de-metastases-da-coluna.html]]></loc><lastmod>2020-01-17T13:42:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-abordagem-genomica-promete-predizer-resposta-a-imunoterapia-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T16:53:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-novo-biossimilar-oncologico.html]]></loc><lastmod>2020-01-15T19:42:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/portaria-altera-criterios-para-unacons-e-cacons.html]]></loc><lastmod>2020-01-22T20:17:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-ja-mostram-impacto-no-rastreamento-do-cancer-colorretal.html]]></loc><lastmod>2020-01-13T16:51:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acupuntura-na-dor-oncologica.html]]></loc><lastmod>2020-01-13T16:13:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-terapia-alvo-no-tratamento-de-gist.html]]></loc><lastmod>2020-01-13T15:49:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/conitec-avalia-incorporacao-de-tratamentos-para-melanoma-no-sus.html]]></loc><lastmod>2020-01-13T16:29:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/video-antonio-buzaid-evandro-azambuja-e-daniela-rosa.html]]></loc><lastmod>2019-12-14T04:51:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/video-cesar-cabello-e-afonso-nazario.html]]></loc><lastmod>2019-12-14T04:53:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/video-gilberto-amorim-e-daniel-gimenes.html]]></loc><lastmod>2019-12-12T15:14:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/video-daniela-rosa-e-felipe-ades.html]]></loc><lastmod>2019-12-12T15:13:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/coralleen-mostra-beneficio-de-ribociclibe-na-neoadjuvancia.html]]></loc><lastmod>2019-12-11T21:44:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/tucatinib-mostra-resultados-de-sobrevida-no-cancer-de-mama-her2-metastatico.html]]></loc><lastmod>2019-12-11T15:13:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/anticorpo-droga-conjugado-mostra-atividade-no-cancer-de-mama-her2-politratado.html]]></loc><lastmod>2019-12-11T15:14:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/duplo-bloqueio-her2-mostra-resultados-de-longo-prazo-no-sabcs-2019.html]]></loc><lastmod>2019-12-11T13:52:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ash-2019/blinatumomab-como-terapia-de-pos-reinducao-melhora-sobrevida-na-leucemia-linfoide-aguda-de-celulas-b.html]]></loc><lastmod>2019-12-10T22:41:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ash-2019/quazar-azacitidina-oral-cc-486-melhora-sobrevida-em-idosos-com-leucemia-mieloide-aguda.html]]></loc><lastmod>2019-12-10T17:43:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ash-2019/daratumumab-carfilzomib-e-dexametasona-aumenta-sobrevida-livre-de-progressao-no-mieloma-recidivado-refratario.html]]></loc><lastmod>2019-12-10T22:40:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ash-2019/mutacoes-drivers-prognosticas-na-leucemia-mieloide-aguda-e-sindrome-mielodisplasica.html]]></loc><lastmod>2019-12-10T22:58:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacinacao-contra-hpv-revisao-da-cochrane-compara-diferentes-esquemas.html]]></loc><lastmod>2019-11-24T18:15:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-mutacional-do-melanoma-no-brasil.html]]></loc><lastmod>2019-11-24T16:49:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sequencia-de-tratamento-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2019-11-25T03:23:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-nova-indicacao-de-daratumumabe-no-tratamento-do-mieloma-multiplo.html]]></loc><lastmod>2019-11-25T03:17:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gog-0213-citorreducao-secundaria-nao-mostrou-ganho-de-sobrevida-no-cancer-de-ovario.html]]></loc><lastmod>2019-11-25T03:17:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-alerta-global-para-os-riscos-do-cigarro-eletronico.html]]></loc><lastmod>2019-11-13T12:35:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-de-resposta-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2019-11-13T12:26:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-regimes-de-tratamento-no-cancer-colorretal-metastatico-com-mutacao-braf-v600e.html]]></loc><lastmod>2019-11-19T11:31:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-combinacao-para-tratamento-de-primeira-linha-do-cancer-renal-avancado.html]]></loc><lastmod>2019-11-12T12:50:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/levofloxacino-profilatico-no-mieloma-multiplo.html]]></loc><lastmod>2019-11-11T02:43:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adesao-ao-tamoxifeno-e-farmacogenetica-no-cancer-de-mama.html]]></loc><lastmod>2019-11-11T01:52:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-pembrolizumabe-na-primeira-linha-de-tratamento-do-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2019-11-10T23:25:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ferramenta-para-desenvolvimento-e-revisao-de-planos-nacionais-de-controle-de-cancer.html]]></loc><lastmod>2019-11-10T18:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tamanho-da-metastase-do-linfonodo-sentinela-e-preditiva-do-envolvimento-do-linfonodo-nao-sentinela-no-cancer-de-endometrio.html]]></loc><lastmod>2019-11-10T17:24:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-nivolumabe-em-dose-fixa-para-todas-as-indicacoes-aprovadas-no-pais.html]]></loc><lastmod>2019-11-11T03:01:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/primeira-linha-no-carcinoma-renal-nao-celulas-claras-e-sarcomatoide-evidencias-de-mundo-real.html]]></loc><lastmod>2019-11-06T13:32:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/text-e-soft-nova-analise-mostra-desfechos-de-recorrencia-a-distancia.html]]></loc><lastmod>2019-11-04T19:54:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-fibras-e-iogurte-e-risco-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T16:57:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lei-obriga-sus-a-realizar-diagnostico-de-cancer-em-ate-30-dias.html]]></loc><lastmod>2019-10-31T18:09:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/sboc-reconhece-especialistas-por-sua-contribuicao-a-oncologia.html]]></loc><lastmod>2019-10-29T16:46:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/sbco-quer-valorizar-a-cirurgia-oncologica.html]]></loc><lastmod>2019-10-30T15:29:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/premio-jovem-oncologista-sboc-2019.html]]></loc><lastmod>2019-10-29T16:08:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/producao-cientifica-e-educacao-medica.html]]></loc><lastmod>2019-10-29T13:35:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/i-consenso-brasileiro-de-tratamento-do-carcinoma-urotelial.html]]></loc><lastmod>2019-10-29T13:34:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-de-mutacoes-do-cancer-colorretal.html]]></loc><lastmod>2019-10-24T14:45:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cardiotoxicidade-prevencao-e-resultados.html]]></loc><lastmod>2019-10-28T05:43:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/massagem-oncologica-em-pacientes-com-neuropatia-periferica-induzida-por-quimioterapia.html]]></loc><lastmod>2019-10-22T22:59:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dor-oncologica-ansiedade-depressao-e-suporte-social.html]]></loc><lastmod>2019-10-22T20:48:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-de-atividade-fisica-para-sobreviventes-de-cancer.html]]></loc><lastmod>2019-10-31T19:56:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-breakthrough-biopsia-liquida-e-diagnostico-precoce.html]]></loc><lastmod>2019-10-16T21:35:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/marcadores-geneticos-de-resposta-a-radioterapia-e-previsao-de-recorrencia.html]]></loc><lastmod>2019-10-16T21:22:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diferenciacao-escamosa-indica-mau-prognostico-no-carcinoma-endometrioide-de-baixo-e-medio-risco.html]]></loc><lastmod>2019-10-15T17:17:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custo-efetividade-do-teste-multigenico-para-todas-as-pacientes-com-cancer-de-mama.html]]></loc><lastmod>2019-10-21T14:41:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-manejo-da-osteoporose-em-sobreviventes-com-doenca-nao-metastatica.html]]></loc><lastmod>2019-10-22T19:15:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nobel-de-medicina-reconhece-estudos-sobre-adaptacao-celular-a-disponibilidade-de-oxigenio.html]]></loc><lastmod>2019-10-08T14:40:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adenocarcinoma-de-pulmao-no-sul-do-brasil.html]]></loc><lastmod>2020-04-24T17:04:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incidencia-de-melanoma-aumenta-em-homens-jovens-nos-eua-e-canada.html]]></loc><lastmod>2019-10-07T11:52:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidor-de-parp-no-cancer-de-prostata.html]]></loc><lastmod>2019-10-05T12:43:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/perspectivas-no-cancer-urotelial.html]]></loc><lastmod>2019-09-30T15:57:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/resultados-encorajadores-no-tratamento-do-colangiocarcinoma.html]]></loc><lastmod>2019-09-30T15:40:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/biopsia-liquida-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:07:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/video-angelica-paulino-e-graziela.html]]></loc><lastmod>2019-09-29T17:37:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/video-slamon.html]]></loc><lastmod>2019-10-01T20:01:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/monaleesa-3-mostra-resultados-de-sobrevida-global.html]]></loc><lastmod>2019-09-30T15:59:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/panorama-gu-o-que-ha-de-novo.html]]></loc><lastmod>2019-09-29T08:54:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/olaparibe-e-bevacizumabe-como-terapia-de-manutencao-no-tratamento-do-cancer-de-ovario.html]]></loc><lastmod>2019-09-28T19:30:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/osimertinibe-apresenta-resultados-de-sobrevida-global.html]]></loc><lastmod>2019-09-28T17:07:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/imunoterapia-em-combinacao-no-tratamento-do-cancer-de-pulmao-avancado.html]]></loc><lastmod>2020-04-24T17:07:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/biopsia-liquida-e-valor-prognostico-no-cancer-colorretal.html]]></loc><lastmod>2019-09-28T13:53:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/video-prostata.html]]></loc><lastmod>2019-09-28T07:26:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/checkmate-459-imunoterapia-na-primeira-linha-de-tratamento-do-carcinoma-hepatocelular-avancado.html]]></loc><lastmod>2019-09-28T10:39:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/radicals-rt-estudo-discute-beneficios-da-radioterapia-pos-prostatectomia.html]]></loc><lastmod>2019-09-28T13:55:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/astro-2019/astro-2019-novidades-do-congresso-americano-de-radioterapia-2.html]]></loc><lastmod>2019-09-23T14:10:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/astro-2019/resultado-cosmetico-da-irradiacao-total-vs-parcial-da-mama-apos-a-lumpectomia.html]]></loc><lastmod>2019-09-20T16:03:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/astro-2019/astro-2019-sabr-no-cancer-de-prostata-oligometastatico.html]]></loc><lastmod>2019-09-18T19:03:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/astro-2019/efeito-abscopal-da-sbrt-no-cancer-de-pulmao-metastatico-apos-a-progressao-ao-tratamento-com-anti-pd-1.html]]></loc><lastmod>2020-04-24T17:09:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-lacog-gu-e-larcg-para-o-tratamento-cirurgico-do-carcinoma-de-celulas-renais.html]]></loc><lastmod>2019-09-16T02:34:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/identificacao-de-micrornas-circulantes-livres-de-celulas-para-a-deteccao-precoce-de-cancer-de-mama.html]]></loc><lastmod>2019-09-12T20:32:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/wclc-2019/wclc-2019-estudo-do-gbot-lacog-mostra-perfil-genomico-no-cancer-de-pulmao-no-brasil.html]]></loc><lastmod>2020-04-24T17:09:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/wclc-2019/wclc-2019-estudo-brasileiro-discute-terapia-sistemica-e-risco-de-recorrencia-do-derrame-pleural-maligno.html]]></loc><lastmod>2019-09-17T01:52:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/wclc-2019/estudo-compara-modelos-europeu-e-americano-de-rastreamento-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:10:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/wclc-2019/irradiacao-craniana-profilatica-nao-aumenta-sobrevida-no-cpnpc-avancado.html]]></loc><lastmod>2019-09-09T20:45:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-alpelisibe-no-cancer-de-mama-avancado-ou-metastatico.html]]></loc><lastmod>2019-09-10T14:46:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/wclc-2019/wclc-2019-apresenta-os-destaques-do-encontro-anual.html]]></loc><lastmod>2019-09-10T13:42:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-diretriz-traz-recomendacoes-para-radioterapia-no-cancer-de-pancreas.html]]></loc><lastmod>2019-09-16T01:54:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/wclc-2019/wclc-2019-radiografia-da-realizacao-de-testes-moleculares-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:10:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/wclc-2019/declaracao-iaslc-cessacao-do-tabagismo-apos-o-diagnostico-de-cancer.html]]></loc><lastmod>2019-09-11T19:57:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-quality-care-symposium/brasileira-recebe-quality-care-symposium-merit-awards.html]]></loc><lastmod>2019-09-10T22:03:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-quality-care-symposium/participacao-em-estudos-clinicos-impacta-a-sobrevida-de-pacientes-com-cpnpc-metastatico.html]]></loc><lastmod>2019-09-04T13:16:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbiota-e-impacto-prognostico-no-cancer-colorretal.html]]></loc><lastmod>2019-09-10T18:32:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-quality-care-symposium/percepcoes-de-medicos-pesquisadores-e-pacientes-sobre-o-recrutamento-em-estudos-clinicos-de-cancer.html]]></loc><lastmod>2019-09-05T15:57:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cerumenograma-no-diagnostico-de-cancer.html]]></loc><lastmod>2019-09-04T19:57:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metastases-cerebrais-durante-o-tratamento-com-anti-pd-1-em-pacientes-com-melanoma-metastatico.html]]></loc><lastmod>2019-09-01T19:41:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-discute-caminhos-para-o-tratamento-do-cancer-de-bexiga.html]]></loc><lastmod>2019-09-01T15:05:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-para-o-manejo-da-constipacao-em-pacientes-com-cancer-avancado.html]]></loc><lastmod>2019-09-01T12:56:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimio-neoadjuvante-quimiorradiacao-vs-quimiorradiacao-isolada-no-cancer-cervical.html]]></loc><lastmod>2019-09-01T14:54:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-doencas-cardiovasculares-em-sobreviventes-de-20-tipos-de-cancer.html]]></loc><lastmod>2019-09-02T02:51:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-em-cinco-anos-de-dabrafenibe-e-trametinibe-no-melanoma-metastatico.html]]></loc><lastmod>2019-08-23T00:09:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variaveis-preditivas-de-resposta-a-imunoterapia.html]]></loc><lastmod>2019-08-23T13:13:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-a-enzalutamida-para-tratamento-do-cancer-de-prostata-metastatico-hormonio-sensivel.html]]></loc><lastmod>2019-08-22T15:33:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uspstf-amplia-recomendacoes-para-testes-de-mutacao-brca-1-2.html]]></loc><lastmod>2019-09-02T02:37:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-antibioticos-e-risco-de-cancer.html]]></loc><lastmod>2019-08-21T22:31:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estatinas-e-prevencao-do-cancer-hepatocelular-na-hepatite-viral.html]]></loc><lastmod>2019-09-01T22:59:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cdc-relata-novos-casos-de-doenca-pulmonar-associada-ao-uso-de-cigarro-eletronico.html]]></loc><lastmod>2019-08-27T12:20:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-associado-a-obesidade-aumenta-entre-os-mais-jovens.html]]></loc><lastmod>2019-08-26T15:34:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reducao-precoce-da-dose-de-quimioterapia-adjuvante-impacta-sobrevida-no-cancer-de-mama.html]]></loc><lastmod>2019-09-02T01:21:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tapur-palbociclibe-nao-mostra-atividade-no-cancer-pancreatico.html]]></loc><lastmod>2019-08-21T22:11:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/o-exercicio-de-cuidar-3.html]]></loc><lastmod>2019-08-18T19:36:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/entrectinib-fda-aprova-nova-terapia-agnostica.html]]></loc><lastmod>2019-08-16T16:29:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/crescem-vendas-de-biossimilares-na-oncologia-brasileira.html]]></loc><lastmod>2019-08-16T15:18:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-e-sobrevida-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2019-08-18T15:22:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estro-publica-recomendacoes-para-radioterapia-pos-reconstrucao-de-mama.html]]></loc><lastmod>2019-08-14T23:57:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/orator-qualidade-de-vida-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2019-08-14T18:51:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-profilaxia-e-tratamento-do-tromboembolismo-venoso-em-pacientes-com-cancer.html]]></loc><lastmod>2019-08-14T18:15:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/olaparibe-mostra-resultados-no-cancer-de-prostata.html]]></loc><lastmod>2019-08-19T15:17:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uspstf-nao-recomenda-rastreamento-de-cancer-de-pancreas-em-adultos-assintomaticos.html]]></loc><lastmod>2019-08-08T22:20:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-subtipos-no-cancer-de-mama-luminal-a.html]]></loc><lastmod>2019-08-15T20:32:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/versao-brasileira-da-escala-de-vergonha-e-estigma-para-pacientes-com-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2019-08-04T16:10:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-do-icesp-discute-quimioterapia-no-cancer-de-esofago.html]]></loc><lastmod>2019-08-02T15:47:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-reprodutivos-associados-ao-risco-de-cancer-de-mama-na-sindrome-de-li-fraumeni.html]]></loc><lastmod>2019-08-05T00:04:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ribociclibe-mostra-beneficio-de-sobrevida-no-cancer-de-mama-avancado.html]]></loc><lastmod>2019-08-04T14:31:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qual-o-melhor-metodo-de-imagem-para-rastreamento-de-cancer-de-mama-em-mulheres-com-historia-familiar.html]]></loc><lastmod>2019-08-08T12:18:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-carcinoma-hepatocelular-apos-a-erradicacao-do-virus-da-hepatite-c.html]]></loc><lastmod>2019-08-05T00:07:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incorporacao-da-abiraterona-no-sus.html]]></loc><lastmod>2019-07-26T16:53:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-promete-acelerar-diagnostico-de-cancer-de-mama.html]]></loc><lastmod>2019-08-05T00:02:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/portec-3-padroes-de-recorrencia-no-cancer-endometrial-de-alto-risco.html]]></loc><lastmod>2019-07-30T11:56:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nejm-critica-limites-estatisticos-e-discute-novas-regras-para-publicacao.html]]></loc><lastmod>2019-08-04T23:21:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-celular-mostra-resultados-promissores-em-pacientes-com-cancer-de-pancreas.html]]></loc><lastmod>2019-07-23T14:25:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-manejo-do-pescoco-no-carcinoma-oral-de-celulas-escamosas-e-de-orofaringe.html]]></loc><lastmod>2019-08-05T00:02:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-e-severidade-de-danos-evitaveis-aos-pacientes.html]]></loc><lastmod>2019-08-04T23:06:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-bebidas-acucaradas-e-risco-de-cancer.html]]></loc><lastmod>2019-07-12T20:29:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/indice-de-confianca-pesquisa-clinica-e-registro-de-drogas-anticancer.html]]></loc><lastmod>2019-07-14T15:39:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-cervicovaginal-e-risco-de-cancer-de-ovario.html]]></loc><lastmod>2019-07-15T01:42:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/beacon-combinacao-de-terapias-alvo-mostra-resultados-no-cancer-colorretal-avancado.html]]></loc><lastmod>2019-07-09T23:51:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/triagem-reduz-mortalidade-por-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:12:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-gi-2019/cancer-gastrico-em-mulheres-com-menos-de-40-anos-na-america-latina.html]]></loc><lastmod>2019-07-08T14:01:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-recomendacoes-de-conduta-para-adjuvancia-no-cancer-de-pancreas.html]]></loc><lastmod>2019-07-01T01:44:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-variante-genetica-e-cancer-de-mama-na-pre-menopausa.html]]></loc><lastmod>2019-07-01T02:43:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-prevalencia-de-dor-cronica-em-sobreviventes-de-cancer.html]]></loc><lastmod>2019-07-01T03:13:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-e-cancer-de-prostata-agressivo.html]]></loc><lastmod>2019-07-01T01:01:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ingrediente-de-brocolis-suprime-crescimento-do-tumor.html]]></loc><lastmod>2019-06-25T13:12:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tempo-de-soroconversao-do-anticorpo-hpv16-e6-antes-do-cancer-de-orofaringe.html]]></loc><lastmod>2019-07-01T03:11:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/numero-de-sobreviventes-de-cancer-nos-estados-unidos-deve-ultrapassar-22-milhoes-ate-2030.html]]></loc><lastmod>2019-06-14T15:57:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/oncologista-brasileiro-recebe-o-global-oncology-young-investigator-awards-2019.html]]></loc><lastmod>2019-06-14T12:27:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exposicao-ocupacional-a-agrotoxicos-e-resposta-a-imunoquimioterapia-no-linfoma-difuso-de-grandes-celulas-b-2.html]]></loc><lastmod>2019-06-14T15:57:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/radioterapia-na-asco-2019.html]]></loc><lastmod>2019-06-18T16:13:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/imunoterapia-e-nefrectomia-citorredutora-no-cancer-renal-metastatico.html]]></loc><lastmod>2019-06-04T02:56:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/margetuximab-anti-her2-e-nova-promessa.html]]></loc><lastmod>2019-06-04T15:34:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/inibidor-do-receptor-pan-her-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2019-06-04T00:56:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/cirurgia-em-metastases-hepaticas.html]]></loc><lastmod>2019-06-04T06:05:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/anticorpo-conjugado-e-nova-promessa-no-cancer-urotelial.html]]></loc><lastmod>2019-06-03T17:11:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/dabrafenibe-e-trametinibe-mostram-resultados-de-longo-prazo-no-tratamento-do-melanoma.html]]></loc><lastmod>2019-06-04T03:29:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/vacinacao-contra-o-hpv-na-america-latina.html]]></loc><lastmod>2019-06-02T22:58:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/enzalutamida-nova-opcao-no-cancer-de-prostata-metastatico-hormonio-sensivel.html]]></loc><lastmod>2019-06-02T16:26:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/inibidor-de-parp-no-cancer-de-pancreas-metastatico-brca-mutado.html]]></loc><lastmod>2019-06-13T19:10:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/desafios-do-acesso-no-diagnostico-e-tratamento-do-cancer.html]]></loc><lastmod>2019-06-04T04:46:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/perfil-molecular-de-lesoes-precursoras-do-cancer-oral.html]]></loc><lastmod>2019-06-02T22:02:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/jipang-combinacao-de-quimioterapia-no-cpnpc-nao-escamosas-ressecado-estadio-ii-iiia.html]]></loc><lastmod>2019-06-02T03:36:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/quimio-adjuvante-no-cpnpc-estadio-i-com-alto-risco-de-recorrencia.html]]></loc><lastmod>2019-06-02T01:21:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/duracao-da-terapia-adjuvante-baseada-em-oxaliplatina-no-cancer-colorretal-estadio-ii-de-alto-risco.html]]></loc><lastmod>2019-06-02T04:06:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/horg-idea-tres-versus-seis-meses-de-folfox-ou-capox-adjuvante-no-cancer-de-colon.html]]></loc><lastmod>2019-06-01T21:18:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/video-prostata.html]]></loc><lastmod>2019-06-01T12:45:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/apalutamida-mostra-beneficios-no-mcspc.html]]></loc><lastmod>2019-06-02T04:46:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/getug-afu-16-hormonioterapia-e-radioterapia-na-terapia-de-resgate-apos-a-prostatectomia-radical.html]]></loc><lastmod>2019-06-01T06:10:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/keynote-048-primeira-linha-no-carcinoma-de-celulas-escamosas-de-cabeca-e-pescoco-recorrente-metastatico.html]]></loc><lastmod>2019-06-01T06:12:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/tpextreme-primeira-linha-no-carcinoma-espinocelular-de-cabeca-e-pescoco-recorrente-metastatico.html]]></loc><lastmod>2019-06-01T06:11:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/monaleesa-7-ribociclibe-aumenta-a-sobrevida-no-cancer-de-mama-avancado.html]]></loc><lastmod>2019-06-07T12:40:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/quimioterapia-oral-adesao-e-seguranca-farmaceutica.html]]></loc><lastmod>2019-05-31T14:33:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/caquexia-em-sobreviventes-de-cec-de-cabeca-e-pescoco.html]]></loc><lastmod>2019-05-30T22:27:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/subtipos-moleculares-e-resposta-ao-tratamento-adjuvante-no-cancer-gastrico.html]]></loc><lastmod>2019-05-30T14:17:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/avaliacao-geriatrica-e-risco-de-morte-no-idoso-com-cancer-2.html]]></loc><lastmod>2019-05-28T16:45:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-alpelisib-no-cancer-de-mama-avancado-ou-metastatico.html]]></loc><lastmod>2019-05-26T23:41:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/asco-2019-estudo-brasileiro-mostra-associacao-de-esquistossomose-e-cancer-colorretal.html]]></loc><lastmod>2019-05-22T17:41:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-aplicacoes-e-perspectivas-de-expansao.html]]></loc><lastmod>2019-05-19T22:16:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/subtipos-moleculares-e-selecao-de-tratamento-no-cancer-colorretal.html]]></loc><lastmod>2019-05-19T19:21:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-aua-diagnostico-e-tratamento-do-cancer-de-testiculo.html]]></loc><lastmod>2019-05-14T13:21:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resposta-terapeutica-e-risco-de-progressao-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2019-05-12T22:39:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sabr-comet-radioterapia-estereotatica-vs-tratamento-paliativo-padrao-no-cancer-oligometastatico.html]]></loc><lastmod>2019-05-12T21:46:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exposicao-ocupacional-a-agrotoxicos-e-resposta-a-imunoquimioterapia-no-linfoma-difuso-de-grandes-celulas-b.html]]></loc><lastmod>2019-05-09T16:24:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-clinica-e-registro-de-antineoplasicos.html]]></loc><lastmod>2019-05-08T02:04:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/astro-e-aua-atualizam-diretrizes-para-radioterapia-adjuvante-e-de-resgate-apos-prostatectomia.html]]></loc><lastmod>2019-05-05T22:34:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/doenca-axilar-residual-pos-qt-neo-e-fatores-preditivos.html]]></loc><lastmod>2019-05-05T18:16:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-compara-protocolos-para-remocao-de-melanina-do-dna-genomico.html]]></loc><lastmod>2019-05-02T15:12:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-em-mulheres-jovens.html]]></loc><lastmod>2019-05-05T18:33:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-desenvolve-solucao-de-baixo-custo-para-o-manejo-do-derrame-pleural-maligno.html]]></loc><lastmod>2019-04-29T14:06:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hiperprogressao-e-imunoterapia-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:13:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imuno-oncologia-um-cenario-em-expansao.html]]></loc><lastmod>2019-04-28T14:16:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eventos-adversos-e-inibidores-de-checkpoint-imune.html]]></loc><lastmod>2019-05-04T21:06:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-do-mieloma-multiplo-guideline-asco-e-cancer-care-ontario.html]]></loc><lastmod>2019-04-22T02:26:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quando-menos-e-mais-no-tratamento-do-cancer-de-colo-uterino.html]]></loc><lastmod>2019-04-21T20:59:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/a-vacina-contra-a-gripe-e-segura-para-pacientes-com-cancer-que-recebem-inibidores-de-checkpoint-imuneulti.html]]></loc><lastmod>2019-04-21T19:05:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carcinoma-hepatocelular-evidencias-e-avancos.html]]></loc><lastmod>2019-04-29T17:02:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hpv73-e-cancer-do-colo-do-utero.html]]></loc><lastmod>2019-04-20T18:11:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pembrolizumabe-na-1-linha-do-cpnpc-metastatico.html]]></loc><lastmod>2019-04-17T11:54:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-oxaliplatina-adjuvante-no-cancer-de-colon-estadio-iii.html]]></loc><lastmod>2019-04-17T16:16:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/um-terco-dos-pacientes-com-cancer-utiliza-medicina-complementar-e-alternativa.html]]></loc><lastmod>2019-04-22T02:24:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-de-manutencao-nao-aumenta-sobrevida-no-cppc.html]]></loc><lastmod>2019-04-11T19:10:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-da-vida-real-sugere-menor-sobrevida-global-com-imunoterapia-em-idosos.html]]></loc><lastmod>2019-05-23T01:47:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-da-acp-sobre-rastreamento-do-cancer-de-mama-em-mulheres-com-risco-medio.html]]></loc><lastmod>2019-04-22T02:30:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/radioterapia-estereotatica-no-cancer-de-pulmao-estadio-1-inoperavel.html]]></loc><lastmod>2020-04-24T17:14:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/conflitos-de-interesse-na-oncologia-as-licoes-do-memorial.html]]></loc><lastmod>2019-04-07T14:57:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exercicio-fisico-e-risco-cardiovascular-em-pacientes-com-cancer-de-mama-inicial.html]]></loc><lastmod>2019-04-07T20:51:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/emergencias-oncologicas-qual-o-impacto-economico-e-para-o-paciente.html]]></loc><lastmod>2019-04-07T20:56:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-primeiro-rituximabe-biossimilar.html]]></loc><lastmod>2019-04-07T15:42:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-em-sobreviventes.html]]></loc><lastmod>2019-04-07T14:38:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/passado-presente-e-futuro-da-imuno-oncologia.html]]></loc><lastmod>2019-04-04T01:33:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/inibicao-de-hdac-pode-combater-a-resistencia-ao-anti-pd-1-em-pacientes-com-melanoma.html]]></loc><lastmod>2019-04-04T00:17:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/analise-da-incidencia-e-mortalidade-do-cancer-de-prostata-no-mundo.html]]></loc><lastmod>2019-04-04T01:40:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/combinacao-de-viroterapia-e-radioterapia-em-pacientes-vulneraveis-com-cancer-de-esofago.html]]></loc><lastmod>2019-04-03T15:38:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/gilteritinib-melhora-a-sobrevida-de-pacientes-com-leucemia-mieloide-aguda.html]]></loc><lastmod>2019-04-02T18:34:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/marcadores-de-resistencia-no-cancer-de-ovario.html]]></loc><lastmod>2019-04-04T01:08:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/risco-de-cancer-hereditario-na-populacao-de-caico.html]]></loc><lastmod>2019-04-02T11:28:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/tatton-trial-combinacao-de-inibidores-de-met-e-egfr-no-cancer-de-pulmao-pre-tratado.html]]></loc><lastmod>2020-04-24T17:14:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/combinacao-de-imunoterapia-no-carcinoma-neuroendocrino-de-alto-grau.html]]></loc><lastmod>2019-04-01T12:13:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/excesso-de-peso-antes-dos-50-anos-e-risco-de-morte-por-cancer-de-pancreas.html]]></loc><lastmod>2019-03-31T23:12:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/terapia-car-t-cel-dirigida-ao-her2-no-sarcoma-avancado.html]]></loc><lastmod>2019-03-31T18:22:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fulvestranto-anastrazol-combinacao-mostra-ganho-de-sobrevida-no-cancer-de-mama.html]]></loc><lastmod>2019-04-07T23:04:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variantes-germinativas-do-cdh1-e-habitos-alimentares-em-pacientes-com-cancer-gastrico-precoce-no-brasil.html]]></loc><lastmod>2019-04-02T12:30:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-discordancias-e-limitacoes.html]]></loc><lastmod>2019-03-29T13:45:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desprescricao-nos-cuidados-em-cancer-quando-parar.html]]></loc><lastmod>2019-03-25T20:31:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estilo-de-vida-e-mortes-por-cancer-no-brasil.html]]></loc><lastmod>2019-03-24T20:03:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-pesquisas-em-microbioma-esperam-melhorar-resultados-no-tratamento-do-cancer.html]]></loc><lastmod>2019-03-18T22:29:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-adjuvancia-no-cancer-do-trato-biliar-ressecavel.html]]></loc><lastmod>2019-03-18T12:05:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/embolizacao-transarterial-hepatica-em-pacientes-com-tumores-neuroendocrinos.html]]></loc><lastmod>2019-03-11T01:38:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-examina-hpv-no-cancer-de-penis.html]]></loc><lastmod>2019-03-11T01:36:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/talent-lenvatinibe-em-tumores-neuroendocrinos-pancreaticos-e-gastrointestinais.html]]></loc><lastmod>2019-03-09T16:42:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alta-carga-tumoral-e-tratamento-no-sistema-publico-associados-a-cardiopatia-carcinoide-e-menor-sobrevida-global.html]]></loc><lastmod>2019-03-07T20:45:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/suplementos-de-soja-e-risco-de-cancer-de-mama.html]]></loc><lastmod>2019-03-06T18:32:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/campanha-alerta-para-infeccao-pelo-hpv.html]]></loc><lastmod>2019-03-04T12:21:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacoes-egfr-e-kras-na-maior-serie-de-adenocarcinomas-pulmonares-brasileiros.html]]></loc><lastmod>2019-03-11T01:32:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lion-linfadenectomia-no-cancer-de-ovario-avancado.html]]></loc><lastmod>2019-03-11T01:39:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-pede-cautela-com-cirurgia-robotica-em-cancer.html]]></loc><lastmod>2019-03-01T15:13:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-sitc-2019/asco-sitc-apresenta-avancos-na-imunoterapia.html]]></loc><lastmod>2019-02-28T20:33:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-sitc-2019/novas-descobertas-sobre-resposta-imune-adaptativa-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:15:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-sitc-2019/combo-associa-inibidor-de-checkpoint-e-vacina-no-tratamento-do-cpnpc.html]]></loc><lastmod>2019-02-28T14:56:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-sitc-2019/checkmate-384-apoia-nova-opcao-de-dose-em-cpnpc.html]]></loc><lastmod>2019-02-28T14:54:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-rastreamento-do-cancer-colorretal-adaptado-a-disponibilidade-de-recursos.html]]></loc><lastmod>2019-03-11T01:33:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-do-inca-pode-acelerar-as-pesquisas-com-car-t-cells.html]]></loc><lastmod>2019-02-27T12:41:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aveloz-estudo-mostra-atividade-citotoxica-de-fitoterapico-brasileiro.html]]></loc><lastmod>2019-02-26T20:04:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/video-ricardo-dos-reis-e-sergio-serrano.html]]></loc><lastmod>2019-02-22T13:50:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-identifica-nova-linhagem-celular-no-cancer-cervical.html]]></loc><lastmod>2019-03-01T14:25:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/video-rui-manuel-reis-e-gilberto-lopes.html]]></loc><lastmod>2019-02-21T21:08:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/video-andrey-soares-e-ana-paula-garcia-cardoso.html]]></loc><lastmod>2019-02-19T13:51:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/video-powles.html]]></loc><lastmod>2019-02-19T13:57:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/video-andrey-e-bastos.html]]></loc><lastmod>2019-02-16T15:33:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/darolutamida-mostra-resultados-de-eficacia-e-seguranca-no-cancer-de-prostata.html]]></loc><lastmod>2019-02-15T07:59:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/arches-enzalutamida-adt-no-cancer-de-prostata-resistente-a-castracao.html]]></loc><lastmod>2019-03-21T16:13:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/spartan-apalutamida-mostra-dados-de-eficacia-e-seguranca-no-cancer-de-prostata-de-alto-risco.html]]></loc><lastmod>2019-02-15T08:27:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/denosumabe-e-hipocalcemia-no-cancer-de-prostata.html]]></loc><lastmod>2019-02-26T20:53:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/checkmate-650-imunoterapia-no-cancer-de-prostata-resistente-a-castracao.html]]></loc><lastmod>2019-02-15T06:09:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/latitude-analise-final-confirma-eficacia-na-primeira-linha.html]]></loc><lastmod>2019-02-15T15:58:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/imunoterapia-em-nova-combinacao-mostra-eficacia-no-cancer-renal-avancado.html]]></loc><lastmod>2019-02-17T00:29:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/lupsma-no-cancer-de-prostata.html]]></loc><lastmod>2019-02-11T22:07:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/raca-e-resposta-terapeutica-no-cancer-de-prostata.html]]></loc><lastmod>2019-02-11T22:51:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-massa-corporal-e-risco-de-cancer.html]]></loc><lastmod>2019-02-11T13:29:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variantes-da-linhagem-germinativa-no-cancer-de-prostata.html]]></loc><lastmod>2019-02-11T10:28:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gastrectomia-no-cancer-gastrico-inicial.html]]></loc><lastmod>2019-02-08T12:57:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/deficit-cognitivo-no-tratamento-do-cancer.html]]></loc><lastmod>2019-02-07T20:25:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-perspectivas-e-evidencias.html]]></loc><lastmod>2019-02-06T19:59:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-do-inca-investiga-necessidades-dos-sobreviventes-de-cancer-no-brasil.html]]></loc><lastmod>2019-02-04T18:03:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-discute-tecnica-cirurgica-no-cancer-de-mama.html]]></loc><lastmod>2019-02-04T00:26:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/progresso-nos-canceres-raros-o-avanco-do-ano.html]]></loc><lastmod>2019-02-03T19:38:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resseccao-do-linfonodo-cardiofrenico-no-cancer-de-ovario.html]]></loc><lastmod>2019-01-31T17:09:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atrasos-no-tratamento-do-cancer-do-colo-do-utero.html]]></loc><lastmod>2019-01-30T18:30:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-reve-indicacao-de-olaratumabe-para-o-tratamento-de-sarcoma.html]]></loc><lastmod>2019-02-03T22:15:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-de-infeccoes-virais-em-pacientes-com-cancer-recem-diagnosticado.html]]></loc><lastmod>2019-01-28T15:30:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/primeira-linha-de-tratamento-do-cancer-gastrico-avancado.html]]></loc><lastmod>2019-01-28T15:32:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gi-2019/quimioterapia-neoadjuvante-vs-cirurgia-upfront-no-cancer-de-pancreas-ressecavel.html]]></loc><lastmod>2019-01-20T23:10:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gi-2019/mega-pembrolizumabe-trastuzumabe-capecitabina-e-oxaliplatina-no-adenocarcinoma-esofagogastrico-metastatico-her2-positivo.html]]></loc><lastmod>2019-01-20T23:31:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gi-2019/trecc-retratamento-da-terapia-anti-egfr-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2019-01-20T23:27:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gi-2019/keynote-181-pembrolizumabe-em-segunda-linha-no-cancer-de-esofago-avancado.html]]></loc><lastmod>2019-01-20T23:36:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gi-2019/acompanhamento-de-rotina-no-cancer-colorretal-nao-metastatico-apos-resseccao.html]]></loc><lastmod>2019-01-18T21:53:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-mostra-cancer-associado-a-poluicao-ambiental-em-sao-paulo.html]]></loc><lastmod>2024-05-04T12:06:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/seguranca-e-manejo-de-inibidores-de-parp.html]]></loc><lastmod>2024-05-05T00:44:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/omega-3-e-vitamina-d-na-prevencao-do-cancer-mito-ou-verdade.html]]></loc><lastmod>2019-01-07T13:35:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-opcao-na-primeira-linha-de-llc.html]]></loc><lastmod>2019-01-10T21:42:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/ano-de-surpresas-na-oncoginecologia.html]]></loc><lastmod>2019-01-21T01:50:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/cancer-de-cabeca-e-pescoco-um-ano-em-revisao-4.html]]></loc><lastmod>2019-01-21T01:49:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/os-destaques-do-ano-na-oncohematologia.html]]></loc><lastmod>2019-01-21T01:48:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/panorama-gu-o-ano-em-review.html]]></loc><lastmod>2019-01-21T01:51:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/oncologia-toracica-o-que-foi-destaque-em-2018.html]]></loc><lastmod>2019-01-21T01:52:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consulta-publica-avalia-incorporacao-do-brentuximabe-vedotina-para-linfoma-de-hodgkin-pos-transplante.html]]></loc><lastmod>2018-12-14T18:24:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/sabcs-2018-radioterapia-adjuvante-no-cancer-de-mama.html]]></loc><lastmod>2018-12-11T17:15:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/as-licoes-de-sabcs2018.html]]></loc><lastmod>2018-12-12T15:06:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/tamoxifeno-em-baixa-dose-na-neoplasia-intraepitelial.html]]></loc><lastmod>2018-12-11T15:25:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/destaques-de-oncogenetica-no-sabcs-2018.html]]></loc><lastmod>2018-12-06T19:50:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/trastuzumabe-entansina-no-cancer-de-mama-her2-invasor-com-doenca-residual-apos-qt-neo.html]]></loc><lastmod>2018-12-08T18:37:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/radioterapia-parcial-ou-total-da-mama-apos-lumpectomia.html]]></loc><lastmod>2018-12-07T04:17:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/katherine-t-dm1-adjuvante-no-cancer-de-mama-her2-com-doenca-residual-invasiva.html]]></loc><lastmod>2018-12-08T18:44:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/daratumumabe-aumenta-a-sobrevida-livre-de-progressao-no-mieloma-multiplo-inelegivel-ao-transplante.html]]></loc><lastmod>2018-12-05T13:30:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/uso-de-anticoagulantes-orais-em-pacientes-com-cancer.html]]></loc><lastmod>2018-12-06T00:18:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/identificada-mutacao-na-proteina-bcl2-que-causa-resistencia-a-venetoclax.html]]></loc><lastmod>2018-12-07T04:17:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/capecitabina-adjuvante-nao-melhora-resultados-no-cancer-de-mama-triplo-negativo-em-estagio-inicial.html]]></loc><lastmod>2018-12-06T04:49:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/ibrutinibe-e-eficaz-e-seguro-em-pacientes-jovens-com-llc-nao-tratados-previamente.html]]></loc><lastmod>2018-12-06T04:48:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imuno-oncologia-o-cenario-da-pesquisa-clinica-em-2018.html]]></loc><lastmod>2018-12-03T21:58:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/tisagenlecleucel-mostra-remissoes-duradouras-em-criancas-e-jovens-adultos-com-leucemia.html]]></loc><lastmod>2018-12-03T14:28:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/resultados-de-longo-prazo-do-tisagenlecleucel-no-linfoma-difuso-de-grandes-celulas-b.html]]></loc><lastmod>2018-12-02T21:42:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/menos-quimioterapia-no-linfoma-difuso-de-grandes-celulas-b.html]]></loc><lastmod>2018-12-02T15:15:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/ibrutinibe-concomitante-melhora-os-resultados-da-terapia-cart-t-cell-em-llc.html]]></loc><lastmod>2018-12-03T13:47:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/ibrutinibe-e-superior-a-quimioimunoterapia-em-pacientes-idosos-com-leucemia-linfocitica-cronica.html]]></loc><lastmod>2018-12-02T16:36:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/luspatercept-reduz-a-necessidade-de-transfusoes-de-sangue.html]]></loc><lastmod>2018-12-01T20:51:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/colonoscopia-no-rastreamento-do-cancer-colorretal-o-que-indicar-na-populacao-idosa.html]]></loc><lastmod>2018-12-01T04:40:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-carne-quanto-e-seguro.html]]></loc><lastmod>2018-11-25T23:09:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-de-terapias-alvo-mostra-resultados-em-tumores-do-trato-digestivo.html]]></loc><lastmod>2018-11-30T17:43:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/toxicidades-cardiovasculares-associadas-a-inibidores-do-checkpoint-imunologico.html]]></loc><lastmod>2018-11-26T20:38:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-o-atezolizumabe-no-cancer-de-mama-triplo-negativo-pd-l1.html]]></loc><lastmod>2018-11-13T19:09:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vitamina-d-e-omega-3-nao-previnem-cancer-e-doencas-cardiovasculares.html]]></loc><lastmod>2018-11-26T20:37:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cannabis-e-canabinoides-na-oncologia.html]]></loc><lastmod>2018-11-26T01:46:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/painel-multigenes-e-confirmacao-diagnostica-no-cancer-de-tireoide.html]]></loc><lastmod>2018-11-25T23:55:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/histerectomia-minimamente-invasiva-vs-aberta-no-cancer-do-colo-do-utero.html]]></loc><lastmod>2018-11-04T22:17:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/microbiota-e-cancer-novas-perspectivas.html]]></loc><lastmod>2018-11-05T00:48:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/destaques-do-congresso-astro-2018.html]]></loc><lastmod>2018-10-29T13:19:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guia-pratico-baseado-em-evidencia-de-radioterapia-hipofracionada-para-cancer-de-prostata-localizado.html]]></loc><lastmod>2018-10-25T13:44:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/imunoterapia-melhora-a-sobrevida-em-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2018-10-22T15:49:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/imunoterapia-neoadjuvante-em-cancer-de-colon.html]]></loc><lastmod>2018-10-22T19:02:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/radioterapia-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2018-10-22T22:15:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/javelin-avelumabe-e-axitinibe-no-carcinoma-de-celulas-renais.html]]></loc><lastmod>2018-10-22T14:32:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/olaparibe-aumenta-a-sobrevida-livre-de-progressao-no-cancer-de-ovario-avancado.html]]></loc><lastmod>2018-10-21T16:32:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/solar-1-inibidor-de-pik3ca-no-cancer-de-mama.html]]></loc><lastmod>2018-10-22T19:50:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/paloma-3-mostra-beneficio-de-sobrevida-global.html]]></loc><lastmod>2018-10-22T18:52:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/imunoterapia-melhora-sobrevida-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2018-10-22T18:36:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/terapia-epigenetica-no-cancer-de-mama-avancado.html]]></loc><lastmod>2018-10-20T20:16:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/seguranca-da-imunoterapia-em-pacientes-com-cancer-hiv-positivo.html]]></loc><lastmod>2018-10-20T14:39:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/adesao-ao-tratamento-hormonal-e-risco-de-recorrencia-no-cancer-de-mama.html]]></loc><lastmod>2018-10-19T12:30:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/esmo-2018-discute-seis-meses-de-trastuzumabe-no-cancer-de-mama-her2.html]]></loc><lastmod>2018-10-19T14:49:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/esmo-debate-acesso-e-desigualdades-no-cenario-europeu.html]]></loc><lastmod>2018-10-19T10:05:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/diferencas-de-genero-no-cancer-esofagogastrico.html]]></loc><lastmod>2018-10-19T09:01:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-apalutamida-no-cancer-de-prostata-nao-metastatico-resistente-a-castracao.html]]></loc><lastmod>2018-10-19T12:31:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-talazoparib-no-tratamento-do-cancer-de-mama-brca-mutado.html]]></loc><lastmod>2018-10-19T12:42:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-combinacao-de-imunoterapicos-para-o-tratamento-do-cancer-renal.html]]></loc><lastmod>2018-10-16T00:26:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/seguimento-de-pacientes-com-cancer-de-pulmao-operados-que-exames-e-qual-a-frequencia.html]]></loc><lastmod>2020-04-24T19:54:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ibcsg-23-01-mostra-dados-de-10-anos.html]]></loc><lastmod>2018-10-14T20:52:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sunitinibe-e-pazopanibe-no-cancer-renal.html]]></loc><lastmod>2018-10-15T19:19:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/retratamento-com-inibidores-de-checkpoint-imune.html]]></loc><lastmod>2018-10-10T11:17:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/efeitos-da-quimioterapia-adjuvante-na-funcao-cognitiva-de-sobreviventes-de-cancer-colorretal.html]]></loc><lastmod>2018-10-15T02:20:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-associa-mutacao-e-cancer-de-pancreas-em-mulheres.html]]></loc><lastmod>2018-10-14T21:50:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/edicao-genomica-e-variantes-geneticas-de-brca1-na-predisposicao-ao-cancer.html]]></loc><lastmod>2018-10-02T19:55:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-recebem-premio-nobel-de-medicina-por-sua-contribuicao-para-o-tratamento-do-cancer.html]]></loc><lastmod>2018-10-01T19:12:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/wclc-2018-impacto-na-pratica-clinica.html]]></loc><lastmod>2018-09-30T22:51:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nelson-tomografia-para-o-gerenciamento-de-volume-de-nodulo-reduz-mortalidade-por-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:56:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impower133-atezolizumabe-no-cancer-de-pulmao-pequenas-celulas.html]]></loc><lastmod>2020-04-24T19:57:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacific-durvalumabe-no-cpnpc-irressecavel-sem-progressao-apos-quimiorradioterapia.html]]></loc><lastmod>2018-09-25T21:50:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-amplia-indicacao-da-lenalidomida.html]]></loc><lastmod>2018-09-25T22:01:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radio-oncologista-brasileiro-e-premiado-pela-iaslc.html]]></loc><lastmod>2018-09-24T18:57:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/necessidades-emocionais-nao-atendidas-dos-sobreviventes-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:58:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sunitinibe-ou-pazopanibe-no-sus-para-cancer-renal-metastatico.html]]></loc><lastmod>2018-09-25T02:18:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-das-comunidades-de-pacientes-e-cuidadores-focadas-em-fatores-oncogenicos-na-pesquisa-clinica.html]]></loc><lastmod>2018-09-25T02:17:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncologista-brasileira-recebe-premio-no-wclc-2018.html]]></loc><lastmod>2018-09-23T14:24:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/igcs-2018-destaques-no-cancer-ginecologico.html]]></loc><lastmod>2018-09-18T13:11:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-mais-trastuzumabe-sequencial-ou-simultanea-no-cancer-de-mama-her2.html]]></loc><lastmod>2018-09-16T22:38:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-pode-melhorar-resultados-no-cancer-de-pulmao-pequenas-celulas.html]]></loc><lastmod>2020-04-24T20:02:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-criterios-de-ineligibilidade-para-uso-de-cisplatina-no-carcinoma-de-cabeca-e-pescoco.html]]></loc><lastmod>2018-09-17T00:52:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/globocan-2018-carga-global-do-cancer.html]]></loc><lastmod>2018-09-17T01:42:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/jacob-estudo-discute-bloqueio-her2-no-cancer-gastrico-ou-jeg.html]]></loc><lastmod>2018-09-17T00:46:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-no-sus.html]]></loc><lastmod>2018-09-17T00:49:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iaslc-promessas-no-tratamento-do-mesotelioma.html]]></loc><lastmod>2018-09-10T12:58:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/jco-atualiza-diretrizes-para-pacientes-com-imunossupressao-associada-ao-cancer.html]]></loc><lastmod>2018-09-17T01:39:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-nova-indicacao-do-afatinibe.html]]></loc><lastmod>2018-09-05T22:03:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-neoadjuvante-em-dose-densa-no-cancer-de-bexiga.html]]></loc><lastmod>2018-09-16T04:43:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-de-corticosteroides-afeta-eficacia-da-imunoterapia.html]]></loc><lastmod>2018-09-15T18:25:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacoes-erbb2-erbb3-no-cancer-colorretal.html]]></loc><lastmod>2018-09-02T22:24:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diferencas-de-genero-na-oncologia.html]]></loc><lastmod>2018-09-02T22:47:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-e-mecanismo-de-resistencia.html]]></loc><lastmod>2018-09-02T21:46:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-intensivo-de-cancer-de-mama-com-ressonancia-magnetica-bianual-nas-pacientes-com-mutacao-no-gene-brca1.html]]></loc><lastmod>2018-08-30T20:03:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-discute-uso-de-placebo-em-estudos-clinicos-na-oncologia.html]]></loc><lastmod>2018-08-27T02:59:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/larcg-e-lacog-gu-assinam-recomendacoes-para-o-tratamento-do-cancer-renal.html]]></loc><lastmod>2018-08-27T03:16:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-precoce-de-alcool-e-risco-de-cancer-de-prostata-de-alto-grau.html]]></loc><lastmod>2018-09-02T21:50:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-lanca-escala-para-apoiar-medicina-de-precisao.html]]></loc><lastmod>2018-09-02T22:34:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacao-muc16-e-desfechos-no-cancer-gastrico.html]]></loc><lastmod>2018-08-19T03:22:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nccn-publica-guideline-para-neoplasia-trofoblastica-gestacional.html]]></loc><lastmod>2018-08-19T17:14:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-e-sobrevida-no-carcinoma-ductal-in-situ.html]]></loc><lastmod>2018-08-19T12:14:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/suspensao-de-corticoide-por-dez-semanas-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2018-08-30T01:45:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/frequencia-de-carcinoma-basocelular-e-risco-aumentado-de-cancer.html]]></loc><lastmod>2018-08-20T01:10:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sequenciamento-genomico-amplo-e-sobrevida-no-cpnpc-avancado.html]]></loc><lastmod>2018-08-19T17:29:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/identificados-genes-de-risco-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2018-08-21T20:39:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/maconha-medicinal-na-oncologia.html]]></loc><lastmod>2018-08-19T14:17:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trauma-da-infancia-e-preditivo-de-estadiamento-consumo-de-alcool-e-sintomas-emocionais-em-pacientes-com-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2018-08-19T13:41:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/primeira-transposicao-uterina-para-preservacao-da-fertilidade-no-cancer-cervical.html]]></loc><lastmod>2018-08-06T03:23:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-e-prevencao-de-tumores-de-colon-e-mama.html]]></loc><lastmod>2018-08-03T20:19:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inflamacao-promove-polipose-intestinal.html]]></loc><lastmod>2018-08-03T14:01:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/celulas-tumorais-circulantes-e-recidiva-no-cancer-de-mama.html]]></loc><lastmod>2018-08-06T03:40:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-projeta-aumento-da-mortalidade-por-cancer-de-pulmao-entre-mulheres-ate-2030.html]]></loc><lastmod>2020-04-24T20:09:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/densidade-de-trafego-e-risco-de-cancer-em-sao-paulo.html]]></loc><lastmod>2018-08-01T19:18:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/painel-de-microrna-pode-identificar-cancer-de-tireoide-em-nodulos-indeterminados.html]]></loc><lastmod>2018-08-06T03:15:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alimentacao-saudavel-associada-a-menor-risco-de-cancer.html]]></loc><lastmod>2018-08-06T03:47:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ferramenta-avalia-fragilidade-e-preve-sobrevida-no-mieloma-multiplo-recem-diagnosticado.html]]></loc><lastmod>2018-07-27T03:19:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/miles-adicao-de-cisplatina-no-tratamento-em-primeira-linha-de-idosos-com-cpnpc-avancado.html]]></loc><lastmod>2018-08-06T03:56:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-estereotaxica-aumenta-sobrevida-no-cancer-de-pulmao-inicial.html]]></loc><lastmod>2020-04-24T20:10:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/transplante-de-pulmao-limites-e-resultados.html]]></loc><lastmod>2020-04-24T20:10:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-neoadjuvante-no-adenocarcinoma-pancreatico-borderline-ressecavel.html]]></loc><lastmod>2018-07-22T16:25:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dose-e-sobrevida-no-mieloma-multiplo.html]]></loc><lastmod>2018-07-27T13:08:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nodulos-pulmonares-e-vigilancia-ativa.html]]></loc><lastmod>2018-07-23T20:19:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-testicular-impacto-e-risco-do-tratamento.html]]></loc><lastmod>2018-07-16T18:16:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/painel-de-biomarcadores-melhora-avaliacao-de-risco-de-cancer-de-pulmao-em-fumantes.html]]></loc><lastmod>2020-04-24T20:12:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-venetoclax-para-o-tratamento-de-leucemia-linfoide-cronica.html]]></loc><lastmod>2018-07-22T11:48:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/soft-e-text-mostram-dados-atualizados.html]]></loc><lastmod>2018-07-22T02:19:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-combinacao-de-imunoterapicos-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2018-07-12T14:48:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atualizacao-das-diretrizes-do-teste-her2-no-cancer-de-mama.html]]></loc><lastmod>2018-07-11T19:45:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-do-hpv-no-rastreamento-do-cancer-cervical.html]]></loc><lastmod>2018-07-09T14:19:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/watch-and-wait-no-cancer-de-reto.html]]></loc><lastmod>2018-07-08T22:26:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/avaliacao-automatizada-da-densidade-mamaria-em-exames-de-rastreamento.html]]></loc><lastmod>2018-07-09T13:46:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/descobertos-63-novos-loci-associados-ao-risco-de-cancer-de-prostata.html]]></loc><lastmod>2018-07-09T00:28:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-identificam-nova-variante-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:46:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/razor-cistectomia-radical-robotica-x-aberta-no-cancer-de-bexiga.html]]></loc><lastmod>2018-07-09T16:45:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pl-dos-agrotoxicos-avanca.html]]></loc><lastmod>2018-07-10T08:12:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-composto-mostra-eficacia-em-inibir-metastases.html]]></loc><lastmod>2018-07-09T00:47:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-avalia-apalutamida-no-cancer-de-prostata-metastatico-hormonio-sensivel.html]]></loc><lastmod>2018-06-25T20:53:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-da-dieta-e-diminuicao-do-risco-de-morte-em-sobreviventes-de-cancer.html]]></loc><lastmod>2018-06-26T22:56:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-mostram-perfil-das-mutacoes-brca-no-brasil.html]]></loc><lastmod>2018-06-19T13:36:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/crispr-cas9-pode-aumentar-risco-de-cancer.html]]></loc><lastmod>2018-06-19T12:42:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidores-de-jak-associados-ao-desenvolvimento-de-linfomas.html]]></loc><lastmod>2018-06-19T11:50:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eha-2018-discute-avancos-e-controversias-na-oncohematologia.html]]></loc><lastmod>2018-06-18T18:26:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/abordagens-para-cessacao-do-tabagismo.html]]></loc><lastmod>2018-06-16T03:57:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-de-terapias-integrativas-no-cancer-de-mama.html]]></loc><lastmod>2018-06-20T12:43:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-quimioterapia-e-terapia-alvo-adjuvantes-no-cancer-de-mama-inicial.html]]></loc><lastmod>2018-06-25T01:23:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-avaliacao-e-gestao-de-vulnerabilidades-em-idosos-recebendo-quimioterapia.html]]></loc><lastmod>2018-05-28T03:16:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-cuidados-paliativos-adaptados-a-disponibilidade-de-recursos-limitados.html]]></loc><lastmod>2018-06-19T12:48:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacoes-esr1-e-resistencia-a-terapia-endocrina.html]]></loc><lastmod>2018-05-10T20:36:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-interchange-sobrevida-do-cabeca-e-pescoco-na-america-do-sul.html]]></loc><lastmod>2018-05-12T14:45:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-nao-demonstra-associacao-entre-vitamina-d-e-reducao-do-risco-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:22:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eventos-adversos-imuno-relacionados-associado-a-agentes-anti-pd-1-e-anti-pd-l1.html]]></loc><lastmod>2018-05-02T19:27:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/zika-virus-e-tumores-embrionarios-do-snc.html]]></loc><lastmod>2018-04-26T23:56:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-entre-os-100-trabalhos-de-maior-impacto-em-cirurgia.html]]></loc><lastmod>2018-04-27T18:53:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-aponta-crescimento-do-numero-de-casos-de-cancer-atribuiveis-a-obesidade-no-brasil.html]]></loc><lastmod>2018-05-01T22:19:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/posh-mutacao-hereditaria-e-desfecho-no-cancer-de-mama.html]]></loc><lastmod>2018-04-26T19:45:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pancreatite-aguda-e-risco-de-cancer-pancreatico.html]]></loc><lastmod>2018-04-26T19:45:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tatuagem-biologica-e-diagnostico-precoce-do-cancer.html]]></loc><lastmod>2018-04-26T19:13:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/burnout-um-desafio-silencioso.html]]></loc><lastmod>2018-04-19T12:56:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/agrotoxicos-e-cancer-conhecemos-a-realidade.html]]></loc><lastmod>2018-04-27T14:52:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/critics-estrategias-de-tratamento-no-cancer-gastrico.html]]></loc><lastmod>2018-04-27T14:18:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aacr-2018-crizotinibe-mostra-resultados-no-tumor-miofibroblastico-inflamatorio-alk-positivo.html]]></loc><lastmod>2018-04-18T01:58:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/estudo-brasileiro-explora-assinaturas-moleculares-de-celulas-tronco-nos-tumores.html]]></loc><lastmod>2018-04-18T01:50:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/neoadjuvancia-no-cancer-de-colo-uterino---onde-estamos.html]]></loc><lastmod>2018-04-15T19:16:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-preservacao-da-fertilidade-em-pacientes-com-cancer.html]]></loc><lastmod>2018-04-16T00:43:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/mutacoes-nao-codificadoras-e-alteracoes-na-expressao-genica-dos-tumores.html]]></loc><lastmod>2018-04-13T21:13:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sarcopenia-no-paciente-oncologico.html]]></loc><lastmod>2018-04-16T15:28:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/seguranca-do-paciente-em-pesquisa-clinica.html]]></loc><lastmod>2018-04-09T14:21:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-para-tratamento-do-cancer-de-prostata-metastatico-hormonio-sensivel.html]]></loc><lastmod>2018-04-15T19:56:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destaques-do-sgo-2018.html]]></loc><lastmod>2018-04-02T12:17:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/seguranca-de-medicamentos-em-oncologia.html]]></loc><lastmod>2018-04-01T23:28:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/import-low-mostra-dados-na-conferencia-europeia.html]]></loc><lastmod>2018-04-01T20:49:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intersticio-descoberta-de-novo-orgao-e-seu-impacto-na-oncologia.html]]></loc><lastmod>2018-04-06T15:41:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-papel-do-medico-na-adesao-a-vacina-contra-hpv-em-meninos.html]]></loc><lastmod>2018-04-01T21:49:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/toxicidade-dos-inibidores-de-checkpoint-no-cancer-de-ovario-recorrente.html]]></loc><lastmod>2018-03-27T14:29:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/erradicacao-do-h-pylori-beneficia-pacientes-com-cancer-gastrico-precoce.html]]></loc><lastmod>2018-04-10T22:13:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nccn-atualiza-guideline-de-tratamento-do-cancer-de-colon.html]]></loc><lastmod>2018-03-29T14:02:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-papel-do-microbioma-intestinal-no-cancer-de-pancreas.html]]></loc><lastmod>2018-03-26T14:38:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/mri-ou-biopsia-padrao-no-diagnostico-do-cancer-de-prostata.html]]></loc><lastmod>2018-03-29T20:28:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/portec-3-quimiorradioterapia-adjuvante-vs-radioterapia-isolada-no-cancer-de-endometrio-de-alto-risco.html]]></loc><lastmod>2018-03-19T02:37:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-para-tratamento-do-cancer-em-pacientes-soropositivos.html]]></loc><lastmod>2018-03-19T01:01:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/novas-diretrizes-para-hipofracionamento-no-cancer-de-mama.html]]></loc><lastmod>2018-03-19T00:59:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-de-risco-cardiovascular-em-sobreviventes-de-cancer-testicular.html]]></loc><lastmod>2018-03-19T02:42:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alteracoes-nos-principais-genes-drivers-e-resultados-no-adenocarcinoma-de-pancreas-ressecado.html]]></loc><lastmod>2018-03-19T02:36:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-confirma-presenca-de-produtos-quimicos-cancerigenos-em-usuarios-de-cigarros-eletronicos.html]]></loc><lastmod>2018-03-19T02:09:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guidelines-do-nccn-estudo-questiona-valor-da-evidencia.html]]></loc><lastmod>2018-03-08T16:46:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-penis-estudo-de-revisao-mostra-cenario-nos-eua.html]]></loc><lastmod>2018-03-18T18:11:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-25-anos-de-aprovacao-acelerada.html]]></loc><lastmod>2018-03-08T16:53:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-compara-assinaturas-genicas.html]]></loc><lastmod>2018-03-04T21:29:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-ovario-familiar-e-padrao-hereditario.html]]></loc><lastmod>2018-03-05T19:43:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adjuvancia-com-inibidores-de-aromatase-apos-a-menopausa.html]]></loc><lastmod>2018-03-08T21:24:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/a-fotografia-do-cancer-de-pulmao-no-brasil.html]]></loc><lastmod>2020-04-24T17:24:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/abordagem-tumoral-agnostica-um-novo-paradigma-2.html]]></loc><lastmod>2018-03-04T23:38:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/evidencias-e-controversias-na-prostatectomia.html]]></loc><lastmod>2018-02-26T02:41:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exercicio-melhora-mobilidade-do-braco-apos-cirurgia-de-cancer-de-mama.html]]></loc><lastmod>2018-03-04T23:17:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-custo-do-cancer-nos-brics.html]]></loc><lastmod>2018-02-25T03:28:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-paliativos-e-qualidade-de-vida.html]]></loc><lastmod>2018-02-25T03:43:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exercicio-pre-operatorio-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:25:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caminhos-geneticos-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2018-02-25T03:49:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-do-uspstf-para-rastreamento-em-cancer-de-ovario-2.html]]></loc><lastmod>2018-02-19T13:23:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/calor-quimioterapia-adjuvante-no-cancer-de-mama-er.html]]></loc><lastmod>2018-02-19T00:36:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-na-imunoterapia-uma-contribuicao-brasileira.html]]></loc><lastmod>2018-02-19T00:43:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/big-impacto-da-radioterapia-pos-mastectomia.html]]></loc><lastmod>2018-02-14T19:17:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gu-2018/prosper-enzalutamida-reduz-risco-de-metastase-no-cancer-de-prostata-resistente-a-castracao.html]]></loc><lastmod>2018-02-19T01:45:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gu-2018/stampede-adicao-de-quimioterapia-a-terapia-hormonal-para-cancer-de-prostata-melhora-qualidade-de-vida.html]]></loc><lastmod>2018-02-23T21:07:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gu-2018/spartan-apalutamida-adia-desenvolvimento-de-metastases-no-cancer-de-prostata.html]]></loc><lastmod>2018-02-19T01:00:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-colorretal-e-microbioma-intestinal.html]]></loc><lastmod>2018-02-05T01:06:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/marcadores-de-resposta-imune-no-cancer-renal.html]]></loc><lastmod>2018-02-05T00:26:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/os-numeros-do-cancer-no-brasil.html]]></loc><lastmod>2018-02-04T23:32:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-identifica-mutacoes-do-gene-brca2-associadas-ao-cancer-de-mama-e-ovario-2.html]]></loc><lastmod>2018-02-04T21:41:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsias-no-seguimento-do-cancer-de-mama.html]]></loc><lastmod>2018-02-05T00:19:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-intraperitoneal-hipertermica-no-cancer-de-ovario.html]]></loc><lastmod>2018-02-04T20:16:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avanco-do-ano.html]]></loc><lastmod>2018-02-05T00:23:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-publica-guideline-sobre-tratamento-do-mesotelioma-pleural-maligno.html]]></loc><lastmod>2018-02-05T00:03:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibicao-de-checkpoint-imune-em-subgrupo-de-pacientes-com-cancer-de-prostata-inicial.html]]></loc><lastmod>2018-02-05T00:13:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-livre-de-doenca-como-surrogate-endpoint-no-carcinoma-de-celulas-renais-localizado.html]]></loc><lastmod>2018-02-04T23:48:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-e-diagnostico-precoce-sp-414.html]]></loc><lastmod>2018-02-02T15:35:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gi-2018/biopsia-liquida-e-deteccao-precoce-do-cancer-colorretal.html]]></loc><lastmod>2018-01-22T00:11:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-neoadjuvante-e-recidiva-local-no-cancer-de-mama.html]]></loc><lastmod>2018-01-22T00:10:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/endocrinopatias-induzidas-por-imunoterapia-guia-pratico-de-diagnostico-e-manejo.html]]></loc><lastmod>2018-01-14T13:55:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mecanismo-de-resistencia-aos-inibidores-de-checkpoint-imune.html]]></loc><lastmod>2018-01-08T21:58:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/beneficio-clinico-em-xeque.html]]></loc><lastmod>2018-01-22T01:57:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-novos-tratamentos-contra-o-cancer.html]]></loc><lastmod>2018-01-21T23:53:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/ash-2017/eficacia-e-seguranca-da-terapia-car-t-cells.html]]></loc><lastmod>2018-02-01T15:50:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/san-antonio-2017/destaques-de-san-antonio-2017.html]]></loc><lastmod>2017-12-12T19:46:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-nivolumabe-para-tratamento-do-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2017-12-11T01:38:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sus-incorpora-pertuzumabe-na-primeira-linha-de-tratamento-do-cancer-de-mama-metastatico-her2.html]]></loc><lastmod>2017-12-19T14:31:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-e-diabetes-aumentam-carga-global-de-cancer.html]]></loc><lastmod>2017-11-29T20:25:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-alerta-para-a-relacao-entre-alcool-e-cancer.html]]></loc><lastmod>2017-12-06T00:36:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aplicativo-identifica-erros-em-mais-de-60-artigos-cientificos-sobre-genetica-e-cancer.html]]></loc><lastmod>2017-11-27T01:22:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-triplo-negativo-tem-potencial-alvo-terapeutico.html]]></loc><lastmod>2017-12-17T20:30:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-pembrolizumabe-para-tratamento-de-pacientes-com-cancer-de-bexiga-avancado.html]]></loc><lastmod>2017-11-27T00:45:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/flaura-resultados-no-cancer-de-pulmao-avancado.html]]></loc><lastmod>2020-04-24T17:26:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/thycat-teste-avalia-qualidade-de-vida-em-sobreviventes-de-cancer-de-tireoide.html]]></loc><lastmod>2017-11-26T21:46:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-gastrico-e-inibidores-de-bomba-de-protons.html]]></loc><lastmod>2017-11-20T12:16:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/varfarina-e-incidencia-de-cancer.html]]></loc><lastmod>2017-11-12T14:26:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-rol-de-procedimentos-da-ans.html]]></loc><lastmod>2017-11-13T01:36:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-intestinal-e-resposta-a-inibidores-de-checkpoint-imune.html]]></loc><lastmod>2017-11-12T12:30:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/a-carga-global-do-cancer-em-jovens.html]]></loc><lastmod>2017-11-12T21:08:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/isquemia-remanescente-apos-resseccao-hepatica-e-resultados-de-sobrevida.html]]></loc><lastmod>2017-11-03T20:19:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-da-asco-para-a-prevencao-e-tratamento-da-obesidade.html]]></loc><lastmod>2017-11-07T12:39:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/novos-loci-associados-ao-cancer-de-mama.html]]></loc><lastmod>2017-10-30T05:10:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/sbrt-tem-nova-diretoria.html]]></loc><lastmod>2017-10-30T06:12:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/valorizacao-da-cirurgia-oncologica.html]]></loc><lastmod>2017-10-30T06:11:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/sboc-tem-nova-diretoria.html]]></loc><lastmod>2017-10-28T02:02:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/potencial-clinico-do-escarro-na-deteccao-de-mutacoes-driver-no-cpnpc.html]]></loc><lastmod>2017-10-30T05:05:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gbot-anuncia-vencedores-do-premio-ronaldo-ribeiro-de-pesquisa-clinica.html]]></loc><lastmod>2017-10-27T11:55:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-robotica-o-beneficio-vale-o-custo.html]]></loc><lastmod>2017-10-30T03:17:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/semana-brasileira-de-oncologia-discute-incorporacao-e-acesso.html]]></loc><lastmod>2017-10-26T13:02:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inspire-parceria-agiliza-diagnostico-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:29:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-segunda-terapia-genica-de-car-t-cells.html]]></loc><lastmod>2017-10-30T04:39:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-molecular-e-selecao-terapeutica-no-cancer-de-pulmao-como-estamos.html]]></loc><lastmod>2020-04-24T17:29:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/wclc-2017-ac-camargo-mostra-dados-do-mesotelioma.html]]></loc><lastmod>2017-10-18T15:04:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-anunciam-hsd3b1-como-biomarcador-preditivo-no-cancer-de-prostata.html]]></loc><lastmod>2017-10-16T01:48:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/um-pacto-pela-pesquisa-em-cancer.html]]></loc><lastmod>2017-10-13T02:45:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-ovario-seroso-e-microambiente-tumoral.html]]></loc><lastmod>2017-10-16T01:02:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metanalise-disfuncao-endocrina-com-inibidores-de-checkpoint.html]]></loc><lastmod>2017-10-15T21:04:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-e-resposta-a-inibidores-de-checkpoint.html]]></loc><lastmod>2017-10-15T02:58:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/astro-irradiacao-pelvica-adjuvante-no-cancer-endometrial-de-alto-risco.html]]></loc><lastmod>2017-10-02T15:01:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inca-e-itc-mostram-numeros-do-controle-do-tabaco-no-brasil.html]]></loc><lastmod>2017-10-01T23:34:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacoes-spop-no-cancer-de-prostata-orientam-novo-racional-terapeutico.html]]></loc><lastmod>2017-10-01T23:21:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidores-de-checkpoint-imune-desafios-e-perspectivas.html]]></loc><lastmod>2017-10-01T23:25:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/miro-esofagectomia-minimamente-invasiva.html]]></loc><lastmod>2017-09-25T13:58:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/terapias-alvo-e-imunoterapia-no-melanoma.html]]></loc><lastmod>2017-10-01T23:50:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/checkmate-214-nivolumabe-e-ipilimumabe-no-carcinoma-renal-avancado-ou-metastatico.html]]></loc><lastmod>2017-09-18T03:02:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/presenca-brasileira-na-esmo-2017.html]]></loc><lastmod>2017-09-15T20:53:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-publica-guideline-sobre-comunicacao-medico-paciente.html]]></loc><lastmod>2017-09-15T19:50:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/keynote-028-pembrolizumabe-em-tnes-pancreaticos-ou-carcinoides.html]]></loc><lastmod>2017-09-15T19:51:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prosper-enzalutamida-adt-no-cancer-de-prostata-nao-metastatico.html]]></loc><lastmod>2017-09-14T18:23:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/ifct-0302-seguimento-de-pacientes-com-cancer-de-pulmao-completamente-ressecado.html]]></loc><lastmod>2020-04-24T17:31:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/keynote-040-imunoterapia-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2017-09-12T19:47:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/terapias-alvo-no-melanoma-metastatico.html]]></loc><lastmod>2017-09-20T22:17:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/nivo-versus-ipi-no-melanoma-de-alto-risco.html]]></loc><lastmod>2017-09-20T22:15:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/keynote-045-pembrolizumabe-em-segunda-linha-no-cancer-de-bexiga.html]]></loc><lastmod>2017-09-11T19:08:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/monarch-3-resultados-no-cancer-de-mama-receptor-hormonal.html]]></loc><lastmod>2017-09-11T17:40:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/maps2-nivolumabe-ipiimumabe-no-mesotelioma-pleural-maligno.html]]></loc><lastmod>2017-09-11T20:19:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/ramucirumabe-e-docetaxel-no-carcinoma-urotelial-de-bexiga.html]]></loc><lastmod>2017-09-15T19:36:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/avancos-no-cancer-de-pulmao-egfr-mutado.html]]></loc><lastmod>2020-04-24T17:32:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/pacific-durvalumab-no-cancer-de-pulmao-avancado.html]]></loc><lastmod>2020-04-24T17:32:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/abiraterona-e-docetaxel-no-cancer-de-prostata-de-alto-risco.html]]></loc><lastmod>2017-09-11T17:42:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/flot4-superioridade-da-terapia-tripla-com-docetaxel-no-cancer-gastrico.html]]></loc><lastmod>2017-09-11T17:43:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/estudo-miro-mostra-vantagem-da-esofagectomia-minimamente-invasiva.html]]></loc><lastmod>2017-09-11T17:44:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/esmo-2017-apresenta-resultados-do-icon-8.html]]></loc><lastmod>2017-09-17T04:19:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-para-o-tratamento-de-tumores-neuroendocrinos.html]]></loc><lastmod>2017-09-04T14:58:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/primeira-terapia-genetica-e-aprovada-pelo-fda.html]]></loc><lastmod>2017-09-04T03:33:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretiva-de-vontade-e-cuidados-de-final-de-vida.html]]></loc><lastmod>2017-09-04T03:14:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/apesar-dos-avancos-combate-ao-tabagismo-ainda-e-desafio.html]]></loc><lastmod>2017-08-29T18:42:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/comprometimento-linfonodal-e-prognostico-na-neoplasia-de-anus.html]]></loc><lastmod>2017-09-04T23:00:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comparacao-entre-regimes-de-quimioterapia-neoadjuvante-no-adenocarcinoma-esofagico.html]]></loc><lastmod>2017-08-28T11:50:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/prevencao-e-diagnostico-oportuno.html]]></loc><lastmod>2017-08-24T17:38:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/desafios-da-oncologia-de-precisao.html]]></loc><lastmod>2017-08-24T14:35:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-e-diagnostico-precoce.html]]></loc><lastmod>2017-08-21T02:25:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atlas-do-transcriptoma-mapeia-17-principais-tipos-de-cancer.html]]></loc><lastmod>2017-08-21T01:15:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/grupo-brasileiro-assina-diretrizes-para-manejo-de-toxicidades-imunomediadas.html]]></loc><lastmod>2017-08-21T15:08:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-diretrizes-para-imunoterapia-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:30:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-discute-toxicidade-com-inibidores-de-checkpoint-imune.html]]></loc><lastmod>2017-08-20T22:53:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-promessa-no-cancer-de-mama-hormonio-dependente.html]]></loc><lastmod>2017-08-14T12:43:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/selecao-molecular-no-cancer-de-pancreas.html]]></loc><lastmod>2017-08-14T13:01:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sus-incorpora-o-trastuzumabe-para-o-tratamento-do-cancer-de-mama-her2-metastatico.html]]></loc><lastmod>2017-08-07T05:52:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-baiocchi.html]]></loc><lastmod>2017-08-07T06:50:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacoes-e-resposta-a-inibidores-de-checkpoint-no-cancer-renal.html]]></loc><lastmod>2017-08-07T06:58:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gordura-saturada-pode-aumentar-o-risco-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:31:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dieta-com-baixo-teor-de-gordura-e-mortalidade-por-cancer-de-mama.html]]></loc><lastmod>2017-07-24T01:13:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncologia-clinica-e-cirurgia-oncologica-reconhecidas-como-especialidades-medicas.html]]></loc><lastmod>2017-07-24T03:42:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prostatectomia-ou-observacao.html]]></loc><lastmod>2017-07-24T01:14:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/um-alerta-a-oncologia-de-precisao.html]]></loc><lastmod>2017-07-18T03:28:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-oral-e-interacao-medicamentosa.html]]></loc><lastmod>2017-07-24T04:58:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avancos-e-promessas-na-oncohematologia.html]]></loc><lastmod>2017-07-10T05:02:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/reconhecimento-em-cuidados-paliativos.html]]></loc><lastmod>2017-07-24T15:00:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/avancos-e-controversias-no-phttp-www-onconews-com-br-site-administrator-index-phpoption-com-content-view-article-layout-edit-id-2722-imagesanorama-gi.html]]></loc><lastmod>2017-07-03T02:51:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/grandes-estudos-pequenos-resultados.html]]></loc><lastmod>2017-07-03T21:40:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brasil-inaugura-banco-multicentrico-de-cancer-de-testiculo.html]]></loc><lastmod>2017-07-01T19:36:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/o-valor-da-prevencao.html]]></loc><lastmod>2017-06-30T21:57:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/gbot-aponta-os-destaques-da-oncologia-toracica.html]]></loc><lastmod>2017-06-26T05:57:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/archer-1050-dacomitinib-no-tratamento-de-primeira-linha-do-cpnpc-avancado-egfr-mutado.html]]></loc><lastmod>2020-04-24T18:35:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/calm-intervencao-psicologica-em-pacientes-com-cancer-avancado.html]]></loc><lastmod>2017-06-12T15:10:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/genes-de-suscetibilidade-ao-cancer-de-mama.html]]></loc><lastmod>2017-06-12T14:32:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-pembrolizumabe-no-tratamento-do-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:36:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/aphinity-resultados-decepcionam-na-asco-2017.html]]></loc><lastmod>2017-06-12T17:16:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/maps-2-resultados-iniciais-sugerem-eficacia-da-imunoterapia-no-mesotelioma.html]]></loc><lastmod>2017-06-12T05:27:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/tabela-lba-3-fizazi.html]]></loc><lastmod>2017-06-12T15:00:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/estudo-estabelece-novo-padrao-de-quimioterapia-adjuvante-no-cancer-de-colon.html]]></loc><lastmod>2017-06-12T15:47:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/ferramenta-online-para-paciente-reportar-sintomas-aumenta-sobrevida.html]]></loc><lastmod>2018-05-02T14:43:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/radioterapia-em-dose-unica-para-metastase-ossea-na-realidade-brasileira.html]]></loc><lastmod>2017-06-12T00:21:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/stampede-abiraterona-na-primeira-linha-do-cancer-de-prostata-avancado.html]]></loc><lastmod>2017-06-12T15:02:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/nova-droga-mostra-eficacia-em-diversos-canceres-adultos-e-pediatricos.html]]></loc><lastmod>2017-06-03T23:38:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/gravidez-apos-cancer-de-mama-nao-aumenta-chance-de-recorrencia.html]]></loc><lastmod>2017-06-12T17:22:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/platinum-hipogonadismo-apos-o-cancer-testicular.html]]></loc><lastmod>2017-06-03T21:34:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/terapia-online-stream-melhora-a-qualidade-de-vida-apos-o-diagnostico.html]]></loc><lastmod>2017-06-12T15:12:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/rt-em-dose-unica-na-compressao-medular.html]]></loc><lastmod>2017-06-02T18:05:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/qualidade-de-vida-do-paciente-em-foco-na-asco-2017.html]]></loc><lastmod>2017-06-12T15:17:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/abordagem-reduz-o-medo-da-recidiva-em-sobreviventes-de-cancer.html]]></loc><lastmod>2017-06-12T15:20:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/imunoterapia-em-pacientes-de-melanoma-avancado-com-metastases-cerebrais.html]]></loc><lastmod>2017-06-12T20:05:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-custo-do-tabaco-para-o-brasil.html]]></loc><lastmod>2017-06-01T21:53:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/cancer-gastrico---tumores-avancados-multidisciplinaridade-e-avancos-no-tratamento-oncologico.html]]></loc><lastmod>2017-05-28T23:04:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/asco-mostra-avancos-e-promessas-em-llc.html]]></loc><lastmod>2017-05-30T21:40:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/car-t-mostra-segunda-geracao-em-lla.html]]></loc><lastmod>2017-05-28T12:53:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/asco-2017-mostra-avancos-em-mieloma-multiplo.html]]></loc><lastmod>2017-05-29T00:44:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/selumetinib-nao-traz-beneficio-significativo-ao-tratamento-do-cpnpc-kras-mutado-previamente-tratado.html]]></loc><lastmod>2017-05-23T21:53:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imvigor211-atezolizumabe-nao-melhora-a-sobrevida-em-cancer-de-bexiga.html]]></loc><lastmod>2017-05-22T20:24:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/asco-2017-quimioterapia-oral-prolonga-a-sobrevida-no-cancer-do-trato-biliar.html]]></loc><lastmod>2017-05-29T00:47:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/estilo-de-vida-saudavel-e-sobrevida-em-pacientes-com-cancer-de-colon.html]]></loc><lastmod>2017-06-17T22:29:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/asco-2017-apesar-do-alto-grau-de-protecao-vacina-contra-hpv-tem-baixa-adesao-entre-jovens-adultos-nos-eua.html]]></loc><lastmod>2017-05-29T00:48:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/asco-e-os-destaques-da-reuniao-anual.html]]></loc><lastmod>2017-05-29T00:49:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-pulmao-em-foco.html]]></loc><lastmod>2020-04-24T16:55:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/um-tributo-a-memoria.html]]></loc><lastmod>2017-05-08T13:21:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-para-terapia-adjuvante-no-cpnpc.html]]></loc><lastmod>2017-05-03T20:09:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-demonstra-beneficio-da-medicina-de-precisao-em-pacientes-com-cancer-avancado.html]]></loc><lastmod>2017-05-02T04:09:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/diretrizes-para-radioterapia-no-cancer-de-orofaringe.html]]></loc><lastmod>2017-05-02T04:11:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncologistas-burnout-e-exaustao-profissional.html]]></loc><lastmod>2018-08-15T14:37:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-segunda-geracao-aposta-nos-inibidores-ido.html]]></loc><lastmod>2017-04-25T12:12:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-astro-para-radioterapia-no-cancer-de-orofaringe.html]]></loc><lastmod>2017-04-24T14:58:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/exame-de-psa-no-rastreamento-do-cancer-de-prostata.html]]></loc><lastmod>2017-08-15T17:54:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-para-cancer-de-pancreas-potencialmente-curavel.html]]></loc><lastmod>2017-04-16T00:58:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-para-paineis-de-oncologia-baseados-em-sequenciamento-de-proxima-geracao.html]]></loc><lastmod>2017-04-16T00:59:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uspstf-reve-diretrizes-para-rastreamento-do-cancer-de-prostata.html]]></loc><lastmod>2017-04-16T19:13:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-e-hiperprogressao.html]]></loc><lastmod>2017-05-01T19:54:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-abordagem-sensibiliza-tumores-de-pancreas-antes-da-quimioterapia.html]]></loc><lastmod>2017-04-10T14:37:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tabagismo-o-impacto-da-carga-global.html]]></loc><lastmod>2017-04-10T12:44:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-regular-de-aspirina-e-menor-mortalidade-por-cancer.html]]></loc><lastmod>2017-04-06T18:37:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-de-antibiotico-e-cancer-colorretal.html]]></loc><lastmod>2017-04-10T14:39:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-de-st-gallen-no-cancer-de-prostata-avancado.html]]></loc><lastmod>2017-04-02T21:15:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/irecist-novos-criterios-de-resposta-em-imuno-oncologia.html]]></loc><lastmod>2017-04-03T13:17:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/destaques-do-sgo-2017.html]]></loc><lastmod>2017-04-02T21:55:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-lado-negro-da-revisao-por-pares.html]]></loc><lastmod>2017-03-28T20:27:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-alerta-para-implantes-mamarios-e-risco-de-cancer.html]]></loc><lastmod>2017-04-03T00:37:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preservacao-de-orgao-no-cancer-anal.html]]></loc><lastmod>2017-03-23T13:42:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/rodrigo-hanriot.html]]></loc><lastmod>2017-05-15T14:07:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-discute-risco-de-segunda-neoplasia-em-mieloma-multiplo.html]]></loc><lastmod>2017-03-17T15:59:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bisfosfonatos-uso-adjuvante-no-cancer-de-mama.html]]></loc><lastmod>2017-03-08T20:13:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/cancer-e-fertilidade.html]]></loc><lastmod>2017-03-23T13:33:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/linfonodo-sentinela-no-estadiamento-do-cancer-de-endometrio.html]]></loc><lastmod>2017-03-03T16:11:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-do-cancer-de-ovario-em-mulheres-de-alto-risco.html]]></loc><lastmod>2017-03-02T19:59:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibicao-combinada-de-pd-1-e-ctla-4-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2017-03-02T12:59:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/valor-dos-biomarcadores-no-cancer-colorretal-depende-da-localizacao-do-tumor.html]]></loc><lastmod>2017-02-23T20:49:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resposta-a-imunoterapia-e-microbioma-intestinal.html]]></loc><lastmod>2017-02-22T20:46:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gu-2017/selecao-molecular-no-cancer-de-prostata.html]]></loc><lastmod>2017-02-21T19:19:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gu-2017/biopsia-liquida-no-cancer-de-prostata-avancado.html]]></loc><lastmod>2017-02-21T14:18:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/publicado-i-consenso-brasileiro-em-cancer-de-prostata-avancado.html]]></loc><lastmod>2017-03-06T02:20:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gu-2017/estudo-brasileiro-e-destaque-na-asco-gu.html]]></loc><lastmod>2017-04-03T19:48:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/hormonioterapia-no-cancer-de-mama.html]]></loc><lastmod>2017-05-15T15:03:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/painel-gi-evidencias-para-a-pratica-clinica.html]]></loc><lastmod>2017-04-13T12:25:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/selecao-molecular-no-cancer-colorretal.html]]></loc><lastmod>2017-02-12T23:25:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/braquiterapia-intersticial-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2017-02-12T17:42:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-colorretal-e-predisposicao-hereditaria.html]]></loc><lastmod>2017-02-12T23:36:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-aponta-os-destaques-da-pesquisa-em-cancer.html]]></loc><lastmod>2017-02-06T20:00:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-para-o-tratamento-do-h-pylori.html]]></loc><lastmod>2017-02-07T17:51:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-daratumumabe-para-tratamento-do-mieloma-multiplo.html]]></loc><lastmod>2017-01-31T18:22:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ansiedade-em-parceiros-de-jovens-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2017-01-24T17:11:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-diminuicao-da-atividade-fisica-apos-o-diagnostico.html]]></loc><lastmod>2017-01-24T13:56:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tabagismo-custa-us-1-trilhao-por-ano-a-economia-mundial.html]]></loc><lastmod>2017-01-17T16:00:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/projeto-genie-conjunto-de-dados-genomicos-sobre-o-cancer.html]]></loc><lastmod>2017-01-12T15:41:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-global-qualidade-de-vida-e-seguranca-dos-novos-medicamentos.html]]></loc><lastmod>2017-01-09T01:09:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-adjuvante-tardia-e-sobrevida-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:42:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-achados-na-classificacao-genomica-do-cancer-de-esofago.html]]></loc><lastmod>2017-01-06T14:09:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/epigenetica-cancer-e-nutricao.html]]></loc><lastmod>2017-01-04T14:06:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-nivolumabe-para-cancer-renal.html]]></loc><lastmod>2016-12-20T20:40:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/san-antonio-2016/destaques-de-san-antonio.html]]></loc><lastmod>2016-12-12T02:15:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/mundial-de-pulmao-2016/ascend-4-mostra-resultados-no-congresso-mundial-de-pulmao.html]]></loc><lastmod>2020-04-24T18:45:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/ash-2016/gallium-obinutuzumab-aumenta-sobrevida-em-linfoma-folicular.html]]></loc><lastmod>2016-12-12T17:51:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/ash-2016/beneficio-e-seguranca-da-reducao-ou-interrupcao-do-tratamento-da-leucemia-mieloide-cronica.html]]></loc><lastmod>2016-12-12T02:50:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/san-antonio-2016/beneficio-limitado-da-terapia-prolongada-com-letrozol-no-cancer-de-mama-inicial-hr-na-pos-menopausa.html]]></loc><lastmod>2016-12-12T00:57:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/ash-2016/ash-2016-cpx-351-melhora-sobrevida-em-pacientes-com-leucemia-mieloide-aguda.html]]></loc><lastmod>2016-12-12T00:59:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/ash-2016/ash-2016-e-os-destaques-da-oncohematologia.html]]></loc><lastmod>2016-12-12T03:48:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/edicao-de-genes-crispr-e-testada-pela-primeira-vez-em-humanos.html]]></loc><lastmod>2016-11-22T15:15:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-integracao-dos-cuidados-paliativos-ao-tratamento-padrao-em-oncologia.html]]></loc><lastmod>2016-11-21T19:49:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-testes-her2-no-adenocarcinoma-gastroesofagico.html]]></loc><lastmod>2016-11-23T17:46:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/terapia-endocrina-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2016-11-20T20:45:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/avaliacao-histologica-de-resposta-a-terapia-neoadjuvante-no-cancer-de-mama.html]]></loc><lastmod>2016-11-17T18:24:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/roberto-de-almeida-gil.html]]></loc><lastmod>2016-11-21T14:53:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/segunda-opiniao-no-cancer-de-prostata.html]]></loc><lastmod>2016-11-09T11:57:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/farmacovigilancia-um-alerta-para-a-oncologia.html]]></loc><lastmod>2016-11-03T12:42:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-de-pulmao-em-nao-fumantes.html]]></loc><lastmod>2020-04-24T18:50:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aumenta-incidencia-do-cancer-anal.html]]></loc><lastmod>2016-11-03T02:54:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/receptor-de-prolactina-e-valor-prognostico-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2016-11-03T03:07:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gestao-de-risco-no-cancer-de-bexiga.html]]></loc><lastmod>2016-11-08T19:38:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trio-013-interacao-medicamentosa-no-cancer-gastroesofagico.html]]></loc><lastmod>2016-10-28T14:49:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-epigenetico-para-classificar-cancer-de-sitio-primario-oculto.html]]></loc><lastmod>2016-11-07T14:28:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/talidomida-ministerio-nega-desabastecimento.html]]></loc><lastmod>2016-10-24T03:26:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-para-rastreamento-do-cancer-do-colo-do-utero.html]]></loc><lastmod>2016-10-24T02:25:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/antineoplasicos-de-uso-oral-e-seguranca-farmaceutica.html]]></loc><lastmod>2016-11-03T12:44:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacinacao-contra-hpv-em-meninos.html]]></loc><lastmod>2017-05-05T01:47:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/novo-inibidor-de-parp-mostra-resultados-no-cancer-de-ovario.html]]></loc><lastmod>2016-10-13T02:54:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/judicializacao-direito-ou-desvio.html]]></loc><lastmod>2016-10-13T16:34:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/esmo-imunoterapia-no-tratamento-do-cancer-de-bexiga-metastatico.html]]></loc><lastmod>2016-10-13T16:29:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/efeito-abscopal-em-melanoma.html]]></loc><lastmod>2016-10-13T02:42:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-pembrolizumabe-no-tratamento-de-melanoma.html]]></loc><lastmod>2016-10-04T14:45:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/top-20.html]]></loc><lastmod>2016-10-04T20:49:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/esmo-ki-67-e-risco-de-metastase-axilar.html]]></loc><lastmod>2016-10-09T22:22:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-ovario-e-contraceptivos-orais.html]]></loc><lastmod>2016-09-26T18:16:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sarcoma-e-hereditariedade.html]]></loc><lastmod>2016-09-26T03:57:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-protect-vigilancia-ativa-cirurgia-ou-radioterapia-no-cancer-de-prostata-localizado.html]]></loc><lastmod>2016-09-27T02:15:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/polimorfismos-no-cancer-esofagico.html]]></loc><lastmod>2016-09-29T22:13:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mortalidade-por-cancer-de-ovario-aumenta-no-brasil.html]]></loc><lastmod>2016-09-26T04:42:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/o-cancer-e-a-saude-publica.html]]></loc><lastmod>2016-09-12T02:33:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-avalia-expressao-de-pd-l1-pd-l2-em-cancer-de-mama.html]]></loc><lastmod>2016-09-12T02:34:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/i-consenso-em-cancer-de-prostata-avancado.html]]></loc><lastmod>2017-03-09T16:23:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/menopausa-terapia-hormonal-e-cancer-de-mama-qual-a-verdadeira-dimensao-do-aumento-do-risco.html]]></loc><lastmod>2016-09-11T22:15:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-evidencias-em-favor-da-triagem-do-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:53:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-em-carcinoma-ductal-in-situ.html]]></loc><lastmod>2016-08-29T01:38:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/em-12-paises-europeus-mortalidade-por-cancer-supera-doencas-cardiovasculares.html]]></loc><lastmod>2016-08-17T20:01:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-mostra-novas-tecnicas-na-gestao-do-cancer-de-tireoide.html]]></loc><lastmod>2016-08-15T04:59:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-prognosticos-e-adjuvancia-no-adenocarcinoma-cervical.html]]></loc><lastmod>2016-08-15T05:12:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hipec-na-carcinomatose-peritoneal-em-idosos.html]]></loc><lastmod>2016-08-15T04:27:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-publica-guideline-para-cancer-de-ovario-avancado.html]]></loc><lastmod>2016-08-09T16:58:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vigilancia-ativa-no-cancer-renal.html]]></loc><lastmod>2016-08-15T03:10:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/portec-3-quimiorradioterapia-no-cancer-de-endometrio-de-alto-risco.html]]></loc><lastmod>2016-08-15T04:20:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-robotica-x-aberta-resultados-semelhantes-em-cancer-de-prostata-localizado.html]]></loc><lastmod>2016-08-02T16:13:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacinacao-contra-o-hpv-desafia-o-cenario-global.html]]></loc><lastmod>2016-07-29T19:30:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-publica-guideline-para-cancer-de-pancreas.html]]></loc><lastmod>2016-07-27T22:40:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-falta-de-acesso-a-terapia-anti-her2-no-sus.html]]></loc><lastmod>2016-08-08T02:15:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ca-125-na-vigilancia-do-cancer-de-ovario.html]]></loc><lastmod>2016-08-09T16:48:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diferentes-expectativas-entre-oncologistas-e-pacientes.html]]></loc><lastmod>2016-08-01T02:41:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/american-cancer-society-atualiza-guideline-de-vacinacao-contra-hpv.html]]></loc><lastmod>2016-08-02T21:04:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mismatch-repair-no-cancer-retal.html]]></loc><lastmod>2016-07-21T21:42:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-no-cancer-de-prostata.html]]></loc><lastmod>2016-07-22T19:39:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-estudo-valida-escala-de-beneficio-clinico.html]]></loc><lastmod>2016-07-14T20:29:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/os-numeros-de-morte-por-cancer-no-mundo.html]]></loc><lastmod>2016-07-13T15:31:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diagnostico-de-diabetes-e-incidencia-de-cancer.html]]></loc><lastmod>2016-07-13T15:34:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-publica-guideline-para-o-tratamento-do-cancer-colorretal-metastatico.html]]></loc><lastmod>2016-07-07T23:29:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/jco-diretrizes-para-a-adjuvancia-no-cancer-de-mama.html]]></loc><lastmod>2016-07-04T19:49:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/asco-publica-guideline-para-o-tratamento-do-cancer-do-colo-do-utero.html]]></loc><lastmod>2016-07-04T01:46:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avancos-e-promessas-no-cancer-de-pancreas.html]]></loc><lastmod>2016-07-04T03:48:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-imunoterapia-no-cancer-colorretal.html]]></loc><lastmod>2016-07-05T18:37:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brocolis-na-quimioprevencao-do-cancer-oral.html]]></loc><lastmod>2016-06-27T14:11:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/psa-e-risco-de-cancer-de-prostata.html]]></loc><lastmod>2016-06-27T02:19:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-para-tratamento-do-cancer-de-colo-do-utero.html]]></loc><lastmod>2016-07-01T17:30:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/melanoma-na-asco-2016.html]]></loc><lastmod>2016-06-20T15:17:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desemprego-cancer-e-politicas-de-saude.html]]></loc><lastmod>2016-06-15T22:43:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/custo-e-acesso-no-tratamento-do-cancer.html]]></loc><lastmod>2016-06-13T03:05:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/dez-anos-de-terapia-hormonal-no-cancer-de-mama.html]]></loc><lastmod>2016-06-16T02:28:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/espac-4-capecitabina-gemcitambina-adjuvante-no-cancer-de-pancreas.html]]></loc><lastmod>2016-07-04T03:49:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/quimiorradioterapia-em-glioblastoma.html]]></loc><lastmod>2016-06-13T03:07:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/imunoterapia-anti-pd-l1-em-cancer-de-bexiga-avancado.html]]></loc><lastmod>2016-06-13T03:03:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/castor-anti-cd-38-em-mieloma-multiplo.html]]></loc><lastmod>2016-06-13T03:03:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/pesquisadora-brasileira-fala-de-hpv-e-cancer-na-52-asco.html]]></loc><lastmod>2016-06-05T18:08:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/localizacao-do-tumor-afeta-resultados-no-cancer-colorretal.html]]></loc><lastmod>2016-06-13T15:50:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/asco-2016-estudos-avaliam-pembrolizumab-em-cabeca-e-pescoco.html]]></loc><lastmod>2016-06-02T21:11:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-da-mayo-clinic-poe-em-xeque-criterios-de-aprovacao-do-fda.html]]></loc><lastmod>2016-06-02T21:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/preview-os-estudos-mais-aguardados-da-asco.html]]></loc><lastmod>2016-06-02T16:02:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fundacao-do-cancer-inicia-formacao-de-profissionais-em-radioterapia.html]]></loc><lastmod>2016-05-24T16:13:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qual-o-melhor-momento-para-iniciar-a-privacao-androgenica-no-cancer-de-prostata.html]]></loc><lastmod>2016-05-24T15:54:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consorcio-propoe-nova-classificacao-prognostica-em-llc.html]]></loc><lastmod>2016-05-23T04:49:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/controversias-do-psa-no-rastreamento-do-cancer-de-prostata.html]]></loc><lastmod>2016-05-23T06:04:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-nivolumabe-para-linfoma-de-hodgkin.html]]></loc><lastmod>2016-05-23T03:49:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neosphere-dados-de-longo-prazo-da-terapia-neoadjuvante-no-cancer-de-mama-her2.html]]></loc><lastmod>2016-05-23T03:50:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-alvo-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:01:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-nao-mostra-beneficio-da-disseccao-linfonodal-em-melanoma.html]]></loc><lastmod>2016-05-10T22:44:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/heracles-trastuzumabe-e-lapatinibe-em-cancer-colorretal-metastatico-her2.html]]></loc><lastmod>2016-05-10T19:00:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-cobimetinibe-para-o-tratamento-combinado-do-melanoma.html]]></loc><lastmod>2016-05-09T01:52:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/uma-nova-realidade.html]]></loc><lastmod>2016-05-02T20:04:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/cirurgia-no-tratamento-do-cancer-e-desafio-global.html]]></loc><lastmod>2016-05-02T18:09:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/painel-europeu-recomenda-bisfosfonato-adjuvante-em-cancer-de-mama.html]]></loc><lastmod>2016-05-17T12:59:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-com-participacao-brasileira-propoe-nova-classificacao-em-cancer-de-tireoide.html]]></loc><lastmod>2016-04-25T01:39:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/aacr-2016/anti-pd1-resultados-de-longo-prazo-no-melanoma-metastatico.html]]></loc><lastmod>2016-05-16T13:58:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lux-lung-7-terapia-anti-egfr-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:02:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/elcc-2016/elcc-2016-e-as-novidades-em-oncologia-toracica.html]]></loc><lastmod>2016-05-03T22:19:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nomogramas-risco-em-sarcomas-de-partes-moles-de-extremidades.html]]></loc><lastmod>2016-04-14T18:32:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-de-quimio-e-radio-aumenta-sobrevida-em-gliomas.html]]></loc><lastmod>2016-04-13T15:28:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aspirina-na-prevencao-do-cancer-colorretal.html]]></loc><lastmod>2016-04-13T15:06:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/presente-e-futuro-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:03:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncore-observacao-em-cancer-retal.html]]></loc><lastmod>2016-04-11T02:36:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-drogas-ampliam-estrategias-de-tratamento-ao-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:03:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-registro-de-nivolumabe-no-brasil.html]]></loc><lastmod>2016-04-11T01:55:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/big-data-pequenos-resultados.html]]></loc><lastmod>2016-04-11T01:56:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/indice-glicemico-e-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:04:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-cuidados-de-longo-prazo-em-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2016-04-07T02:15:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-aponta-os-destaques-do-ano-na-pesquisa-em-cancer.html]]></loc><lastmod>2016-04-07T02:14:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/selecao-terapeutica-no-cancer-de-prostata-resistente-a-castracao.html]]></loc><lastmod>2016-03-28T03:43:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-critica-aprovacao-da-fosfoetanolamina-no-senado.html]]></loc><lastmod>2016-03-28T03:36:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diagnostico-e-tratamento-da-insuficiencia-renal-relacionada-ao-mieloma.html]]></loc><lastmod>2016-03-28T03:45:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ephos-b-mostra-resultados-do-combo-anti-her2-em-apenas-11-dias.html]]></loc><lastmod>2016-05-16T14:04:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/rastreamento-e-vigilancia-ativa-em-cancer-de-prostata.html]]></loc><lastmod>2016-08-23T02:23:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/imunoterapia-a-proxima-fronteira.html]]></loc><lastmod>2017-05-15T14:02:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/ganhador-do-nobel-fala-sobre-infeccoes-que-causam-cancer.html]]></loc><lastmod>2016-03-14T04:48:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/camara-aprova-projeto-de-lei-para-producao-e-uso-da-fosfoetanolamina.html]]></loc><lastmod>2016-03-15T01:32:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sirflox-radioterapia-interna-seletiva-sirt-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2016-03-07T01:47:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/linfedema-apos-o-cancer-de-mama.html]]></loc><lastmod>2016-03-07T00:20:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/tratamento-cirurgico-do-cancer-renal.html]]></loc><lastmod>2016-03-06T23:15:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/novas-abordagens-no-cancer-renal-metastatico.html]]></loc><lastmod>2016-03-08T14:32:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/cancer-de-prostata-localmente-avancado.html]]></loc><lastmod>2016-03-06T23:08:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/avancos-da-imunoterapia-em-cancer-urotelial.html]]></loc><lastmod>2016-03-06T23:08:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/queda-no-orcamento-previsto-para-a-saude-em-2016.html]]></loc><lastmod>2016-02-18T20:59:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-crizotinibe-para-tratamento-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:05:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-biomarcadores-e-terapia-sistemica-adjuvante-em-cancer-de-mama.html]]></loc><lastmod>2016-02-22T00:03:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hematuria-como-marcador-de-cancer-oculto.html]]></loc><lastmod>2016-02-15T03:13:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dia-mundial-do-cancer.html]]></loc><lastmod>2016-02-07T22:54:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gi-2016/asco-gi-inibidores-de-pd-1-em-tumores-do-trato-digestivo.html]]></loc><lastmod>2016-02-01T14:45:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-cancer-e-desnutricao-como-enfrentar.html]]></loc><lastmod>2016-01-31T20:04:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/endeavour-carfilzomib-em-mieloma-multiplo.html]]></loc><lastmod>2016-01-24T22:55:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gu-2016/radioterapia-hipofracionada-em-cancer-de-prostata.html]]></loc><lastmod>2016-01-22T19:19:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gu-2016/asco-gu-cabozantinib-mostra-superioridade-em-cancer-renal-avancado.html]]></loc><lastmod>2016-01-18T04:07:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gu-2016/asco-gu-estrategias-no-carcinoma-urotelial-metastatico.html]]></loc><lastmod>2016-01-18T02:36:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gu-2016/terapia-androgenica-bipolar-em-homens-com-cancer-de-prostata-hormonio-sensivel.html]]></loc><lastmod>2016-02-15T02:17:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/limitacao-no-fornecimento-da-bcg-para-tratamento-do-cancer-de-bexiga.html]]></loc><lastmod>2016-01-11T13:38:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gu-2016/chaarted-apresenta-dados-de-qualidade-de-vida.html]]></loc><lastmod>2016-01-18T02:24:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/jama-pesquisa-com-200-mil-gemeos-e-risco-de-cancer.html]]></loc><lastmod>2016-01-07T14:19:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-prostata-no-rol-da-ans.html]]></loc><lastmod>2016-01-07T11:39:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/novidades-promissoras-na-neuro-oncologia.html]]></loc><lastmod>2016-01-07T11:36:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/consolidacao-de-resultados.html]]></loc><lastmod>2016-01-04T23:14:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/entusiasmo-e-decepcao.html]]></loc><lastmod>2016-01-04T23:21:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/da-pesquisa-a-pratica-clinica.html]]></loc><lastmod>2016-01-20T19:02:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/avancos-e-perspectivas-no-cancer-de-mama.html]]></loc><lastmod>2016-01-04T23:11:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/novo-paradigma.html]]></loc><lastmod>2020-04-24T19:06:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/imunoterapia-em-tumores-gastrointestinais.html]]></loc><lastmod>2015-12-21T14:00:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lancet-estudo-britanico-mostra-beneficios-do-mms-no-rastreamento-do-cancer-de-ovario.html]]></loc><lastmod>2016-01-04T23:39:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015/sabcs-2015-capecitabina-em-pacientes-de-cancer-de-mama-com-doenca-residual-apos-quimioterapia-neoadjuvante.html]]></loc><lastmod>2016-01-05T14:06:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015/sabcs-2015-calgb-alliance-neoadjuvancia-em-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2016-01-05T14:07:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/jco-publica-guideline-para-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2015-12-21T23:41:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/ash-2015-estudo-grall-r-2005-pesquisa-uso-do-rituximab-em-lla.html]]></loc><lastmod>2016-11-28T17:28:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/57-ash-nova-geracao-de-agentes-promete-impactar-a-pratica-clinica.html]]></loc><lastmod>2016-01-05T14:01:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/beneficencia-portuguesa-de-sao-paulo-e-hospital-israelita-albert-einstein-anunciam-parceria-em-oncologia.html]]></loc><lastmod>2015-12-01T03:05:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inca-estima-596-070-novos-casos-de-cancer-em-2016.html]]></loc><lastmod>2016-06-03T19:29:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sboc-reforca-importancia-da-prevencao-do-cancer.html]]></loc><lastmod>2015-11-27T03:06:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ciencia-ou-desinformacao.html]]></loc><lastmod>2015-11-27T17:15:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/dialogo-de-experts-cancer-renal-metastatico.html]]></loc><lastmod>2024-05-05T10:09:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consulta-publica-sus-atualiza-protocolo-clinico-e-diretrizes-terapeuticas-em-cancer-de-prostata.html]]></loc><lastmod>2015-11-26T22:32:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/em-conferencia-especialistas-discutem-guideline-para-cancer-de-mama-avancado.html]]></loc><lastmod>2015-11-17T00:45:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-clinica-em-pauta-no-ii-sponco.html]]></loc><lastmod>2015-11-11T23:53:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/experts-elaboram-consenso-em-cancer-de-prostata-avancado.html]]></loc><lastmod>2015-11-11T23:56:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/i-consenso-brasileiro-em-cancer-de-prostata-avancado.html]]></loc><lastmod>2015-11-05T01:16:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/controle-de-dor-e-necessidade-nao-atendida.html]]></loc><lastmod>2015-11-11T20:01:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ans-atualiza-rol-de-procedimentos.html]]></loc><lastmod>2015-11-11T13:33:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avancos-e-selecao-terapeutica-em-melanoma.html]]></loc><lastmod>2020-04-24T20:31:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-diretrizes-para-a-gestao-de-nodulos-e-cancer-de-tireoide.html]]></loc><lastmod>2015-10-22T21:27:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-de-radioterapia-e-imunoterapia-em-pacientes-com-melanoma-metastatico.html]]></loc><lastmod>2017-05-15T14:46:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/swog-0819-e-squire-novas-perspectivas-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:08:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resistencia-aos-antibioticos-no-tratamento-do-cancer.html]]></loc><lastmod>2015-10-19T01:18:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hiroshima-e-nagasaki-o-risco-de-cancer-entre-os-filhos-de-sobreviventes.html]]></loc><lastmod>2015-10-19T01:19:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-em-populacoes-indigenas.html]]></loc><lastmod>2015-10-18T20:55:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/efeitos-colaterais-do-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2016-02-29T03:08:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/assinaturas-geneticas-no-cancer-de-mama.html]]></loc><lastmod>2015-10-15T16:20:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/congresso-discute-panorama-da-cirurgia-oncologica.html]]></loc><lastmod>2015-10-14T17:53:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/jco-publica-serie-especial-sobre-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2015-10-13T19:13:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consorcio-internacional-identifica-4-subtipos-de-cancer-de-intestino.html]]></loc><lastmod>2015-10-14T19:35:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/hot-topics-em-cancer-de-mama.html]]></loc><lastmod>2015-11-16T07:06:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/individualizacao-da-terapia-endocrina.html]]></loc><lastmod>2017-05-15T13:59:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/imunoterapia-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:08:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/checkmate-025-e-o-ensaio-meteor.html]]></loc><lastmod>2015-09-29T21:34:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/meteor-cabozantinib-comprova-beneficio-de-sobrevida-em-cancer-renal-avancado.html]]></loc><lastmod>2015-09-27T22:57:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/mais-de-75-dos-pacientes-de-cancer-nao-tem-acesso-a-cirurgia.html]]></loc><lastmod>2015-09-29T14:38:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/estudos-mais-aguardados-na-ecco-esmo-2015.html]]></loc><lastmod>2015-09-27T18:56:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/imunoterapia-deve-concentrar-atencoes-no-congresso-europeu-de-oncologia.html]]></loc><lastmod>2015-09-27T13:43:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/top-5-em-neuro-oncologia.html]]></loc><lastmod>2015-09-29T21:16:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-da-classificacao-tnm-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:10:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hereditariedade-no-cancer-de-testiculo.html]]></loc><lastmod>2015-09-11T13:06:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-guideline-sobre-selecao-genetica.html]]></loc><lastmod>2015-09-07T22:20:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assinatura-genetica-no-cancer-de-prostata.html]]></loc><lastmod>2015-09-11T14:03:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-alcool-e-risco-de-cancer.html]]></loc><lastmod>2015-09-09T19:50:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-do-sistema-internacional-de-estadiamento-em-mieloma-multiplo.html]]></loc><lastmod>2015-08-25T18:52:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-agressivo-nao-aumenta-sobrevida-no-cdis.html]]></loc><lastmod>2015-08-24T04:10:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-de-especialistas-em-cancer-de-vesicula-biliar.html]]></loc><lastmod>2015-08-24T01:57:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-consenso-para-exames-de-imagem-em-tumores-cerebrais.html]]></loc><lastmod>2015-08-18T19:41:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/letrozol-e-fertilidade-apos-o-cancer-de-mama.html]]></loc><lastmod>2015-08-17T22:39:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exame-de-urina-e-diagnostico-precoce-do-cancer-de-bexiga.html]]></loc><lastmod>2015-08-13T16:12:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/chaarted-novo-paradigma-no-cancer-de-prostata.html]]></loc><lastmod>2015-08-11T03:46:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamentos-de-baixo-custo-reduzem-mortalidade-em-cancer-de-mama-precoce.html]]></loc><lastmod>2015-08-09T16:03:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-em-exame-de-urina-podem-detectar-cancer-de-pancreas-em-fase-inicial.html]]></loc><lastmod>2015-08-09T17:29:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-endometrio-e-contraceptivos-orais.html]]></loc><lastmod>2015-08-09T16:27:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cao-aro-aio-04-nova-opcao-de-tratamento-em-cancer-retal.html]]></loc><lastmod>2015-07-26T23:56:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-encontram-ligacao-entre-oncogene-e-obesidade.html]]></loc><lastmod>2015-07-28T13:57:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-taskforce-apresenta-nova-estrategia-contra-o-cancer-na-inglaterra.html]]></loc><lastmod>2015-07-23T15:34:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exame-pre-natal-e-diagnostico-de-cancer-materno.html]]></loc><lastmod>2015-07-26T23:58:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dois-tercos-dos-pacientes-com-cancer-de-laringe-avancado-nao-recebem-tratamento-recomendado.html]]></loc><lastmod>2015-07-13T01:54:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cetuximabe-em-segunda-linha-em-pacientes-com-cancer-colorretal-metastatico.html]]></loc><lastmod>2015-07-13T04:40:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/astro-publica-diretriz-para-radioterapia-no-cpnpc-localmente-avancado.html]]></loc><lastmod>2015-07-06T02:13:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-citricos-e-melanoma.html]]></loc><lastmod>2015-07-13T01:50:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pertuzumab-neoadjuvante-e-recomendado-na-ue-no-cancer-de-mama-inicial.html]]></loc><lastmod>2015-06-29T00:29:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-e-o-uso-medicinal-da-maconha.html]]></loc><lastmod>2015-06-29T00:33:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comissao-europeia-aprova-nivolumabe-opdivo-em-primeira-linha-e-no-tratamento-de-melanoma-avancado.html]]></loc><lastmod>2015-06-22T12:04:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tabagismo-e-mortalidade-em-12-tipos-de-cancer.html]]></loc><lastmod>2015-06-18T13:56:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inca-tem-novo-diretor-geral.html]]></loc><lastmod>2015-06-16T16:37:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/o-custo-da-inovacao.html]]></loc><lastmod>2015-06-09T15:17:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/um-alerta-para-os-biossimilares.html]]></loc><lastmod>2016-01-24T23:48:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/asco-2015-o-ano-da-imunoterapia-para-o-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:12:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/cancer-de-cabeca-e-pescoco-e-destaque-na-asco.html]]></loc><lastmod>2015-06-03T06:58:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/asco-2015-quimioterapia-adjuvante-no-cancer-de-prostata.html]]></loc><lastmod>2015-05-31T22:19:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/asco-2015-cirurgia-linfonodal-nao-impacta-sobrevida-em-melanoma.html]]></loc><lastmod>2017-05-15T14:31:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/novidades-na-oncohematologia-sao-apresentadas-na-asco.html]]></loc><lastmod>2015-06-03T04:39:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/imunoterapia-e-destaque-na-abertura-da-asco-2015.html]]></loc><lastmod>2015-06-03T05:56:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/panorama-gastrointestinal-na-asco-2015.html]]></loc><lastmod>2015-06-05T19:15:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/asco-2015-selecao-molecular-e-imunoterapia-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:15:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/stampede-docetaxel-no-cancer-de-prostata-avancado.html]]></loc><lastmod>2015-05-25T15:33:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/eloquent-2-mostra-resultados-em-mieloma-multiplo.html]]></loc><lastmod>2015-06-03T04:48:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/nicotinamida-e-quimioprevencao-no-cancer-de-pele.html]]></loc><lastmod>2015-05-25T15:37:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/kantar-health-aponta-os-destaques-da-asco-2015.html]]></loc><lastmod>2015-05-25T15:29:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lancet-destaca-resultados-do-aethera-em-linfoma-de-hodgkin.html]]></loc><lastmod>2015-05-11T16:52:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/marcadores-preditivos-de-resistencia-ao-tamoxifeno.html]]></loc><lastmod>2015-05-11T05:59:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estresse-reduz-eficacia-do-paclitaxel-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2015-05-11T05:55:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cisplatina-ou-carboplatina-em-cancer-cervical-recorrente-ou-metastatico.html]]></loc><lastmod>2015-05-11T05:57:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcador-osteogenico-em-cancer-de-prostata-agressivo.html]]></loc><lastmod>2015-05-04T03:43:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/forum-discutiu-realidade-e-perspectivas-da-oncologia-brasileira.html]]></loc><lastmod>2015-05-04T03:45:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ooforectomia-diminui-mortalidade-no-cancer-de-mama-brca.html]]></loc><lastmod>2015-04-26T21:44:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/alivio-merecido.html]]></loc><lastmod>2015-04-15T15:12:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/medicina-de-qualidade.html]]></loc><lastmod>2015-04-12T23:33:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-de-mama-e-historia-de-cancer-de-prostata.html]]></loc><lastmod>2015-04-06T13:34:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uma-biografia-do-cancer.html]]></loc><lastmod>2015-04-01T03:58:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nccn-publica-novo-guideline-para-cessacao-do-tabagismo.html]]></loc><lastmod>2015-03-30T17:01:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/1-simposio-gtg/consenso-brasileiro-de-colon.html]]></loc><lastmod>2015-03-30T04:27:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-obinutuzumabe-para-llc.html]]></loc><lastmod>2015-03-30T14:14:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biossimilares-disputa-acirrada.html]]></loc><lastmod>2015-03-30T14:14:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mulheres-obesas-tem-40-mais-chances-de-ter-cancer.html]]></loc><lastmod>2015-03-30T14:15:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desafios-e-perspectivas-da-pesquisa-clinica-brasileira.html]]></loc><lastmod>2015-03-30T14:15:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aspirina-e-risco-de-cancer-colorretal.html]]></loc><lastmod>2015-03-18T01:55:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-e-risco-de-cancer-de-tireoide.html]]></loc><lastmod>2015-03-16T03:58:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/18-jornada-uropatologia/o-mapa-do-cancer-renal-na-america-latina.html]]></loc><lastmod>2015-03-16T04:02:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/um-alerta-para-a-dor-no-cancer.html]]></loc><lastmod>2015-03-09T14:36:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-lea-tem-resultados-negativos.html]]></loc><lastmod>2015-03-05T10:27:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-pancreas-e-subtipos-moleculares.html]]></loc><lastmod>2015-03-02T05:05:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gu-2015/getug-15-mostra-na-asco-gu-dados-de-longo-prazo.html]]></loc><lastmod>2015-03-05T00:45:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gu-2015/comet-resultados-finais-na-asco-gu.html]]></loc><lastmod>2015-03-02T03:17:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gu-2015/assure-resultados-negativos-na-asco-gu.html]]></loc><lastmod>2015-03-02T12:15:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gu-2015/asco-gu-e-o-panorama-do-cancer-geniturinario.html]]></loc><lastmod>2015-03-02T12:14:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-identifica-a-chave-para-o-cancer-de-pancreas.html]]></loc><lastmod>2015-02-24T16:16:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-orofaringe-e-hpv-um-novo-cenario.html]]></loc><lastmod>2015-02-22T19:41:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reposicao-hormonal-e-risco-de-cancer-de-ovario.html]]></loc><lastmod>2015-02-23T01:33:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-anuncia-os-cinco-maiores-avancos-da-oncologia.html]]></loc><lastmod>2015-02-11T12:50:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-pos-prostatectomia.html]]></loc><lastmod>2015-02-09T18:17:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hospices-beneficios-dos-cuidados-paliativos.html]]></loc><lastmod>2015-02-09T18:17:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-estrategias-para-o-tratamento-do-glioblastoma.html]]></loc><lastmod>2016-01-26T23:41:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/?view=article&amp;id=971:o-melhor-de-2014&amp;catid=195]]></loc><lastmod>2015-02-02T01:55:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/medicina-de-precisao-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:17:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-por-fusao-no-cancer-de-prostata-de-alto-risco.html]]></loc><lastmod>2015-01-29T21:45:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gi-2015/tribe-folfoxiri-mostra-superioridade.html]]></loc><lastmod>2015-01-19T01:23:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-de-longo-prazo-confirma-beneficios-da-abiraterona.html]]></loc><lastmod>2015-01-19T02:08:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gi-2015/raise-estudo-e-um-dos-destaques-da-asco-gi.html]]></loc><lastmod>2015-01-19T01:29:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-de-terapias-alvo-na-era-da-medicina-de-precisao.html]]></loc><lastmod>2015-01-07T18:25:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-terapia-biologica-no-cancer-de-ovario.html]]></loc><lastmod>2015-01-05T22:11:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-anti-pd-1-nivolumabe-no-tratamento-de-melanoma.html]]></loc><lastmod>2015-01-05T17:38:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-clinico-e-cessacao-do-tabagismo.html]]></loc><lastmod>2014-12-21T14:27:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-ramucirumabe-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:18:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/san-antonio-2014/soft-supressao-ovariana-mais-tamoxifeno-reduz-recorrencia-do-cancer-de-mama.html]]></loc><lastmod>2014-12-21T14:23:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/san-antonio-2014/fergi-ii-pictilisibe-no-cancer-de-mama-receptor-hormonal.html]]></loc><lastmod>2014-12-21T23:04:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/ash-2014/resonate-resultados-de-fase-ii-na-56-ash.html]]></loc><lastmod>2014-12-11T01:51:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-enzalutamida-no-tratamento-do-cancer-de-prostata.html]]></loc><lastmod>2016-03-11T21:05:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/os-beneficios-da-soja-mito-ou-realidade.html]]></loc><lastmod>2014-12-07T21:42:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eua-promove-consorcios-para-estudar-uso-off-label-no-tratamento-do-cancer.html]]></loc><lastmod>2014-12-04T14:22:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/jco-publica-guideline-sobre-radioterapia-adjuvante-no-cancer-de-prostata.html]]></loc><lastmod>2014-12-03T13:14:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avancos-e-desafios-na-atencao-oncologica-brasileira.html]]></loc><lastmod>2014-11-27T19:16:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidores-de-checkpoint-imunologico-em-cancer-do-cerebro.html]]></loc><lastmod>2014-11-24T17:06:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/farmacogenomica-e-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:18:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-identifica-mecanismo-dos-antiinflamatorios-ligado-a-prevencao-do-cancer-de-colon.html]]></loc><lastmod>2014-11-24T00:45:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/desafios-e-oportunidades-na-pesquisa-clinica-brasileira.html]]></loc><lastmod>2014-11-23T14:31:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/abiraterona-no-cancer-de-prostata-de-alto-risco.html]]></loc><lastmod>2014-11-17T13:20:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-alvo-aumenta-sobrevida-em-cancer-de-esofago.html]]></loc><lastmod>2014-11-10T17:26:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guidelines-para-terapias-complementares-em-cancer-de-mama.html]]></loc><lastmod>2014-11-10T15:44:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/efeito-secundario-da-inibicao-do-egfr-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:19:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mirna-34-uma-nova-arma-contra-o-cancer.html]]></loc><lastmod>2014-11-10T21:37:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/celulas-tumorais-circulantes-e-resposta-a-quimioterapia.html]]></loc><lastmod>2014-11-03T00:32:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/amaro-radioterapia-associada-a-menor-morbidade-na-axila-positiva.html]]></loc><lastmod>2014-10-28T20:12:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-colorretal-obesidade-e-risco-de-segundo-cancer.html]]></loc><lastmod>2014-10-21T15:57:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/proteina-sirt-6-tem-papel-oncogenico-no-cancer-de-pele.html]]></loc><lastmod>2014-10-21T15:47:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-esterotaxica-ablativa-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:19:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-surpreende-no-tratamento-de-leucemia.html]]></loc><lastmod>2014-10-26T22:44:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/europa-debate-novos-criterios-para-estudos-clinicos-em-tumores-raros.html]]></loc><lastmod>2014-10-16T22:49:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/radiofarmacos-no-tratamento-do-cancer-de-prostata.html]]></loc><lastmod>2014-10-16T21:44:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bloqueio-de-pd-l1-pode-evitar-resistencia-adquirida-a-radioterapia-fracionada.html]]></loc><lastmod>2014-10-15T13:09:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dislipidemia-e-recorrencia-do-cancer-de-prostata.html]]></loc><lastmod>2014-10-12T23:45:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lacog-critica-as-barreiras-para-a-pesquisa-clinica.html]]></loc><lastmod>2014-10-13T03:37:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-para-cancer-de-mama-avancado-her2-negativo.html]]></loc><lastmod>2014-10-08T18:41:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretor-da-anvisa-fala-em-novos-desfechos-para-registro-de-oncologicos.html]]></loc><lastmod>2014-10-08T14:14:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/abiraterona-confirma-resultados-positivos-em-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2014-09-29T03:10:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/impress-nao-mostra-beneficio-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:21:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/cleopatra-confirma-superioridade-do-pertuzumabe-em-cancer-de-mama-metastatico-her2.html]]></loc><lastmod>2014-10-02T04:16:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-post-e-a-selecao-molecular-em-cancer-de-pumao.html]]></loc><lastmod>2020-04-24T19:21:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/llc-na-era-da-terapia-alvo.html]]></loc><lastmod>2014-09-22T14:06:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/jco-publica-serie-especial-sobre-radioterapia.html]]></loc><lastmod>2014-09-14T23:18:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-anti-pd-1-para-melanoma-metastatico.html]]></loc><lastmod>2014-09-07T03:46:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/identificada-mutacao-ret-no-cancer-de-pulmao-de-pequenas-celulas.html]]></loc><lastmod>2020-04-24T19:22:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-avastin-para-cancer-cervical.html]]></loc><lastmod>2014-08-31T22:09:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resposta-a-terapia-com-platina-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2014-08-31T22:07:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-para-terapia-endocrina-adjuvante-em-cancer-de-mama-receptor-hormonal-positivo.html]]></loc><lastmod>2014-09-09T00:40:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sorafenibe-melhora-a-sobrevida-livre-de-progressao-em-cancer-de-tireoide-iodo-refratario.html]]></loc><lastmod>2014-08-18T01:00:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-gene-relacionado-ao-cancer-de-mama-hereditario.html]]></loc><lastmod>2014-08-17T23:49:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aspirina-e-prevencao-do-cancer.html]]></loc><lastmod>2014-08-07T11:52:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-confirma-alta-prevalencia-do-hpv-no-norte-brasileiro.html]]></loc><lastmod>2015-11-27T03:09:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ministerio-publico-exige-fim-da-fila-para-a-radioterapia.html]]></loc><lastmod>2014-07-21T13:41:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-genes-no-cancer-de-rim.html]]></loc><lastmod>2014-07-07T21:38:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-paliativos-na-agenda-global.html]]></loc><lastmod>2014-06-29T23:01:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-de-sangue-e-o-risco-de-cancer-de-mama.html]]></loc><lastmod>2014-07-18T16:34:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/th3resa-mostra-beneficios-do-trastuzumab-emtansine.html]]></loc><lastmod>2014-06-16T23:08:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/19-eha-novo-agente-mostra-atividade-em-llc-de-alto-risco.html]]></loc><lastmod>2014-06-16T18:27:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/revel-mostra-ganhos-de-sobrevida-em-segunda-linha-no-cpnpc.html]]></loc><lastmod>2014-06-11T13:47:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/presidente-da-sboc-comenta-os-destaques-em-cprc-da-50-asco.html]]></loc><lastmod>2014-06-09T03:11:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avaliacao-e-gestao-da-dor-no-paciente-oncologico.html]]></loc><lastmod>2014-06-10T18:45:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/sus-tem-disparidades-regionais-na-mortalidade-por-cancer-do-snc.html]]></loc><lastmod>2014-06-06T21:55:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/text-e-soft-inibidores-de-aromatase-no-cancer-de-mama.html]]></loc><lastmod>2014-06-12T02:40:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cigarro-eletronico-divide-opiniao-de-especialistas.html]]></loc><lastmod>2014-06-07T14:05:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bevacizumabe-mostra-papel-em-cancer-de-ovario.html]]></loc><lastmod>2014-05-21T15:34:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ramucirumab-e-aprovado-pelo-fda-para-cancer-de-estomago.html]]></loc><lastmod>2014-05-24T20:40:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-terapia-sistemica-em-cancer-de-mama-her-2-positivo.html]]></loc><lastmod>2014-05-17T15:35:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-faz-historia.html]]></loc><lastmod>2014-05-26T03:33:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-terapia-para-2-linha-de-cpnpc.html]]></loc><lastmod>2014-05-26T03:43:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-guideline-para-biopsia-de-sentinela-em-cancer-de-mama-inicial.html]]></loc><lastmod>2014-06-02T05:19:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ooforectomia-profilatica-em-brca1.html]]></loc><lastmod>2014-04-16T17:45:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mito-7-mostra-ganho-de-qualidade-de-vida-com-regime-semanal-no-cancer-de-ovario.html]]></loc><lastmod>2014-05-05T03:00:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/triagem-para-sindrome-de-lynch.html]]></loc><lastmod>2014-04-21T00:00:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/estro-33/novo-teste-pode-prever-recorrencia-do-cancer-de-prostata.html]]></loc><lastmod>2014-05-05T03:08:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-linhas-de-conduta-clinica-tem-foco-na-qualidade-de-vida.html]]></loc><lastmod>2014-05-21T16:52:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/elcc-2014/elcc-2014-expressao-de-pd-l1-e-pd-1-em-um-coorte-de-pacientes-com-nsclc-molecularmente-selecionados.html]]></loc><lastmod>2020-04-24T19:24:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mortalidade-por-cancer-de-mama-no-brasil.html]]></loc><lastmod>2014-04-20T22:44:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gu-2014/prevail-e-a-enzalutamida-no-cprc.html]]></loc><lastmod>2014-05-05T03:09:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gu-2014/estudo-switch-compara-sequencia-de-drogas-alvo-em-mrcc.html]]></loc><lastmod>2014-03-12T19:19:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gi-2014/cairo-3-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2014-03-12T18:43:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gi-2014/imunoterapia-no-cancer-de-pancreas.html]]></loc><lastmod>2014-03-12T18:37:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gi-2014/a-familia-ras-e-o-cancer-colorretal-avancado.html]]></loc><lastmod>2014-03-12T17:12:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gu-2014/terapia-de-privacao-androgenica---qual-a-duracao-ideal.html]]></loc><lastmod>2014-03-12T17:08:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/campanha-incentiva-o-diagnostico-precoce.html]]></loc><lastmod>2014-03-12T17:05:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/home-page/buscar.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/home-page/login-page.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens.html]]></loc><lastmod>2014-03-05T00:24:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/atividade-fisica-e-dor-em-pacientes-de-cancer.html]]></loc><lastmod>2024-02-23T18:46:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/oncologia-toracica-e-os-avancos-de-2020.html]]></loc><lastmod>2020-12-26T16:30:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/esmo-2020-amplia-perspectivas-no-tratamento-do-cancer.html]]></loc><lastmod>2020-10-19T03:05:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/telemedicina-no-cuidado-oncologico.html]]></loc><lastmod>2020-07-11T18:50:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/retrospectiva-2019-e-os-destaques-do-panorama-gu.html]]></loc><lastmod>2020-02-04T22:33:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/avancos-na-oncologia-gastrointestinal.html]]></loc><lastmod>2020-02-04T22:36:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/cancer-de-cabeca-e-pescoco-em-foco.html]]></loc><lastmod>2020-01-20T21:02:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/highlights-em-oncologia-de-precisao.html]]></loc><lastmod>2020-01-22T20:25:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/panorama-da-oncoginecologia.html]]></loc><lastmod>2020-04-23T18:55:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/agilidade-no-diagnostico.html]]></loc><lastmod>2020-04-07T21:11:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/crescem-vendas-de-biossimilares-na-oncologia-brasileira.html]]></loc><lastmod>2019-11-11T22:09:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/microbioma-e-cancer-limites-e-oportunidades.html]]></loc><lastmod>2019-08-21T15:30:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/consorcio-do-microbioma-humano-10-anos-de-pesquisa.html]]></loc><lastmod>2019-03-24T21:01:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/cancer-de-mama-em-foco.html]]></loc><lastmod>2019-02-03T14:05:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/big-data-limites-e-possibilidades.html]]></loc><lastmod>2018-08-29T15:18:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/destaques-onco---21-anos-de-atualizacao-cientifica.html]]></loc><lastmod>2018-07-06T11:50:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/biossimilares-preparam-expansao.html]]></loc><lastmod>2018-02-26T16:36:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/cuidado-centrado-no-paciente-oncologico.html]]></loc><lastmod>2018-02-19T14:04:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/integralidade-da-assistencia-oncologica.html]]></loc><lastmod>2017-12-16T18:52:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/cuidados-integrativos-e-saude-global.html]]></loc><lastmod>2017-12-16T18:55:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/desnutricao-no-cancer-preocupa-especialistas.html]]></loc><lastmod>2017-12-16T18:57:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/impacto-da-atividade-fisica.html]]></loc><lastmod>2017-12-16T19:00:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/atencao-aos-aspectos-psicologicos.html]]></loc><lastmod>2018-01-15T12:06:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/beneficios-da-acupuntura.html]]></loc><lastmod>2017-12-16T19:06:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/ioga-mostra-resultados.html]]></loc><lastmod>2017-12-16T19:11:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/apoio-a-pratica-medica-2.html]]></loc><lastmod>2017-12-16T16:49:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/mutacoes-acionaveis-e-selecao-terapeutica.html]]></loc><lastmod>2017-08-21T21:18:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/biopsia-liquida-a-proxima-fronteira.html]]></loc><lastmod>2017-08-21T21:17:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/pesquisa-clinica-em-debate.html]]></loc><lastmod>2017-08-07T07:04:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/custo-e-beneficio-clinico.html]]></loc><lastmod>2017-08-07T03:21:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/rastreamento-desafios-e-controversias.html]]></loc><lastmod>2017-05-15T14:53:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/evidencias-validam-prevencao-secundaria-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:42:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/sociedade-europeia-publica-recomendacoes-para-o-rastreamento-do-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:42:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/controle-do-cancer-cervical-expoe-fragilidade-do-modelo-brasileiro.html]]></loc><lastmod>2017-05-15T15:04:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/novos-metodos-no-rastreamento-do-cancer-cervical.html]]></loc><lastmod>2017-05-19T15:38:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/holanda-mostra-resultados-do-rastreamento-com-teste-de-hpv-de-alto-risco.html]]></loc><lastmod>2017-05-15T15:00:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/mamografia-em-nova-versao.html]]></loc><lastmod>2017-05-15T15:01:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/viabilidade-do-rastreio-populacional.html]]></loc><lastmod>2017-05-15T15:02:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/importancia-da-atencao-primaria.html]]></loc><lastmod>2017-05-15T15:02:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/cuidados-paliativos-em-perspectiva.html]]></loc><lastmod>2017-03-22T19:49:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/promessas-e-resultados-na-neuro-oncologia.html]]></loc><lastmod>2017-02-12T12:38:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/estrategias-no-tratamento-do-melanoma.html]]></loc><lastmod>2017-02-01T20:41:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/atualizacao-em-patologia-oncologica.html]]></loc><lastmod>2017-01-29T21:05:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/altos-e-baixos-da-ginecologia-oncologica.html]]></loc><lastmod>2017-01-29T21:06:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/destaques-da-uro-oncologia.html]]></loc><lastmod>2017-01-29T21:06:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/novas-fronteiras-na-oncologia-toracica.html]]></loc><lastmod>2017-01-30T00:46:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/carne-processada-e-fator-de-risco.html]]></loc><lastmod>2016-12-12T01:26:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/inca-atualiza-consenso-de-nutricao-oncologica.html]]></loc><lastmod>2016-12-12T01:27:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/cresce-preocupacao-global-com-obesidade.html]]></loc><lastmod>2016-12-12T01:28:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/o-efeito-domino-da-judicializacao.html]]></loc><lastmod>2016-11-17T12:22:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/foco-na-qualidade-de-vida.html]]></loc><lastmod>2016-11-15T17:24:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/terapia-personalizada-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:49:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/caminhos-para-a-atencao-oncologica.html]]></loc><lastmod>2016-09-09T18:17:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/transicao-epidemiologica-e-assistencia-em-rede.html]]></loc><lastmod>2016-09-09T18:17:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/o-desafio-de-integrar-dados-em-saude.html]]></loc><lastmod>2016-09-09T18:17:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/um-alerta-para-os-sinais-do-cancer.html]]></loc><lastmod>2016-09-09T18:16:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/prevencao-e-aposta-para-diagnostico-precoce.html]]></loc><lastmod>2016-09-09T18:16:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/atencao-para-o-cancer-colorretal.html]]></loc><lastmod>2016-09-08T18:10:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/mercado-aquecido.html]]></loc><lastmod>2016-07-04T04:38:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/mitos-e-verdades-da-intercambialidade.html]]></loc><lastmod>2016-05-09T19:28:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/desafios-e-oportunidades.html]]></loc><lastmod>2016-05-02T20:09:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/pdps-e-os-desafios-da-producao-nacional.html]]></loc><lastmod>2016-06-29T21:37:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/pesquisa-mostra-desconhecimento-medico.html]]></loc><lastmod>2016-05-09T19:15:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/portabilidade-e-baixo-custo.html]]></loc><lastmod>2016-05-01T14:35:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/intervencao-minima.html]]></loc><lastmod>2016-02-22T01:40:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/entre-a-fe-e-a-ciencia.html]]></loc><lastmod>2016-05-02T19:26:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/preco-e-valor.html]]></loc><lastmod>2016-01-07T11:38:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/controversia-em-cancer-oral.html]]></loc><lastmod>2015-12-18T14:18:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/a-luz-como-aliada.html]]></loc><lastmod>2015-12-21T13:55:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/dez-anos-depois.html]]></loc><lastmod>2016-04-27T01:30:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/expansao-da-radioterapia-ainda-nao-saiu-do-papel.html]]></loc><lastmod>2015-10-26T00:00:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/lei-dos-60-dias-nao-e-realidade-no-sus.html]]></loc><lastmod>2015-10-26T00:01:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/rede-de-assistencia-mantem-contrastes-regionais.html]]></loc><lastmod>2015-10-26T00:01:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/incentivo-fiscal-para-a-atencao-oncologica.html]]></loc><lastmod>2015-10-25T19:17:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/pesquisas-made-in-brazil.html]]></loc><lastmod>2016-03-02T13:05:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/o-mapa-do-cancer-no-brasil.html]]></loc><lastmod>2015-10-25T16:50:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/discordancias-diagnosticas.html]]></loc><lastmod>2015-08-27T23:41:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/estrategias-de-triagem-para-o-cancer-colorretal.html]]></loc><lastmod>2015-08-24T01:42:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/imuno-oncologia-continua-em-alta.html]]></loc><lastmod>2015-08-24T02:50:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/melanoma-prevencao-primaria-e-secundaria.html]]></loc><lastmod>2015-08-24T01:34:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/rastreamento-do-cancer-do-colo-uterino.html]]></loc><lastmod>2015-08-24T01:09:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/quimioterapia-e-seguranca-ocupacional.html]]></loc><lastmod>2015-08-24T00:23:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/uma-nova-via-terapeutica.html]]></loc><lastmod>2015-08-28T18:31:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/o-peso-da-obesidade.html]]></loc><lastmod>2015-08-28T18:34:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/anvisa-nova-aprovacao-em-llc.html]]></loc><lastmod>2015-12-24T11:45:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/passado-e-presente-da-sindrome-de-lynch.html]]></loc><lastmod>2015-06-30T17:09:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/o-desafio-da-subnotificacao.html]]></loc><lastmod>2015-04-15T15:27:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/um-olhar-para-alem-do-cancer.html]]></loc><lastmod>2015-04-14T01:48:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/medicina-sem-fronteiras.html]]></loc><lastmod>2015-07-06T14:55:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/novos-medicos-para-um-novo-tempo.html]]></loc><lastmod>2015-03-30T04:33:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/pontes-do-conhecimento.html]]></loc><lastmod>2015-02-05T18:23:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/incentivos-fiscais-podem-financiar-pesquisa-brasileira.html]]></loc><lastmod>2014-11-18T23:53:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/politicas-publicas-estamos-no-caminho-certo-sp-755.html]]></loc><lastmod>2016-06-03T20:12:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/videocirurgia-ganha-espaco.html]]></loc><lastmod>2014-11-17T17:54:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/oportunidades-para-a-terapia-sistemica-em-onco-ginecologia.html]]></loc><lastmod>2014-11-17T17:42:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/novos-tempos-para-as-big-pharma.html]]></loc><lastmod>2014-11-18T14:34:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/ritmo-de-consolidacao.html]]></loc><lastmod>2014-11-15T21:42:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/progressos-e-conquistas-no-cancer-de-prostata.html]]></loc><lastmod>2014-11-06T03:27:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/tempo-de-otimismo.html]]></loc><lastmod>2014-11-04T11:43:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/imunoterapia-e-a-bola-da-vez.html]]></loc><lastmod>2014-10-02T19:39:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/cancer-e-obesidade-sinal-de-alerta.html]]></loc><lastmod>2014-09-04T20:26:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/sempre-a-mao.html]]></loc><lastmod>2014-09-03T23:25:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/inovacao-com-responsabilidade.html]]></loc><lastmod>2014-11-15T21:54:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/a-proxima-fronteira.html]]></loc><lastmod>2014-11-15T21:54:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/mabs-made-in-brazil.html]]></loc><lastmod>2014-11-15T21:53:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/novas-abordagens-para-o-cancer-de-prostata-resistente-a-castracao.html]]></loc><lastmod>2018-02-07T17:08:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/reportagens/fusoes-e-incorporacoes-movimentam-oncologia.html]]></loc><lastmod>2014-03-12T19:31:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se.html]]></loc><lastmod>2014-03-05T00:27:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2o-simposio-desafios-em-oncologia-molecular.html]]></loc><lastmod>2025-02-04T21:35:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/asco-gu-2025.html]]></loc><lastmod>2025-01-06T12:08:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/asco-gi-2025.html]]></loc><lastmod>2025-01-20T17:20:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ash-2024.html]]></loc><lastmod>2024-10-31T16:32:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/sabcs-2024.html]]></loc><lastmod>2024-10-31T15:10:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ficare-2024.html]]></loc><lastmod>2024-10-30T19:13:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iarc-e-opas-realizam-webinar-para-lancar-novo-programa-de-e-learning-para-prevencao-do-cancer.html]]></loc><lastmod>2024-10-17T15:57:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/inca-realiza-terceira-edicao-do-wine-2024.html]]></loc><lastmod>2024-09-25T19:50:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/inca-promove-i-workshop-em-epigenetica-de-doencas.html]]></loc><lastmod>2024-08-21T20:45:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/8o-next-frontiers.html]]></loc><lastmod>2024-08-16T21:24:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/wclc-2024.html]]></loc><lastmod>2024-08-27T22:52:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2o-congresso-dasa-de-oncologia.html]]></loc><lastmod>2024-08-03T02:45:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/igcs-2024.html]]></loc><lastmod>2024-07-12T01:07:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/infecto-icesp-2024.html]]></loc><lastmod>2024-06-28T21:27:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-aborda-oncologia-translacional.html]]></loc><lastmod>2024-07-07T15:57:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-gi-2024.html]]></loc><lastmod>2024-06-21T14:54:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/icesp-realiza-oficina-em-cuidados-paliativos.html]]></loc><lastmod>2024-06-13T14:57:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/onco-jornada-medicina-de-precisao-e-diagnostico.html]]></loc><lastmod>2024-05-21T21:24:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-gineco-2024.html]]></loc><lastmod>2024-05-15T12:43:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-breast-cancer-2024.html]]></loc><lastmod>2024-05-15T12:53:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/asco-2024.html]]></loc><lastmod>2024-05-14T21:23:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/imunobiologicos-em-pauta.html]]></loc><lastmod>2024-05-05T09:37:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/top-10-controle-de-sintomas.html]]></loc><lastmod>2024-05-09T09:01:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/medicina-de-precisao-em-cancer-gastrointestinal.html]]></loc><lastmod>2024-05-05T09:52:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/8-simposio-de-educacao-em-saude.html]]></loc><lastmod>2024-05-05T08:59:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/nccn-2024.html]]></loc><lastmod>2024-05-05T09:43:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/aacr-2024.html]]></loc><lastmod>2024-05-05T09:50:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-summit-latin-america.html]]></loc><lastmod>2024-02-24T23:38:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/aacr-on-campus.html]]></loc><lastmod>2024-02-16T23:45:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-forum-em-prevencao-de-cancer-na-america-latina-e-caribe.html]]></loc><lastmod>2024-02-18T16:36:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/elcc-2024.html]]></loc><lastmod>2025-03-25T17:25:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/nutricao-e-cancer.html]]></loc><lastmod>2024-02-02T19:27:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-uro-oncologia-einstein-goiania.html]]></loc><lastmod>2024-01-24T11:48:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/implicacoes-cirurgicas-da-ressonancia-magnetica-do-reto.html]]></loc><lastmod>2023-11-24T19:21:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/best-in-oncology-2023.html]]></loc><lastmod>2023-10-30T17:13:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-2023.html]]></loc><lastmod>2024-08-23T21:26:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-cancer-colorretal.html]]></loc><lastmod>2023-10-01T16:59:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/figado-pancreas-e-vias-biliares.html]]></loc><lastmod>2023-10-01T16:47:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-cancer-de-mama-3.html]]></loc><lastmod>2023-10-01T16:39:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/mastologia-em-pauta.html]]></loc><lastmod>2023-10-01T16:28:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-workshop-de-pesquisa-clinica.html]]></loc><lastmod>2023-08-27T20:36:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/imon-2023---enfermagem-oncologica.html]]></loc><lastmod>2023-10-02T21:10:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-internacional-de-melanoma-e-imuno-oncologia.html]]></loc><lastmod>2023-08-27T19:35:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/4-board-review-eva.html]]></loc><lastmod>2023-08-27T18:16:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/7-next-frontiers-to-cure-cancer.html]]></loc><lastmod>2023-08-27T17:12:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-de-linfomas-cutaneos-do-inca.html]]></loc><lastmod>2023-08-27T16:21:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/top-10-oncology-nursing-3-edicao.html]]></loc><lastmod>2023-08-09T19:10:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/5-meeting-the-minds---enfermeiros-e-farmaceuticos.html]]></loc><lastmod>2023-08-06T16:44:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/17-cancer-de-mama-gramado.html]]></loc><lastmod>2023-08-06T16:21:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/viii-simposio-internacional-de-cancer-de-pulmao-oncologia-dor.html]]></loc><lastmod>2023-08-06T16:04:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-intersections.html]]></loc><lastmod>2023-08-06T15:50:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/8-simposio-internacional-de-tumores-gastrointestinais.html]]></loc><lastmod>2023-08-06T15:48:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/top-10-onco-urologia-2023.html]]></loc><lastmod>2023-08-03T21:08:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/x-jornada-de-cuidados-paliativos-do-icesp.html]]></loc><lastmod>2023-08-01T17:16:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/azpire-oncology-summit.html]]></loc><lastmod>2023-06-21T22:11:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/inca-promove-segunda-edicao-do-workshop-wine.html]]></loc><lastmod>2023-06-21T16:58:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-breast-cancer-2023.html]]></loc><lastmod>2023-04-02T18:02:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/bbcs-2023.html]]></loc><lastmod>2023-04-02T17:27:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-internacional-de-onco-hematologia.html]]></loc><lastmod>2023-04-02T17:04:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/aacr-annual-meeting-2023.html]]></loc><lastmod>2023-04-02T16:47:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-simposio-de-estomaterapia.html]]></loc><lastmod>2023-04-02T13:33:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-oncologia-toracica.html]]></loc><lastmod>2023-04-02T13:20:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xiv-congresso-internacional-de-uro-oncologia.html]]></loc><lastmod>2023-04-02T12:30:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/13-brazilian-lymphoma-conference.html]]></loc><lastmod>2023-03-28T16:08:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/inca-sedia-curso-global-sobre-genomica-de-celulas-unicas.html]]></loc><lastmod>2023-03-06T15:35:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/imon-2022-enfermagem-oncologica.html]]></loc><lastmod>2022-10-11T16:00:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-moonshot-brasil-sul---ix-congresso-internacional-do-iop.html]]></loc><lastmod>2022-10-11T13:47:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/top-10-pulmao-2022.html]]></loc><lastmod>2022-08-15T22:34:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-workshop-de-pesquisa-clinica.html]]></loc><lastmod>2022-08-05T14:10:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/7-simposio-internacional-de-cancer-de-pulmao-oncologia-dor.html]]></loc><lastmod>2022-07-31T21:11:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-de-cancer-de-mama---hcor.html]]></loc><lastmod>2022-07-31T20:56:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ix-jornada-de-cuidados-paliativos-do-icesp.html]]></loc><lastmod>2022-07-31T20:07:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-internacional-oncologia-americas-2022.html]]></loc><lastmod>2022-07-31T19:37:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-congresso-brasileiro-de-cancer-digestivo.html]]></loc><lastmod>2022-08-10T22:15:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xiii-board-review-in-medical-oncology.html]]></loc><lastmod>2022-07-31T18:08:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ficare-2022.html]]></loc><lastmod>2022-07-31T17:53:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/top-10-oncology-nursing.html]]></loc><lastmod>2022-07-13T19:49:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-simposio-internacional-de-onco-hematologia.html]]></loc><lastmod>2022-04-17T19:20:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xvii-congresso-paulista-de-urologia.html]]></loc><lastmod>2022-08-22T01:43:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-breast-cancer-2022.html]]></loc><lastmod>2022-04-17T18:46:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/6-next-frontiers-to-cure-cancer.html]]></loc><lastmod>2022-04-17T18:13:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xiii-congresso-internacional-de-uro-oncologia.html]]></loc><lastmod>2022-04-07T18:38:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-workshop-de-inovacao-e-empreendedorismo-do-inca.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-radiologia-mamaria.html]]></loc><lastmod>2022-03-20T14:36:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/conferencia-brasileira-de-cancer-de-mama-2022.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/3-simposio-sobre-cancer-de-ovario-2.html]]></loc><lastmod>2022-03-20T13:35:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/bbcs-2022.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/4-simposio-nacional-do-gbcp.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ganepao-2022.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/da-ciencia-para-a-pratica-clinica.html]]></loc><lastmod>2022-03-10T16:59:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/avancos-e-perspectivas-em-tumores-neuroendocrinos.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/asco-gu-2022.html]]></loc><lastmod>2022-01-31T17:39:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/medicina-integrativa.html]]></loc><lastmod>2022-01-31T18:02:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-doenca-trofoblastica-gestacional.html]]></loc><lastmod>2021-11-07T22:34:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/15-cancer-de-mama-gramado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-congresso-paulista-de-cuidados-paliativos.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-semana-brasileira-da-oncologia.html]]></loc><lastmod>2021-10-24T20:50:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ix-simposio-de-ginecologia-oncologica.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-nacional-gbot.html]]></loc><lastmod>2021-10-24T20:28:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-congresso-pan-amazonico-de-oncologia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-forum-de-pesquisa-translacional.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/neopulmao-usp-2021.html]]></loc><lastmod>2021-10-14T19:31:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xperience-forum-oncologia.html]]></loc><lastmod>2021-10-01T18:45:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/meeting-the-minds-updates---oncologia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-meeting-the-minds---enfermeiros-e-farmaceuticos.html]]></loc><lastmod>2021-09-17T00:37:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-congresso-brasil-germanico-de-oncologia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-cancer-gastrointestinal-2.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cirurgia-de-cabeca-e-pescoco-2.html]]></loc><lastmod>2021-08-29T19:06:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-workshop-de-pesquisa-clinica.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/genomic-summit-2021.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-melanoma-e-imuno-oncologia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-simposio-internacional-de-cancer-de-pulmao-2.html]]></loc><lastmod>2021-08-15T22:32:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/4-simposio-multidisciplinar-em-oncohematologia-e-imunoterapia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-paulista-de-dor-2021.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/prevencao-primaria-do-cancer.html]]></loc><lastmod>2021-08-15T21:56:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-intersections.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-simposio-de-farmacia-do-icesp-sp-908.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/imon-2021-enfermagem-oncologica.html]]></loc><lastmod>2021-08-15T20:46:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xperiencetalks.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ginecologia-oncologica-3.html]]></loc><lastmod>2021-07-18T21:24:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-2021.html]]></loc><lastmod>2024-08-23T21:27:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xi-breast-cancer-weekend.html]]></loc><lastmod>2021-07-04T20:49:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xii-board-review-in-medical-oncology.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-simposio-internacional-de-uro-oncologia-oncologia-d-or-sp-467.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/9-interamerican-oncology-conference.html]]></loc><lastmod>2021-07-05T00:12:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-curso-de-inverno-em-oncologia-molecular.html]]></loc><lastmod>2021-07-05T00:14:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/onco-hpb-2021.html]]></loc><lastmod>2021-06-29T19:55:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/10-simposio-internacional-de-mastologia-sim-rio-2016.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/next-frontiers-to-cure-cancer-2021.html]]></loc><lastmod>2021-06-10T23:41:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2021-asco-annual-meeting.html]]></loc><lastmod>2024-04-18T12:19:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/meeting-the-minds-enfermeiros-e-farmaceuticos-oncologicos.html]]></loc><lastmod>2021-05-24T01:34:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/torax-2021.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/top-10-pulmao-2021.html]]></loc><lastmod>2021-04-25T23:27:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/aacr-annual-meeting-2021.html]]></loc><lastmod>2021-03-29T00:55:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/enfermagem-oncologica-3.html]]></loc><lastmod>2021-03-29T00:53:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-breast-cancer.html]]></loc><lastmod>2021-03-29T00:51:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/congresso-europeu-de-hematologia.html]]></loc><lastmod>2021-03-29T00:47:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-gineco-2021.html]]></loc><lastmod>2021-03-29T00:45:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-gi.html]]></loc><lastmod>2021-03-29T00:43:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/elcc-2021.html]]></loc><lastmod>2021-03-15T04:39:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/sgo-2021.html]]></loc><lastmod>2025-03-11T13:15:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/nccn-2021-virtual-annual-conference.html]]></loc><lastmod>2021-03-15T04:43:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-internacional-de-oncologia-cutanea.html]]></loc><lastmod>2021-03-15T01:19:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vacina-covid.html]]></loc><lastmod>2021-03-01T01:05:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/desafios-em-oncologia-molecular.html]]></loc><lastmod>2021-03-01T01:11:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/asco-gu-2021.html]]></loc><lastmod>2021-01-31T22:53:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/sabcs-2020.html]]></loc><lastmod>2024-10-31T14:56:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/top-8-sarcoma-melanoma-e-tumores-raros.html]]></loc><lastmod>2020-12-04T18:55:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-simposio-de-cancer-de-pulmao.html]]></loc><lastmod>2020-11-29T18:51:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-gbcp-2020.html]]></loc><lastmod>2020-11-15T21:47:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/destaques-em-oncologia-sc-2020.html]]></loc><lastmod>2020-11-19T20:29:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-congresso-brasileiro-de-oncoginecologia-moonshot.html]]></loc><lastmod>2020-11-11T19:01:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/meeting-the-minds-2020-i-hematologia-e-oncologia.html]]></loc><lastmod>2020-11-10T22:45:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cpu-2020.html]]></loc><lastmod>2020-11-10T21:53:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/viii-congresso-brasileiro-de-cuidados-paliativos.html]]></loc><lastmod>2020-11-04T22:24:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-uni-onco.html]]></loc><lastmod>2020-11-02T22:36:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/best-in-oncology-2020.html]]></loc><lastmod>2020-11-02T19:02:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/8-simposio-internacional-oncoclinicas.html]]></loc><lastmod>2020-11-02T18:45:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-de-cancer-de-mama-do-df.html]]></loc><lastmod>2020-11-02T18:26:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-breastmit-2020.html]]></loc><lastmod>2020-11-02T18:14:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-uro-oncologia-3.html]]></loc><lastmod>2020-11-02T17:52:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-melanoma-e-sarcoma.html]]></loc><lastmod>2020-11-02T17:42:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/dor-oncologica-2.html]]></loc><lastmod>2020-11-02T17:16:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/hemo-2020.html]]></loc><lastmod>2020-11-02T16:54:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/oncologia-de-precisao-para-mastologistas-e-ginecologistas.html]]></loc><lastmod>2020-12-01T12:37:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/doencas-tumorais-e-traumaticas-da-unha.html]]></loc><lastmod>2020-11-02T16:01:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/top-10-cabeca-e-pescoco.html]]></loc><lastmod>2020-11-02T15:57:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xx-congresso-brasileiro-de-doenca-trofoblastica-gestacional.html]]></loc><lastmod>2020-10-19T21:06:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/16-jornada-paulista-de-mastologia.html]]></loc><lastmod>2020-09-28T20:50:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-internacional-de-oncologia-de-brasilia.html]]></loc><lastmod>2020-09-28T20:50:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/uro-usp-2020.html]]></loc><lastmod>2020-09-28T20:49:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/23-congresso-da-sobrice.html]]></loc><lastmod>2020-10-18T23:44:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/melanoma-e-imuno-oncologia.html]]></loc><lastmod>2020-10-05T02:22:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/meeting-the-minds-oncologia.html]]></loc><lastmod>2020-09-17T21:55:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-simposio-virtual-internacional-de-cardio-oncologia.html]]></loc><lastmod>2020-09-08T16:17:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-jornada-odontologica-do-ibcc.html]]></loc><lastmod>2020-09-08T15:36:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/medicina-integrativa-em-foco.html]]></loc><lastmod>2020-08-23T22:09:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-congresso-brasil-germanico-de-oncologia.html]]></loc><lastmod>2020-08-23T21:42:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-cancer-de-mama-2.html]]></loc><lastmod>2020-08-23T21:32:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xi-congresso-internacional-de-uro-oncologia.html]]></loc><lastmod>2020-08-11T00:23:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/tumores-neuroendocrinos-em-foco.html]]></loc><lastmod>2020-05-11T00:39:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cancer-de-mama-metastatico.html]]></loc><lastmod>2020-05-11T20:56:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/urgencias-e-emergencias-oncologicas.html]]></loc><lastmod>2020-07-12T20:28:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ganepao-2020.html]]></loc><lastmod>2020-07-12T20:29:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xiv-curso-de-revisao-em-hematologia-e-hemoterapia.html]]></loc><lastmod>2020-03-09T19:19:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xi-board-review-in-medical-oncology.html]]></loc><lastmod>2020-07-12T20:33:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-congresso-brasileiro-de-cancer-do-aparelho-digestivo.html]]></loc><lastmod>2020-07-26T23:32:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/concan-2020.html]]></loc><lastmod>2020-07-13T18:37:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xi-congresso-franco-brasileiro-de-oncologia.html]]></loc><lastmod>2020-07-12T23:18:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/inovacao-e-futuro-da-oncologia.html]]></loc><lastmod>2020-03-09T13:30:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/reuniao-clinica-de-onco-hematologia.html]]></loc><lastmod>2020-03-03T18:29:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2020-highlights-of-ash.html]]></loc><lastmod>2020-03-01T20:49:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/dor-oncologica.html]]></loc><lastmod>2020-03-01T20:36:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-oncogenetica.html]]></loc><lastmod>2020-03-01T20:21:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-uro-oncologia-2.html]]></loc><lastmod>2020-07-13T00:34:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/11-brazilian-lymphoma-conference.html]]></loc><lastmod>2020-03-01T18:49:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cancer-de-endometrio.html]]></loc><lastmod>2020-02-28T16:08:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-de-onco-hematologia.html]]></loc><lastmod>2020-01-26T19:39:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/viii-simposio-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T16:53:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/capacitacao-em-tecnicas-estereotaxicas.html]]></loc><lastmod>2020-01-26T19:32:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xv-edicao-do-simposio-edwaldo-camargo---pet-ct.html]]></loc><lastmod>2020-01-26T19:37:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/conferencia-brasileira-de-cancer-de-mama-2020.html]]></loc><lastmod>2020-02-09T23:06:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/oncologia-para-nao-oncologistas.html]]></loc><lastmod>2020-01-26T18:58:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/23-congresso-brasileiro-de-mastologia.html]]></loc><lastmod>2020-01-26T18:54:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/workshop-de-oncomastologia.html]]></loc><lastmod>2020-02-07T19:10:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/oncologia-de-precisao.html]]></loc><lastmod>2019-11-24T22:51:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/destaques-em-imuno-oncologia.html]]></loc><lastmod>2019-11-24T18:53:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-discute-pet-ct.html]]></loc><lastmod>2019-11-24T18:19:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cancer-de-pulmao-em-foco-2.html]]></loc><lastmod>2020-04-24T16:55:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xiii-jornada-de-cirurgia-de-cabeca-e-pescoco-e-vi-simposio-de-cirurgia-plastica-reconstrutora.html]]></loc><lastmod>2019-11-11T00:44:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T16:56:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-simposio-internacional-de-hepatocarcinoma.html]]></loc><lastmod>2019-11-25T03:18:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-congresso-paulista-de-cuidados-paliativos.html]]></loc><lastmod>2019-11-11T03:27:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-simposio-de-uro-oncologia.html]]></loc><lastmod>2019-11-11T00:05:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/avancos-na-oncologia-e-hematologia.html]]></loc><lastmod>2019-11-10T23:53:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cancer-de-ovario-em-pauta.html]]></loc><lastmod>2019-11-10T23:43:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/gu-review-2019.html]]></loc><lastmod>2019-10-28T04:30:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vii-simposio-internacional-de-melanoma.html]]></loc><lastmod>2019-10-28T04:11:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ficare-2019.html]]></loc><lastmod>2019-10-28T03:48:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-prostate-day.html]]></loc><lastmod>2019-11-07T12:37:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-simposio-do-gbcp.html]]></loc><lastmod>2019-10-28T03:29:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/biopsia-liquida.html]]></loc><lastmod>2019-11-04T14:37:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/sarcoma-melanoma-2.html]]></loc><lastmod>2019-10-28T03:15:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/imunoterapia-e-suas-aplicacoes-terapeuticas.html]]></loc><lastmod>2019-09-16T01:24:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-internacional-em-oncogenetica.html]]></loc><lastmod>2019-09-02T14:46:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-congresso-mineiro-de-cuidados-paliativos.html]]></loc><lastmod>2019-09-01T16:41:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-congresso-paraense-de-cuidados-paliativos.html]]></loc><lastmod>2019-09-01T15:58:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-cancer-urologico-do-ctcan.html]]></loc><lastmod>2019-09-01T15:44:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/evidencias-em-cuidados-paliativos.html]]></loc><lastmod>2019-09-01T16:17:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/board-review-sboc-2019.html]]></loc><lastmod>2019-08-18T19:20:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/igcs-2019.html]]></loc><lastmod>2019-09-16T02:38:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/meeting-internacional-leforte.html]]></loc><lastmod>2019-08-18T16:44:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/medicina-integrativa-e-humanizacao.html]]></loc><lastmod>2019-08-23T17:12:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-congresso-internacional-de-diagnostico-por-imagem.html]]></loc><lastmod>2019-08-18T22:22:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-encontro-de-terapias-avancadas.html]]></loc><lastmod>2019-08-04T21:07:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-em-oncohematologia-e-imunoterapia.html]]></loc><lastmod>2019-08-04T20:42:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/intersections-2019.html]]></loc><lastmod>2019-08-04T20:24:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/imuno-oncologia-em-foco.html]]></loc><lastmod>2019-08-04T20:04:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-internacional-americas-oncologia.html]]></loc><lastmod>2019-08-04T19:54:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cuidados-paliativos-2.html]]></loc><lastmod>2019-08-04T19:37:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/jornada-de-cirurgia-oncologica-2.html]]></loc><lastmod>2019-08-04T19:09:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/x-board-review.html]]></loc><lastmod>2019-08-12T13:22:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/oncologia-translacional.html]]></loc><lastmod>2019-08-04T18:51:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-oncobiologia.html]]></loc><lastmod>2019-08-04T18:40:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/fisioterapia-em-oncologia.html]]></loc><lastmod>2019-08-04T18:22:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/maratona-cirurgica-uro-oncologia.html]]></loc><lastmod>2019-08-18T17:19:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cbu-2019.html]]></loc><lastmod>2019-08-18T17:01:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/emergencias-oncologicas-3.html]]></loc><lastmod>2019-11-24T22:55:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/oncologia-molecular.html]]></loc><lastmod>2019-06-30T23:10:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xiii-simposio-multiprofissional-de-medicina-intensiva.html]]></loc><lastmod>2019-06-30T22:57:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-board-review-ginecologico-eva-nordeste.html]]></loc><lastmod>2019-07-01T03:10:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/3-simposio-de-espiritualidade-em-saude.html]]></loc><lastmod>2019-07-01T03:09:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/asco-direct---cancer-de-prostata-em-foco.html]]></loc><lastmod>2019-06-13T12:28:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/gastrao-2019.html]]></loc><lastmod>2019-06-25T12:39:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-congresso-catarinense-de-cuidados-paliativos.html]]></loc><lastmod>2019-05-05T22:03:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-simposio-de-cancer-de-pulmao-ctcan.html]]></loc><lastmod>2020-04-24T17:13:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cancer-de-mama-em-foco.html]]></loc><lastmod>2019-05-05T20:42:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-simposio-internacional-de-tumores-gastrointestinais.html]]></loc><lastmod>2019-05-05T20:29:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-5-anos-dom-oncologia.html]]></loc><lastmod>2019-05-05T20:07:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-congresso-de-oncologia-do-hospital-sao-domingos.html]]></loc><lastmod>2019-05-05T19:58:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/14-cancer-de-mama-gramado.html]]></loc><lastmod>2019-08-07T19:49:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/board-review-xiii-curso-de-revisao-em-hematologia-e-hemoterapia.html]]></loc><lastmod>2019-05-05T19:22:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/best-of-asco-2019.html]]></loc><lastmod>2019-05-05T19:00:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/22-congresso-da-sobrice.html]]></loc><lastmod>2019-05-05T18:51:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/13-conferencia-brasileira-sobre-melanoma.html]]></loc><lastmod>2019-05-05T18:45:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-jornada-clinica-ultrassonografica-em-ginecologia-e-obstetricia.html]]></loc><lastmod>2019-04-08T00:27:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ferramentas-em-uro-oncologia.html]]></loc><lastmod>2019-04-22T02:28:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/qualidade-de-vida-e-cuidados-paliativos.html]]></loc><lastmod>2019-04-08T16:07:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/latin-american-symposium-and-trainingin-biobanking.html]]></loc><lastmod>2019-03-10T23:07:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-redcap.html]]></loc><lastmod>2019-03-10T21:49:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-regional-de-melanoma.html]]></loc><lastmod>2019-03-10T21:37:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/4-next-frontiers-to-cure-cancer.html]]></loc><lastmod>2019-04-22T02:28:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/brazilian-breast-cancer-symposium-2019.html]]></loc><lastmod>2019-03-10T20:10:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/torax-2019.html]]></loc><lastmod>2019-03-10T20:02:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-de-ginecologia-oncologica-eva.html]]></loc><lastmod>2019-03-10T19:51:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/seminarios-regionais-sobrafo-2019---curitiba.html]]></loc><lastmod>2019-03-10T19:36:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-simposio-de-cancer-ginecologico.html]]></loc><lastmod>2019-04-07T18:14:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/22-congresso-brasileiro-de-mastologia.html]]></loc><lastmod>2019-03-11T00:53:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/x-congresso-internacional-de-uro-oncologia.html]]></loc><lastmod>2019-03-10T18:59:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/3-simposio-internacional-do-gtg.html]]></loc><lastmod>2019-03-11T01:17:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/workshop-em-cancer-de-prostata.html]]></loc><lastmod>2019-03-10T18:17:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/tratamento-integrado-da-dor.html]]></loc><lastmod>2019-03-10T18:06:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/nutricao-em-oncologia.html]]></loc><lastmod>2019-03-10T17:59:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/pesquisa-clinica-informacao-e-divulgacao.html]]></loc><lastmod>2019-01-24T14:32:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xiv-simposio-professor-edwaldo-camargo-pet-ct.html]]></loc><lastmod>2019-01-20T20:34:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vii-simposio-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:15:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-ecip.html]]></loc><lastmod>2019-03-10T22:58:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-de-onco-hematologia.html]]></loc><lastmod>2019-01-20T19:34:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-meeting-of-innovation-in-oncology.html]]></loc><lastmod>2019-01-20T19:25:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/conferencia-brasileira-de-cancer-de-mama.html]]></loc><lastmod>2019-01-20T18:43:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/acesso-a-medicacao-no-brasil.html]]></loc><lastmod>2019-01-20T18:18:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-summit-latin-america-2019.html]]></loc><lastmod>2019-01-20T18:09:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/10-brazilian-lymphoma-conference.html]]></loc><lastmod>2019-01-20T17:56:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/radioterapia-e-controle-de-qualidade.html]]></loc><lastmod>2018-11-25T19:55:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/neuro-oncologia.html]]></loc><lastmod>2018-11-25T19:36:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cirurgia-de-cabeca-e-pescoco.html]]></loc><lastmod>2018-11-25T19:20:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cirurgia-oncologica-2.html]]></loc><lastmod>2018-11-25T18:50:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/educacao-em-saude.html]]></loc><lastmod>2018-11-25T18:35:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-propulmao-360.html]]></loc><lastmod>2020-04-24T17:16:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-forum-nacional-de-cardio-oncologia.html]]></loc><lastmod>2018-11-25T16:54:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-encontro-multiprofissional-de-radioterapia.html]]></loc><lastmod>2018-11-25T15:37:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/emergencias-oncologicas-2.html]]></loc><lastmod>2018-11-04T18:08:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:16:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/gu-review-2018.html]]></loc><lastmod>2018-11-04T17:32:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-latino-americano-de-imuno-oncologia.html]]></loc><lastmod>2018-11-04T17:17:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-fononcologia.html]]></loc><lastmod>2018-11-04T16:19:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/congresso-brasileiro-de-oncoginecologia.html]]></loc><lastmod>2018-11-04T16:05:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-brazilian-radiosurgery-society-congress.html]]></loc><lastmod>2018-11-04T15:47:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-congresso-brasileiro-de-nutricao-oncologica.html]]></loc><lastmod>2018-11-04T15:28:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/enfermagem-oncologica-2.html]]></loc><lastmod>2018-11-04T15:12:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-prostate-day.html]]></loc><lastmod>2018-11-04T15:01:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-gbot-2018.html]]></loc><lastmod>2018-11-04T14:48:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/enfermagem-onco-hematologica.html]]></loc><lastmod>2018-11-04T14:31:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/oncologia-integrativa.html]]></loc><lastmod>2018-11-04T14:16:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vii-congresso-internacional-de-cuidados-paliativos.html]]></loc><lastmod>2018-11-04T14:05:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/sarcoma-melanoma.html]]></loc><lastmod>2018-11-04T13:37:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/moonshot-brasil-sul.html]]></loc><lastmod>2018-11-04T13:18:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-simposio-de-cancer-urologico---getuc.html]]></loc><lastmod>2018-11-04T13:15:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vii-jornada-de-cuidados-paliativos-do-inca.html]]></loc><lastmod>2018-10-14T19:03:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/6-simposio-internacional-do-grupo-oncoclinicas.html]]></loc><lastmod>2018-10-14T18:50:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/sexualidade-da-mulher-com-cancer-ginecologico.html]]></loc><lastmod>2018-10-14T18:37:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-norte-mineiro-de-cancer-de-mama.html]]></loc><lastmod>2018-10-14T18:28:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/anatomia-pelvica-laparoscopica-e-tecnicas-cirurgicas-em-ginecologia.html]]></loc><lastmod>2018-10-14T18:17:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-mastologia.html]]></loc><lastmod>2018-10-14T17:42:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/farmacia-hospitalar-em-oncologia.html]]></loc><lastmod>2018-09-30T20:00:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-internacional-de-imuno-oncologia-translacional.html]]></loc><lastmod>2018-09-30T20:05:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-discute-cardio-oncologia.html]]></loc><lastmod>2018-09-30T19:43:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/jornada-paulista-de-mastologia-2018.html]]></loc><lastmod>2018-09-30T19:34:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/spdor-2018.html]]></loc><lastmod>2018-09-30T19:24:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-congresso-de-oncologia-do-hospital-santa-lucia.html]]></loc><lastmod>2018-09-30T19:12:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-internacional-fluminense-de-oncologia.html]]></loc><lastmod>2018-09-30T19:03:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-internacional-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:54:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/bioetica-e-pesquisa-clinica.html]]></loc><lastmod>2018-09-30T18:47:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-de-oncologia-ginecologica.html]]></loc><lastmod>2018-09-30T18:38:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-de-cancer-de-ovario-bento-goncalves-2018.html]]></loc><lastmod>2018-09-30T18:07:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/hemo-2018.html]]></loc><lastmod>2018-10-29T13:00:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/encontro-de-oncologia-e-hematologia.html]]></loc><lastmod>2018-09-30T17:45:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/congresso-brasileiro-de-cancer-colorretal-e-peritonio.html]]></loc><lastmod>2018-09-30T17:35:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/medicina-nuclear.html]]></loc><lastmod>2018-09-27T12:12:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/praticas-integrativas-e-complementares.html]]></loc><lastmod>2018-09-02T18:15:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/radioterapia-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2018-09-02T18:12:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-aacr-international-conference.html]]></loc><lastmod>2018-09-02T16:58:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/terapia-subcutanea.html]]></loc><lastmod>2018-09-02T16:42:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/maratona-de-cirurgia-oncologica.html]]></loc><lastmod>2018-09-02T16:23:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/x-congresso-franco-brasileiro-de-oncologia.html]]></loc><lastmod>2018-08-19T22:40:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cancer-de-mama-em-pauta.html]]></loc><lastmod>2018-08-19T22:12:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-uro-oncologia.html]]></loc><lastmod>2018-08-19T21:53:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/tumores-ginecologicos.html]]></loc><lastmod>2018-08-19T21:39:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/rastreamento-mamografico.html]]></loc><lastmod>2018-08-19T21:21:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/board-review-sboc.html]]></loc><lastmod>2018-08-19T21:03:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-onconordeste.html]]></loc><lastmod>2018-08-19T20:47:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/carcinoma-hepatocelular.html]]></loc><lastmod>2018-08-19T20:33:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cancer-de-cabeca-e-pescoco-em-foco.html]]></loc><lastmod>2018-08-19T20:09:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cirurgia-robotica-e-endoscopica-de-cabeca-e-pescoco.html]]></loc><lastmod>2018-08-19T19:53:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xx-congresso-da-sociedade-brasileira-de-radioterapia.html]]></loc><lastmod>2018-08-05T21:21:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-simposio-internacional-de-melanoma.html]]></loc><lastmod>2018-08-05T21:18:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/controversias-em-cancer-de-mama.html]]></loc><lastmod>2018-08-05T21:16:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/nutricao-oncologica.html]]></loc><lastmod>2018-08-05T21:13:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ix-board-review-in-medical-oncology.html]]></loc><lastmod>2018-08-13T12:47:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-sencop.html]]></loc><lastmod>2018-08-05T21:07:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/connect-2018.html]]></loc><lastmod>2018-08-05T21:05:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cancer-gastrointestinal-e-melanoma.html]]></loc><lastmod>2018-08-05T21:01:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/concan-2018.html]]></loc><lastmod>2018-08-05T20:58:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/oncohematologia-e-imunoterapia.html]]></loc><lastmod>2018-08-05T20:56:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-simposio-de-oncologia-do-hospital-do-cancer-de-mt.html]]></loc><lastmod>2018-08-09T12:22:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-sul-capixaba-de-oncologia.html]]></loc><lastmod>2018-07-22T23:27:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ligas-de-oncologia.html]]></loc><lastmod>2018-08-09T22:49:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/radiologia-intervencionista.html]]></loc><lastmod>2018-07-22T23:01:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/tumores-de-mama-e-gastrointestinais.html]]></loc><lastmod>2018-07-22T22:59:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/inovacao-em-oncologia.html]]></loc><lastmod>2018-07-22T22:34:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/50-anos-do-hospital-santa-rita.html]]></loc><lastmod>2018-07-22T22:14:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/atualizacao-em-cancer-de-mama-2.html]]></loc><lastmod>2018-07-22T21:43:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/diagnostico-do-cancer.html]]></loc><lastmod>2018-07-22T21:15:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/top-10-pulmao.html]]></loc><lastmod>2020-04-24T19:46:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-imagem.html]]></loc><lastmod>2018-07-09T23:32:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/uro-oncologia-e-cirurgia-robotica.html]]></loc><lastmod>2018-07-09T23:23:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ginecologia-oncologica-2.html]]></loc><lastmod>2018-07-09T23:13:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/enfermagem-oncologica.html]]></loc><lastmod>2018-07-09T23:02:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/oncologia-toracica-e-ginecologia-oncologica.html]]></loc><lastmod>2018-07-09T16:49:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/gastrao-2018.html]]></loc><lastmod>2018-06-26T14:42:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/emergencias-oncologicas.html]]></loc><lastmod>2018-08-15T19:57:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/discussoes-em-imuno-oncologia.html]]></loc><lastmod>2018-06-24T23:11:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/espiritualidade-em-saude.html]]></loc><lastmod>2018-07-19T15:06:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cuidados-paliativos-em-foco.html]]></loc><lastmod>2018-07-19T21:45:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-de-radioterapia-do-inca.html]]></loc><lastmod>2018-07-10T01:40:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/psicologia-em-cuidados-paliativos-do-inca.html]]></loc><lastmod>2018-06-25T00:53:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/21-congresso-brasileiro-de-mastologia.html]]></loc><lastmod>2018-06-24T21:21:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/epidemiologia-e-bioestatistica.html]]></loc><lastmod>2018-06-24T20:39:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/terapia-alvo-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:47:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cancer-de-pulmao-em-foco.html]]></loc><lastmod>2020-04-24T16:55:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/medicina-intensiva.html]]></loc><lastmod>2018-06-10T21:20:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/mamografia-para-tecnicos-em-radiologia.html]]></loc><lastmod>2018-06-10T21:17:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/revisao-em-hematologia.html]]></loc><lastmod>2018-06-10T21:15:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/manejo-do-cancer-de-ovario.html]]></loc><lastmod>2018-05-27T21:06:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/farmacia-oncologica.html]]></loc><lastmod>2018-05-14T00:34:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/odontologia-para-pacientes-oncologicos.html]]></loc><lastmod>2018-05-14T00:31:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-congresso-de-oncologia-de-pelotas.html]]></loc><lastmod>2018-05-23T21:34:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-de-dor.html]]></loc><lastmod>2018-05-14T00:25:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cirurgia-oncologica.html]]></loc><lastmod>2018-05-14T00:19:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/atualizacao-em-cancer-de-mama.html]]></loc><lastmod>2018-05-14T00:16:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/equipe-assistencial-na-radioterapia.html]]></loc><lastmod>2018-05-14T00:11:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cuidados-paliativos-para-nao-paliativistas.html]]></loc><lastmod>2018-05-14T00:06:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-cancer-de-mama.html]]></loc><lastmod>2018-05-13T12:45:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/atualizacao-em-mastologia.html]]></loc><lastmod>2018-04-27T14:04:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/semana-de-enfermagem-do-inca.html]]></loc><lastmod>2018-04-27T03:32:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-melanoma.html]]></loc><lastmod>2018-04-28T00:02:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/genomica-do-cancer.html]]></loc><lastmod>2018-04-27T02:17:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cancer-de-pancreas.html]]></loc><lastmod>2018-04-27T19:59:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/oncologia-ortopedica.html]]></loc><lastmod>2018-04-15T16:53:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/avancos-na-oncologia-toracica.html]]></loc><lastmod>2018-04-15T15:23:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ginecologia-oncologica.html]]></loc><lastmod>2018-04-20T14:43:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cuidados-paliativos.html]]></loc><lastmod>2018-04-14T21:29:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/lung-care.html]]></loc><lastmod>2018-04-13T22:07:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/jornada-brasileira-de-oncoplastica-2.html]]></loc><lastmod>2018-04-13T21:19:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/enfermagem-em-cuidados-paliativos-oncologicos.html]]></loc><lastmod>2018-04-01T20:38:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/terapia-celular.html]]></loc><lastmod>2018-04-01T20:24:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-oncologia-cutanea.html]]></loc><lastmod>2018-04-01T20:12:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-internacional-de-melanoma.html]]></loc><lastmod>2020-04-23T19:35:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-ecip.html]]></loc><lastmod>2018-03-04T13:13:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/oncoplastia-mamaria.html]]></loc><lastmod>2018-02-19T01:53:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-international-symposium-on-molecular-genetics-of-breast-cancer.html]]></loc><lastmod>2018-03-07T21:06:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ix-congresso-brasileiro-de-farmaceuticos-em-oncologia.html]]></loc><lastmod>2018-02-04T23:49:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-simposio-de-fisioterapia-em-mastologia-oncologica-do-inca.html]]></loc><lastmod>2018-02-04T23:47:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-jornada-de-cirurgia-de-cabeca-e-pescoco-e-cirurgia-plastica-reconstrutora.html]]></loc><lastmod>2018-02-04T23:44:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-congresso-brasil-germanico-de-oncologia-e-hematologia-cbgoh.html]]></loc><lastmod>2018-03-27T13:12:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ganepao-2018.html]]></loc><lastmod>2018-05-28T02:52:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/curso-de-atualizacao-em-assistencia-de-enfermagem-em-radioterapia.html]]></loc><lastmod>2018-02-04T23:36:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-onco-hpb.html]]></loc><lastmod>2018-02-04T23:33:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-curso-internacional-de-radiobiologia.html]]></loc><lastmod>2018-02-04T23:31:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/highlights-of-ash-2018.html]]></loc><lastmod>2018-02-04T23:28:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/conferencia-brasileira-de-cancer-de-mama-2018.html]]></loc><lastmod>2018-02-19T21:30:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/snola-2018.html]]></loc><lastmod>2018-03-07T16:37:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-integrado-norte-nordeste-de-oncologia-toracica.html]]></loc><lastmod>2018-03-19T02:12:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-internacional-de-onco-hematologia.html]]></loc><lastmod>2018-01-21T17:12:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-simposio-internacional-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:26:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/best-of-asco-2018.html]]></loc><lastmod>2018-01-21T15:51:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-congresso-brasileiro-de-dor-oncologica-sobramid.html]]></loc><lastmod>2018-05-14T17:20:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/3-simposio-de-imuno-oncologia.html]]></loc><lastmod>2018-01-21T15:15:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/next-frontiers-to-cure-cancer-2018.html]]></loc><lastmod>2018-03-09T14:51:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ix-congresso-internacional-de-uro-oncologia.html]]></loc><lastmod>2018-01-21T14:37:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-simposio-internacional-de-tumores-gastrointestinais.html]]></loc><lastmod>2018-01-21T14:37:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2018-gastrointestinal-cancers-symposium-2018.html]]></loc><lastmod>2017-12-17T19:25:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/asco-sitc-clinical-immuno-oncology-symposium-2018.html]]></loc><lastmod>2017-12-17T16:53:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/top-10-imuno-oncologia.html]]></loc><lastmod>2017-12-13T16:35:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2017-sabcs.html]]></loc><lastmod>2024-10-31T15:03:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ash-2017.html]]></loc><lastmod>2017-11-26T19:35:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xvii-curso-de-radioterapia-de-ultima-geracao-e-controle-de-qualidade.html]]></loc><lastmod>2017-11-26T17:54:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-terapia-nutricional-hospitalar-multiprofissional.html]]></loc><lastmod>2017-11-26T17:42:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vii-congresso-brasileiro-das-ligas-de-cancerologia.html]]></loc><lastmod>2017-11-26T17:25:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-jornada-do-centro-oeste-de-cuidados-paliativos.html]]></loc><lastmod>2017-11-26T17:05:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-de-farmacia-oncologica-do-ibcc.html]]></loc><lastmod>2017-11-26T16:48:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-simposio-de-nutricao-e-oncologia-do-ibcc.html]]></loc><lastmod>2017-11-26T16:35:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-de-cancer-de-pulmao-e-atualizacao-pos-congresso-mundial-de-pulmao-wclc-2017.html]]></loc><lastmod>2020-04-24T17:28:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/5-simposio-internacional-do-grupo-oncoclinicas.html]]></loc><lastmod>2017-11-16T13:53:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-internacional-de-cancer-de-pulmao-do-hospital-moinhos-de-vento.html]]></loc><lastmod>2020-04-24T17:28:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-internacional-de-cardio-oncologia-do-hospital-sirio-libanes.html]]></loc><lastmod>2017-11-16T13:50:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-de-nutricao-oncologica-do-inca.html]]></loc><lastmod>2017-11-16T13:49:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-do-grupo-oncotorax.html]]></loc><lastmod>2017-11-14T15:59:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-simposio-de-oncologia-do-hospital-de-cancer-de-mt.html]]></loc><lastmod>2017-11-12T20:58:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/13-jornada-paulista-de-mastologia-jpm-2017.html]]></loc><lastmod>2017-11-12T17:13:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-internacional-de-oncocardiologia.html]]></loc><lastmod>2017-11-12T17:11:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-congresso-de-oncologia-do-hospital-santa-lucia.html]]></loc><lastmod>2017-11-12T17:08:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/fronteiras-da-linfologia-em-oncologia.html]]></loc><lastmod>2017-11-12T17:06:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/best-in-oncology-2017.html]]></loc><lastmod>2017-11-10T21:06:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/gu-review-2017.html]]></loc><lastmod>2017-11-06T13:45:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ficare-2017.html]]></loc><lastmod>2017-10-30T00:55:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/encontro-multidisciplinar-online-em-oncologia-emonco.html]]></loc><lastmod>2017-10-30T00:53:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/4-congresso-pan-amazonico-de-oncologia.html]]></loc><lastmod>2017-10-30T00:50:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-congresso-paulista-de-cuidados-paliativos.html]]></loc><lastmod>2017-11-12T19:07:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-semana-brasileira-de-oncologia.html]]></loc><lastmod>2017-10-15T23:38:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/31-congresso-brasileiro-de-patologia.html]]></loc><lastmod>2017-10-15T18:50:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/radiation-oncology-international-meeting-2017.html]]></loc><lastmod>2017-10-15T18:43:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/hemo-2017.html]]></loc><lastmod>2017-10-15T18:38:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/13-simposio-mineiro-de-enfermagem-em-oncologia.html]]></loc><lastmod>2017-10-15T18:32:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-simposio-de-melanoma-do-hospital-mae-de-deus.html]]></loc><lastmod>2017-10-15T18:28:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xii-congresso-brasileiro-de-estomaterapia.html]]></loc><lastmod>2017-10-15T18:25:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/6-international-adrenal-cancer-symposium.html]]></loc><lastmod>2017-10-01T19:22:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/20-congresso-brasileiro-de-mastologia.html]]></loc><lastmod>2017-10-01T19:19:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-internacional-de-cuidados-paliativos.html]]></loc><lastmod>2017-10-01T19:17:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-de-dor-e-cuidados-paliativos.html]]></loc><lastmod>2017-10-01T19:14:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/genomica-e-oncologia-de-precisao.html]]></loc><lastmod>2017-10-01T19:03:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/congresso-inca-80-anos.html]]></loc><lastmod>2017-09-18T20:16:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vii-congresso-internacional-de-ginecologia-oncologica.html]]></loc><lastmod>2017-09-25T21:58:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-seminario-de-odontologia-do-icesp.html]]></loc><lastmod>2017-09-25T21:59:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-praticas-integrativas-e-complementares.html]]></loc><lastmod>2017-09-18T01:29:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/seminario-regional-sobrafo-vitoria.html]]></loc><lastmod>2017-09-18T01:27:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-simposio-multidisciplinar-em-oncologia.html]]></loc><lastmod>2017-09-18T01:25:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/enfermagem-em-mastologia-oncologica.html]]></loc><lastmod>2017-09-18T01:21:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-internacional-de-imuno-oncologia.html]]></loc><lastmod>2017-09-18T01:18:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-simposio-internacional-de-citopatologia-do-hiae.html]]></loc><lastmod>2017-09-18T01:15:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-simposio-de-neuro-oncologia.html]]></loc><lastmod>2017-09-18T01:12:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-de-cuidados-paliativos-do-hiae.html]]></loc><lastmod>2017-09-03T20:52:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vii-eneo.html]]></loc><lastmod>2017-09-03T20:49:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/como-eu-trato-onco-hematologia.html]]></loc><lastmod>2017-09-12T21:08:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-curso-de-oncologia-para-nao-oncologistas.html]]></loc><lastmod>2017-09-03T20:44:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/the-new-era-of-molecular-genetics.html]]></loc><lastmod>2017-09-03T20:41:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-paulista-de-controversias-no-tratamento-da-dor-no-cancer.html]]></loc><lastmod>2017-09-03T20:39:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-maratona-de-ginecologia-onccologica-magion.html]]></loc><lastmod>2017-09-04T02:31:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-encontro-brasileiro-de-servicos-de-cuidados-paliativos.html]]></loc><lastmod>2017-09-03T20:32:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-simposio-internacional-de-oncologia-translacional-e-pesquisa-clinica.html]]></loc><lastmod>2017-09-03T20:29:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-simposio-de-cancerologia.html]]></loc><lastmod>2017-08-21T01:25:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-congresso-internacional-de-diagnostico-por-imagem.html]]></loc><lastmod>2017-08-21T01:24:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xxxvi-congresso-brasileiro-de-urologia.html]]></loc><lastmod>2017-08-21T01:23:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/12-cancer-de-mama-gramado.html]]></loc><lastmod>2017-08-21T01:57:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-encontro-de-nutricao-em-cuidados-paliativos-do-inca.html]]></loc><lastmod>2017-08-21T01:58:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-simposio-de-cancer-urologico-do-ctcan.html]]></loc><lastmod>2017-08-21T01:58:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-em-oncologia-do-hcp.html]]></loc><lastmod>2017-08-17T23:59:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/top-10-cancer-gastrointestinal.html]]></loc><lastmod>2017-10-02T13:26:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/jornada-de-cirurgia-oncologica.html]]></loc><lastmod>2017-08-29T21:41:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-simposio-internacional-do-gtg.html]]></loc><lastmod>2017-08-17T23:58:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/viii-board-review-in-medical-oncology.html]]></loc><lastmod>2017-08-07T07:05:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/3-icgeb-workshop-on-human-papillomavirus-and-associated-malignancies.html]]></loc><lastmod>2017-08-21T01:59:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-simposio-internacional-multidisciplinar-de-cancer-de-mama.html]]></loc><lastmod>2017-08-01T12:09:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-de-cuidados-paliativos.html]]></loc><lastmod>2017-08-07T07:06:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/hpb-cancer.html]]></loc><lastmod>2017-08-07T07:06:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/44-isobm-annual-congress.html]]></loc><lastmod>2017-08-21T02:01:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/sbtmo-2017.html]]></loc><lastmod>2017-08-07T07:07:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/seminario-regional-sobrafo---recife.html]]></loc><lastmod>2017-07-23T22:24:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/viii-congresso-brasileiro-de-cirurgia-do-figado-pancreas-e-vias-biliares.html]]></loc><lastmod>2017-08-21T02:02:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-2017.html]]></loc><lastmod>2021-07-04T19:23:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/top-10-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:32:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-interonco.html]]></loc><lastmod>2017-07-24T20:27:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/4-congresso-tjcc.html]]></loc><lastmod>2017-09-25T14:48:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/12-conferencia-brasileira-sobre-melanoma.html]]></loc><lastmod>2017-07-24T20:28:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-seminario-de-cuidados-no-final-da-vida.html]]></loc><lastmod>2017-07-18T20:42:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/4-simposio-baiano-de-cancer-de-pele.html]]></loc><lastmod>2017-07-18T20:42:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ix-jornada-mineira-de-urologia.html]]></loc><lastmod>2017-06-26T19:59:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/encontro-internacional-sobre-cancer-de-mama.html]]></loc><lastmod>2017-06-26T19:59:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-internacional-icoi.html]]></loc><lastmod>2017-06-26T20:00:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-simposio-de-cancer-ginecologico.html]]></loc><lastmod>2017-06-26T20:00:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/best-of-asco-2017.html]]></loc><lastmod>2017-06-26T20:00:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-de-cancer-de-mama.html]]></loc><lastmod>2017-06-26T20:01:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/sequenciamento-genetico-em-ngs-e-pcr-digital.html]]></loc><lastmod>2017-06-26T20:01:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/7-forum-nacional-de-politicas-de-saude-em-oncologia.html]]></loc><lastmod>2017-06-26T20:02:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/abordagem-pratica-em-nodulos-pulmonares.html]]></loc><lastmod>2017-06-26T20:02:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/20-destaques-onco.html]]></loc><lastmod>2017-06-26T20:02:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/oncologia-integrada-iv.html]]></loc><lastmod>2017-06-23T20:46:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-simposio-internacional-de-melanoma.html]]></loc><lastmod>2017-06-20T21:24:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/7-simposio-internacional-de-mastologia.html]]></loc><lastmod>2017-06-12T19:44:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xxiv-jornada-de-patologia---cancer-de-pele.html]]></loc><lastmod>2017-06-07T21:15:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/asco-2017.html]]></loc><lastmod>2017-05-31T21:31:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/meeting-of-minds-2017.html]]></loc><lastmod>2017-05-28T22:51:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xi-simposio-multidisciplinar-em-medicina-intensiva.html]]></loc><lastmod>2017-05-28T22:54:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/jornada-brasileira-de-oncoplastica.html]]></loc><lastmod>2017-05-22T13:24:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/seminario-regional-sobrafo-cuiaba.html]]></loc><lastmod>2017-05-22T13:24:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/goiania-breast-cancer-symposium.html]]></loc><lastmod>2017-05-15T15:11:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-sobre-manejo-de-metastase-vertebral.html]]></loc><lastmod>2017-05-15T15:10:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-simposio-internacional-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:40:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/aacr-international-conference-on-translational-cancer-medicine.html]]></loc><lastmod>2017-05-02T04:19:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xv-jornada-paulista-de-urologia.html]]></loc><lastmod>2017-04-24T18:26:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/fronteiras-da-medicina.html]]></loc><lastmod>2017-04-24T17:05:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xx-congresso-brasileiro-de-cirurgia-toracica---torax2017.html]]></loc><lastmod>2017-05-02T04:20:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-de-imuno-oncologia.html]]></loc><lastmod>2017-04-17T01:20:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-congresso-internacional-de-neuro-oncologia.html]]></loc><lastmod>2017-04-17T01:20:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-congresso-einstein-de-cirurgia-robotica.html]]></loc><lastmod>2017-04-17T01:21:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/next-frontiers-to-cure-cancer-2017.html]]></loc><lastmod>2017-04-24T15:07:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-forum-de-controversias-em-cirurgia-toracica.html]]></loc><lastmod>2017-04-24T15:01:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-internacional-de-coloproctologia.html]]></loc><lastmod>2017-03-20T20:04:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/hipec-international-meeting.html]]></loc><lastmod>2017-03-20T20:05:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/viii-breast-cancer-weekend.html]]></loc><lastmod>2017-03-20T20:05:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-internacional-de-terapia-nutricional.html]]></loc><lastmod>2017-03-14T00:01:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-intersections.html]]></loc><lastmod>2017-04-15T00:30:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/viii-congresso-internacional-de-uro-oncologia.html]]></loc><lastmod>2017-03-27T12:06:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cirurgia-oncologica-do-aparelho-digestivo.html]]></loc><lastmod>2017-03-09T17:14:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/asco-sitc-clinical-immuno-oncology-symposium.html]]></loc><lastmod>2017-02-22T03:11:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2017-genitourinary-cancers-symposium.html]]></loc><lastmod>2017-02-12T14:12:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2017-cancer-survivorship-symposium.html]]></loc><lastmod>2017-02-12T14:10:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2017-gastrointestinal-cancers-symposium.html]]></loc><lastmod>2017-01-17T19:57:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-congresso-sul-sudeste-da-sociedade-brasileira-de-cirurgia-oncologica.html]]></loc><lastmod>2016-11-20T15:50:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-encontro-de-cancerologia-do-interior-paulista.html]]></loc><lastmod>2016-11-20T13:27:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-congresso-brasileiro-de-nutricao-oncologica.html]]></loc><lastmod>2016-11-14T17:47:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/3-congresso-multidisciplinar-em-oncologia.html]]></loc><lastmod>2016-11-14T17:48:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/alem-do-tratamento-do-cancer-de-prostata.html]]></loc><lastmod>2016-11-14T17:49:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ix-congresso-franco-brasileiro-de-oncologia.html]]></loc><lastmod>2016-11-06T19:39:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/hemo-2016.html]]></loc><lastmod>2016-11-06T19:40:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-simposio-gbot.html]]></loc><lastmod>2016-10-24T01:07:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/4-simposio-internacional-do-grupo-oncoclinicas.html]]></loc><lastmod>2016-10-23T18:48:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-simposio-de-imuno-oncologia-e-melanoma.html]]></loc><lastmod>2016-10-21T18:27:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-de-nutricao-em-oncologia.html]]></loc><lastmod>2016-11-04T19:26:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/sp-onco-iii.html]]></loc><lastmod>2016-10-30T12:51:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-congresso-de-farmacia-hospitalar-em-oncologia-do-inca.html]]></loc><lastmod>2016-10-30T12:52:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-internacional-de-imuno-oncologia.html]]></loc><lastmod>2016-10-30T12:49:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-onconordeste.html]]></loc><lastmod>2016-10-17T20:30:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-eva-lacog-2016.html]]></loc><lastmod>2016-10-23T18:48:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-de-nutricao-oncologica-do-inca.html]]></loc><lastmod>2016-10-14T00:19:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/esmo-2016.html]]></loc><lastmod>2016-10-14T00:19:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/congresso-brasileiro-e-jornada-paulista-de-mastologia.html]]></loc><lastmod>2016-10-03T20:03:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-multidisciplinar-em-transplante-de-celulas-tronco-hematopoieticas.html]]></loc><lastmod>2016-10-03T20:05:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/dermatoscopia-e-atualizacao-em-oncologica-cutanea.html]]></loc><lastmod>2016-10-03T20:04:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-jornada-de-psicologia-em-cuidados-paliativos-do-inca.html]]></loc><lastmod>2016-10-03T20:04:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-encontro-ibero-americano-sobre-leucemia-linfocitica-cronica-ibam.html]]></loc><lastmod>2016-09-21T20:33:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/5-simposio-internacional-de-oncologia-toracica.html]]></loc><lastmod>2016-09-21T21:23:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/magion---maratona-de-cirurgia-ginecologica-oncologica-laparoscopica.html]]></loc><lastmod>2016-09-21T15:18:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/3-forum-de-lideres-do-setor-de-saude.html]]></loc><lastmod>2016-09-21T15:20:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xviii-congresso-de-cirurgia-do-rio-de-janeiro.html]]></loc><lastmod>2016-09-21T15:23:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-de-neuro-oncologia.html]]></loc><lastmod>2016-09-21T15:22:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-brasileiro-de-imuno-oncologia.html]]></loc><lastmod>2016-09-21T15:22:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/6-encontro-nacional-de-endoscopia-oncologica-eneo.html]]></loc><lastmod>2016-09-21T15:21:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-centro-oeste-de-estomaterapia.html]]></loc><lastmod>2016-09-21T15:21:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xiv-congresso-paulista-de-urologia.html]]></loc><lastmod>2016-09-11T19:59:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-simposio-de-atualizacao-em-radioterapia-i-simposio-multiprofissional-de-radioterapia.html]]></loc><lastmod>2016-09-11T19:58:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-multidisciplinar-em-oncologia.html]]></loc><lastmod>2016-09-11T19:59:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/congresso-brasileiro-de-cancer-do-aparelho-digestivo.html]]></loc><lastmod>2016-08-22T13:51:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xxi-congresso-sogesp-2016.html]]></loc><lastmod>2016-08-28T13:29:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-de-oncologia-e-hematologia-da-ufmg.html]]></loc><lastmod>2016-08-22T13:50:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/curso-de-revisao-em-oncologia-clinica.html]]></loc><lastmod>2016-07-25T01:34:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/congresso-centro-oeste-da-sociedade-brasileira-de-cirurgia-oncologica.html]]></loc><lastmod>2016-08-16T00:09:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xix-destaques-onco.html]]></loc><lastmod>2016-06-27T02:23:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-de-espiritualidade-em-oncologia-icesp.html]]></loc><lastmod>2016-06-27T02:23:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-congresso-norte-nordeste-da-sbco.html]]></loc><lastmod>2016-07-04T01:10:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-internacional-de-oncologia-e-oncogeriatria.html]]></loc><lastmod>2016-08-07T17:26:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-congresso-internacional-de-ginecologia-oncologica-do-hospital-israelita-albert-einstein.html]]></loc><lastmod>2016-08-16T00:14:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/11-edicao-do-cancer-de-mama-gramado-2016.html]]></loc><lastmod>2016-08-22T13:46:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/7-icno-cbnc-internacional-conference-nutritional-oncology-congresso-brasileiro-de-nutricao-e-cancer.html]]></loc><lastmod>2016-06-20T00:25:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xviii-congresso-da-sociedade-brasileira-de-radioterapia.html]]></loc><lastmod>2016-06-20T00:25:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/52-congresso-anual-da-asco.html]]></loc><lastmod>2016-06-08T19:36:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-simposio-de-cancerologia.html]]></loc><lastmod>2016-08-16T00:14:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-simposio-internacional-multidisciplinar-de-cancer-de-mama.html]]></loc><lastmod>2016-08-07T17:26:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-uro-onco-cepon.html]]></loc><lastmod>2016-08-22T13:46:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-de-melhores-praticas-em-cuidados-paliativos.html]]></loc><lastmod>2016-08-07T17:27:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-curso-de-inverno-em-oncologia-molecular.html]]></loc><lastmod>2016-08-07T17:27:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/6-simposio-internacional-de-mastologia---sim-rio-2016.html]]></loc><lastmod>2016-08-07T17:28:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-discute-tumores-de-mama-e-gastrointestinais.html]]></loc><lastmod>2016-05-23T22:15:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/viii-congresso-brasileiro-de-farmaceuticos-em-oncologia.html]]></loc><lastmod>2016-05-18T13:10:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/goiania-breast-cancer-symposium-gbsc-2016.html]]></loc><lastmod>2016-05-15T20:06:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/42-congresso-pernambucano-de-ginecologia-e-obstetricia-e-2-simposio-de-oncologia-ginecologica.html]]></loc><lastmod>2016-05-23T22:19:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-forum-brasileiro-de-farmacoeconomia-de-medicamentos-biologicos-e-inovadores.html]]></loc><lastmod>2016-05-08T22:08:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/highlights-of-ash-r-na-america-latina.html]]></loc><lastmod>2016-05-01T14:40:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/global-academic-program-gap-2016.html]]></loc><lastmod>2016-05-01T14:39:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-simposio-internacional-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:05:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/4-eyeforpharma-brasil.html]]></loc><lastmod>2016-04-15T14:05:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/7-brazilian-lymphoma-conference-e-14-lymphoma-interchange-meeting.html]]></loc><lastmod>2016-04-11T13:28:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/oncoplastia-2016.html]]></loc><lastmod>2016-05-01T14:41:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/46-jornada-paulista-de-radiologia.html]]></loc><lastmod>2016-05-01T14:40:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-congresso-internacional-de-cancer-ginecologico.html]]></loc><lastmod>2016-04-03T23:45:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/snola-2016.html]]></loc><lastmod>2016-04-03T23:43:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xx-jornada-de-patologia.html]]></loc><lastmod>2016-03-28T02:10:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vii-congresso-de-uro-oncologia.html]]></loc><lastmod>2016-03-06T23:05:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-internacional-de-uro-oncologia.html]]></loc><lastmod>2016-02-28T17:34:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-simposio-de-cancer-de-mama-ctcan.html]]></loc><lastmod>2016-03-21T13:47:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-internacional-de-tumores-gastrointestinais.html]]></loc><lastmod>2016-03-06T23:05:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/asco-gu.html]]></loc><lastmod>2016-01-21T15:21:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/integracao-e-atualizacao-cientifica.html]]></loc><lastmod>2015-11-16T00:21:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/hemo-2015.html]]></loc><lastmod>2015-11-02T19:18:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-simposio-de-melanoma-do-instituto-do-cancer-do-hospital-mae-de-deus.html]]></loc><lastmod>2015-11-16T15:57:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-internacional-de-imuno-oncologia.html]]></loc><lastmod>2015-11-16T15:57:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/da-biologia-a-terapia.html]]></loc><lastmod>2015-11-13T12:06:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/19-congresso-brasileiro-de-oncologia-clinica.html]]></loc><lastmod>2015-11-13T12:05:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/4-simposio-anual-do-nucleo-de-oncologia-toracica-do-instituto-coi.html]]></loc><lastmod>2015-10-21T14:39:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-internacional-de-imagem-em-oncologia.html]]></loc><lastmod>2015-10-16T21:05:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-internacional-multidisciplinar-do-hospital-do-cancer-de-barretos.html]]></loc><lastmod>2015-10-16T21:06:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xxi-congresso-brasileiro-de-nutricao-parenteral-e-enteral.html]]></loc><lastmod>2015-10-21T14:41:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xii-congresso-da-sociedade-brasileira-de-cirurgia-oncologica---sbco.html]]></loc><lastmod>2015-10-19T13:07:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/11-jornada-paulista-de-mastologia.html]]></loc><lastmod>2015-10-05T02:58:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/congresso-europeu-de-cancer-2015-ecco18-esmo40.html]]></loc><lastmod>2015-10-05T02:59:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/curso-de-doencas-mieloproliferativas-e-linfoproliferativas.html]]></loc><lastmod>2015-10-05T03:00:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/seminarios-regionais-sobrafo-2015-salvador.html]]></loc><lastmod>2015-10-05T03:00:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/concan-2015.html]]></loc><lastmod>2015-09-07T22:27:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/jornada-pan-amazonica-de-hematologia-e-hemoterapia.html]]></loc><lastmod>2015-09-07T22:25:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/10-edicao-do-cancer-de-mama-gramado-2015.html]]></loc><lastmod>2015-08-31T12:18:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-mineiro-de-cuidado-paliativo.html]]></loc><lastmod>2015-09-18T13:41:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iii-simposio-internacional-de-melanoma.html]]></loc><lastmod>2015-09-21T11:37:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-de-neuro-oncologia.html]]></loc><lastmod>2015-09-21T11:37:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/11-conferencia-brasileira-sobre-melanoma.html]]></loc><lastmod>2020-04-24T20:32:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/instituto-coi-promove-simposio-anual-do-nucleo-de-oncologia-gastrointestinal.html]]></loc><lastmod>2015-08-09T22:43:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/experts-em-mamografia-em-minicurso-de-pos-graduacao-na-usp.html]]></loc><lastmod>2015-08-09T22:43:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-internacional-de-personalizacao-em-oncologia-mamaria.html]]></loc><lastmod>2015-07-27T15:52:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-curso-de-inverno-em-oncologia-em-oncologia-molecular.html]]></loc><lastmod>2015-08-02T12:49:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/5-congresso-da-academia-internacional-de-cancer-oral.html]]></loc><lastmod>2015-07-12T21:26:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/encontro-de-gastroenterologia-do-hcfmusp.html]]></loc><lastmod>2015-07-07T19:34:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/17th-milan-breast-cancer-conference.html]]></loc><lastmod>2015-06-19T02:41:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-discute-cuidado-paliativo.html]]></loc><lastmod>2015-06-18T22:09:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ix-simposio-internacional-de-atualizacao-em-temas-de-hematologia---board-review.html]]></loc><lastmod>2015-06-18T22:11:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/insight-2015.html]]></loc><lastmod>2015-06-17T22:24:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xvii-congresso-da-sociedade-brasileira-de-radioterapia.html]]></loc><lastmod>2015-06-17T22:24:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-simposio-internacional-multidisciplinar-de-cancer-de-mama.html]]></loc><lastmod>2015-06-14T22:00:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/11-congresso-internacional-de-cancer-gastrico-igcc.html]]></loc><lastmod>2015-06-14T21:59:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2015-asco-annual-meeting.html]]></loc><lastmod>2015-06-09T16:59:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xix-jornada-de-patologia.html]]></loc><lastmod>2015-06-04T22:02:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/3-eyeforpharma-brasil.html]]></loc><lastmod>2015-05-29T12:58:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cancer-de-mama-no-xviii-congresso-brasileiro-de-mastologia.html]]></loc><lastmod>2015-05-20T14:15:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/avancos-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2015-05-18T00:33:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/interonco-2015.html]]></loc><lastmod>2015-05-18T00:34:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-congresso-internacional-de-neuro-oncologia.html]]></loc><lastmod>2015-05-11T04:04:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/10-edicao-do-simposio-de-pet-ct-em-oncologia.html]]></loc><lastmod>2015-04-30T15:56:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-fronteiras-da-medicina.html]]></loc><lastmod>2015-04-10T03:15:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xiv-jornada-paulista-de-urologia.html]]></loc><lastmod>2015-04-30T15:58:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xxvii-congresso-brasileiro-de-cirurgia-dermatologica.html]]></loc><lastmod>2015-04-30T15:59:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/5-forum-nacional-de-politicas-de-saude-em-oncologia.html]]></loc><lastmod>2015-04-30T16:00:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/jornada-de-oncoplastia-2015.html]]></loc><lastmod>2015-04-15T13:18:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-internacional-de-coloproctologia-prof-daher-cutait.html]]></loc><lastmod>2015-05-03T20:46:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/1-simposio-internacional-do-gtg.html]]></loc><lastmod>2015-03-18T16:14:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xvi-encontro-nacional-de-profissionais-em-pesquisa-clinica.html]]></loc><lastmod>2015-03-18T16:15:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/longevidade-e-testamento-vital.html]]></loc><lastmod>2015-03-18T16:17:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/anestesia-e-o-brasil.html]]></loc><lastmod>2015-03-18T16:18:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vi-congresso-internacional-de-uro-oncologia.html]]></loc><lastmod>2015-03-09T14:41:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-internacional-de-tratamento-multidisciplinar-de-uro-oncologia.html]]></loc><lastmod>2015-03-02T11:32:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xviii-jornada-de-patologia-patologia-urologica.html]]></loc><lastmod>2015-02-24T13:39:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-cancer-geniturinario.html]]></loc><lastmod>2015-02-03T20:40:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xxiii-simposio-internacional-de-hemoterapia-e-terapia-celular.html]]></loc><lastmod>2015-02-22T11:35:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/cancer-hereditario-da-epidemiologia-a-clinica.html]]></loc><lastmod>2015-02-13T13:34:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vii-curso-de-verao-de-pesquisa-em-oncologia.html]]></loc><lastmod>2014-12-11T12:14:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-de-cancer-gastrointestinal.html]]></loc><lastmod>2014-12-11T11:22:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-internacional-de-medicina-integrativa---saude-alem-da-cura.html]]></loc><lastmod>2014-12-04T18:27:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-congresso-norte-e-nordeste-da-sbco-2.html]]></loc><lastmod>2014-12-04T18:27:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/curso-de-imersao-em-oncologia-brasil-italia-2014-capitulo-vii-cabeca-e-pescoco.html]]></loc><lastmod>2014-11-16T21:22:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/advances-in-the-management-of-colorectal-cancer-a-latin-american-perspective.html]]></loc><lastmod>2014-11-16T21:20:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/10-jornada-paulista-de-mastologia-jpm.html]]></loc><lastmod>2014-11-12T11:27:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-scientific-interchange-meeting-oncoclinicas-e-dana-faber.html]]></loc><lastmod>2014-11-11T13:29:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/encontro-pos-astro-2014.html]]></loc><lastmod>2014-11-10T21:17:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/hemo-2014.html]]></loc><lastmod>2014-11-03T00:12:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xvii-congresso-mineiro-de-urologia.html]]></loc><lastmod>2014-10-20T03:52:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-congresso-de-oncologia-dor-meeting-with-experts.html]]></loc><lastmod>2014-10-20T03:51:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ix-simposio-latino-americano-de-uro-oncologia-vii-jornada-de-uro-oncologia-usp-unicamp-e-unesp.html]]></loc><lastmod>2014-10-20T03:51:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/v-congresso-internacional-de-cancer-ginecologico.html]]></loc><lastmod>2014-10-27T01:18:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-de-nutricao-em-oncologia.html]]></loc><lastmod>2014-10-20T03:46:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-congresso-paulista-de-fisioterapia-em-oncologia.html]]></loc><lastmod>2014-10-20T03:46:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-congresso-multidisciplinar-do-instituto-do-cancer-do-hospital-mae-de-deus.html]]></loc><lastmod>2014-09-29T17:17:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/viii-congresso-franco-brasileiro-de-oncologia.html]]></loc><lastmod>2014-09-29T17:12:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/4-encontro-do-i-simposio-interinstitucional-de-mastologia.html]]></loc><lastmod>2014-09-23T21:20:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/28-congresso-brasileiro-de-medicina-nuclear.html]]></loc><lastmod>2014-09-23T14:41:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-congresso-todos-juntos-contra-o-cancer.html]]></loc><lastmod>2014-09-14T23:42:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/i-simposio-paulista-de-oncologia.html]]></loc><lastmod>2014-09-15T00:02:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xii-oncocesp---encontro-de-oncologia-do-centro-oeste-paulista.html]]></loc><lastmod>2014-09-12T17:59:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/iv-international-symposium-on-translational-oncology.html]]></loc><lastmod>2014-09-09T17:36:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/heterogeneidade-intratumoral.html]]></loc><lastmod>2014-09-09T00:41:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/congresso-de-oncologia-do-instituto-do-cancer-mae-de-deus.html]]></loc><lastmod>2014-09-09T00:02:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xiii-congresso-paulista-de-urologia.html]]></loc><lastmod>2014-08-31T16:56:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/ii-simposio-internacional-de-melanoma.html]]></loc><lastmod>2014-08-31T16:47:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vii-encontro-internacional-de-hepatologia.html]]></loc><lastmod>2014-08-27T15:41:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/desafios-e-perspectivas-no-setor-de-saude-em-2015.html]]></loc><lastmod>2014-08-27T15:36:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/2-congresso-internacional-de-simulacao-realistica.html]]></loc><lastmod>2014-08-26T00:44:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/3-encontro-do-i-simposio-interinstitucional-de-mastologia.html]]></loc><lastmod>2014-08-25T20:02:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/best-of-asco-2014-annual-meeting.html]]></loc><lastmod>2017-05-15T14:29:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/workshop-brasileiro-de-cancer-epigenomico-2014.html]]></loc><lastmod>2014-08-10T15:28:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/20-congresso-de-anestesia-regional-e-controle-da-dor---lasra-2014.html]]></loc><lastmod>2014-08-10T15:03:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/congresso-da-sociedade-brasileira-de-transplante-de-medula-ossea-sbtmo.html]]></loc><lastmod>2014-08-10T15:05:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-internacional-discute-evolucao-do-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2014-08-04T01:44:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-destaca-avancos-no-tratamento-do-mieloma-multiplo.html]]></loc><lastmod>2014-08-04T01:41:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xvii-jornada-de-patologia-vii-encontro-internacional-de-patologia-investigativa-iii-encontrando-o-especialista.html]]></loc><lastmod>2014-08-04T01:38:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/pos-asco-oncomed-bh.html]]></loc><lastmod>2014-07-28T23:33:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/curso-internacional-de-colonoscopia.html]]></loc><lastmod>2014-07-28T16:36:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/41-gastrao-programacao-para-a-pratica.html]]></loc><lastmod>2014-07-21T01:58:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/xviii-congresso-da-sociedade-brasileira-de-transplante-de-medula-ossea-sbtmo.html]]></loc><lastmod>2014-07-02T16:20:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/simposio-medico-the-advances-in-multiple-myeloma-treatment.html]]></loc><lastmod>2014-06-14T15:43:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/50-asco.html]]></loc><lastmod>2017-05-15T14:21:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/curso-de-imersao-em-oncologia-brasil---italia-2014---cancer-tgi-alto.html]]></loc><lastmod>2014-04-17T02:46:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/vii-congresso-brasileiro-de-farmaceuticos-em-oncologia.html]]></loc><lastmod>2014-04-17T02:40:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/agende-se/highlights-of-ash-2014.html]]></loc><lastmod>2014-04-17T02:37:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview.html]]></loc><lastmod>2014-03-05T00:29:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview/tratado-de-oncologia---volumes-1-e-2.html]]></loc><lastmod>2014-11-08T03:54:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview/enfermagem-em-oncologia.html]]></loc><lastmod>2014-10-29T02:27:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview/oncologia-colegio-brasileiro-de-radiologia-e-diagnostico-por-imagem.html]]></loc><lastmod>2014-10-13T04:23:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview/imuno-histoquimica-dos-linfomas.html]]></loc><lastmod>2014-06-18T13:09:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview/tratamento-cirurgico-do-cancer-gastrointestinal.html]]></loc><lastmod>2014-04-16T17:10:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview/moc-drogas---agentes-oncologicos.html]]></loc><lastmod>2014-05-04T12:47:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview/manual-de-tratamento-da-dor.html]]></loc><lastmod>2014-06-10T19:38:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview/condutas-nutricionais-no-pos-cirurgico-oncologico.html]]></loc><lastmod>2014-04-16T17:13:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview/manual-de-oncologia-clinica-do-brasil-moc.html]]></loc><lastmod>2017-05-15T14:34:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview/rotinas-para-cancer-de-estomago-esofago-figado-e-pancreas.html]]></loc><lastmod>2014-03-12T16:52:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview/diagnostico-e-tratamento-de-tumores-osseos.html]]></loc><lastmod>2014-03-12T16:29:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview/a-c-camargo-compartilha-rotinas-baseadas-em-evidencias.html]]></loc><lastmod>2014-03-12T16:25:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/bookreview/cancer-uma-visao-multiprofissional.html]]></loc><lastmod>2014-03-12T16:19:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas.html]]></loc><lastmod>2014-03-05T00:21:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/novo-diretor-geral-quer-reforcar-o-protagonismo-do-inca.html]]></loc><lastmod>2023-05-04T14:16:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/cirurgia-oncologica-em-pauta.html]]></loc><lastmod>2022-04-25T12:11:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/radioterapia-o-que-mudou-em-2020.html]]></loc><lastmod>2020-11-23T21:01:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/desafios-da-gestao-em-oncologia.html]]></loc><lastmod>2020-10-20T00:30:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/racionalidade-na-pratica-medica.html]]></loc><lastmod>2020-08-31T16:30:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/pesquisa-e-assistencia.html]]></loc><lastmod>2020-05-25T02:30:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/nova-era-na-oncohematologia.html]]></loc><lastmod>2020-04-27T02:14:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/em-defesa-da-saude-publica.html]]></loc><lastmod>2020-05-20T00:15:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/desafios-da-cirurgia-oncologica.html]]></loc><lastmod>2020-02-09T18:36:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/a-proxima-fronteira-na-medicina-diagnostica.html]]></loc><lastmod>2020-01-27T16:23:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/cirurgia-robotica-da-mama.html]]></loc><lastmod>2020-01-26T20:04:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/avancos-e-promessas-da-oncologia-de-precisao.html]]></loc><lastmod>2019-10-31T21:55:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/a-terceira-onda.html]]></loc><lastmod>2019-11-19T12:04:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/pesquisa-clinica-em-pauta-2.html]]></loc><lastmod>2019-08-16T15:06:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/a-corrida-por-biomarcadores-2.html]]></loc><lastmod>2019-07-01T14:28:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/acog-gu-novo-chair-discute-avancos-e-ambiente-de-pesquisa.html]]></loc><lastmod>2019-05-20T03:27:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/caminhos-para-a-pesquisa-e-assistencia-2.html]]></loc><lastmod>2019-05-02T13:17:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/alianca-contra-o-tabaco-2.html]]></loc><lastmod>2019-05-02T13:16:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/em-defesa-da-oncogenetica.html]]></loc><lastmod>2018-12-17T22:38:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/por-uma-agenda-positiva-na-pesquisa-em-cancer.html]]></loc><lastmod>2018-12-18T16:14:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/eficiencia-e-humanizacao-no-tratamento-do-cancer.html]]></loc><lastmod>2018-09-17T01:52:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/regulacao-acesso-e-seguranca-do-paciente.html]]></loc><lastmod>2018-06-25T04:09:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/etica-acesso-e-inovacao.html]]></loc><lastmod>2018-06-19T11:30:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/desafios-e-perspectivas.html]]></loc><lastmod>2020-10-24T22:53:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/imunoterapia-a-nova-vanguarda.html]]></loc><lastmod>2018-01-10T12:56:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/entrevista-santini.html]]></loc><lastmod>2018-11-07T19:11:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/inca-80-anos.html]]></loc><lastmod>2017-10-06T17:40:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/novo-diretor-medico-da-oncologia-clinica-e-hematologia-da-bp.html]]></loc><lastmod>2017-09-18T03:16:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/o-desafio-da-sustentabilidade.html]]></loc><lastmod>2017-07-17T21:49:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/licoes-de-vida-de-humberto-torloni.html]]></loc><lastmod>2017-06-08T19:00:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/evidencia-e-credibilidade-cientifica.html]]></loc><lastmod>2017-05-03T01:14:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/pioneirismo-e-excelencia.html]]></loc><lastmod>2017-04-25T22:01:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/o-papel-do-prescritor-e-o-acesso-ao-tratamento-do-cancer.html]]></loc><lastmod>2017-04-18T20:49:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/um-novo-paradigma.html]]></loc><lastmod>2017-02-12T14:06:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/pesquisa-clinica-em-pauta.html]]></loc><lastmod>2016-12-15T17:44:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/avancos-e-promessas.html]]></loc><lastmod>2017-04-25T02:16:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/o-valor-da-evidencia.html]]></loc><lastmod>2020-04-24T18:52:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/licoes-da-nutricao-oncologica.html]]></loc><lastmod>2016-07-17T20:05:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/protagonismo-e-experiencia.html]]></loc><lastmod>2016-05-04T23:20:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/estrategia-de-gestao.html]]></loc><lastmod>2016-05-01T19:44:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/ciencia-e-sociedade.html]]></loc><lastmod>2016-01-20T16:17:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/a-hora-da-virada.html]]></loc><lastmod>2015-10-26T02:09:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/mamografia-de-qualidade-como-garantir.html]]></loc><lastmod>2015-09-28T15:04:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/contrastes-e-desafios.html]]></loc><lastmod>2015-08-25T13:13:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/palavra-de-expert.html]]></loc><lastmod>2017-06-26T18:58:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/novo-padrao-de-cuidados-em-llc.html]]></loc><lastmod>2015-04-14T16:18:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/caos-da-radioterapia-continua.html]]></loc><lastmod>2015-04-08T18:27:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/brasil-lanca-consenso-de-dor-oncologica.html]]></loc><lastmod>2015-04-08T18:13:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/cancer-regulacao-e-acesso.html]]></loc><lastmod>2015-02-01T14:04:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/pacto-social.html]]></loc><lastmod>2014-11-17T17:15:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/o-retrato-da-desigualdade.html]]></loc><lastmod>2014-10-01T19:24:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/acolher-e-cuidar.html]]></loc><lastmod>2017-04-27T16:56:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/uma-janela-de-oportunidades.html]]></loc><lastmod>2017-06-26T18:58:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/seguranca-oncologica-e-preservacao-estetica.html]]></loc><lastmod>2014-07-21T02:07:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/em-defesa-da-oncoplastica.html]]></loc><lastmod>2014-06-12T13:42:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/entrevistas/um-tributo-a-experiencia.html]]></loc><lastmod>2017-05-07T21:39:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/cancer-cervical-em-mulheres-idosas.html]]></loc><lastmod>2014-05-16T20:42:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/engajamento-e-comunicacao-com-atencao-primaria-diminuem-na-fase-de-sobrevivencia-do-cancer-de-mama.html]]></loc><lastmod>2025-12-03T15:52:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-isolada-mostra-preservacao-duradoura-de-orgao-em-pacientes-com-carcinoma-de-laringe.html]]></loc><lastmod>2025-11-26T10:16:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-ultraprocessados-aumenta-risco-de-adenomas-colorretais-de-inicio-precoce-em-mulheres.html]]></loc><lastmod>2025-11-24T16:55:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/percepcao-de-saude-e-limitacoes-funcionais-determinam-trajetoria-de-qualidade-de-vida-em-idosas-com-cancer-de-mama.html]]></loc><lastmod>2025-11-24T10:14:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metformina-aliada-ao-jejum-noturno-prolongado-mostra-perfil-inicial-de-seguranca-em-estudo-pre-cirurgico-de-cancer-de-mama.html]]></loc><lastmod>2025-11-24T07:44:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-reforca-impacto-positivo-da-atividade-fisica-em-mulheres-com-cancer-de-mama-metastatico.html]]></loc><lastmod>2025-11-21T11:16:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-analisa-quimiorradioterapia-adjuvante-no-oligodendroglioma-anaplasico.html]]></loc><lastmod>2025-11-18T19:30:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-associacao-entre-triglicerideos-elevados-e-aumento-do-risco-de-cancer-colorretal.html]]></loc><lastmod>2025-11-24T11:49:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/degeneracao-do-trato-corticoespinhal-apos-tratamento-multimodal-em-glioma-de-alto-grau.html]]></loc><lastmod>2025-11-18T19:22:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-impacto-da-radioterapia-pelvica-na-funcao-sexual-de-mulheres-com-cancer-ginecologico.html]]></loc><lastmod>2025-11-18T11:28:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/supremo-irradiacao-da-parede-toracica-apos-mastectomia-nao-melhora-sobrevida-em-10-anos-no-cancer-de-mama-de-risco-intermediario.html]]></loc><lastmod>2025-11-13T17:45:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-debate-valor-no-tratamento-do-cancer.html]]></loc><lastmod>2025-11-13T17:06:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/com-23-anos-de-seguimento-estudo-europeu-mostra-que-triagem-com-psa-reduz-mortalidade-por-cancer-de-prostata.html]]></loc><lastmod>2025-11-13T15:54:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-moderada-e-consistente-reduz-risco-de-canceres-do-sistema-digestivo-aponta-estudo.html]]></loc><lastmod>2025-11-13T13:00:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nomograma-preve-resposta-patologica-completa-apos-neoadjuvancia-no-cancer-de-mama.html]]></loc><lastmod>2025-11-10T16:42:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-custo-utilidade-da-avaliacao-geriatrica-estruturada-em-idosos-com-cancer.html]]></loc><lastmod>2025-11-10T11:01:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tabagismo-e-qualidade-de-vida-a-longo-prazo-em-pacientes-com-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2025-11-10T10:48:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ucp2-e-stat1-podem-ser-marcadores-prognosticos-para-o-desenvolvimento-do-cancer-cervical.html]]></loc><lastmod>2025-11-10T19:41:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-avalia-papel-do-ctdna-no-melanoma-de-alto-risco.html]]></loc><lastmod>2025-11-07T13:29:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-quimioterapico-em-idosos-com-cancer-de-pancreas-metastatico-revela-padroes-distintos-na-pratica-clinica.html]]></loc><lastmod>2025-11-06T12:28:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consorcio-do-nci-avanca-na-compreensao-da-tolerabilidade-ao-tratamento-oncologico.html]]></loc><lastmod>2025-11-03T16:18:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-de-sangue-pode-permitir-a-deteccao-precoce-do-cancer.html]]></loc><lastmod>2025-10-31T17:09:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estilo-de-vida-e-prevencao-do-cancer-de-mama-na-pos-menopausa.html]]></loc><lastmod>2025-10-30T16:34:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-deve-estimular-diretrizes-para-o-controle-do-cancer-em-paises-de-baixa-e-media-renda.html]]></loc><lastmod>2025-10-28T15:57:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-prediz-o-risco-de-eventos-cardiacos-agudos-em-mulheres-tratadas-com-rt-pos-operatoria-no-cancer-de-mama.html]]></loc><lastmod>2025-10-28T15:26:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mioesteatose-esta-associada-ao-estadiamento-tnm-avancado-e-as-caracteristicas-tumorais-em-mulheres-jovens-com-cancer-de-mama.html]]></loc><lastmod>2025-10-14T19:39:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/medo-de-mas-noticias-dificulta-rastreamento-do-cancer-do-colo-do-utero.html]]></loc><lastmod>2025-10-14T12:28:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-que-mais-de-70-dos-pacientes-oncologicos-sofrem-com-ansiedade-relacionada-a-exames-de-imagem.html]]></loc><lastmod>2025-10-14T10:40:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prodige-13-estudo-questiona-beneficio-da-vigilancia-com-antigeno-carcinoembrionario-e-tomografia-em-pacientes-com-cancer-colorretal-ressecado.html]]></loc><lastmod>2025-10-14T18:17:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-propoe-marco-temporal-para-definicao-de-cura-no-cancer-de-colon.html]]></loc><lastmod>2025-10-10T12:03:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-analisa-as-iniquidades-no-tratamento-do-cancer.html]]></loc><lastmod>2025-10-09T16:21:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tropion-breast02-dato-dxd-demonstra-ganho-de-sobrevida-global-no-cancer-de-mama-triplo-negativo-sem-indicacao-de-imunoterapia.html]]></loc><lastmod>2025-10-08T19:01:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-aponta-disparidades-no-acesso-a-preservacao-da-fertilidade-em-jovens-com-cancer-de-mama.html]]></loc><lastmod>2025-10-08T17:06:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/troca-de-icdk-4-6-pos-progressao-melhora-slp.html]]></loc><lastmod>2025-10-07T19:04:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-ligacao-entre-inflamacao-e-dimensoes-da-fadiga-em-mulheres-com-cancer-de-mama-em-estagio-inicial.html]]></loc><lastmod>2025-10-07T11:55:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perda-de-peso-impacta-negativamente-a-sobrevida-em-pacientes-com-cancer-de-pancreas-aponta-meta-analise.html]]></loc><lastmod>2025-10-07T10:59:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/indice-de-risco-nutricional-e-cancer-gastrointestinal-em-idosos.html]]></loc><lastmod>2025-10-06T17:13:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-que-gastroenterostomia-endoscopica-e-superior-a-gastroenterostomia-cirurgica-na-obstrucao-gastrica-maligna.html]]></loc><lastmod>2025-10-06T16:37:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intensificacao-da-radioterapia-de-resgate-guiada-por-pet-psma-melhora-resultados-em-pacientes-com-recorrencia-apos-prostatectomia-radical.html]]></loc><lastmod>2025-10-06T09:44:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-associacao-genomica-ampla-identifica-29-variantes-em-subsitios-do-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2025-10-03T17:06:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mortes-por-cancer-renal-devem-dobrar-ate-2050.html]]></loc><lastmod>2025-10-03T16:37:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-impacto-economico-e-assistencial-da-ausencia-de-cuidados-paliativos-em-pacientes-com-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2025-10-03T15:09:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-estima-risco-de-cancer-de-ovario-apos-cancer-de-mama-brca-1-2.html]]></loc><lastmod>2025-10-03T12:27:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-maior-carga-de-doencas-cronicas-em-pessoas-vivendo-com-hiv-e-canceres-nao-relacionados-a-aids.html]]></loc><lastmod>2025-10-03T11:14:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-associacao-entre-sono-e-satisfacao-sexual-em-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2025-10-02T18:23:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-de-cancer-de-pulmao-em-sobreviventes-de-cancer-mostra-potencial-para-deteccao-precoce-de-novos-tumores.html]]></loc><lastmod>2025-10-02T15:31:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/torpedo-mostra-que-imrt-e-feixe-de-protons-tem-resultados-comparaveis-de-qualidade-de-vida-no-cancer-de-orofaringe.html]]></loc><lastmod>2025-10-01T15:20:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-multicentrico-de-fase-3-mostra-resultados-da-radioterapia-adjuvante-no-cancer-de-bexiga-de-alto-risco.html]]></loc><lastmod>2025-10-01T15:28:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/distribuicao-da-gordura-corporal-tem-impacto-no-risco-de-cancer.html]]></loc><lastmod>2025-09-30T12:40:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-avalia-papel-das-abordagens-psicossociais-nos-cuidados-oncologicos-paliativos.html]]></loc><lastmod>2025-09-30T10:04:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-descreve-desfechos-e-estrategias-de-tratamento-no-carcinoma-metaplasico-de-mama-em-mulheres-brasileiras.html]]></loc><lastmod>2025-09-29T15:23:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cobertura-global-da-vacina-contra-hpv-ainda-esta-aquem-da-meta-da-oms-revela-revisao-sistematica.html]]></loc><lastmod>2025-09-29T14:14:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-explora-vae-como-abordagem-diagnostica-e-terapeutica-no-cancer-de-mama.html]]></loc><lastmod>2025-09-25T17:12:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-t-dxd-mais-pertuzumabe-como-primeira-linha-para-pacientes-com-cancer-de-mama-metastatico-her2-positivo.html]]></loc><lastmod>2025-09-25T12:27:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exemplo-brasileiro-ilustra-o-uso-de-bracos-controle-inferiores-na-pesquisa-em-cancer.html]]></loc><lastmod>2025-09-24T17:19:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perdas-de-produtividade-global-em-consequencia-do-cancer-ultrapassaram-us-560-bilhoes-em-2022.html]]></loc><lastmod>2025-09-24T16:14:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/jovens-adultos-sobreviventes-de-cancer-nos-eua-podem-enfrentar-riscos-sociais-elevados.html]]></loc><lastmod>2025-09-24T15:10:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/patritumab-deruxtecan-mostra-atividade-promissora-em-pacientes-com-cancer-de-mama-metastatico-hr-positivo-que-progrediram-a-inibidores-de-cdk4-6.html]]></loc><lastmod>2025-09-23T20:43:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pros-mostram-desafios-na-comunicacao-dos-testes-geneticos-de-linha-germinativa-para-pacientes-com-cancer-de-prostata.html]]></loc><lastmod>2025-09-23T19:20:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-analisa-fitoterapia-japonesa-no-tratamento-do-cancer.html]]></loc><lastmod>2025-09-23T19:08:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cistite-aguda-pode-preceder-o-cancer-urogenital.html]]></loc><lastmod>2025-09-23T15:57:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-o-microambiente-imunologico-do-cancer-colorretal-e-novas-abordagens-imunoterapeuticas.html]]></loc><lastmod>2025-09-23T10:44:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aspirina-em-baixa-dose-reduz-recorrencia-do-cancer-colorretal-em-pacientes-com-mutacoes-em-pi3k.html]]></loc><lastmod>2025-09-23T10:39:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-reforca-importancia-da-vacina-contra-o-hpv-em-adolescentes-mais-jovens.html]]></loc><lastmod>2025-09-23T09:37:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-multiomica-mostra-caracteristicas-clinicas-e-moleculares-do-cancer-de-mama-triplo-negativo-her2-low.html]]></loc><lastmod>2025-09-22T21:05:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vazios-regulatorios-e-falta-de-treinamento-a-profissionais-de-saude-ainda-sao-barreiras-ao-planejamento-antecipado-de-cuidados.html]]></loc><lastmod>2025-09-22T19:00:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-confirma-associacao-entre-consumo-de-alcool-e-canceres-do-trato-digestivo-superior.html]]></loc><lastmod>2025-09-22T15:57:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relatorio-da-aacr-destaca-impacto-vital-de-investimentos-federais-na-pesquisa-oncologica.html]]></loc><lastmod>2025-09-19T11:22:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lesao-nervosa-induzida-por-cancer-promove-resistencia-a-terapia-anti-pd-1.html]]></loc><lastmod>2025-09-19T09:49:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/monografias-do-arc-novo-volume-sobre-talco-e-acrilonitrila.html]]></loc><lastmod>2025-09-18T19:45:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-identifica-padroes-de-uso-de-antibioticos-de-amplo-espectro-no-fim-da-vida-de-pacientes-com-cancer-avancado.html]]></loc><lastmod>2025-09-18T12:12:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estatisticas-do-cancer-de-prostata-revelam-aumento-da-doenca-avancada.html]]></loc><lastmod>2025-09-16T19:27:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/deteccao-precoce-de-multiplos-canceres-baseada-em-biopsia-liquida-da-exploracao-da-evidencia-a-implementacao.html]]></loc><lastmod>2025-09-15T16:42:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-adjuvante-de-baixa-dose-reduz-toxicidade-em-pacientes-com-cancer-de-orofaringe-hpv-associado.html]]></loc><lastmod>2025-09-15T15:58:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sugere-seguranca-da-terapia-hormonal-preservadora-de-fertilidade-em-mulheres-jovens-com-cancer-de-endometrio-em-estagio-inicial.html]]></loc><lastmod>2025-09-14T19:11:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-combina-gocatamig-e-ifinatamab-deruxtecana-no-cancer-de-pulmao-de-celulas-pequenas-refratario-ou-recidivado.html]]></loc><lastmod>2025-09-11T14:45:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-reforca-importancia-de-alimentos-nao-processados-para-a-prevencao-do-cancer.html]]></loc><lastmod>2025-09-09T15:03:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-lung05-analise-final-mostra-respostas-duraveis-de-t-dxd-no-cpcnp-her2-mutado-previamente-tratado.html]]></loc><lastmod>2025-09-09T14:10:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-lung06-estudo-de-fase-3-avalia-t-dxd-pembro-como-terapia-de-primeira-linha-no-cpcnp-her2-e-pd-l1.html]]></loc><lastmod>2025-09-09T09:00:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-reforca-importancia-da-imuno-histoquimica-para-diagnostico-de-her2-no-cancer-de-pulmao.html]]></loc><lastmod>2025-09-07T10:30:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-aponta-que-exposicao-solar-na-adolescencia-pode-reduzir-risco-de-cancer-de-mama.html]]></loc><lastmod>2025-09-05T16:09:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-antiviral-contra-hepatite-c-reduz-risco-de-cancer-de-pulmao-e-linfoma-nao-hodgkin.html]]></loc><lastmod>2025-09-05T12:53:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-revela-carga-global-de-cancer-atribuivel-ao-hiv.html]]></loc><lastmod>2025-09-03T18:29:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/medidas-antropometricas-e-triagem-nutricional-em-idosos-com-cancer.html]]></loc><lastmod>2025-09-16T19:14:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-associa-tabagismo-passivo-ao-aumento-do-risco-de-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2025-09-03T14:16:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-caso-controle-avalia-qualidade-de-vida-fadiga-e-forca-muscular-em-mulheres-com-cancer-de-mama.html]]></loc><lastmod>2025-09-02T18:20:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-eficacia-da-metformina-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2025-09-02T18:11:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intervencao-remota-promove-perda-de-peso-significativa-em-mulheres-com-cancer-de-mama.html]]></loc><lastmod>2025-09-01T09:31:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-propoe-modelo-simples-para-prever-risco-de-doenca-renal-cronica-apos-o-tratamento-com-cisplatina.html]]></loc><lastmod>2025-08-29T11:57:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-discordancia-entre-objetivos-de-cuidado-e-tratamento-recebido-em-pacientes-com-cancer-avancado.html]]></loc><lastmod>2025-08-28T10:13:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intervencoes-psicologicas-e-nutricionais-integradas-otimizam-recuperacao-pos-operatoria-em-pacientes-com-cancer-colorretal.html]]></loc><lastmod>2025-08-25T23:12:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-desigualdades-raciais-no-uso-de-antidepressivos-e-ansioliticos-entre-sobreviventes-do-cancer.html]]></loc><lastmod>2025-08-25T11:34:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-aponta-alta-taxa-de-cuidados-agressivos-no-fim-da-vida-em-pacientes-com-cancer-de-mama-metastatico-hr-her2.html]]></loc><lastmod>2025-08-25T08:33:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pro-duce-monitoramento-remoto-de-epros-com-sinais-vitais-melhora-qualidade-de-vida-durante-tratamento-com-t-dxd.html]]></loc><lastmod>2025-08-25T16:27:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acupuntura-mostra-eficacia-no-tratamento-da-neuropatia-periferica-induzida-por-quimioterapia.html]]></loc><lastmod>2025-08-22T11:22:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-coorte-reforca-o-papel-dos-lipidios-sericos-como-potenciais-fatores-de-risco-modificaveis-para-cancer-colorretal.html]]></loc><lastmod>2025-08-21T18:22:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-investiga-associacao-entre-o-uso-de-contraceptivos-orais-e-risco-de-cancer-de-figado.html]]></loc><lastmod>2025-08-18T13:32:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-avalia-canabinoides-para-a-prevencao-de-nauseas-e-vomitos-induzidos-por-quimioterapia.html]]></loc><lastmod>2025-08-18T12:53:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fumo-passivo-no-cancer-de-pulmao-afeta-risco-de-recorrencia-e-sobrevida.html]]></loc><lastmod>2025-08-13T19:51:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trastuzumabe-deruxtecana-mostra-controle-sustentado-da-carcinomatose-leptomeningea-no-cancer-de-mama-her2.html]]></loc><lastmod>2025-08-13T17:41:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sugere-associacao-inversa-entre-capacidade-antioxidante-total-da-dieta-e-risco-de-cancer-de-mama.html]]></loc><lastmod>2025-08-13T14:23:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/beneficio-da-oxaliplatina-em-pacientes-com-cancer-colorretal-estagios-ii-a-iii-com-idade-avancada.html]]></loc><lastmod>2025-08-12T21:32:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-paliativos-ambulatoriais-e-controle-dos-sintomas-do-cancer.html]]></loc><lastmod>2025-08-12T21:17:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-descolonizacao-bacteriana-para-prevencao-de-mucosite-oral-aguda-por-radiacao.html]]></loc><lastmod>2025-08-11T20:32:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exercicios-pre-operatorios-e-desfechos-cirurgicos-no-cancer-colorretal-em-pacientes-idosos.html]]></loc><lastmod>2025-08-11T13:35:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/papel-da-reabilitacao-protetica-na-alimentacao-social-e-retorno-ao-trabalho-em-sobreviventes-de-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2025-08-08T15:36:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-resseccao-peritumoral-na-sobrevida-do-glioblastoma-primario.html]]></loc><lastmod>2025-08-08T14:55:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/efeitos-cognitivos-dos-inibidores-da-aromatase-em-pacientes-com-cancer-de-mama-em-estagio-inicial.html]]></loc><lastmod>2025-08-07T02:42:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sugere-que-consumo-de-alimentos-ultraprocessados-aumenta-risco-de-cancer-de-pulmao.html]]></loc><lastmod>2025-08-06T14:01:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-analisa-mutacoes-preditoras-de-malignidade-em-nodulos-tireoidianos.html]]></loc><lastmod>2025-08-06T09:05:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-amplia-compreensao-do-derrame-pleural-maligno-no-cancer-de-pulmao.html]]></loc><lastmod>2025-08-05T19:32:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/associacao-da-dieta-e-estilo-de-vida-com-a-recorrencia-do-cancer-de-colon-em-subgrupos-de-pacientes-com-base-em-caracteristicas-moleculares.html]]></loc><lastmod>2025-08-05T18:59:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alteracoes-no-status-her2-low-e-her2-ultralow-em-biopsias-de-cancer-de-mama-avancado-conforme-o-metodo-de-avaliacao.html]]></loc><lastmod>2025-08-04T20:07:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/derivacao-e-validacao-da-classificacao-do-estadiamento-patologico-ajcc9v-para-carcinoma-de-orofaringe-hpv-positivo.html]]></loc><lastmod>2025-08-04T17:25:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-analisa-recorrencia-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2025-08-01T15:37:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-enfoca-o-papel-multidimensional-da-epidemiologia-na-prevencao-do-cancer.html]]></loc><lastmod>2025-07-31T18:35:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-avalia-custo-efetividade-da-biopsia-liquida-para-deteccao-precoce-do-cancer-de-pulmao-no-brasil.html]]></loc><lastmod>2025-07-30T18:52:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consorcio-europeu-latino-americano-de-pesquisa-busca-erradicar-o-cancer-de-vesicula-biliar-prevenivel.html]]></loc><lastmod>2025-07-30T17:40:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cessacao-do-tabagismo-e-carga-de-sintomas-em-pacientes-apos-cirurgia-oncologica.html]]></loc><lastmod>2025-07-30T14:23:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adopt-lung-analisa-beneficio-de-durvalumabe-adjuvante-no-cpcnp.html]]></loc><lastmod>2025-07-29T18:17:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relacoes-familiares-e-sobrecarga-do-cuidador-familiar-de-pacientes-com-cancer-terminal.html]]></loc><lastmod>2025-07-28T20:42:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-associacao-entre-exposicao-a-poluentes-e-proteinas-plasmaticas-em-idosos.html]]></loc><lastmod>2025-07-25T18:25:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/coast-atualizacao-avalia-durvalumabe-isolado-ou-em-combinacao-com-novos-agentes-no-cpcnp-estagio-iii-irressecavel.html]]></loc><lastmod>2025-07-25T13:12:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/abordagem-de-aprendizado-de-maquina-identifica-a-enzima-mmp2-como-alvo-chave-no-cancer-cervical-avancado.html]]></loc><lastmod>2025-07-24T21:35:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acompanhamento-de-longo-prazo-do-estudo-de-fase-iii-flaura2-confirma-beneficio-de-osimertinibe-no-cpcnp.html]]></loc><lastmod>2025-07-24T12:25:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-destaca-aprendizados-sobre-toxicidade-aguda-e-tardia-apos-duas-decadas-de-experiencia-com-sbrt-pancreatica.html]]></loc><lastmod>2025-07-23T09:51:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/letramento-em-saude-de-sobreviventes-de-cancer-e-adesao-as-diretrizes-nutricionais.html]]></loc><lastmod>2025-07-22T21:23:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-carne-e-risco-de-cancer-hepatobiliar-no-estudo-de-dieta-e-saude-do-nih-aarp.html]]></loc><lastmod>2025-07-22T15:59:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-explora-implicacoes-da-dieta-no-risco-de-carcinoma-hepatocelular.html]]></loc><lastmod>2025-07-21T22:04:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imagem-da-extensao-extranodal-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2025-07-21T19:36:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-avalia-carga-da-tuberculose-entre-pacientes-com-cancer.html]]></loc><lastmod>2025-07-21T16:01:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/grupo-de-pesquisa-em-cancer-e-envelhecimento-destaca-intervencoes-para-melhorar-a-qualidade-de-vida-e-a-sobrevivencia-de-idosos-com-cancer.html]]></loc><lastmod>2025-07-18T11:52:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alteracoes-em-keap1-e-stk11-lkb1-aumentam-a-sensibilidade-a-inibicao-de-atr-no-cpcnp-com-mutacao-kras.html]]></loc><lastmod>2025-07-16T17:45:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-equivalencia-de-versao-abreviada-de-questionario-de-funcionalidade-autorrelatada-em-pacientes-com-cancer.html]]></loc><lastmod>2025-07-16T17:37:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metapac-estudo-avalia-assinaturas-plasmaticas-multimetabolitos-para-pacientes-em-risco-ou-com-suspeita-de-cancer-de-pancreas.html]]></loc><lastmod>2025-07-16T14:37:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-pandemia-de-covid-19-nos-desfechos-de-pacientes-cirurgicos-com-cancer-colorretal.html]]></loc><lastmod>2025-07-15T11:44:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-de-hpv-de-alto-risco-preve-falha-ao-tratamento-de-lesoes-precursoras-do-cancer-cervical.html]]></loc><lastmod>2025-07-14T14:35:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-associacao-entre-imc-e-risco-de-cancer-de-mama-entre-mulheres-na-pos-menopausa-com-e-sem-doencas-cardiometabolicas.html]]></loc><lastmod>2025-07-14T08:24:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/t-dxd-prolonga-a-sobrevida-global-no-tratamento-de-segunda-linha-para-pacientes-com-adenocarcinoma-gastrico-metastatico-ou-gej-her2-positivo.html]]></loc><lastmod>2025-07-12T09:01:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/matterhorn-estudo-global-confirma-eficacia-de-durvalumabe-perioperatorio-no-cancer-gastrico-ou-gej.html]]></loc><lastmod>2025-07-11T15:17:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisas-ampliam-compreensao-de-tumores-associados-a-hpv.html]]></loc><lastmod>2025-07-10T20:10:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perspectivas-de-sobreviventes-sobre-a-ototoxicidade-induzida-por-cisplatina-e-barreiras-ao-seu-monitoramento.html]]></loc><lastmod>2025-07-10T10:07:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-promissora-de-platina-mais-etoposideo-com-durvalumabe-no-cpcp-avancado-com-metastases-cerebrais.html]]></loc><lastmod>2025-07-08T19:02:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/poluicao-do-ar-esta-relacionada-a-diferentes-assinaturas-genomicas-do-cancer-de-pulmao-em-nunca-fumantes.html]]></loc><lastmod>2025-07-08T14:09:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-doenca-cardiovascular-entre-sobreviventes-de-cancer.html]]></loc><lastmod>2025-07-07T18:13:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/astro-atualiza-diretriz-de-radioterapia-para-tratamento-do-glioma-difuso-de-alto-grau.html]]></loc><lastmod>2025-07-07T17:33:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mudancas-na-atividade-fisica-ao-longo-do-tempo-e-risco-de-cancer.html]]></loc><lastmod>2025-07-07T12:43:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-compara-pembrolizumabe-e-alternativas-terapeuticas-no-cpcnp.html]]></loc><lastmod>2025-07-04T19:09:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-que-sobreviventes-de-cancer-de-mama-podem-enfrentar-menor-risco-de-doenca-de-alzheimer.html]]></loc><lastmod>2025-07-04T08:40:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-analisa-morbidade-perioperatoria-da-cistectomia-radical-em-idosos.html]]></loc><lastmod>2025-07-03T16:17:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-e-toxicidade-gastrointestinal-em-pacientes-que-recebem-inibidores-da-bomba-de-protons-durante-tratamento-com-icis.html]]></loc><lastmod>2025-07-03T12:53:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-analisa-ingestao-de-dioxido-de-titanio-como-excipiente-em-medicamentos-e-risco-de-cancer.html]]></loc><lastmod>2025-07-02T17:26:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-tratamento-do-cancer-em-areas-de-conflito-e-o-exemplo-do-iraque.html]]></loc><lastmod>2025-07-01T15:28:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exposicao-ao-radonio-em-ambientes-fechados-aumenta-risco-de-cancer-de-pulmao.html]]></loc><lastmod>2025-06-30T17:15:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-subutilizacao-e-disparidades-raciais-nos-cuidados-de-fim-de-vida-entre-pacientes-com-tumores-neuroendocrinos.html]]></loc><lastmod>2025-06-30T16:31:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ferramenta-preditiva-avalia-capacidade-de-permanecer-em-casa-apos-cirurgia-oncologica-em-idosos.html]]></loc><lastmod>2025-06-30T14:49:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/autocoleta-no-rastreamento-do-cancer-cervical.html]]></loc><lastmod>2025-06-30T14:44:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-mostra-eficacia-na-deteccao-precoce-do-carcinoma-de-celulas-renais.html]]></loc><lastmod>2025-06-27T18:24:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-bons-resultados-de-pacientes-nonagenarios-apos-resseccao-cirurgica-de-cancer-de-pulmao.html]]></loc><lastmod>2025-06-27T17:43:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dor-pos-operatoria-apos-acupuntura-intraoperatoria-um-estudo-controlado-randomizado.html]]></loc><lastmod>2025-06-26T14:07:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gordura-subcutanea-corporal-resposta-a-qrt-e-prognostico-em-pacientes-com-cancer-de-esofago.html]]></loc><lastmod>2025-06-25T15:59:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-estatisticas-de-tratamento-e-sobrevida-do-cancer-nos-eua.html]]></loc><lastmod>2025-06-24T10:51:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/expressao-de-erbb2-low-por-raca-e-etnia-entre-pacientes-com-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2025-06-24T10:36:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mindfulness-e-tai-chi-sao-eficazes-no-controle-do-distress-em-pacientes-com-cancer.html]]></loc><lastmod>2025-06-24T10:31:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-e-fatores-associados-a-niveis-clinicamente-importantes-de-fadiga-dor-e-insonia-em-sobreviventes-de-cancer.html]]></loc><lastmod>2025-06-24T08:24:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-internacional-avalia-os-desfechos-da-resseccao-oncologica-estendida-para-cancer-de-vesicula-biliar.html]]></loc><lastmod>2025-06-21T17:40:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/durvalumabe-mostra-ganho-de-slp-no-cpcnp-irressecavel-com-mutacao-egfr.html]]></loc><lastmod>2025-06-26T15:36:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/beneficios-a-longo-prazo-da-psilocibina-em-dose-unica-em-pacientes-com-cancer-e-depressao.html]]></loc><lastmod>2025-06-19T11:33:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-estudo-mostra-que-radiacao-uv-e-responsavel-por-mais-de-80-dos-casos-de-melanoma-no-mundo.html]]></loc><lastmod>2025-06-17T17:23:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-do-cancer-anal-e-custo-efetividade-em-individuos-de-alto-risco.html]]></loc><lastmod>2025-06-17T16:24:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-discute-como-avaliar-comunicar-e-atuar-sobre-o-risco-individual-de-toxicidades-a-longo-prazo-apos-o-cancer-de-mama.html]]></loc><lastmod>2025-06-17T12:30:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alto-impacto-da-quimioterapia-na-reserva-ovariana-em-sobreviventes-de-cancer-de-mama-em-idade-reprodutiva.html]]></loc><lastmod>2025-06-17T09:17:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/triagem-de-baixo-valor-para-o-controle-do-cancer-afeta-pacientes-e-sistemas-de-saude.html]]></loc><lastmod>2025-06-13T10:54:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-analisa-ancestralidade-e-risco-genetico-no-cancer-colorretal.html]]></loc><lastmod>2025-06-12T20:49:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-amplia-compreensao-de-tumores-neuroepiteliais-de-snc.html]]></loc><lastmod>2025-06-17T15:30:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-paliativos-integrados-melhoram-a-qualidade-de-vida-de-pacientes-com-cancer-avancado.html]]></loc><lastmod>2025-06-16T14:21:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-analisa-custo-e-valor-no-cancer-de-pulmao-avancado.html]]></loc><lastmod>2025-06-11T16:43:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/omissao-da-irradiacao-linfonodal-regional-apos-resposta-a-qt-neo-em-pacientes-com-cancer-de-mama-selecionados.html]]></loc><lastmod>2025-06-10T20:55:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desafios-para-o-controle-do-cancer-na-america-latina.html]]></loc><lastmod>2025-06-09T16:50:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-de-sobrevida-e-prognostico-do-cpcnp-avancado-com-mutacao-her2-e-metastases-cerebrais.html]]></loc><lastmod>2025-06-09T18:06:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/autogestao-da-fadiga-e-do-diabetes-entre-sobreviventes-de-cancer-de-pancreas-ressecavel.html]]></loc><lastmod>2025-06-06T15:56:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-associados-a-mudanca-de-vigilancia-ativa-para-tratamento-em-homens-com-cancer-de-prostata-de-baixo-risco.html]]></loc><lastmod>2025-05-29T16:00:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-esofagico-e-vazamento-anastomotico-pos-esofagectomia-em-pacientes-com-cancer.html]]></loc><lastmod>2025-05-28T18:45:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-e-tendencias-de-limitacoes-da-vida-diaria-entre-sobreviventes-de-cancer-gastrointestinal.html]]></loc><lastmod>2025-05-27T16:08:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tipo-e-duracao-da-quimioterapia-de-inducao-tem-impacto-na-sobrevida-no-lacc.html]]></loc><lastmod>2025-05-28T17:58:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-avalia-sarcopenia-em-pacientes-com-cancer-de-mama-metastatico.html]]></loc><lastmod>2025-05-26T15:11:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/utilidade-e-impacto-de-um-servico-de-consulta-em-saude-sexual-para-mulheres.html]]></loc><lastmod>2025-05-23T14:06:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-de-sobrevida-da-terapia-local-direcionada-a-metastase-pulmonar-no-carcinoma-adenoide-cistico.html]]></loc><lastmod>2025-05-23T13:53:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-relatados-por-pacientes-tratados-com-imrt-apos-prostatectomia-radical.html]]></loc><lastmod>2025-05-20T19:00:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-qualidade-da-dieta-em-sobreviventes-de-cancer.html]]></loc><lastmod>2025-05-20T18:03:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-aumento-do-cancer-de-pancreas-de-inicio-precoce-e-fatores-de-risco.html]]></loc><lastmod>2025-05-22T17:03:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/machine-learning-modelo-brasileiro-preve-infeccao-em-pacientes-submetidos-a-quimioterapia.html]]></loc><lastmod>2025-05-20T13:30:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diamond-inibicao-dupla-de-ctla-4-e-pd-l1-mais-trastuzumabe-no-cancer-de-mama-her2-avancado-resistente-a-trastuzumabe.html]]></loc><lastmod>2025-05-15T13:26:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-preditivos-de-fertilidade-no-cancer-de-mama-apos-interrupcao-do-tratamento-adjuvante.html]]></loc><lastmod>2025-05-15T13:28:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eficacia-de-terapias-anti-her2-apos-tratamento-com-t-dxd-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2025-05-19T20:24:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/seguranca-da-gestacao-apos-diagnostico-previo-de-cancer-de-mama-durante-a-gravidez-em-jovens-portadoras-de-brca.html]]></loc><lastmod>2025-05-19T20:25:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-avalia-eficacia-e-seguranca-de-t-dxd-no-cancer-de-mama-her2-metastatico.html]]></loc><lastmod>2025-05-19T20:26:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-aponta-variantes-geneticas-associadas-a-dpi-em-pacientes-tratados-com-t-dxd.html]]></loc><lastmod>2025-05-15T13:27:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ribociclibe-terapia-endocrina-neoadjuvante-no-cancer-de-mama-inicial-hr-her2-de-risco-intermediario.html]]></loc><lastmod>2025-05-15T10:13:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-breast06-nova-analise-confirma-beneficio-de-t-dxd-no-cancer-de-mama-her2-low-ultralow.html]]></loc><lastmod>2025-05-15T05:09:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-global-apoia-cirurgias-de-reducao-de-risco-de-cancer-em-portadoras-de-brca.html]]></loc><lastmod>2025-05-14T17:13:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-praticas-para-o-tratamento-da-doenca-trofoblastica-gestacional.html]]></loc><lastmod>2025-05-14T15:34:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trajetoria-da-saude-mental-e-fisica-em-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2025-05-13T17:29:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-mostra-potencial-da-sinalizacao-eph-efrina-na-oncologia-de-precisao-em-canceres-orais-e-maxilofaciais.html]]></loc><lastmod>2025-05-12T16:59:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incidencia-e-prevalencia-de-resistencia-antimicrobiana-em-pacientes-ambulatoriais-com-cancer.html]]></loc><lastmod>2025-05-12T11:39:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-retrata-20-anos-da-epidemiologia-do-cancer-de-mama-em-sao-paulo-e-padroes-de-tratamento.html]]></loc><lastmod>2025-05-09T19:10:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brasileira-e-reconhecida-com-premio-internacional-por-excelencia-em-psico-oncologia.html]]></loc><lastmod>2025-05-09T14:20:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-compara-ferramentas-desenvolvidas-no-brasil-para-o-rastreamento-de-sarcopenia-no-cancer-de-mama.html]]></loc><lastmod>2025-05-15T14:46:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-readministracao-de-durvalumabe-apos-pneumonite-sintomatica-moderada-no-cpcnp-localmente-avancado.html]]></loc><lastmod>2025-05-07T15:11:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-cirurgicos-e-oncologicos-da-gastrectomia-laparoscopica-versus-aberta-apos-qt-neo-no-cancer-gastrico-localmente-avancado.html]]></loc><lastmod>2025-05-07T10:15:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-investiga-utilizacao-global-de-cuidados-paliativos-por-pacientes-com-cancer.html]]></loc><lastmod>2025-05-07T19:45:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/enrt-mostra-beneficio-de-sobrevida-no-cancer-de-prostata.html]]></loc><lastmod>2025-05-06T19:24:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-e-impacto-prognostico-da-caquexia-na-sobrevida-global-em-pacientes-com-cancer-gastrointestinal.html]]></loc><lastmod>2025-05-06T15:32:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-diretriz-para-terapia-sistemica-em-pacientes-com-cancer-de-prostata.html]]></loc><lastmod>2025-05-05T18:12:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/associacao-de-dor-ansiedade-e-sintomas-depressivos-com-resultados-do-sono-em-pacientes-com-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2025-05-05T15:45:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gasolina-e-carcinogenica-para-humanos.html]]></loc><lastmod>2025-05-05T13:29:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tendencias-no-tratamento-cirurgico-excessivo-do-cancer-de-prostata.html]]></loc><lastmod>2025-05-05T12:03:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-mostra-evidencias-e-desafios-da-terapia-endocrina-estendida-no-cancer-de-mama.html]]></loc><lastmod>2025-05-02T17:47:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/beneficios-dos-cuidados-paliativos-precoces-no-bem-estar-psicologico-status-funcional-e-qvrs-em-pacientes-e-cuidadores.html]]></loc><lastmod>2025-05-04T14:10:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-viabilidade-do-algoritmo-core-em-pacientes-com-cancer-de-mama-estagio-i-iii-recem-diagnosticado-submetidas-a-cirurgia-em-primeira-linha.html]]></loc><lastmod>2025-04-29T15:22:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fertilidade-e-gravidez-em-pacientes-jovens-com-cancer-de-mama-avancado.html]]></loc><lastmod>2025-04-28T19:08:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/como-o-paciente-oncologico-e-conduzido-ao-centro-cirurgico-e-impacto-emocional.html]]></loc><lastmod>2025-04-28T19:07:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/flot-tfox-supera-folfox-como-1l-no-cancer-gastrico-jge-avancado.html]]></loc><lastmod>2025-04-28T13:11:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assinaturas-mutacionais-do-cancer-colorretal-de-inicio-precoce.html]]></loc><lastmod>2025-04-25T19:08:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/9a-classificacao-tnm-para-cpcnp-ressecado-cirurgicamente-melhora-acuracia-prognostica.html]]></loc><lastmod>2025-04-24T09:35:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-investiga-padroes-de-sintomas-que-precedem-o-tratamento-agudo-em-pacientes-com-cancer.html]]></loc><lastmod>2025-04-24T09:27:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tendencias-do-cancer-de-orofaringe-no-brasil.html]]></loc><lastmod>2025-04-22T19:47:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tecnologia-de-reproducao-assistida-e-segura-em-jovens-portadoras-de-brca-apos-cancer-de-mama.html]]></loc><lastmod>2025-04-22T18:07:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-avalia-quimio-de-inducao-no-carcinoma-de-nasofaringe-localmente-avancado.html]]></loc><lastmod>2025-04-26T21:10:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-toracica-de-alta-dose-versus-dose-padrao-aumenta-sobrevida-no-cppc-em-estagio-limitado.html]]></loc><lastmod>2025-04-21T16:07:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-fatores-que-influenciam-a-radioterapia-paliativa-no-cancer-avancado.html]]></loc><lastmod>2025-04-21T11:53:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-mostra-que-resseccao-anatomica-foi-associada-a-melhor-sobrevida-no-cancer-de-pulmao-inicial.html]]></loc><lastmod>2025-04-22T14:57:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caracteristicas-do-tecido-adiposo-como-marcador-prognostico-do-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2025-04-17T18:21:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-estudo-explora-a-relacao-entre-nivel-de-escolaridade-e-risco-de-cancer-de-mama-por-subtipo-na-coorte-epic.html]]></loc><lastmod>2025-04-17T16:05:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncologia-geriatrica-e-pouco-representada-nas-diretrizes-de-tratamento-do-cancer-na-europa.html]]></loc><lastmod>2025-04-17T10:40:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mulheres-poder-e-cancer.html]]></loc><lastmod>2025-04-16T22:04:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-ablativa-no-cancer-pancreatico-ressecavel.html]]></loc><lastmod>2025-04-16T16:33:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-investiga-caracteristicas-de-sistemas-nacionais-de-cancer-associadas-ao-melhor-controle-do-cancer.html]]></loc><lastmod>2025-04-15T15:03:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-comprometimento-cognitivo-em-pacientes-com-cancer-de-mama-e-insonia.html]]></loc><lastmod>2025-04-16T17:57:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-adesao-as-preferencias-dos-pacientes-para-tratamentos-de-suporte-a-vida.html]]></loc><lastmod>2025-04-20T14:53:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/especialistas-atualizam-diretrizes-para-a-vigilancia-da-sindrome-de-li-fraumeni.html]]></loc><lastmod>2025-04-16T13:20:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapias-direcionadas-a-fgfr2-podem-prevenir-ou-retardar-alguns-canceres-de-pancreas-com-mutacao-kras.html]]></loc><lastmod>2025-04-14T21:47:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-brasileiros-desenvolvem-nomograma-para-prever-prognostico-no-cancer-cervical.html]]></loc><lastmod>2025-04-17T13:17:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/litespartk-004-resultados-de-longo-prazo-confirmam-beneficio-de-belzumitan-no-cancer-renal-associado-a-doenca-de-vhl.html]]></loc><lastmod>2025-04-14T17:53:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-desenvolve-recomendacoes-para-implementacao-e-avaliacao-de-qualidade-de-comites-moleculares-na-pratica-clinica.html]]></loc><lastmod>2025-04-14T14:45:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-associacao-entre-comorbidades-na-meia-idade-e-desfechos-de-cancer.html]]></loc><lastmod>2025-04-11T12:19:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-de-escopo-analisa-implementacao-de-diretrizes-em-cuidados-paliativos.html]]></loc><lastmod>2025-04-11T11:57:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/subtipos-moleculares-do-carcinoma-de-celulas-renais-diferem-entre-brancos-e-negros.html]]></loc><lastmod>2025-04-10T18:29:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-para-analises-de-custo-efetividade-de-biomarcadores-na-oncologia.html]]></loc><lastmod>2025-04-10T13:23:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dados-de-consorcio-internacional-mostram-que-consumo-de-cha-de-ervas-pode-reduzir-risco-de-cancer-de-bexiga.html]]></loc><lastmod>2025-04-09T19:43:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-prognostico-apos-resposta-patologica-completa-ao-tratamento-neoadjuvante-no-cancer-de-mama-em-estagio-inicial.html]]></loc><lastmod>2025-04-10T20:36:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimio-perioperatoria-no-cancer-gastrico-com-instabilidade-de-microssatelites-ou-deficiencia-de-reparo-de-incompatibilidade.html]]></loc><lastmod>2025-04-09T13:41:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preferable-effect-impacto-do-exercicio-na-saude-sexual-e-nos-sintomas-do-tratamento-em-mulheres-com-cancer-de-mama-metastatico.html]]></loc><lastmod>2025-04-08T15:05:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-do-cancer-e-potencial-impacto-na-saude-sexual-e-reprodutiva.html]]></loc><lastmod>2025-04-08T14:24:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mypath-ncp-solucao-busca-integrar-cuidado-nutricional-a-rotina-do-tratamento-do-cancer.html]]></loc><lastmod>2025-04-07T18:45:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neurosafe-metodo-melhora-a-funcao-eretil-e-a-continencia-urinaria-apos-prostatectomia-assistida-por-robo.html]]></loc><lastmod>2025-04-07T16:00:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ludicas-estudo-multicentrico-avalia-disfuncao-sexual-em-pacientes-com-cancer-de-pulmao.html]]></loc><lastmod>2025-04-07T11:37:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/beneficio-da-manutencao-com-olaparibe-no-cancer-de-ovario-de-acordo-com-o-tipo-e-local-da-mutacao-brca1-2.html]]></loc><lastmod>2025-04-07T11:29:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nowac-pesquisa-avalia-atividade-fisica-e-mortalidade-em-pacientes-com-melanoma.html]]></loc><lastmod>2025-04-04T19:27:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-analisa-mutagenese-induzida-pela-fumaca-do-tabaco-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2025-04-04T14:00:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comprometimento-cognitivo-relacionado-ao-cancer-um-guia-pratico-para-oncologistas.html]]></loc><lastmod>2025-04-04T12:32:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-maior-risco-de-mortalidade-em-pacientes-com-cancer-e-historico-de-diabetes-ou-doenca-cardiovascular.html]]></loc><lastmod>2025-04-04T12:27:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nccn-destaca-necessidade-de-apoio-a-saude-mental-e-a-cessacao-do-tabagismo-no-tratamento-do-cancer.html]]></loc><lastmod>2025-04-03T19:55:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-durvalumabe-perioperatorio-no-cancer-de-bexiga-com-invasao-muscular.html]]></loc><lastmod>2025-04-04T22:35:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidores-de-sglt2-podem-melhorar-resultados-de-sobrevida-no-cancer-gastrointestinal.html]]></loc><lastmod>2025-04-02T13:13:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-aponta-caracteristicas-associadas-ao-cancer-de-mama-de-intervalo.html]]></loc><lastmod>2025-04-02T13:14:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resposta-patologica-em-pacientes-com-cancer-de-mama-inicial-her2-low-versus-her2-zero-em-tratamento-neoadjuvante.html]]></loc><lastmod>2025-03-31T14:58:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/api-cat-apixabana-em-dose-reduzida-nao-e-inferior-a-dose-completa-em-pacientes-com-cancer-ativo-e-tev.html]]></loc><lastmod>2025-03-31T13:54:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-analisa-resistencia-a-platina-no-carcinoma-ovariano.html]]></loc><lastmod>2025-03-31T10:05:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/percepcoes-conhecimento-e-atitudes-da-populacao-sobre-fatores-de-risco-associados-ao-cancer-de-prostata.html]]></loc><lastmod>2025-03-28T11:32:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-compara-metodos-de-triagem-para-prevencao-do-cancer-cervical-em-mulheres-vivendo-com-hiv.html]]></loc><lastmod>2025-03-27T22:45:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/insema-estudo-avalia-omissao-da-cirurgia-axilar-no-cancer-de-mama.html]]></loc><lastmod>2025-03-27T07:02:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-guiada-por-microultrassonografia-vs-biopsia-guiada-por-ressonancia-magnetica-no-diagnostico-do-cancer-de-prostata.html]]></loc><lastmod>2025-03-26T19:27:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-qualidade-de-vida-em-pacientes-com-cancer-de-pancreas-localmente-avancado.html]]></loc><lastmod>2025-03-26T15:45:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-hipofracionada-em-pacientes-idosos.html]]></loc><lastmod>2025-03-25T13:00:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-anunciam-modelo-que-pode-prever-o-carcinoma-hepatocelular.html]]></loc><lastmod>2025-03-24T15:11:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-de-mundo-real-nao-mostra-impacto-do-subtratamento-em-pacientes-idosas-selecionadas-com-cancer-de-mama-inicial.html]]></loc><lastmod>2025-03-21T18:33:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-combinacao-de-atividade-fisica-e-dexametasona-para-fadiga-relacionada-ao-cancer.html]]></loc><lastmod>2025-03-21T16:59:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-resultados-de-sobrevida-no-carcinoma-adenoide-cistico-de-cabeca-e-pescoco.html]]></loc><lastmod>2025-03-21T15:46:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avancos-e-desafios-no-manejo-do-cancer-de-prostata-avancado.html]]></loc><lastmod>2025-03-20T20:16:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-analisa-carga-de-doencas-associadas-a-poluicao-do-ar-domestico-em-204-paises.html]]></loc><lastmod>2025-03-20T20:00:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/suplementacao-de-vitamina-d-melhora-resposta-patologica-completa-em-pacientes-com-cancer-de-mama-submetidas-a-quimioterapia-neoadjuvante.html]]></loc><lastmod>2025-03-20T21:19:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/durvalumabe-e-bvac-c-no-cancer-cervical.html]]></loc><lastmod>2025-03-20T19:04:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/software-baseado-em-ia-melhora-margem-na-ablacao-termica-de-tumores-hepaticos.html]]></loc><lastmod>2025-03-20T21:15:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-de-doenca-residual-pode-refinar-tratamento-adjuvante-com-osimertinibe-no-cancer-de-pulmao.html]]></loc><lastmod>2025-03-18T16:10:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-analisam-cenario-da-terapia-genica-no-brasil-desafios-e-perspectivas.html]]></loc><lastmod>2025-03-16T21:51:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-e-significancia-prognostica-de-anormalidades-pulmonares-intersticiais-no-cancer-de-pulmao.html]]></loc><lastmod>2025-03-14T19:20:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/polar-eficacia-do-resfriamento-e-compressao-das-maos-na-prevencao-da-neuropatia-induzida-por-taxano.html]]></loc><lastmod>2025-03-11T17:10:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-confirma-beneficio-de-5fu-adjuvante-no-cancer-do-trato-biliar-ressecado.html]]></loc><lastmod>2025-03-11T14:54:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disfagia-estado-nutricional-e-qualidade-de-vida-em-pacientes-com-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2025-03-11T11:47:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/programa-digital-valoriza-medicina-integrativa-no-tratamento-do-cancer.html]]></loc><lastmod>2025-03-14T17:51:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/crioablacao-parcial-primaria-da-glandula-mostra-resultados-encorajadores-no-cancer-de-prostata.html]]></loc><lastmod>2025-03-14T17:05:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-analisa-consumo-de-cafe-e-mortalidade-no-cancer-colorretal-em-pacientes-com-doenca-cardiometabolica.html]]></loc><lastmod>2025-03-10T17:16:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-avalia-indice-de-massa-corporal-como-fator-de-risco-no-cancer-de-penis.html]]></loc><lastmod>2025-03-10T14:47:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oferta-de-medicos-no-brasil-afeta-resultados-do-cancer-de-mama.html]]></loc><lastmod>2025-03-07T13:40:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-dinamarques-com-gemeos-sugere-que-exposicao-a-tinta-de-tatuagem-esta-associada-a-linfoma-e-cancer-de-pele.html]]></loc><lastmod>2025-03-07T19:41:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/declinio-da-saude-fisica-apos-quimioterapia-ou-terapia-endocrina-em-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2025-03-13T01:11:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/colocare-sedentarismo-e-atividade-fisica-um-ano-apos-o-diagnostico-de-cancer-colorretal.html]]></loc><lastmod>2025-03-08T17:47:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consorcio-headspace-analisa-como-os-sistemas-de-saude-afetam-o-diagnostico-de-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2025-02-28T12:37:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/induct-durvalumabe-neoadjuvante-no-cancer-urotelial-de-alto-risco.html]]></loc><lastmod>2025-02-25T17:08:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-descreve-comportamento-clinico-do-cancer-de-mama-em-jovens-portadoras-de-brca.html]]></loc><lastmod>2025-03-07T13:00:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/solucoes-do-mundo-real-para-a-implementacao-de-testes-de-biomarcadores-preditivos-no-cpcnp-ressecavel.html]]></loc><lastmod>2025-02-25T16:55:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-investiga-impacto-de-intervencoes-nutricionais-em-idosos-com-cancer.html]]></loc><lastmod>2025-02-25T14:48:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estimativas-atualizadas-destacam-importancia-crescente-da-atividade-fisica-na-prevencao-do-cancer.html]]></loc><lastmod>2025-03-13T00:53:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-avalia-associacao-entre-padroes-alimentares-e-risco-de-cancer-gastrico.html]]></loc><lastmod>2025-02-25T14:27:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-propoe-caminhos-para-melhorar-a-colaboracao-internacional-no-atendimento-oncologico.html]]></loc><lastmod>2025-03-09T15:28:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncologistas-continuam-a-prescrever-tratamento-excessivo-em-pacientes-com-cancer-no-fim-da-vida.html]]></loc><lastmod>2025-02-24T17:38:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consistencia-interobservador-e-desafios-diagnosticos-no-cancer-de-mama-her2-ultralow.html]]></loc><lastmod>2025-02-21T19:05:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-adjuvante-e-sobrevida-no-adenocarcinoma-pancreatico-localizado-apos-mfolfirinox-neoadjuvante.html]]></loc><lastmod>2025-02-20T18:41:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ema-autoriza-datopotamab-deruxtecan-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2025-02-24T18:14:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-analisa-como-aumentar-a-eficiencia-dos-programas-de-triagem-de-cancer.html]]></loc><lastmod>2025-02-21T20:20:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-aposta-em-aprendizado-de-maquina-e-biomarcadores-para-prever-a-recorrencia-do-cap.html]]></loc><lastmod>2025-03-06T14:16:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iarc-publica-nova-monografia-e-mostra-pfoa-associado-a-cancer-de-testiculo-e-renal.html]]></loc><lastmod>2025-02-20T19:43:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-preditivo-para-delirium-mostra-resultados-em-pacientes-com-cancer-avancado-em-cuidados-paliativos.html]]></loc><lastmod>2025-03-16T19:44:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-relacao-de-toxicidades-classificadas-por-medicos-e-pacientes-com-declinio-funcional-em-idosos-com-cancer.html]]></loc><lastmod>2025-02-19T13:51:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/retratamento-com-ici-pode-oferecer-beneficio-de-sobrevida-no-cpcnp-irressecavel-com-progressao.html]]></loc><lastmod>2025-02-12T16:57:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/segmentectomia-toracoscopica-vs-lobectomia-no-cpcnp-inicial-com-stas.html]]></loc><lastmod>2025-02-12T16:51:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nejm-zenocutuzumab-mostra-eficacia-e-seguranca-em-tumores-solidos-avancados.html]]></loc><lastmod>2025-02-12T10:53:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/edoxaban-e-qualidade-de-vida-no-tratamento-de-tev-associado-ao-cancer.html]]></loc><lastmod>2025-02-12T10:09:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/primeiro-relatorio-do-registro-brasileiro-de-biopsia-renal-tem-participacao-de-21-centros-do-pais.html]]></loc><lastmod>2025-02-11T14:14:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mais-de-75-dos-oncologistas-nao-solicitam-testes-de-biomarcadores-conforme-diretrizes-para-cancer-gastrico-gej.html]]></loc><lastmod>2025-02-11T14:07:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacientes-recebem-informacao-insuficiente-sobre-efeitos-colaterais-do-tratamento-do-cancer.html]]></loc><lastmod>2025-02-11T13:59:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intervencoes-de-exercicios-e-melhora-da-depressao-ansiedade-e-qualidade-de-vida-em-idosos-com-cancer.html]]></loc><lastmod>2025-02-11T08:00:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-diretrizes-para-terapia-sistemica-no-cancer-anal.html]]></loc><lastmod>2025-02-10T19:09:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-compara-eficacia-e-seguranca-de-tratamentos-ablativos-no-cancer-renal-2.html]]></loc><lastmod>2025-02-10T15:07:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-til-revisao-da-sitc-se-apresenta-como-guia-pratico-para-desmistificar-um-tratamento-complexo.html]]></loc><lastmod>2025-02-07T12:50:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dados-de-mundo-real-apoiam-quimioimunoterapia-no-cppc.html]]></loc><lastmod>2025-02-07T08:15:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-relatados-pelo-paciente-analise-compara-radioterapia-4d-e-rt-padrao-no-cancer-de-pulmao.html]]></loc><lastmod>2025-02-09T14:03:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variacao-geografica-e-tendencias-na-incidencia-de-cancer-de-pulmao-por-subtipo-histologico.html]]></loc><lastmod>2025-03-13T00:42:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/coinfeccao-pelo-virus-epstein-barr-e-malaria-na-amazonia-brasileira.html]]></loc><lastmod>2025-02-07T14:18:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/burnout-na-oncologia-diminui-mas-ainda-preocupa.html]]></loc><lastmod>2025-02-05T09:35:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/expectativa-de-vida-e-percepcao-de-saude-em-sobreviventes-de-cancer-raro-e-cancer-comum.html]]></loc><lastmod>2025-02-05T08:57:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/testes-genomicos-no-brasil-desafios-e-oportunidades.html]]></loc><lastmod>2025-02-04T15:25:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neuropatia-periferica-induzida-por-quimioterapia-afeta-4-em-cada-10-pacientes.html]]></loc><lastmod>2025-03-14T18:14:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/doenca-metabolica-em-individuos-com-imc-normal-e-risco-de-cancer.html]]></loc><lastmod>2025-02-04T09:33:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-padroes-de-cancer-de-mama-no-brasil-por-faixas-etarias.html]]></loc><lastmod>2025-02-03T17:57:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metanalise-mostra-interacao-entre-toxicidade-aguda-e-tardia-na-rt-do-cancer-de-prostata.html]]></loc><lastmod>2025-02-05T15:38:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-analisa-mortalidade-por-cancer-em-343-cidades-latino-americanas.html]]></loc><lastmod>2025-02-02T18:41:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-de-ia-identifica-esteatose-hepatica-como-preditor-de-mortalidade-em-fumantes-com-alta-carga-tabagica.html]]></loc><lastmod>2025-01-31T14:06:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-analisa-falhas-na-triagem-do-cancer-de-pulmao-com-o-protocolo-de-tc-de-baixa-dose.html]]></loc><lastmod>2025-01-31T23:12:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-atividade-fisica-e-marcadores-de-estresse-oxidativo-em-pacientes-com-cancer.html]]></loc><lastmod>2025-01-31T23:17:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/optimo-pesquisa-busca-otimizar-vacinacao-contra-hpv-para-prevencao-de-cancer-em-criancas-e-adolescentes-vivendo-com-hiv.html]]></loc><lastmod>2025-01-31T03:18:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-mostra-que-resseccoes-pulmonares-anatomicas-melhoram-a-sobrevida-no-cpcnp.html]]></loc><lastmod>2025-01-29T16:22:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-validam-escore-de-galad-na-deteccao-do-carcinoma-hepatocelular-na-cirrose.html]]></loc><lastmod>2025-01-29T12:17:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/associacao-da-gravidez-com-progressao-tumoral-em-pacientes-com-glioma.html]]></loc><lastmod>2025-02-03T02:25:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-prospectivo-analisa-percepcao-estetica-apos-cirurgia-conservadora-da-mama.html]]></loc><lastmod>2025-01-28T18:33:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uicc-destaca-o-cuidado-centrado-na-pessoa-para-marcar-o-dia-mundial-do-cancer.html]]></loc><lastmod>2025-01-28T18:31:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-analisa-acesso-a-medicamentos-em-54-paises-de-baixa-e-media-renda.html]]></loc><lastmod>2025-01-28T16:38:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-analisa-triagem-cervical-em-mulheres-vulneraveis.html]]></loc><lastmod>2025-01-28T15:59:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-alimentos-ultraprocessados-aumenta-risco-de-morte.html]]></loc><lastmod>2025-01-28T14:35:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-diretrizes-para-cancer-de-ovario-avancado-recem-diagnosticado.html]]></loc><lastmod>2025-02-02T18:05:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relatorio-revela-declinio-alarmante-em-testes-de-cancer-feminino-em-todo-o-mundo.html]]></loc><lastmod>2025-01-28T10:43:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eortc-atualiza-questionario-para-avaliar-qualidade-de-vida-no-cancer-de-mama.html]]></loc><lastmod>2025-01-27T22:26:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tropion-lung05-dato-dxd-mostra-resultados-no-cpcnp-avancado-metastatico-com-alteracoes-genomicas-acionaveis.html]]></loc><lastmod>2025-01-27T17:13:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-disparidades-globais-na-oferta-de-radioterapia.html]]></loc><lastmod>2025-01-24T16:21:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-disparidades-no-diagnostico-de-tumores-de-cabeca-e-pescoco-no-brasil.html]]></loc><lastmod>2025-01-23T18:16:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/politicas-de-saude-na-america-latina-negligenciam-cancer-raro-e-sarcoma.html]]></loc><lastmod>2025-01-23T17:08:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-adjuvante-de-dose-densa-mostra-resultados-no-cancer-de-mama-re.html]]></loc><lastmod>2025-01-13T23:56:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-elabora-diretriz-para-o-tratamento-sistemico-do-carcinoma-espinocelular-anal-estagio-i-iii.html]]></loc><lastmod>2025-02-02T11:49:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/procalcitonina-serica-no-apoio-a-decisao-de-tratamento-em-pacientes-com-cancer-com-sepse-ou-infeccao-respiratoria.html]]></loc><lastmod>2024-12-05T20:42:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/infinity-tremelimumabe-e-durvalumabe-neoadjuvante-no-cancer-gastrico-ou-jeg-ressecavel.html]]></loc><lastmod>2024-12-05T14:14:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-compara-abordagens-cirurgicas-no-carcinoma-papilar-de-tireoide-de-risco-intermediario-n1b.html]]></loc><lastmod>2024-12-05T20:25:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/privacao-androgenica-e-risco-cardiovascular-no-cancer-de-prostata.html]]></loc><lastmod>2024-12-05T14:00:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-associacoes-entre-atividade-fisica-vigorosa-microambiente-imunologico-e-progressao-do-cancer-de-prostata.html]]></loc><lastmod>2024-12-04T21:56:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-clinicopatologica-da-claudina-18-2-heterogeneidade-intratumoral-e-sobrevida-no-cancer-gastrico-metastatico-ou-irressecavel.html]]></loc><lastmod>2024-12-05T00:41:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exio-estudo-avalia-impacto-da-atividade-fisica-em-pacientes-tratados-com-inibidores-de-checkpoint.html]]></loc><lastmod>2024-12-03T21:38:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/realidade-da-radioterapia-e-problema-global.html]]></loc><lastmod>2024-12-03T13:07:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iarc-avalia-carcinogenicidade-da-hidroclorotiazida-voriconazol-e-tacrolimus.html]]></loc><lastmod>2025-02-20T19:38:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-compara-eficacia-de-terapias-locorregionais-para-carcinoma-hepatocelular.html]]></loc><lastmod>2024-12-03T15:02:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-enzimatica-pancreatica-melhora-a-qualidade-de-vida-dos-pacientes-e-o-padrao-de-cuidados.html]]></loc><lastmod>2024-12-02T14:52:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-fase-ii-mostra-resultados-de-sbrt-seguida-por-quimiorradioterapia-e-imunoterapia-adjuvante-no-cpcnp-avancado.html]]></loc><lastmod>2024-12-02T14:53:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-de-um-programa-de-exercicios-e-mindfulness-online-no-desempenho-fisico-de-sobreviventes-de-transplante-de-celulas-hematopoieticas.html]]></loc><lastmod>2024-12-02T13:47:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/triagem-e-tratamento-para-erradicacao-do-h-pylori-em-pacientes-com-historico-familiar-de-cancer-gastrico.html]]></loc><lastmod>2024-12-02T13:50:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/selecao-de-pacientes-com-cancer-de-mama-em-estagio-inicial-para-terapia-endocrina-estendida.html]]></loc><lastmod>2024-12-02T14:10:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incidencia-e-mortalidade-de-cancer-colorretal-apos-resultados-negativos-do-rastreamento-por-colonoscopia.html]]></loc><lastmod>2024-11-29T01:24:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carcinoma-seroso-de-alto-grau-apos-salpingo-ooforectomia-em-portadores-de-variantes-brca1-2.html]]></loc><lastmod>2024-11-29T02:58:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-antitumoral-e-analise-de-biomarcadores-para-dato-dxd-em-xenoenxertos-de-cancer-de-mama-derivados-de-pacientes.html]]></loc><lastmod>2024-11-29T03:27:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-relatam-pela-primeira-vez-o-perfil-brasileiro-da-classificacao-promise-do-cancer-endometrial.html]]></loc><lastmod>2024-11-27T20:15:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eficacia-do-osimertinibe-em-pacientes-com-cpcnp-egfr-com-recorrencia-pos-operatoria-versus-doenca-irressecavel-de-novo.html]]></loc><lastmod>2024-11-28T00:34:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-alcool-mesmo-em-baixas-doses-aumenta-risco-de-cancer-de-mama-em-mulheres.html]]></loc><lastmod>2024-11-26T18:23:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/parceria-entre-inca-bndes-e-ministerio-da-saude-consolida-complexo-de-excelencia-em-assistencia-pesquisa-e-ensino.html]]></loc><lastmod>2024-11-26T17:53:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-investiga-resistencia-adquirida-ao-inibidor-de-parp-no-cancer-de-prostata-avancado.html]]></loc><lastmod>2024-11-26T13:34:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-identificam-painel-de-assinatura-de-5-genes-associado-a-progressao-do-cancer-de-prostata-e-pior-prognostico.html]]></loc><lastmod>2024-11-26T13:10:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tendencias-atuais-e-resultados-clinicos-da-pancreatoduodenectomia-assistida-por-robo.html]]></loc><lastmod>2024-11-26T15:58:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/escore-de-risco-poligenico-estilo-de-vida-saudavel-e-risco-de-cancer-colorretal.html]]></loc><lastmod>2024-11-25T22:00:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-avalia-limiar-seguro-de-retencao-de-indocianina-verde-apos-hepatectomia-e-mostra-importancia-do-gerenciamento-nutricional.html]]></loc><lastmod>2024-11-25T21:53:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/osimertinibe-quimioterapia-apos-progressao-em-pacientes-com-cpcnp-metastatico-com-mutacao-egfr.html]]></loc><lastmod>2024-11-26T00:02:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-sistemico-de-primeira-linha-para-metastases-hepaticas-colorretais-inicialmente-irressecaveis.html]]></loc><lastmod>2024-11-25T16:55:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/farmacoequidade-global-no-tratamento-do-cancer.html]]></loc><lastmod>2024-11-22T12:44:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-neoadjuvante-melhora-os-resultados-em-cancer-raro-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-11-22T08:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/padrao-alimentar-pro-inflamatorio-e-risco-de-cancer-de-mama-total-e-por-subtipos-entre-mulheres-norte-americanas.html]]></loc><lastmod>2024-11-23T02:57:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-compara-padroes-operatorios-do-colegio-americano-de-cirurgioes-e-resultados-no-cancer-de-mama.html]]></loc><lastmod>2024-11-21T19:08:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-analisa-incerteza-versus-beneficio-clinico-no-tratamento-do-cancer-e-mostra-as-preferencias-dos-pacientes.html]]></loc><lastmod>2024-11-21T21:32:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-descreve-padroes-de-leucemia-em-185-paises.html]]></loc><lastmod>2024-11-21T15:55:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/treinamento-de-resistencia-versus-alta-intensidade-em-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2024-11-23T01:47:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eficacia-de-intervencoes-proativas-de-saude-em-sobreviventes-de-cancer-de-prostata.html]]></loc><lastmod>2024-11-22T13:01:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioprevencao-com-aspirina-em-pacientes-com-sindrome-de-lynch.html]]></loc><lastmod>2024-11-21T10:08:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-fatores-de-risco-associados-ao-linfedema-mamario-apos-cirurgia-conservadora-da-mama.html]]></loc><lastmod>2024-11-19T20:36:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-das-tendencias-globais-de-pesquisa-em-cuidados-paliativos-mostra-necessidade-de-fortalecer-a-cooperacao-internacional.html]]></loc><lastmod>2024-11-19T20:29:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/niveis-mais-altos-de-glicose-e-sobrevida-reduzida-em-pacientes-com-cpcnp-tratados-com-imunoterapia.html]]></loc><lastmod>2024-11-21T01:41:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-anatomicos-associados-a-complicacoes-apos-prostatectomia-radical.html]]></loc><lastmod>2024-11-20T02:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/escore-prognostico-simples-preve-recorrencia-apos-pancreatoduodenectomia-no-carcinoma-ampular.html]]></loc><lastmod>2024-11-21T03:02:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-analisa-modelos-de-tomada-de-decisao-e-o-respeito-a-autonomia-de-pacientes-com-cancer-no-fim-da-vida.html]]></loc><lastmod>2024-11-19T00:38:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-que-custo-e-fadiga-do-rastreamento-dificultam-vigilancia-na-sindrome-de-li-fraumeni.html]]></loc><lastmod>2024-11-18T18:53:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/artigo-discute-solucoes-para-reduzir-disparidades-globais-no-acesso-ao-tratamento-oncologico.html]]></loc><lastmod>2024-11-19T01:01:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perspectivas-sobre-consultas-de-telemedicina-relatadas-por-pacientes-com-cancer.html]]></loc><lastmod>2024-11-19T14:41:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hipec-em-cirurgia-citorredutora-aumenta-a-sobrevida-no-cancer-de-ovario-recorrente.html]]></loc><lastmod>2024-11-14T23:56:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metodos-estatisticos-na-pesquisa-em-cancer-vies-e-interpretacao-de-evidencias.html]]></loc><lastmod>2024-11-14T20:57:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/survey-revela-que-oncologistas-tem-duvidas-sobre-o-manejo-clinico-da-supressao-da-funcao-ovariana-no-cancer-de-mama-pre-menopausa.html]]></loc><lastmod>2024-11-14T19:30:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-como-implementar-programas-antitabaco-integrados-ao-tratamento-do-cancer.html]]></loc><lastmod>2024-11-14T19:20:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estilo-de-vida-saudavel-e-resultados-psicossociais-entre-sobreviventes-de-cancer.html]]></loc><lastmod>2024-11-14T11:29:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preditores-associados-a-perda-de-peso-em-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2024-11-14T11:01:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/condicoes-cronicas-de-saude-incapacidade-e-limitacoes-fisicas-e-cognitivas-entre-sobreviventes-de-cancer-lgbtq.html]]></loc><lastmod>2024-11-15T13:55:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-associacoes-entre-padroes-alimentares-e-cancer-colorretal-em-individuos-do-uk-biobank.html]]></loc><lastmod>2024-11-14T10:27:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disfuncao-sexual-entre-sobreviventes-de-longo-prazo-de-linfoma-de-hodgkin.html]]></loc><lastmod>2024-11-14T09:59:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/letramento-limitado-em-saude-fragilidade-e-qualidade-de-vida-entre-idosos-com-cancer.html]]></loc><lastmod>2024-11-14T09:51:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/geracao-sem-tabaco-pode-reduzir-1-2-milhao-de-mortes-por-cancer-de-pulmao-ate-2095.html]]></loc><lastmod>2024-11-13T23:50:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-o-custo-da-obesidade-na-saude-brasileira.html]]></loc><lastmod>2024-11-13T23:49:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-pesquisas-destacam-o-potencial-da-vacinacao-de-dose-unica-contra-o-hpv-para-a-prevencao-do-cancer-cervical-em-ambientes-de-poucos-recursos.html]]></loc><lastmod>2024-11-13T17:28:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-analisa-o-melhor-padrao-de-cuidados-no-cancer-de-pancreas-avancado.html]]></loc><lastmod>2024-11-12T22:05:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-de-alcool-e-cannabis-associado-a-biomarcadores-cardiometabolicos-entre-sobreviventes-de-cancer.html]]></loc><lastmod>2024-11-13T02:47:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/opera-resultados-de-5-anos-mostram-que-boost-de-braquiterapia-aumenta-taxa-de-preservacao-de-orgao-no-cancer-retal.html]]></loc><lastmod>2024-11-11T19:46:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caminhos-e-desafios-para-reduzir-a-toxicidade-climatica-do-tratamento-do-cancer.html]]></loc><lastmod>2024-11-12T03:29:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/paola-1-terapias-subsequentes-no-cancer-de-ovario-avancado-recidivado-apos-olaparibe-de-manutencao.html]]></loc><lastmod>2024-11-12T03:24:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dbcg-07-read-10-anos-de-acompanhamento-do-uso-adjuvante-de-antraciclinas-no-cancer-de-mama-top2a-normal.html]]></loc><lastmod>2024-11-08T19:08:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eventos-adversos-e-complicacoes-de-longo-prazo-apos-o-tratamento-do-cancer-de-prostata.html]]></loc><lastmod>2024-11-10T15:46:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-de-predicao-de-risco-de-cancer-de-mama-integra-risco-monogenico-poligenico-e-epidemiologico.html]]></loc><lastmod>2024-11-10T15:37:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-nutricao-e-suporte-psicologico-para-pacientes-e-sobreviventes-de-cancer-de-bexiga.html]]></loc><lastmod>2024-11-10T15:31:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exames-de-imagem-na-rotina-pos-operatoria-podem-melhorar-resultados-no-adenocarcinoma-pancreatico.html]]></loc><lastmod>2024-11-07T16:50:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-que-cerca-de-40-dos-casos-de-cancer-de-mama-rh-pos-menopausa-estao-associados-ao-excesso-de-gordura-corporal.html]]></loc><lastmod>2024-11-07T14:47:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-analisa-disparidades-globais-na-carga-do-cancer-e-projecoes-para-2050.html]]></loc><lastmod>2024-11-06T19:55:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/venda-ilegal-de-cigarros-avulsos-contribui-para-a-iniciacao-ao-tabagismo-entre-jovens.html]]></loc><lastmod>2024-11-07T20:03:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sabcs-2024-anuncia-programa-cientifico-e-abre-espaco-para-presenca-brasileira.html]]></loc><lastmod>2024-11-06T15:50:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/associacao-do-escore-prognostico-de-glasgow-com-fragilidade-mortalidade-e-resultados-adversos-em-idosos-com-cancer.html]]></loc><lastmod>2024-11-06T08:36:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-de-inteligencia-artificial-melhora-precisao-diagnostica-da-pneumonite-radioinduzida-no-cancer-de-pulmao.html]]></loc><lastmod>2024-11-05T18:51:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exposicao-a-pesticidas-incidencia-e-mortalidade-de-cancer-de-prostata.html]]></loc><lastmod>2024-11-05T13:31:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-na-adolescencia-e-inicio-da-idade-adulta-e-risco-de-cancer-de-mama-precoce.html]]></loc><lastmod>2024-11-05T13:23:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/registros-de-cancer-de-base-populacional-falham-no-acompanhamento-de-longo-prazo-da-recorrencia-do-cancer-de-mama.html]]></loc><lastmod>2024-11-04T20:32:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-sarcopenia-pre-operatoria-e-comprometimento-imunonutricional-nos-resultados-pos-operatorios-do-cpcnp.html]]></loc><lastmod>2024-11-04T16:04:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nobrola-olaparibe-em-monoterapia-no-tnbc-avancado-com-hrd-e-sem-mutacoes-brca1-2.html]]></loc><lastmod>2024-11-04T15:18:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-oncologicos-da-vigilancia-ativa-versus-cirurgia-ou-ablacao-para-pacientes-com-pequenas-massas-renais.html]]></loc><lastmod>2024-11-03T23:16:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intervencoes-no-estilo-de-vida-e-sarcopenia-no-cancer-colorretal-avancado.html]]></loc><lastmod>2024-11-03T23:20:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-avancos-na-compreensao-da-biologia-e-gestao-do-cancer-vulvar.html]]></loc><lastmod>2024-11-01T14:16:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-seguranca-farmacologica-de-diferentes-tratamentos-sistemicos-na-populacao-idosa.html]]></loc><lastmod>2024-11-01T14:03:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-conclui-que-obesidade-aumenta-risco-de-cancer-de-tireoide.html]]></loc><lastmod>2024-11-01T14:03:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-do-estilo-de-vida-moderno-na-saude-circadiana-e-sua-contribuicao-para-a-adipogenese-e-risco-de-cancer.html]]></loc><lastmod>2024-11-03T23:26:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-que-biopsia-liquida-e-menos-eficaz-que-a-colonoscopia-no-rastreamento-do-cancer-colorretal.html]]></loc><lastmod>2024-10-31T18:21:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inicio-dos-cuidados-paliativos-indicadores-de-qualidade-de-fim-de-vida-e-utilizacao-de-recursos-de-saude.html]]></loc><lastmod>2024-11-03T23:35:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-aprovacao-acelerada-a-asciminib-para-leucemia-mieloide-cronica-recem-diagnosticada.html]]></loc><lastmod>2024-10-31T15:49:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-reforcam-importancia-do-gerenciamento-e-preservacao-da-fertilidade-no-cancer-ginecologico.html]]></loc><lastmod>2024-10-30T18:27:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-analisa-impacto-do-tratamento-do-cancer-na-fertilidade-masculina.html]]></loc><lastmod>2024-10-30T18:15:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-segundo-tumor-primario-em-sobreviventes-de-cancer-de-mama-brca1-e-brca2.html]]></loc><lastmod>2024-10-30T16:16:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-prognosticos-no-cancer-de-pulmao-de-celulas-pequenas-em-estagio-limitado.html]]></loc><lastmod>2024-10-30T21:37:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-uso-de-cannabis-e-risco-de-cancer.html]]></loc><lastmod>2024-10-29T15:56:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-amplia-evidencias-sobre-aspirina-profilatica-em-pacientes-de-cancer.html]]></loc><lastmod>2024-10-29T15:48:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/austragalus-na-reducao-da-fadiga-induzida-por-quimioterapia-no-cancer-de-mama.html]]></loc><lastmod>2024-10-29T14:55:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-dupla-mais-quimioterapia-beneficia-subgrupo-de-pacientes-com-cancer-de-pulmao.html]]></loc><lastmod>2024-11-07T21:53:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-reforca-importancia-de-compartilhar-as-melhores-praticas-para-avancar-no-rastreamento-do-cancer-cervical.html]]></loc><lastmod>2024-10-28T14:46:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/natalee-resultados-finais-de-sobrevida-livre-de-doenca-invasiva-mostram-beneficio-de-ribociclibe-no-cancer-de-mama-inicial-hr-her2.html]]></loc><lastmod>2024-10-25T21:35:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-carga-do-cancer-relacionada-a-dieta-em-204-paises-entre-1990-e-2019.html]]></loc><lastmod>2024-10-25T18:46:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/depressao-em-pacientes-com-cancer-de-cabeca-e-pescoco-em-comparacao-com-outros-tipos-de-cancer.html]]></loc><lastmod>2024-10-28T01:30:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-compara-risco-de-cancer-colorretal-13-anos-apos-colonoscopia-de-qualidade-inferior-qualidade-superior-e-sem-triagem.html]]></loc><lastmod>2024-10-25T09:35:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/equacao-antropometrica-mostra-capacidade-diagnostica-para-identificar-sarcopenia-em-mulheres-com-cancer-de-mama.html]]></loc><lastmod>2024-10-24T18:47:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/status-socioeconomico-tabagismo-e-cancer-de-pulmao-analise-de-vies-no-estudo-synergy.html]]></loc><lastmod>2024-10-24T18:37:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-desenvolver-um-cancer-primario-subsequente-entre-sobreviventes-de-cancer-adultos.html]]></loc><lastmod>2024-10-24T14:15:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-analisa-efeitos-da-prevalencia-do-tabagismo-e-expectativa-de-vida-de-2022-a-2050.html]]></loc><lastmod>2024-10-23T18:09:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-evidencias-da-antecipacao-da-ocorrencia-de-cancer-em-familias-com-sindrome-de-lynch-associada-a-mlh1.html]]></loc><lastmod>2024-10-23T18:01:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exercicios-aerobicos-tem-impacto-positivo-na-funcao-cognitiva-pos-quimioterapia-no-cancer-de-mama.html]]></loc><lastmod>2024-10-23T17:42:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/excesso-de-mortalidade-em-pessoas-com-diagnosticos-simultaneos-de-hiv-e-cancer.html]]></loc><lastmod>2024-10-24T01:09:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-e-risco-de-segundo-cancer-primario.html]]></loc><lastmod>2024-10-22T18:26:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acupuntura-na-prevencao-da-anorexia-induzida-por-quimioterapia.html]]></loc><lastmod>2024-10-22T18:02:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/segmentectomia-mostra-sobrevida-global-comparavel-a-lobectomia-no-cpcnp-em-estagio-inicial.html]]></loc><lastmod>2024-10-22T16:37:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-risco-de-cancer-e-interacao-com-micotoxinas-alimentares-e-virus-oncogenicos.html]]></loc><lastmod>2024-10-21T19:24:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-zolbetuximabe-para-o-tratamento-do-cancer-gastrico-ou-jeg-cldn-18-2.html]]></loc><lastmod>2024-10-22T22:22:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-prediz-reacoes-de-hipersensibilidade-a-paclitaxel-no-tratamento-do-cancer.html]]></loc><lastmod>2024-10-21T19:06:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iniciativas-apontam-caminhos-para-melhorar-a-qualidade-da-assistencia-oncologica-em-ambientes-de-recursos-limitados.html]]></loc><lastmod>2024-10-21T18:27:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/poluicao-do-ar-e-incidencia-de-cancer-de-mama-em-estudo-de-coorte-multietnica.html]]></loc><lastmod>2024-10-18T21:08:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/educacao-medica-em-oncologia-geriatrica-e-o-desafio-global-do-controle-do-cancer.html]]></loc><lastmod>2024-10-18T17:57:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-que-conservacao-da-mama-e-cirurgia-oncoplastica-estao-associadas-a-melhor-qualidade-de-vida.html]]></loc><lastmod>2024-10-18T17:48:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/triagem-suplementar-com-mamografia-com-contraste-em-mulheres-com-alto-risco-de-cancer-de-mama.html]]></loc><lastmod>2024-10-18T21:22:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-de-mundo-real-avalia-aceitacao-de-tres-meses-de-oxaliplatina-adjuvante-no-cancer-colorretal-estagio-iii.html]]></loc><lastmod>2024-10-17T19:59:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-de-suplementos-alimentares-no-tratamento-do-cancer-e-controverso.html]]></loc><lastmod>2024-10-17T10:44:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acido-tranexamico-profilatico-nao-reduz-a-transfusao-de-sangue-pos-cistectomia-no-cancer-de-bexiga.html]]></loc><lastmod>2024-10-16T17:35:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-descreve-resultados-do-cancer-de-mama-em-adolescentes-e-jovens-adultas.html]]></loc><lastmod>2024-10-16T15:49:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/psa-e-rnm-podem-reduzir-sobrediagnostico-no-rastreamento-do-cancer-de-prostata.html]]></loc><lastmod>2024-10-16T15:16:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/t-dxd-mostra-eficacia-e-seguranca-no-cancer-de-mama-avancado-her2-low-em-pacientes-com-metastase-cerebral-ativa.html]]></loc><lastmod>2024-10-14T16:49:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-de-risco-ambientais-para-cancer-de-vesicula-biliar.html]]></loc><lastmod>2024-10-14T14:35:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pro4all-medidas-de-resultados-relatados-por-pacientes-no-cancer-de-mama-na-pesquisa-e-pratica-clinica.html]]></loc><lastmod>2024-10-14T12:29:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/astro-2024-pacientes-relatam-qualidade-de-vida-com-pbt-e-imrt-no-cancer-de-prostata.html]]></loc><lastmod>2024-10-11T17:47:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-mostra-reducao-da-recorrencia-a-distancia-em-mulheres-com-cancer-de-mama-em-ensaios-clinicos-entre-1990-e-2009.html]]></loc><lastmod>2024-10-11T17:09:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/questionario-validado-tem-limitacoes-para-interpretar-parametros-clinicamente-significativos-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-10-11T15:04:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-da-dieta-em-sobreviventes-de-cancer-de-prostata.html]]></loc><lastmod>2024-10-10T18:38:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-descreve-protocolos-institucionais-de-terapia-focal-no-cancer-de-prostata.html]]></loc><lastmod>2024-10-10T18:29:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-nao-mostra-associacao-entre-uso-de-antibioticos-e-cancer-colorretal-em-pacientes-com-menos-de-50-anos.html]]></loc><lastmod>2024-10-10T18:23:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-aerobica-e-depressao-em-pacientes-com-cancer.html]]></loc><lastmod>2024-10-10T16:17:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-tabaco-sem-fumaca-e-noz-de-areca-e-responsavel-por-1-em-cada-3-casos-de-cancer-oral.html]]></loc><lastmod>2024-10-09T18:08:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/contraceptivos-e-risco-de-cancer-de-mama-em-mulheres-com-mutacoes-germinativas-brca1-e-brca2.html]]></loc><lastmod>2024-10-09T17:54:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-de-metabolitos-plasmaticos-muda-em-resposta-a-presenca-de-cancer-de-prostata-avancado.html]]></loc><lastmod>2024-10-09T15:05:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mortalidade-por-cancer-aumenta-no-brasil-em-municipios-de-alta-renda-e-supera-mortes-por-doencas-cardiovasculares.html]]></loc><lastmod>2024-10-08T16:59:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preditores-de-retorno-ao-trabalho-em-pacientes-tratados-para-metastases-de-snc.html]]></loc><lastmod>2024-10-08T16:57:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neoplasia-mucinosa-papilar-intraductal-nao-e-fator-prognostico-no-cancer-pancreatico-ressecado.html]]></loc><lastmod>2024-10-08T15:27:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/colocare-estudo-analisa-impacto-do-alcool-e-tabagismo-no-cancer-colorretal.html]]></loc><lastmod>2024-10-08T08:32:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-mostra-sacituzumab-govitecan-no-cancer-de-mama-triplo-negativo-metastatico.html]]></loc><lastmod>2024-10-07T20:17:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-revela-o-risco-genetico-do-cancer-de-pulmao-independente-do-tabagismo.html]]></loc><lastmod>2024-10-08T00:18:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nobel-de-medicina-reconhece-descoberta-do-microrna.html]]></loc><lastmod>2024-10-07T17:09:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-destaca-evolucao-do-tratamento-do-cancer-do-trato-biliar.html]]></loc><lastmod>2024-10-04T16:01:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lista-modelo-de-medicamentos-essenciais-prioridades-e-desafios.html]]></loc><lastmod>2024-10-04T15:02:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ferramenta-mostra-eficacia-na-avaliacao-de-risco-de-fratura-em-pacientes-com-cancer.html]]></loc><lastmod>2024-10-04T14:45:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fracionamento-reduz-risco-de-malignidades-secundarias-na-radioterapia-adjuvante-do-cancer-de-mama.html]]></loc><lastmod>2024-10-04T19:11:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-propoe-recomendacoes-para-reduzir-o-burnout-e-proteger-a-saude-dos-profissionais-que-atuam-na-oncologia.html]]></loc><lastmod>2024-10-04T11:17:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-o-que-comer-para-a-prevencao-do-cancer.html]]></loc><lastmod>2024-10-04T10:58:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alliance-mostra-resultados-da-radioterapia-hipofracionada-pos-mastectomia-na-prevencao-da-recorrencia-do-cancer-de-mama.html]]></loc><lastmod>2024-10-03T17:20:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-a-acalabrutinibe-no-linfoma-de-celulas-do-manto-nao-tratado.html]]></loc><lastmod>2024-10-03T14:12:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-maranhense-explora-o-microambiente-imune-do-cancer-de-penis.html]]></loc><lastmod>2024-10-02T17:08:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-de-fim-de-vida-e-sofrimento-emocional-entre-oncologistas.html]]></loc><lastmod>2024-10-02T16:11:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-de-h-pylori-associado-ao-fit-nao-impactou-incidencia-e-mortalidade-do-cancer-gastrico.html]]></loc><lastmod>2024-10-02T11:58:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-a-t-dxd-no-cancer-de-mama-metastatico-her2-low-ultralow-previamente-tratado-com-terapia-endocrina.html]]></loc><lastmod>2024-10-01T16:35:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-de-longo-prazo-no-colangiocarcinoma-intra-hepatico-avancado-tratado-com-infusao-arterial-hepatica.html]]></loc><lastmod>2024-10-01T15:16:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-compara-experiencias-de-brasil-e-canada-no-tratamento-do-cancer-durante-a-pandemia-de-covid-19.html]]></loc><lastmod>2024-10-01T12:41:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-amamentacao-entre-jovens-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2024-09-30T17:50:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alcool-e-risco-de-cancer-de-pulmao-em-homens-com-diferentes-genotipos-de-receptores-do-hormonio-de-crescimento.html]]></loc><lastmod>2024-09-30T17:41:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/olanzapina-mostra-beneficio-clinico-e-estatisticamente-significativo-no-controle-da-nausea-refrataria-induzida-por-quimioterapia.html]]></loc><lastmod>2024-09-27T21:16:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-populacional-associa-doenca-inflamatoria-pelvica-a-tumores-borderline-de-ovario-serosos.html]]></loc><lastmod>2024-09-27T19:31:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-oral-e-risco-de-cancer-de-celulas-escamosas-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-09-28T04:17:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eficacia-da-vacina-contra-a-influenza-em-pacientes-imunocomprometidos-com-cancer.html]]></loc><lastmod>2024-09-27T16:55:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-osimertinibe-no-cpcnp-avancado-com-mutacao-de-egfr-apos-quimiorradiacao.html]]></loc><lastmod>2024-09-26T16:21:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/doenca-cardiovascular-e-avc-em-idosos-sobreviventes-e-em-tratamento-contra-o-cancer.html]]></loc><lastmod>2024-09-25T19:46:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-reforca-evidencias-da-associacao-entre-obesidade-e-risco-de-cancer.html]]></loc><lastmod>2024-09-25T19:32:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/integracao-precoce-de-cuidados-paliativos-em-oncologia.html]]></loc><lastmod>2024-09-25T19:27:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/testes-de-hpv-clinicamente-validados-mostram-seguranca-comparavel-no-rastreamento-do-cancer-cervical.html]]></loc><lastmod>2024-09-24T21:10:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intervencao-de-exercicios-fisicos-e-nutricao-mostra-beneficio-em-pacientes-com-leucemia-e-linfoma-durante-a-quimioterapia.html]]></loc><lastmod>2024-09-24T21:03:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/simposio-da-asco-destaca-iniciativa-com-impacto-na-reducao-do-cancer-de-pulmao.html]]></loc><lastmod>2024-09-24T20:58:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aconselhamento-sobre-atividade-fisica-pode-reduzir-quedas-de-pacientes-idosos-com-cancer.html]]></loc><lastmod>2024-09-25T02:17:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/orator-resultados-finais-mostram-dados-oncologicos-e-de-qualidade-de-vida-de-rt-e-tors-no-cancer-de-orofaringe.html]]></loc><lastmod>2024-09-23T21:26:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-prognostico-preve-risco-de-carcinoma-hepatocelular-em-pacientes-com-hepatite-cronica.html]]></loc><lastmod>2024-09-23T21:16:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metabolitos-circulantes-da-via-triptofano-quinurenina-estao-associados-a-mortalidade-no-cancer-colorretal.html]]></loc><lastmod>2024-09-23T20:19:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-mostra-resultados-superiores-versus-sbrt-no-cpcnp-estagio-i-ressecavel.html]]></loc><lastmod>2024-09-23T15:21:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aspartame-metileugenol-e-isoeugenol-e-a-nova-classificacao-de-risco-da-iarc.html]]></loc><lastmod>2024-09-20T19:51:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-revela-biomarcadores-que-auxiliam-a-tomada-de-decisao-no-cppc.html]]></loc><lastmod>2024-09-20T19:12:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-impacto-da-pandemia-de-covid-19-na-mortalidade-por-cancer-no-brasil.html]]></loc><lastmod>2024-09-19T19:47:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/padrao-de-atividade-fisica-interfere-na-reducao-do-risco-de-cancer-colorretal.html]]></loc><lastmod>2024-09-19T19:22:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mamografia-tomossintese-e-ia-na-classificacao-de-pequenas-massas-mamarias.html]]></loc><lastmod>2024-09-19T19:18:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relatorio-da-aacr-destaca-fatores-de-risco-modificaveis-e-toxicidade-financeira-do-cancer.html]]></loc><lastmod>2024-09-23T13:14:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/durvalumabe-mostra-resultados-de-eficacia-e-seguranca-no-cppc-em-estagio-extenso-e-pneumonia-intersticial-idiopatica.html]]></loc><lastmod>2024-09-18T21:04:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-retarda-o-desenvolvimento-do-adenocarcinoma-ductal-pancreatico-associado-a-obesidade.html]]></loc><lastmod>2024-09-18T21:04:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inca-e-fiocruz-iniciam-agenda-conjunta-contra-cigarro-eletronico.html]]></loc><lastmod>2024-09-11T23:40:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-trimodal-no-cancer-de-bexiga-t1-de-alto-grau.html]]></loc><lastmod>2024-09-05T22:53:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vance-associacao-de-celulas-t-citotoxicas-do-virus-epstein-barr-a-qt-nao-melhora-sobrevida-no-carcinoma-de-nasofaringe.html]]></loc><lastmod>2024-09-05T22:49:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-eficacia-da-qt-apos-progressao-ao-parpi-no-cancer-de-ovario.html]]></loc><lastmod>2024-09-04T22:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/composicao-corporal-em-pacientes-com-cancer-de-mama-inicial-tratadas-com-inibidores-de-aromatase-adjuvante.html]]></loc><lastmod>2024-09-04T21:09:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dados-de-mundo-real-mostram-que-linfadenectomia-foi-associada-a-melhor-sobrevida-global-no-melanoma-vulvar.html]]></loc><lastmod>2024-09-03T19:46:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-impacto-do-estilo-de-vida-na-funcao-fisica-de-sobreviventes-de-cancer-mais-velhos.html]]></loc><lastmod>2024-09-03T11:28:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alimentacao-oral-e-segura-e-confortavel-em-pacientes-com-cancer-gastrico-submetidos-a-gastrectomia-total-radical.html]]></loc><lastmod>2024-09-02T18:18:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-risco-aumentado-de-fraturas-osteoporoticas-apos-terapia-com-inibidores-de-checkpoint-imunologico.html]]></loc><lastmod>2024-09-02T18:01:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sympro-lung-monitoramento-online-de-sintomas-por-meio-de-pros-e-qualidade-de-vida.html]]></loc><lastmod>2024-09-02T13:45:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dieta-baseada-em-vegetais-e-sobrevida-de-pacientes-com-cancer-colorretal-metastatico.html]]></loc><lastmod>2024-09-02T11:38:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-sistemica-no-fim-de-vida-ainda-e-frequente-em-pacientes-com-tumores-solidos.html]]></loc><lastmod>2024-08-30T19:53:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-aumento-do-numero-de-gestantes-que-fumam-no-brasil.html]]></loc><lastmod>2024-08-29T22:24:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/utilidade-diagnostica-e-clinica-de-painel-multigenes-em-pacientes-com-neuropatia.html]]></loc><lastmod>2024-08-29T22:05:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sintomas-cognitivos-em-diversos-tipos-de-cancer.html]]></loc><lastmod>2024-08-29T21:38:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-dados-revelam-que-perfil-molecular-pode-guiar-decisoes-cirurgicas-e-de-rt-no-tratamento-de-meningiomas.html]]></loc><lastmod>2024-08-28T17:31:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ensaio-nao-mostra-beneficio-da-adicao-de-oxaliplatina-ao-regime-fp-bev-em-idosos-com-cancer-colorretal-metastatico-irressecavel.html]]></loc><lastmod>2024-08-28T16:10:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relarc-extensao-da-linfadenectomia-para-tratamento-cirurgico-do-cancer-de-colon-direito.html]]></loc><lastmod>2024-08-28T16:03:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-desenvolve-criterios-para-avaliar-potencial-agnostico-de-terapias-contra-o-cancer.html]]></loc><lastmod>2024-08-28T14:23:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inflamacao-atividade-fisica-e-sobrevida-livre-de-doenca-no-cancer-de-colon.html]]></loc><lastmod>2024-08-26T22:27:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-associacao-da-terapia-hormonal-na-menopausa-com-risco-de-cancer-de-ovario-e-endometrio.html]]></loc><lastmod>2024-08-26T22:23:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-associacao-entre-adiposidade-pre-e-pos-diagnostico-e-mortalidade-por-cancer-de-prostata.html]]></loc><lastmod>2024-08-26T22:30:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-destaca-papel-dos-dentistas-para-enfrentar-o-cancer-oral-no-brasil.html]]></loc><lastmod>2024-08-23T19:51:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ressonancia-magnetica-e-correlacao-radiopatologica-no-cancer-de-mama-luminal-com-baixa-expressao-de-receptor-de-estrogenio.html]]></loc><lastmod>2024-08-23T19:43:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/olaparibe-sem-privacao-de-androgeno-no-cancer-de-prostata-com-recorrencia-bioquimica-de-alto-risco.html]]></loc><lastmod>2024-08-23T16:08:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/extrato-oral-de-cannabis-para-prevencao-secundaria-de-nauseas-e-vomitos-induzidos-por-quimioterapia.html]]></loc><lastmod>2024-08-23T20:00:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/breast-cancer-index-no-cancer-de-mama-hr-em-mulheres-na-pre-menopausa.html]]></loc><lastmod>2024-08-23T12:56:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-randomizado-mostra-papel-do-mindfulness-no-controle-da-dor-do-cancer.html]]></loc><lastmod>2024-08-22T15:24:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-de-vida-em-pacientes-com-cancer-de-bexiga-submetidos-a-cistectomia-ou-quimiorradioterapia.html]]></loc><lastmod>2024-08-22T11:17:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sugere-impacto-das-medidas-de-resultados-relatados-pelo-paciente-no-tratamento-do-cancer.html]]></loc><lastmod>2024-08-22T10:27:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-a-opiniao-das-mulheres-sobre-inteligencia-artificial-no-rastreio-do-cancer-de-mama.html]]></loc><lastmod>2024-08-21T15:52:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/articuno-osimertinibe-no-cpcnp-com-mutacoes-incomuns-de-egfr.html]]></loc><lastmod>2024-08-21T12:41:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-mostra-discordancia-entre-diretrizes-e-pratica-clinica-na-oncologia.html]]></loc><lastmod>2024-08-19T22:34:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/expressao-de-proteinas-e-impacto-prognostico-nos-sarcomas-sinoviais-metastaticos.html]]></loc><lastmod>2024-08-19T22:20:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-avaliou-a-aceitacao-a-conclusao-e-as-preferencias-para-o-rastreio-do-cancer-do-colo-do-utero.html]]></loc><lastmod>2024-08-19T23:26:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-reconhece-t-dxd-como-terapia-inovadora-no-cancer-de-mama-metastatico-her2-low-her2-ultralow.html]]></loc><lastmod>2024-08-19T20:25:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-de-risco-ajuda-a-prever-futilidade-da-resseccao-inicial-para-cancer-de-pancreas-anatomicamente-ressecavel.html]]></loc><lastmod>2024-08-16T20:44:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eficacia-e-seguranca-da-cirurgia-oncoplastica-versus-cirurgia-conservadora-de-mama-convencional.html]]></loc><lastmod>2024-08-16T20:27:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-durvalumabe-no-cpcnp-ressecavel.html]]></loc><lastmod>2024-08-16T16:30:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/enicto-exercicio-e-nutricao-para-melhorar-os-resultados-do-tratamento-do-cancer.html]]></loc><lastmod>2024-08-16T15:07:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-baseados-em-mrna-urinario-para-cancer-de-bexiga-sem-invasao-muscular.html]]></loc><lastmod>2024-08-15T20:13:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disparidades-na-expectativa-de-vida-global-o-impacto-do-cancer-feminino.html]]></loc><lastmod>2024-08-15T19:52:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-durvalumabe-no-cancer-de-pulmao-de-celulas-pequenas-em-estagio-limitado.html]]></loc><lastmod>2024-08-15T13:53:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-paliativos-melhoram-resultados-de-sobrevida-no-cancer-avancado.html]]></loc><lastmod>2024-08-14T20:36:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mapeamento-do-linfonodo-sentinela-melhora-deteccao-de-linfonodo-para-aortico-isolado-positivo-no-cancer-endometrial.html]]></loc><lastmod>2024-08-14T20:32:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/peliculas-ou-curativos-de-barreira-na-prevencao-da-radiodermatite.html]]></loc><lastmod>2024-08-14T20:45:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ue-aprova-combinacao-de-durvalumabe-e-olaparibe-no-cancer-de-endometrio-avancado-ou-recorrente.html]]></loc><lastmod>2024-08-14T14:59:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-global-revela-disparidades-na-carga-de-cancer-em-homens-entre-paises.html]]></loc><lastmod>2024-08-14T20:05:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-indica-que-uso-de-cannabis-aumenta-risco-de-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-08-13T22:16:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-mostra-resultados-de-osimertinibe-no-cpcnp-metastatico-com-mutacao-atipica-de-egfr.html]]></loc><lastmod>2024-08-13T19:58:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/medidas-de-pros-na-avaliacao-da-neuropatia-induzida-por-quimioterapia.html]]></loc><lastmod>2024-08-13T19:47:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bfr14-dados-de-longo-prazo-recomendam-continuacao-de-imatinibe-em-pacientes-com-gist-avancado.html]]></loc><lastmod>2024-08-09T20:23:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mastectomia-bilateral-nao-reduz-mortalidade-por-cancer-de-mama.html]]></loc><lastmod>2024-08-11T23:09:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ensaio-randomizado-nao-mostra-beneficio-da-rt-hipofracionada-pos-mastectomia-apos-reconstrucao-baseada-em-implante.html]]></loc><lastmod>2024-08-09T21:48:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/necessidades-de-cuidados-de-suporte-apos-cirurgia-em-pacientes-com-cancer-de-mama.html]]></loc><lastmod>2024-08-09T10:08:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/classificador-genomico-e-risco-de-recorrencia-uma-analise-de-mundo-real.html]]></loc><lastmod>2024-08-08T17:58:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-modificaveis-na-sindrome-de-lynch-e-prevencao-do-cancer.html]]></loc><lastmod>2024-08-08T17:45:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/herb-trastuzumabe-deruxtecana-mostra-atividade-no-cancer-do-trato-biliar-expressando-her2.html]]></loc><lastmod>2024-08-07T23:13:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-fornece-uma-abordagem-pratica-para-o-tratamento-do-tromboembolismo-venoso-associado-ao-cancer.html]]></loc><lastmod>2024-08-07T22:06:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-da-literatura-global-analisa-genotipos-do-papilomavirus-humano-no-cancer-cervical-invasivo.html]]></loc><lastmod>2024-08-07T21:51:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-global-com-imrt-isolada-e-comparavel-a-quimiorradioterapia-no-cancer-de-nasofaringe-de-baixo-risco.html]]></loc><lastmod>2024-08-07T21:45:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-e-cognicao-em-sobreviventes-mais-velhas-de-cancer-de-mama.html]]></loc><lastmod>2024-08-07T13:06:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-insights-e-debates-em-andamento-iaslc-nao-recomenda-a-triagem-do-cancer-de-pulmao-em-nunca-fumantes.html]]></loc><lastmod>2024-08-06T20:05:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vigilancia-ativa-pode-de-escalonar-tratamento-e-evitar-cirurgia-no-escc-localmente-avancado.html]]></loc><lastmod>2024-08-11T23:02:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-asciminib-no-tratamento-da-lmc-recem-diagnosticada.html]]></loc><lastmod>2024-08-06T03:55:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/amplify-duracao-fixa-de-acalabrutinibe-venetoclax-mostra-resultados-de-slp-na-primeira-linha-da-llc.html]]></loc><lastmod>2024-08-06T14:18:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/unidades-linfoides-funcionais-cranioencefalicas-em-glioblastoma.html]]></loc><lastmod>2024-08-02T23:48:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-primeira-terapia-celular-para-um-tumor-solido.html]]></loc><lastmod>2024-08-03T17:08:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-multicentrico-prospectivo-analisa-prevalencia-de-transtornos-emocionais-em-pacientes-com-cancer-recem-diagnosticados.html]]></loc><lastmod>2024-08-02T21:56:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-terapias-de-resgate-apos-tratamento-focal-no-cancer-de-prostata.html]]></loc><lastmod>2024-08-02T16:05:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-de-aspirina-estilo-de-vida-e-incidencia-de-cancer-colorretal.html]]></loc><lastmod>2024-08-03T17:35:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-aponta-diferencas-nas-taxas-de-cancer-entre-geracoes.html]]></loc><lastmod>2024-08-03T17:07:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/t-dxd-em-tumores-solidos-avancados-com-amplificacao-de-her2-identificada-por-cfdna.html]]></loc><lastmod>2024-08-03T18:20:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/calgb-140503-analise-secundaria-mostra-recorrencia-no-cpcnp-com-invasao-da-pleura-visceral.html]]></loc><lastmod>2024-08-01T21:13:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/testes-geneticos-e-risco-de-cancer-na-populacao-masculina.html]]></loc><lastmod>2024-08-01T19:58:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variabilidade-na-prescricao-de-terapias-sistemicas-contra-o-cancer-nos-ultimos-30-dias-de-vida.html]]></loc><lastmod>2024-08-01T18:34:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-mostra-associacao-entre-tumores-hepaticos-e-hepatectomia-oncologica-parcial-no-brasil.html]]></loc><lastmod>2024-08-01T19:25:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/transplante-de-microbiota-fecal-pode-superar-resistencia-a-imunoterapia.html]]></loc><lastmod>2024-07-31T21:17:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nomogramas-estabelecem-psma-pet-como-novo-biomarcador-prognostico-no-cancer-de-prostata.html]]></loc><lastmod>2024-07-30T19:29:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelagem-aplicada-a-coorte-de-100-milhoes-de-brasileiros-e-equidade-em-saude-de-precisao.html]]></loc><lastmod>2024-07-30T19:17:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comite-de-medicamentos-para-uso-humano-recomenda-zolbetuximabe-na-uniao-europeia-para-cancer-gastrico-ou-gej.html]]></loc><lastmod>2024-07-30T18:45:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/definindo-e-entendendo-atrasos-no-diagnostico-entre-pacientes-com-cancer-de-pancreas.html]]></loc><lastmod>2024-07-30T20:11:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/apendicectomia-e-risco-de-cancer-colorretal.html]]></loc><lastmod>2024-07-29T20:38:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/medicamentos-nao-estatinas-para-reducao-do-colesterol-e-risco-de-cancer-de-figado.html]]></loc><lastmod>2024-07-29T15:30:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ensaio-randomizado-mostra-importancia-do-perfil-genomico-no-cancer-de-sitio-primario-desconhecido.html]]></loc><lastmod>2024-07-26T18:34:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-para-ensaios-clinicos-podem-acelerar-o-desenvolvimento-de-novas-terapias-anticancer.html]]></loc><lastmod>2024-07-26T18:29:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-insuficiente-cresce-como-preocupacao-global.html]]></loc><lastmod>2024-07-25T16:36:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-e-funcao-pulmonar-no-cpcnp-estagio-ia-apos-resseccao-sublobar-versus-lobectomia.html]]></loc><lastmod>2024-07-25T14:32:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/blinatumomabe-mostra-beneficio-de-sobrevida-global-em-adultos-com-leucemia-linfoblastica-aguda-mrd-negativa.html]]></loc><lastmod>2024-07-25T14:05:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aegean-comite-consultivo-da-fda-reconhece-papel-de-durvalumabe-no-cpcnp-ressecavel.html]]></loc><lastmod>2024-07-26T21:42:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rt-hipofracionada-reduz-complicacoes-em-pacientes-com-implantes.html]]></loc><lastmod>2024-07-26T21:41:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prognosis-rct-avaliacao-geriatrica-e-hospitalizacoes-em-idosos-frageis-em-tratamento-oncologico-com-intencao-curativa.html]]></loc><lastmod>2024-07-25T09:35:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/testes-de-deteccao-pan-cancer-novo-paradigma-a-espera-de-evidencias.html]]></loc><lastmod>2024-07-24T20:22:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nivel-de-magnesio-no-sangue-e-risco-de-cancer-de-figado-em-pacientes-com-cirrose-hepatica.html]]></loc><lastmod>2024-07-24T13:46:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/liga-contra-o-cancer-inaugura-nova-unidade-e-reforca-interiorizacao-da-prevencao-e-controle.html]]></loc><lastmod>2024-07-23T19:53:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/centro-de-diagnostico-e-ensino-do-serido-e-novo-polo-de-prevencao-do-cancer-e-deteccao-precoce.html]]></loc><lastmod>2024-07-23T19:47:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/artigo-discute-analises-de-sobrevida-global-em-ensaios-clinicos-de-oncologia.html]]></loc><lastmod>2024-07-23T09:33:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disparidades-raciais-e-etnicas-nos-resultados-cardiovasculares-entre-sobreviventes-de-cancer.html]]></loc><lastmod>2024-07-22T12:25:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-de-longo-prazo-da-womens-health-initiative-nao-mostra-beneficio-da-terapia-hormonal-no-cancer-colorretal.html]]></loc><lastmod>2024-07-22T08:56:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-preditivo-de-neuropatia-periferica-induzida-por-taxanos-em-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2024-07-23T00:38:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-das-analises-de-custo-efetividade-que-examinam-tratamentos-para-caquexia.html]]></loc><lastmod>2024-07-19T22:49:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aplicativo-de-atividade-fisica-e-pros-em-pacientes-com-cancer-de-mama-metastatico.html]]></loc><lastmod>2024-07-19T22:36:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/implicacoes-clinicas-da-deficiencia-de-reparo-de-recombinacao-homologa-em-tumores-do-trato-biliar.html]]></loc><lastmod>2024-07-19T22:21:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-analisa-qualidade-dos-registros-de-cancer-de-base-populacional-no-brasil.html]]></loc><lastmod>2024-08-10T18:23:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-segundos-tumores-e-linfoma-de-celulas-t-apos-terapia-com-car-t.html]]></loc><lastmod>2024-07-19T21:24:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbiota-intestinal-e-preditiva-da-toxicidade-gastrointestinal-aguda-induzida-por-radioterapia-em-pacientes-com-cancer-de-prostata.html]]></loc><lastmod>2024-07-19T21:06:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preocupacao-com-fertilidade-afeta-a-qualidade-de-vida-no-cancer-testicular.html]]></loc><lastmod>2024-07-19T14:42:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eua-divulgam-diretrizes-para-triagem-do-cancer-anal-em-pessoas-com-hiv.html]]></loc><lastmod>2024-07-19T14:37:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-pioneiro-mostra-avancos-da-inteligencia-artificial-na-deteccao-precoce-do-cancer-de-mama.html]]></loc><lastmod>2024-07-19T13:59:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exercicios-fisicos-como-terapia-neoadjuvante-no-cancer-de-prostata.html]]></loc><lastmod>2024-07-18T22:34:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-de-modulacao-hormonal-e-menor-risco-de-demencia-em-pacientes-com-cancer-de-mama.html]]></loc><lastmod>2024-07-18T19:20:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perda-de-rnaseh2b-e-inibicao-de-parp-no-cancer-de-prostata-avancado.html]]></loc><lastmod>2024-07-18T19:21:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fosp-oncocentro-mostra-panorama-epidemiologico-do-cancer-de-cabeca-e-pescoco-em-sao-paulo.html]]></loc><lastmod>2024-07-17T20:09:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gravidez-apos-transplante-alogenico-de-celulas-hematopoieticas.html]]></loc><lastmod>2024-07-17T14:53:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-peniano-diretriz-de-pratica-clinica-esmo-euracan-para-diagnostico-tratamento-e-acompanhamento.html]]></loc><lastmod>2024-07-16T18:54:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/melhorando-os-resultados-do-tratamento-de-idosos-com-cancer-e-comorbidades.html]]></loc><lastmod>2024-07-17T10:47:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-de-sobreviventes-de-cancer-nos-estados-unidos.html]]></loc><lastmod>2024-07-17T23:02:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-da-liga-contra-o-cancer-analisa-linfoma-de-hodgkin-em-pacientes-que-vivem-com-hiv-na-era-da-terapia-antirretroviral-combinada.html]]></loc><lastmod>2024-07-15T23:38:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brecadd-guiado-por-pet-supera-ebeacopp-no-linfoma-de-hodgkin-classico-avancado.html]]></loc><lastmod>2024-07-15T23:07:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-propoe-recomendacoes-para-o-tratamento-do-carcinoma-anaplasico-da-tireoide-com-variante-patogenica-braf-v600e.html]]></loc><lastmod>2024-07-15T20:02:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brasileiro-e-coautor-de-um-dos-artigos-mais-citados-na-oncologia.html]]></loc><lastmod>2024-07-15T19:34:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vitamina-d-e-reducao-de-risco-no-cancer-de-mama.html]]></loc><lastmod>2024-07-15T13:19:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-nao-mostra-impacto-do-projeto-orbis-no-acesso-ao-tratamento-do-cancer.html]]></loc><lastmod>2024-07-13T00:08:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-promessa-na-reducao-do-risco-de-cancer-associado-a-obesidade.html]]></loc><lastmod>2024-07-12T21:26:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-preditivo-no-carcinoma-hepatocelular.html]]></loc><lastmod>2024-07-12T21:06:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fumar-narquile-aumenta-risco-de-mortalidade-por-cancer.html]]></loc><lastmod>2024-07-12T20:43:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-relata-taxas-de-mortalidade-em-subtipos-histologicos-raros-de-cancer-de-prostata.html]]></loc><lastmod>2024-07-12T20:27:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ensaio-clinico-randomizado-de-nao-inferioridade-da-termoablacao-na-prevencao-do-cancer-do-colo-do-utero-interpretacao-das-evidencias-e-avaliacao-de-sua-aplicabilidade-para-a-pratica-clinica-brasileira.html]]></loc><lastmod>2024-07-15T20:42:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/numero-de-casos-e-mortes-por-cancer-atribuiveis-a-fatores-de-risco-potencialmente-modificaveis-nos-eua.html]]></loc><lastmod>2024-07-15T12:13:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comorbidades-vitamina-d-e-risco-de-mortalidade-em-cinco-anos-em-pacientes-com-cancer-de-colon.html]]></loc><lastmod>2024-07-12T15:22:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estado-nutricional-de-idosos-com-cancer-de-pulmao-e-sintomas-de-depressao.html]]></loc><lastmod>2024-07-12T14:18:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tils-densos-em-metastases-hepaticas-de-cancer-colorretal-e-melhora-da-sobrevida-global.html]]></loc><lastmod>2024-07-11T20:48:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tendencias-de-mortalidade-prematura-por-tipo-de-cancer-em-183-paises.html]]></loc><lastmod>2024-07-11T23:25:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-pulmao-em-nunca-fumantes-e-exposicao-ao-amianto.html]]></loc><lastmod>2024-07-11T19:59:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gestao-do-tratamento-em-idosas-com-cancer-de-mama-inicial.html]]></loc><lastmod>2024-07-11T02:24:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-publica-recomendacoes-de-consenso-sobre-dados-genomicos-em-tumores-solidos.html]]></loc><lastmod>2024-07-11T01:02:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-e-pros-no-cancer-de-colon-com-3-meses-de-capox-adjuvante.html]]></loc><lastmod>2024-07-11T02:24:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/idade-inicial-personalizada-para-rastreamento-do-cancer-gastrico-com-base-nos-perfis-de-risco.html]]></loc><lastmod>2024-07-11T01:58:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncologia-integrativa-para-pacientes-com-cancer-de-pulmao.html]]></loc><lastmod>2024-07-11T02:11:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estimativas-de-cura-e-risco-de-morte-por-outras-causas-no-cancer-de-cabeca-e-pescoco-colorretal-e-mama.html]]></loc><lastmod>2024-07-11T02:17:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vigilancia-do-cancer-de-pancreas-e-sobrevida-em-individuos-de-alto-risco.html]]></loc><lastmod>2024-07-09T17:05:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-avalia-preparo-dos-oncologistas-para-o-atendimento-de-pacientes-lgbtq-com-cancer.html]]></loc><lastmod>2024-07-09T16:55:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pet-ct-com-18f-psma-mostra-resultados-no-estadiamento-do-cancer-de-prostata.html]]></loc><lastmod>2024-07-09T16:46:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/conhecimento-sobre-cdis-e-decisao-informada-entre-vigilancia-ativa-e-cirurgia.html]]></loc><lastmod>2024-07-09T16:39:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assinaturas-do-metaboloma-plasmatico-preve-resposta-a-nact-no-cancer-de-mama.html]]></loc><lastmod>2024-07-08T21:26:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prodige-23-analise-final-de-sg-confirma-beneficio-da-qt-de-inducao-com-mfolfirinox-no-cancer-retal-localmente-avancado.html]]></loc><lastmod>2024-07-08T18:38:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/u-pro-crm-projetando-ensaios-de-determinacao-de-dose-centrados-no-paciente-com-integracao-de-pros.html]]></loc><lastmod>2024-07-08T14:15:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-ultra-hipofracionada-para-cancer-de-prostata-incluindo-vesiculas-seminais-no-volume-alvo.html]]></loc><lastmod>2024-07-24T16:13:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-e-toxicidade-financeira-a-visao-de-pesquisadores-e-profissionais-de-saude.html]]></loc><lastmod>2024-07-05T21:48:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diferencas-de-sexo-na-incidencia-mortalidad5e-e-sobrevivencia-do-cancer.html]]></loc><lastmod>2024-07-06T02:33:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nrg-oncology-rtog-0617-e-o-uso-padrao-da-imrt-no-cancer-de-pulmao-irressecavel.html]]></loc><lastmod>2024-07-05T20:12:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uniao-europeia-aprova-osimertinibe-qt-em-primeira-linha-no-cpcnp-egfr-mutado.html]]></loc><lastmod>2024-07-05T23:13:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-discute-papel-da-equipe-multidisciplinar-na-nutricao-do-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-07-05T14:52:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-alerta-para-risco-de-tromboembolismo-venoso-com-qt-neoadjuvante-no-cancer-de-ovario-avancado.html]]></loc><lastmod>2024-07-12T19:54:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exposicao-a-violencia-afeta-a-sinalizacao-de-glicocorticoides-em-tumores-de-pulmao.html]]></loc><lastmod>2024-07-04T18:57:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/maior-serie-de-casos-confirma-seguranca-oncologica-da-traquelectomia-vaginal-no-cancer-cervical-inicial.html]]></loc><lastmod>2024-07-07T14:23:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/criterios-de-cura-endoscopica-em-pacientes-submetidos-a-cirurgia-para-cancer-gastrico-inicial.html]]></loc><lastmod>2024-07-04T16:19:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-pede-acoes-urgentes-em-defesa-da-pesquisa-em-cancer.html]]></loc><lastmod>2024-07-04T15:18:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-que-influenciam-a-persistencia-da-terapia-endocrina-adjuvante-em-5-anos-em-mulheres-jovens-com-cancer-de-mama.html]]></loc><lastmod>2024-07-04T14:07:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/connect-estudo-avalia-papel-dos-oncologistas-na-promocao-da-atividade-fisica.html]]></loc><lastmod>2024-07-04T13:00:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-pode-melhorar-o-rendimento-diagnostico-da-triagem-do-cancer-colorretal.html]]></loc><lastmod>2024-07-03T21:40:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ambiente-imune-caracteristicas-clinicas-e-patologicas-do-adenocarcinoma-pancreatico.html]]></loc><lastmod>2024-07-03T21:30:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-alerta-para-associacao-entre-cancer-e-doenca-periodontal.html]]></loc><lastmod>2024-07-04T16:28:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sugere-necessidade-de-imagens-suplementares-a-mamografia-na-vigilancia-do-carcinoma-lobular-invasivo-da-mama.html]]></loc><lastmod>2024-07-03T21:03:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tils-no-cancer-de-mama-triplo-negativo-estagio-i-nao-tratado-com-quimioterapia.html]]></loc><lastmod>2024-07-03T18:40:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/efeito-preventivo-do-treinamento-neuromuscular-na-neuropatia-induzida-por-quimioterapia.html]]></loc><lastmod>2024-07-03T16:52:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-de-mundo-real-confirma-ganho-de-sg-com-durvalumabe-no-cancer-do-trato-biliar-avancado.html]]></loc><lastmod>2024-07-05T19:53:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-expande-criterios-de-elegibilidade-para-a-pesquisa-em-cancer.html]]></loc><lastmod>2024-07-02T19:30:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-entre-parentes-de-primeiro-grau-e-risco-de-multiplos-tumores-primarios.html]]></loc><lastmod>2024-07-02T15:05:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incidencia-de-cancer-peritoneal-apos-ooforectomia-entre-portadores-de-mutacao-brca1-e-brca2.html]]></loc><lastmod>2024-07-08T03:16:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/painel-internacional-publica-recomendacoes-de-consenso-no-lipossarcoma-avancado.html]]></loc><lastmod>2024-07-02T12:17:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/epigenetica-encontra-terapia-com-celulas-car-t-para-combater-o-cancer.html]]></loc><lastmod>2024-07-02T12:19:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/epic-cuidado-paliativo-precoce-no-cancer-gastrointestinal-superior-metastatico.html]]></loc><lastmod>2024-07-02T12:19:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-qt-adjuvante-na-sobrevida-apos-resposta-patologica-completa-no-cancer-retal.html]]></loc><lastmod>2024-07-02T12:47:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/poluicao-atmosferica-pode-aumentar-risco-cardiovascular-para-pacientes-com-cancer.html]]></loc><lastmod>2024-07-01T16:54:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reabilitacao-em-dependentes-de-alcool-e-risco-de-cancer.html]]></loc><lastmod>2024-07-01T15:46:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/topaz-1-sobrevida-em-tres-anos-seguranca-e-sobrevida-estendida-em-longo-prazo-de-durvalumabe-no-trato-biliar.html]]></loc><lastmod>2024-07-14T20:23:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rationale-306-novos-dados-apoiam-metodo-de-analise-do-biomarcador-pd-l1.html]]></loc><lastmod>2024-06-29T12:26:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-em-pessoas-vivendo-com-hiv-e-em-transplantados-de-orgaos-solidos.html]]></loc><lastmod>2024-06-28T17:09:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/transmet-transplante-de-figado-qt-em-metastases-hepaticas-irressecaveis-do-cancer-colorretal.html]]></loc><lastmod>2024-06-28T16:55:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-populacional-mostra-resultados-obstetricos-adversos-entre-sobreviventes-de-cancer.html]]></loc><lastmod>2024-06-28T16:36:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-mostra-nao-inferioridade-da-ablacao-termica-na-prevencao-do-cancer-cervical.html]]></loc><lastmod>2024-07-12T20:22:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-aprovacao-acelerada-a-epcoritamabe-para-linfoma-folicular-recidivado-ou-refratario.html]]></loc><lastmod>2024-06-27T21:21:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/testes-de-expressao-genica-e-selecao-de-tratamento-no-cancer-de-mama.html]]></loc><lastmod>2024-06-27T20:09:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/astro-atualiza-diretriz-de-radioterapia-para-pacientes-com-cancer-de-orofaringe-relacionado-ao-hpv.html]]></loc><lastmod>2024-07-08T15:48:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/associacao-entre-cancer-gastrico-e-osteoporose.html]]></loc><lastmod>2024-06-28T21:02:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anti-hipertensivo-e-toxicidade-intestinal-grave-induzida-por-capox.html]]></loc><lastmod>2024-06-27T13:12:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-do-mundo-real-mostra-sbrt-no-cancer-de-pancreas.html]]></loc><lastmod>2024-06-27T11:30:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resposta-radiologica-e-reducao-de-custos-com-177-ludotate-em-nets-avancados.html]]></loc><lastmod>2024-06-27T11:29:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/decipher-pesquisa-com-ctdna-avalia-t-dxd-no-adenocarcinoma-esofagogastrico-her2-positivo.html]]></loc><lastmod>2024-06-27T11:28:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/himalaya-nova-analise-continua-a-apoiar-o-esquema-stride-no-carcinoma-hepatolecular-irressecavel.html]]></loc><lastmod>2024-06-27T11:27:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gastos-com-saude-devem-aumentar-quase-tres-vezes-ate-2050.html]]></loc><lastmod>2024-06-26T21:54:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-de-consenso-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-06-26T20:43:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eortc-quimioterapia-sistemica-mostra-beneficio-no-cancer-colorretal-com-metastases-hepaticas-ressecaveis.html]]></loc><lastmod>2024-06-26T13:18:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-agrupada-mostra-beneficio-da-acupuntura-no-controle-de-efeitos-colaterais-da-terapia-endocrina.html]]></loc><lastmod>2024-07-07T13:55:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/niagara-durvalumabe-mostra-eficacia-no-cancer-de-bexiga-musculo-invasivo.html]]></loc><lastmod>2024-06-26T11:12:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ccj-aprova-imunoterapia-no-sus.html]]></loc><lastmod>2024-06-26T01:00:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variantes-raras-da-linha-germinativa-e-predisposicao-ao-cancer-de-mama-her2-positivo.html]]></loc><lastmod>2024-06-24T21:24:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gestao-de-sintomas-baseada-em-relatos-do-paciente-melhora-status-funcional-no-cancer-de-pulmao.html]]></loc><lastmod>2024-06-25T00:17:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estilo-de-vida-ocidental-e-carga-de-cancer-colorretal.html]]></loc><lastmod>2024-06-24T17:16:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-de-anti-inflamatorios-nao-esteroides-e-risco-de-cancer-de-pancreas-no-womens-health-initiative.html]]></loc><lastmod>2024-06-24T23:55:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-final-sugere-beneficio-de-sg-de-dabrafenibe-mais-trametinibe-no-melanoma-avancado.html]]></loc><lastmod>2024-06-21T20:38:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-reune-estrategias-de-prevencao-e-manejo-da-saude-ossea-no-cancer-de-prostata.html]]></loc><lastmod>2024-06-23T11:45:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/folfirinox-modificado-perioperatorio-no-cancer-de-pancreas-ressecavel.html]]></loc><lastmod>2024-06-23T12:29:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-adc-confirma-eficacia-no-cancer-de-ovario-resistente-a-platina.html]]></loc><lastmod>2024-06-21T19:36:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acompanhamento-pos-operatorio-estendido-em-pacientes-com-cancer-gastrico.html]]></loc><lastmod>2024-06-23T11:38:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pancreas-view-ferramenta-otimiza-selecao-de-tratamento-no-cancer-de-pancreas.html]]></loc><lastmod>2024-06-21T15:21:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/manejo-da-dor-de-pacientes-em-cuidados-paliativos-e-transtorno-por-uso-de-substancias.html]]></loc><lastmod>2024-06-23T11:27:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/duo-e-nova-analise-confirma-beneficio-de-durvalumabe-no-cancer-endometrial-avancado.html]]></loc><lastmod>2024-06-21T12:34:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preditores-de-sucesso-da-cirurgia-de-citorreducao-de-intervalo-no-cancer-de-ovario-avancado.html]]></loc><lastmod>2024-06-21T12:33:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uniao-europeia-aprova-capivasertibe-mais-fulvestranto-no-cancer-de-mama-er-her2.html]]></loc><lastmod>2024-06-20T22:14:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alliance-inibidor-de-cox-2-reduz-o-risco-de-recorrencia-no-cancer-colorretal-estagio-iii-com-mutacao-pik3ca.html]]></loc><lastmod>2024-06-20T20:19:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/icesp-apresenta-experiencia-institucional-com-sarcoma-uterino.html]]></loc><lastmod>2024-06-21T11:43:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/canto-desigualdades-afetam-qualidade-de-vida-e-se-aprofundam-apos-o-diagnostico-e-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2024-06-20T15:09:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resposta-patologica-completa-no-cancer-de-pancreas-ressecado-apos-qt-pre-operatoria.html]]></loc><lastmod>2024-06-20T11:49:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/early-egfr-prevalencia-de-mutacoes-de-egfr-no-cpcnp-ressecado-estagio-i-iii.html]]></loc><lastmod>2024-06-20T11:07:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-como-tratamento-para-insonia-em-pacientes-com-cancer.html]]></loc><lastmod>2024-06-20T10:52:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-alimentos-ultraprocessados-e-risco-de-cancer-gastrointestinal.html]]></loc><lastmod>2024-06-19T12:15:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-populacional-mostra-quem-esta-em-risco-de-nodulos-pulmonares-na-tc-de-baixa-dose.html]]></loc><lastmod>2024-06-18T15:08:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perspectivas-do-paciente-de-cancer-sobre-o-significado-da-vida.html]]></loc><lastmod>2024-06-18T14:50:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/daratumumabe-mostra-resultados-no-mieloma-multiplo.html]]></loc><lastmod>2024-06-18T14:55:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/epcore-nhl-1-monoterapia-com-epcoritamabe-no-linfoma-folicular-recidivado-ou-refratario.html]]></loc><lastmod>2024-06-17T22:46:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desnutricao-e-sarcopenia-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2024-06-17T22:33:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relatorio-da-american-cancer-society-enfoca-cancer-na-populacao-lgbtq.html]]></loc><lastmod>2024-06-17T22:27:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sugere-que-descalonamento-de-tki-e-viavel-no-cancer-de-pulmao-avancado.html]]></loc><lastmod>2024-06-17T21:24:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/espectrometria-de-massa-ferramenta-poderosa-na-transicao-entre-pesquisa-e-assistencia.html]]></loc><lastmod>2024-06-18T00:14:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-cafe-e-associado-a-menor-risco-de-recorrencia-do-cancer-colorretal.html]]></loc><lastmod>2024-06-17T20:32:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/epcoritamabe-mostra-resultados-encorajadores-como-primeira-linha-na-transformacao-de-richter.html]]></loc><lastmod>2024-06-20T14:08:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-combinacao-de-durvalumabe-no-cancer-de-endometrio-avancado-ou-recorrente.html]]></loc><lastmod>2024-06-17T16:32:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gestao-farmacologica-do-delirium-no-fim-da-vida-da-evidencia-a-pratica.html]]></loc><lastmod>2024-06-21T19:39:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-e-premiada-como-publicacao-de-maior-impacto-nos-ultimos-5-anos.html]]></loc><lastmod>2024-06-14T23:14:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/seguranca-do-paciente-uma-necessidade-global.html]]></loc><lastmod>2024-06-14T19:18:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/idade-e-etnia-como-fenotipos-de-alto-risco-no-cancer-de-ovario-mucinoso.html]]></loc><lastmod>2024-06-14T21:39:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/positive-preservacao-da-fertilidade-e-reproducao-assistida-em-pacientes-com-cancer-de-mama-rh.html]]></loc><lastmod>2024-06-17T02:18:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disturbios-motores-relacionados-a-neuropatia-periferica-induzida-por-oxaliplatina.html]]></loc><lastmod>2024-06-17T01:40:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-pre-operatoria-qualidade-do-sono-e-dor-pos-operatoria.html]]></loc><lastmod>2024-06-17T02:10:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relacao-dose-e-exposicao-de-exercicios-e-recorrencia-a-distancia-no-cancer-de-mama-primario.html]]></loc><lastmod>2024-06-17T01:46:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pi-cai-inteligencia-artificial-na-deteccao-do-cancer-de-prostata.html]]></loc><lastmod>2024-06-13T23:12:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-segundos-tumores-e-linfoma-de-celulas-t-apos-terapia-com-car-t-cells.html]]></loc><lastmod>2024-06-13T23:07:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cairo4-nao-mostra-beneficio-da-resseccao-do-tumor-primario-no-mcrc-sincrono.html]]></loc><lastmod>2024-06-13T22:52:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-financiada-pela-industria-do-tabaco-ainda-aparece-nas-principais-revistas-medicas.html]]></loc><lastmod>2024-06-13T20:15:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/efeito-protetor-da-ingestao-de-folato-no-cancer-gastrico-e-modificado-pelo-consumo-de-alcool.html]]></loc><lastmod>2024-06-13T23:30:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atraso-na-terapia-adjuvante-do-cancer-de-mama-nao-metastatico-e-impacto-no-prognostico.html]]></loc><lastmod>2024-06-14T12:09:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-incidencia-de-cancer-ginecologico-e-uso-de-antipsicoticos.html]]></loc><lastmod>2024-06-14T19:33:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preditores-de-cuidados-intensivos-no-fim-de-vida-entre-idosos-com-tumores-solidos.html]]></loc><lastmod>2024-06-13T13:41:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-associacao-inversa-entre-a-expressao-de-rkip-e-egfr-no-cancer-cervical.html]]></loc><lastmod>2024-06-13T12:34:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-durante-a-vigilancia-ativa-no-cancer-de-prostata.html]]></loc><lastmod>2024-06-13T11:52:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/next-estudo-avalia-tratamento-neoadjuvante-no-cancer-de-esofago-localmente-avancado.html]]></loc><lastmod>2024-06-13T12:06:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/padroes-temporais-mostram-que-geracao-x-tem-maior-aumento-na-incidencia-do-cancer.html]]></loc><lastmod>2024-06-14T12:48:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perda-de-peso-e-controle-da-obesidade-tem-impacto-no-cancer-endometrial.html]]></loc><lastmod>2024-06-12T21:21:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-buscam-aprimorar-cuidados-paliativos-e-de-fim-de-vida.html]]></loc><lastmod>2024-06-12T21:05:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-pet-psma-no-estadiamento-do-cancer-de-prostata.html]]></loc><lastmod>2024-06-12T20:52:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fragilidade-como-indicador-prognostico-em-idosos-com-cancer-de-pulmao.html]]></loc><lastmod>2024-06-11T20:15:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-do-h-pylori-e-risco-de-cancer-gastrico-entre-individuos-com-alto-risco-genetico.html]]></loc><lastmod>2024-06-11T19:36:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-osimertinibe-no-cpcnp-irressecavel-estagio-iii-egfrm.html]]></loc><lastmod>2024-06-11T17:56:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ressonancia-magnetica-e-sobrevida-no-adenocarcinoma-ductal-pancreatico.html]]></loc><lastmod>2024-06-10T20:45:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-de-predicao-de-risco-de-cancer-de-cabeca-e-pescoco-e-validado-na-coorte-do-uk-biobank.html]]></loc><lastmod>2024-06-10T20:35:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-oncogenese-e-implicacoes-terapeuticas.html]]></loc><lastmod>2024-06-10T20:12:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/netter-2-radioligante-mostra-resultados-na-primeira-linha-de-tratamento-de-gep-nets.html]]></loc><lastmod>2024-06-19T17:27:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/watchful-waiting-em-pacientes-com-cancer-de-prostata-nao-metastatico-e-baixa-expectativa-de-vida.html]]></loc><lastmod>2024-06-19T13:58:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/topaz-1-nova-analise-de-sobrevida-global-apoia-durvalumabe-como-padrao-ouro-no-cancer-do-trato-biliar.html]]></loc><lastmod>2024-06-07T21:39:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidores-da-sinalizacao-do-receptor-de-androgenos-no-cancer-de-prostata-e-eventos-cardiovasculares.html]]></loc><lastmod>2024-06-07T21:32:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-de-vida-global-e-risco-de-mortalidade-em-pacientes-com-cancer.html]]></loc><lastmod>2024-06-07T19:51:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fenotipos-de-composicao-corporal-antes-da-qt-e-mortalidade-por-cancer-de-ovario.html]]></loc><lastmod>2024-06-07T20:05:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sarcopenia-e-mortalidade-em-pacientes-com-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-06-07T19:39:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esteatose-hepatica-disfuncao-metabolica-e-risco-de-cancer.html]]></loc><lastmod>2024-06-06T21:01:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/igf-i-livre-circulante-e-risco-de-cancer-de-prostata.html]]></loc><lastmod>2024-06-06T21:06:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/falta-de-educacao-em-saude-limita-a-adocao-de-biossimilares-em-oncologia-nos-eua.html]]></loc><lastmod>2024-06-06T19:16:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-de-sobrevida-global-mostra-beneficio-de-durvalumabe-pos-qrt-no-cpcnp-irressecavel.html]]></loc><lastmod>2024-06-05T17:18:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncotrust-1-pesquisa-global-explora-conflitos-de-interesse-na-oncologia.html]]></loc><lastmod>2024-06-05T17:11:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-aumento-de-sobrevida-no-cancer-gastrico-em-uma-coorte-brasileira.html]]></loc><lastmod>2024-06-05T16:56:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ministerio-da-saude-e-inca-promovem-campanha-de-prevencao-ao-uso-de-cigarros-eletronicos.html]]></loc><lastmod>2024-05-30T16:05:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guia-propoe-recomendacoes-para-a-pesquisa-de-patologia-tumoral-baseada-em-evidencias-2.html]]></loc><lastmod>2024-06-04T15:06:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-relacionados-a-doenca-de-alzheimer-e-declinio-cognitivo-relacionado-ao-cancer.html]]></loc><lastmod>2024-05-30T16:00:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pronto-socorro-e-diagnostico-de-cancer-em-idosos.html]]></loc><lastmod>2024-05-30T15:56:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/himalaya-pros-de-tremelimumabe-mais-durvalumabe-no-carcinoma-hepatocelular-irressecavel.html]]></loc><lastmod>2024-05-29T21:56:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/barreiras-ao-rastreamento-do-cancer-do-colo-do-utero-em-sete-paises-europeus-2.html]]></loc><lastmod>2024-06-03T13:10:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desdiferenciacao-sarcomatoide-no-carcinoma-de-celulas-claras-de-rim.html]]></loc><lastmod>2024-05-28T19:31:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-mostra-que-rastreamento-do-cap-baseado-em-risco-e-mri-e-custo-efetivo-no-contexto-europeu.html]]></loc><lastmod>2024-05-28T17:59:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/astro-atualiza-diretrizes-de-radioterapia-paliativa-para-metastases-osseas-sintomaticas.html]]></loc><lastmod>2024-05-27T22:14:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fits-via-correio-aumentam-o-rastreamento-do-cancer-colorretal-nos-eua-entre-minorias-e-populacoes-de-baixa-renda.html]]></loc><lastmod>2024-05-27T19:44:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gerenciando-desafios-de-saude-sexual-em-sobreviventes-do-cancer-de-mama.html]]></loc><lastmod>2024-05-27T19:36:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-e-insights-sobre-cuidados-paliativos-em-oncologia.html]]></loc><lastmod>2024-05-27T19:37:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-cigarro-eletronico-na-inglaterra-tem-crescimento-acentuado-entre-jovens.html]]></loc><lastmod>2024-05-25T01:13:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/escore-prognostico-de-glasgow-modificado-como-biomarcador-de-sg-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2024-05-25T01:04:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/determinantes-sociais-da-saude-na-eliminacao-do-cancer-do-colo-do-utero.html]]></loc><lastmod>2024-05-25T00:57:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atencao-primaria-entre-sobreviventes-de-cancer-5-a-7-anos-apos-o-diagnostico.html]]></loc><lastmod>2024-05-24T22:09:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intervencoes-para-insonia-em-pacientes-e-sobreviventes-de-cancer.html]]></loc><lastmod>2024-05-24T22:02:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/seguranca-de-intervalos-mais-longos-do-teste-de-hpv-para-cancer-cervical.html]]></loc><lastmod>2024-05-24T21:52:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/manejo-ideal-da-pneumonite-por-radiacao.html]]></loc><lastmod>2024-05-23T14:47:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-simulacao-nao-mostra-risco-aumentado-de-glioma-em-usuarios-de-telefone-celular.html]]></loc><lastmod>2024-05-22T22:46:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-bariatrica-e-reducao-do-risco-de-cancer-de-mama.html]]></loc><lastmod>2024-05-22T18:30:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/right-choice-resultados-finais-confirmam-eficacia-de-ribociclibe-mais-terapia-endocrina.html]]></loc><lastmod>2024-05-22T16:12:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desdiferenciacao-sarcomatoide-e-preditor-de-mortalidade-no-cancer-renal-de-celulas-claras.html]]></loc><lastmod>2024-05-28T19:40:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neocombi-atualiza-resultados-de-5-anos-de-dabrafenibe-trametinibe-neoadjuvante-no-melanoma.html]]></loc><lastmod>2024-05-21T20:48:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analises-exploratoria-de-biomarcadores-em-pacientes-do-estudo-destiny-gastric01.html]]></loc><lastmod>2024-05-21T21:42:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diabetes-e-risco-de-cancer-em-idosas-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2024-05-21T20:22:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/crise-visceral-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2024-05-22T12:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/projeto-de-consenso-dos-consorcios-idea-e-accent-padroniza-dados-para-pesquisa-no-cancer-de-colon.html]]></loc><lastmod>2024-05-21T12:31:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mulheres-recebem-menos-qt-e-tem-pior-sobrevida-que-homens-no-cancer-de-pancreas.html]]></loc><lastmod>2024-05-21T12:17:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/saude-mental-em-pacientes-com-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-05-20T19:27:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-sistemico-no-fim-de-vida-nao-melhora-a-sobrevida-em-pacientes-com-cancer-avancado.html]]></loc><lastmod>2024-05-20T16:44:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-de-tratamento-da-fadiga-em-adultos-sobreviventes-de-cancer.html]]></loc><lastmod>2024-05-26T16:42:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sabr-no-cancer-oligometastatico.html]]></loc><lastmod>2024-05-20T17:02:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/barreiras-ao-rastreamento-do-cancer-do-colo-do-utero-em-sete-paises-europeus.html]]></loc><lastmod>2024-05-20T13:20:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-pode-acelerar-declinio-funcional-em-idosas-com-cancer-de-mama-inicial.html]]></loc><lastmod>2024-05-20T13:08:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bioengenharia-e-inteligencia-artificial-no-diagnostico-do-cancer-de-pulmao-inicial.html]]></loc><lastmod>2024-05-20T13:00:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/experiencia-suica-analisa-projeto-orbis-e-acesso-a-medicamentos-contra-o-cancer.html]]></loc><lastmod>2024-05-20T12:33:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-demonstra-associacao-entre-uso-de-talco-genital-e-aumento-do-risco-de-cancer-de-ovario.html]]></loc><lastmod>2024-05-17T19:49:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/train-3-duração-da-qt-neoadjuvante-no-câncer-de-mama-her2-guiada-por-ressonância-magnética-2.html]]></loc><lastmod>2024-05-16T23:58:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sedentarismo-aumenta-risco-de-avc-isquemico-em-sobreviventes-de-cancer.html]]></loc><lastmod>2024-05-16T05:00:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/benchmark-para-cirurgia-de-exenteração-pelvica-no-cancer-retal.html]]></loc><lastmod>2024-05-16T04:57:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variantes-germinativas-com-alongamento-de-telomeros-predispoem-ao-cancer-papilar-de-tireoide.html]]></loc><lastmod>2024-05-16T04:58:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-agrupada-e-perfil-genomico-do-adenocarcinoma-do-intestino-delgado.html]]></loc><lastmod>2024-05-16T04:59:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-para-o-rastreamento-do-cancer-anal-em-grupos-de-alto-risco.html]]></loc><lastmod>2024-05-24T22:49:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/maioria-das-aprovações-da-fda-para-tratamento-do-câncer-não-mostra-benefício-de-sobrevida.html]]></loc><lastmod>2024-05-15T20:04:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inteligência-artificial-e-resultados-de-saúde-mental-em-pacientes-com-câncer.html]]></loc><lastmod>2024-05-15T18:16:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-funcionais-físicos-e-cognitivos-em-sobreviventes-de-câncer-tratados-com-quimioterapia.html]]></loc><lastmod>2024-05-15T17:42:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relatório-da-aacr-discute-disparidades-do-câncer.html]]></loc><lastmod>2024-05-16T00:57:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/parcer-lições-importantes-para-a-gestão-do-câncer-do-colo-do-útero.html]]></loc><lastmod>2024-05-14T20:37:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/função-pulmonar-prejudicada-e-risco-de-câncer-de-pulmão.html]]></loc><lastmod>2024-05-15T12:20:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acupuntura-para-xerostomia-crônica-induzida-por-radiação-no-câncer-de-cabeça-e-pescoço.html]]></loc><lastmod>2024-05-15T12:23:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inteligência-artificial-como-ferramenta-de-apoio-à-gestão-de-cuidados-de-saúde.html]]></loc><lastmod>2024-05-14T12:20:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-doença-cardiovascular-em-longo-prazo-em-sobreviventes-de-câncer-de-mama.html]]></loc><lastmod>2024-05-14T12:23:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/síndrome-metabólica-e-câncer-de-mama-na-pós-menopausa.html]]></loc><lastmod>2024-05-14T12:25:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-apresentação-distinta-do-melanoma-em-pacientes-negros.html]]></loc><lastmod>2024-05-14T12:27:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-preexistente-de-diabetes-e-câncer-de-mama-em-mulheres-de-baixa-renda.html]]></loc><lastmod>2024-05-14T12:29:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-primeira-vacina-terapêutica-de-mrna-contra-o-câncer-relacionado-ao-vírus-epstein-barr.html]]></loc><lastmod>2024-05-14T12:30:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/venetoclax-e-agentes-hipometilantes-em-octo-e-nonagenários-com-leucemia-mieloide-aguda.html]]></loc><lastmod>2024-05-13T21:17:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inclusão-equitativa-de-diversas-populações-em-ensaios-clínicos-oncológicos.html]]></loc><lastmod>2024-05-13T21:21:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dietas-à-base-de-plantas-e-progressão-da-doença-em-homens-com-câncer-de-próstata.html]]></loc><lastmod>2024-05-13T21:28:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-preditivo-do-benefício-de-capecitabina-de-manutenção-no-tnbc-em-estágio-inicial.html]]></loc><lastmod>2024-05-13T21:59:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/topaz-1-pros-de-durvalumabe-no-câncer-do-trato-biliar-avançado.html]]></loc><lastmod>2024-05-13T22:03:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fastoch-viabilidade-de-resultados-relatados-eletronicamente-por-pacientes-idosos-com-câncer.html]]></loc><lastmod>2024-05-13T22:11:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/análise-pan-câncer-integrativa-das-características-moleculares-da-dieta-restritiva-no-microambiente-tumoral.html]]></loc><lastmod>2024-05-13T22:15:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/echo-acalabrutinibe-em-primeira-linha-demonstra-resultados-de-slp-no-linfoma-de-células-do-manto.html]]></loc><lastmod>2024-05-13T22:36:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fenótipos-e-marcadores-bioquímicos-no-câncer-de-mama-pós-menopausa.html]]></loc><lastmod>2024-05-13T22:42:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisão-da-women’s-health-initiative-mostra-efeito-da-reposição-hormonal-com-estrogênio.html]]></loc><lastmod>2024-05-13T22:50:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sistema-de-notificação-de-citopatologia-pancreaticobiliar.html]]></loc><lastmod>2024-05-13T23:00:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimiorradioterapia-definitiva-no-carcinoma-espinocelular-de-esôfago-localmente-avançado.html]]></loc><lastmod>2024-05-13T23:05:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacinas-terapêuticas-para-pacientes-com-nic-de-alto-grau-associada-ao-hpv.html]]></loc><lastmod>2024-05-13T23:09:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iarc-realiza-estudo-prospectivo-sobre-tatuagens-e-câncer.html]]></loc><lastmod>2024-05-13T23:13:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nutrição-enteral-baseada-no-índice-nutricional-prognóstico-em-pacientes-cirúrgicos-com-neoplasias-orais.html]]></loc><lastmod>2024-05-13T23:16:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/linfadenectomia-hilar-esplênica-laparoscópica-com-preservação-do-baço-no-câncer-gástrico-proximal-avançado-ressecável.html]]></loc><lastmod>2024-05-15T12:33:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aconselhamento-nutricional-contínuo-e-qualidade-de-vida-de-pacientes-submetidos-à-gastrectomia.html]]></loc><lastmod>2024-05-13T23:22:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisão-sistemática-e-meta-análise-enfoca-dados-de-segurança-de-trastuzumabe-deruxtecana.html]]></loc><lastmod>2024-05-13T23:26:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/função-erétil-e-radioterapia-de-resgate-na-recorrência-bioquímica-do-câncer-de-próstata.html]]></loc><lastmod>2024-05-14T00:22:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-adição-de-durvalumabe-à-qt-no-tratamento-de-primeira-linha-do-câncer-de-endométrio.html]]></loc><lastmod>2024-05-14T00:27:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eficácia-e-segurança-do-cemiplimabe-no-câncer-de-pele-não-melanoma.html]]></loc><lastmod>2024-05-14T00:29:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-biomarcador-diagnóstico-e-prognóstico-em-pacientes-com-massas-renais-suspeitas.html]]></loc><lastmod>2024-05-14T00:31:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/primer-doença-residual-mínima-e-valor-prognóstico-no-mieloma-múltiplo.html]]></loc><lastmod>2024-05-14T00:34:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/escalas-de-avaliação-da-função-física-na-reabilitação-do-linfedema-de-membros-superiores.html]]></loc><lastmod>2024-05-14T00:43:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/train-3-duração-da-qt-neoadjuvante-no-câncer-de-mama-her2-guiada-por-ressonância-magnética.html]]></loc><lastmod>2024-05-14T00:47:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/implicações-da-gravidez-na-ncm-do-pâncreas.html]]></loc><lastmod>2024-05-14T00:50:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atualizações-críticas-em-tumores-neuroendócrinos-9ª-edição-do-ajcc.html]]></loc><lastmod>2024-05-14T01:05:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-clínico-patológico-e-resposta-à-qt-neo-no-carcinoma-lobular-invasivo-da-mama.html]]></loc><lastmod>2024-05-14T01:10:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-de-vida-em-longo-prazo-de-sobreviventes-de-cancer-de-testiculo.html]]></loc><lastmod>2024-05-26T17:32:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-propoe-intervalo-mais-longo-apos-a-primeira-colonoscopia-com-resultados-negativos-para-cancer-colorretal.html]]></loc><lastmod>2024-05-14T13:18:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-de-cuidados-no-cancer-metastatico.html]]></loc><lastmod>2024-05-14T13:21:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sedentarismo-e-resultados-no-cancer-colorretal.html]]></loc><lastmod>2024-05-14T13:30:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cenario-do-cancer-de-boca-e-orofaringe-no-brasil-mostra-vazios-na-assistencia.html]]></loc><lastmod>2024-05-14T13:33:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-dos-ensaios-portec-mostra-impacto-da-idade-no-cancer-de-endometrio.html]]></loc><lastmod>2024-05-14T13:34:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-multigenico-e-valor-prognostico-no-cancer-de-mama.html]]></loc><lastmod>2024-05-14T13:37:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/influencia-da-terapia-pos-progressao-nas-estimativas-de-sg-em-estudos-de-fase-3.html]]></loc><lastmod>2024-05-14T13:40:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fowarc-estudo-analisa-rt-pre-operatoria-no-larc-de-inicio-precoce.html]]></loc><lastmod>2024-05-14T13:44:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/integracao-de-cuidados-paliativos-e-intensidade-de-cuidados-de-fim-de-vida-no-cpcnp.html]]></loc><lastmod>2024-05-15T13:04:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-136-supostos-genes-de-suscetibilidade-e-56-potenciais-genes-alvo-associados-ao-cancer-colorretal-sp-999.html]]></loc><lastmod>2024-05-15T12:38:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-conjugado-para-o-tratamento-do-cancer-cervical-metastatico.html]]></loc><lastmod>2024-05-14T13:57:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adt-e-radioterapia-na-oligorrecorrencia-nodal-do-cancer-de-prostata.html]]></loc><lastmod>2024-05-14T14:07:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/solidao-e-risco-de-morte-em-sobreviventes-de-cancer.html]]></loc><lastmod>2024-05-14T14:09:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/triagem-e-tratamento-para-cessacao-de-tabagismo-entre-pacientes-oncologicos-por-raca-e-etnia-sp-148.html]]></loc><lastmod>2024-05-14T14:15:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-baseado-em-inteligencia-artificial-mostra-valor-preditivo-no-cancer-de-mama.html]]></loc><lastmod>2024-05-14T14:18:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imc-elevado-e-resultados-de-sobrevida-em-tumores-ginecologicos.html]]></loc><lastmod>2024-05-14T14:20:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-identifica-50-novas-regioes-genomicas-associadas-ao-risco-de-cancer-renal-sp-219.html]]></loc><lastmod>2024-05-14T14:23:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dieta-e-medicamentos-no-risco-do-cancer-de-bexiga.html]]></loc><lastmod>2024-05-14T14:28:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fundacao-oncocentro-de-sao-paulo-completa-50-anos-sp-754.html]]></loc><lastmod>2024-05-14T14:30:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-prognosticos-e-preditivos-de-resposta-a-enzalutamida-em-homens-em-vigilancia-para-o-cancer-de-prostata.html]]></loc><lastmod>2024-05-14T14:34:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imrt-hipofracionada-no-cancer-cervical.html]]></loc><lastmod>2024-05-15T12:42:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/integracao-da-terapia-car-t-e-transplante-alogenico-melhora-o-controle-tumoral-sp-798.html]]></loc><lastmod>2024-05-15T12:46:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/genevieve-cabazitaxel-versus-paclitaxel-na-neoadjuvancia-do-cancer-de-mama.html]]></loc><lastmod>2024-05-14T14:48:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comissao-europeia-aprova-enzalutamida-no-cancer-de-prostata-com-recorrencia-bioquimica-de-alto-risco-sp-308.html]]></loc><lastmod>2024-05-14T14:52:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/arrependimento-com-as-escolhas-de-tratamento-no-cancer-de-prostata.html]]></loc><lastmod>2024-05-14T15:07:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-colorretal-em-sergipe-tem-tendencias-crescentes-de-mortalidade-sp-493.html]]></loc><lastmod>2024-05-14T15:10:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-analisa-impacto-de-fatores-climaticos-em-33-tipos-de-cancer-em-37-paises.html]]></loc><lastmod>2024-05-14T15:15:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adcs-pesquisadores-apostam-na-cooperacao-para-acelerar-o-progresso.html]]></loc><lastmod>2024-05-14T15:19:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/immunoreact-7-uso-regular-de-aspirina-e-ativacao-da-vigilancia-imunologica-no-cancer-colorretal.html]]></loc><lastmod>2024-05-14T15:25:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dieta-saudavel-reduz-risco-de-doencas-cardiovasculares-em-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2024-05-14T15:28:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carga-global-do-cancer-uterino-de-1990-a-2019-sp-508.html]]></loc><lastmod>2024-05-14T15:31:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iarc-mostra-barreiras-ao-rastreamento-do-cancer-na-america-latina-e-caribe-sp-492.html]]></loc><lastmod>2024-05-14T15:36:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacientes-de-cancer-apresentam-maior-risco-de-morte-por-covid-19.html]]></loc><lastmod>2024-05-14T19:21:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-adnex-no-diagnostico-de-cancer-de-ovario.html]]></loc><lastmod>2024-05-14T20:15:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mortalidade-por-cancer-de-figado-cresce-em-todas-as-regioes-brasileiras.html]]></loc><lastmod>2024-05-14T20:17:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disparidades-etnicas-nos-padroes-de-cancer-de-mama-no-brasil.html]]></loc><lastmod>2024-05-14T20:36:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-confirma-eficacia-de-durvalumabe-apos-qrt-no-cpcnp-estagio-iii-irressecavel-sp-284.html]]></loc><lastmod>2024-05-14T20:38:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adesao-as-diretrizes-de-nutricao-e-atividade-fisica-da-american-cancer-society-entre-sobreviventes.html]]></loc><lastmod>2024-05-14T20:41:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/toxicidade-financeira-em-pacientes-jovens-com-cancer-de-mama-sp-647.html]]></loc><lastmod>2024-05-14T20:43:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-relatados-pelo-paciente-como-estrategia-de-recrutamento-para-ensaios-clinicos.html]]></loc><lastmod>2024-05-14T20:47:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tendencias-e-preditores-de-qualidade-de-vida-em-sobreviventes-de-cancer-de-pulmao.html]]></loc><lastmod>2024-05-14T20:50:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neoplasias-neuroendocrinas-gastricas.html]]></loc><lastmod>2024-05-14T20:52:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/precede-consorcio-global-refina-vigilancia-para-individuos-de-alto-risco-de-cancer-pancreatico-sp-173.html]]></loc><lastmod>2024-05-14T20:59:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-agrupada-avalia-subnotificacao-de-sintomas-subjetivos-e-seu-valor-prognostico.html]]></loc><lastmod>2024-05-14T21:02:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diferencas-nos-objetivos-dos-cuidados-de-fim-de-vida-entre-pacientes-e-cuidadores.html]]></loc><lastmod>2024-05-14T21:08:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/testes-geneticos-germinativos-permanecem-subutilizados-no-cancer-pancreatico.html]]></loc><lastmod>2024-05-14T21:12:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/regulacao-positiva-dos-genes-shelterin-e-cst-e-associada-a-pior-prognostico-no-cancer-de-prostata.html]]></loc><lastmod>2024-05-14T21:19:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brasileeira-estudo-de-mundo-real-corrobora-beneficio-de-ribociclibe-no-cancer-de-mama.html]]></loc><lastmod>2024-05-14T21:25:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/triagem-de-psa-e-mortalidade-por-cancer-de-prostata-em-15-anos-analise-secundaria-do-cap-trial-sp-716.html]]></loc><lastmod>2024-05-14T21:31:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iarc-analisa-novas-metricas-para-o-rastreamento-do-cancer.html]]></loc><lastmod>2024-05-14T21:36:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carga-global-da-mortalidade-por-cancer-de-bexiga-em-2020-e-estimativas-para-2040-sp-659.html]]></loc><lastmod>2024-05-14T21:42:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/realidade-virtual-para-manejo-da-dor-em-pacientes-hospitalizados-com-cancer.html]]></loc><lastmod>2024-05-14T21:46:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/deficiencia-de-vitamina-b12-apos-gastrectomia-total-para-cancer-gastrico.html]]></loc><lastmod>2024-05-14T21:52:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adicao-de-olaparibe-a-terapia-de-manutencao-no-cancer-de-ovario-brca-like-sp-179.html]]></loc><lastmod>2024-05-14T22:39:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reunioes-multidisciplinares-e-sobrevida-global-de-pacientes-com-cancer.html]]></loc><lastmod>2024-05-14T22:41:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-de-urina-pode-ser-alternativa-a-cistoscopia-em-pacientes-com-alto-risco-de-recorrencia-do-cancer-de-bexiga-sp-438.html]]></loc><lastmod>2024-05-14T22:45:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/topaz-1-mostra-resultados-historicos-de-sg-com-durvalumabe-no-cancer-do-trato-biliar-avancado.html]]></loc><lastmod>2024-05-14T22:47:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tenec-trial-sugere-viabilidade-de-temozolomida-intermitente-em-tumores-neuroendocrinos-avancados.html]]></loc><lastmod>2024-05-14T22:53:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/segundo-cancer-de-mama-primario-em-jovens-sobreviventes-de-cancer-de-mama-sp-577.html]]></loc><lastmod>2024-05-16T23:35:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-mostra-que-intervalo-de-5-anos-e-seguro-para-rastreamento-do-cancer-de-prostata.html]]></loc><lastmod>2024-05-14T23:14:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-de-enzalutamida-e-177-lu-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2024-05-14T23:16:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sociedades-medicas-atualizam-recomendacoes-para-cancer-de-prostata-clinicamente-localizado-sp-558.html]]></loc><lastmod>2024-05-14T23:28:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gemcitabina-com-cisplatina-e-imrt-melhora-os-resultados-no-cancer-vulvar-localmente-avancado.html]]></loc><lastmod>2024-05-16T23:40:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comissao-alerta-para-carga-global-do-cancer-de-prostata-em-2040-e-propoe-medidas-urgentes-sp-964.html]]></loc><lastmod>2024-05-14T23:40:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-de-oncoproteinas-na-triagem-do-cancer-do-colo-do-utero-em-paises-de-baixa-e-media-renda.html]]></loc><lastmod>2024-05-16T23:49:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/localizacao-primaria-do-tumor-do-colon-transverso-como-biomarcador-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2024-05-16T23:53:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iarc-analisa-mais-de-200-agentes-com-potencial-de-carcinogenicidade-sp-131.html]]></loc><lastmod>2024-05-16T23:56:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dieta-pobre-em-carboidratos-e-risco-de-carcinoma-hepatocelular.html]]></loc><lastmod>2024-05-16T23:48:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inteligencia-artificial-na-vigilancia-do-cancer-de-pancreas.html]]></loc><lastmod>2024-05-16T23:58:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/representatividade-global-fontes-de-financiamento-e-investigacao-custo-efetividade-no-cancer-de-avancado.html]]></loc><lastmod>2024-05-17T00:02:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fenotipos-e-marcadores-bioquimicos-no-cancer-de-mama-pos-menopausa-uma-analise-do-uk-biobank.html]]></loc><lastmod>2024-05-17T00:04:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/linfadenectomia-pelvica-padrao-ou-estendida-na-cistectomia-radical.html]]></loc><lastmod>2024-05-14T23:09:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/padroes-de-expressao-do-receptor-hormonal-afetam-resultados-no-cancer-de-mama-her2.html]]></loc><lastmod>2024-05-17T00:09:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sul-coreano-valida-o-descritor-n-proposto-pela-9-edicao-do-sistema-tnm.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudos-abrem-caminhos-para-car-t-cells-em-tumores-solidos-sp-735.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncologia-de-precisao-estudo-questiona-beneficio-clinico.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacientes-latino-americanos-ainda-sao-sub-representados-na-pesquisa-em-cancer-do-pulmao.html]]></loc><lastmod>2024-04-11T16:50:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ici-folfiri-combinacao-mostra-atividade-antitumoral-no-cancer-gastrico-avancado-sp-663.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tnt-mostra-resultados-semelhantes-ao-tratamento-padrao-no-cancer-retal-localmente-avancado.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/optical-qt-neo-versus-cirurgia-inicial-no-cancer-de-colon-localmente-avancado-sp-781.html]]></loc><lastmod>2024-04-11T15:48:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-cognitivo-comportamental-virtual-para-insonia-e-comprometimento-cognitivo-em-sobreviventes-de-cancer.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radicals-rt-avalia-radioterapia-apos-prostatectomia-radical.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-toxicidade-e-sobrevida-em-pacientes-tratados-com-inibidores-de-checkpoint.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/globocan-2022-incidencia-e-mortalidade-para-36-tipos-de-cancer-em-185-paises.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adriatic-durvalumabe-mostra-beneficio-de-sobrevida-no-cpcp-com-doenca-limitada.html]]></loc><lastmod>2024-04-06T14:30:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-e-dispositivo-vestivel-como-complemento-ao-ecog-ps-no-cancer-de-pulmao-avancado.html]]></loc><lastmod>2024-04-04T18:46:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dora-olaparibe-durvalumabe-como-manutencao-sem-qt-no-cancer-de-mama-triplo-negativo-avancado.html]]></loc><lastmod>2024-04-04T14:44:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-mostra-eficacia-e-seguranca-de-cemiplimabe-no-cancer-cervical-avancado.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-propoe-novo-criterio-de-elegibilidade-para-triagem-do-cancer-de-pulmao-sp-469.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ctdna-e-recorrencia-em-pacientes-com-cancer-de-mama-ressecavel.html]]></loc><lastmod>2024-04-03T20:51:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/calgb-40601-neoaltto-e-nsabp-b-41-subtipos-e-resultados-de-sobrevida-no-cancer-de-mama.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-europeu-enfoca-impacto-financeiro-do-cancer-para-pacientes-e-familiares-sp-305.html]]></loc><lastmod>2024-04-03T12:45:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-internacional-define-dados-essenciais-para-a-pesquisa-clinica-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/valor-prognostico-do-numero-de-linfonodos-examinados-em-pacientes-com-cancer-ampular.html]]></loc><lastmod>2024-04-04T19:54:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-populacional-mostra-associacao-entre-tuberculose-e-risco-de-cancer.html]]></loc><lastmod>2024-04-02T19:45:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/negligencia-medica-na-vigilancia-ativa.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aceita-pedido-de-licenca-biologica-de-dato-dxd-no-cancer-de-mama-metastatico-hr-her2.html]]></loc><lastmod>2024-04-02T19:09:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-de-fim-de-vida-e-caminhos-para-a-assistencia-oncologica-centrada-no-paciente.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-de-idosos-com-leucemia-mieloide-aguda-apos-o-transplante-de-celulas-tronco.html]]></loc><lastmod>2024-04-21T16:38:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/machine-learning-pode-otimizar-encaminhamento-para-cuidados-paliativos-precoces-sp-377.html]]></loc><lastmod>2024-03-28T18:23:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disparidades-no-tratamento-do-cancer-em-pessoas-com-hiv-nos-eua.html]]></loc><lastmod>2024-05-03T14:27:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-confirma-aumento-da-incidencia-de-cancer-de-inicio-precoce-sp-263.html]]></loc><lastmod>2024-03-28T14:15:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/poluicao-e-associada-a-incidencia-e-mortalidade-por-cancer.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/zolbetuximab-e-aprovado-no-japao-para-o-tratamento-do-cancer-gastrico.html]]></loc><lastmod>2024-03-27T17:05:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/osimertinibe-mais-tratamento-local-para-metastases-cerebrais-no-cpcnp-com-mutacao-de-egfr-sp-745.html]]></loc><lastmod>2024-03-27T15:34:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gene-do-cancer-colorretal-implicado-em-ampla-gama-de-tumores-solidos.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/escore-prognostico-no-linfoma-de-hodgkin-com-predominancia-de-linfocitos-nodulares.html]]></loc><lastmod>2024-03-27T14:15:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/significancia-clinica-epidemiologica-e-patologica-da-expressao-erbb2-low-no-cancer-de-mama-sp-431.html]]></loc><lastmod>2024-04-24T18:48:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-tem-assinaturas-distintas-por-raca-etnia-e-idade-no-cancer-retal.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-descobre-como-atingir-celulas-de-cancer-de-mama-adormecidas-e-prevenir-recaidas.html]]></loc><lastmod>2024-05-03T14:27:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-enfatiza-necessidade-de-equidade-global-em-ensaios-clinicos-de-cancer.html]]></loc><lastmod>2024-04-13T15:22:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/programa-de-estilo-de-vida-multimodal-em-jovens-sobreviventes-de-cancer.html]]></loc><lastmod>2024-03-25T19:22:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ema-da-parecer-positivo-a-enzalutamida-no-cancer-de-prostata-com-recorrencia-bioquimica-de-alto-risco.html]]></loc><lastmod>2024-03-25T17:03:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-gravidez-no-prognostico-do-cancer-de-mama.html]]></loc><lastmod>2024-04-01T20:02:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/swog-s1216-biomarcadores-osseos-e-sg-no-cancer-de-prostata-avancado.html]]></loc><lastmod>2024-03-25T14:52:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vigilancia-por-ressonancia-magnetica-e-mortalidade-por-cancer-de-mama-brca1-2.html]]></loc><lastmod>2024-03-25T15:30:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/raca-composicao-corporal-e-sobrevida-em-idosos-com-tumores-gastrointestinais.html]]></loc><lastmod>2024-03-22T19:06:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-aponta-caminho-para-imunoterapia-no-cancer-de-prostata.html]]></loc><lastmod>2024-03-22T15:14:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/colonialismo-e-epidemiologia-do-cancer-de-cabeca-e-pescoco-no-brasil.html]]></loc><lastmod>2024-03-21T19:08:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-dimensiona-pagamentos-da-industria-farmaceutica-a-oncologistas-na-holanda.html]]></loc><lastmod>2024-03-21T16:27:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/expressao-de-her2-e-preditiva-e-prognostica-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2024-04-01T20:15:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estuda-mostra-diferencas-no-uso-e-frequencia-de-radioterapia-em-8-tipos-de-cancer.html]]></loc><lastmod>2024-04-09T00:48:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cannabis-e-canabinoides-em-adultos-com-cancer.html]]></loc><lastmod>2024-03-20T20:54:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-crescimento-de-tratamento-anticancer-agressivo-nas-ultimas-2-semanas-de-vida.html]]></loc><lastmod>2024-03-19T23:26:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-explora-ligacao-genetica-entre-cancer-colorretal-e-consumo-de-carne.html]]></loc><lastmod>2024-03-19T16:21:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-ao-cancer-de-pancreas-aumenta-em-20-anos.html]]></loc><lastmod>2024-03-19T12:32:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/expressao-vista-e-imunoterapia-de-precisao.html]]></loc><lastmod>2024-03-19T12:21:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gempax-gemcitabina-e-paclitaxel-em-segunda-linda-no-cancer-de-pancreas-metastatico.html]]></loc><lastmod>2024-03-24T22:53:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/subnotificacao-de-sintomas-e-seu-valor-prognostico.html]]></loc><lastmod>2024-03-18T15:32:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tabagismo-pre-tratamento-e-sobrevida-apos-qrt-no-cpcnp-localmente-avancado.html]]></loc><lastmod>2024-03-18T13:54:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-reune-recomendacoes-para-atrair-pacientes-para-a-pesquisa-em-cancer.html]]></loc><lastmod>2024-03-24T22:18:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-celular-com-car-t-bivalente-e-nova-promessa-no-glioblastoma-recorrente.html]]></loc><lastmod>2024-03-18T12:08:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-tislelizumab-no-cancer-de-esofago.html]]></loc><lastmod>2024-03-15T19:17:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/solidao-ameaca-a-saude-e-impacta-resultados-de-fim-de-vida.html]]></loc><lastmod>2024-03-15T18:11:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/evolucao-epigenetica-do-glioma-mutacao-idh1-e-regime-de-tratamento.html]]></loc><lastmod>2024-03-15T16:32:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dieta-para-reducao-do-risco-de-diabetes-e-cancer-colorretal.html]]></loc><lastmod>2024-03-14T19:02:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/apoio-psicossocial-ainda-nao-e-realidade-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2024-03-14T16:34:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobreviventes-do-cancer-de-prostata-e-qualidade-de-vida.html]]></loc><lastmod>2024-03-14T15:59:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-adaptada-em-pacientes-com-cancer-de-pancreas-avancado.html]]></loc><lastmod>2024-03-13T14:54:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-amivantamabe-como-primeira-linha-no-cpcnp.html]]></loc><lastmod>2024-03-13T16:09:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/euro-ski-analise-final-confirma-viabilidade-da-interrupcao-de-tkis-na-lmc.html]]></loc><lastmod>2024-03-15T19:23:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desnutricao-no-carcinoma-hepatocelular-e-fatores-de-risco.html]]></loc><lastmod>2024-04-01T20:11:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assinatura-das-celulas-b-e-prognostico-no-cancer-de-mama-er.html]]></loc><lastmod>2024-03-12T17:36:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/apresentacao-dos-sintomas-e-tempo-para-o-diagnostico-de-cancer.html]]></loc><lastmod>2024-03-12T12:57:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/padroes-de-tratamento-no-mcprc-e-genes-de-reparo-de-recombinacao-homologa.html]]></loc><lastmod>2024-03-20T21:33:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-25-anos-de-cirurgia-no-cancer-gastrico.html]]></loc><lastmod>2024-03-21T18:22:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trajetorias-dos-scores-de-sindrome-metabolica-e-risco-de-cancer.html]]></loc><lastmod>2024-03-11T16:00:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-aprovacao-acelerada-para-zanubrutinibe-no-linfoma-folicular-recidivante-ou-refratario.html]]></loc><lastmod>2024-03-08T19:34:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gengibre-amargo-e-qualidade-de-vida-em-pacientes-com-cancer-avancado.html]]></loc><lastmod>2024-03-08T18:43:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/epigenoma-e-heterogeneidade-etnica-de-morbidades-relacionadas-ao-tabagismo.html]]></loc><lastmod>2024-03-14T23:57:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mortalidade-por-cancer-de-penis-no-brasil.html]]></loc><lastmod>2024-03-08T20:28:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/clover-durvalumabe-e-quimiorradioterapia-no-cpcnp-estagio-iii-irressecavel.html]]></loc><lastmod>2024-03-08T14:39:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dieta-baseada-em-vegetais-e-qualidade-de-vida-em-sobreviventes-de-cancer-de-prostata.html]]></loc><lastmod>2024-03-08T12:15:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-paliativos-e-economia-de-custos-na-hospitalizacao-por-cancer-metastatico.html]]></loc><lastmod>2024-03-15T18:22:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acuracia-da-biopsia-do-linfonodo-sentinela-no-cancer-de-mama-masculino.html]]></loc><lastmod>2024-03-15T16:49:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ooforectomia-bilateral-reduz-risco-de-morte-por-todas-as-causas-em-mulheres-com-mutacoes-brca1-2.html]]></loc><lastmod>2024-03-13T19:12:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-mortalidade-em-20-anos-em-homens-com-cancer-de-mama-rh-estagio-i-a-iii.html]]></loc><lastmod>2024-03-06T16:02:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disturbios-comportamentais-afetam-os-resultados-do-paciente-de-cancer.html]]></loc><lastmod>2024-03-06T15:58:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reabilitacao-cognitiva-online-para-sobreviventes-de-cancer.html]]></loc><lastmod>2024-03-06T19:03:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-de-cannabis-entre-pacientes-e-sobreviventes-de-cancer-nos-eua.html]]></loc><lastmod>2024-03-05T20:43:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/indice-de-beta-defensina-como-biomarcador-do-cancer-oral.html]]></loc><lastmod>2024-03-05T17:09:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-com-radioligante-marca-avancos-no-tratamento-de-tumores-neuroendocrinos.html]]></loc><lastmod>2024-03-05T16:56:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/indice-de-massa-corporal-alteracao-de-peso-e-prognostico-de-cancer.html]]></loc><lastmod>2024-03-05T14:59:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-novo-combo-no-cpcnp.html]]></loc><lastmod>2024-03-04T18:58:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ema-avalia-datopotamabe-deruxtecana-no-cpcnp-avancado-e-no-cancer-de-mama-hr-her2.html]]></loc><lastmod>2024-03-04T18:54:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consulta-publica-e-o-tratamento-do-cancer-de-mama-no-sus.html]]></loc><lastmod>2024-03-04T16:07:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-anticancer-no-fim-de-vida-entre-adolescentes-e-jovens-adultos-com-cancer.html]]></loc><lastmod>2024-03-03T12:41:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-emite-declaracao-sobre-determinantes-sociais-da-saude-e-tratamento-do-cancer.html]]></loc><lastmod>2024-03-02T12:19:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cadonilimab-mostra-resultados-no-tratamento-do-cancer-do-colo-do-utero.html]]></loc><lastmod>2024-02-29T19:36:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-acidente-vascular-cerebral-em-sobreviventes-de-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-02-29T19:30:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fumo-passivo-diminui-eficacia-da-quimioterapia-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-02-29T19:22:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-investiga-ensaios-clinicos-de-car-t-em-tumores-solidos.html]]></loc><lastmod>2024-02-29T15:20:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disestesia-oral-na-assistencia-oncologica.html]]></loc><lastmod>2024-02-28T19:56:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/medo-de-recorrencia-do-cancer-entre-sobreviventes-de-melanoma-cutaneo-localizado.html]]></loc><lastmod>2024-02-28T15:06:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-analisa-sobrevida-prolongada-de-pacientes-com-cancer-em-cuidados-paliativos.html]]></loc><lastmod>2024-03-08T13:16:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-da-dieta-risco-e-sobrevida-no-cancer-de-ovario.html]]></loc><lastmod>2024-02-28T14:29:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-neoadjuvante-melhora-os-resultados-no-colangiocarcinoma-intra-hepatico-avancado.html]]></loc><lastmod>2024-03-01T15:59:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/homens-com-subfertilidade-e-risco-de-cancer-familial.html]]></loc><lastmod>2024-02-27T20:53:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disparidades-etnicas-e-raciais-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2024-02-26T19:38:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-desvenda-novas-evidencias-associadas-ao-cancer-colorretal-de-inicio-precoce.html]]></loc><lastmod>2024-02-26T19:42:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reprogramacao-metabolica-microbiota-e-resultados-em-pacientes-com-melanoma-do-estudo-mind-dc.html]]></loc><lastmod>2024-02-26T17:58:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cursos-de-inducao-reduzidos-de-bcg-no-cancer-de-bexiga-nao-musculo-invasivo-de-alto-risco.html]]></loc><lastmod>2024-02-27T00:45:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/emulsificantes-de-aditivos-alimentares-e-risco-de-cancer.html]]></loc><lastmod>2024-02-26T23:54:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rationale-315-tislelizumabe-mostra-resultados-no-cpcnp-ressecavel.html]]></loc><lastmod>2024-02-25T21:35:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/determinantes-sociais-da-saude-e-qualidade-de-vida-em-pacientes-cirurgicos.html]]></loc><lastmod>2024-02-25T01:13:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/a-revolucao-teranostica-no-cancer-de-prostata.html]]></loc><lastmod>2024-02-23T19:26:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/insights-translacionais-e-sobrevida-global-de-patritumabe-deruxtecana-no-cpcnp-com-mutacao-de-egfr.html]]></loc><lastmod>2024-02-23T11:48:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-seu-paciente-de-cancer-hesita-em-tomar-vacinas.html]]></loc><lastmod>2024-02-22T14:19:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/boost-de-rt-e-toxicidade-cardiaca-no-cancer-de-mama.html]]></loc><lastmod>2024-03-11T00:29:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modificacao-da-dose-de-qt-paliativa-em-idosos-com-cancer.html]]></loc><lastmod>2024-02-23T19:11:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obstrucao-ureteral-associada-ao-cancer-de-ovario.html]]></loc><lastmod>2024-02-23T18:38:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fusao-cognitiva-versus-fusao-por-software-na-deteccao-do-cancer-de-prostata.html]]></loc><lastmod>2024-02-21T21:15:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/evolucao-da-expressao-her2-low-entre-biopsia-pre-tratamento-e-doenca-residual-apos-terapia-neoadjuvante.html]]></loc><lastmod>2024-02-20T21:40:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacientes-com-cancer-metastatico-tiveram-maior-hospitalizacao-e-morte-por-covid-19.html]]></loc><lastmod>2024-02-20T19:44:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-do-gene-cyp2a6-consumo-de-nicotina-e-suscetibilidade-ao-cancer-de-pulmao.html]]></loc><lastmod>2024-02-21T21:39:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-compara-risco-de-fratura-em-20-tipos-de-cancer.html]]></loc><lastmod>2024-02-20T17:46:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/osimertinibe-e-o-primeiro-inibidor-de-egfr-a-mostrar-beneficio-de-slp-no-cpcnp-estagio-iii.html]]></loc><lastmod>2024-02-20T20:04:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/associacao-do-uso-de-metformina-e-estatina-com-o-prognostico-do-cancer-de-colon.html]]></loc><lastmod>2024-02-19T19:12:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-aprovacao-acelerada-para-lifeleucel-no-tratamento-do-melanoma.html]]></loc><lastmod>2024-02-19T16:57:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/elotuzumabe-nao-mostra-beneficio-no-mieloma-multiplo-recem-diagnosticado.html]]></loc><lastmod>2024-02-19T16:47:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-e-dor-em-pacientes-de-cancer.html]]></loc><lastmod>2024-02-16T18:21:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-da-assistencia-oncologica-nos-cuidados-de-fim-de-vida.html]]></loc><lastmod>2024-03-05T21:30:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vigilancia-ativa-e-estilo-de-vida-no-cancer-de-prostata.html]]></loc><lastmod>2024-02-24T22:55:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/causas-e-formas-de-morte-em-pacientes-com-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-02-15T20:40:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-irinotecano-lipossomal-no-cancer-de-pancreas-metastatico.html]]></loc><lastmod>2024-02-15T20:25:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nefrectomia-parcial-no-idoso-com-mrcc.html]]></loc><lastmod>2024-02-15T19:15:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avancos-nos-metodos-estatisticos-para-pesquisa-sobre-vigilancia-do-cancer.html]]></loc><lastmod>2024-02-16T15:44:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/apple-osimertinibe-inicial-vs-abordagem-sequencial-no-cpcnp-avancado-com-mutacao-egfr.html]]></loc><lastmod>2024-02-14T19:26:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/genotipagem-do-hpv-no-rastreio-e-prevencao-do-cancer.html]]></loc><lastmod>2024-02-15T13:34:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/olaparibe-mostra-beneficio-de-sg-e-rslp-no-cancer-de-prostata-brca-mutado.html]]></loc><lastmod>2024-02-09T17:01:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-inflamatorios-e-prognostico-no-cancer-de-mama.html]]></loc><lastmod>2024-02-09T16:55:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-intestinal-e-toxicidades-induzidas-por-quimioterapia-no-cancer-de-mama.html]]></loc><lastmod>2024-02-09T14:32:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/janssen-submete-novo-pedido-a-ema-para-ampliar-indicacao-de-amivantamabe.html]]></loc><lastmod>2024-02-09T20:35:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avancos-no-tratamento-reduzem-risco-de-recorrencia-tardia-do-cancer-colorretal.html]]></loc><lastmod>2024-02-07T15:59:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/suplemento-multivitaminico-pos-diagnostico-e-sobrevida-no-cancer-colorretal.html]]></loc><lastmod>2024-02-07T15:45:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-desvenda-redes-imunologicas-que-estimulam-resposta-a-til-act-no-melanoma.html]]></loc><lastmod>2024-02-07T14:30:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inteligencia-artificial-no-diagnostico-endoscopico.html]]></loc><lastmod>2024-05-09T08:56:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-de-metformina-e-incidencia-de-cancer.html]]></loc><lastmod>2024-02-07T13:31:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-do-bolsa-familia-na-mortalidade-por-cancer-de-mama-no-brasil.html]]></loc><lastmod>2024-02-18T15:18:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-descobertas-sobre-o-cancer-colorretal-de-inicio-precoce.html]]></loc><lastmod>2024-02-06T15:29:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/criterios-aprimorados-para-estadiamento-do-cancer-pancreatico.html]]></loc><lastmod>2024-02-08T21:46:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/osimertinibe-mostra-resultados-superiores-a-durvalumabe-como-consolidacao-no-cpcnp-com-mutacao-egfr.html]]></loc><lastmod>2024-02-06T13:56:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/claudina-18-2-como-novo-biomarcador-no-cancer-gastrico.html]]></loc><lastmod>2024-02-06T13:56:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diabetes-tipo-2-e-progressao-do-cancer-de-figado.html]]></loc><lastmod>2024-02-02T19:52:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ingestao-de-polifenois-e-cancer-gastrico-na-regiao-amazonica.html]]></loc><lastmod>2024-02-14T20:11:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aptidao-cardiorrespiratoria-incidencia-e-mortalidade-por-cancer-de-prostata.html]]></loc><lastmod>2024-02-01T21:04:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/realidade-brasileira-do-carcinoma-hepatocelular.html]]></loc><lastmod>2024-05-04T12:26:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acupuntura-mostra-beneficio-de-qualidade-de-vida-no-cancer-de-mama.html]]></loc><lastmod>2024-02-01T11:27:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perda-de-peso-nao-intencional-e-diagnostico-de-cancer.html]]></loc><lastmod>2024-01-24T20:32:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mirtazapina-como-estimulante-do-apetite-em-pacientes-com-cpcnp-e-anorexia.html]]></loc><lastmod>2024-01-24T20:08:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assinatura-genomica-e-risco-de-recorrencia-no-cancer-de-mama.html]]></loc><lastmod>2024-03-03T21:15:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-resistencia-a-insulina-e-morte-por-cancer-de-prostata.html]]></loc><lastmod>2024-01-24T14:25:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sbrt-mostra-eficacia-e-seguranca-em-metastases-osseas-nao-espinhais.html]]></loc><lastmod>2024-01-23T20:33:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cemiplimabe-mostra-resultados-em-pacientes-transplantados-com-cscc.html]]></loc><lastmod>2024-03-14T19:24:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncotherad-mostra-resultados-no-cancer-de-bexiga-nao-musculo-invasivo-nao-respondente-ao-bcg.html]]></loc><lastmod>2024-01-23T18:38:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pro-mostra-qualidade-de-vida-no-ecog-acrin-ea1131.html]]></loc><lastmod>2024-01-23T16:24:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/transtornos-por-uso-de-substancias-entre-sobreviventes-de-cancer.html]]></loc><lastmod>2024-01-24T19:19:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reexposicao-a-inibidores-braf-mek-no-melanoma-avancado.html]]></loc><lastmod>2024-01-23T16:00:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-investiga-resistencia-adquirida-aos-inibidores-de-checkpoint-no-cpcnp.html]]></loc><lastmod>2024-01-26T14:30:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incidencia-de-seminoma-mais-que-dobrou-na-holanda-em-20-anos.html]]></loc><lastmod>2024-01-22T19:11:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sabcs-2023-e-os-avancos-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2023-12-11T15:10:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disfuncao-sexual-em-mulheres-com-cancer-de-mama-no-nordeste-do-brasil.html]]></loc><lastmod>2023-12-06T02:13:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/concentracao-serica-de-vitamina-d-e-mortalidade-em-pacientes-com-cancer.html]]></loc><lastmod>2023-12-04T22:38:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/profiles-diferencas-socioeconomicas-e-qvrs-em-sobreviventes-de-cancer.html]]></loc><lastmod>2023-12-04T22:26:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/associacao-entre-abstinencia-de-cigarro-e-custos-de-saude-em-pacientes-com-cancer.html]]></loc><lastmod>2023-12-01T18:20:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mamografia-de-rastreamento-regular-reduz-significativamente-mortes-por-cancer-de-mama.html]]></loc><lastmod>2023-12-01T17:11:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-estrategias-para-aumentar-o-rastreamento-do-cancer-do-colo-do-utero.html]]></loc><lastmod>2023-11-30T19:50:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-ultraprocessados-e-risco-de-cancer.html]]></loc><lastmod>2023-11-30T18:49:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sarcopenia-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2023-11-30T18:20:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brotamento-tumoral-e-papel-prognostico-no-carcinoma-espinocelular-oral.html]]></loc><lastmod>2023-11-30T17:19:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/riomeso-dados-de-mundo-real-da-imunoterapia-combinada-no-mesotelioma-pleural.html]]></loc><lastmod>2023-11-30T14:36:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prognostico-e-risco-de-suicidio-apos-diagnostico-de-cancer.html]]></loc><lastmod>2023-11-30T18:23:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avaliacao-multimodal-do-tratamento-neoadjuvante-e-irradiacao-da-cadeia-linfonodal-de-mamaria-interna.html]]></loc><lastmod>2023-11-28T23:14:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/virus-epstein-barr-e-resultados-em-pacientes-com-cancer-gastrico.html]]></loc><lastmod>2023-11-28T19:06:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-avalia-pneumonite-no-cpcnp-em-pacientes-tratados-com-durvalumabe.html]]></loc><lastmod>2023-11-28T19:00:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-o-primeiro-tratamento-sistemico-para-tumores-desmoides.html]]></loc><lastmod>2023-11-28T18:50:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tecidos-moles-axilares-impacto-no-manejo-axilar-e-nos-resultados-do-cancer-de-mama.html]]></loc><lastmod>2023-11-28T18:46:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelos-prognosticos-e-preditivos-baseados-em-resultados-relatados-pelo-paciente-na-pratica-clinica.html]]></loc><lastmod>2023-11-28T19:29:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-molecular-de-pacientes-com-crc-e-diferencas-raciais-na-resposta-ao-tratamento-padrao.html]]></loc><lastmod>2023-11-27T18:51:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cessacao-do-tabagismo-e-risco-de-cancer-de-pancreas-em-individuos-com-pre-diabetes-e-diabetes.html]]></loc><lastmod>2023-11-27T17:37:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/unicorn-osimertinibe-em-primeira-linha-no-cpcnp-com-mutacoes-incomuns-de-egfr.html]]></loc><lastmod>2023-11-27T16:12:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-nao-clinicos-associados-ao-tratamento-de-idosas-com-cdis-de-baixo-grau-recem-diagnosticado.html]]></loc><lastmod>2023-11-27T16:04:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carga-global-da-lma-em-adultos.html]]></loc><lastmod>2023-11-24T15:17:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microscopia-confocal-de-refletancia-no-diagnostico-de-melanoma.html]]></loc><lastmod>2023-11-24T14:57:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prova-de-conceito-mostra-potencial-de-eus-hifu-no-tratamento-do-cancer.html]]></loc><lastmod>2023-11-24T14:50:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-populacional-descreve-o-cancer-do-remanescente-gastrico.html]]></loc><lastmod>2023-11-23T19:31:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cirrose-e-carcinoma-hepatocelular-no-diabetes-tipo-2-e-menor-com-glp-1ras.html]]></loc><lastmod>2023-11-23T19:11:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/erdafitinibe-prolonga-sobrevida-global-no-carcinoma-urotelial-metastatico.html]]></loc><lastmod>2023-11-23T15:03:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-de-risco-para-recorrencia-tardia-apos-5-anos-de-tratamento-adjvante-no-cancer-de-mama-er.html]]></loc><lastmod>2023-11-23T14:51:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/seguranca-e-eficacia-de-durvalumabe-na-primeira-linha-em-pacientes-com-cpcnp-avancado-ps-ecog-2.html]]></loc><lastmod>2023-11-23T14:47:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/proteomica-na-classificacao-de-risco-de-gist.html]]></loc><lastmod>2023-11-23T14:25:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/privacao-socioeconomica-e-cuidados-de-fim-de-vida-em-pacientes-com-cancer.html]]></loc><lastmod>2023-11-23T20:20:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/profound-olaparibe-no-cancer-de-prostata-metastatico-resistente-a-castracao-e-alteracoes-brca1-2.html]]></loc><lastmod>2023-11-22T19:14:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impact-acupuntura-versus-massagem-para-controle-da-dor-em-pacientes-com-cancer-avancado.html]]></loc><lastmod>2023-11-22T17:56:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/scot-fatores-associados-a-neuropatia-periferica-induzida-por-quimioterapia-no-cancer-colorretal.html]]></loc><lastmod>2023-11-22T12:26:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ctdna-na-pratica-clinica.html]]></loc><lastmod>2023-11-22T14:37:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/segundo-cancer-de-pulmao-primario-em-sobreviventes-nao-tabagistas.html]]></loc><lastmod>2023-11-22T17:58:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/telemedicina-planejamento-de-cuidados-avancados-e-hospitalizacoes-nao-planejadas-em-pacientes-de-alto-risco.html]]></loc><lastmod>2023-11-21T20:17:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-recebe-pedido-de-licenca-suplementar-para-amivantamab-no-cpcnp.html]]></loc><lastmod>2023-11-21T19:49:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/amivantamabe-mais-qt-novo-padrao-para-cpcnp-com-mutacao-do-exon-20-do-egfr.html]]></loc><lastmod>2023-11-19T14:04:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gastos-do-cancer-colorretal-atribuiveis-ao-consumo-de-carne-vermelha-e-processada-no-brasil.html]]></loc><lastmod>2023-11-17T21:33:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-capivasertibe-mais-fulvestranto-no-cancer-de-mama-hr-her2.html]]></loc><lastmod>2023-11-20T00:03:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-enzalutamida-no-cancer-de-prostata-com-recorrencia-bioquimica-de-alto-risco.html]]></loc><lastmod>2023-11-18T04:44:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relatorio-da-american-cancer-society-analisa-disparidades-do-cancer-nos-eua.html]]></loc><lastmod>2023-11-17T16:14:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/redistribuicao-de-terapias-orais-melhora-acessibilidade-no-tratamento-do-cancer-indica-estudo-holandes.html]]></loc><lastmod>2023-11-22T10:49:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adultos-sobreviventes-de-cancer-infantil-e-risco-de-cancer-colorretal.html]]></loc><lastmod>2023-11-17T12:30:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/capacidade-de-exercicio-em-pacientes-com-caquexia.html]]></loc><lastmod>2023-11-17T19:23:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/orientacao-clinica-da-asco-para-cenarios-de-escassez-de-medicamentos-antineoplasicos.html]]></loc><lastmod>2023-11-17T18:39:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/testes-imunoquimicos-fecais-insatisfatorios-no-rastreamento-de-cancer-colorretal.html]]></loc><lastmod>2023-11-16T19:35:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diana-5-dieta-e-recorrencia-do-cancer-de-mama.html]]></loc><lastmod>2023-11-16T16:46:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brainstorm-estudo-multicentrico-internacional-investiga-metastases-no-snc-em-tumores-solidos.html]]></loc><lastmod>2023-11-14T17:48:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gastrectomia-redutora-de-risco-e-impacto-na-qualidade-de-vida-2.html]]></loc><lastmod>2023-11-14T17:38:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/distribuicao-global-do-estagio-do-cancer-de-mama-ao-diagnostico.html]]></loc><lastmod>2023-11-14T15:14:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disparidades-raciais-e-diretrizes-de-cuidados-do-cancer-colorretal-de-inicio-precoce-nos-eua.html]]></loc><lastmod>2023-11-14T13:07:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/planejamento-de-cuidados-oncologicos-barreiras-e-limites.html]]></loc><lastmod>2023-11-14T11:27:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/citologia-cervical-e-teste-de-hpv-podem-predizer-recorrencia-da-neoplasia-intraepitelial-cervical.html]]></loc><lastmod>2023-11-17T18:59:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caminhos-para-superar-os-desafios-do-acesso.html]]></loc><lastmod>2023-11-13T21:33:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/abordagem-cirurgica-multiprofissional-no-cancer-de-ovario.html]]></loc><lastmod>2023-11-13T21:14:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/toripalimabe-axitinibe-neoadjuvante-tem-bons-resultados-no-melanoma-de-mucosa.html]]></loc><lastmod>2023-11-13T20:10:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/insuficiencia-de-vitamina-d-e-neuropatia-periferica-induzida-por-paclitaxel.html]]></loc><lastmod>2023-11-13T18:52:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-papel-do-brasil-na-formacao-de-oncologistas-angolanos.html]]></loc><lastmod>2023-11-12T17:56:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incisao-inframamaria-versus-periareolar-complicacoes-precoces-na-mastectomia-preservadora-de-mamilo.html]]></loc><lastmod>2023-11-10T19:19:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/emerald-1-resultados-de-durvalumabe-bevacizumabe-no-cancer-de-figado-elegivel-para-embolizacao.html]]></loc><lastmod>2023-11-13T21:16:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-em-nodulos-regionais-no-cancer-de-mama-inicial.html]]></loc><lastmod>2023-11-16T17:02:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-molecular-e-tomada-de-decisao-no-carcinoma-de-origem-desconhecida.html]]></loc><lastmod>2023-11-09T18:02:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-global-apos-falha-do-tratamento-em-pacientes-com-cancer-retal-2.html]]></loc><lastmod>2023-11-10T19:55:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-relatados-pelo-paciente-e-predicao-dinamica-do-risco-de-descontinuacao-do-tratamento.html]]></loc><lastmod>2023-11-09T13:35:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/toxicidade-relacionada-a-quimioterapia-qualidade-de-vida-e-funcionamento-fisico-em-pacientes-idosos.html]]></loc><lastmod>2023-11-09T16:04:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-com-estrogenio-vaginal-e-cancer-de-mama-apos-falso-positivo-na-mamografia.html]]></loc><lastmod>2023-11-08T21:43:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-compara-cosmese-e-qv-da-irradiacao-parcial-vs-irradiacao-total-da-mama.html]]></loc><lastmod>2023-11-13T19:54:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trastuzumabe-deruxtecana-e-aprovado-no-cpcnp-com-mutacao-her2.html]]></loc><lastmod>2023-11-08T16:36:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pagamentos-da-industria-a-oncologistas-influenciam-selecao-de-tratamento.html]]></loc><lastmod>2023-11-09T14:44:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-tem-impacto-na-reducao-de-mortes-por-cancer-de-pulmao-em-20-anos.html]]></loc><lastmod>2023-11-08T11:01:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/efeito-masculinizante-da-terapia-hormonal-no-tecido-mamario-em-individuos-transgeneros.html]]></loc><lastmod>2023-11-07T19:00:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-com-estrogenio-vaginal-em-pacientes-com-cancer-de-mama.html]]></loc><lastmod>2023-11-13T18:47:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-enfortumabe-vedotina-pembrolizumabe-no-cancer-urotelial.html]]></loc><lastmod>2023-11-08T16:37:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/polifenois-podem-aumentar-resposta-a-anti-pd-1-pd-l1.html]]></loc><lastmod>2023-11-07T19:18:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ocorrencia-de-cancer-de-mama-apos-um-resultado-falso-positivo-na-mamografia.html]]></loc><lastmod>2023-11-14T17:47:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tact2-esquema-de-quimioterapia-e-impacto-na-qualidade-de-vida.html]]></loc><lastmod>2023-11-18T14:08:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/colopec-hipec-adjuvante-em-pacientes-com-cancer-de-colon-localmente-avancado.html]]></loc><lastmod>2023-11-08T20:54:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gravidade-do-diabetes-e-resultados-do-cancer-colorretal-apos-resseccao.html]]></loc><lastmod>2023-11-06T16:42:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sogug-imanol-olaparibe-de-manutencao-no-mcrpc-responsivo-ou-estavel-apos-docetaxel.html]]></loc><lastmod>2023-11-06T14:56:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/papel-do-cirurgiao-no-tratamento-locorregional-do-cancer-de-mama-estagio-iv.html]]></loc><lastmod>2023-11-02T12:05:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bases-moleculares-e-inovacoes-terapeuticas-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2024-05-09T08:54:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qt-neo-e-reconstrucao-mamaria-imediata-com-retalho-do-musculo-latissimo-do-dorso-e-implante-de-silicone.html]]></loc><lastmod>2023-11-01T16:51:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-apresenta-evidencias-no-carcinoma-espinocelular-glotico.html]]></loc><lastmod>2023-11-01T18:38:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-de-consenso-em-ensaios-de-ctdna.html]]></loc><lastmod>2023-11-10T21:13:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gastrectomia-redutora-de-risco-e-impacto-na-qualidade-de-vida.html]]></loc><lastmod>2023-10-31T19:28:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iaslc-conclui-proposta-de-revisao-para-a-9-classificacao-tnm.html]]></loc><lastmod>2024-05-09T09:02:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/malignidades-secundarias-em-sobreviventes-de-linfoma-de-celulas-do-manto.html]]></loc><lastmod>2023-11-02T00:08:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/amplificacao-superexpressao-e-positividade-de-her2-no-cancer-colorretal.html]]></loc><lastmod>2023-10-31T14:07:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-global-apos-falha-do-tratamento-em-pacientes-com-cancer-retal.html]]></loc><lastmod>2023-10-31T17:00:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-analisa-tumores-na-bolsa-do-marcapasso.html]]></loc><lastmod>2024-06-15T11:31:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prioridades-para-a-pesquisa-em-cancer-no-cenario-pos-covid-19.html]]></loc><lastmod>2023-10-30T15:27:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desnutricao-e-resultados-adversos-apos-cirurgia-para-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2023-11-06T19:06:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preorts-radioterapia-pre-operatoria-do-sarcoma-de-partes-moles.html]]></loc><lastmod>2023-10-28T11:39:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-cerebral-em-cuidados-de-fim-de-vida-limites-e-indicacoes.html]]></loc><lastmod>2023-10-28T11:33:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avaliacao-geriatrica-remota-e-cuidados-de-suporte-para-idosos-com-cancer-avancado.html]]></loc><lastmod>2023-10-28T02:40:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-de-um-programa-remoto-de-atividade-fisica-nos-efeitos-colaterais-imuno-relacionados-e-na-qualidade-de-vida.html]]></loc><lastmod>2023-10-28T12:25:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tentacle-rectum-sobrevida-livre-de-estoma-apos-resseccao-de-cancer-de-reto-com-fistula-anastomotica.html]]></loc><lastmod>2023-11-01T14:43:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disparidades-raciais-e-etnicas-e-diferencas-de-sobrevida-em-estudos-de-cancer-de-mama.html]]></loc><lastmod>2023-10-27T13:15:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quando-e-como-falar-sobre-cuidados-paliativos-e-planejamento-de-cuidados-avancados.html]]></loc><lastmod>2023-10-31T15:33:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/yoga-na-prevencao-de-complicacoes-do-tratamento-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2023-10-27T16:12:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-no-esmo-2023.html]]></loc><lastmod>2023-10-26T22:28:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/seguranca-da-gravidez-apos-cancer-de-mama-rh-em-mulheres-jovens.html]]></loc><lastmod>2023-10-26T18:56:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-aumenta-risco-de-recorrencia-no-cancer-de-mama-rh.html]]></loc><lastmod>2023-10-26T18:50:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-agnosticos-e-estratificacao-de-risco-no-cancer-de-prostata.html]]></loc><lastmod>2023-10-26T21:09:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-e-estratificacao-de-risco-na-vigilancia-ativa-do-cancer-de-prostata.html]]></loc><lastmod>2023-10-26T15:45:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resposta-patologica-de-tumores-e-linfonodos-no-cpcnp-apos-qt-neoadjuvante.html]]></loc><lastmod>2023-10-26T15:42:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-infeccao-pelo-hiv-na-sobrevida-de-pacientes-brasileiros-com-linfoma-difuso-de-grandes-celulas-b.html]]></loc><lastmod>2023-10-27T01:27:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/testes-geneticos-e-uso-personalizado-de-imatinibe-adjuvante-na-saude-brasileira.html]]></loc><lastmod>2023-10-25T21:23:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/declaracao-da-iaslc-sobre-a-documentacao-do-tabagismo-em-ensaios-clinicos.html]]></loc><lastmod>2023-10-25T20:47:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-usa-biopsia-liquida-como-ferramenta-prognostica-no-cancer-de-pulmao.html]]></loc><lastmod>2023-10-19T19:32:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-comparativa-idade-periodo-coorte.html]]></loc><lastmod>2023-10-19T13:39:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/her3-dxd-na-doenca-metastatica-e-relacao-da-disseccao-axilar-com-terapia-sistemica.html]]></loc><lastmod>2023-10-18T20:41:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/predict-validacao-da-ferramenta-prognostica-no-cancer-de-mama.html]]></loc><lastmod>2023-10-18T17:23:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pet-scan-monitora-papel-da-estatina-em-associacao-com-a-terapia-anti-her2.html]]></loc><lastmod>2023-10-18T14:45:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevencao-e-negligenciada-na-pesquisa-em-cancer.html]]></loc><lastmod>2023-10-17T21:18:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/selenio-e-vitamina-e-para-prevencao-da-recorrencia-e-progressao-no-cancer-de-bexiga.html]]></loc><lastmod>2023-10-17T16:07:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-pan-cancer-de-alvos-de-adcs-e-preditores-de-resposta-ao-tratamento.html]]></loc><lastmod>2023-10-17T13:34:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadora-fala-sobre-estudo-que-investigou-status-da-mutacao-egfr-na-maior-coorte-brasileira-de-cancer-de-pulmao.html]]></loc><lastmod>2023-10-16T20:54:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combo-osimertinibe-qt-recebe-revisao-prioritaria-nos-eua-para-cpcnp-com-mutacao-de-egfr.html]]></loc><lastmod>2023-10-16T20:15:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/valor-prognostico-de-comorbidades-em-idosos-com-cancer.html]]></loc><lastmod>2023-10-17T12:41:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consideracoes-eticas-sobre-biopsias-no-cancer-de-pancreas-em-estagio-inicial.html]]></loc><lastmod>2023-10-16T12:11:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/burnout-e-preferencias-de-valorizacao-entre-oncologistas.html]]></loc><lastmod>2023-10-16T12:08:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-no-cancer-de-mama.html]]></loc><lastmod>2023-10-13T16:55:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/formacao-aumenta-o-indice-de-reconstrucao-mamaria-e-a-qualificacao-de-cirurgioes.html]]></loc><lastmod>2023-10-13T20:44:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-intensivo-nao-afeta-qv-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2023-10-13T20:03:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-robotica-versus-cirurgia-laparoscopica-no-cancer-de-colon.html]]></loc><lastmod>2024-05-07T19:04:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-de-vida-em-ensaios-de-fase-3-de-nao-inferioridade.html]]></loc><lastmod>2023-10-13T20:15:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desvantagem-socioeconomica-e-tabagismo-em-pacientes-com-cancer.html]]></loc><lastmod>2023-10-13T17:12:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-discute-surrogates-na-pesquisa-de-imuno-oncologicos.html]]></loc><lastmod>2023-10-11T19:01:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-escore-de-risco-preditivo-de-sg-apos-cirurgia-de-metastases-hepaticas-colorretais-bilobares.html]]></loc><lastmod>2023-10-13T14:36:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rationale-301-tislelizumabe-em-primeira-linha-no-carcinoma-hepatocelular-irressecavel.html]]></loc><lastmod>2023-10-11T17:04:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mastecomia-contralateral-profilatica-em-jovens-e-analise-final-do-estudo-shorther.html]]></loc><lastmod>2023-10-13T16:59:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ki67-como-biomarcador-prognostico-apos-neoadjuvancia-do-cancer-de-mama.html]]></loc><lastmod>2023-10-11T19:04:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/achados-clinicos-de-imagem-e-patologicos-em-uma-coorte-de-adenocarcinoma-gastrico.html]]></loc><lastmod>2023-10-10T18:33:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/spiral-rt-durvalumabe-apos-radioterapia-no-cpcnp-inelegivel-para-quimiorradioterapia.html]]></loc><lastmod>2023-10-10T16:07:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pln-para-identificacao-de-nodulos-pulmonares-incidentais-na-tc.html]]></loc><lastmod>2023-10-10T13:37:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relevancia-prognostica-da-lateralidade-tumoral-em-idosos-com-cancer-de-colon.html]]></loc><lastmod>2023-10-10T17:19:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/salpingo-ooforectomia-profilatica-no-cancer-de-mama-brca-mutado.html]]></loc><lastmod>2023-10-10T11:15:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recorrencia-bioquimica-no-cancer-de-prostata-nao-metastatico.html]]></loc><lastmod>2023-10-10T11:11:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-pos-diagnostico-e-mortalidade.html]]></loc><lastmod>2023-10-09T19:01:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estatinas-podem-reduzir-incidencia-e-mortalidade-por-cancer-colorretal-em-populacao-de-risco.html]]></loc><lastmod>2023-10-16T20:00:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caracteristicas-clinicas-e-histopatologicas-e-sld-no-melanoma-acral-estagio-i-ii.html]]></loc><lastmod>2023-10-16T19:49:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exame-baseado-em-ctdna-mostra-acuracia-na-deteccao-do-cancer-colorretal.html]]></loc><lastmod>2023-10-09T15:29:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/target-tp-tromboprofilaxia-dirigida-ao-risco-em-tumores-de-pulmao-e-gi.html]]></loc><lastmod>2023-10-09T00:56:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/decisao-de-tratamento-na-obstrucao-intestinal-maligna-2.html]]></loc><lastmod>2023-10-06T19:54:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adesao-as-diretrizes-em-pacientes-obesas-com-cancer-de-endometrio.html]]></loc><lastmod>2023-10-06T19:36:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividades-da-vida-diaria-pos-mastectomia.html]]></loc><lastmod>2023-10-06T19:30:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esteatose-hepatica-nao-alcoolica-de-inicio-precoce-e-risco-de-cancer.html]]></loc><lastmod>2023-10-06T16:31:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-para-ensaios-clinicos-em-cancer-de-bexiga.html]]></loc><lastmod>2023-10-06T14:17:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qt-neoadjuvante-e-sobrevida-no-osteossarcoma-extra-esqueletico-ressecado.html]]></loc><lastmod>2023-10-06T11:28:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-emite-recomendacoes-para-avaliacao-da-toxicidade-ovariana-em-ensaios-clinicos.html]]></loc><lastmod>2023-10-05T15:48:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-e-gravidade-da-reinfeccao-por-sars-cov-2-em-pacientes-com-cancer.html]]></loc><lastmod>2023-10-05T15:18:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/crioablacao-e-inibidores-de-checkpoint-no-cancer-de-mama-triplo-negativo-de-alto-risco.html]]></loc><lastmod>2023-10-05T15:01:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-e-impacto-do-diabetes-na-sobrevida-do-mieloma-multiplo-em-diferentes-grupos-raciais.html]]></loc><lastmod>2023-10-05T16:52:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caracteristicas-clinico-demograficas-e-resultados-de-sarcomas-induzidos-por-radiacao.html]]></loc><lastmod>2023-10-04T19:53:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/omissao-do-tratamento-cirurgico-e-qualidade-de-vida.html]]></loc><lastmod>2023-10-04T14:20:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-compara-modalidades-de-tratamento-no-lcm.html]]></loc><lastmod>2023-10-04T13:38:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-em-octogenarios-apos-cirurgia-eletiva-de-cancer-colorretal.html]]></loc><lastmod>2023-10-04T12:55:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aconselhamento-genetico-por-ancestralidade-no-cancer-epitelial-de-ovario.html]]></loc><lastmod>2023-10-04T12:40:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-transperineal-na-deteccao-do-cancer-de-prostata.html]]></loc><lastmod>2023-10-03T18:08:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hipofracionamento-e-seguro-e-melhora-qualidade-de-vida-pos-mastectomia-e-reconstrucao.html]]></loc><lastmod>2023-10-03T19:52:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preferencias-do-paciente-para-reconstrucao-mamaria-pos-mastectomia.html]]></loc><lastmod>2023-10-13T15:06:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pessoas-que-vivem-com-cancer-e-necessidades-de-informacao.html]]></loc><lastmod>2023-10-03T19:49:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/complicacoes-intraoperatorias-da-esofagectomia-minimamente-invasiva.html]]></loc><lastmod>2023-10-02T21:41:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-do-colo-do-utero-e-sobrevida-em-mulheres-com-transtorno-mental.html]]></loc><lastmod>2023-10-02T16:48:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-diretrizes-para-terapia-sistemica-para-gep-nets.html]]></loc><lastmod>2023-10-02T15:31:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-no-cpcnp-metastatico-doenca-de-novo-vs-recorrencia-a-distancia.html]]></loc><lastmod>2023-10-02T15:03:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diversidade-racial-e-etnica-e-desafio-para-a-pesquisa-clinica.html]]></loc><lastmod>2023-09-29T19:34:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-paliativos-e-desigualdades-na-assistencia-oncologica.html]]></loc><lastmod>2023-09-29T19:08:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tendencias-de-mortalidade-por-cancer-colorretal-na-america-latina.html]]></loc><lastmod>2023-09-30T15:26:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-pandemia-de-covid-19-no-diagnostico-do-cancer.html]]></loc><lastmod>2023-09-29T17:26:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/machine-learning-determinantes-sociais-da-saude-e-readmissoes-hospitalares.html]]></loc><lastmod>2023-09-30T16:19:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-segunda-curetagem-uterina-na-ntg.html]]></loc><lastmod>2023-09-29T20:01:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metastases-osseas-e-radiacao-profilatica.html]]></loc><lastmod>2023-09-28T20:46:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pandora-durvalumabe-como-consolidacao-da-neoadjuvancia-no-larc.html]]></loc><lastmod>2023-09-28T22:37:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/a-integracao-de-cuidados-paliativos-em-oncologia.html]]></loc><lastmod>2023-09-28T19:18:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ototoxicidade-associada-a-carboplatina-em-altas-doses.html]]></loc><lastmod>2023-09-28T20:47:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rt-parcial-acelerada-versus-rt-padrao-ou-hipofracionada-no-cancer-de-mama-inicial.html]]></loc><lastmod>2023-10-01T22:46:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pcr-e-sobrevida-global-no-cancer-de-mama-tratado-com-qt-neoadjuvante.html]]></loc><lastmod>2023-09-28T13:42:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/isa-krd-no-mieloma-multiplo-de-alto-risco-recem-diagnosticado.html]]></loc><lastmod>2023-10-01T22:41:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sound-omissao-da-cirurgia-axilar-vs-biopsia-do-linfonodo-sentinela.html]]></loc><lastmod>2023-09-27T12:12:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custos-socioeconomicos-para-sobreviventes-de-melanoma-metastatico.html]]></loc><lastmod>2023-09-26T15:33:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-assistida-por-vacuo-na-resseccao-de-cancer-de-mama.html]]></loc><lastmod>2023-09-27T10:50:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tabagismo-prejudica-eficacia-de-folfirinox-neo-no-cancer-de-pancreas.html]]></loc><lastmod>2023-09-26T14:12:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/politica-nacional-de-saude-bucal-nao-reduziu-a-mortalidade-por-cancer-oral.html]]></loc><lastmod>2023-09-27T12:36:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metabolomica-para-o-diagnostico-de-cancer-de-bexiga.html]]></loc><lastmod>2024-05-03T13:33:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metastases-cerebrais-de-melanoma-tratadas-com-radiocirurgia-estereotatica.html]]></loc><lastmod>2023-09-25T13:40:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-cenario-do-cpcnp-avancado-no-sistema-privado-de-saude-brasileiro.html]]></loc><lastmod>2023-09-25T12:12:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/selpercatinibe-e-capmatinibe-no-cancer-de-pulmao.html]]></loc><lastmod>2023-10-01T22:44:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-e-rt-com-ou-sem-terapia-endocrina-no-cdis-de-mama.html]]></loc><lastmod>2023-09-27T13:11:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tropion-breast01-datopotamab-deruxtecan-no-cancer-de-mama-hr-her2-low-ou-negativo.html]]></loc><lastmod>2023-10-01T22:45:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-bariatrica-e-prevencao-do-cancer-hematologico-associado-a-obesidade.html]]></loc><lastmod>2023-11-10T21:28:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-identifica-mutacoes-em-11-genes-associados-ao-cancer-de-prostata-agressivo.html]]></loc><lastmod>2023-09-26T21:48:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preditores-de-miocardite-associada-a-inibidores-de-checkpoint-imune.html]]></loc><lastmod>2023-09-26T12:17:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estruturas-linfoides-terciarias-e-resposta-imune-no-cancer-de-pancreas.html]]></loc><lastmod>2023-09-21T13:39:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metformina-adjuvante-nao-mostra-beneficio-na-reducao-do-risco-de-cancer.html]]></loc><lastmod>2023-09-21T13:19:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gog-8032-subtipos-histologicos-mistos-no-cancer-endometrial.html]]></loc><lastmod>2023-09-27T19:05:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incidencia-do-cancer-de-pancreas-e-mortalidade-em-36-paises-europeus.html]]></loc><lastmod>2023-09-20T22:43:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-desvendam-mecanismo-de-invasao-no-crc.html]]></loc><lastmod>2023-09-20T19:15:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-e-deteccao-precoce-do-cancer.html]]></loc><lastmod>2023-10-13T15:27:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rt-indicacoes-e-impacto-prognostico-no-rms.html]]></loc><lastmod>2023-09-20T12:33:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/plataforma-mostra-caminhos-no-tratamento-do-glioblastoma.html]]></loc><lastmod>2024-03-06T15:33:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-de-risco-para-linfedema-e-cancer-de-mama-em-sobreviventes.html]]></loc><lastmod>2023-09-20T11:59:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adcs-um-novo-campo-de-inovacao.html]]></loc><lastmod>2023-09-20T22:20:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inca-se-prepara-para-iniciar-pesquisa-clinica-com-celulas-car-t.html]]></loc><lastmod>2023-10-01T22:40:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neocoast-imunoterapia-combinada-neoadjuvante-no-cpcnp-ressecavel.html]]></loc><lastmod>2023-09-19T21:47:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incidencia-e-mortalidade-de-cancer-de-tireoide-por-nivel-socioeconomico-no-estado-de-sao-paulo.html]]></loc><lastmod>2023-09-18T20:31:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/integracao-da-radioterapia-pos-operatoria-com-inibidores-de-ciclinas.html]]></loc><lastmod>2023-09-18T15:58:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ntcp-e-planejamento-da-radioterapia-no-cancer-de-mama.html]]></loc><lastmod>2023-09-18T15:47:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-apoia-valor-prognostico-de-piv-em-pacientes-com-cancer.html]]></loc><lastmod>2023-09-18T13:11:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/indice-nutricional-e-prognostico-no-pos-operatorio-do-cancer-gastrico.html]]></loc><lastmod>2023-09-20T20:25:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/panorama-multiomico-traz-dados-ineditos-sobre-o-cancer-urotelial.html]]></loc><lastmod>2023-09-18T12:40:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/b7-h4-como-alvo-terapeutico-no-carcinoma-adenoide-cistico-agressivo.html]]></loc><lastmod>2023-09-17T21:23:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dna-tumoral-circulante-e-selecao-de-pacientes-no-cancer-de-mama.html]]></loc><lastmod>2023-09-18T13:39:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-comparativa-internacional-e-roteiro-para-mercados-biossimilares-sustentaveis.html]]></loc><lastmod>2023-09-29T12:46:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcador-prognostico-no-glioblastoma.html]]></loc><lastmod>2023-09-19T19:41:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carga-global-do-cancer-de-labio-boca-e-faringe-em-adultos-em-204-paises.html]]></loc><lastmod>2023-09-14T15:39:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diferencas-entre-niveis-de-expressao-her2-e-impacto-da-atividade-fisica-e-alimentacao-no-tratamento-quimioterapico-do-cancer-de-mama.html]]></loc><lastmod>2023-09-13T22:41:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacina-contra-o-cancer-mostra-resultados-de-sobrevida.html]]></loc><lastmod>2023-09-13T14:02:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-de-longo-prazo-confirma-ganho-de-sobrevida-com-ev-no-cancer-urotelial.html]]></loc><lastmod>2023-09-14T13:21:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/solucao-valoriza-custo-beneficio-de-testes-moleculares-e-citogeneticos.html]]></loc><lastmod>2023-09-17T23:02:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hipec-mostra-resultados-de-sobrevida-no-cancer-de-ovario-em-10-anos-de-acompanhamento.html]]></loc><lastmod>2023-09-21T20:19:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-prognosticos-no-cancer-testicular-inicial.html]]></loc><lastmod>2023-09-15T21:24:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-em-cancer-lidera-inovacao-no-setor-farmaceutico.html]]></loc><lastmod>2023-09-12T03:15:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-dados-nao-mostram-beneficio-de-selinexor-no-cancer-de-endometrio.html]]></loc><lastmod>2023-09-11T15:57:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-analisa-dieta-e-infeccao-por-h-pylori-no-brasil-central.html]]></loc><lastmod>2023-09-06T16:33:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aconselhamento-genetico-por-ia-versus-tradicional-e-ki-67-score-de-recorrencia-de-21-genes-resistencia-endocrina-e-sobrevida-em-pacientes-com-cancer-de-mama.html]]></loc><lastmod>2023-09-05T22:34:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/niveis-de-psa-apos-o-tratamento-podem-nao-ser-preditor-confiavel-de-sobrevida-no-cancer-de-prostata.html]]></loc><lastmod>2023-09-05T20:34:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-da-eortc-compara-estrategias-no-cancer-cervical.html]]></loc><lastmod>2023-09-05T13:23:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-dados-mostram-beneficio-de-binimetinibe-no-melanoma-braf-v600.html]]></loc><lastmod>2023-09-05T13:14:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tempo-ideal-para-a-cirurgia-no-cancer-de-esofago.html]]></loc><lastmod>2023-09-05T13:00:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atrasos-no-diagnostico-de-cancer-de-cabeca-e-pescoco-associados-a-uso-de-antibioticos.html]]></loc><lastmod>2023-09-04T16:54:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/orientacao-nutricional-para-otimizar-tratamentos-de-fertilidade-em-mulheres-sobreviventes-de-cancer.html]]></loc><lastmod>2023-09-05T15:42:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mezigdomida-e-nova-promessa-no-mieloma-multiplo.html]]></loc><lastmod>2023-08-31T20:16:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/durvalumabe-tremelimumabe-com-mfolfox6-no-ccrm-microssatelite-estavel.html]]></loc><lastmod>2023-08-31T20:11:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-duas-novas-designacoes-de-terapia-inovadora-para-tdx-d.html]]></loc><lastmod>2023-08-31T23:59:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadora-brasileira-investiga-mortalidade-por-cancer-de-mama-em-indigenas-do-amazonas.html]]></loc><lastmod>2023-08-30T23:22:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/supressao-ovariana-tamoxifeno-no-cancer-de-mama-hr-pos-qt-na-pre-menopausa-e-vigilancia-apos-mastectomia-preservadora-de-mamilos-profilatica-em-portadoras-de-mutacao-brca.html]]></loc><lastmod>2023-08-31T16:40:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-analisa-quercetina-no-tratamento-do-melanoma.html]]></loc><lastmod>2023-08-30T18:26:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/toxicidade-financeira-afeta-paciente-de-cancer-e-resultados-do-tratamento.html]]></loc><lastmod>2023-08-30T18:09:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ferramenta-preditiva-avalia-risco-de-suicidio-em-pacientes-com-cancer.html]]></loc><lastmod>2023-08-30T17:59:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-economico-da-mortalidade-por-cancer-entre-individuos-em-idade-produtiva-no-brasil-de-2001-a-2030.html]]></loc><lastmod>2023-08-26T14:58:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/calculadora-pode-predizer-risco-de-recorrencia-apos-tace-adjuvante-no-hepatocarcinoma.html]]></loc><lastmod>2023-08-25T13:14:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/divarasib-em-tumores-solidos-com-mutacao-kras-g12c.html]]></loc><lastmod>2023-08-24T13:40:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-prioritaria-para-enzalutamida-no-cancer-de-prostata-nao-metastatico-sensivel-a-castracao-com-alto-risco-de-recorrencia-bioquimica.html]]></loc><lastmod>2023-08-23T21:59:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-oncologicos-integrativos-para-ansiedade-e-depressao-em-adultos-com-cancer.html]]></loc><lastmod>2023-08-26T18:03:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/omissao-da-radioterapia-adjuvante-no-cancer-de-mama-luminal-a-e-rastreamento-em-mulheres-canadenses-de-40-a-49-anos.html]]></loc><lastmod>2023-08-27T21:31:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nacatrine-carboplatina-neoadjuvante-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2023-08-29T18:52:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/durvalumabe-perioperatorio-no-carcinoma-urotelial-musculo-invasivo.html]]></loc><lastmod>2023-08-28T21:16:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-explicam-risco-de-cancer-de-prostata-metastatico-em-afro-americanos.html]]></loc><lastmod>2023-08-21T13:11:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-alerta-para-discordancias-diagnosticas-em-neoplasias-mielodisplasicas.html]]></loc><lastmod>2024-05-04T20:02:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-molecular-e-nova-promessa-no-diagnostico-do-cancer-de-bexiga.html]]></loc><lastmod>2023-08-18T15:34:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vorasidenibe-em-glioma-de-baixo-grau-com-mutacao-idh.html]]></loc><lastmod>2023-08-22T20:29:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diagnostico-de-cancer-aumenta-em-adultos-mais-jovens.html]]></loc><lastmod>2023-08-26T20:46:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-de-lorazepam-piora-os-resultados-de-sobrevida-no-cancer-pancreatico.html]]></loc><lastmod>2023-08-18T12:02:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tmb-no-cancer-de-mama-evidencias-desafios-e-oportunidades.html]]></loc><lastmod>2023-08-17T18:22:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/redefinindo-as-prioridades-da-pesquisa-em-cancer-em-paises-de-baixa-e-media-renda.html]]></loc><lastmod>2023-08-27T22:37:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-brasileira-inova-na-biopsia-do-linfonodo-sentinela.html]]></loc><lastmod>2023-08-21T19:24:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-pac-pretende-ampliar-atendimento-em-cancer-no-sus.html]]></loc><lastmod>2023-08-15T15:03:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disparidades-na-mortalidade-por-cancer-de-pulmao-no-estado-do-parana.html]]></loc><lastmod>2023-08-14T23:51:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-mostra-resultados-no-cancer-de-penis.html]]></loc><lastmod>2023-08-21T19:21:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/os-custos-do-cancer-pela-falta-de-atividade-fisica-no-brasil.html]]></loc><lastmod>2023-08-27T00:52:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/racismo-desafia-cuidados-de-fim-de-vida-para-pacientes-de-grupos-minoritarios.html]]></loc><lastmod>2023-08-14T23:45:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-perioperatoria-parece-melhorar-resultados-no-cpcnp-inicial.html]]></loc><lastmod>2023-08-14T19:33:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-e-caracteristicas-clinico-patologicas-do-cancer-de-mama-her2-low.html]]></loc><lastmod>2024-05-09T08:55:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-avalia-crioablacao-no-cancer-de-mama-invasivo.html]]></loc><lastmod>2023-08-11T01:18:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/poluicao-do-ar-aumenta-risco-de-diferentes-tipos-de-cancer.html]]></loc><lastmod>2023-08-10T19:35:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/saude-sexual-em-mulheres-sobreviventes-de-cancer.html]]></loc><lastmod>2023-08-10T17:15:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sugere-que-consumo-de-alcool-nao-esta-associado-a-risco-recorrencia-e-morte-por-cancer-de-mama.html]]></loc><lastmod>2023-08-10T13:26:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avelumabe-mostra-beneficio-de-slp-como-segunda-linha-em-pacientes-com-cancer-colorretal-metastatico.html]]></loc><lastmod>2023-08-10T14:00:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/patritumab-deruxtecan-no-cancer-de-mama-inicial-nao-tratado-hr-her2-negativo-e-quimioterapia-neoadjuvante-vs-adjuvante-na-doenca-triplo-negativo-nodulo-clinicamente-negativo-t1.html]]></loc><lastmod>2023-08-10T16:51:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eventos-adversos-cronicos-relacionados-ao-sistema-imune-apos-terapia-anti-pd-1-para-melanoma-de-alto-risco.html]]></loc><lastmod>2023-08-27T01:37:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-e-sobrediagnostico-do-cancer-de-mama-na-mulher-idosa.html]]></loc><lastmod>2023-08-15T15:29:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-metastase-em-portadoras-de-brca2-diagnosticadas-com-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2023-08-27T04:01:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/status-molecular-no-carcinoma-papilifero-de-tireoide-e-associacao-clinico-patologica.html]]></loc><lastmod>2023-08-27T00:17:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-revela-potencial-biomarcador-para-detectar-metastases-linfonodais-do-carcinoma-espinocelular-oral.html]]></loc><lastmod>2023-08-15T13:33:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-nao-mostra-associacao-entre-depressao-e-ansiedade-e-risco-de-cancer.html]]></loc><lastmod>2023-08-08T11:41:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-insights-sobre-a-paisagem-genomica-do-cancer.html]]></loc><lastmod>2023-08-07T19:19:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-canpredict-mostra-desempenho-para-triagem-do-cancer-de-pulmao.html]]></loc><lastmod>2023-08-07T17:50:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oms-lanca-novo-alerta-para-o-controle-do-tabaco.html]]></loc><lastmod>2023-08-07T17:41:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/decisao-de-tratamento-na-obstrucao-intestinal-maligna.html]]></loc><lastmod>2023-08-07T17:25:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/interval-gap4-exercicio-intenso-e-sobrevida-em-pacientes-com-cancer-de-prostata-metastatico.html]]></loc><lastmod>2023-08-04T21:00:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-discute-como-aumentar-a-adesao-a-terapia-endocrina-adjuvante-no-cancer-de-mama.html]]></loc><lastmod>2023-08-04T16:44:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pembrolizumabe-mostra-beneficio-em-idosos-com-cpcnp-avancado.html]]></loc><lastmod>2023-08-06T13:19:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2023-08-04T21:54:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacientes-com-cancer-de-mama-com-maior-imc-tem-maior-probabilidade-de-sofrer-danos-cardiacos-durante-a-quimioterapia.html]]></loc><lastmod>2023-08-04T14:30:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-e-deteccao-precoce-de-cancer.html]]></loc><lastmod>2023-08-03T16:43:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inteligencia-artificial-e-deteccao-de-lesoes-pre-cancerosas-no-colo-do-utero.html]]></loc><lastmod>2023-08-03T19:45:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desafios-da-experiencia-brasileira-no-rastreamento-do-cancer-colorretal.html]]></loc><lastmod>2023-08-03T12:44:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/upregulation-do-her2-apos-terapia-endocrina-neoadjuvante-no-cancer-de-mama-hr-her2-negativo-e-sobrevida-em-5-anos-no-estudo-wsg-adapt-tp.html]]></loc><lastmod>2023-08-10T11:12:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/a-resseccao-cirurgica-e-justificada-para-adenocarcinoma-ductal-pancreatico-com-metastase-de-orgaos-abdominais-distantes.html]]></loc><lastmod>2023-08-04T21:16:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sus-deve-incorporar-terapia-fotodinamica-no-tratamento-do-cancer-de-pele-basocelular.html]]></loc><lastmod>2023-08-01T16:16:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sugere-eficacia-superior-de-osimertinibe-em-metastases-leptomeningeas-do-cpcnp.html]]></loc><lastmod>2023-08-09T15:52:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/evidencias-e-recomendacoes-para-rastreamento-diagnostico-e-tratamento-do-cancer-de-colo-uterino.html]]></loc><lastmod>2023-08-01T12:03:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/car-t-cilta-cel-mostra-novos-resultados-no-mieloma-multiplo.html]]></loc><lastmod>2023-08-01T01:32:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-e-impacto-na-sobrevida-do-cancer-metastatico.html]]></loc><lastmod>2023-07-31T21:04:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-em-cinco-anos-de-pacientes-com-cpcnp-ressecavel-estagio-iiia-no-brasil.html]]></loc><lastmod>2023-07-31T17:55:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-multicentrico-investiga-quimioterapia-de-consolidacao-com-ou-sem-oxaliplatina-e-preservacao-de-orgao-no-cancer-retal-distal.html]]></loc><lastmod>2023-08-01T16:33:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prebioticos-e-probioticos-no-manejo-da-microbiota-para-a-caquexia-do-cancer.html]]></loc><lastmod>2023-08-01T00:49:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-pos-operatoria-moderadamente-hipofracionada-na-america-latina-e-caribe-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2023-07-31T17:27:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/manutencao-com-niraparibe-reduz-significativamente-o-risco-de-progressao-no-cancer-de-ovario-avancado.html]]></loc><lastmod>2023-07-31T19:40:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-da-mutacao-kras-g12c-no-cpcnp-avancado.html]]></loc><lastmod>2023-08-01T14:18:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-agrupada-confirma-beneficio-de-sobrevida-de-inibidores-cdk-4-6-em-mulheres-idosas-com-cancer-de-mama-avancado.html]]></loc><lastmod>2023-07-31T11:23:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perda-do-cromossomo-y-em-homens-se-correlaciona-com-prognostico-no-cancer-de-bexiga.html]]></loc><lastmod>2023-07-31T11:17:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-de-transcricao-subtipo-molecular-e-resposta-a-terapia-anti-egfr-no-cancer-colorretal.html]]></loc><lastmod>2023-07-30T23:51:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aprendizado-de-maquina-mostra-desempenho-superior-aos-nomogramas-para-prever-metastases-linfonodais-do-cancer-de-prostata.html]]></loc><lastmod>2023-08-17T13:10:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-pantumor02-analise-primaria-mostra-beneficio-de-sobrevida-em-tumores-solidos-avancados-com-expressao-her2.html]]></loc><lastmod>2023-07-31T17:17:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-padroes-de-primeira-linha-no-carcinoma-urotelial-metastatico.html]]></loc><lastmod>2023-07-27T13:12:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsias-do-linfonodo-sentinela-devem-ser-evitadas-no-carcinoma-lobular-invasivo-inicial-em-pacientes-acima-de-70-anos.html]]></loc><lastmod>2023-07-26T13:22:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/volume-da-resseccao-hepatica-nao-afeta-significativamente-a-sobrevida-global-na-cirurgia-da-vesicula-biliar.html]]></loc><lastmod>2023-07-26T12:51:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/olaparibe-e-temozolomida-para-leiomiossarcoma-uterino-avancado.html]]></loc><lastmod>2023-07-25T18:19:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imagem-e-valor-preditivo-de-resposta-a-terapia-neoadjuvante-total-no-cancer-retal.html]]></loc><lastmod>2023-08-06T15:05:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-compara-dois-metodos-de-triagem-baseados-no-virus-epstein-barr-na-triagem-do-carcinoma-nasofaringeo.html]]></loc><lastmod>2023-07-24T14:53:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eventos-tardios-ou-de-longo-prazo-associados-ao-tratamento-do-cancer.html]]></loc><lastmod>2023-07-24T13:51:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-quizartinib-para-leucemia-mieloide-aguda-recem-diagnosticada.html]]></loc><lastmod>2023-07-27T13:26:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/economia-comportamental-ajuda-a-combater-o-uso-do-tabaco-em-pacientes-de-cancer.html]]></loc><lastmod>2023-07-20T13:41:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metanalise-de-rede-discute-estrategias-neoadjuvante-no-cancer-esofagico-ou-gej.html]]></loc><lastmod>2023-07-20T13:25:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbiota-da-mucosa-tumoral-pode-predizer-resultados-favoraveis-no-cancer-colorretal.html]]></loc><lastmod>2023-07-20T13:18:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/padrao-de-sono-e-sobrevida-em-pacientes-com-cancer-de-colon-avancado.html]]></loc><lastmod>2023-07-18T02:36:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caracterizacao-molecular-em-carcinomas-periampulares.html]]></loc><lastmod>2023-07-17T15:17:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/autoria-e-inscricao-de-pacientes-em-ensaios-clinicos-globais-em-oncologia.html]]></loc><lastmod>2023-07-15T23:52:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incidencia-e-mortalidade-por-cancer-no-estado-de-sao-paulo.html]]></loc><lastmod>2023-07-15T21:25:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aspartame-e-possivelmente-cancerigeno.html]]></loc><lastmod>2023-07-27T12:49:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-aumenta-o-risco-de-cancer-de-tireoide.html]]></loc><lastmod>2023-07-14T15:33:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metilacao-mlh1-e-sindrome-de-lynch-novos-achados-sobre-o-cancer-hereditario.html]]></loc><lastmod>2023-07-15T21:09:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-e-sobrepeso-associados-a-resultados-adversos-no-tratamento-da-leucemia.html]]></loc><lastmod>2023-07-13T21:21:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-disbiose-e-ganho-de-peso-no-cancer-de-mama.html]]></loc><lastmod>2023-07-13T13:10:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-discute-valor-terapeutico-de-novas-indicacoes-e-indicacoes-suplementares.html]]></loc><lastmod>2023-07-10T16:58:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-de-intensidade-modulada-otimizada-para-disfagia-pode-ser-novo-padrao-para-cancer-de-faringe.html]]></loc><lastmod>2023-07-10T15:55:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/panorama-brasileiro-do-carcinoma-hepatocelular.html]]></loc><lastmod>2023-07-10T02:59:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/especialistas-reavaliam-potencial-efeito-carcinogenico-do-aspartame.html]]></loc><lastmod>2023-07-08T13:32:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cigarro-eletronico-afeta-a-saude-da-prostata.html]]></loc><lastmod>2023-07-07T18:42:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-de-avaliacao-de-risco-e-rastreamento-precoce-no-cancer-colorretal.html]]></loc><lastmod>2023-07-07T18:05:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pirtobrutinib-e-nova-promessa-para-pacientes-com-disturbios-linfoproliferativos-refratarios-aos-inibidores-de-btk.html]]></loc><lastmod>2023-07-13T17:57:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/laparoscopia-de-estadiamento-no-cancer-de-pancreas.html]]></loc><lastmod>2023-07-13T20:50:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-prostata-e-recursos-empregados-no-ultimo-ano-de-vida.html]]></loc><lastmod>2023-07-04T19:01:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-piloto-mostra-resultados-com-celulas-car-t-no-mieloma-multiplo-politratado.html]]></loc><lastmod>2023-07-04T18:34:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/isatuximabe-em-pacientes-com-mieloma-multiplo-recidivado-com-risco-ultra-alto.html]]></loc><lastmod>2023-07-04T18:27:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rusfertida-mostra-resultados-na-policitemia-vera.html]]></loc><lastmod>2023-07-04T18:21:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ibrutinibe-nao-aumenta-sobrevida-global-na-llc-inicial.html]]></loc><lastmod>2023-07-04T17:39:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/triagem-e-aconselhamento-genetico-no-cancer-de-mama.html]]></loc><lastmod>2023-07-03T12:45:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/associacao-de-her2dx-com-pcr-e-sobrevida-no-cancer-de-mama-her2-e-prevalencia-de-cancer-de-mama-em-cirurgias-ortopedicas.html]]></loc><lastmod>2023-06-28T18:30:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-do-cirurgiao-e-sobrevida-do-paciente-apos-resseccao-no-cpcnp.html]]></loc><lastmod>2023-07-03T16:45:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imatinibe-neoadjuvante-e-eficaz-para-gists-gastricos-10-cm.html]]></loc><lastmod>2023-07-15T23:48:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/enfortumabe-vedotina-pembrolizumabe-no-cancer-urotelial-avancado.html]]></loc><lastmod>2023-06-28T14:20:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-entre-mulheres-com-sindrome-dos-ovarios-policisticos-dobra-apos-a-menopausa.html]]></loc><lastmod>2023-06-28T13:49:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/escore-prognostico-de-glasgow-modificado-no-cancer-renal-metastatico.html]]></loc><lastmod>2023-06-28T13:30:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vegfr2-superexpresso-sugere-melhores-desfechos-no-mesotelioma-pleural.html]]></loc><lastmod>2023-07-25T21:19:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-genomico-para-triagem-do-hpv-mostra-viabilidade-na-africa-subsaariana.html]]></loc><lastmod>2023-07-13T19:18:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/associacao-entre-meningioma-e-cancer-de-mama.html]]></loc><lastmod>2023-06-26T17:01:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sugere-viabilidade-da-biopsia-liquida-no-diagnostico-precoce-de-cancer.html]]></loc><lastmod>2023-06-22T18:42:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-nova-indicacao-de-sacituzumabe-govitecana-no-cancer-de-mama.html]]></loc><lastmod>2023-06-22T14:45:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custo-e-valor-na-oncohematologia.html]]></loc><lastmod>2023-06-21T13:20:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desfechos-e-fatores-prognosticos-no-carcinoma-lobular-invasivo-triplo-negativo-tn-e-ctdna-na-doenca-luminal-e-tn.html]]></loc><lastmod>2023-06-20T12:31:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-no-asco-2023---parte-2.html]]></loc><lastmod>2023-06-15T01:10:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-no-asco-2023.html]]></loc><lastmod>2023-06-06T00:36:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-epcoritamabe-no-linfoma-difuso-de-grandes-celulas-b-recidivado-refratario.html]]></loc><lastmod>2023-06-01T11:41:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pet-ct-na-doenca-localmente-avancada-e-disseccao-de-linfonodo-axilar-em-homens-com-cancer-de-mama-invasivo.html]]></loc><lastmod>2023-05-31T14:14:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudos-wsg-tp-ii-e-maintain-avaliam-eficacia-da-terapia-endocrina-em-diferentes-cenarios-e-combinacoes.html]]></loc><lastmod>2023-05-24T19:13:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-e-imunoterapia-em-pessoas-vivendo-com-hiv.html]]></loc><lastmod>2023-05-17T18:13:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-endocrina-para-prevencao-primaria-e-secundaria-e-adesao-as-recomendacoes-de-estilo-de-vida.html]]></loc><lastmod>2023-05-17T17:53:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-trimodal-versus-cistectomia-no-cancer-de-bexiga-musculo-invasivo.html]]></loc><lastmod>2023-05-16T11:17:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-e-diabetes-prevencao-e-fatores-de-risco.html]]></loc><lastmod>2023-05-11T20:32:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-randomizado-discute-prevencao-da-radiodermite.html]]></loc><lastmod>2023-05-11T20:22:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-do-estudo-monarche-e-valor-clinico-da-expressao-do-receptor-de-progesterona-no-cancer-de-mama-luminal.html]]></loc><lastmod>2023-05-11T13:53:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/programas-de-triagem-do-cancer-de-colo-do-utero-baseados-em-risco-em-ambientes-com-recursos-limitados.html]]></loc><lastmod>2023-05-08T20:50:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incidencia-de-cancer-apos-diagnostico-de-asma.html]]></loc><lastmod>2023-05-08T12:48:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-ajustado-por-raca-e-etnia-e-ensaio-genomico-na-doenca-erbb2-positivo-apos-qt-neoadjuvante-2.html]]></loc><lastmod>2023-05-03T18:40:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-estendida-estudo-japones-mostra-resultados-no-cancer-de-mama-rh-na-pos-menopausa.html]]></loc><lastmod>2023-05-02T12:49:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resposta-patologica-completa-e-prognostico-apos-qt-neo-terapia-anti-her2-no-cancer-de-mama-inicial-her2.html]]></loc><lastmod>2023-04-27T15:36:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/albert-einstein-se-prepara-para-pesquisa-brasileira-com-celulas-car-t.html]]></loc><lastmod>2023-04-26T18:58:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-a-laser-vaginal-em-pacientes-com-cancer-de-mama-sintomaticas-e-antraciclina-taxano-na-doenca-inicial-ressecavel.html]]></loc><lastmod>2023-04-18T22:37:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lidocaina-peritumoral-pre-cirurgica-e-sobrevida-no-cancer-de-mama-inicial.html]]></loc><lastmod>2023-04-14T12:08:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-sistemica-na-doenca-her2-convertida-em-axila-positiva-pos-cirurgia-e-pet-ct-vs-tc-no-paciente-metastatico.html]]></loc><lastmod>2023-04-12T03:03:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aceita-pedido-de-biossimilar-de-bevacizumabe.html]]></loc><lastmod>2023-04-26T14:45:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esquema-alternativo-de-exemestano-e-tratamento-de-fertilidade-e-incidencia-de-cancer-de-mama.html]]></loc><lastmod>2023-04-06T00:49:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/abordagem-cirurgica-radical-e-resultados-no-cancer-de-pancreas.html]]></loc><lastmod>2023-04-02T23:39:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acosog-z11102-recidiva-local-apos-terapia-conservadora-da-mama-em-pacientes-com-multiplas-lesoes-mamarias.html]]></loc><lastmod>2023-04-02T18:14:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/antibioticos-periquimioterapia-e-resultados-de-sobrevida-no-adenocarcinoma-ductal-pancreatico.html]]></loc><lastmod>2023-04-03T00:06:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cessacao-do-tabagismo-entre-pacientes-com-ccr-diminui-risco-de-morte.html]]></loc><lastmod>2023-03-30T15:51:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/contraceptivos-hormonais-combinados-e-apenas-de-progestagenio-e-risco-de-cancer-de-mama.html]]></loc><lastmod>2023-03-29T16:02:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-publica-guia-com-orientacoes-para-apoiar-a-aprovacao-acelerada-em-oncologia.html]]></loc><lastmod>2023-04-03T00:54:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/canabinoides-no-cancer-de-mama-e-resultados-de-longo-prazo-do-estudo-apt.html]]></loc><lastmod>2023-03-22T18:20:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/poseidon-durvalumabe-e-tremelimumabe-na-primeira-linha-do-cpcnp-metastatico.html]]></loc><lastmod>2023-03-20T18:36:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/canrisk-prostate-modelo-de-risco-de-cancer-de-prostata.html]]></loc><lastmod>2023-03-20T15:15:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/5-anos-de-follow-up-do-estudo-rapido.html]]></loc><lastmod>2023-04-03T01:54:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-do-cancer-e-declinio-cognitivo.html]]></loc><lastmod>2023-03-16T13:21:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-neoadjuvante-e-abordagens-de-preservacao-da-bexiga-na-doenca-musculo-invasiva.html]]></loc><lastmod>2023-03-29T13:13:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudos-avaliam-radioterapia-no-cancer-de-mama.html]]></loc><lastmod>2023-03-15T19:32:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-mostra-modelo-de-inteligencia-artificial-com-alto-desempenho-para-prever-mortes-por-cancer.html]]></loc><lastmod>2023-03-21T13:34:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adaura-estudo-de-fase-iii-demonstra-beneficio-de-sobrevida-global-com-osimertinibe-adjuvante-no-cpcnp.html]]></loc><lastmod>2023-03-13T18:37:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mortalidade-por-cancer-relacionado-ao-trabalho-no-brasil.html]]></loc><lastmod>2023-03-13T14:01:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-em-idosas-brca-mutado-e-sobrevida-em-5-anos-do-estudo-wsg-adapt-tp.html]]></loc><lastmod>2023-03-08T16:42:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prognostico-do-cancer-de-mama-inicial-em-pacientes-com-sindrome-de-li-fraumeni.html]]></loc><lastmod>2023-03-06T21:06:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-em-pacientes-com-sindrome-de-li-fraumeni-e-acompanhamento-de-12-anos-do-estudo-soft.html]]></loc><lastmod>2023-03-02T12:17:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analises-dos-estudos-acosog-z1031-e-shorther-avaliam-terapia-endocrina-no-cancer-de-mama.html]]></loc><lastmod>2023-02-16T13:50:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recusa-a-quimioterapia-e-sobrevida-em-pacientes-idosas-e-tor1b-como-biomarcador-preditivo-de-metastases-osseas.html]]></loc><lastmod>2023-02-09T16:24:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-de-mama-contralateral-em-pacientes-com-variantes-patogenicas-germinativas.html]]></loc><lastmod>2023-02-05T20:41:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/s1416-inibidor-de-parp-mostra-beneficio-no-cancer-de-mama-triplo-negativo-brca-like.html]]></loc><lastmod>2023-02-06T02:40:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adaura-osimertinibe-adjuvante-no-cpcnp-estagio-ib-iiia-egfr-mutado-ressecado.html]]></loc><lastmod>2023-02-06T02:21:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/papel-atual-da-resseccao-pulmonar-robotica-no-tratamento-primario-do-cancer-de-pulmao.html]]></loc><lastmod>2023-02-06T02:17:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caracterizacao-e-construcao-do-registro-nacional-da-doenca-de-von-hippel-lindau-no-brasil.html]]></loc><lastmod>2023-02-03T00:51:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/soraya-mirvetuximabe-soravtansina-no-cancer-de-ovario-resistente-a-platina-com-alta-expressao-do-fra.html]]></loc><lastmod>2023-02-06T02:26:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-disparidades-na-sobrevida-ao-cancer-em-32-paises.html]]></loc><lastmod>2023-02-06T00:47:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-pembrolizumabe-como-tratamento-adjuvante-no-cancer-de-pulmao-de-celulas-nao-pequenas.html]]></loc><lastmod>2023-01-30T14:22:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oms-atualiza-recomendacoes-para-vacina-contra-hpv.html]]></loc><lastmod>2023-01-31T12:11:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-analisa-evidencias-e-desafios-do-rastreamento-do-cancer-de-pulmao.html]]></loc><lastmod>2022-12-23T13:52:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sabcs-2022-e-o-impacto-na-pratica-clinica-3.html]]></loc><lastmod>2022-12-15T15:04:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aceita-submissao-de-analise-prioritaria-de-epcoritamabe-para-o-tratamento-de-lgcb-recidivado-refratario.html]]></loc><lastmod>2022-12-02T16:06:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-primeiro-produto-de-microbiota-fecal.html]]></loc><lastmod>2022-12-02T14:58:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-quimioterapia-no-carcinoma-lobular-invasivo-inicial-e-razao-neutrofilo-linfocito-na-doenca-oligometastatica.html]]></loc><lastmod>2022-11-30T19:41:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/everolimo-adjuvante-no-cancer-de-mama-inicial-e-resultados-de-10-anos-do-estudo-amaros.html]]></loc><lastmod>2022-11-24T21:33:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/a-carga-global-do-cancer-de-mama-2020-2040.html]]></loc><lastmod>2022-11-21T12:21:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/her2-low-como-fator-preditivo-de-resposta-a-quimioterapia-neoadjuvante-no-cancer-de-mama-inicial-e-margetuximabe-na-doenca-avancado-her2-positivo.html]]></loc><lastmod>2022-11-17T16:32:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-fratura-em-idosos-sobreviventes-de-cancer.html]]></loc><lastmod>2022-11-15T20:13:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-em-sobreviventes-de-cancer-de-mama-masculino-e-novas-possibilidades-de-entrega-da-radioterapia-na-doenca-inicial.html]]></loc><lastmod>2022-11-10T20:07:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-combinacao-de-imunoterapicos-no-tratamento-do-carcinoma-hepatocelular-avancado.html]]></loc><lastmod>2022-11-09T13:14:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imuno-oncologicos-e-mortes-por-covid-19.html]]></loc><lastmod>2022-11-07T13:03:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/durvalumabe-neoadjuvante-no-cancer-de-mama-inicial-triplo-negativo-e-omissao-da-cirurgia-em-pacientes-com-cancer-de-mama-invasivo-com-resposta-a-terapia-sistemica.html]]></loc><lastmod>2022-11-01T15:04:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/talazoparibe-em-mutacoes-diferentes-de-brca1-e-brca2-e-omissao-de-cirurgia-axilar-para-recidiva-ipsilateral-apos-cirurgia-conservadora.html]]></loc><lastmod>2022-10-25T15:37:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-de-mama-em-sobreviventes-de-cancer-infantil-e-pet-fes-para-avaliar-o-status-re-da-doenca-metastatica-recem-diagnosticada.html]]></loc><lastmod>2022-10-20T12:08:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-identificam-super-potencializador-do-cancer-de-colon.html]]></loc><lastmod>2022-10-19T14:31:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-publica-recomendacoes-para-o-desenvolvimento-de-drogas-agnosticas-em-oncologia.html]]></loc><lastmod>2022-10-19T13:45:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sarcomas-de-partes-moles-toracicos-em-sobreviventes-de-cancer-de-mama-nos-eua.html]]></loc><lastmod>2022-10-25T12:54:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atualizacao-do-estudo-de-fase-3-olympia-e-resultados-no-cancer-de-mama-her2-low-versus-her2-zero-apos-quimioterapia-neoadjuvante.html]]></loc><lastmod>2022-10-13T15:15:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-analisa-interacao-entre-microbioma-e-cancer-de-endometrio.html]]></loc><lastmod>2022-10-10T18:26:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inflamacao-cronica-e-declinio-cognitivo-em-sobrevivente-de-cancer-de-mama.html]]></loc><lastmod>2022-10-18T17:48:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-pembrolizumabe-no-tratamento-adjuvante-do-melanoma-iib-ou-iiic.html]]></loc><lastmod>2022-10-20T12:04:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-neoadjuvante-na-doenca-inicial-her2-positivo-e-tumores-neuroendocrinos-primarios-da-mama.html]]></loc><lastmod>2022-10-04T17:51:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dificuldades-financeiras-e-resultados-clinicos-no-tratamento-do-cancer.html]]></loc><lastmod>2022-10-03T16:31:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estratificacao-de-escores-de-risco-poligenico-para-cancer-de-mama-em-amostras-brasileiras.html]]></loc><lastmod>2022-09-29T19:15:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-discute-custo-e-acesso-no-tratamento-do-cancer.html]]></loc><lastmod>2022-10-03T15:28:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incontinencia-urinaria-em-mulheres-com-cancer-de-mama-em-uso-de-inibidores-da-aromatase.html]]></loc><lastmod>2022-09-29T14:19:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inflamacao-e-declinio-clinico-apos-quimioterapia-adjuvante-em-idosos-com-cancer-de-mama.html]]></loc><lastmod>2022-09-27T15:31:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/os-efeitos-da-pandemia-de-covid-19-na-prevencao-e-cuidados-em-cancer.html]]></loc><lastmod>2022-09-26T22:58:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/save-colonografia-por-tc-unica-ou-teste-imunoquimico-fecal-para-rastreamento-populacional-de-cancer-colorretal.html]]></loc><lastmod>2022-09-26T19:29:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-guideline-de-iparp-no-cancer-epitelial-de-ovario.html]]></loc><lastmod>2022-09-26T19:26:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/parametros-expandidos-de-vigilancia-ativa-no-carcinoma-papilifero-de-tireoide-de-baixo-risco.html]]></loc><lastmod>2022-09-22T17:20:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-no-esmo-2022.html]]></loc><lastmod>2022-09-25T12:26:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-recomendacoes-abordam-o-uso-de-terapias-integrativas-para-o-manejo-da-dor-em-pacientes-com-cancer.html]]></loc><lastmod>2022-10-04T21:56:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/subtipo-clinico-resposta-ao-tratamento-e-sobrevida-em-cancer-de-mama-metastatico-recorrente-em-comparacao-com-doenca-metastatica-de-novo.html]]></loc><lastmod>2022-09-14T17:59:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/manejo-cirurgico-de-pacientes-com-cancer-de-mama-com-mutacao-brca.html]]></loc><lastmod>2022-09-06T14:49:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preservacao-de-fertilidade-e-rcb-residual-cancer-burden-conforme-o-subtipo-tumoral.html]]></loc><lastmod>2022-08-31T22:29:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevencao-do-cancer-de-prostata-fatal.html]]></loc><lastmod>2022-08-31T15:06:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/padroes-de-alto-grau-no-adenocarcinoma-pulmonar.html]]></loc><lastmod>2022-08-30T17:38:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microambiente-tumoral-sistema-imune-e-resposta-a-terapia-com-car-t-cells.html]]></loc><lastmod>2022-08-30T16:48:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevencao-e-controle-do-cancer-evidencias-e-contextos-socioeconomicos.html]]></loc><lastmod>2022-08-29T17:59:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/padrao-de-tratamento-no-carcinoma-neuroendocrino-gi-avancado.html]]></loc><lastmod>2022-08-25T17:57:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cientistas-revelam-potencial-da-biopsia-liquida-no-cancer-de-pulmao-de-pequenas-celulas.html]]></loc><lastmod>2022-08-25T16:25:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adc-em-metastases-cerebrais-e-omissao-da-congelacao-intraoperatoria-para-reducao-de-overtreatment.html]]></loc><lastmod>2022-08-24T15:41:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-cannabis-e-tumores-urologicos.html]]></loc><lastmod>2022-08-24T14:01:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custo-efetividade-da-radioterapia-estereotatica-corporal-no-tratamento-do-cpcnp-estagio-i.html]]></loc><lastmod>2022-08-21T22:35:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eficacia-e-toxicidade-de-anticorpos-droga-conjugado-no-tratamento-de-cancer-urotelial-metastatico.html]]></loc><lastmod>2022-08-21T21:43:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-preditivos-e-desfechos-apos-transplante-alogenico-de-celulas-tronco-para-adultos-com-lla-no-brasil.html]]></loc><lastmod>2022-08-21T21:28:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/chance-cohort-cancer-de-mama-hereditario-no-ceara.html]]></loc><lastmod>2022-08-21T23:12:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/epidemiologia-dos-tumores-urologicos-no-brasil.html]]></loc><lastmod>2022-08-24T20:08:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custo-efetividade-do-teste-genetico-brca-1-2-e-estrategias-preventiva.html]]></loc><lastmod>2022-08-22T01:14:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/beneficio-de-longo-prazo-de-goserrelina-e-ou-tamoxifeno-adjuvante-em-pacientes-na-pre-menopausa-com-cancer-de-mama.html]]></loc><lastmod>2022-08-18T13:18:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-a-combinacao-de-olaparibe-e-abiraterona-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2022-08-18T18:45:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-breast02-resultados-preliminares-confirmam-eficacia-de-trastuzumabe-deruxtecana-no-cancer-de-mama-metastatico-her2-positivo.html]]></loc><lastmod>2022-08-16T21:24:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/macroglobulinemia-de-waldenstroem-padroes-clinicos-e-resultados-na-america-latina.html]]></loc><lastmod>2022-08-15T18:11:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-mostra-atividade-no-tratamento-do-sarcoma-metastatico.html]]></loc><lastmod>2022-08-21T21:24:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ensaios-pivotais-e-disparidades-na-oncohematologia.html]]></loc><lastmod>2022-08-25T20:24:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-hormonal-vaginal-em-pacientes-com-cancer-de-mama-inicial.html]]></loc><lastmod>2022-08-11T00:48:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-e-sobrevida-no-cancer-de-colon-avancado.html]]></loc><lastmod>2022-08-17T20:52:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/equidade-e-acesso-a-assistencia-oncologica.html]]></loc><lastmod>2022-08-09T13:23:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-nao-inferioridade-compara-irradiacao-parcial-e-irradiacao-total-no-cancer-de-mama-de-baixo-risco.html]]></loc><lastmod>2022-08-15T12:57:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-aponta-beneficio-marginal-de-novos-medicamentos-contra-o-cancer-aprovados-pela-fda.html]]></loc><lastmod>2022-08-05T16:09:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qual-o-papel-da-cirurgia-conservadora-de-repeticao-no-manejo-da-recorrencia-ipsilateral-do-cancer-de-mama.html]]></loc><lastmod>2022-08-04T14:11:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lenalidomida-e-risco-secundario-de-neoplasias-mieloides-relacionadas-a-tp53.html]]></loc><lastmod>2022-08-01T02:49:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exposicao-a-longo-prazo-a-incendios-florestais-e-mortalidade-por-cancer.html]]></loc><lastmod>2022-07-31T21:35:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-desafios-para-a-cirurgia-no-cancer-de-pulmao.html]]></loc><lastmod>2022-07-26T19:31:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aspirina-e-quimioprevencao-do-cancer-de-ovario.html]]></loc><lastmod>2022-08-01T01:37:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-terapias-e-risco-cardiovascular-no-linfoma-de-hodgkin.html]]></loc><lastmod>2022-08-01T01:52:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-trastuzumabe-deruxtecana-no-cancer-de-mama-metastatico-her2-low.html]]></loc><lastmod>2022-07-26T13:01:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-endocrina-no-cancer-de-mama-pre-menopausa-estudo-reporta-20-anos-de-acompanhamento.html]]></loc><lastmod>2022-07-25T13:33:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-identificam-proteina-com-papel-chave-no-cancer-colorretal.html]]></loc><lastmod>2022-07-25T12:56:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-e-autismo-novas-evidencias.html]]></loc><lastmod>2022-07-25T12:39:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comissao-europeia-amplia-indicacao-de-trastuzumabe-deruxtecana-no-cancer-de-mama-her2-positivo.html]]></loc><lastmod>2022-07-19T20:13:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metanalise-discute-perfil-de-toxicidade-de-terapias-sistemicas-no-carcinoma-hepatocelular-avancado.html]]></loc><lastmod>2022-08-03T17:14:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-gastrico-e-cirurgia-preservadora.html]]></loc><lastmod>2022-07-19T20:41:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brentuximabe-vedotina-mostra-resultados-de-sobrevida-global-no-linfoma-de-hodgkin-estadio-iii-ou-iv.html]]></loc><lastmod>2022-07-14T18:26:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-de-uso-de-cannabis-em-pacientes-com-cancer-invasivo-nos-eua.html]]></loc><lastmod>2022-07-13T19:14:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-sbco-cirurgia-de-preservacao-da-fertilidade-no-cancer-do-colo-do-utero.html]]></loc><lastmod>2022-07-13T16:51:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trastuzumabe-deruxtecana-reconfigura-o-tratamento-do-cancer-de-mama-avancado.html]]></loc><lastmod>2022-07-13T00:42:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/enact-enzalutamida-versus-vigilancia-ativa-no-cancer-de-prostata.html]]></loc><lastmod>2022-08-05T14:50:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-do-cancer-cervical-e-morbidade-reprodutiva.html]]></loc><lastmod>2022-07-12T15:50:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/agentes-de-saude-e-cuidados-no-cancer-avancado.html]]></loc><lastmod>2022-07-07T13:32:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/manejo-da-axila-apos-os-estudos-monarche-e-olympia.html]]></loc><lastmod>2022-08-01T02:15:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-discute-biossimilares-na-oncologia-latinoamericana.html]]></loc><lastmod>2022-07-07T13:02:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-de-medula-ossea-nao-agrega-valor-a-avaliacao-de-resposta-no-linfoma-folicular.html]]></loc><lastmod>2022-08-04T21:22:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/durvalumabe-mostra-resultados-como-estrategia-perioperatoria-no-cancer-de-pulmao.html]]></loc><lastmod>2022-07-01T12:24:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ressonancia-magnetica-na-neoadjuvancia-e-anidrase-carbonica-como-indicador-prognostico-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2022-06-30T13:11:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/conhecimentos-atitudes-e-praticas-de-vigilancia-ativa-em-cancer-de-prostata-entre-urologistas-brasileiros.html]]></loc><lastmod>2022-06-28T14:24:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-toracica-brasileira-desafios-e-perspectivas.html]]></loc><lastmod>2022-06-28T12:24:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-cenario-do-cancer-na-africa-e-estimativas-para-2040.html]]></loc><lastmod>2022-06-27T22:51:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/falha-bioquimica-nao-e-endpoint-para-sobrevida-global-no-cancer-de-prostata-recorrente.html]]></loc><lastmod>2022-06-27T21:20:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidores-de-parp-no-carcinoma-urotelial-metastatico.html]]></loc><lastmod>2022-06-27T19:51:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ctdna-recorrencia-tardia-e-impacto-dos-estudos-rxponder-e-monarche-no-manejo-cirurgico-da-axila.html]]></loc><lastmod>2022-06-24T03:14:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eha-2022-axi-cel-apresenta-resultados-no-linfoma-de-grandes-celulas-b.html]]></loc><lastmod>2022-06-22T21:46:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/congresso-dedicado-ao-cancer-ginecologico-destaca-programa-brasileiro-de-cancer-cervical.html]]></loc><lastmod>2022-06-22T12:25:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-gi-reune-mais-de-300-pesquisas-ineditas-no-cancer-gastrointestinal.html]]></loc><lastmod>2022-06-22T12:08:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/capmatinibe-recebe-aprovacao-da-ue-para-o-tratamento-de-cancer-de-pulmao-metex14.html]]></loc><lastmod>2022-06-23T13:37:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-oculto-em-pacientes-submetidas-a-mastectomia-profilatica-e-efeito-da-metformina-na-sobrevida-livre-de-doenca-invasiva.html]]></loc><lastmod>2022-06-16T23:26:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-no-asco-2022.html]]></loc><lastmod>2022-06-13T01:24:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-axilar-apos-neoadjuvancia-mari-study-e-resultados-de-eventos-adversos-do-estudo-monarche.html]]></loc><lastmod>2022-06-02T18:40:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/papel-da-disseccao-do-linfonodo-axilar-e-resultados-promissores-do-elacestrant.html]]></loc><lastmod>2022-05-25T16:21:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/compostos-canabinoides-pesquisas-e-aplicacoes-na-oncologia-2.html]]></loc><lastmod>2022-05-30T18:18:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-prostata-e-nutricao-o-que-sabemos.html]]></loc><lastmod>2022-05-23T21:34:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-com-paciente-acordado-no-glioblastoma-multiforme-em-areas-eloquentes.html]]></loc><lastmod>2022-05-26T18:57:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-doenca-cardiovascular-e-terapia-local-isolada-na-doenca-estagio-i.html]]></loc><lastmod>2022-05-18T23:52:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbiota-fecal-no-diagnostico-do-cancer-pancreatico.html]]></loc><lastmod>2022-05-18T10:44:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atrasos-na-cirurgia-e-impacto-na-sobrevida-no-cancer-de-esofago.html]]></loc><lastmod>2022-05-17T18:25:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ikema-resultados-atualizados-reforcam-eficacia-de-isatuximabe-no-mieloma-multiplo-recidivado.html]]></loc><lastmod>2022-05-16T15:37:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-discute-estrategias-de-ehealth-no-cancer-de-mama.html]]></loc><lastmod>2022-05-12T14:29:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eficacia-preditiva-dos-testes-de-expressao-genica-e-ibandronato-adjuvante-no-cancer-de-mamaeficacia-preditiva-dos-testes-de-expressao-genica-e-ibandronato-adjuvante-no-cancer-de-mama.html]]></loc><lastmod>2022-05-12T13:27:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-reverso-do-cancer-de-mama-e-impacto-da-adesao-a-terapia-endocrina-em-idosas.html]]></loc><lastmod>2022-05-05T13:11:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-genomico-melhora-classificacao-diagnostica-e-resultados-clinicos-na-neuro-oncologia.html]]></loc><lastmod>2022-05-01T22:30:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-pulmao-de-celulas-nao-pequenas-com-metastase-no-snc-analise-de-mundo-real.html]]></loc><lastmod>2022-05-01T21:43:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desafios-do-acesso-a-oncologia-de-precisao-para-pacientes-com-cancer.html]]></loc><lastmod>2022-05-01T21:41:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-de-linfonodo-sentinela-no-carcinoma-espinocelular-inicial-de-labio-e-cavidade-oral.html]]></loc><lastmod>2022-05-01T20:59:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/arches-analise-final-mostra-beneficio-de-sg-de-enzalutamida-mais-adt-no-cancer-de-prostata-metastatico-hormonio-sensivel.html]]></loc><lastmod>2022-05-01T20:46:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nivolumabe-mostra-dados-de-qualidade-de-vida-no-cancer-urotelial.html]]></loc><lastmod>2022-05-01T20:09:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bacterias-e-grupos-de-risco-no-cancer-de-prostata.html]]></loc><lastmod>2022-05-01T18:18:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/de-escalonamento-do-tratamento-neoadjuvante-e-irradiacao-dos-linfonodos-de-cadeia-mamaria-interna-no-cancer-de-mama-precoce.html]]></loc><lastmod>2022-04-27T16:11:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-designacao-de-terapia-inovadora-para-trastuzumabe-deruxtecana-no-cancer-de-mama-her2-low.html]]></loc><lastmod>2022-05-01T20:37:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-vida-real-mostra-que-mulher-idosa-e-menos-propensa-a-receber-padrao-de-1-linha-no-cancer-de-mama-metastatico-her2.html]]></loc><lastmod>2022-05-01T19:44:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tislelizumabe-mostra-beneficio-de-sobrevida-global-como-primeira-linha-no-cancer-de-esofago-avancado.html]]></loc><lastmod>2022-05-01T20:53:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidor-de-fgfr-mostra-atividade-pan-cancer.html]]></loc><lastmod>2022-05-01T22:14:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-define-criterios-em-ensaios-de-cancer-de-pancreas-para-doenca-ressecavel-e-borderline.html]]></loc><lastmod>2022-05-01T20:18:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/coast-novas-combinacoes-de-imunoterapia-mostram-resultados-no-cancer-de-pulmao.html]]></loc><lastmod>2022-05-01T19:32:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/transtorno-do-espectro-do-autismo-e-risco-de-cancer.html]]></loc><lastmod>2022-04-27T11:32:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-abordagem-mostra-resultados-no-rastreamento-do-cancer-de-mama.html]]></loc><lastmod>2022-05-01T23:08:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caracteristicas-diferencas-clinicas-e-resultados-de-pacientes-com-cancer-de-mama-her2-negativo-ou-com-baixa-expressao-de-her2.html]]></loc><lastmod>2022-04-21T02:34:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trastuzumabe-deruxtecana-obtem-revisao-prioritaria-do-fda-como-opcao-no-cancer-de-pulmao.html]]></loc><lastmod>2022-05-01T19:53:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/privacao-androgenica-adjuvante-no-cancer-de-prostata-qual-a-duracao-ideal.html]]></loc><lastmod>2022-04-27T18:28:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gerenciamento-do-cancer-de-prostata-durante-a-pandemia-de-covid-19.html]]></loc><lastmod>2022-04-17T01:21:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caracterizacao-molecular-e-clinico-patologica-do-cancer-de-pulmao-fator-de-splicing-mutado.html]]></loc><lastmod>2022-04-17T00:37:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/coinfeccao-com-virus-epstein-barr-afeta-a-persistencia-do-hpv-oral.html]]></loc><lastmod>2022-04-17T00:34:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perda-de-peso-e-diagnostico-subsequente-de-cancer.html]]></loc><lastmod>2022-04-17T00:26:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avaliacao-global-do-tabagismo-durante-a-fase-inicial-da-pandemia-de-covid-19.html]]></loc><lastmod>2022-04-25T20:38:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-paliativos-continuam-subutilizados-na-rotina-da-assistencia-oncologica.html]]></loc><lastmod>2022-04-17T13:03:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacina-baseada-em-peptideos-induz-resposta-imune-de-celulas-t-em-pacientes-com-deficiencia-de-celulas-b.html]]></loc><lastmod>2022-04-17T00:23:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mortalidade-apos-recorrencia-tardia-e-fadiga-de-longo-prazo-em-sobreviventes.html]]></loc><lastmod>2022-04-13T23:40:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-cabozantinibe-em-combinacao-com-nivolumabe-na-primeira-linha-do-carcinoma-de-celulas-renais-avancado.html]]></loc><lastmod>2022-04-12T15:08:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exercicio-fisico-e-pos-operatorio-do-cancer-de-mama.html]]></loc><lastmod>2022-04-17T14:20:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carcinoma-da-orofaringe-associado-a-hpv-da-epidemiologia-a-rotina-clinica.html]]></loc><lastmod>2022-04-17T12:03:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lumpectomia-promove-sobrevida-equivalente-a-mastectomia-em-mulheres-jovens-om-cancer-de-mama.html]]></loc><lastmod>2022-04-17T22:57:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/espectro-mutacional-de-genes-de-suscetibilidade-ao-cancer-de-mama-no-nordeste-do-brasil.html]]></loc><lastmod>2022-04-17T13:42:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ans-realiza-consulta-publica-para-avaliar-a-incorporacao-de-novos-agentes-no-tratamento-do-cancer.html]]></loc><lastmod>2022-04-07T19:56:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/irradiacao-eletiva-do-pescoco-ipsilateral-e-nao-inferior-a-irradiacao-total-no-cancer-de-nasofaringe-inicial.html]]></loc><lastmod>2022-04-17T13:36:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acompanhamento-de-longo-prazo-do-estudo-brightness-e-valor-prognostico-dos-stils-no-tnbc.html]]></loc><lastmod>2022-04-07T12:19:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcador-mostra-especificidade-e-sensibilidade-no-diagnostico-do-cancer-pancreatico.html]]></loc><lastmod>2022-04-25T16:35:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pancreatite-e-cancer-de-pancreas-magnitude-da-associacao-e-forca-das-evidencias.html]]></loc><lastmod>2022-04-06T19:18:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radiogenomica-locus-de-suscetibilidade-associado-a-mucosite-induzida-por-radioterapia.html]]></loc><lastmod>2022-04-17T13:24:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/overview-sarcoma-adulto-e-trajetoria-clinica-no-brasil.html]]></loc><lastmod>2022-04-26T17:28:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nccn-2022-discute-progressos-e-desafios-no-tratamento-do-melanoma.html]]></loc><lastmod>2022-04-06T19:14:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/axi-cel-terapia-car-t-cells-tem-nova-aprovacao-do-fda.html]]></loc><lastmod>2022-04-05T14:44:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consulta-publica-para-nova-incorporacao-no-sus.html]]></loc><lastmod>2022-04-05T14:49:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hipofracionamento-moderado-para-radioterapia-de-resgate-em-pacientes-com-recorrencia-bioquimica-apos-prostatectomia.html]]></loc><lastmod>2022-04-03T21:41:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intervencoes-para-fibrose-radioinduzida-em-pacientes-com-cancer-de-mama.html]]></loc><lastmod>2022-04-04T00:35:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/testagem-para-mutacao-de-egfr-em-pacientes-com-cpcnp-estagio-inicial-e-avancado.html]]></loc><lastmod>2022-04-04T00:33:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-prognosticos-no-cancer-do-colo-do-utero-localmente-avancado-com-metastase-linfonodal-pelvica.html]]></loc><lastmod>2022-04-04T00:35:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avaliacao-genetica-de-pacientes-com-leucemia-linfoblastica-aguda-em-ambiente-com-recursos-limitados.html]]></loc><lastmod>2022-04-04T00:34:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mecanismos-geneticos-de-resistencia-adquirida-a-inibidores-nao-covalentes-da-tirosina-quinase-de-bruton.html]]></loc><lastmod>2022-04-03T16:51:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/conjugado-droga-anticorpo-nao-mostra-resultados-no-mesotelioma-pleural-maligno-recidivado-mesotelina-positivo.html]]></loc><lastmod>2022-04-13T17:06:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-na-prevencao-da-recorrencia-do-cancer-de-mama-pos-cirurgia.html]]></loc><lastmod>2022-04-03T14:30:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adocantes-artificiais-e-risco-de-cancer.html]]></loc><lastmod>2022-04-03T02:04:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-melhora-efeitos-colaterais-fisicos-e-mentais-do-tratamento-contra-o-cancer-de-mama.html]]></loc><lastmod>2022-04-04T00:37:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nccn-2022-reforca-compromisso-com-melhores-praticas-nos-cuidados-em-cancer.html]]></loc><lastmod>2022-03-31T17:32:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-breast03-estudo-confirma-eficacia-de-trastuzumabe-deruxtecana-no-cancer-de-mama-metastatico-her2-positivo.html]]></loc><lastmod>2022-04-04T00:31:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/experiencia-global-no-cancer-gastroesofagico-egfr-amplificado.html]]></loc><lastmod>2022-03-31T13:53:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-esquema-de-inducao-melhora-resultados-no-cancer-de-nasofaringe.html]]></loc><lastmod>2022-04-03T16:24:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vesper-quimioterapia-perioperatoria-no-cancer-de-bexiga-musculo-invasivo-nao-metastatico.html]]></loc><lastmod>2022-04-04T00:38:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-promessa-na-macroglobulinemia-de-waldenstroem.html]]></loc><lastmod>2022-03-31T14:14:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-aponta-que-sobrediagnostico-de-cancer-de-mama-baseado-em-rastreamento-e-menor-do-que-o-estimado.html]]></loc><lastmod>2022-03-28T21:48:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gastrectomia-ou-preservacao-do-estomago-no-cancer-gastrico.html]]></loc><lastmod>2022-04-04T00:30:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-no-cancer-de-pancreas-limitrofe-e-localmente-avancado.html]]></loc><lastmod>2022-04-04T01:06:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/linfocitos-tumorais-infiltrantes-e-informacoes-prognosticas-no-cancer-de-mama-ductal-in-situ-de-baixo-risco.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/breast-breaking-news.html]]></loc><lastmod>2022-03-24T17:48:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sarcopenia-e-sobrevida-global-no-adenocarcinoma-ductal-pancreatico.html]]></loc><lastmod>2022-03-25T16:45:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-177lu-psma-617-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tendencias-na-incidencia-do-cancer-de-prostata-metastatico-sp-351.html]]></loc><lastmod>2022-03-24T14:18:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-sistemica-neoadjuvante-afeta-subtipo-molecular-no-tnbc-sp-692.html]]></loc><lastmod>2022-04-03T16:58:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/elcc-destaca-registros-de-cancer-e-biomarcadores-no-cancer-de-pulmao.html]]></loc><lastmod>2022-03-23T18:11:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lacc-histerectomia-radical-aberta-vs-minimamente-invasiva-no-cancer-cervical-em-estagio-inicial.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bilcap-capecitabina-adjuvante-em-tumores-do-trato-biliar.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brotamento-tumoral-como-biomarcador-prognostico-no-cancer-de-colon.html]]></loc><lastmod>2022-04-03T15:48:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-opdualag-no-tratamento-do-melanoma-irressecavel-ou-metastatico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/deteccao-de-variantes-germinativas-em-pacientes-brasileiras-com-cancer-de-mama-via-painel-multigenico.html]]></loc><lastmod>2022-03-20T22:27:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ressonancia-magnetica-no-reestadiamento-apos-terapia-neoadjuvante-para-cancer-retal-sp-463.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pneumonite-induzida-por-everolimus-em-pacientes-com-neoplasias-neuroendocrinas-sp-314.html]]></loc><lastmod>2022-03-20T16:17:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-colorretal-e-obesidade-ao-longo-da-vida-sp-453.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/american-cancer-society-atualiza-diretrizes-de-nutricao-e-atividade-fisica-para-sobreviventes-de-cancer.html]]></loc><lastmod>2022-03-20T18:31:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-de-saude-dos-eua-aumenta-endividamento-pessoal-para-o-tratamento-do-cancer.html]]></loc><lastmod>2022-03-17T20:49:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacientes-de-cancer-e-resposta-a-vacina-de-mrna-contra-sars-cov-2.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rucaparibe-mostra-resultados-no-cancer-de-ovario.html]]></loc><lastmod>2022-03-19T20:30:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/um-em-cada-5-participantes-de-ensaios-de-fase-iii-usa-medicamentos-complementares.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-acesso-subotimo-ao-diagnostico-e-tratamento-de-tumores-neuroendocrinos-no-brasil.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-status-do-receptor-hormonal-e-resultados-de-sobrevida.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ostomia-protetora-nao-reduz-taxa-de-vazamento-anastomotico.html]]></loc><lastmod>2022-04-03T14:08:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-olaparibe-adjuvante-no-cancer-de-mama-de-alto-risco-sp-397.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-novo-inibidor-de-parp-no-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ressonancia-magnetica-multiparametrica-ou-ultrassonografia-multiparametrica-no-diagnostico-do-cancer-de-prostata-sp-376.html]]></loc><lastmod>2022-03-14T11:27:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mede-eficacia-das-vacinas-sars-cov-2-no-mieloma-multiplo.html]]></loc><lastmod>2022-03-20T18:06:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-da-asco-para-o-tratamento-adjuvante-do-cancer-de-colon-estagio-ii.html]]></loc><lastmod>2022-03-20T15:51:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/saude-sexual-e-cancer-de-mama.html]]></loc><lastmod>2022-03-09T13:05:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/coleta-inadequada-de-linfonodos-impacta-sobrevida-no-cancer-retal-sp-217.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estado-nutricional-e-risco-cirurgico-no-cancer-de-esofago-sp-211.html]]></loc><lastmod>2022-03-20T18:26:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/padrao-alimentar-e-cancer-de-bexiga.html]]></loc><lastmod>2024-05-05T00:40:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sacituzumab-govitecan-mostra-ganho-de-slp-no-cancer-de-mama-metastatico-hr-her2.html]]></loc><lastmod>2022-03-08T16:53:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estatura-e-risco-de-cancer-colorretal.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-discute-sindrome-de-werner-e-toxicidade-no-tratamento-do-cancer-sp-298.html]]></loc><lastmod>2022-03-20T20:05:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-discute-carcinoma-hepatocelular-relacionado-a-doenca-hepatica-gordurosa-nao-alcoolica.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estroma-fibrogenico-e-desenvolvimento-do-cancer.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mapa-da-agua-alerta-para-substancias-cancerigenas-na-agua-que-sai-da-torneira-sp-529.html]]></loc><lastmod>2022-03-09T12:00:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/icaria-novos-dados-de-sobrevida-de-isatuximabe-no-mieloma-multiplo.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-nivolumabe-em-combinacao-com-quimioterapia-na-neoadjuvancia-do-cancer-de-pulmao-sp-340.html]]></loc><lastmod>2022-03-06T19:35:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/em-pacientes-com-carcinoma-espinocelular-de-cabeca-e-pescoco-localmente-avancado-de-alto-risco-pos-operatorio-a-quimiorradioterapia-com-cisplatina-semanal-40-mg-m2-produz-eficacia-comparavel-ao-regime-de-cisplatina-de-3-semanas-estudo-de-nao-inferioridade-reportou-resultados-no-journal-of-clinical-oncology-em-artigo-de-kiyota-et-al-mostrando-que-a-quimiorradioterapia-com-cisplatina-semanal-pod-sp-.html]]></loc><lastmod>2022-03-04T17:41:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-agente-mostra-resultados-na-trombocitopenia-induzida-por-quimioterapia.html]]></loc><lastmod>2022-03-03T13:26:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-de-vida-no-tratamento-de-sarcomas.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-paliativa-na-oncologia-toracica-e-efeitos-esofagicos.html]]></loc><lastmod>2022-03-06T22:18:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preopanc-resultados-de-longo-prazo-mostram-beneficio-da-neoadjuvancia-no-cancer-de-pancreas-sp-697.html]]></loc><lastmod>2022-03-05T20:52:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fdg-pet-e-descalonamento-de-dose-no-cancer-de-orofaringe.html]]></loc><lastmod>2022-02-25T18:24:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-dupla-com-inibidores-de-checkpoint-apresenta-resultados-promissores-em-cancer-de-mama-altamente-mutado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dispositivo-nao-endoscopico-na-vigilancia-do-esofago-de-barrett.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidor-de-aromatase-em-mulheres-pre-menopausadas-com-supressao-ovariana-e-reducao-do-risco-de-recorrencia-do-cancer-de-mama-sp-504.html]]></loc><lastmod>2022-02-24T12:14:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-primeira-terapia-genica-no-tratamento-do-cancer.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/citorreducao-secundaria-no-cancer-de-ovario-sensivel-a-platina-tem-impacto-na-sobrevida-global-sp-675.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-breast04-novo-paradigma-no-cancer-de-mama-her2.html]]></loc><lastmod>2022-03-09T14:27:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hot-topics-em-oncologia-mamaria-sp-544.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-determinantes-geneticos-e-implicacoes.html]]></loc><lastmod>2022-02-16T12:38:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desigualdades-no-acesso-rastreamento-do-cancer-do-colo-uterino.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-de-risco-e-mortalidade-qual-o-cenario-brasileiro.html]]></loc><lastmod>2022-02-14T10:55:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mortalidade-por-cancer-de-prostata-no-brasil-1990-a-2019-sp-240.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-pos-operatoria-moderadamente-hipofracionada-para-cancer-de-mama.html]]></loc><lastmod>2022-02-09T16:40:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mulheres-tem-mais-eventos-adversos-com-imunoterapias-e-terapias-alvo-sp-983.html]]></loc><lastmod>2022-02-07T20:49:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/valor-da-perda-de-heterozigosidade-para-a-classificacao-da-variante-brca1.html]]></loc><lastmod>2022-02-07T15:34:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rituximabe-e-resposta-a-vacina-contra-covid-19.html]]></loc><lastmod>2022-02-04T18:43:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cmed-define-preco-para-zanubrutinibe-para-o-tratamento-do-linfoma-de-celulas-do-manto.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-poligenico-estilo-de-vida-e-cancer-colorretal-em-idade-precoce.html]]></loc><lastmod>2022-02-04T15:00:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assedio-sexual-contra-oncologias-qual-a-incidencia.html]]></loc><lastmod>2022-02-01T23:44:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imatinibe-um-marco-no-tratamento-do-cancer-falta-para-o-paciente-brasileiro.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/axicabtagene-ciloleucel-fda-atualiza-prescricao-e-inclui-corticosteroide-profilatico-sp-972.html]]></loc><lastmod>2022-01-31T20:29:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intrigue-ripretinib-vs-sunitinibe-em-pacientes-com-gist-previamente-tratados-com-imatinibe.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/evita-caracteristicas-das-pacientes-diagnosticadas-com-cancer-do-colo-do-utero-no-brasil-sp-410.html]]></loc><lastmod>2022-01-28T13:42:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metanalise-discute-obesidade-e-recorrencia-bioquimica-no-cancer-de-prostata.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobreviventes-do-cancer-de-mama-e-efeitos-de-longo-prazo-14-anos-de-analise.html]]></loc><lastmod>2022-01-27T20:13:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-do-cancer-de-pulmao-e-populacao-alvo-sp-409.html]]></loc><lastmod>2022-01-28T13:06:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recorrencia-sintomatica-e-resultados-de-sobrevida-apos-o-tratamento-curativo-do-cancer-gastrico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-novo-tratamento-para-melanoma-uveal-sp-912.html]]></loc><lastmod>2022-01-26T23:35:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-prediz-risco-de-fadiga-grave-em-sobreviventes-de-cancer-de-mama-sp-621.html]]></loc><lastmod>2022-01-26T23:29:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-nova-revisao-prioritaria-para-trastuzumabe-deruxtecana-no-cancer-de-mama-her2-positivo-metastatico.html]]></loc><lastmod>2022-01-18T16:34:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacoes-kras-e-impacto-na-sobrevida-no-cancer-colorretal-sp-303.html]]></loc><lastmod>2022-01-17T12:35:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sedentarismo-piora-resultados-em-sobreviventes-de-cancer.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assinatura-genica-como-biomarcador-prognostico-e-preditivo-em-pacientes-com-cancer-de-mama-lobular-invasivo.html]]></loc><lastmod>2021-11-30T12:05:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ativacao-da-via-cgas-sting-e-resposta-a-terapia-neoadjuvante-no-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perspectiva-epigenetica-dos-tumores-de-cabeca-e-pescoco-sp-494.html]]></loc><lastmod>2021-11-27T23:01:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/presenca-brasileira-na-63-ash.html]]></loc><lastmod>2021-11-27T22:32:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-e-mutacoes-mutyh.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/validacao-multi-institucional-de-um-modelo-de-risco-de-cancer-de-mama-baseado-em-mamografia-sp-541.html]]></loc><lastmod>2021-11-27T20:24:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acalabrutinibe-na-llc-com-transformacao-de-richter.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-fator-prognostico-no-cancer-endometrial.html]]></loc><lastmod>2021-11-26T21:36:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/burnout-e-seguranca-do-paciente-na-onco-hematologia.html]]></loc><lastmod>2021-11-26T15:26:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nao-ha-impacto-da-via-de-administracao-da-profilaxia-na-reducao-de-recidiva-de-snc-no-linfoma-nao-hodgkin-agressivo-sp-651.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-miosteatose-no-prognostico-de-pacientes-com-cancer-de-colon-e-reto-nao-metastatico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/classificacao-prognostica-de-sg-em-pacientes-com-cancer-de-mama-e-metastase-cerebral-recorrente.html]]></loc><lastmod>2021-11-22T20:34:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/um-marco-importante-em-tumores-neuroendocrinos-de-midgut-sp-723.html]]></loc><lastmod>2021-11-17T17:23:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-pos-mastectomia-apos-resposta-patologica-nodal-completa-a-quimioterapia-neoadjuvante-um-preludio-para-nsabp-b-51-sp-729.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biossimilares-e-economia-de-custos.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-doencas-relacionadas-a-idade-em-sobreviventes-jovens-de-linfoma-nao-hodgkin-de-celulas-b.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/protocolo-de-recuperacao-aprimorada-apos-cirurgia-toracica-adaptado-a-realidade-brasileira.html]]></loc><lastmod>2021-11-08T22:37:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/repensando-o-rastreamento-do-cancer-cervical-pos-covid-19-no-brasil-sp-489.html]]></loc><lastmod>2021-11-07T17:41:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-discute-populacao-alvo-e-rastreamento-do-cancer-de-pulmao-no-brasil.html]]></loc><lastmod>2021-11-08T01:15:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-estereotatica-no-tratamento-de-oligometastases-de-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trastuzumabe-com-ou-sem-quimioterapia-no-cancer-de-mama-pt1n0-her2-estagio-1.html]]></loc><lastmod>2021-11-07T14:37:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impact-trial-reporta-resultados-de-gefitinibe-adjuvante-no-cancer-de-pulmao-sp-353.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/as-taxas-de-recorrencia-local-sao-mais-altas-em-pacientes-elegiveis-a-cirurgia-conservadora-da-mama-apos-a-quimioterapia-neoadjuvante-sp-558.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-estereotatica-em-pacientes-com-cancer-de-pulmao-avancado-oligoprogressivo.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assinatura-genica-traz-novos-dados-sobre-linfomas-cutaneos-de-celulas-t.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-mutacional-do-carcinoma-epidermoide-de-esofago-em-pacientes-brasileiros.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ressonancia-magnetica-pre-operatoria-no-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-zanubrutinibe-no-linfoma-de-celulas-de-manto.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/padroes-de-tratamento-e-resultados-da-terapia-sistemica-paliativa-em-pacientes-com-carcinoma-do-ducto-salivar-e-adenocarcinoma.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sequenciamento-de-rna-expressao-alvo-e-novas-terapias-em-sarcomas-de-tecidos-moles.html]]></loc><lastmod>2021-10-24T17:37:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avancos-no-tratamento-do-cancer-urotelial-metastatico.html]]></loc><lastmod>2021-10-25T02:36:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/telessaude-e-aconselhamento-genetico-de-cancer-durante-a-pandemia-sp-466.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metodos-contemporaneos-de-escalonamento-de-dose-para-estudos-de-fase-inicial-na-era-da-imunoterapia.html]]></loc><lastmod>2021-10-20T19:27:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/testes-geneticos-em-irmaos-para-variantes-geneticas-de-suscetibilidade-ao-cancer.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-com-meta-analise-discute-lobectomia-no-cancer-de-pulmao.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mulher-idosa-e-mais-propensa-a-receber-tratamento-subotimo-no-cancer-de-mama-metastatico-her2-sp-364.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-discute-padrao-de-primeira-linha-no-carcinoma-hepatocelular-irressecavel.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-para-o-manejo-da-dor-associada-ao-cancer.html]]></loc><lastmod>2021-10-25T02:36:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/distancia-tumor-mamilo-1-cm-prediz-patologia-retromamilar-negativa-apos-quimioterapia-neoadjuvante-sp-495.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meeting-the-minds-especialistas-discutem-questoes-centrais-em-oncologia-e-hematologia.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-combinacao-no-tratamento-de-segunda-linha-do-cancer-colorretal-metastatico-braf-mutado.html]]></loc><lastmod>2021-10-06T14:27:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-trastuzumab-deruxtecan-no-cancer-de-mama-metastatico-politratado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qual-o-impacto-da-exposicao-ao-estrogenio-exogeno-no-cancer-de-mama-re-her2-negativo-em-estagio-inicial.html]]></loc><lastmod>2021-10-06T16:34:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-cemiplimabe-no-cancer-cervical-avancado-sp-270.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/indice-de-toxicidade-e-adesao-a-terapia-endocrina-no-cdis-sp-450.html]]></loc><lastmod>2021-09-28T15:17:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/identificacao-genetica-na-lma-em-adultos-acima-de-60-anos-sp-488.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preditores-de-linfonodos-axilares-nao-sentinela-positivos-em-pacientes-com-biopsia-de-linfonodo-sentinela-positivo-apos-terapia-neoadjuvante.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ipen-paralisa-producao-de-radiofarmacos.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/regime-simplificado-de-pre-medicacao-antes-de-paclitaxel-em-pacientes-com-cancer-de-mama-inicial-sp-532.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/conitec-abre-consulta-publica-para-incorporar-inibidores-de-ciclinas-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2021-09-13T14:29:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-alvo-e-tratamento-endocrino-combinados-no-cancer-de-mama-luminal-sp-993.html]]></loc><lastmod>2021-09-12T16:38:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-de-inducao-no-cancer-de-cavidade-oral-avancado.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/determinantes-sociais-da-saude-e-sobrevida-em-pacientes-brasileiros-com-glioblastoma.html]]></loc><lastmod>2021-09-12T14:34:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevencao-e-tratamento-da-xerostomia-no-tratamento-do-cancer-sp-565.html]]></loc><lastmod>2021-09-13T13:05:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-versus-linfadenectomia-inguinofemoral-no-cancer-vulvar.html]]></loc><lastmod>2021-09-13T16:10:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/a-perda-de-positividade-her2-apos-terapia-alvo-neoadjuvante-esta-associada-a-resultados-oncologicos-inferiores.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-dupla-imunoterapia-no-tratamento-de-primeira-linha-do-cancer-de-pulmao-em-primeira-linha.html]]></loc><lastmod>2021-09-09T16:29:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobreviventes-de-cancer-tem-maior-risco-de-psoriase.html]]></loc><lastmod>2021-09-30T17:35:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-compara-cirurgia-aberta-laparoscopia-e-robotica-na-pancreatoduodenectomia-sp-855.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-em-cirurgia-aposta-em-modelo-cooperativo.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/medo-de-recidiva-em-pacientes-com-cancer-de-prostata-localizado-sp-270.html]]></loc><lastmod>2021-08-30T01:09:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-guarda-chuva-analisa-evidencias-da-associacao-entre-dieta-e-risco-de-cancer-em-11-locais-anatomicos.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-em-combo-neoadjuvante-no-cancer-de-bexiga-supera-resultados-historicos.html]]></loc><lastmod>2021-08-29T20:05:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/micra-trial-e-possivel-omitir-a-cirurgia-apos-a-neoadjuvancia.html]]></loc><lastmod>2021-08-29T18:50:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-nao-mostra-beneficio-no-cancer-de-mama-triplo-negativo-metastatico.html]]></loc><lastmod>2021-08-29T14:54:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biossimilares-na-oncologia-brasileira-como-estamos.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/escore-de-risco-perioperatorio-para-pacientes-octogenarios-elegiveis-para-cirurgia-de-cancer-retal.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-pandemia-de-covid-19-nas-hospitalizacoes-relacionadas-ao-cancer-no-brasil.html]]></loc><lastmod>2021-08-27T15:58:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-e-vigilancia-ativa-no-cancer-de-prostata-sp-437.html]]></loc><lastmod>2021-08-29T17:17:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/status-her2-low-e-resposta-a-quimioterapia-neoadjuvante-no-cancer-de-mama-inicial-her2-negativo-sp-764.html]]></loc><lastmod>2021-08-25T15:09:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-do-cancer-de-mama-estagios-i-e-ii-com-micrometastases-nodais-tratado-com-mastectomia-sem-terapia-axilar.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/stella-eficacia-seguranca-e-imunogenicidade-de-bevacizumabe-biossimilar-mb02-no-cpcnp-avancado.html]]></loc><lastmod>2021-08-24T21:00:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/manifestacoes-orais-da-doenca-do-enxerto-contra-hospedeiro-em-pacientes-submetidos-a-transplante-alogenico-de-celulas-tronco-hematopoeticas.html]]></loc><lastmod>2021-08-17T15:33:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-funcionais-e-oncologicos-da-cirurgia-renal-para-tumores-hilares-sp-651.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consideracoes-praticas-para-o-hipofracionamento-da-prostata-em-paises-em-desenvolvimento-sp-291.html]]></loc><lastmod>2021-08-16T10:25:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diferencas-em-carga-mutacional-expressao-de-pd-l1-e-desfechos-clinicos-com-imunoterapia-em-cpcnp-com-mutacoes-alvo-sp-437.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consideracoes-praticas-para-agilizar-o-tratamento-do-cancer-de-mama-no-brasil-sp-576.html]]></loc><lastmod>2021-08-16T03:16:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/evolucao-da-terapia-neoadjuvante-no-cancer-retal-localmente-avancado-sp-723.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/causas-de-morte-em-ex-trabalhadores-da-industria-de-cimento-amianto-no-estado-de-sao-paulo-sp-392.html]]></loc><lastmod>2021-08-15T23:38:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anti-pd-1-e-terapia-celular-adotiva-mostram-resultados-promissores-no-cpcnp.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/manejo-da-recorrencia-de-tumor-de-mama-ipsilateral-apos-cirurgia-de-conservacao-da-mama.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destiny-breast03-trastuzumabe-deruxtecan-mostra-ganho-de-slp-no-cancer-de-mama-metastatico-her2-positivo-sp-779.html]]></loc><lastmod>2021-08-12T13:19:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapias-neoadjuvantes-e-biomarcadores-de-sobrevida-no-cancer-de-mama-her2.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-endocrina-neoadjuvante-como-alternativa-a-qt-neo-em-pacientes-com-cancer-de-mama-rh.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hpv-e-cancer-cervical-em-mulheres-hiv-positivas.html]]></loc><lastmod>2021-09-02T19:54:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ecog-acrin-entinostat-nao-tem-papel-no-cancer-de-mama-avancado.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-e-microbioma-vaginal-pos-cirurgia-bariatrica.html]]></loc><lastmod>2021-08-15T23:16:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/empower-lung-3-cemiplimabe-mostra-resultados-no-tratamento-de-primeira-linha-do-cpcnp-avancado-sp-504.html]]></loc><lastmod>2021-08-06T16:46:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avapritinibe-apresenta-novos-dados-no-gist-avancado.html]]></loc><lastmod>2021-08-10T15:38:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-cabozantinibe-no-tratamento-de-cancer-de-figado-sp-138.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-clinica-em-cancer-se-recupera-apos-impacto-inicial-da-pandemia-de-covid-19.html]]></loc><lastmod>2021-08-15T23:05:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-colorretal-laparoscopica-alta-hospitalar-em-24-horas-e-risco-de-readmissao-sp-339.html]]></loc><lastmod>2021-08-03T14:17:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidores-de-checkpoint-imune-e-endocrinopatias.html]]></loc><lastmod>2021-08-01T22:27:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/duracao-ideal-da-terapia-hormonal-adjuvante-em-pacientes-na-pos-menopausa-com-cancer-de-mama-hr.html]]></loc><lastmod>2021-08-01T21:23:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/covid-te-avaliacao-de-risco-para-tromboembolismo-venoso-em-pacientes-hospitalizados-com-cancer-e-covid-19-sp-890.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-oncologicos-em-pacientes-com-cancer-endometrial-e-metastases-de-baixo-volume-sp-499.html]]></loc><lastmod>2021-08-03T18:44:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-sistematico-de-sars-cov-2-em-pacientes-assintomaticos-com-cancer-sp-447.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variante-r337h-no-gene-tp53-no-perfil-genomico-do-tumor-e-testagem-para-sindrome-de-li-fraumeni.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-investiga-infeccoes-por-variantes-do-sars-cov-2.html]]></loc><lastmod>2021-08-01T15:17:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/icaria-mm-resultados-atualizados-de-isatuximabe-no-mieloma-multiplo-recidivado-e-refratario-sp-943.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estilo-de-vida-pode-atenuar-risco-de-cancer-hereditario-sp-648.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/relatorio-da-oms-destaca-necessidade-de-regulamentacao-de-cigarros-eletronicos.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desintensificacao-terapeutica-no-cancer-de-pancreas-metastatico.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biobanco-de-barretos-apoia-pesquisa-translacional-em-oncologia.html]]></loc><lastmod>2025-05-05T15:10:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-promessa-no-hepatocarcinoma-avancado-sp-593.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/supressao-androgenica-de-curto-prazo-e-radioterapia-no-cancer-de-prostata-de-risco-intermediario-sp-669.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidores-do-receptor-androgenico-no-idoso-com-cancer-de-prostata-resistente-a-castracao-sp-348.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sexo-e-estagio-clinico-explicam-diferencas-no-cancer-de-pulmao-sp-982.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-de-risco-para-disgeusia-durante-quimioterapia-sp-698.html]]></loc><lastmod>2021-07-26T14:05:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estimulacao-ovariana-e-cancer-de-mama-existe-risco-sp-693.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-adjuvante-no-cancer-de-prostata.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perspectiva-dos-oncologistas-sobre-atendimento-odontologico-no-tratamento-do-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nala-resultados-em-pacientes-com-cancer-de-mama-her2-positivo-e-metastases-do-sistema-nervoso-central-sp-244.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/plasma-convalescente-e-sobrevida-em-pacientes-com-cancer-hematologico-e-covid-19.html]]></loc><lastmod>2021-07-19T19:10:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-carne-vermelha-e-mutacoes-associadas-a-danos-no-dna-em-pacientes-com-cancer-colorretal-sp-614.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-enfortumab-vedotin-no-cancer-urotelial-avancado.html]]></loc><lastmod>2021-07-14T13:01:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/orient-32-novo-regime-mostra-beneficio-como-primeira-linha-no-carcinoma-hepatocelular.html]]></loc><lastmod>2021-07-14T14:51:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custo-dos-oncologicos-nos-eua-cresce-150-em-uma-decada-sp-383.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combo-adjuvante-aumenta-sobrevida-no-cancer-pancreatico-sp-370.html]]></loc><lastmod>2021-07-07T13:44:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-genomico-em-pacientes-com-cancer-de-mama-inicial-uma-experiencia-no-sus.html]]></loc><lastmod>2021-07-04T22:32:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-asiatico-reporta-resultados-de-nova-abordagem-perioperatoria-no-cancer-gastrico-localmente-avancado.html]]></loc><lastmod>2021-07-18T20:50:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/5-vs-2-anos-de-bisfofonato-adjuvante-no-cancer-de-mama-inicial-sp-821.html]]></loc><lastmod>2021-07-01T02:28:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-de-mama-e-rastreamento-em-pessoas-transgeneros.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/subestimacao-histologica-e-biopsia-do-linfonodo-sentinela-no-cdis-sp-222.html]]></loc><lastmod>2021-06-22T16:42:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/salpingectomia-ooforectomia-e-qualidade-de-vida-em-portadores-de-variantes-patogenicas-brca1-2.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-tratamento-para-mutacao-de-cancer-de-pulmao-com-mutacao-met.html]]></loc><lastmod>2021-06-17T16:39:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/subtipos-de-cancer-de-mama-baseados-em-pam50-e-imunohistoquimica-e-mortalidade-pela-doenca.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diabetes-e-risco-de-cancer-colorretal.html]]></loc><lastmod>2021-05-31T15:37:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/remocao-do-linfonodo-sentinela-apos-qt-neoadjuvante-em-pacientes-com-linfonodos-clinicamente-negativos-sp-213.html]]></loc><lastmod>2021-05-27T02:24:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tendencias-na-incidencia-e-morbidade-do-carcinoma-de-celulas-de-merkel-no-brasil.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fdg-pet-ct-e-envolvimento-da-medula-ossea-no-estadiamento-inicial-de-pacientes-com-linfoma-nao-hodgkin-agressivo.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pet-ct-no-controle-do-cancer-de-prostata-sp-976.html]]></loc><lastmod>2021-05-24T01:28:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/calgb-90601-apresenta-resultados-no-carcinoma-urotelial.html]]></loc><lastmod>2021-05-23T21:24:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-global-avalia-imunogenicidade-da-vacina-contra-covid-19-em-pacientes-oncohematologicos-tratados-com-terapia-celular.html]]></loc><lastmod>2021-05-23T04:05:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resposta-patologica-do-cdis-ao-tratamento-neoadjuvante-no-cancer-de-mama-her2-sp-198.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desigualdades-socioeconomicas-e-a-covid-19-no-brasil.html]]></loc><lastmod>2021-05-20T16:34:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cemiplimabe-mostra-atividade-e-seguranca-no-carcinoma-basocelular-avancado.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidor-de-checkpoint-mostra-resultados-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2021-05-14T02:11:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-terapia-endocrina-adjuvante-no-prognostico-do-cancer-de-mama-inicial-hr-pequeno-positivo-her2-negativo-sp-337.html]]></loc><lastmod>2021-05-24T01:45:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidor-de-parp-rucaparib-mostra-resultados-em-pacientes-com-cancer-de-pancreas-sp-856.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacoes-kras-no-cancer-de-pulmao-a-experiencia-de-barretos.html]]></loc><lastmod>2021-05-10T04:03:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sindromes-hereditarias-de-predisposicao-ao-cancer-no-brasil.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/haprog-nova-ferramenta-prognostica-no-auxilio-a-decisao.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nectur-histerectomia-radical-no-carcinoma-cervical-neuroendocrino-de-alto-grau-em-estagio-inicial.html]]></loc><lastmod>2021-05-09T21:51:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/seguimento-de-mulheres-rastreadas-para-cancer-de-colo-do-utero-no-sus-em-sao-paulo-sp-827.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fusao-brd4-notch3-e-caracteristicas-clinicas-em-pacientes-com-cancer.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desfechos-e-fatores-prognosticos-de-pacientes-com-cancer-colorretal-submetidos-a-metastasectomia-pulmonar-sp-539.html]]></loc><lastmod>2021-05-09T19:09:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custo-do-cancer-de-prostata-metastatico-pela-metodologia-custeio-baseado-em-atividade-e-tempo-tdabc-sp-414.html]]></loc><lastmod>2021-05-09T17:54:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ressonancia-magnetica-pre-operatoria-e-status-da-margem-cirurgica-no-cancer-de-mama-sp-770.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metagenomica-sugere-novas-associacoes-entre-bacterias-virus-e-cancer.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-clinico-de-multiplas-infeccoes-de-dna-viral-no-transplante-de-celulas-tronco-hematopoeticas.html]]></loc><lastmod>2021-05-10T00:50:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ice3-crioablacao-no-cancer-de-mama-de-baixo-risco-sp-849.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/publicacao-do-inca-reune-principais-agentes-cancerigenos-ambientais-e-ocupacionais-sp-881.html]]></loc><lastmod>2021-04-30T19:37:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-do-linfonodo-sentinela-no-cancer-de-cabeca-e-pescoco-inicial.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacina-contra-covid-em-pacientes-com-cancer---resultados-da-pfizer---biontech-mostram-importancia-da-dose-de-reforco.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eliot-recorrencia-em-longo-prazo-e-resultados-de-sobrevida-no-cancer-de-mama-inicial-sp-459.html]]></loc><lastmod>2021-04-29T11:22:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-do-icesp-avalia-linfadenectomia-estendida-no-cancer-de-prostata-de-alto-risco-sp-942.html]]></loc><lastmod>2021-04-26T02:28:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cronoterapia-com-temozolomida-em-pacientes-com-glioblastoma-sp-444.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-mutacao-egfr-no-cpcnp-apos-radiocirurgia-para-metastases-cerebrais-sp-331.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assistencia-oncologica-durante-a-pandemia-da-covid-19-no-brasil-sp-568.html]]></loc><lastmod>2021-04-25T22:41:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/criterios-de-elegibilidade-para-estudos-de-vigilancia-ativa-em-pacientes-com-carcinoma-ductal-in-situ-sp-900.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-analisa-revisao-prioritaria-de-enfortumabe-vedotin-no-cancer-urotelial-avancado.html]]></loc><lastmod>2021-04-19T21:24:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comissao-europeia-aprova-isatuximabe-no-mieloma-multiplo.html]]></loc><lastmod>2024-05-04T20:02:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tapur-nova-analise-mostra-beneficio-da-imunoterapia-no-cancer-de-mama-metastatico-sp-611.html]]></loc><lastmod>2021-04-25T21:25:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caracterizacao-do-cancer-de-mama-com-baixa-expressao-do-receptor-de-estrogenio-sp-539.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-de-distress-emocional-por-tipo-de-cancer-sp-360.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-sacituzumabe-govitecano-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2021-04-22T03:50:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-novo-regime-de-dose-de-cetuximabe.html]]></loc><lastmod>2021-04-08T18:49:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-e-selecao-de-pacientes-no-cancer-de-pulmao-sp-520.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-adjuvante-no-cancer-de-mama-com-micrometastases-de-linfonodos-axilares-sp-758.html]]></loc><lastmod>2021-03-31T12:47:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-isatuximabe-no-tratamento-do-mieloma-multiplo-recidivado-e-refratario.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tamoxifeno-e-densidade-mamografica.html]]></loc><lastmod>2021-03-29T03:42:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/contagens-de-ctcs-como-fator-prognostico-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2021-03-28T22:27:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-redes-sociais-e-cancer-de-pulmao-em-tempos-de-covid-19.html]]></loc><lastmod>2021-03-28T18:45:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-pandemia-da-covid-19-em-idosos-com-cancer.html]]></loc><lastmod>2021-03-28T17:35:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bloqueio-concomitante-de-egfr-braf-mek-no-adenocarcinoma-pulmonar-metastatico.html]]></loc><lastmod>2021-03-28T16:54:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tendencias-de-incidencia-e-mortalidade-por-cancer-de-prostata-em-sergipe.html]]></loc><lastmod>2021-04-02T18:39:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/manejo-axilar-apos-terapia-endocrina-neoadjuvante-no-cancer-de-mama-rh.html]]></loc><lastmod>2021-03-25T00:29:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-pembrolizumabe-para-cancer-de-esofago-ou-gej.html]]></loc><lastmod>2021-03-23T23:55:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-pulmao-e-risco-genetico.html]]></loc><lastmod>2021-03-23T15:25:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/privacao-socioeconomica-e-resultados-de-cancer-em-participantes-de-estudos-clinicos.html]]></loc><lastmod>2021-03-22T15:10:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-cemiplimabe-no-carcinoma-basocelular-localmente-avancado-e-metastatico.html]]></loc><lastmod>2021-03-22T12:35:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prognosticos-de-sobrevida-no-seminoma-metastatico.html]]></loc><lastmod>2021-03-28T20:19:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ctdna-e-achados-acionaveis-no-adenocarcinoma-pancreatico-avancado-e-metastatico.html]]></loc><lastmod>2021-03-17T20:17:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tecido-glandular-residual-da-mama-apos-mastectomia.html]]></loc><lastmod>2021-03-17T14:15:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eficacia-da-triagem-por-fit-nos-resultados-do-cancer-colorretal.html]]></loc><lastmod>2021-03-19T02:31:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sequenciamento-genomico-como-alternativa-a-analise-citogenetica-na-oncohematologia.html]]></loc><lastmod>2021-03-15T06:15:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevencao-e-tratamento-da-recorrencia-do-cancer-de-endometrio.html]]></loc><lastmod>2021-03-15T02:41:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-niraparibe-no-tratamento-do-cancer-de-ovario.html]]></loc><lastmod>2021-03-15T02:42:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microambiente-tumoral-do-cancer-de-bexiga-nao-musculo-invasivo-apos-imunoterapia-intravesical-com-o-oncotherad-associado-ao-prp.html]]></loc><lastmod>2021-03-14T18:53:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/canabinoides-no-glioblastoma-multiforme.html]]></loc><lastmod>2021-03-14T18:47:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-discute-impacto-da-covid-19-no-tratamento-do-cancer.html]]></loc><lastmod>2021-03-15T06:20:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gtg-realiza-consenso-para-o-manejo-do-cancer-esofagico.html]]></loc><lastmod>2021-03-23T11:58:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-her2-nao-metastatico-e-terapia-anti-her2-sem-quimioterapia.html]]></loc><lastmod>2021-03-10T12:38:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incidencia-de-cancer-de-mama-em-mulheres-jovens-no-brasil.html]]></loc><lastmod>2021-03-08T18:55:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-biomarcador-de-resposta-a-inibidores-de-checkpoint.html]]></loc><lastmod>2021-03-09T15:50:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reinfeccao-por-sars-cov-2-e-reativacao-viral.html]]></loc><lastmod>2021-03-05T18:09:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/momento-ideal-de-cirurgia-apos-quimioterapia-neoadjuvante-no-cancer-de-mama.html]]></loc><lastmod>2021-03-03T23:47:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/papel-da-dieta-na-incidencia-de-cancer-colorretal.html]]></loc><lastmod>2021-02-28T18:06:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caracterizacao-clinico-patologica-e-molecular-de-familias-em-risco-para-a-sindrome-de-lynch.html]]></loc><lastmod>2021-03-01T20:51:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-olhar-sobre-a-ativacao-de-ras-em-alteracoes-do-braf.html]]></loc><lastmod>2021-02-28T19:58:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ip1-prostagram-triagem-de-cancer-de-prostata-de-base-populacional-com-ressonancia-magnetica-ou-ultrassonografia.html]]></loc><lastmod>2021-02-28T20:17:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/respostas-patologicas-e-biomarcadores-preditivos-no-melanoma-avancado.html]]></loc><lastmod>2021-02-28T17:24:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ctong1104-resultados-finais-de-sobrevida-global-no-cancer-de-pulmao.html]]></loc><lastmod>2021-02-25T20:23:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ans-atualiza-rol-de-procedimentos-2.html]]></loc><lastmod>2021-03-02T15:37:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/enzalutamida-mostra-ganho-de-sobrevida-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2021-02-28T20:22:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/conservacao-da-mama-versus-mastectomia-para-pacientes-brca-mutado.html]]></loc><lastmod>2021-02-24T13:08:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-primaria-no-cancer-de-mama-estadio-iv-de-novo-com-metastase-ossea.html]]></loc><lastmod>2021-02-17T18:55:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-cemiplimab-rwlc-no-carcinoma-basocelular-localmente-avancado-e-metastatico.html]]></loc><lastmod>2021-02-10T19:41:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/capecitabina-no-cancer-de-mama-triplo-negativo-em-estagio-inicial.html]]></loc><lastmod>2021-02-09T20:39:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-adjuvante-pos-histerectomia-no-cancer-cervical.html]]></loc><lastmod>2021-02-01T19:47:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reconstrucao-imediata-da-mama-e-seguranca-oncologica.html]]></loc><lastmod>2021-02-02T19:58:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-da-asco-analisa-radioterapia-no-cancer-de-pulmao-pequenas-celulas.html]]></loc><lastmod>2021-01-31T18:54:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-combinacao-de-cabozantinibe-e-nivolumabe-no-cancer-renal-avancado.html]]></loc><lastmod>2021-01-27T19:59:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prioridades-para-o-idoso-com-cancer.html]]></loc><lastmod>2021-02-03T16:45:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-neoadjuvante-total-no-cancer-retal-localmente-avancado-2.html]]></loc><lastmod>2021-01-31T15:08:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-robotica-na-cirurgia-hepatica.html]]></loc><lastmod>2021-01-18T23:56:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-trastuzumab-deruxtecan-no-cancer-gastrico-her2-positivo.html]]></loc><lastmod>2021-01-16T15:53:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obstrucao-intestinal-maligna-eficacia-e-seguranca-da-quimioterapia.html]]></loc><lastmod>2021-01-11T12:20:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sequenciamento-completo-do-exoma-de-mulheres-de-alto-risco-para-cancer-de-mama-e-ovario-hereditario.html]]></loc><lastmod>2021-01-08T20:12:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/manejo-da-axila-no-cancer-de-mama.html]]></loc><lastmod>2020-12-15T17:04:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/epidemiologia-do-melanoma-uveal-no-brasil.html]]></loc><lastmod>2020-12-11T12:43:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acalabrutinibe-em-monoterapia-eventos-cardiovasculares-em-pacientes-com-leucemia-linfocitica-cronica-sp-615.html]]></loc><lastmod>2021-05-17T15:31:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/existe-beneficio-do-tratamento-cirurgico-no-cancer-de-mama-estadio-iv.html]]></loc><lastmod>2020-12-11T15:10:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acalabrutinibe-em-monoterapia-no-linfoma-celular-do-manto-refratario-recidivado.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-e-os-desafios-da-precisao-diagnostica.html]]></loc><lastmod>2020-11-30T01:30:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oslo-comet-cirurgia-aberta-ou-laparoscopica-de-metastases-hepaticas.html]]></loc><lastmod>2020-11-29T19:27:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/multiplas-linhas-de-tratamento-no-ovario-seroso-de-alto-grau-o-que-prediz-resposta.html]]></loc><lastmod>2020-11-29T18:43:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-das-mutacoes-brca1-2-na-eficacia-da-cirurgia-citorredutora-secundaria.html]]></loc><lastmod>2020-11-29T19:18:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/plataforma-genomica-e-resposta-a-quimio-neoadjuvante-em-pacientes-jovens-com-cancer-de-mama-inicial-hr.html]]></loc><lastmod>2020-11-30T12:22:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custo-efetividade-de-olaparibe-de-manutencao-no-cancer-de-pancreas-metastatico-brca-mutado.html]]></loc><lastmod>2020-11-30T00:24:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reclassificacao-de-casos-de-cancer-de-mama-her2-de-acordo-com-as-diretrizes-asco-cap-2018.html]]></loc><lastmod>2020-11-27T12:32:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dexametasona-e-sobrevida-em-pacientes-com-glioblastoma-tratados-com-imunoterapia.html]]></loc><lastmod>2020-11-30T21:01:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intensidade-de-atividade-fisica-e-mortalidade.html]]></loc><lastmod>2020-11-27T13:14:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tendencias-na-mortalidade-por-melanoma-no-brasil.html]]></loc><lastmod>2020-11-23T19:45:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ressonancia-magnetica-e-acuracia-diagnostica-no-carcinoma-endometrial.html]]></loc><lastmod>2020-11-20T23:20:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estrategias-de-preservacao-da-fertilidade-em-mulheres-com-cancer-de-mama.html]]></loc><lastmod>2020-11-20T15:43:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/durvalumabe-fda-aprova-nova-indicacao-de-dose-fixa.html]]></loc><lastmod>2020-11-20T14:45:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-analise-discute-vitamina-d-e-risco-de-cancer-avancado.html]]></loc><lastmod>2020-11-20T14:08:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-pulmonar-patogenese-e-prognostico-do-cancer-de-pulmao.html]]></loc><lastmod>2020-11-15T21:12:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uspstf-reve-recomendacoes-para-o-rastreamento-do-cancer-colorretal.html]]></loc><lastmod>2020-11-17T22:15:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/clarinet-extension-lanreotida-autogel-em-tumores-neuroendocrinos-enteropancreaticos-avancados.html]]></loc><lastmod>2020-11-15T18:41:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perspectivas-futuras-da-terapia-alvo-no-cancer-de-pulmao-de-celulas-nao-pequenas-avancado.html]]></loc><lastmod>2020-11-16T16:07:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hematopoiese-clonal-em-genes-de-reparo-de-dna-e-teste-de-interferencia-de-cfdna-no-cancer-de-prostata.html]]></loc><lastmod>2020-11-16T00:59:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avaliacao-linfonodal-em-pacientes-com-cancer-de-mama-inicial-e-receptor-hormonal-positivo.html]]></loc><lastmod>2020-11-13T19:15:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/drogas-anticancer-e-metabolitos-em-efluentes-hospitalares-e-avaliacao-da-ecotoxicologia.html]]></loc><lastmod>2020-11-09T16:41:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-foundationone-r-expande-indicacao-de-teste-diagnostico-complementar.html]]></loc><lastmod>2020-11-09T15:19:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgias-bilaterais-no-cancer-de-mama-unilateral.html]]></loc><lastmod>2020-11-06T13:20:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uniao-europeia-aprova-olaparibe-no-cancer-de-prostata-e-ovario.html]]></loc><lastmod>2020-11-05T20:54:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-e-tratamento-com-abiraterona-no-cancer-de-prostata.html]]></loc><lastmod>2020-11-03T21:05:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dna-tumoral-circulante-e-sobrevida-livre-de-progressao-no-melanoma-avancado.html]]></loc><lastmod>2020-11-02T15:03:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/retalho-miocutaneo-do-musculo-obliquo-externo-modificado-pos-mastectomia-no-cancer-de-mama-localmente-avancado.html]]></loc><lastmod>2020-10-30T14:54:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metastases-hepaticas-do-cancer-colorretal-da-evidencia-a-pratica-clinica.html]]></loc><lastmod>2020-11-03T01:35:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/valor-prognostico-do-estadiamento-axilar-apos-quimioterapia-neoadjuvante-no-cancer-de-mama-inflamatorio.html]]></loc><lastmod>2020-10-28T15:24:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trastuzumab-deruxtecan-recebe-revisao-prioritaria-para-cancer-gastrico-her2.html]]></loc><lastmod>2020-10-28T16:28:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brocolis-e-efeitos-da-quimioterapia-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2020-10-28T13:05:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metabolismo-tumoral-e-resposta-terapeutica-no-cancer-de-pancreas.html]]></loc><lastmod>2020-10-28T12:14:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-agentes-no-cancer-de-prostata-resistente-a-castracao.html]]></loc><lastmod>2020-10-22T22:24:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-em-idosos-sobreviventes-de-cancer.html]]></loc><lastmod>2020-10-22T20:00:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alteracoes-no-microbioma-e-progressao-no-mieloma-multiplo.html]]></loc><lastmod>2020-10-22T15:01:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gog0209-alternativas-no-cancer-de-endometrio.html]]></loc><lastmod>2020-11-12T17:08:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hiperglicemia-e-prognostico-no-cancer-de-mama.html]]></loc><lastmod>2020-11-02T22:58:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/daratumumabe-no-mieloma-multiplo-recem-diagnosticado.html]]></loc><lastmod>2020-10-22T22:21:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-combinacao-de-cabozantinibe-e-nivolumabe-no-cancer-renal-avancado.html]]></loc><lastmod>2020-10-21T19:54:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-a-osimertinibe-adjuvante-no-cancer-de-pulmao-egfrm.html]]></loc><lastmod>2020-10-20T19:22:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biossimilares-conquistam-espaco-na-agenda-global.html]]></loc><lastmod>2020-10-19T03:04:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/superficie-do-implante-e-recorrencia-do-cancer-de-mama.html]]></loc><lastmod>2020-10-19T00:23:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neuro-oncologia-radiocirurgia-estereotaxica-hipofracionada-na-cavidade-cirurgica-cerebral.html]]></loc><lastmod>2020-10-18T18:59:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/premio-nobel-reconhece-descobertas-com-impacto-no-tratamento-e-prevencao-do-cancer.html]]></loc><lastmod>2020-10-18T18:04:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/siog-2020-avaliacao-geriatrica-pragmatica-em-uma-unidade-ambulatorial-de-oncologia.html]]></loc><lastmod>2020-10-18T17:25:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alimentacao-nutricao-e-atividade-fisica-para-a-prevencao-do-cancer.html]]></loc><lastmod>2020-10-19T14:45:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cabosun-sobrevida-ajustada-pela-qualidade-na-primeira-linha-de-tratamento-do-cancer-renal.html]]></loc><lastmod>2020-10-19T22:19:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/antibioticos-risco-de-cancer-e-eficacia-do-tratamento-oncologico.html]]></loc><lastmod>2020-10-15T13:34:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/petacc6---oxaliplatina-perioperatoria-nao-mostra-beneficio-na-quimiorradioterapia.html]]></loc><lastmod>2020-10-14T01:11:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-e-sobrevida-no-cancer-endometrial.html]]></loc><lastmod>2020-10-14T00:33:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-inflamatorio-nos-eua-retrata-disparidades-raciais.html]]></loc><lastmod>2020-10-13T22:53:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-obesidade-e-status-metabolico.html]]></loc><lastmod>2020-10-13T22:56:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-do-tratamento-na-morbi-mortalidade-de-sobreviventes-de-linfoma-de-hodgkin.html]]></loc><lastmod>2020-10-09T18:58:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radiolocalizacao-intraoperatoria-e-margem-de-resseccao-no-cancer-de-prostata.html]]></loc><lastmod>2020-10-09T16:05:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ureteroscopia-no-carcinoma-urotelial.html]]></loc><lastmod>2020-10-05T23:35:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microbioma-e-cancer-de-mama-na-pre-e-pos-menopausa.html]]></loc><lastmod>2020-10-04T23:31:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/formacao-em-oncologia-na-america-latina.html]]></loc><lastmod>2020-10-04T19:01:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-de-intervalo-e-tumores-detectados-no-rastreamento-organizado.html]]></loc><lastmod>2020-10-04T18:33:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avaliacao-de-risco-genetico-no-cancer-colorretal-com-deficiencia-de-mismatch-repair.html]]></loc><lastmod>2020-10-03T17:35:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aacr-discute-assistencia-oncologica-a-minorias.html]]></loc><lastmod>2020-10-05T02:46:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/micrornas-no-cancer-de-pulmao.html]]></loc><lastmod>2020-10-01T22:30:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/taxas-de-pobreza-e-mortes-por-cancer.html]]></loc><lastmod>2020-09-30T14:18:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/raves-mostra-nao-inferioridade-da-radioterapia-de-resgate-no-cancer-de-prostata.html]]></loc><lastmod>2020-09-30T00:52:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/getg-afu-17-resultados-de-fase-iii-favorecem-radioterapia-de-resgate-no-cancer-de-prostata-localizado-de-alto-risco.html]]></loc><lastmod>2020-09-30T01:02:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-de-privacao-androgenica-e-sars-cov-2-no-cancer-de-prostata.html]]></loc><lastmod>2020-09-29T22:31:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nutricao-e-cancer-de-ovario-o-papel-da-ingestao-de-acidos-graxos-trans-industriais.html]]></loc><lastmod>2020-09-29T22:19:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibicao-de-cdk4-6-no-cancer-de-mama-inicial.html]]></loc><lastmod>2020-09-29T16:48:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-covid-19-na-assistencia-oncologica-o-cenario-global.html]]></loc><lastmod>2020-09-30T15:43:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-anti-refluxo-e-risco-de-cancer-de-pulmao.html]]></loc><lastmod>2020-09-29T02:02:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ingestao-de-cafe-e-sobrevida-em-pacientes-com-cancer-colorretal-avancado-ou-metastatico.html]]></loc><lastmod>2020-10-05T02:37:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-de-sobrevida-global-de-enfortumab-vedotin-ejfv-no-cancer-urotelial-avancado.html]]></loc><lastmod>2020-09-28T16:27:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/checkmate-274-nivolumabe-adjuvante-no-carcinoma-urotelial.html]]></loc><lastmod>2020-09-28T15:10:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-e-qualidade-de-vida-em-idosos-com-cancer-de-pulmao.html]]></loc><lastmod>2020-09-23T18:27:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/celulas-imunes-no-tecido-mamario.html]]></loc><lastmod>2020-09-23T17:40:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-de-sars-cov-2-em-pacientes-com-cancer-assintomaticos-antes-do-inicio-do-tratamento-sistemico.html]]></loc><lastmod>2020-09-17T12:31:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bloqueio-duplo-de-cd47-e-her2-e-radiorresistencia-no-cancer-de-mama.html]]></loc><lastmod>2020-09-15T16:45:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avancos-e-promessas-no-mesotelioma-pleural-maligno.html]]></loc><lastmod>2020-09-17T17:53:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-de-imunoterapia-na-primeira-linha-do-cancer-renal-avancado.html]]></loc><lastmod>2020-09-11T19:51:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/subtipo-molecular-e-sensibilidade-a-radioterapia-fracionada-no-cancer-de-mama.html]]></loc><lastmod>2020-09-11T16:41:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reexposicao-a-irinotecano-mais-cetuximabe-no-cancer-colorretal.html]]></loc><lastmod>2020-09-06T20:57:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/polimorfismo-egf-61a-g-s-nao-prediz-resposta-a-tkis-no-cancer-de-pulmao.html]]></loc><lastmod>2020-09-08T15:24:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncofertilidade-prioridade-global.html]]></loc><lastmod>2020-09-06T20:03:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-em-associacao-com-eribulina-nao-mostra-beneficio-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2020-09-06T19:48:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-regime-aumenta-profundidade-de-resposta-no-mieloma-multiplo.html]]></loc><lastmod>2020-09-06T18:18:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/virus-oncolitico-e-car-t-cells-em-tumores-solidos.html]]></loc><lastmod>2020-09-06T16:47:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modalidade-de-tratamento-e-sobrevida-no-cancer-de-laringe-estagio-iv.html]]></loc><lastmod>2020-09-06T16:30:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-nao-encontra-associacao-entre-anti-hipertensivos-e-cancer.html]]></loc><lastmod>2020-09-07T00:03:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fatores-preditivos-de-recorrencia-no-adenocarcinoma-da-juncao-esofagogastrica.html]]></loc><lastmod>2020-09-02T13:42:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-com-hipofracionamento-moderado-no-cancer-de-mama.html]]></loc><lastmod>2020-09-01T18:34:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-endocrina-neoadjuvante-estadiamento-axilar-e-cirurgia-conservadora-da-mama.html]]></loc><lastmod>2020-09-01T19:43:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/parametros-prognosticos-no-cancer-de-mama-lobular-hr-positivo.html]]></loc><lastmod>2020-08-27T22:36:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-de-mama-em-sobreviventes-de-transplante-de-medula-ossea.html]]></loc><lastmod>2020-09-06T17:37:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tabagismo-e-risco-de-cancer-colorretal.html]]></loc><lastmod>2020-08-28T20:15:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevalencia-da-covid-19-e-mortalidade-em-pacientes-de-cancer.html]]></loc><lastmod>2020-08-26T14:24:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desafios-para-a-equidade-no-tratamento-do-cancer-testicular.html]]></loc><lastmod>2020-08-23T19:54:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/letalidade-da-neoplasia-trofoblastica-gestacional-em-mulheres-brasileiras.html]]></loc><lastmod>2020-08-23T18:21:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-novo-regime-de-combinacao-com-daratumumabe-no-mieloma-multiplo-recidivante-refratario.html]]></loc><lastmod>2020-08-24T03:24:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/icesp-publica-recomendacoes-para-a-pesquisa-clinica-durante-a-covid-19.html]]></loc><lastmod>2020-08-22T00:51:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-mundo-real-revela-cenario-de-tratamento-do-cancer-de-prostata-metastatico.html]]></loc><lastmod>2020-08-23T17:14:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-nova-indicacao-de-enzalutamida-no-cancer-de-prostata.html]]></loc><lastmod>2020-08-20T18:47:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-aos-40-anos-e-mortalidade-por-cancer-de-mama.html]]></loc><lastmod>2020-08-24T02:37:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avaliacao-do-tratamento-da-axila-positiva-n1-pos-qt-neoadjuvante.html]]></loc><lastmod>2020-08-19T14:40:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bio-manguinhos-fiocruz-passa-a-fornecer-trastuzumabe-biossimilar-ao-sus.html]]></loc><lastmod>2020-08-19T14:36:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-durvalumabe-em-dose-fixa.html]]></loc><lastmod>2020-08-19T14:09:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acidente-com-cesio-137-e-incidencia-de-cancer-de-mama-em-goiania.html]]></loc><lastmod>2020-08-21T22:47:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diabetes-alteracao-de-peso-e-risco-de-cancer-de-pancreas.html]]></loc><lastmod>2020-08-23T14:00:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-basket-discute-novos-agentes-em-tumores-solidos.html]]></loc><lastmod>2020-08-13T14:05:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/via-met-no-cancer-de-pulmao-qual-o-melhor-tratamento.html]]></loc><lastmod>2020-08-12T21:10:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/importancia-da-categorizacao-do-receptor-de-estrogenio-no-cancer-de-mama.html]]></loc><lastmod>2020-08-12T14:42:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bio-manguinhos-fiocruz-passa-a-fornecer-rituximabe-ao-sus.html]]></loc><lastmod>2020-08-12T14:00:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-primeira-biopsia-liquida-por-ngs.html]]></loc><lastmod>2020-08-12T21:14:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-genomico-do-cancer-de-prostata-de-novo.html]]></loc><lastmod>2020-08-10T02:37:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-guideline-sobre-tratamento-do-cancer-de-pancreas-metastatico.html]]></loc><lastmod>2020-08-10T04:19:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacoes-no-tp53-e-sindrome-mielodisplasica-de-alto-risco.html]]></loc><lastmod>2020-08-11T16:53:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ash-diretrizes-de-tratamento-da-leucemia-mieloide-aguda-em-idosos.html]]></loc><lastmod>2020-08-09T22:04:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sindrome-de-lynch-em-pacientes-com-cancer-de-endometrio-no-brasil.html]]></loc><lastmod>2020-08-09T21:43:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-e-sobrevida-no-idoso-com-comorbidades-2.html]]></loc><lastmod>2020-08-10T14:47:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/interaact-estudo-avalia-quimioterapia-ideal-no-cancer-anal-avancado.html]]></loc><lastmod>2020-08-05T16:29:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fgfr3-e-sensibilidade-a-platina-no-cancer-de-bexiga-avancado.html]]></loc><lastmod>2020-08-05T14:03:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-quimio-hormonal-neoadjuvante-no-cancer-de-prostata-de-alto-risco.html]]></loc><lastmod>2020-08-09T21:12:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-ingles-estima-aumento-de-mortes-por-cancer-pos-pandemia-de-covid-19.html]]></loc><lastmod>2020-08-04T18:30:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/europa-apresenta-estimativas-de-incidencia-e-mortalidade-em-27-paises.html]]></loc><lastmod>2020-08-04T16:29:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/betabloqueadores-e-inibidores-de-checkpoint-imune.html]]></loc><lastmod>2020-08-05T15:51:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-hormonal-incidencia-e-mortalidade-cancer-de-mama-especifica.html]]></loc><lastmod>2020-08-03T20:25:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avancos-no-tratamento-da-llc.html]]></loc><lastmod>2021-05-13T18:53:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-designacao-de-terapia-inovadora-a-osimertinibe-na-adjuvancia-do-cpnpc.html]]></loc><lastmod>2020-07-30T18:50:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/triagem-e-tratamento-do-virus-da-hepatite-b-em-pacientes-com-cancer.html]]></loc><lastmod>2020-08-09T20:17:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/papel-prognostico-dos-tils-no-cancer-de-mama-subtipo-luminal.html]]></loc><lastmod>2020-07-26T20:37:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-brasileiro-de-carcinoma-incidental-de-vesicula-biliar.html]]></loc><lastmod>2020-07-26T20:02:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-no-acompanhamento-do-carcinoma-de-orofaringe.html]]></loc><lastmod>2020-07-26T19:13:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-perioperatoria-e-cirurgica-no-cancer-gastrico-avancado.html]]></loc><lastmod>2020-07-26T19:57:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variante-ashkenazi-do-tp53.html]]></loc><lastmod>2020-07-27T12:31:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hipec-resistencia-a-platina-e-sensibilidade-aos-inibidores-da-parp-no-cancer-de-ovario.html]]></loc><lastmod>2020-07-26T17:27:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sarcomas-e-sindrome-de-lynch.html]]></loc><lastmod>2020-07-27T00:15:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gravidez-apos-cancer-de-mama-em-pacientes-com-mutacoes-germinativas-nos-genes-brca1-2.html]]></loc><lastmod>2020-07-24T16:13:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/clonalidade-e-mutacoes-driver-no-cancer-de-pulmao-braf-mutado-nao-v600.html]]></loc><lastmod>2020-07-28T16:39:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/polipos-serrilhados-proximais-e-risco-de-cancer-colorretal.html]]></loc><lastmod>2020-07-22T14:11:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-adjuvante-no-cancer-de-mama-triplo-negativo-estagio-i.html]]></loc><lastmod>2020-07-21T21:29:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-de-cancer-durante-a-pandemia-de-covid-19.html]]></loc><lastmod>2020-07-21T14:18:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/termometro-de-distress-da-nccn-disponivel-em-portugues.html]]></loc><lastmod>2020-07-17T17:16:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-e-doenca-residual-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2020-07-15T13:30:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atezolizumabe-nao-mostra-beneficio-no-cancer-de-ovario.html]]></loc><lastmod>2020-07-15T00:58:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidores-de-checkpoint-em-pacientes-com-alta-instabilidade-de-microssatelites.html]]></loc><lastmod>2020-07-15T01:01:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-ou-cuidados-de-suporte-no-cancer-colorretal-avancado.html]]></loc><lastmod>2020-07-12T23:53:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pontuacao-de-risco-poligenico-e-cancer-de-mama.html]]></loc><lastmod>2020-07-08T00:08:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imc-e-sobrevida-apos-quimioterapia-no-cancer-de-mama.html]]></loc><lastmod>2020-07-13T20:44:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preservacao-da-fertilidade-no-tratamento-do-cancer.html]]></loc><lastmod>2020-07-09T13:50:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-do-inca-mostra-resultados-de-cancer-e-covid-19.html]]></loc><lastmod>2020-07-08T18:06:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avaliacao-da-aderencia-ao-tratamento-endocrino-no-cancer-de-mama.html]]></loc><lastmod>2020-07-02T15:29:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-avelumabe-como-tratamento-de-manutencao-no-carcinoma-urotelial-localmente-avancado-ou-metastatico.html]]></loc><lastmod>2020-07-01T13:30:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-bariatrica-e-risco-de-cancer-mama-ovario-e-endometrio.html]]></loc><lastmod>2020-07-03T20:55:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-astro-radioterapia-no-cancer-do-colo-do-utero.html]]></loc><lastmod>2020-06-28T18:19:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metformina-e-radiossensibilizacao-no-tratamento-neoadjuvante-do-cancer-retal.html]]></loc><lastmod>2020-06-25T18:19:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/linfonodo-sentinela-positivo-e-quimioterapia-neoadjuvante.html]]></loc><lastmod>2020-06-24T16:31:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-de-vida-no-linfoma-de-hodgkin.html]]></loc><lastmod>2020-07-01T14:57:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/implicacoes-e-desafios-da-pan-genomica.html]]></loc><lastmod>2020-06-23T23:57:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nomograma-prediz-risco-no-melanoma-cutaneo.html]]></loc><lastmod>2020-06-23T18:01:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/marcadores-inflamatorios-e-infeccao-do-trato-urinario-apos-biopsia-transretal-da-prostata.html]]></loc><lastmod>2020-06-24T18:28:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-designacao-fast-track-para-irinotecano-lipossomal.html]]></loc><lastmod>2020-06-22T15:28:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-vacina-nonavalente-contra-hpv-na-prevencao-do-cancer-de-orofaringe.html]]></loc><lastmod>2020-07-15T14:21:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/religiosidade-e-espiritualidade-no-cancer.html]]></loc><lastmod>2020-06-18T14:59:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metabolismo-do-carbono-1-no-cancer-de-mama-invasivo.html]]></loc><lastmod>2020-06-18T14:32:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-acs-dieta-atividade-fisica-e-prevencao-do-cancer.html]]></loc><lastmod>2020-06-18T16:47:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tumor-filoide-maligno-da-mama.html]]></loc><lastmod>2020-06-17T13:36:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/testes-geneticos-no-cancer-de-prostata-como-e-para-quem.html]]></loc><lastmod>2020-06-14T17:10:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/abordagem-tecido-agnostica-no-tratamento-do-cancer.html]]></loc><lastmod>2020-06-14T16:34:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-de-caso-transformacao-histologica-como-mecanismo-de-resistencia.html]]></loc><lastmod>2020-06-12T15:16:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sabr-comet-radioterapia-estereotatica-no-cancer-oligometastatico.html]]></loc><lastmod>2020-06-12T01:22:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nefrectomia-citorredutora-na-era-das-terapias-alvo.html]]></loc><lastmod>2020-06-11T18:21:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/variaveis-clinicopatologicas-e-predicao-de-risco.html]]></loc><lastmod>2020-06-11T18:50:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/licoes-do-de-escalonamento-de-dose-no-cancer-de-cabeca-e-pescoco-hpv-positivo.html]]></loc><lastmod>2020-06-14T21:57:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-bifasico-descreve-desenvolvimento-do-cancer-de-pancreas.html]]></loc><lastmod>2020-06-11T19:30:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fire-radiocirurgia-estereotatica-em-metastases-cerebrais.html]]></loc><lastmod>2020-06-15T15:45:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-do-cancer-deve-superar-us-245-bi-em-2030.html]]></loc><lastmod>2020-06-10T16:48:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrepeso-e-obesidade-em-pacientes-com-cancer-de-mama-metastatico-tratadas-com-inibidor-de-cdk-4-6.html]]></loc><lastmod>2020-06-10T16:19:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/keynote-361-pembrolizumabe-nao-atinge-endpoint-primario.html]]></loc><lastmod>2020-06-10T01:11:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comissao-europeia-aprova-combinacao-de-terapias-alvo-no-cancer-colorretal-metastatico-com-mutacao-brafv600e.html]]></loc><lastmod>2020-06-09T22:32:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perda-de-pten-e-resposta-imune-no-tratamento-do-cancer.html]]></loc><lastmod>2020-06-10T17:30:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-do-cancer-de-mama-na-mulher-idosa-qual-a-evidencia.html]]></loc><lastmod>2020-06-09T18:00:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carcinoma-endometrioide-associado-a-cicatriz-provocada-por-endometriose.html]]></loc><lastmod>2020-06-08T19:26:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comissao-europeia-aprova-formulacao-subcutanea-de-daratumumabe-para-tratamento-do-mieloma-multiplo.html]]></loc><lastmod>2020-06-08T17:57:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exercicios-de-resistencia-e-prevencao-do-cancer.html]]></loc><lastmod>2020-06-11T18:23:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ascend-acalabrutinibe-na-llc-recorrente-ou-refrataria-sp-486.html]]></loc><lastmod>2021-05-13T18:09:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/linfoma-anaplasico-de-celulas-grandes-associado-ao-implante-mamario.html]]></loc><lastmod>2020-05-27T14:33:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-com-platina-e-sobrevida-no-cancer-de-pancreas-metastatico-hr-mutado.html]]></loc><lastmod>2020-05-27T21:33:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/recomendacoes-internacionais-para-pacientes-com-cancer-durante-a-pandemia-da-covid-19.html]]></loc><lastmod>2020-05-25T01:34:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/interacao-entre-cancer-e-disturbio-pos-septico.html]]></loc><lastmod>2020-05-27T16:23:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atividade-fisica-melhora-dos-sintomas-e-qualidade-de-vida-em-pacientes-com-cancer-de-pulmao.html]]></loc><lastmod>2020-05-25T01:31:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-analisa-dez-anos-da-experiencia-institucional-no-tratamento-do-cancer-de-endometrio.html]]></loc><lastmod>2020-05-25T01:32:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-orientacoes-para-praticas-de-oncologia-durante-a-pandemia-de-covid-19.html]]></loc><lastmod>2020-05-19T18:16:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-ripretinib-para-o-tratamento-de-quarta-linha-de-gist.html]]></loc><lastmod>2020-05-18T19:59:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-rucaparib-para-cancer-de-prostata-metastatico-resistente-a-castracao-brca-mutado.html]]></loc><lastmod>2020-05-18T19:59:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-em-combinacao-na-primeira-linha-de-tratamento-do-cpnpc-com-expressao-de-pd-l1.html]]></loc><lastmod>2020-05-18T19:58:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioablacao-no-cancer-urotelial.html]]></loc><lastmod>2020-05-25T01:19:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custo-e-valor-no-tratamento-do-cancer-2.html]]></loc><lastmod>2020-06-10T16:52:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/calgb-40903-duvidas-e-controversias-na-gestao-do-cdis.html]]></loc><lastmod>2020-05-14T22:22:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/letrozol-neoadjuvante-no-cdis-2.html]]></loc><lastmod>2020-05-14T22:21:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidor-de-parp-como-manutencao-no-cancer-de-ovario-avancado.html]]></loc><lastmod>2021-05-07T23:28:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-paliativos-e-o-paciente-oncologico-na-pandemia-de-covid-19.html]]></loc><lastmod>2020-05-11T15:59:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncologia-reforca-olhar-centrado-no-paciente-durante-a-covid-19.html]]></loc><lastmod>2020-05-11T16:47:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-robotica-ginecologica-durante-a-pandemia-de-covid-19.html]]></loc><lastmod>2020-05-10T23:50:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ferramenta-de-triagem-para-encaminhamento-a-cuidados-paliativos-ambulatoriais.html]]></loc><lastmod>2020-05-11T00:42:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/boas-praticas-recomendacoes-para-a-adocao-de-biossimilares-na-oncologia.html]]></loc><lastmod>2020-05-08T16:48:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-discute-prognostico-no-derrame-pleural-maligno.html]]></loc><lastmod>2020-05-08T18:16:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-de-deprivacao-androgenica-e-risco-de-infeccao-por-sars-cov-2.html]]></loc><lastmod>2020-05-08T14:11:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-da-duracao-da-radioterapia-na-sobrevida-global-do-carcinoma-espinocelular-de-canal-anal.html]]></loc><lastmod>2020-05-27T17:34:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-quimioendocrina-adjuvante-e-sobrevida-no-cancer-de-mama.html]]></loc><lastmod>2020-05-07T20:17:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-primeira-terapia-alvo-no-cpnpc-com-mutacao-no-exon-14-do-gene-met.html]]></loc><lastmod>2020-05-07T04:36:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comparacao-da-incisao-cirurgica-no-cancer-de-vulva.html]]></loc><lastmod>2020-05-11T01:48:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-clinica-em-cancer-e-regulacao-na-covid-19.html]]></loc><lastmod>2020-05-07T19:29:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsias-de-prostata-na-vigilancia-ativa.html]]></loc><lastmod>2020-05-05T18:27:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-formulacao-subcutanea-de-daratumumabe-para-tratamento-do-mieloma-multiplo.html]]></loc><lastmod>2020-05-05T12:46:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acido-tranexamico-na-disseccao-axilar-no-cancer-de-mama.html]]></loc><lastmod>2020-05-05T12:48:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hernata-vinorelbina-como-alternativa-a-taxanos-no-cancer-de-mama-her2.html]]></loc><lastmod>2020-05-11T01:47:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-psicologico-em-profissionais-da-saude-em-tempos-de-pandemia-da-covid-19.html]]></loc><lastmod>2020-04-28T18:21:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-anti-pd-1-mostra-ganho-de-sobrevida-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-28T17:43:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alteracoes-nas-diretrizes-internacionais-de-tratamento-do-cancer-de-cabeca-e-pescoco-durante-a-pandemia-2.html]]></loc><lastmod>2020-04-26T23:15:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidores-da-5-alfa-redutase-e-quimioprevencao-primaria-para-cancer-de-prostata.html]]></loc><lastmod>2020-04-27T23:48:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/amiloidose-cardiaca.html]]></loc><lastmod>2020-04-27T01:08:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncologia-brasileira-aposta-em-areas-livres-de-covid-19.html]]></loc><lastmod>2020-04-29T19:19:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/olaparibe-mostra-sobrevida-global-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2020-04-27T03:22:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-primeira-terapia-alvo-no-colangiocarcinoma.html]]></loc><lastmod>2020-04-25T01:02:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-modelo-de-predicao-de-risco-de-cancer-de-pancreas.html]]></loc><lastmod>2020-04-25T00:58:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-anticorpo-droga-conjugado-no-cancer-de-mama-triplo-negativo-metastatico.html]]></loc><lastmod>2020-10-07T23:00:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-tucatinib-no-cancer-de-mama-her2-irressecavel-ou-metastatico.html]]></loc><lastmod>2020-04-25T00:47:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-car-t-cells-para-lla-b-utiliza-abordagem-point-of-care.html]]></loc><lastmod>2020-04-25T00:38:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-de-cabozantinibe-e-nivolumabe-atinge-endpoint-primario-no-cancer-renal.html]]></loc><lastmod>2020-04-25T00:42:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-a-base-de-platina-no-cancer-de-prostata-metastatico-com-alteracoes-nos-genes-de-reparo-do-dna.html]]></loc><lastmod>2020-04-24T21:17:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-estereotatica-corporea-no-cancer-de-pulmao-de-celulas-nao-pequenas.html]]></loc><lastmod>2020-04-24T20:29:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-de-resgate-para-leucemia-mieloide-aguda-refrataria-ou-recidivada.html]]></loc><lastmod>2020-04-23T14:33:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/grupo-frances-de-sarcoma-publica-recomendacoes-durante-a-covid-19.html]]></loc><lastmod>2020-04-25T01:24:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nanomedicina-pode-aumentar-resposta-a-imunoterapia.html]]></loc><lastmod>2020-04-26T21:14:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/calavi-estudo-avalia-acalabrutinib-no-tratamento-da-hipercitocinemia-associada-a-covid-19.html]]></loc><lastmod>2020-04-14T23:28:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-publica-orientacao-sobre-alocacao-de-recursos-limitados-durante-a-pandemia-de-covid-19.html]]></loc><lastmod>2020-04-14T17:09:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adaura-osimertinibe-mostra-beneficio-no-cpcnp.html]]></loc><lastmod>2020-04-13T18:18:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-de-cancer-de-mama-durante-o-periodo-de-encubacao-da-covid-19.html]]></loc><lastmod>2024-05-04T20:06:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tailorx-quimioterapia-terapia-endocrina-e-comprometimento-cognitivo.html]]></loc><lastmod>2020-04-26T19:44:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oriole-observacao-vs-radioterapia-estereotatica-no-cancer-de-prostata-oligometastatico.html]]></loc><lastmod>2020-04-23T16:22:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/solo3-mostra-resultados-no-cancer-de-ovario-recidivado-resistente-a-platina.html]]></loc><lastmod>2020-04-11T15:12:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nccn-publica-recomendacoes-para-pacientes-e-profissionais-de-saude-durante-a-pandemia-do-covid-19.html]]></loc><lastmod>2020-04-09T22:03:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-combinacao-de-tratamentoterapias-alvo-no-cancer-colorretal-metastatico-brafv600e-mutado.html]]></loc><lastmod>2020-04-09T16:11:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/raca-e-etnia-tem-impacto-no-diagnostico-e-tratamento-do-cancer.html]]></loc><lastmod>2020-04-08T18:30:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-adjuvante-no-cancer-de-vias-biliares.html]]></loc><lastmod>2020-04-08T16:02:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trastuzumabe-pos-progressao-nao-mostra-beneficio-no-cancer-gastrico-ou-jeg.html]]></loc><lastmod>2020-04-13T01:09:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-modelo-de-decisao-de-tratamento-em-eventos-imunorrelacionados.html]]></loc><lastmod>2020-04-26T20:10:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aacr-anuncia-encontros-em-formato-virtual.html]]></loc><lastmod>2020-04-06T16:42:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacoes-esr1-e-resistencia-a-terapia-endocrina-neoadjuvante-no-cancer-de-mama-er.html]]></loc><lastmod>2020-04-06T14:36:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-vai-avaliar-ruxolitinibe-no-tratamento-de-pacientes-com-hipercitocinemia-associada-ao-covid-19.html]]></loc><lastmod>2020-04-03T20:50:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/amamentacao-e-risco-de-cancer-de-ovario.html]]></loc><lastmod>2020-04-12T21:28:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perspectivas-no-cancer-de-ovario-avancado-e-selecao-de-pacientes.html]]></loc><lastmod>2020-04-15T19:05:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/epis-e-protecao-individual-na-covid-19.html]]></loc><lastmod>2020-03-31T18:23:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-durvalumabe-no-cancer-de-pulmao-pequenas-celulas.html]]></loc><lastmod>2020-04-24T19:49:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/covid-19-recomendacoes-de-cuidados-em-cancer-de-mama.html]]></loc><lastmod>2020-03-31T01:43:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-alvo-no-cancer-de-mama-em-idosos.html]]></loc><lastmod>2020-03-30T14:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/idea-france---nova-analise-discute-depositos-tumorais.html]]></loc><lastmod>2020-04-03T13:33:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dna-tumoral-circulante-e-biopsia-liquida-em-tumores-geniturinarios.html]]></loc><lastmod>2020-03-30T05:29:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iniciativa-reune-dados-sobre-covid-19-e-cancer.html]]></loc><lastmod>2020-03-31T02:15:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/papel-prognostico-do-microrna-no-cancer-epitelial-de-ovario.html]]></loc><lastmod>2020-03-27T18:23:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/transmissao-de-covid-19-em-pacientes-com-cancer-em-hospital-de-wuhan.html]]></loc><lastmod>2020-03-31T02:21:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custo-e-valor-no-tratamento-do-cancer.html]]></loc><lastmod>2020-03-25T21:32:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-gilteritinibe-para-tratamento-da-leucemia-mieloide-aguda.html]]></loc><lastmod>2020-03-24T17:57:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/encontro-anual-da-asco-sera-realizado-em-formato-virtual.html]]></loc><lastmod>2020-03-24T14:42:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-revela-crescimento-global-da-incidencia-de-cancer-de-figado.html]]></loc><lastmod>2020-03-24T13:23:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/covid-19-recomendacao-propoe-manejo-de-pacientes-com-cancer-de-pulmao-avancado.html]]></loc><lastmod>2020-04-24T19:50:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/covid-19-e-as-perspectivas-da-saude-5-0.html]]></loc><lastmod>2020-03-31T02:27:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cigarro-eletronico-e-cancer-de-bexiga.html]]></loc><lastmod>2020-03-25T16:09:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ensaios-clinicos-durante-a-covid-19.html]]></loc><lastmod>2020-03-19T18:35:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/transgeneros-e-cancer.html]]></loc><lastmod>2020-03-19T18:26:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/covid-19-e-a-telessaude.html]]></loc><lastmod>2020-03-31T02:27:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/como-gerenciar-o-tratamento-do-cancer-durante-a-pandemia-de-covid-19.html]]></loc><lastmod>2020-03-31T02:29:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/caspian-durvalumab-confirma-beneficio-de-sobrevida-global-no-cancer-de-pulmao-pequenas-celulas.html]]></loc><lastmod>2020-03-18T22:15:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gap-de-eficacia-da-pesquisa-clinica-ao-mundo-real.html]]></loc><lastmod>2020-03-25T16:24:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-colorretal-guideline-traz-recomendacoes-para-cenarios-de-recursos-limitados.html]]></loc><lastmod>2020-03-29T19:46:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mortalidade-por-cancer-de-figado-e-vias-viliares-no-brasil.html]]></loc><lastmod>2020-03-18T12:54:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fiocruz-informa-pesquisadores-sobre-covid-19.html]]></loc><lastmod>2020-03-31T02:33:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neoplasia-induzida-por-radioterapia-no-cancer-de-mama-familial.html]]></loc><lastmod>2020-03-25T14:37:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/encontro-anual-da-asco-pode-ganhar-novo-formato.html]]></loc><lastmod>2020-03-16T00:52:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teratoma-e-valor-prognostico-em-tumores-testiculares.html]]></loc><lastmod>2020-03-16T03:12:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estratificacao-de-risco-no-cancer-de-prostata.html]]></loc><lastmod>2020-03-30T03:41:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acessibilidade-da-populacao-negra-ao-cuidado-oncologico-no-brasil.html]]></loc><lastmod>2020-03-11T14:57:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/enets-2020-e-o-cenario-de-tumores-neuroendocrinos.html]]></loc><lastmod>2020-03-13T18:02:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-encontra-presenca-de-amianto-em-amostras-de-talco.html]]></loc><lastmod>2020-03-10T21:13:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eloquent-1-elotuzumab-nao-atinge-endpoint-primario-no-mieloma-multiplo-sem-tratamento-previo.html]]></loc><lastmod>2020-03-10T16:04:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-incentiva-inclusao-de-pacientes-idosos-em-estudos-clinicos-de-cancer.html]]></loc><lastmod>2020-03-12T16:37:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/covid-19-em-pacientes-com-cancer-de-pulmao.html]]></loc><lastmod>2020-04-26T19:16:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mortalidade-morbidade-e-prognostico-na-resseccao-de-metastases-cerebrais.html]]></loc><lastmod>2020-03-06T12:23:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacific-atualiza-dados-de-sobrevida-global.html]]></loc><lastmod>2020-03-16T02:49:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-nova-terapia-para-mieloma-multiplo.html]]></loc><lastmod>2020-03-05T20:47:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/enterocolite-grave-apos-capox-adjuvante-para-cancer-colorretal.html]]></loc><lastmod>2020-03-06T14:32:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tabagismo-e-padrao-de-recorrencia-no-cancer-de-orofaringe-hpv-positivo.html]]></loc><lastmod>2020-03-04T21:29:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/serie-de-4-artigos-enfoca-cancer-de-pancreas.html]]></loc><lastmod>2020-03-04T20:25:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modificacao-da-dieta-e-mortalidade-por-cancer-de-mama.html]]></loc><lastmod>2020-03-01T01:12:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/infeccao-pelo-virus-da-dengue-pode-aumentar-o-risco-de-leucemia.html]]></loc><lastmod>2020-03-01T01:06:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-adota-novas-regras-para-registro-de-terapias-avancadas.html]]></loc><lastmod>2020-02-29T14:56:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desafios-no-rastreamento-do-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T16:51:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prescricao-de-analgesicos-em-pacientes-com-cancer-de-mama-e-metastases-osseas.html]]></loc><lastmod>2020-03-01T01:57:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tromboembolismo-no-cancer-de-pulmao-ros1.html]]></loc><lastmod>2020-04-24T16:50:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-combinacao-de-neratinibe-e-capecitabina-no-cancer-de-mama-metastatico-her2.html]]></loc><lastmod>2020-02-27T20:44:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-recomendacao-de-vigilancia-pos-polipectomia.html]]></loc><lastmod>2020-03-01T22:46:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/transfusao-de-sangue-e-qualidade-de-vida-em-neoplasias-hematologicas.html]]></loc><lastmod>2020-03-02T02:00:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/icesp-investiga-neoadjuvancia-no-cancer-de-prostata.html]]></loc><lastmod>2020-02-27T15:25:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-em-metastases-hepaticas-do-cancer-gastrico.html]]></loc><lastmod>2020-02-26T15:10:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-de-cancer-de-genomas-inteiros.html]]></loc><lastmod>2020-03-02T02:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-discute-cancer-gastrico-e-qualidade-de-vida.html]]></loc><lastmod>2020-02-17T07:06:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/genomica-na-prevencao-do-cancer-hereditario.html]]></loc><lastmod>2020-03-02T02:07:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-epidemiologico-do-melanoma-da-mucosa-no-brasil.html]]></loc><lastmod>2020-02-09T23:48:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-destaca-avancos-do-ano-na-pesquisa-em-cancer.html]]></loc><lastmod>2020-02-08T01:21:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-brasileiro-enfoca-sarcomas-de-partes-moles-de-extremidades.html]]></loc><lastmod>2020-02-03T12:04:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-combinacao-para-tratamento-da-leucemia-linfocitica-cronica.html]]></loc><lastmod>2020-01-28T21:53:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/canabinoides-e-progressao-do-cancer-de-cabeca-e-pescoco-hpv.html]]></loc><lastmod>2020-01-28T18:46:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-promessa-no-cancer-de-prostata-resistente-a-castracao.html]]></loc><lastmod>2020-01-21T17:18:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resistencia-ao-anti-fgfr-no-colangiocarcinoma.html]]></loc><lastmod>2020-01-21T14:04:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-promessa-na-sindrome-mielodisplasica.html]]></loc><lastmod>2020-01-22T20:15:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-cenario-da-neuro-oncologia-e-os-avancos-de-2020.html]]></loc><lastmod>2019-12-05T21:18:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-regulamento-para-uso-medicinal-de-produtos-derivados-da-cannabis.html]]></loc><lastmod>2019-12-04T17:48:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/especialistas-discutem-recomendacoes-para-tratamento-do-cancer-de-penis.html]]></loc><lastmod>2019-12-04T21:39:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-omega-3-e-cancer-colorretal.html]]></loc><lastmod>2019-11-25T01:14:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ramucirumabe-nao-aumenta-sobrevida-global-no-carcinoma-urotelial.html]]></loc><lastmod>2019-11-24T16:15:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reposicao-de-testosterona-em-sobreviventes-de-cancer.html]]></loc><lastmod>2019-11-25T02:07:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alectinibe-no-cancer-de-pulmao-de-celulas-nao-pequenas-com-rearranjo-ret-metastaticos-refratarios-a-quimioterapia.html]]></loc><lastmod>2020-04-24T17:05:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gilteritinibe-ou-quimioterapia-para-lma-recidivada-ou-refrataria-com-mutacao-flt3.html]]></loc><lastmod>2019-11-18T14:36:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carcinoma-mucinoso-papilar-intraductal-e-cancer-de-pancreas.html]]></loc><lastmod>2019-11-27T16:27:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fraturas-por-insuficiencia-pelvica-apos-radioterapia-para-cancer-ginecologico.html]]></loc><lastmod>2019-11-11T03:28:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/checkmate-9la-imunoterapia-volta-a-apresentar-bons-resultados-no-cpnpc.html]]></loc><lastmod>2019-10-23T13:14:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-erdafitinibe-para-tratamento-do-cancer-urotelial.html]]></loc><lastmod>2019-10-28T02:17:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-apalutamida-no-cancer-de-prostata-metastatico-sensivel-a-castracao.html]]></loc><lastmod>2019-09-18T15:19:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cenario-de-incerteza-na-pesquisa-em-cancer.html]]></loc><lastmod>2019-09-17T19:22:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resposta-a-terapia-anti-egfr-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2019-09-16T02:35:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-avalia-eficacia-de-tamoxifeno-em-creme-para-minimizar-contratura-capsular-de-mamas-irradiadas.html]]></loc><lastmod>2019-09-15T18:47:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reposicao-hormonal-aumenta-risco-de-cancer-de-mama-na-pos-menopausa.html]]></loc><lastmod>2020-05-04T02:16:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-indicacao-de-pembrolizumabe-no-cpnpc.html]]></loc><lastmod>2019-09-16T02:37:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/capmatinib-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:10:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/funcionarios-se-unem-pela-manutencao-dos-servicos-da-fosp.html]]></loc><lastmod>2019-09-02T11:45:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-gramado-chega-a-14-edicao.html]]></loc><lastmod>2019-09-02T17:15:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-incentiva-inclusao-de-pacientes-do-sexo-masculino-em-ensaios-clinicos-de-cancer-de-mama.html]]></loc><lastmod>2019-08-28T17:41:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ferramenta-prognostica-para-tumores-neuroendocrinos.html]]></loc><lastmod>2019-08-29T21:08:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pembrolizumabe-no-cancer-de-pulmao-com-expressao-muito-alta-de-pd-l1.html]]></loc><lastmod>2020-04-24T17:11:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carcinoma-de-celulas-de-merkel-e-resposta-a-imunoterapia.html]]></loc><lastmod>2019-08-27T11:29:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-clinica-e-representacao-racial.html]]></loc><lastmod>2019-08-23T13:04:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neptune-estudo-nao-mostrou-ganho-de-sobrevida-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:11:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ferramenta-auxilia-escolha-de-tratamento-de-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2019-09-11T16:05:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lacog-1018-inibidor-de-ciclinas-no-cancer-de-ovario.html]]></loc><lastmod>2019-08-20T15:39:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-combinacao-para-o-tratamento-do-cancer-renal-avancado-ou-metastatico.html]]></loc><lastmod>2019-08-23T19:08:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/paola1-resultados-mostram-beneficio-de-sobrevida-no-cancer-de-ovario.html]]></loc><lastmod>2019-08-16T17:05:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-mostra-resultados-promissores-no-cancer-de-pulmao-pequenas-celulas-recidivado.html]]></loc><lastmod>2020-04-24T17:11:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/invictus-estudo-mostra-ganho-de-sobrevida-no-gist-avancado.html]]></loc><lastmod>2019-08-20T00:38:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-inicial-mostra-ganho-de-sobrevida-no-cancer-de-pancreas.html]]></loc><lastmod>2019-08-14T18:34:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preditores-de-resposta-a-terapia-anti-pd-1.html]]></loc><lastmod>2019-08-18T15:10:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/toxicidade-financeira-no-tratamento-oncologico.html]]></loc><lastmod>2019-08-14T12:22:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comissao-europeia-amplia-indicacao-de-ibrutinibe.html]]></loc><lastmod>2019-08-14T00:11:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/genomica-e-tema-de-serie-especial.html]]></loc><lastmod>2019-08-12T19:18:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-novo-teste-promete-sensibilidade-na-avaliacao-de-doenca-residual.html]]></loc><lastmod>2019-08-08T17:24:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/calgb-49907-atualiza-resultados.html]]></loc><lastmod>2019-08-05T00:06:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-adjuvante-em-pacientes-com-cancer-gastrico-tratados-com-quimioterapia-perioperatoria-e-cirurgia-radical.html]]></loc><lastmod>2019-08-05T00:05:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/distress-psicologico-em-pacientes-com-cancer-de-colo-do-utero-e-maior-risco-de-mortalidade-cancer-especifica.html]]></loc><lastmod>2019-08-04T13:11:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-promessa-no-carcinoma-urotelial.html]]></loc><lastmod>2019-07-31T12:58:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/melanoma-e-risco-de-cancer-familiar.html]]></loc><lastmod>2019-07-26T15:24:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-avalia-novo-regime-de-tratamento-no-cancer-anal.html]]></loc><lastmod>2019-07-26T15:19:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/checkmate-227-imunoterapia-mostra-novos-resultados-em-cpnpc.html]]></loc><lastmod>2019-07-25T20:29:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tendencias-confirmam-elevacao-de-ccr-em-adultos-jovens.html]]></loc><lastmod>2019-07-24T13:08:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inovacao-x-beneficio-clinico.html]]></loc><lastmod>2019-08-04T23:06:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-e-incidencia-de-cancer-colorretal-em-jovens-adultos.html]]></loc><lastmod>2019-07-17T17:22:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eventos-imunomediados-e-re-exposicao-a-inibidores-de-checkpoint.html]]></loc><lastmod>2019-07-14T18:40:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desnutricao-no-paciente-oncologico-como-melhorar-a-triagem-nutricional.html]]></loc><lastmod>2019-07-11T16:59:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/margem-cirurgica-no-melanoma-cutaneo-localizado.html]]></loc><lastmod>2019-07-05T15:54:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adt-demencia-e-doenca-de-alzheimer.html]]></loc><lastmod>2019-07-14T23:50:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/celulas-tumorais-circulantes-na-avaliacao-de-resposta-ao-tratamento-neoadjuvante-do-cancer-de-reto.html]]></loc><lastmod>2019-07-01T17:49:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimiorradioterapia-nao-mostra-beneficio-de-sobrevida-livre-de-recidiva-no-cancer-de-endometrio.html]]></loc><lastmod>2019-07-01T03:16:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/springer-3.html]]></loc><lastmod>2019-06-30T03:09:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/springer-2.html]]></loc><lastmod>2019-06-29T20:02:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/video-springer.html]]></loc><lastmod>2019-06-29T17:17:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/crioablacao-em-metastases-osseas-de-tumores-neuroendocrinos.html]]></loc><lastmod>2019-06-30T16:42:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-no-diagnostico-do-cancer-de-ovario-onde-estamos.html]]></loc><lastmod>2019-07-01T01:21:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atualizacao-sobre-melanoma-da-mucosa.html]]></loc><lastmod>2019-06-25T16:04:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-segunda-neoplasia-em-sobreviventes-de-gist.html]]></loc><lastmod>2019-05-22T17:47:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/car-t-cells-em-mieloma-multiplo-e-as-licoes-para-a-pesquisa-translacional.html]]></loc><lastmod>2019-05-19T21:39:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consulta-publica-avalia-incorporacao-da-abiraterona-no-cprcm-com-quimioterapia-previa.html]]></loc><lastmod>2019-05-19T21:13:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-nova-aprovacao-no-tratamento-do-cancer-renal-avancado.html]]></loc><lastmod>2019-05-20T03:34:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-genomico-e-resultados-clinicos-no-cancer-de-prostata.html]]></loc><lastmod>2019-05-17T12:25:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/microambiente-tumoral-no-glioblastoma.html]]></loc><lastmod>2019-05-06T00:34:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adesao-ao-guideline-nutricional-em-pacientes-com-cancer-de-mama-precoce.html]]></loc><lastmod>2019-05-06T01:08:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-continua-melhora-desfechos-e-qualidade-de-vida-no-cancer-de-mama-avancado.html]]></loc><lastmod>2019-04-30T17:38:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-discute-cancer-lipidios-e-regulacao-celular.html]]></loc><lastmod>2019-04-29T20:33:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/keynote-062-pembrolizumabe-nao-e-superior-a-quimioterapia-na-primeira-linha-do-cancer-gastrico.html]]></loc><lastmod>2019-04-29T17:09:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/profile-1001-crizotinibe-mostra-dados-de-longo-prazo-no-cpnpc.html]]></loc><lastmod>2019-05-04T21:50:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-recidiva-no-cdis-e-fatores-preditivos.html]]></loc><lastmod>2019-05-05T17:34:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacao-brca-e-resposta-a-platina-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2019-04-28T17:31:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-clinica-em-melanoma-tendencias-e-combinacoes.html]]></loc><lastmod>2019-04-28T14:06:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bright-1-linha-no-linfoma-nao-hodgkin-indolente.html]]></loc><lastmod>2019-05-06T01:20:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desafios-e-oportunidades-de-estudos-clinicos-em-oncologia-de-precisao-na-america-latina.html]]></loc><lastmod>2019-04-24T20:38:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-pembrolizumabe-em-combinacao-com-axitinibe-na-primeira-linha-do-cancer-renal-avancado.html]]></loc><lastmod>2019-08-23T19:01:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-por-feixe-de-protons-o-fim-da-bolha.html]]></loc><lastmod>2019-04-21T12:08:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-asco-e-ash-reconhecem-seguranca-da-epoetina-alfa-biossimilar.html]]></loc><lastmod>2019-04-17T19:40:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-erdafitinib-para-o-tratamento-do-carcinoma-urotelial-com-alteracoes-no-fgfr.html]]></loc><lastmod>2019-04-15T17:21:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fulvestranto-anastrazol-combinacao-mostra-ganho-de-sobrevida-na-1-linha.html]]></loc><lastmod>2019-06-27T17:08:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neuro-oncologia-modelo-quer-avancar-na-pesquisa-em-glioblastoma.html]]></loc><lastmod>2019-04-08T13:41:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-cemiplimabe-para-carcinoma-espinocelular-de-pele.html]]></loc><lastmod>2019-04-07T23:30:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dose-de-antineoplasicos-em-pacientes-com-comprometimento-renal-e-hepatico.html]]></loc><lastmod>2019-04-07T14:34:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-promessa-no-cancer-urotelial-2.html]]></loc><lastmod>2019-04-02T12:29:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-nivolumabe-para-tratamento-adjuvante-do-melanoma.html]]></loc><lastmod>2019-03-28T14:29:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-venetoclax-em-combinacao-com-rituximabe-no-tratamento-da-llc.html]]></loc><lastmod>2019-03-25T21:35:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dados-moleculares-e-recidiva-no-cancer-de-mama.html]]></loc><lastmod>2019-03-24T21:34:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-abemaciclibe-no-cancer-de-mama.html]]></loc><lastmod>2021-03-17T15:51:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metagenomica-amplia-sequenciamento-e-ajuda-a-decifrar-microbioma-humano.html]]></loc><lastmod>2019-03-18T21:40:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-trazimera-biossimilar-do-trastuzumabe.html]]></loc><lastmod>2019-03-14T22:28:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cardiotoxicidade-no-tratamento-oncologico.html]]></loc><lastmod>2019-03-10T22:41:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacientes-jovens-com-cancer-colorretal-e-erros-diagnosticos.html]]></loc><lastmod>2019-03-14T15:07:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assinatura-prognostica-no-cancer-colorretal.html]]></loc><lastmod>2019-03-14T15:06:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-imunoterapia-para-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2019-03-14T15:05:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/video-alvaro-alencar.html]]></loc><lastmod>2019-02-25T12:50:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/barretos-investiga-microendoscopia-no-rastreamento-cervical.html]]></loc><lastmod>2019-02-21T22:24:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/barretos-investe-na-pesquisa-translacional.html]]></loc><lastmod>2019-02-21T21:02:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/barretos-promove-i-meeting-of-innovation-in-oncology.html]]></loc><lastmod>2019-02-21T22:24:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-publica-novas-indicacoes-de-medicamentos-contra-o-cancer.html]]></loc><lastmod>2019-02-20T14:18:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-novas-indicacoes-do-anti-pd-1-pembrolizumabe.html]]></loc><lastmod>2019-02-12T13:27:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-mostra-resultados-de-canabidiol-no-glioma-de-alto-grau.html]]></loc><lastmod>2019-02-04T00:24:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-denosumabe-em-tumores-de-celulas-gigantes.html]]></loc><lastmod>2019-02-03T22:22:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/angiossarcoma-associado-a-radioterapia-no-cancer-de-mama.html]]></loc><lastmod>2019-02-01T14:05:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-amplia-indicacao-de-pemetrexede-na-primeira-linha-do-cpnpc.html]]></loc><lastmod>2019-02-03T17:39:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esophacap-e-promessa-para-o-rastreamento-do-cancer-de-esofago.html]]></loc><lastmod>2019-01-29T19:13:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-com-participacao-brasileira-avalia-imunoterapia-no-cancer-de-prostata.html]]></loc><lastmod>2019-01-22T20:09:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-venetoclax-na-lma.html]]></loc><lastmod>2019-01-21T12:50:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/painel-oncoalvo-e-opcao-para-ampliar-acesso-ao-diagnostico-molecular.html]]></loc><lastmod>2019-01-14T11:12:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/farmaceuticas-reforcam-aliancas-para-a-pesquisa-em-cancer.html]]></loc><lastmod>2019-01-09T22:12:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sus-incorpora-sunitinibe-e-pazopanibe-no-tratamento-do-carcinoma-renal-de-celulas-claras-metastatico.html]]></loc><lastmod>2019-01-04T14:55:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-primeiro-biossimilar-para-linfoma-nao-hodgkin.html]]></loc><lastmod>2018-12-11T16:54:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-primeira-terapia-alvo-anti-flt3-em-lma.html]]></loc><lastmod>2018-12-01T23:15:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/survey-revela-como-os-oncologistas-usam-a-ngs.html]]></loc><lastmod>2018-11-26T01:41:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ash-2018-hematologia-em-pauta.html]]></loc><lastmod>2018-11-26T01:34:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/onconews-participa-do-crics10.html]]></loc><lastmod>2018-11-30T18:01:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/manejo-do-cancer-de-prostata-agressivo.html]]></loc><lastmod>2018-11-25T23:42:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mystic-durvalumabe-nao-atinge-resultados-no-cpnpc-estadio-iv.html]]></loc><lastmod>2018-11-19T19:39:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-pembrolizumabe-no-carcinoma-hepatocelular-previamente-tratado.html]]></loc><lastmod>2018-11-12T19:26:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-olaparibe-em-apresentacao-de-comprimidos.html]]></loc><lastmod>2018-11-04T21:33:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avelumabe-obtem-precificacao-da-cmed-para-carcinoma-de-celulas-de-merkel.html]]></loc><lastmod>2018-10-29T17:49:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-cabozantinibe-no-cancer-renal-avancado-ou-metastatico.html]]></loc><lastmod>2018-10-15T19:30:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eortc-propoe-consenso-para-avaliar-oligometastases-no-cancer-de-prostata.html]]></loc><lastmod>2018-10-14T22:22:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidores-de-checkpoint-no-carcinoma-de-celulas-renais-metastatico-dados-de-mundo-real.html]]></loc><lastmod>2018-10-15T02:18:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/incorporacao-de-sunitinibe-ou-pazopanibe-no-sus-para-cancer-renal-metastatico.html]]></loc><lastmod>2018-10-17T14:44:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-2018-debate-acesso-ao-tratamento-ideal.html]]></loc><lastmod>2018-10-08T12:20:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-de-aspirina-e-risco-de-carcinoma-hepatocelular.html]]></loc><lastmod>2018-10-14T21:25:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mais-acuracia-na-biopsia-transtoracica.html]]></loc><lastmod>2018-10-01T00:43:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-primeiro-anti-pd-1-para-carcinoma-espinocelular-avancado.html]]></loc><lastmod>2018-10-01T21:00:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/wclc-2018-os-destaques-do-mundial-de-pulmao.html]]></loc><lastmod>2020-04-24T19:56:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exposicao-a-poluicao-do-ar-em-mulheres-fumantes-e-nao-fumantes-com-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:18:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adesao-a-servicos-de-cessacao-do-tabagismo-durante-exames-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:58:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/confiabilidade-de-caes-treinados-na-identificacao-de-nodulos-pulmonares-malignos.html]]></loc><lastmod>2018-09-25T12:19:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-das-mulheres-com-cpnpc-e-maior-em-comparacao-com-os-homens.html]]></loc><lastmod>2018-09-25T01:17:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impower132-atezolizumabe-em-combinacao-com-carboplatina-e-pemetrexede-no-cpnpc-nao-escamoso-estadio-iv.html]]></loc><lastmod>2018-09-25T02:16:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-genetico-abrangente-auxilia-na-identificacao-de-opcoes-terapeuticas-personalizadas.html]]></loc><lastmod>2018-09-23T22:37:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/presenca-brasileira-em-encontro-mundial-de-ginecologia-oncologica.html]]></loc><lastmod>2018-09-17T19:32:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-perspectivas-no-tratamento-de-glioblastoma.html]]></loc><lastmod>2018-09-15T15:54:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aura3-eficacia-do-osimertinibe-no-sistema-nervoso-central-em-pacientes-com-cpnpc-avancado-t790m.html]]></loc><lastmod>2020-04-24T20:36:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-conjugada-mostra-novos-resultados-no-linfoma-de-hodgkin.html]]></loc><lastmod>2018-09-16T03:54:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/conflito-de-interesses-na-pesquisa-em-cancer.html]]></loc><lastmod>2018-09-16T04:53:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ativacao-da-resposta-imune-no-cancer-de-pulmao-pequenas-celulas.html]]></loc><lastmod>2020-04-24T20:03:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-tratamento-alvo-para-macroglobulinemia-de-waldenstroem.html]]></loc><lastmod>2018-08-27T17:11:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-de-imunoterapia-no-melanoma-com-metastase-cerebral.html]]></loc><lastmod>2018-08-24T14:01:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inca-realiza-encontro-internacional-de-pesquisa-em-cancer.html]]></loc><lastmod>2018-08-30T20:03:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uspstf-atualiza-diretrizes-de-rastreamento-do-cancer-de-colo-do-utero.html]]></loc><lastmod>2018-09-03T01:02:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-lenvatinibe-para-carcinoma-hepatocelular-irressecavel.html]]></loc><lastmod>2018-09-01T22:38:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-autoriza-novo-tratamento-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T20:04:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/doenca-inflamatoria-pelvica-aumenta-risco-de-cancer-de-ovario.html]]></loc><lastmod>2018-08-19T22:58:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/talazoparib-no-cancer-de-mama-avancado-brca-mutado.html]]></loc><lastmod>2018-08-19T19:00:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gene-zumbi-explica-baixa-incidencia-de-cancer-entre-elefantes.html]]></loc><lastmod>2018-08-17T15:17:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/leuginase-nao-mostra-eficacia-e-oferece-risco-elevado-de-imunogenicidade.html]]></loc><lastmod>2018-08-21T12:28:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prostatite-e-risco-de-cancer-de-prostata.html]]></loc><lastmod>2018-08-19T11:49:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comunicacao-medico-paciente-e-melhores-resultados-no-tratamento-oncologico.html]]></loc><lastmod>2018-08-19T13:13:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acupuntura-e-controle-de-sintomas-do-tratamento-com-inibidores-de-aromatase.html]]></loc><lastmod>2018-08-19T12:49:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/importacao-excepcional-da-lenalidomida.html]]></loc><lastmod>2018-08-13T16:27:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perfil-genomico-do-cancer-de-apendice.html]]></loc><lastmod>2018-08-27T18:59:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exames-de-sangue-na-vigilancia-de-linfoma-qual-o-valor.html]]></loc><lastmod>2018-08-19T16:49:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carcinoma-de-queratinocitos-cenario-atual-e-perspectivas.html]]></loc><lastmod>2018-08-06T03:51:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-ribociclibe-para-tratamento-do-cancer-de-mama-metastatico-rh-her2.html]]></loc><lastmod>2018-08-07T17:46:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comissao-europeia-aprova-trazimera-biossimilar-do-trasutzumabe.html]]></loc><lastmod>2019-03-14T20:49:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidor-de-egfr-em-metastases-cerebrais-do-cpnpc.html]]></loc><lastmod>2018-08-01T11:57:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mioepitelio-celular-e-cancer-de-mama.html]]></loc><lastmod>2018-07-31T12:11:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-amplia-indicacao-da-enzalutamida.html]]></loc><lastmod>2018-08-05T22:54:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/agencia-europeia-de-medicamentos-restringe-uso-do-radium-223.html]]></loc><lastmod>2018-07-30T21:48:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lenalidomida-esta-disponivel-para-comercializacao-no-brasil.html]]></loc><lastmod>2018-07-27T03:23:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/causas-de-morte-e-sobrevida-no-adenocarcinoma-pancreatico.html]]></loc><lastmod>2018-07-30T12:33:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-everolimo-generico.html]]></loc><lastmod>2018-07-26T04:36:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-no-cancer-de-mama.html]]></loc><lastmod>2018-08-06T03:09:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-biossimilar-indicado-para-tratamento-de-neutropenia.html]]></loc><lastmod>2018-07-26T04:36:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/poliovirus-recombinante-no-glioma-recorrente.html]]></loc><lastmod>2018-07-22T17:50:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/preservacao-de-orgaos-no-cancer-de-esofago.html]]></loc><lastmod>2018-07-22T16:11:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamentos-alternativos-e-resultados-de-sobrevida.html]]></loc><lastmod>2018-07-23T04:06:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-e-qualidade-de-vida-no-cancer-ginecologico.html]]></loc><lastmod>2018-07-23T20:21:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tempo-para-inicio-do-tratamento-e-mortalidade-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T20:11:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reproducao-assistida-e-risco-de-cancer.html]]></loc><lastmod>2018-07-22T15:11:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/potenciais-novos-alvos-terapeuticos-no-carcinoma-renal-de-celulas-claras.html]]></loc><lastmod>2018-07-17T12:33:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-enzalutamida-no-cancer-de-prostata-resistente-a-castracao-nao-metastatico.html]]></loc><lastmod>2018-07-16T14:16:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tardox-nova-promessa-terapeutica.html]]></loc><lastmod>2018-07-22T18:09:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-durvalumabe-para-tratamento-do-cpnpc-localmente-avancado.html]]></loc><lastmod>2018-07-22T17:11:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/abordagem-axilar-no-cancer-de-mama.html]]></loc><lastmod>2018-07-22T18:46:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/enzalutamida-mostra-resultados-de-sobrevida-no-cancer-de-prostata.html]]></loc><lastmod>2018-07-30T13:50:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/paloma3-mostra-dados-de-sobrevida.html]]></loc><lastmod>2018-06-28T12:37:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diabetes-e-cancer-de-pancreas.html]]></loc><lastmod>2018-06-21T13:34:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-em-cancer-como-interpretar.html]]></loc><lastmod>2018-06-20T14:11:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-em-homens-caracteristicas-e-desafios.html]]></loc><lastmod>2018-06-20T12:08:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/subtipos-histologicos-no-cancer-de-testiculo.html]]></loc><lastmod>2018-06-25T02:49:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacoes-btk-e-plcg2-e-recidiva-de-pacientes-com-leucemia-linfocitica-cronica-em-tratamento-com-ibrutinibe.html]]></loc><lastmod>2018-06-26T11:11:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/innovate-combinacao-mostra-eficacia-em-pacientes-com-macroglobulinemia-de-waldenstroem.html]]></loc><lastmod>2018-06-25T00:57:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cdk12-e-imunoterapia-no-cancer-de-prostata.html]]></loc><lastmod>2018-06-18T17:17:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ema-restringe-inibidores-de-checkpoint-no-cancer-de-bexiga.html]]></loc><lastmod>2018-06-15T14:13:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/parceria-lacog-gu-e-eortc.html]]></loc><lastmod>2018-06-14T13:36:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-novos-tratamentos-contra-o-cancer-2.html]]></loc><lastmod>2018-06-14T13:36:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-fda-faz-alerta-de-seguranca-no-cancer-urotelial.html]]></loc><lastmod>2018-05-28T03:32:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-anvisa-autoriza-novas-indicacoes.html]]></loc><lastmod>2018-05-28T03:34:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estrategias-para-refinar-o-screening-tomografico-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:20:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gemcitabina-adjuvante-no-cancer-de-bexiga.html]]></loc><lastmod>2018-05-27T16:29:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/larcg-cancer-renal-em-idosos-na-america-latina.html]]></loc><lastmod>2018-05-25T12:15:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bacteremia-e-cancer-colorretal.html]]></loc><lastmod>2018-05-28T02:51:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-promessa-no-cancer-urotelial.html]]></loc><lastmod>2018-05-23T12:15:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eficacia-de-inibidores-de-checkpoint-em-homens-e-mulheres.html]]></loc><lastmod>2018-05-18T13:01:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/celulas-t-ativadas-podem-prever-resposta-a-estrategias-de-imunoterapia.html]]></loc><lastmod>2018-05-16T15:48:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-epoetina-alfa-biossimilar.html]]></loc><lastmod>2018-05-16T15:28:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-de-cancer-gastrointestinal-em-pacientes-com-fibrose-cistica.html]]></loc><lastmod>2018-05-15T17:37:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacinacao-profilatica-contra-hpv-e-cancer-cervical.html]]></loc><lastmod>2018-05-14T03:49:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uspstf-e-o-rastreamento-para-o-cancer-de-prostata.html]]></loc><lastmod>2018-05-14T03:44:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/obesidade-e-cancer-de-prostata-metastatico.html]]></loc><lastmod>2018-05-09T12:05:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sigmoidoscopia-e-risco-de-cancer-colorretal-em-homens-e-mulheres.html]]></loc><lastmod>2018-05-12T16:27:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/subnotificacao-de-informacoes-sobre-pacientes-obesos-em-ensaios-clinicos-randomizados.html]]></loc><lastmod>2018-05-07T19:11:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-astro-combinacao-de-radioterapia-com-terapia-alvo-molecular-e-imunoterapia.html]]></loc><lastmod>2018-05-01T21:57:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-promessa-no-carcinoma-espinocelular-cutaneo.html]]></loc><lastmod>2018-04-30T19:07:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-discute-cirurgia-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2018-05-01T20:20:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/banco-de-cancer-testicular-estimula-contribuicao-a-pesquisa-brasileira.html]]></loc><lastmod>2018-04-27T22:12:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/deteccao-precoce-do-cancer-primeiros-resultados-do-circulating-cell-free-genome-atlas-study-ccga.html]]></loc><lastmod>2018-04-18T16:48:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/checkmate-227-nivolumabe-mais-ipilimumabe-no-cancer-de-pulmao-com-alta-carga-mutacional.html]]></loc><lastmod>2020-04-24T17:22:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bloqueio-neoadjuvante-de-pd-1-no-cancer-de-pulmao-ressecavel.html]]></loc><lastmod>2020-04-24T17:23:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/keynote-189-pembrolizumabe-mais-quimioterapia-no-cancer-de-pulmao-nao-pequenas-celulas-metastatico.html]]></loc><lastmod>2020-04-24T17:23:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/larc-participa-de-encontro-mundial-sobre-cancer-renal.html]]></loc><lastmod>2018-04-18T01:44:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/elcc-2018-e-os-destaques-da-oncologia-toracica.html]]></loc><lastmod>2018-04-16T15:12:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biomarcadores-sao-promessa-no-mesotelioma.html]]></loc><lastmod>2018-04-17T22:06:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacoes-e-resposta-a-tkis-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:24:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pagamentos-a-medicos-e-prescricao-de-medicamentos.html]]></loc><lastmod>2018-04-12T21:55:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/parametros-histopatologicos-diferenciais-em-metastases-hepaticas-do-cancer-colorretal.html]]></loc><lastmod>2018-04-12T21:50:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atlas-estudo-nao-mostra-beneficios-no-cancer-renal-de-alto-risco.html]]></loc><lastmod>2018-04-12T21:44:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/erradicacao-do-h-pylori-e-incidencia-de-cancer-gastrico-em-idosos.html]]></loc><lastmod>2018-04-15T20:46:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sarcopenia-e-mortalidade-no-cancer-de-mama.html]]></loc><lastmod>2018-04-16T05:01:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/meta-analise-avalia-tkis-de-egfr-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:23:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-do-cancer-do-colo-do-utero-em-mulheres-acima-de-65-anos.html]]></loc><lastmod>2018-03-29T14:07:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-neoadjuvante-total-no-cancer-retal-localmente-avancado.html]]></loc><lastmod>2018-04-01T21:52:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-na-mulher-idosa.html]]></loc><lastmod>2018-03-30T14:53:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-clinica-e-seguranca-do-paciente.html]]></loc><lastmod>2018-05-07T14:09:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vitamina-d-e-cancer-novas-evidencias.html]]></loc><lastmod>2018-03-18T15:04:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perspectivas-da-onco-hematologia.html]]></loc><lastmod>2018-11-04T16:53:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novartis-e-alvo-de-protestos-pelo-acesso-a-oncologicos.html]]></loc><lastmod>2018-03-08T22:14:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-penis-avancado-qual-a-melhor-abordagem.html]]></loc><lastmod>2018-03-18T18:09:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-pertuzumabe-para-tratamento-do-cancer-de-mama-inicial-her2.html]]></loc><lastmod>2018-03-09T11:22:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-alerta-sobre-falsificacao-de-oncologico.html]]></loc><lastmod>2018-03-09T10:29:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevencao-do-hpv-e-controle-do-cancer.html]]></loc><lastmod>2018-03-04T21:29:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-preditivo-baseado-em-ressonancia-magnetica-para-estratificacao-de-risco-de-biopsia-da-prostata.html]]></loc><lastmod>2018-03-04T17:39:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-nivolumabe-em-cancer-de-bexiga.html]]></loc><lastmod>2018-03-01T16:56:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-ingles-poe-em-xeque-superioridade-da-prostatectomia-robotica.html]]></loc><lastmod>2018-02-26T02:42:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/metanalise-mostra-vantagens-da-prostatectomia-robotica.html]]></loc><lastmod>2018-02-26T02:43:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-apalutamida-no-tratamento-do-cancer-de-prostata-nao-metastatico-resistente-a-castracao.html]]></loc><lastmod>2018-02-23T17:10:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imc-e-resultados-de-sobrevida-no-melanoma-metastatico.html]]></loc><lastmod>2018-03-04T19:06:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-avalia-reacoes-com-uso-de-inibidores-de-checkpoint-imune.html]]></loc><lastmod>2018-02-20T20:02:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-de-inducao-no-cancer-colorretal.html]]></loc><lastmod>2018-02-22T15:21:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/beneficios-a-longo-prazo-da-pratica-de-exercicios-durante-a-quimioterapia.html]]></loc><lastmod>2018-02-22T17:35:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/jovens-adultos-sobreviventes-de-cancer-e-acompanhamento-apos-o-fim-do-tratamento.html]]></loc><lastmod>2018-02-23T12:50:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asparagina-e-metastases-no-tnbc.html]]></loc><lastmod>2018-02-19T11:36:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/periodontite-e-risco-de-cancer.html]]></loc><lastmod>2018-02-19T00:54:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trombose-venosa-associada-ao-cancer.html]]></loc><lastmod>2018-02-18T17:12:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nutricao-e-cancer-colorretal.html]]></loc><lastmod>2018-02-19T11:46:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sorafenibe-e-lenvatinibe-no-carcinoma-hepatocelular.html]]></loc><lastmod>2018-02-19T11:32:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alimentos-processados-e-risco-de-cancer.html]]></loc><lastmod>2018-02-18T16:18:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/concord-cancer-e-sobrevida-em-71-paises.html]]></loc><lastmod>2018-02-21T19:54:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-novas-combinacoes-e-tratamentos.html]]></loc><lastmod>2018-01-22T00:02:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-minimamente-invasiva-no-cancer-de-esofago-ressecavel.html]]></loc><lastmod>2018-01-19T20:47:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-inibidor-de-parp-no-cancer-de-mama-brca-mutado.html]]></loc><lastmod>2018-01-14T13:44:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-tratamentos-e-metodos-de-rastreamento-reduzem-mortes-por-cancer-de-mama.html]]></loc><lastmod>2018-01-12T10:59:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-e-gestao-de-risco-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:26:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biopsia-liquida-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2018-01-08T22:07:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-breakthrough-therapy-para-avelumabe-no-cancer-renal.html]]></loc><lastmod>2018-01-09T12:04:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-de-lenvatinibe-e-pembrolizumabe-no-carcinoma-de-celulas-renais-avancado-e-ou-metastatico.html]]></loc><lastmod>2018-01-10T17:57:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-primeiro-biossimilar-do-trastuzumabe.html]]></loc><lastmod>2017-12-19T14:39:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-elotuzumabe-em-mieloma-multiplo.html]]></loc><lastmod>2017-12-19T15:28:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/javelin-mostra-dados-de-avelumab-no-carcinoma-urotelial.html]]></loc><lastmod>2017-12-11T01:15:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/stf-proibe-amianto-no-brasil.html]]></loc><lastmod>2017-11-30T15:04:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prioridades-dos-pacientes-e-estrategias-de-tratamento.html]]></loc><lastmod>2017-11-29T20:19:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/chernobyl-comprovadas-mutacoes-no-cancer-de-tireoide.html]]></loc><lastmod>2017-11-29T20:31:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-para-linfadenectomia-pos-sentinela.html]]></loc><lastmod>2017-11-26T22:33:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-publica-registro-de-generico-da-abiraterona.html]]></loc><lastmod>2017-11-26T22:46:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ctdna-prediz-recidiva-precoce-no-melanoma-ressecado-de-alto-risco-estagio-ii-iii.html]]></loc><lastmod>2017-11-26T22:13:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diabetes-tipo-2-e-risco-de-cancer-de-mama-er-negativo-em-mulheres-afro-americanas.html]]></loc><lastmod>2017-11-22T18:04:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/marcadores-de-risco-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:27:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/flaura-mostra-dados-na-populacao-asiatica.html]]></loc><lastmod>2017-11-20T22:44:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/deficiencia-do-mismatch-repair-em-pacientes-com-cancer-colorretal-nao-aderentes-aos-guidelines-de-testes.html]]></loc><lastmod>2017-11-29T18:42:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-sunitinibe-para-o-tratamento-adjuvante-do-carcinoma-de-celulas-renais-pos-nefrectomia.html]]></loc><lastmod>2017-11-20T12:20:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-discute-biomarcadores-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2017-11-26T22:41:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/banco-de-testiculos-se-mantem-aberto-a-participacao-brasileira.html]]></loc><lastmod>2017-11-12T17:29:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tabela-do-sus-valores-e-perspectivas-no-tratamento-do-cancer.html]]></loc><lastmod>2017-11-10T18:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ingestao-de-fibras-e-mortalidade-em-pacientes-com-cancer-colorretal.html]]></loc><lastmod>2017-11-08T10:27:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sirt-no-carcinoma-hepatocelular.html]]></loc><lastmod>2017-11-12T12:02:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nivolumabe-atualiza-dados-de-sobrevida-global-no-cancer-renal.html]]></loc><lastmod>2017-11-07T19:35:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-genetico-pode-prever-cancer-de-esofago.html]]></loc><lastmod>2017-11-07T13:12:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-paliativos-precoces-resultados-relatados-pelos-pacientes-e-cuidados-de-fim-de-vida.html]]></loc><lastmod>2017-11-07T13:12:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lung-force-mostra-desafios-para-o-rastreio-do-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:27:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intervencao-multimodal-melhorar-funcao-sexual-e-qualidade-de-vida-em-sobreviventes-de-transplante.html]]></loc><lastmod>2017-11-07T18:33:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intervencao-melhora-o-bem-estar-em-jovens-pacientes-com-cancer.html]]></loc><lastmod>2017-11-06T17:14:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aplicativo-movel-e-adesao-a-quimioterapia-oral.html]]></loc><lastmod>2017-11-07T17:06:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacientes-preferem-que-medicos-nao-usem-computador-na-sala-de-exames.html]]></loc><lastmod>2017-10-31T20:15:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ioga-como-terapia-de-suporte-para-pacientes-com-cancer-de-pulmao-e-seus-cuidadores.html]]></loc><lastmod>2020-04-24T17:28:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diferentes-percepcoes-de-prognostico-entre-pacientes-de-leucemia-e-oncologistas.html]]></loc><lastmod>2017-10-31T19:49:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estimulacao-por-eletroterapia-craniana-para-o-tratamento-de-depressao-ansiedade-disturbios-do-sono-e-dor.html]]></loc><lastmod>2017-11-07T18:58:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/wclc-2017-estudo-brasileiro-mostra-potenciais-anos-de-vida-perdidos-por-falta-de-acesso-a-tki-de-egfr.html]]></loc><lastmod>2017-10-31T21:17:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destaques-do-18-wclc.html]]></loc><lastmod>2017-10-30T05:14:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tumores-ginecologicos-na-sboc-2017.html]]></loc><lastmod>2017-10-30T05:15:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-suspende-5-medicamentos-por-falhas-em-boas-praticas-de-fabricacao.html]]></loc><lastmod>2017-10-28T01:55:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-identifica-65-novos-loci-associados-ao-cancer-de-mama.html]]></loc><lastmod>2017-10-30T05:13:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comunicacao-e-qualidade-de-vida-em-destaque-no-simposio-de-cuidados-paliativos-da-asco.html]]></loc><lastmod>2017-10-26T23:24:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/amostra-de-biopsia-e-confiavel-para-avaliacao-da-expressao-de-dll3-no-cppc.html]]></loc><lastmod>2017-10-26T13:15:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacific-qualidade-de-vida-em-pacientes-com-cpnpc-tratados-com-durvalumab.html]]></loc><lastmod>2017-10-19T15:35:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iaslc-publica-novo-atlas-sobre-teste-de-egfr.html]]></loc><lastmod>2017-10-19T20:19:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exercicios-fisicos-e-qualidade-de-vida-em-pacientes-com-cancer-de-pulmao-avancado.html]]></loc><lastmod>2020-04-24T17:29:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cepon-mostra-experiencia-institucional-no-mundial-de-pulmao.html]]></loc><lastmod>2020-04-24T17:30:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/18-conferencia-mundial-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:30:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consulta-publica-avalia-incorporacao-de-cetuximabe-ao-sus.html]]></loc><lastmod>2017-10-10T01:37:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-atezolizumabe-em-duas-indicacoes.html]]></loc><lastmod>2017-10-15T14:13:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacoes-e-resistencia-a-terapia-endocrina-no-cancer-de-mama.html]]></loc><lastmod>2017-10-16T01:01:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-nivolumab-em-linfoma-de-hodgkin.html]]></loc><lastmod>2018-04-24T19:52:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vigilancia-ativa-no-cancer-de-prostata.html]]></loc><lastmod>2017-10-09T03:18:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-propoe-novo-sistema-de-classificacao-das-neoplasias.html]]></loc><lastmod>2017-10-09T03:18:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/astro-2017-aponta-os-destaques-do-programa-cientifico.html]]></loc><lastmod>2017-10-02T01:40:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-primeiro-biossimilar-para-o-tratamento-do-cancer.html]]></loc><lastmod>2017-09-18T01:41:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-na-sindrome-de-li-fraumeni.html]]></loc><lastmod>2017-09-05T21:28:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-de-conduta-e-reacoes-infusionais.html]]></loc><lastmod>2017-09-04T01:34:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alcyone-daratumumabe-na-primeira-linha-em-mieloma-multiplo.html]]></loc><lastmod>2017-08-28T12:01:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/keynote-006-pembrolizumabe-no-melanoma-avancado.html]]></loc><lastmod>2017-08-28T12:02:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-livre-de-metastase-e-forte-surrogate-da-sobrevida-global-no-cancer-de-prostata-localizado.html]]></loc><lastmod>2017-08-28T12:02:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-brasileiro-busca-quantificar-padroes-espaciais-observados-na-formacao-do-melanoma.html]]></loc><lastmod>2017-08-22T21:14:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-nintedanibe-para-tratamento-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:30:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-parcial-da-mama-hipofracionada-apos-cirurgia-conservadora-no-cancer-inicial.html]]></loc><lastmod>2017-08-20T22:10:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/checkmate-214-mostra-taxa-de-resposta-superior.html]]></loc><lastmod>2017-08-16T20:39:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioprevencao-e-fertilidade-no-cancer-de-mama-precoce.html]]></loc><lastmod>2017-08-16T13:31:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aurelia-antiangiogenico-mostra-sobrevida-global-no-cancer-de-ovario.html]]></loc><lastmod>2017-08-16T13:19:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fenotipo-variante-molecular-e-melanoma-amelanotico.html]]></loc><lastmod>2017-08-14T12:51:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/interacoes-entre-drogas-e-drogas-e-ervas-em-pacientes-com-cancer.html]]></loc><lastmod>2017-08-07T06:53:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hospital-de-cancer-de-barretos-inaugura-instituto-de-prevencao.html]]></loc><lastmod>2017-07-26T22:22:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-sequencial-ou-concorrente-a-intensidade-da-dose-faz-diferenca.html]]></loc><lastmod>2017-07-18T03:29:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custo-e-beneficio-no-tratamento-do-cancer.html]]></loc><lastmod>2017-07-12T15:21:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-oral-como-gerenciar-o-uso.html]]></loc><lastmod>2017-07-24T04:56:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/checkmate-026-mostra-resultados-da-imunoterapia-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:33:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/licoes-da-asco-2017.html]]></loc><lastmod>2017-07-11T21:07:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/20-destaques-onco.html]]></loc><lastmod>2017-07-10T05:10:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-pembrolizumabe-na-primeira-linha-de-tratamento-do-cpnpc.html]]></loc><lastmod>2017-06-20T21:10:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fundacao-do-cancer-inaugura-hospital-no-rio-de-janeiro.html]]></loc><lastmod>2017-06-03T17:54:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/decisao-do-fda-e-mais-um-marco-na-medicina-de-precisao.html]]></loc><lastmod>2017-05-23T10:11:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consulta-marcada-estimula-a-triagem-do-cancer-de-mama.html]]></loc><lastmod>2017-05-23T21:03:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aacr-e-lacog-esforcos-na-pesquisa-translacional.html]]></loc><lastmod>2017-05-19T18:01:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/contagem-de-leucocitos-e-resposta-a-imunoterapia-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:38:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-profilaticodo-g-csf-e-seguro-durante-a-quimiorradioterapia-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:39:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-de-resgate-no-cpnpc-pre-tratado-com-inibidores-de-pd-1-pd-l1.html]]></loc><lastmod>2017-05-07T21:34:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/rastreamento-do-cancer-de-pulmao-precisa-ser-mais-frequente-em-homens.html]]></loc><lastmod>2020-04-24T18:40:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-guideline-e-risco-de-cancer-urinario-em-mulheres.html]]></loc><lastmod>2017-05-12T21:48:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/kras-na-biopsia-liquida-em-adenocarcinoma-pancreatico.html]]></loc><lastmod>2017-05-01T17:59:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-publica-parecer-clinico-sobre-terapia-hormonal-no-cancer-de-prostata.html]]></loc><lastmod>2017-05-01T17:27:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-e-vacinacao-anual-contra-a-gripe-em-pacientes-com-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:41:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pace-avaliacao-da-prostatectomia-robotica.html]]></loc><lastmod>2017-05-02T02:08:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/elcc-2017-reune-avancos-no-diagnostico-e-tratamento-do-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:41:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/checkmate-040-imunoterapia-no-carcinoma-hepatocelular.html]]></loc><lastmod>2017-04-24T12:47:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neoadjuvancia-e-selecao-de-risco-em-cancer-de-mama.html]]></loc><lastmod>2017-04-20T14:09:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-amplia-indicacao-do-palbociclibe.html]]></loc><lastmod>2017-04-24T19:58:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/heracles-a-combinacao-de-terapias-alvo-anti-her2-e-eficaz-em-pacientes-com-cancer-colorretal-intensamente-pre-tratados.html]]></loc><lastmod>2017-04-17T18:10:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-terapeutica-mostra-eficacia-no-cancer-de-prostata-resistente-a-castracao.html]]></loc><lastmod>2017-04-15T18:51:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dispositivo-medico-melhora-a-sobrevida-de-pacientes-com-glioblastoma.html]]></loc><lastmod>2017-04-15T15:30:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gist-selecao-molecular-e-resultados-terapeuticos.html]]></loc><lastmod>2017-04-10T19:47:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destaques-da-aacr-2017.html]]></loc><lastmod>2017-04-10T15:02:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/os-highlights-do-encontro-anual-do-nccn.html]]></loc><lastmod>2017-04-07T19:35:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioterapia-de-consolidacao-apos-quimiorradioterapia-concomitante-para-cpnpc-estadio-iii.html]]></loc><lastmod>2017-04-02T21:10:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/irecist-avaliacao-em-estudos-de-imuno-oncologia.html]]></loc><lastmod>2017-03-30T16:37:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sbrt-e-radioterapia-em-dose-unica-no-cpnpc.html]]></loc><lastmod>2017-07-31T21:05:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibidor-de-parp-mostra-resultados-na-sgo.html]]></loc><lastmod>2017-03-17T17:35:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gravidez-e-cancer-de-mama.html]]></loc><lastmod>2017-03-17T15:46:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobrevida-por-cancer-cervical-e-diretrizes-de-conduta.html]]></loc><lastmod>2017-03-15T12:51:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lentidao-no-recrutamento-de-pacientes-em-ensaios-clinicos-de-cancer.html]]></loc><lastmod>2017-03-16T21:34:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibicao-de-pd-l1-e-cd38-pode-melhorar-resposta-tumoral.html]]></loc><lastmod>2017-03-02T14:54:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/keynote-045-pembrolizumabe-no-cancer-de-bexiga-avancado.html]]></loc><lastmod>2017-02-21T17:11:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-em-cancer-resultados-e-evidencias.html]]></loc><lastmod>2017-02-20T16:57:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/goelan-mostra-beneficio-de-androgenos-na-lma-em-idosos.html]]></loc><lastmod>2017-03-06T02:09:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/astellas-selecao-molecular-no-cancer-de-prostata.html]]></loc><lastmod>2017-02-21T19:15:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-perspectivas-no-cancer-urotelial.html]]></loc><lastmod>2017-02-12T23:24:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fires-linfonodo-sentinela-no-cancer-de-endometrio.html]]></loc><lastmod>2017-02-03T11:55:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/abpi-ou-irradiacao-total-no-cancer-de-mama.html]]></loc><lastmod>2017-02-06T17:42:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/keynote-012-pembrolizumabe-no-cancer-urotelial.html]]></loc><lastmod>2017-02-03T11:34:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/jovens-sobreviventes-de-cancer-de-tireoide-enfrentam-maior-risco-de-doencas-cardiacas-e-osteoporose.html]]></loc><lastmod>2017-01-27T12:25:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pacientes-idosas-sao-sub-representadas-em-estudos-de-cancer-de-mama.html]]></loc><lastmod>2017-01-23T19:33:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-regular-de-aspirina-reduz-risco-de-cancer-de-pancreas.html]]></loc><lastmod>2017-02-21T14:25:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consumo-de-alcool-e-risco-de-melanoma.html]]></loc><lastmod>2017-01-09T13:44:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acido-urico-como-marcador-de-progressao-do-cancer-de-nasofaringe.html]]></loc><lastmod>2017-01-09T12:45:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/europa-concede-aprovacao-condicional-para-venetoclax-como-monoterapia-em-llc.html]]></loc><lastmod>2016-12-21T20:41:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-terapia-combinada-no-melanoma-metastatico-braf.html]]></loc><lastmod>2016-12-20T20:29:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-brasileiros-anunciam-novo-grupo-multicentrico-de-pesquisa-em-cancer.html]]></loc><lastmod>2016-12-12T01:10:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-ao-avelumab-para-o-tratamento-do-carcinoma-de-celulas-de-merkel.html]]></loc><lastmod>2016-12-01T22:53:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-daratumumab-em-mieloma-multiplo-recorrente-ou-refratario.html]]></loc><lastmod>2016-11-22T16:10:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/idade-ao-diagnostico-de-cancer-e-risco-cardiaco-futuro.html]]></loc><lastmod>2016-11-22T12:10:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inovacoes-terapeuticas-no-mieloma-multiplo.html]]></loc><lastmod>2016-11-28T17:49:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/v-simposio-do-grupo-brasileiro-de-oncologia-toracica.html]]></loc><lastmod>2016-11-07T17:39:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/localizacao-do-tumor-no-cancer-colorretal.html]]></loc><lastmod>2016-11-07T14:03:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/parceria-estrutura-novo-centro-de-excelencia-em-radioterapia.html]]></loc><lastmod>2016-11-03T23:49:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-pembrolizumabe-na-primeira-linha-de-tratamento-do-cpnpc-avancado.html]]></loc><lastmod>2016-11-01T01:42:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-ibrutinibe-para-tratamento-de-macroglobulinemia-de-waldenstrom.html]]></loc><lastmod>2016-11-07T14:28:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-beneficios-da-reconstrucao-mamaria-em-mulheres-idosas.html]]></loc><lastmod>2016-10-28T13:08:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eano-highlights-em-neuro-oncologia.html]]></loc><lastmod>2016-10-24T02:25:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eano-guideline-para-meningiomas.html]]></loc><lastmod>2016-10-28T12:10:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-atezolizumab-para-cancer-de-pulmao-nao-pequenas-celulas.html]]></loc><lastmod>2020-04-24T18:50:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/base-de-evidencias-radioterapia-pos-mastectomia.html]]></loc><lastmod>2016-10-03T16:58:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-para-a-radioterapia-pos-mastectomia.html]]></loc><lastmod>2016-09-29T18:36:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/euramos-1-estrategias-no-osteossarcoma-de-alto-grau.html]]></loc><lastmod>2016-10-03T16:58:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/padrao-de-cuidados-no-osteossarcoma-de-alto-grau.html]]></loc><lastmod>2016-09-26T04:39:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vasectomia-nao-aumenta-risco-de-cancer-de-prostata.html]]></loc><lastmod>2016-09-26T03:55:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-modifica-dosagem-de-nivolumabe-para-tres-indicacoes.html]]></loc><lastmod>2016-09-21T20:31:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-gain-toxicidade-grave-com-quimio-em-dose-densa-em-pacientes-obesos.html]]></loc><lastmod>2016-09-21T20:32:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ansiedade-e-depressao-em-cuidadores-familiares.html]]></loc><lastmod>2016-09-16T15:54:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/iatrogenia-e-risco-acidental-no-diagnostico-de-cancer.html]]></loc><lastmod>2016-09-12T03:17:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-prioritaria-para-pembrolizumabe-na-primeira-linha-de-tratamento-do-cpnpc-avancado.html]]></loc><lastmod>2016-09-16T16:06:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-analises-do-estudo-fire-3.html]]></loc><lastmod>2016-09-11T22:17:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resistencia-a-terapia-de-privacao-de-androgenio-no-cancer-de-prostata.html]]></loc><lastmod>2016-09-11T22:19:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uso-excessivo-de-pet-em-tumores-de-pulmao-e-esofago.html]]></loc><lastmod>2020-04-24T18:53:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guidelines-do-nccn-e-conflitos-de-interesse.html]]></loc><lastmod>2016-09-02T15:40:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-pertuzumabe-para-tratamento-neoadjuvante-do-cancer-de-mama-her2.html]]></loc><lastmod>2017-05-15T14:47:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diagnostico-precoce-de-cancer-de-prostata-cai-nos-eua.html]]></loc><lastmod>2016-09-02T15:40:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/daratumumab-em-mieloma-multiplo.html]]></loc><lastmod>2016-08-22T14:04:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tania-antiangiogenico-no-cancer-de-mama-recorrente.html]]></loc><lastmod>2016-08-15T15:29:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-pembrolizumabe-para-o-tratamento-de-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2016-08-14T19:26:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ribociclibe-em-cancer-de-mama-avancado-hr-her2.html]]></loc><lastmod>2016-08-15T03:50:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/checkmate-026-nivolumabe-falha-em-monoterapia-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:54:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atencao-psicossocial-aos-pacientes-com-cancer-no-brasil.html]]></loc><lastmod>2016-08-04T23:03:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uniao-europeia-aprova-pembrolizumabe-para-o-tratamento-do-cpnpc.html]]></loc><lastmod>2016-08-04T13:00:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/neopterina-um-novo-fator-prognostico.html]]></loc><lastmod>2016-08-03T21:25:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/painel-de-experts-cancer-de-pulmao-nao-pequenas-celulas.html]]></loc><lastmod>2020-04-24T18:54:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/medicina-personalizada-no-cancer-de-tireoide-com-mutacao-braf-v600e.html]]></loc><lastmod>2016-07-28T20:50:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/niveis-de-neopterina-associados-a-sobrevida-no-cancer-de-ovario.html]]></loc><lastmod>2016-08-01T02:47:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-precoce-em-mieloma-smouldering-de-alto-risco.html]]></loc><lastmod>2016-07-27T21:19:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacao-rara-associada-a-melhor-prognostico-no-cancer-de-intestino.html]]></loc><lastmod>2016-07-27T21:06:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brentuximabe-vedotina-mostra-resultados-de-longo-prazo.html]]></loc><lastmod>2016-07-27T15:33:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-mostra-resultados-positivos-para-potencial-trastuzumabe-biossimilar.html]]></loc><lastmod>2016-08-01T02:52:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/regorafenibe-mostra-ganho-de-sobrevida-no-cancer-de-figado-refratario.html]]></loc><lastmod>2016-07-21T16:43:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/risco-e-vigilancia-no-carcinoma-hepatocelular.html]]></loc><lastmod>2016-07-20T17:12:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ibrutinibe-recebe-indicacao-em-linfoma-de-celulas-do-manto.html]]></loc><lastmod>2016-07-17T23:50:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-registra-ramucirumabe-no-cancer-gastroesofagico.html]]></loc><lastmod>2016-07-11T21:17:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estratificacao-de-risco-no-cancer-de-ovario.html]]></loc><lastmod>2016-07-18T21:27:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tailor-cetuximab-folfox-na-primeira-linha.html]]></loc><lastmod>2016-07-07T23:43:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brasileiro-e-eleito-pesquisador-destaque-conquer-cancer-foundation.html]]></loc><lastmod>2016-07-05T20:04:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hospital-sao-jose-inaugura-novas-instalacoes.html]]></loc><lastmod>2016-07-02T17:08:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimiorradioterapia-nao-aumenta-sobrevida-no-cancer-gastrico.html]]></loc><lastmod>2016-06-30T16:05:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-nivolumabe-em-cancer-de-bexiga.html]]></loc><lastmod>2016-06-28T02:48:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/grupo-oncoclinicas-inaugura-onconcentro-bh.html]]></loc><lastmod>2017-05-15T14:48:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pollux-novos-dados-com-daratumumabe-no-mieloma-multiplo.html]]></loc><lastmod>2016-06-20T15:26:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/euro-ski-mostra-dados-sobre-interrupcao-de-tki-em-lmc.html]]></loc><lastmod>2016-06-13T03:24:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-regime-combinado-de-lenvatinib-e-everolimus-para-o-tratamento-de-ccr-avancado.html]]></loc><lastmod>2016-05-20T17:01:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anti-pd-1-mostra-dados-de-uso-continuo-em-cancer-renal.html]]></loc><lastmod>2016-05-18T18:07:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/abiraterona-e-enzalutamida-tem-impacto-na-qualidade-de-vida.html]]></loc><lastmod>2016-05-17T15:13:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-identifica-potencial-tratamento-alvo-para-o-cancer-de-pancreas.html]]></loc><lastmod>2016-05-16T16:49:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/autismo-e-cancer-possuem-genes-de-risco-em-comum.html]]></loc><lastmod>2016-05-12T20:49:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/omega-3-e-imunoprevencao-do-cancer-colorretal.html]]></loc><lastmod>2016-05-12T21:01:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/disfuncao-cardiaca-relacionada-ao-tratamento-de-cancer-de-mama.html]]></loc><lastmod>2016-05-12T17:38:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/venetoclax-para-o-tratamento-de-llc-aguarda-posicao-da-anvisa.html]]></loc><lastmod>2016-05-11T20:16:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qual-o-melhor-regime-de-inducao-em-linfoma-de-hodgkin.html]]></loc><lastmod>2016-05-10T22:46:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cold-cap-pesquisa-com-participacao-brasileira-mostra-eventos-adversos.html]]></loc><lastmod>2016-05-17T16:33:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resorce-mostra-ganho-de-sobrevida-no-carcinoma-hepatocelular.html]]></loc><lastmod>2016-05-08T17:05:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-mage-a3-nao-melhora-sobrevida-livre-de-doenca-em-cpnpc.html]]></loc><lastmod>2016-05-06T12:58:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exposicao-a-poluentes-e-associada-a-diferentes-tipos-de-cancer.html]]></loc><lastmod>2016-05-03T13:20:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fertilidade-e-cancer-pacientes-mais-jovens-tem-menos-acesso-a-bancos-de-semen.html]]></loc><lastmod>2016-05-02T01:23:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gap-brazil-propoe-abordagem-global-do-cancer.html]]></loc><lastmod>2016-04-27T14:13:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bisfosfonatos-risco-x-beneficio-do-uso-prolongado.html]]></loc><lastmod>2016-04-26T23:51:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/snola-2016-a-importancia-do-tcga-nos-gliomas.html]]></loc><lastmod>2016-04-29T02:22:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/icon-s-nova-classificacao-do-cancer-de-orofaringe-hpv.html]]></loc><lastmod>2016-04-25T01:33:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imuno-oncologia-e-tema-de-simposio-promovido-pela-sboc.html]]></loc><lastmod>2016-04-25T01:01:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/toxt-eventos-adversos-de-longo-prazo-no-tratamento-do-cancer.html]]></loc><lastmod>2016-04-19T17:14:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radiocirurgia-da-cavidade-cirurgica-em-metastases-cerebrais.html]]></loc><lastmod>2016-04-19T14:27:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assinatura-genetica-e-selecao-de-risco-no-cancer-de-prostata.html]]></loc><lastmod>2016-04-11T12:42:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-adjuvante-em-glioblastoma.html]]></loc><lastmod>2016-07-01T12:55:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-oncologica-e-os-desafios-da-carga-global-do-cancer.html]]></loc><lastmod>2016-04-09T23:01:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/chorus-neoadjuvancia-no-cancer-de-ovario-avancado.html]]></loc><lastmod>2016-04-04T00:45:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacao-kras-e-prognostico-em-cancer-de-pancreas.html]]></loc><lastmod>2016-04-01T12:55:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/adjuvancia-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:05:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/agencia-europeia-amplia-indicacao-de-nivolumab.html]]></loc><lastmod>2016-04-01T12:31:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nilotinibe-e-aprovado-em-primeira-linha-para-leucemia-mieloide-cronica.html]]></loc><lastmod>2016-04-01T13:08:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brentuximabe-vedotina-e-aprovado-para-retratamento-em-hodgkin.html]]></loc><lastmod>2016-03-28T03:18:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimio-intraperitoneal-no-cancer-de-ovario.html]]></loc><lastmod>2016-03-24T15:18:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cabozantinib-nao-mostra-beneficio-em-cancer-de-ovario.html]]></loc><lastmod>2016-03-24T15:06:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/senado-aprova-uso-da-fosfoetanolamina.html]]></loc><lastmod>2016-03-23T13:31:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fosfoetanolamina-nao-mostra-atividade-antitumoral-nos-primeiros-testes-in-vitro.html]]></loc><lastmod>2016-03-23T02:03:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exame-de-sangue-pode-prever-agressividade-do-cancer-de-prostata-pre-cirurgia.html]]></loc><lastmod>2016-03-18T22:40:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comissao-de-assuntos-sociais-do-senado-aprova-liberacao-do-uso-da-fosfoetanolamina.html]]></loc><lastmod>2016-03-23T02:04:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cou-aa-302-abiraterona-mostra-novos-dados-no-congresso-europeu.html]]></loc><lastmod>2016-03-15T16:44:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/import-low-radioterapia-em-cancer-de-mama-inicial.html]]></loc><lastmod>2016-03-14T03:46:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/enzalutamida-anvisa-aprova-indicacao-pre-quimioterapia.html]]></loc><lastmod>2016-03-14T04:57:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimio-adjuvante-em-dose-densa-amplia-sobrevida-em-mulheres-pre-menopausa.html]]></loc><lastmod>2016-03-14T13:43:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-a-etnia-faz-diferenca.html]]></loc><lastmod>2016-05-16T14:04:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/painel-genomico-plan-b-mostra-resultados-de-longo-prazo.html]]></loc><lastmod>2016-03-14T03:13:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/geparsepto-nab-paclitaxel-aumenta-taxa-de-resposta-completa-no-cancer-de-mama-inicial.html]]></loc><lastmod>2016-03-14T02:16:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/canada-atualiza-recomendacoes-para-a-triagem-de-cancer-colorretal.html]]></loc><lastmod>2016-03-06T23:03:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/participacao-brasileira-em-estudo-sobre-eribulina-em-lipossarcoma.html]]></loc><lastmod>2016-02-28T23:10:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custo-valor-e-qualidade-de-vida.html]]></loc><lastmod>2016-02-25T11:41:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/palbociclibe-recebe-nova-aprovacao-do-fda.html]]></loc><lastmod>2016-02-22T19:37:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/marcador-prognostico-em-cancer-de-colon.html]]></loc><lastmod>2016-02-29T15:58:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-prostata-e-disseccao-linfonodal.html]]></loc><lastmod>2016-02-10T14:01:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-custo-do-cancer-em-15-paises-europeus.html]]></loc><lastmod>2016-02-04T00:47:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-atualiza-as-diretrizes-de-antiemeticos.html]]></loc><lastmod>2016-01-31T22:12:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sobreviventes-de-cancer-de-tireoide-tem-maior-risco-de-um-segundo-cancer.html]]></loc><lastmod>2016-01-26T18:31:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lenvatinib-recebe-revisao-prioritaria-do-fda-para-carcinoma-de-celulas-renais-avancado-em-combinacao-com-everolimus.html]]></loc><lastmod>2016-01-20T12:12:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/proteina-associada-a-metastases-em-glioblastoma.html]]></loc><lastmod>2016-01-19T14:47:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-nova-aprovacao-no-melanoma-metastatico.html]]></loc><lastmod>2016-01-19T14:48:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-amplia-indicacao-de-pembrolizumab.html]]></loc><lastmod>2016-01-04T13:08:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-axitinibe-para-carcinoma-de-celulas-renais.html]]></loc><lastmod>2015-12-16T19:47:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pembrolizumabe-recebe-fast-review-da-anvisa.html]]></loc><lastmod>2015-12-04T19:27:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comissao-europeia-aprova-carfilzomib-para-uso-combinado-no-mieloma-multiplo-recidivado.html]]></loc><lastmod>2015-11-27T17:13:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-daratumumab-em-mieloma-multiplo.html]]></loc><lastmod>2015-11-20T00:39:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novembro-azul-51-dos-homens-nunca-consultaram-um-urologista.html]]></loc><lastmod>2017-05-15T14:50:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-e-educacao-continuada-sao-prioridade-do-gtg.html]]></loc><lastmod>2015-11-12T18:17:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisa-clinica-em-debate.html]]></loc><lastmod>2015-11-02T14:11:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncogenetica-ganha-importancia.html]]></loc><lastmod>2015-11-03T04:37:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/processo-de-decisao.html]]></loc><lastmod>2015-11-03T04:38:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cuidados-paliativos-na-oncologia.html]]></loc><lastmod>2015-10-30T03:38:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-primeira-terapia-oncolitica-para-melanoma-metastatico.html]]></loc><lastmod>2015-10-29T02:18:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bevacizumabe-e-erlotinibe-em-primeira-linha-em-cancer-colorretal.html]]></loc><lastmod>2015-10-29T02:18:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bloqueio-hormonal-e-radioterapia-no-resgate-de-recaida-bioquimica-pos-prostatectomia.html]]></loc><lastmod>2015-10-27T15:40:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hormonioterapia-adjuvante-no-cancer-epitelial-de-ovario.html]]></loc><lastmod>2015-10-26T02:29:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/abordagem-colaborativa-entre-radioterapia-e-cuidados-paliativos-baseada-em-relatos-de-pacientes.html]]></loc><lastmod>2015-10-22T21:43:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-revisao-prioritaria-para-onivyde-r-em-cancer-de-pancreas-metastatico.html]]></loc><lastmod>2015-10-22T21:25:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/irradiacao-parcial-em-cancer-de-mama-estadio-inicial.html]]></loc><lastmod>2015-10-21T14:52:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inotuzumab-ozogamicina-recebe-designacao-breakthrough-therapy-do-fda-para-lla.html]]></loc><lastmod>2015-10-20T13:18:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/swog-0819.html]]></loc><lastmod>2015-10-20T13:10:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/squire.html]]></loc><lastmod>2015-10-20T13:11:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/beacon-inibidor-de-topoisomerase-nao-demonstra-superioridade-no-cancer-de-mama-avancado.html]]></loc><lastmod>2015-10-16T21:25:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trabectedina-em-leiomiossarcoma-e-lipossarcomas.html]]></loc><lastmod>2015-10-14T16:13:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anti-pd-1-nivolumab-e-aprovado-pelo-fda-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:08:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diferencas-geneticas-na-recorrencia-do-cancer-de-colon-entre-negros-brancos-e-asiaticos.html]]></loc><lastmod>2015-10-13T21:50:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sueco-associa-altura-e-risco-de-cancer.html]]></loc><lastmod>2015-10-08T14:53:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-concede-aprovacao-acelerada-para-o-pembrolizumab-em-cpnpc-avancado.html]]></loc><lastmod>2015-10-05T02:34:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diretrizes-para-sobreviventes-de-cancer-colorretal.html]]></loc><lastmod>2015-09-24T12:26:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/destaques-da-neurocirurgia-oncologica.html]]></loc><lastmod>2015-09-22T15:05:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-estereotaxica-em-idosos-com-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:10:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/amgen-amplia-pesquisas-em-imunoterapia.html]]></loc><lastmod>2015-09-16T22:39:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/concan-2015-inibidores-de-parp-no-cancer-de-ovario.html]]></loc><lastmod>2015-09-16T22:40:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/concan-2015-multidisciplinaridade-no-tratamento-do-cancer.html]]></loc><lastmod>2015-09-16T22:40:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/checkmate-012-nivolumabe-ipilimumabe-em-primeira-linha-de-cpnpc-avancado.html]]></loc><lastmod>2015-09-14T00:24:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gianni-bonadonna-morre-aos-81.html]]></loc><lastmod>2015-09-11T12:59:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ibandronato-na-dor-ossea-em-cancer-de-prostata-metastatico.html]]></loc><lastmod>2015-09-07T22:33:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exame-de-sangue-pode-prever-recidiva-em-cancer-de-mama.html]]></loc><lastmod>2015-09-07T22:25:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/erlotinibe-em-baixas-doses-nao-e-recomendado-em-cpnpc.html]]></loc><lastmod>2015-09-16T19:21:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/reducao-do-risco-de-cancer-colorretal.html]]></loc><lastmod>2015-09-02T15:16:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alteracao-molecular-e-resistencia-no-cancer-de-prostata.html]]></loc><lastmod>2015-09-11T14:05:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mulheres-negras-tem-menor-sobrevida-em-cancer-endometrial.html]]></loc><lastmod>2015-08-31T18:35:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/bristol-reforca-estrategia-em-imuno-oncologia.html]]></loc><lastmod>2015-08-27T15:37:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/em-cancer-de-mama-decisao-da-ans-preocupa.html]]></loc><lastmod>2015-08-26T20:56:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-prostata-novas-opcoes-de-tratamento-podem-chegar-a-saude-suplementar.html]]></loc><lastmod>2015-09-04T13:10:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/intervencao-na-dieta-e-terapia-alvo-em-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2015-08-24T23:21:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-do-md-anderson-revela-uma-nova-visao-sobre-a-progressao-do-tumor.html]]></loc><lastmod>2015-08-21T12:28:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/brentuximabe-vedotina-tem-nova-indicacao-em-linfoma-de-hodgkin.html]]></loc><lastmod>2016-03-17T19:06:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anti-pd-l1-da-roche-mostra-resultados-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:11:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-novo-medicamento-para-cancer-de-pele-localmente-avancado.html]]></loc><lastmod>2017-05-15T14:45:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-ovario-como-frear-a-recorrencia.html]]></loc><lastmod>2015-08-09T22:53:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-ibrutinibe-para-leucemia-linfoide-cronica.html]]></loc><lastmod>2015-08-09T22:50:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/calculo-da-dose-de-radiacao-da-tomografia-computadorizada-para-o-feto.html]]></loc><lastmod>2015-08-09T21:45:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-sugere-que-niveis-de-radiacao-da-mamografia-sao-superestimados.html]]></loc><lastmod>2015-08-09T21:35:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/efeito-colateral-da-radioterapia-em-cancer-de-prostata-pode-ser-reduzido.html]]></loc><lastmod>2015-08-04T13:32:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alianca-da-bms-aquece-imunoterapia.html]]></loc><lastmod>2015-08-03T13:13:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imuno-oncologia-novas-pesquisas-avancam.html]]></loc><lastmod>2015-07-29T18:07:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/h-pylori-e-prevencao-do-cancer-gastrico.html]]></loc><lastmod>2015-07-28T14:19:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/declaracao-para-melhoria-da-atencao-ao-cancer-no-brasil-e-entregue-ao-ministerio-da-saude.html]]></loc><lastmod>2015-08-13T15:17:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/squire-necitumumab-no-cpnpc-escamoso.html]]></loc><lastmod>2015-07-26T23:51:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-das-drenagens-linfaticas-em-cancer-de-mama.html]]></loc><lastmod>2015-09-14T18:41:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-amplia-indicacao-de-carfilzomib-em-mieloma-multiplo.html]]></loc><lastmod>2015-07-24T20:36:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/europa-aprova-pembrolizumab-em-melanoma-avancado.html]]></loc><lastmod>2015-07-24T12:19:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/canada-realiza-primeiro-ensaio-clinico-de-terapia-viral.html]]></loc><lastmod>2015-07-23T14:54:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/uniao-europeia-aprova-imunoterapia-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:11:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cpo-aposta-na-desospitalizacao.html]]></loc><lastmod>2015-07-20T18:34:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/checkmate-025-superioridade-do-nivolumab-em-cancer-renal-avancado.html]]></loc><lastmod>2015-07-20T18:04:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/julho-verde-um-apelo-a-prevencao-do-cancer-oral.html]]></loc><lastmod>2015-07-14T14:02:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgioes-dentistas-sao-peca-chave-na-deteccao-precoce.html]]></loc><lastmod>2015-07-14T14:05:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-endossa-guideline-da-astro-sobre-radioterapia-pos-operatoria-em-cancer-de-endometrio.html]]></loc><lastmod>2015-07-12T19:51:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pesquisadores-investigam-utilizacao-de-celulas-car-t-em-glioblastoma.html]]></loc><lastmod>2015-07-06T12:36:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hospital-de-cancer-de-barretos-inicia-rastreamento-de-cancer-colorretal.html]]></loc><lastmod>2015-07-05T09:34:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/polifarmacia-no-cancer-avancado.html]]></loc><lastmod>2015-07-01T20:34:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diagnostico-precoce-em-cancer-de-pancreas.html]]></loc><lastmod>2015-06-29T01:14:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/analise-genomica-do-glioma-difuso-de-baixo-grau.html]]></loc><lastmod>2017-05-15T14:44:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/galeterona-no-cancer-de-prostata-resistente-a-castracao.html]]></loc><lastmod>2015-06-28T14:40:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacina-contra-hpv-e-lesoes-cervicais-de-alto-grau.html]]></loc><lastmod>2015-06-25T02:49:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/t-vec-mostra-taxa-de-resposta-duravel-em-melanoma-avancado.html]]></loc><lastmod>2015-06-22T21:25:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-biomarcadores-preditivos-de-resposta-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2015-06-22T19:41:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/panitumumab-aumenta-sobrevida-em-cancer-colorretal-metastatico.html]]></loc><lastmod>2015-06-22T17:42:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/barretos-e-milao-discutem-casos-via-teleconferencia.html]]></loc><lastmod>2015-06-19T02:31:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/comparacao-entre-inibidores-de-proteassoma-no-mieloma-multiplo-recorrente.html]]></loc><lastmod>2015-06-17T23:08:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacao-genetica-associada-ao-cancer-de-mama-de-alto-risco.html]]></loc><lastmod>2015-06-17T23:08:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/heracles-dupla-inibicao-do-her2-em-cancer-colorretal-metastatico.html]]></loc><lastmod>2015-06-16T19:21:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-na-asco.html]]></loc><lastmod>2015-06-15T15:18:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-mama-receptor-hormonal-positivo.html]]></loc><lastmod>2015-06-15T15:19:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nice-nao-recomenda-enzalutamida-pre-quimio-no-cancer-de-prostata.html]]></loc><lastmod>2015-06-15T15:20:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/linfonodo-em-cancer-de-mama.html]]></loc><lastmod>2015-06-15T04:56:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-mapa-das-pdps.html]]></loc><lastmod>2015-06-09T14:54:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-que-esperar-dos-biologicos.html]]></loc><lastmod>2015-06-09T14:56:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ceo-da-orygen-preve-reducao-de-ate-50-no-preco.html]]></loc><lastmod>2015-06-09T14:57:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avancos-no-cancer-de-pulmao-nao-pequenas-celulas.html]]></loc><lastmod>2020-04-24T19:16:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/presente-e-futuro-do-tratamento-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:15:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impakt-2015-assinaturas-genicas.html]]></loc><lastmod>2015-05-20T13:56:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/atualizacao-da-lista-de-medicamentos-essenciais-da-organizacao-mundial-da-saude-oms.html]]></loc><lastmod>2015-07-14T20:40:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/proteina-pode-explicar-resistencia-a-trastuzumabe.html]]></loc><lastmod>2015-05-20T00:01:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/assinaturas-geneticas-e-resposta-ao-palbociclibe.html]]></loc><lastmod>2015-05-20T00:02:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacinacao-contra-hpv-chega-a-mais-de-57-paises.html]]></loc><lastmod>2015-05-11T15:59:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inovacao-em-linfoma-de-hodgkin-nao-e-realidade-no-sus.html]]></loc><lastmod>2015-05-12T00:17:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/exame-de-sangue-pode-ajudar-a-evitar-efeitos-colaterais-de-drogas-para-cancer-colorretal.html]]></loc><lastmod>2015-05-11T17:00:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-abordagem-pode-melhorar-o-diagnostico-de-cancer-de-ovario.html]]></loc><lastmod>2015-05-11T17:00:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lancet-destaca-imuno-oncologia.html]]></loc><lastmod>2015-05-07T13:44:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-avalia-nova-indicacao-de-nivolumabe-no-melanoma-avancado.html]]></loc><lastmod>2015-05-04T03:42:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-atualiza-recomendacoes-para-rastreio-do-cancer-cervical.html]]></loc><lastmod>2015-05-04T03:39:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cirurgia-em-pacientes-com-cancer-avancado.html]]></loc><lastmod>2015-05-04T03:14:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-gene-no-cancer-de-prostata-agressivo.html]]></loc><lastmod>2015-05-04T02:25:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-recomendacao-para-mamografia-bienal-apos-os-50-anos.html]]></loc><lastmod>2015-05-11T02:37:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-vacina-mostra-resultados-no-cancer-de-pancreas.html]]></loc><lastmod>2015-04-26T18:41:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combinacao-de-olaparibe-e-carboplatina-na-mutacao-brca.html]]></loc><lastmod>2015-04-23T18:21:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sigmoidoscopia-flexivel-no-rastreio-do-cancer-colorretal.html]]></loc><lastmod>2015-05-07T21:33:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/enzalutamida-analise-atualizada-do-prevail-e-novos-estudos.html]]></loc><lastmod>2015-04-15T12:47:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ofatumumabe-recebe-aprovacao-da-anvisa-para-llc.html]]></loc><lastmod>2015-05-12T20:39:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/90-mil-brasileiros-ficam-sem-radioterapia.html]]></loc><lastmod>2015-04-08T18:28:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/europa-aprova-panitumumab-em-primeira-linha-para-cancer-colorretal.html]]></loc><lastmod>2015-04-07T16:49:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/impacto-das-mutacoes-ras-e-pik3caem-cancer-colorretal.html]]></loc><lastmod>2015-04-02T12:12:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/imunoterapia-em-cancer-de-prostata.html]]></loc><lastmod>2015-03-30T03:28:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/oncologistas-brasileiros-no-ecancer.html]]></loc><lastmod>2015-03-23T21:20:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-de-cancer-do-colon-do-gtg.html]]></loc><lastmod>2015-03-23T03:55:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-nivolumabe-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:17:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/azeite-extra-virgem-e-o-efeito-anti-cancer.html]]></loc><lastmod>2015-03-16T04:14:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/genetica-e-risco-de-cancer-de-mama.html]]></loc><lastmod>2015-03-11T15:07:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novidades-da-asco-gu-sao-destaque-em-simposio-de-uro-oncologia.html]]></loc><lastmod>2015-03-11T14:38:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-raro-ainda-um-desafio.html]]></loc><lastmod>2015-02-27T16:34:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/taxanos-no-cancer-de-prostata-e-possivel-selecionar.html]]></loc><lastmod>2015-02-23T18:30:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/riscos-apos-a-exposicao-ao-sol.html]]></loc><lastmod>2015-02-24T13:23:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-para-sobreviventes-de-cancer-de-prostata.html]]></loc><lastmod>2015-02-22T14:56:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novo-modelo-prediz-risco-do-cancer-de-mama-em-mulheres-afro-americanas.html]]></loc><lastmod>2015-02-23T13:45:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novas-variantes-geneticas-associadas-a-toxicidade-grave-do-5-fu.html]]></loc><lastmod>2015-02-18T22:41:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/falha-na-edicao-do-rna-e-progressao-do-melanomafalha-na-edicao-do-rna-e-progressao-do-melanoma.html]]></loc><lastmod>2015-02-18T10:18:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/avc-e-risco-de-cancer.html]]></loc><lastmod>2015-02-17T22:23:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-lenvatinibe-em-cancer-de-tireoide.html]]></loc><lastmod>2015-02-13T22:37:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nice-rejeita-pomalidomida-em-mieloma-multiplo.html]]></loc><lastmod>2015-02-13T22:49:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/gadolin-beneficio-em-linfoma-nao-hodgkin.html]]></loc><lastmod>2015-02-11T15:03:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/quimioirradiacao-neoadjuvante-em-cancer-retal.html]]></loc><lastmod>2015-02-09T18:23:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/combi-d-resultados-finais-no-tratamento-do-melanoma.html]]></loc><lastmod>2015-02-06T18:46:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prevencao-e-o-foco-no-dia-mundial-do-cancer.html]]></loc><lastmod>2015-02-04T14:46:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/blinatumomabe-uma-nova-era-de-tratamento-para-adultos-lla.html]]></loc><lastmod>2015-02-05T15:39:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-e-indice-de-massa-corporal-elevado.html]]></loc><lastmod>2015-02-02T13:31:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-pulmao-ultrapassa-o-de-mama-em-mulheres-da-uniao-europeia.html]]></loc><lastmod>2020-04-24T19:17:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vania-hungria-comenta-o-estudo-aspire-em-mieloma-multiplo.html]]></loc><lastmod>2020-04-24T20:19:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nova-tecnica-identifica-genes-associados-ao-cancer-de-pancreas.html]]></loc><lastmod>2015-01-13T13:04:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/as-licoes-do-atlas-para-a-pesquisa-do-cancer.html]]></loc><lastmod>2015-01-06T15:17:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-neoadjuvante-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2015-01-05T17:43:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/aspire-carfilzomibe-mostra-beneficios-em-mieloma-multiplo.html]]></loc><lastmod>2014-12-21T21:00:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inovacao-na-oncohematologia-nao-chega-ao-paciente-brasileiro.html]]></loc><lastmod>2014-12-19T16:06:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/consenso-de-tratamento-da-dor-oncologica.html]]></loc><lastmod>2014-12-08T00:29:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-de-gist-nova-opcao-pode-chegar-ao-sus.html]]></loc><lastmod>2014-12-05T18:29:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/blincyto-r-recebe-revisao-prioritaria-para-lla.html]]></loc><lastmod>2014-12-04T14:35:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ash-alerta-para-a-pratica-consciente-na-hematologia.html]]></loc><lastmod>2014-12-04T14:35:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tomossintese-no-rastreamento-do-cancer-de-mama.html]]></loc><lastmod>2014-12-03T13:13:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/especialistas-criticam-iniquidades-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2014-11-27T23:29:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/simposio-esmo-de-imunoterapia-no-tratamento-do-cancer.html]]></loc><lastmod>2014-11-23T22:04:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacinas-personalizadas.html]]></loc><lastmod>2014-11-24T00:27:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/classificacao-molecular-em-tumores-cerebrais.html]]></loc><lastmod>2014-11-22T17:24:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/inibicao-das-vias-mek-e-braf-traz-resultado-superior-no-melanoma-brafv600-mutante.html]]></loc><lastmod>2014-11-22T17:02:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tc-de-baixas-doses-no-rastreamento-do-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:19:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esmo-publica-guideline-para-lcm.html]]></loc><lastmod>2014-11-24T00:18:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ii-congresso-de-oncologia-dor-recebe-14-especialistas-dana-farber.html]]></loc><lastmod>2014-11-10T05:28:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/a-c-camargo-promove-ii-bienal-de-oncologia.html]]></loc><lastmod>2014-11-10T05:09:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/baixo-risco-de-carcinoma-hepatocelular-em-pacientes-com-colangite-esclerosante-primaria.html]]></loc><lastmod>2014-11-06T23:12:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/enzalutamida-no-cancer-de-prostata-de-alto-risco.html]]></loc><lastmod>2014-11-03T00:15:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/palbociclibe-no-cancer-de-mama-estrogenio-receptor-positivo.html]]></loc><lastmod>2014-11-03T01:00:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sequencimento-genomico-e-gestao-de-risco-em-cancer-de-mama.html]]></loc><lastmod>2014-11-03T00:23:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novembro-azul-quer-driblar-o-preconceito.html]]></loc><lastmod>2014-11-01T23:54:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sindrome-metabolica-e-cancer-de-mama.html]]></loc><lastmod>2014-10-31T11:52:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/alquilantes-e-fertilidade.html]]></loc><lastmod>2014-11-02T01:43:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-pode-ajudar-a-escolher-o-tratamento-para-o-cancer-de-ovario.html]]></loc><lastmod>2017-05-15T14:40:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-do-cancer-e-deficit-cognitivo.html]]></loc><lastmod>2014-10-23T13:26:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutacao-pik3ca-e-as-terapias-anti-her2-no-cancer-de-mama.html]]></loc><lastmod>2014-10-16T13:57:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/palbociclibe-tem-revisao-prioritaria-pelo-fda.html]]></loc><lastmod>2017-05-15T14:39:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/biofarmaceuticas-800-novos-medicamentos-para-o-tratamento-do-cancer.html]]></loc><lastmod>2014-10-10T13:07:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carfilzomibe-quer-expandir-indicacao-em-mieloma-multiplo.html]]></loc><lastmod>2014-10-03T16:23:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/outubro-rosa-reforca-importancia-da-mamografia-na-prevencao-ao-cancer-de-mama.html]]></loc><lastmod>2014-10-01T16:38:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diagnostico-precoce-do-cancer-de-mama.html]]></loc><lastmod>2017-05-15T14:38:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/efeito-angelina-jolie-e-os-destaques-do-breast-cancer-symposium-2014.html]]></loc><lastmod>2014-09-15T00:05:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/fda-aprova-xtandi-r-pre-quimioterapia.html]]></loc><lastmod>2014-09-14T23:36:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-para-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2014-09-14T23:31:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nice-aprova-lenalidomida.html]]></loc><lastmod>2014-09-01T12:46:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/estudo-da-oxford-diz-que-depressao-e-subtratada-no-paciente-de-cancer.html]]></loc><lastmod>2014-09-15T03:07:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/screening-nao-invasivo-de-cancer-colorretal.html]]></loc><lastmod>2014-08-18T00:58:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nice-autoriza-ipilimumabe-para-melanoma-avancado.html]]></loc><lastmod>2017-05-15T14:38:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/custo-do-acesso-e-um-debate-mundial.html]]></loc><lastmod>2014-08-16T16:05:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nice-rejeita-kadcyla-r.html]]></loc><lastmod>2014-08-18T01:18:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/perda-de-peso-traz-beneficios-no-cancer-de-mama.html]]></loc><lastmod>2014-08-08T01:02:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/proteina-pode-estar-ligada-ao-mecanismo-de-metastase.html]]></loc><lastmod>2014-08-07T17:11:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/5-edicao-do-premio-octavio-frias-de-oliveira.html]]></loc><lastmod>2014-08-05T21:46:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/trebananib-para-o-cancer-de-ovario-recorrente-trinova-1.html]]></loc><lastmod>2014-08-04T20:31:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nice-autoriza-enzalutamida-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2014-09-02T17:02:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diabetes-e-o-risco-aumentado-de-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2014-08-04T01:31:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cobimetinib-apresenta-resultados-em-melanoma.html]]></loc><lastmod>2014-07-20T22:12:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/esperanca-para-o-cancer-de-mama-her2-positivo.html]]></loc><lastmod>2014-07-21T22:12:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vasectomia-e-cancer-de-prostata.html]]></loc><lastmod>2014-07-21T02:01:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hpv-e-cancer-de-orofaringe.html]]></loc><lastmod>2014-07-17T16:56:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-valor-da-comunicacao-medica.html]]></loc><lastmod>2014-07-17T16:48:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mais-atencao-aos-tumores-raros.html]]></loc><lastmod>2014-07-18T19:09:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/belinostat-aprovacao-acelerada-para-linfoma-raro.html]]></loc><lastmod>2014-07-07T00:09:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/robotica-e-risco-cirurgico.html]]></loc><lastmod>2014-07-06T23:05:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-de-protons-no-cancer-de-prostata-nao-tem-evidencias.html]]></loc><lastmod>2014-07-07T00:30:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/overdiagnosis-e-overtreatment-no-cancer.html]]></loc><lastmod>2014-07-06T22:25:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/carboplatina-neoadjuvante-em-cancer-de-mama-geparsixto-gbg-66.html]]></loc><lastmod>2014-06-29T23:03:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/regorafenib-em-gist-e-recomendado-na-europa.html]]></loc><lastmod>2014-06-29T23:05:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-desafios-e-possibilidades.html]]></loc><lastmod>2014-06-29T23:07:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tomossintese-digital-x-mamografia-tradicional.html]]></loc><lastmod>2014-06-29T21:35:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anestesia-sem-opioides-para-o-paciente-oncologico.html]]></loc><lastmod>2014-06-22T22:07:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/planos-de-saude-passam-a-cobrir-esfincter-artificial.html]]></loc><lastmod>2014-06-22T23:23:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mastectomia-e-evidencia-medica.html]]></loc><lastmod>2014-06-28T18:28:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/radioterapia-apos-mastectomia.html]]></loc><lastmod>2014-06-21T05:59:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/anvisa-aprova-vectibix-r-em-colorretal-avancado.html]]></loc><lastmod>2014-06-18T12:48:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/tratamento-multidisciplinar-ainda-e-um-desafio.html]]></loc><lastmod>2014-06-17T11:52:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/nature-destaca-pesquisa-sul-americana.html]]></loc><lastmod>2014-06-21T05:51:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modafinil-nao-tem-evidencia-na-gestao-da-fadiga.html]]></loc><lastmod>2014-06-16T17:12:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/big1-01-publica-achados-sobre-a-cardiotoxicidade-do-trastuzumabe.html]]></loc><lastmod>2014-06-12T13:08:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/abhh-destaca-novo-paradigma-da-onco-hematologia.html]]></loc><lastmod>2014-06-16T16:50:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sbm-lanca-movimento-mamografiaapartirdos40.html]]></loc><lastmod>2014-06-09T01:58:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/falta-de-clareza-e-informacao-dificultam-o-acesso-efetivo-a-lei-dos-60-dias.html]]></loc><lastmod>2014-06-09T02:03:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/acido-zoledronico-ganha-versao-pronta-para-uso.html]]></loc><lastmod>2014-06-06T22:20:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/lei-antifumo-e-regulamentada.html]]></loc><lastmod>2014-06-02T05:10:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/mutirao-antitabagismo.html]]></loc><lastmod>2014-05-30T18:34:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/subtipos-moleculares-tem-papel-preditivo-em-cancer-de-mama.html]]></loc><lastmod>2014-05-21T16:00:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/guideline-cancer-de-mama-her2-positivo-com-metastases-cerebrais.html]]></loc><lastmod>2014-05-26T03:23:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/qualidade-de-vida-no-estudo-aurelia.html]]></loc><lastmod>2014-05-21T15:58:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/pv-10-e-promessa-na-pesquisa-em-melanoma.html]]></loc><lastmod>2014-04-24T20:57:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/escola-de-patologia-avancada-inicia-atividades.html]]></loc><lastmod>2017-05-15T14:35:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/safir-01-mais-um-passo-na-medicina-de-precisao.html]]></loc><lastmod>2014-04-17T19:44:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/prostatectomia-ou-vigilancia-no-cancer-de-prostata-localizado.html]]></loc><lastmod>2014-04-17T02:08:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/medicos-nao-estao-preparados-para-o-teste-genetico-de-cancer-2.html]]></loc><lastmod>2017-05-15T14:36:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-genetico-em-melanoma.html]]></loc><lastmod>2014-04-16T17:33:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/resultados-animadores-do-estudo-paloma-1.html]]></loc><lastmod>2014-04-16T17:05:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/asco-recomenda-enfase-na-historia-familiar-de-cancer.html]]></loc><lastmod>2017-05-15T14:09:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/dupla-mastectomia-na-mutacao-brca.html]]></loc><lastmod>2014-04-16T17:18:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/sunitinibe-em-idosos-com-cancer-renal.html]]></loc><lastmod>2015-02-04T16:20:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/revisao-sistematica-hpv-e-cancer-de-orofaringe.html]]></loc><lastmod>2017-05-15T14:37:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/teste-de-dna-nas-fezes-e-o-cancer-colorretal.html]]></loc><lastmod>2014-04-16T17:21:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cobertura-global-do-cancer-urologico.html]]></loc><lastmod>2014-04-21T02:00:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/diagnostico-precoce-ou-em-excesso.html]]></loc><lastmod>2014-03-12T20:02:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hospital-samaritano-inaugura-centro-da-mama.html]]></loc><lastmod>2014-03-12T16:56:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/vacinacao-contra-hpv-em-sao-paulo.html]]></loc><lastmod>2014-03-12T16:28:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/desenvolvimento-clinico-em-cancer-de-mama-em-2014.html]]></loc><lastmod>2014-03-12T16:26:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ramucirumabe-falha-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2014-03-12T16:14:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ibis-ii-e-o-cancer-de-mama-de-alto-risco.html]]></loc><lastmod>2014-03-12T16:12:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/novos-biomarcadores-em-cancer-de-mama.html]]></loc><lastmod>2014-03-12T16:09:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/ibps-e-a-prevencao-do-cancer-no-esofago-de-barret.html]]></loc><lastmod>2014-03-12T16:07:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/cancer-de-pulmao-em-2013.html]]></loc><lastmod>2020-04-24T19:25:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/eua-e-o-rastreamento-do-cancer-pulmonar.html]]></loc><lastmod>2014-03-12T15:54:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/terapia-ludica-no-tratamento-do-cancer-infantil.html]]></loc><lastmod>2014-03-12T15:30:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/modelo-de-classificacao-de-risco-em-smd.html]]></loc><lastmod>2014-02-20T13:25:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/hda-e-hla-aumentam-risco-de-cancer-de-mama.html]]></loc><lastmod>2014-05-21T16:03:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/o-diagnostico-precoce-em-cancer-de-pancreas.html]]></loc><lastmod>2014-05-21T16:02:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/braquiterapia-x-ebrt-em-cancer-de-mama.html]]></loc><lastmod>2014-05-21T16:11:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/ultimas/do-rastreamento-ao-prognostico-em-cancer-de-mama.html]]></loc><lastmod>2014-05-21T16:04:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/rapido-trial-mais-problemas.html]]></loc><lastmod>2024-05-14T20:55:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/como-o-cancer-do-colo-do-utero-poderia-ser-reduzido-no-brasil.html]]></loc><lastmod>2023-03-27T15:15:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/estrategias-cirurgicas-para-cancer-de-pancreas-na-era-neoadjuvante.html]]></loc><lastmod>2022-04-18T01:19:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/por-caminhos-mais-sustentaveis-para-inovacao-e-acesso.html]]></loc><lastmod>2020-08-28T18:26:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/como-resgatar-o-valor-da-ciencia.html]]></loc><lastmod>2020-08-28T18:29:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/recomendacoes-de-radioterapia-para-o-cancer-de-prostata-no-contexto-do-covid-19.html]]></loc><lastmod>2020-03-31T01:34:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/recorrencia-intra-abdominal-do-cancer-colorretal.html]]></loc><lastmod>2020-02-25T18:30:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/vieses-em-estudos-comparativos-de-cirurgias-oncologicas-por-acesso-minimamente-invasivo-versus-aberto.html]]></loc><lastmod>2020-02-12T19:53:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/radioterapia-no-brasil.html]]></loc><lastmod>2019-08-18T19:00:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/cancer-em-sobreviventes.html]]></loc><lastmod>2019-08-08T12:05:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/doenca-cardiovascular-em-sobreviventes-de-cancer-de-mama-na-pos-menopausa.html]]></loc><lastmod>2019-07-11T15:26:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/quimio-em-dose-densa-intravenosa-versus-intraperitoneal-com-cateter-no-tratamento-de-primeira-linha-do-carcinoma-epitelial-de-ovario.html]]></loc><lastmod>2019-04-28T22:05:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/vigilancia-ativa-de-pequenas-massas-renais.html]]></loc><lastmod>2019-04-20T17:42:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/sgo-2019-destaques-na-ginecologia-oncologica.html]]></loc><lastmod>2019-03-24T18:10:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/radioterapia-hipofracionada-das-drenagens-linfaticas-em-cancer-de-mama.html]]></loc><lastmod>2019-03-10T22:41:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/hot-topics-na-regulacao-epigenetica-da-auto-renovacao-no-cancer-de-pancreas.html]]></loc><lastmod>2019-02-03T21:41:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/acesso-ao-sequenciamento-de-proxima-geracao-em-oncologia-para-o-brasil-2.html]]></loc><lastmod>2019-02-19T13:31:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/anticoagulantes-orais-na-profilaxia-do-tromboembolismo-venoso.html]]></loc><lastmod>2019-01-15T14:56:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/variantes-germinativas-patogenicas-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:16:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/radioterapia-e-oncotype.html]]></loc><lastmod>2018-11-05T01:08:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/emprego-da-radioterapia-com-imrt-no-sus-e-custo-efetivo.html]]></loc><lastmod>2018-09-02T21:23:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/estudo-multicentrico-propoe-escore-de-recorrencia-no-cancer-de-mama-inicial.html]]></loc><lastmod>2018-08-30T22:25:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/avancos-no-tratamento-sistemico-das-metastases-cerebrais-do-melanoma.html]]></loc><lastmod>2018-07-22T19:29:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/uso-de-telas-em-conjunto-das-reconstrucoes-mamarias-com-implantes.html]]></loc><lastmod>2018-07-22T19:30:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/imunoterapia-alerta-de-seguranca-no-cancer-urotelial.html]]></loc><lastmod>2018-05-29T17:29:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/resistencia-a-inibidores-de-parp.html]]></loc><lastmod>2018-05-14T03:18:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/associacao-de-radioterapia-a-terapias-alvo-e-imunoterapia.html]]></loc><lastmod>2018-05-01T21:57:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/tratamento-neoadjuvante-total-no-cancer-de-reto.html]]></loc><lastmod>2018-04-02T11:33:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/tendencias-no-tratamento-e-evolucao-dos-pacientes-com-linfonodos-positivos-em-cancer-de-penis.html]]></loc><lastmod>2018-03-19T02:41:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/vitamina-d-e-cancer.html]]></loc><lastmod>2018-03-18T15:00:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/radioterapia-guiada-por-imagem-no-cancer-de-prostata.html]]></loc><lastmod>2018-02-19T13:24:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/diretriz-de-cancer-de-pulmao-celulas-nao-pequenas-doenca-localizada-e-localmente-avancada.html]]></loc><lastmod>2020-04-24T17:25:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/diretrizes-para-cancer-de-pulmao-pequenas-celulas.html]]></loc><lastmod>2020-04-24T17:25:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/destaques-do-simposio-de-cuidados-paliativos-da-asco-2.html]]></loc><lastmod>2017-11-12T17:03:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/farmacovigilancia-desafios-para-a-implementacao-5.html]]></loc><lastmod>2017-10-18T12:32:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/diagnostico-de-neoplasia-intraepitelial-prostatica.html]]></loc><lastmod>2017-10-01T23:41:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/top-10-em-tumores-gastrointestinais.html]]></loc><lastmod>2017-10-02T13:55:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/reducao-do-volume-de-radiacao-no-cancer-de-mama-inicial-apos-cirurgia-conservadora.html]]></loc><lastmod>2017-08-20T22:10:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/mutacoes-e-marcadores-de-resposta-a-inibidores-de-checkpoint.html]]></loc><lastmod>2017-08-07T07:00:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/interacoes-entre-medicamentos-e-plantas-medicinais.html]]></loc><lastmod>2017-08-07T15:13:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/convert-radioterapia-fracionada-no-cancer-de-pulmao-pequenas-celulas.html]]></loc><lastmod>2020-04-24T18:31:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/medicacoes-orais-em-quimioterapia.html]]></loc><lastmod>2017-07-24T05:12:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/irradiacao-cerebral-profilatica-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:34:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/cuidado-multidisciplinar-em-pacientes-com-metastases-vertebrais.html]]></loc><lastmod>2017-07-01T19:53:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/o-futuro-do-tratamento-do-cancer-de-pancreas.html]]></loc><lastmod>2017-05-16T21:18:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/neuro-oncologia-em-pauta.html]]></loc><lastmod>2017-05-01T19:34:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/ar-protac-dados-pre-clinicos-mostram-eficacia-no-cancer-de-prostata-resistente-a-castracao.html]]></loc><lastmod>2017-04-19T17:37:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/foco-nos-tumores-ginecologicos.html]]></loc><lastmod>2017-03-21T21:52:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/hormonioterapia-de-manutencao-em-carcinoma-seroso-de-baixo-grau-de-ovario-ou-peritoneo.html]]></loc><lastmod>2017-03-20T02:33:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/circuncisao-neonatal-e-prevencao-do-cancer-de-penis.html]]></loc><lastmod>2017-03-04T17:18:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/atividade-fisica-e-cancer.html]]></loc><lastmod>2017-03-06T02:50:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/impacto-do-tabagismo-na-economia-mundial.html]]></loc><lastmod>2017-02-15T19:47:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/hipec-no-brasil---primeiros-passos-em-busca-de-padronizacoes.html]]></loc><lastmod>2016-12-27T14:58:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/farmacovigilancia-em-oncologia-o-que-mais-precisamos-aprender.html]]></loc><lastmod>2016-12-20T14:58:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/igcs-highlights-no-cancer-ginecologico.html]]></loc><lastmod>2016-11-07T18:54:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/dieta-e-cancer.html]]></loc><lastmod>2017-03-03T19:11:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/diretrizes-brasileiras-para-o-rastreamento-do-cancer-do-colo-do-utero.html]]></loc><lastmod>2016-09-12T02:23:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/comunicacao-de-mas-noticias-para-o-paciente-e-sua-familia.html]]></loc><lastmod>2016-08-29T01:50:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/monitoramento-do-ca125-pos-remissao-completa-no-cancer-epitelial-de-ovario-faca-de-dois-gumes.html]]></loc><lastmod>2016-08-01T21:00:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/radium-233-para-o-tratamento-do-cancer-da-prostata-hormonio-independente-com-metastases-osseas.html]]></loc><lastmod>2016-08-02T20:56:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/rastreamento-do-cancer-de-prostata-quando-como-e-para-quem.html]]></loc><lastmod>2016-07-18T01:36:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/hipofracionamento-no-cancer-de-prostata.html]]></loc><lastmod>2016-07-04T03:15:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/por-um-modelo-mais-sustentavel.html]]></loc><lastmod>2016-06-17T00:41:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/europa-propoe-curriculo-global-para-a-oncologia-cirurgica.html]]></loc><lastmod>2016-06-08T14:40:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/destaques-dos-simposios-de-tumores-de-mama-e-gastrointestinais-do-nob.html]]></loc><lastmod>2016-05-23T04:40:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/radioterapia-se-mostra-superior-a-quimio-no-seminoma-inicial.html]]></loc><lastmod>2016-05-10T13:06:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/consumo-de-cigarro-ilegal-aumenta-no-brasil.html]]></loc><lastmod>2016-04-25T16:40:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/valor-em-oncologia-na-era-da-imuno-oncologia.html]]></loc><lastmod>2016-04-11T02:50:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/avancos-na-compreensao-molecular-em-neuro-oncologia.html]]></loc><lastmod>2016-03-30T21:55:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/gerparsepto-nab-paclitaxel-no-cancer-de-mama-inicial.html]]></loc><lastmod>2016-03-14T03:05:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/terapia-de-deprivacao-androgenica-e-risco-de-alzheimer.html]]></loc><lastmod>2016-02-29T02:20:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/endpoints-um-cenario-em-transicao.html]]></loc><lastmod>2016-03-04T14:16:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/relatorio-medico-direito-do-paciente-e-dever-do-medico.html]]></loc><lastmod>2016-02-10T18:44:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/destaques-da-asco-gu.html]]></loc><lastmod>2016-11-14T19:01:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/conitec-nega-imrt-em-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2016-01-07T20:14:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/politicas-para-o-combate-do-cancer-de-prostata.html]]></loc><lastmod>2015-11-20T01:26:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/consenso-de-experts-quimioterapia-precoce-em-cancer-de-prostata-metastatico.html]]></loc><lastmod>2015-10-26T02:02:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/desafios-da-pesquisa-clinica.html]]></loc><lastmod>2015-10-20T15:01:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/o-custo-global-do-cancer-e-estrategias-de-controle.html]]></loc><lastmod>2016-04-26T14:23:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/psico-oncologia-a-escuta-alem-do-cancer.html]]></loc><lastmod>2015-07-23T14:56:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/gtg-comenta-o-estudo-capri-goim-em-cancer-colorretal.html]]></loc><lastmod>2015-07-17T15:33:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/e-quando-as-coisas-nao-saem-como-o-previsto-uma-reflexao-sobre-os-desfechos-negativos.html]]></loc><lastmod>2015-06-12T02:13:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/qual-a-melhor-sequencia-na-progressao-do-carcinoma-de-celulas-renais-metastatico-ccrm.html]]></loc><lastmod>2015-04-30T17:56:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/o-fda-e-as-licoes-da-breakthrough-therapy-designation.html]]></loc><lastmod>2015-03-09T02:32:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/brasil-aguarda-posicao-do-stf-sobre-aditivos-no-tabaco.html]]></loc><lastmod>2015-02-14T18:53:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/abiraterona-no-cancer-de-prostata-resistente-a-castracao-a-analise-do-cou-aa-302.html]]></loc><lastmod>2015-02-01T14:10:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/as-politicas-publicas-enxergam-genero.html]]></loc><lastmod>2014-12-12T16:51:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/imunoterapia-no-tratamento-do-cancer.html]]></loc><lastmod>2014-11-17T11:35:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/opiniao-analise/a-oncologia-e-a-judicializacao-da-saude.html]]></loc><lastmod>2014-11-08T03:50:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/wsso-iniciativa-global-reune-cinco-continentes-para-fortalecer-a-cirurgia-do-cancer.html]]></loc><lastmod>2025-11-19T11:55:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/iarc-atualiza-evidencias-sobre-a-relacao-entre-alcool-e-cancer.html]]></loc><lastmod>2025-06-25T10:58:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/i-simposio-brasileiro-de-medicina-de-precisao.html]]></loc><lastmod>2025-05-08T15:49:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncogenetica-clinica-da-teoria-ao-tratamento-personalizado.html]]></loc><lastmod>2025-04-15T17:31:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/inscricoes-abertas-para-o-xvi-premio-octavio-frias-de-oliveira.html]]></loc><lastmod>2025-03-19T18:27:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/urologista-brasileiro-assina-publicacao-internacional-dedicada-a-cirurgia-robotica.html]]></loc><lastmod>2025-01-23T18:55:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/fellowship-em-oncogenetica.html]]></loc><lastmod>2024-10-08T22:37:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ctc-usp-abre-vagas-de-pos-doutorado-em-terapia-celular-avancada.html]]></loc><lastmod>2024-09-29T22:36:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/icc-abre-processo-seletivo-para-residencia-multiprofissional-e-uniprofissional.html]]></loc><lastmod>2024-09-29T20:02:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ans-inicia-consulta-publica-para-avaliar-incorporacao-de-tepotinibe-no-cancer-de-pulmao.html]]></loc><lastmod>2024-09-05T20:49:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/icc-abre-inscricoes-para-programa-de-residencia-medica.html]]></loc><lastmod>2024-09-17T21:38:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/a-c-camargo-abre-inscricoes-para-programa-de-residencia-multiprofissional.html]]></loc><lastmod>2024-09-04T14:26:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/mestrado-em-oncologia-do-icc-esta-com-inscricoes-abertas.html]]></loc><lastmod>2024-08-23T21:02:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/inca-abre-inscricoes-para-o-curso-de-verao-2025.html]]></loc><lastmod>2024-08-12T00:05:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/premio-jose-eduardo-ermirio-de-moraes.html]]></loc><lastmod>2024-08-03T02:30:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/inca-oferece-23-vagas-no-programa-move-la-america.html]]></loc><lastmod>2024-07-31T21:01:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oms-publica-nova-classificacao-de-tumores-hematolinfoides.html]]></loc><lastmod>2024-07-31T21:04:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ministerio-da-saude-promove-campanha-de-prevencao-ao-uso-de-cigarros-eletronicos.html]]></loc><lastmod>2024-05-28T22:15:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncologia-do-exercicio.html]]></loc><lastmod>2024-05-27T22:26:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cafe-paliativo-integrativo.html]]></loc><lastmod>2024-05-22T13:54:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/slow-medicine-sem-pressa-para-cuidar-bem.html]]></loc><lastmod>2024-05-14T15:13:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-sobre-cancer-do-colo-do-utero.html]]></loc><lastmod>2024-05-05T08:54:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/farmacogenetica-em-oncologia.html]]></loc><lastmod>2024-03-08T20:44:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/introducao-a-oncogenetica.html]]></loc><lastmod>2024-03-06T21:37:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/inca-celebra-dia-mundial-do-cancer.html]]></loc><lastmod>2024-02-17T00:41:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-basico-de-oncologia.html]]></loc><lastmod>2023-11-24T19:29:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/inca-marca-30-anos-da-carreira-de-ciencia-e-tecnologia.html]]></loc><lastmod>2023-11-10T21:25:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/lla-com-rearranjo-do-kmt2a.html]]></loc><lastmod>2023-08-02T20:38:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/anticorpos-biespecificos-no-tratamento-do-mieloma-multiplo-recidivado-refratario.html]]></loc><lastmod>2023-07-26T18:23:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pronon-esta-aberto-a-instituicoes-interessadas-em-apoiar-a-atencao-oncologica.html]]></loc><lastmod>2023-08-01T01:21:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/parceria-amplia-disponibilidade-de-testes-geneticos-no-sus.html]]></loc><lastmod>2023-07-10T20:58:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/linfoma-de-hodgkin-predominancia-linfocitaria-nodular.html]]></loc><lastmod>2023-07-05T17:34:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/estadiamento-e-reestadiamento-do-cancer-retal-com-rm.html]]></loc><lastmod>2023-06-14T15:20:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/novas-combinacoes-de-venetoclax-com-inibidores-de-btk-no-tratamento-da-llc.html]]></loc><lastmod>2023-05-30T20:59:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/tumores-germinativos-em-pacientes-jovens-com-cancer-colorretal.html]]></loc><lastmod>2023-04-10T19:24:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/linfoma-de-hodgkin-r-r.html]]></loc><lastmod>2023-03-22T20:33:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/encontro-online-discute-deep-learning.html]]></loc><lastmod>2023-03-13T01:09:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/registro-brasileiro-de-llc.html]]></loc><lastmod>2023-03-08T17:15:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/haoc-inaugura-centro-de-treinamento-em-cirurgia.html]]></loc><lastmod>2023-03-02T20:52:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/abbvie-e-anima-biotech-anunciam-colaboracao-em-moduladores-biologicos-de-mrna.html]]></loc><lastmod>2023-02-13T15:11:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/tratamento-da-amiloidose-al.html]]></loc><lastmod>2022-11-30T19:24:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/principios-e-pratica-clinica-da-oncologia.html]]></loc><lastmod>2022-11-04T15:46:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cfm-abre-consulta-publica-sobre-cannabis-medicinal.html]]></loc><lastmod>2022-11-07T12:20:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/macroglobulinemia-de-waldenstrom.html]]></loc><lastmod>2022-09-28T16:10:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/gilead-e-kite-oncology-lancam-operacoes-em-terapia-de-celulas-car-t-no-brasil-singapura-e-arabia-saudita.html]]></loc><lastmod>2022-09-07T14:28:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/gilead-planeja-adquirir-os-direitos-globais-remanescentes-do-sacituzumabe-govitecana.html]]></loc><lastmod>2022-09-06T17:06:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/desafios-no-tratamento-do-linfoma-de-celulas-do-manto.html]]></loc><lastmod>2022-08-31T16:39:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/apos-acordo-a-c-camargo-mantem-atendimento-a-pacientes-do-sus.html]]></loc><lastmod>2022-08-18T18:35:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/a-c-camargo-anuncia-que-deixara-de-atender-pacientes-do-sus.html]]></loc><lastmod>2022-08-17T14:08:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-reto-com-resposta-quase-completa-a-qrt.html]]></loc><lastmod>2022-07-14T16:27:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncologista-brasileiro-integra-nova-diretoria-da-esmo.html]]></loc><lastmod>2022-07-05T12:20:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncologista-brasileira-participa-de-manual-de-oncologia-do-md-anderson.html]]></loc><lastmod>2022-06-30T11:28:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-reto-e-doenca-de-crohn.html]]></loc><lastmod>2022-06-09T15:08:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/novo-player-na-oncologia.html]]></loc><lastmod>2022-05-23T21:53:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/tumor-de-reto-alto.html]]></loc><lastmod>2022-05-12T19:51:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/brasileira-integra-rede-global-de-pesquisa-clinica.html]]></loc><lastmod>2022-04-12T11:11:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncologia-da-molecula-a-clinica.html]]></loc><lastmod>2022-04-17T17:54:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/round-de-mastologia.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/international-bordeaux-colorectal-masterclass.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/nova-parceria-entre-blanver-e-pierre-fabre-na-oncologia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/forum-multidisciplinar-de-oncologia-sp-875.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-de-verao-em-oncologia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/psico-oncologista-brasileira-e-premiada-pela-kidney-cancer-association.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/estoque-de-sangue-no-a-c-camargo-cancer-center-esta-no-limite-critico.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/linfoma-de-celula-b-agressivo.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/dasa-avanca-em-oncologia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/fundacao-do-cancer-lanca-premio-marcos-moraes.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/academia-brasileira-de-mastologia-realiza-sessao-solene.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/libbs-lanca-bortezomibe-em-diferentes-apresentacoes.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/microbiota-intestinal-e-cancer.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/jornada-internacional-para-o-avanco-das-pesquisas-em-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/brasileira-integra-conselho-de-administracao-da-ipos.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/asco-constitui-conselho-regional-na-america-latina.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/slago-premia-oncologista-brasileira.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncologia-para-nao-oncologistas-2.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hospital-sao-camilo-sp-assume-gestao-do-ibcc.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/aacr-premia-pesquisadoras-brasileiras.html]]></loc><lastmod>2021-03-25T22:13:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/os-100-trials-que-mudaram-a-historia-da-oncologia.html]]></loc><lastmod>2021-03-02T19:56:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/evento-marca-lancamento-de-trastuzumabe-biossimilar.html]]></loc><lastmod>2021-02-24T18:08:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-mama-360.html]]></loc><lastmod>2021-02-16T22:16:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncologia-nutricional.html]]></loc><lastmod>2020-11-30T00:28:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/bp-e-asco-realizam-workshop-sobre-qualidade-assistencial-em-oncologia.html]]></loc><lastmod>2020-11-12T11:54:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/consulta-publica-para-revisao-do-rol-de-procedimentos-da-ans.html]]></loc><lastmod>2020-10-19T01:16:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/eva-gbtg-lanca-manual-de-tumores-ginecologicos.html]]></loc><lastmod>2020-10-14T16:20:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/residencia-medica-em-mastologia-2.html]]></loc><lastmod>2020-09-29T17:28:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/a-c-camargo-cancer-center-inaugura-nova-unidade-2.html]]></loc><lastmod>2020-09-09T22:03:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/programa-para-mulheres-na-ciencia-2020.html]]></loc><lastmod>2020-08-23T19:12:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cirurgiao-brasileiro-e-reconhecido-como-top-reviewer-pela-ijgc.html]]></loc><lastmod>2020-08-21T21:43:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/centros-brasileiros-recebem-certificacao-de-qualidade-da-asco.html]]></loc><lastmod>2020-07-20T21:33:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cirurgiao-brasileiro-e-escolhido-representante-internacional-da-sso.html]]></loc><lastmod>2020-05-07T22:18:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cirurgia-oncologica-na-epidemia-de-covid-19.html]]></loc><lastmod>2020-03-30T12:00:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ibcc-oncologia-inaugura-unidade-para-atendimento-a-pacientes-do-sus.html]]></loc><lastmod>2020-03-10T20:07:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/linfoma-anaplasico-e-implante-mamario.html]]></loc><lastmod>2020-03-10T18:14:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pos-graduacao-em-onco-hematologia.html]]></loc><lastmod>2020-03-06T12:03:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/uma-conversa-sobre-cancer-de-mama.html]]></loc><lastmod>2020-03-03T21:22:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/asco-reconhece-servicos-brasileiros-pela-pratica-oncologica-de-qualidade.html]]></loc><lastmod>2020-02-11T22:11:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncologista-brasileira-no-corpo-docente-da-esmo.html]]></loc><lastmod>2020-01-23T12:36:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/estudo-de-mundo-real-avalia-trastuzumabe-biossimilar-no-brasil.html]]></loc><lastmod>2019-11-24T16:40:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hospital-sao-lucas-da-pucrs-e-oncoclinicas-anunciam-parceria.html]]></loc><lastmod>2019-11-06T16:55:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cirurgiao-brasileiro-e-homenageado-na-esgo-2019.html]]></loc><lastmod>2019-11-04T22:51:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/biomarcadores-em-oncologia.html]]></loc><lastmod>2019-11-01T13:20:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/parceria-amplia-acesso-ao-diagnostico-molecular-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T16:58:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncologia-clinica-no-dia-a-dia.html]]></loc><lastmod>2019-10-30T12:33:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/nova-diretoria-do-gtg.html]]></loc><lastmod>2019-10-28T01:44:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/a-c-camargo-e-princess-margaret-firmam-parceria.html]]></loc><lastmod>2019-10-15T18:19:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pos-esmo-em-oncoginecologia.html]]></loc><lastmod>2020-04-23T16:17:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/gbop-pontocom.html]]></loc><lastmod>2019-09-16T02:36:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/a-c-camargo-cancer-center-inaugura-nova-unidade.html]]></loc><lastmod>2019-08-29T14:59:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ibcc-oncologia-abre-nova-turma-para-o-curso-sobre-pesquisa-clinica-de-harvard.html]]></loc><lastmod>2019-08-21T19:08:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ibcc-oncologia-anuncia-nova-unidade.html]]></loc><lastmod>2019-08-12T19:02:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/terapia-celular-em-hematologia-2.html]]></loc><lastmod>2019-08-05T12:45:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/asco-reconhece-servicos-brasileiros-como-iniciativas-de-pratica-oncologica-de-qualidade.html]]></loc><lastmod>2019-07-18T12:51:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/nova-ala-para-transplantes-de-medula-ossea-no-hospital-bp.html]]></loc><lastmod>2019-06-24T17:48:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/novo-hospital-tem-foco-na-prevencao-e-diagnostico-precoce-do-cancer.html]]></loc><lastmod>2019-06-13T22:41:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/conscientizacao-sobre-melanoma.html]]></loc><lastmod>2019-05-23T12:51:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/carlos-dzik-e-o-novo-consultor-da-oncologia-no-hospital-sao-camilo.html]]></loc><lastmod>2019-05-03T15:02:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/investimentos-em-oncologia-no-hospital-sao-camilo.html]]></loc><lastmod>2019-04-24T19:46:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/medico-brasileiro-no-conselho-editorial-do-british-journal-of-haematology.html]]></loc><lastmod>2019-06-13T22:45:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/anvisa-divulga-resultados-alcancados-em-2018.html]]></loc><lastmod>2019-04-15T20:30:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/tumores-neuroendocrinos-do-trato-gastrointestinal.html]]></loc><lastmod>2019-04-17T12:20:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/estudo-da-sociedade-brasileira-de-mastologia-analisa-conhecimento-sobre-o-cancer-de-mama.html]]></loc><lastmod>2019-04-11T18:14:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/guia-pratico-de-oncorradiologia.html]]></loc><lastmod>2019-04-08T00:36:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/reconhecimento-em-imagiologia-das-mamas.html]]></loc><lastmod>2019-04-07T15:11:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncologista-brasileira-no-conselho-consultivo-da-enets.html]]></loc><lastmod>2019-03-20T22:24:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/melanoma-em-foco.html]]></loc><lastmod>2019-03-20T20:08:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/melhores-praticas-em-cuidados-paliativos.html]]></loc><lastmod>2019-03-25T01:31:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/premio-life-reconhece-trabalhos-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:15:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/brasileiro-toma-posse-como-presidente-da-ahpba.html]]></loc><lastmod>2019-03-11T01:40:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/especializacao-em-tumores-neuroendocrinos.html]]></loc><lastmod>2019-02-18T21:56:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/fellowship-em-ginecologia-oncologica.html]]></loc><lastmod>2019-01-24T15:21:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cuidados-com-o-corpo-e-a-mente.html]]></loc><lastmod>2019-01-29T15:07:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hematologia-em-pauta.html]]></loc><lastmod>2018-12-12T13:32:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pesquisadora-brasileira-recebe-reconhecimento-internacional.html]]></loc><lastmod>2019-01-09T22:21:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-prostata-em-pauta-2.html]]></loc><lastmod>2018-11-13T15:21:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/reuniao-mensal-sobre-mastologia.html]]></loc><lastmod>2018-11-05T21:40:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/grupo-oncoclinicas-radioterapia-inaugura-nova-unidade-no-rio-de-janeiro.html]]></loc><lastmod>2018-10-08T20:15:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/residencia-medica-em-mastologia.html]]></loc><lastmod>2018-10-08T16:24:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/10-congresso-mundial-de-medicina-de-precisao-e-personalizada.html]]></loc><lastmod>2018-10-16T13:47:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/gtg-atualiza-recomendacoes-no-cancer-colorretal.html]]></loc><lastmod>2018-09-16T23:55:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/terapia-celular-em-hematologia.html]]></loc><lastmod>2018-09-10T11:54:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/espiritualidade-em-oncologia.html]]></loc><lastmod>2018-08-28T13:37:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-mama-uma-filosofia-de-tratamento.html]]></loc><lastmod>2018-08-28T12:45:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T20:08:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hospital-inaugura-oficina-ortopedica.html]]></loc><lastmod>2018-08-15T19:59:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-de-cirurgia-radioguiada.html]]></loc><lastmod>2018-08-07T18:24:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/superando-o-tabagismo.html]]></loc><lastmod>2018-08-07T18:21:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pos-graduacao-em-cuidados-paliativos.html]]></loc><lastmod>2018-08-06T15:26:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2018-07-19T14:50:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/novartis-anuncia-novo-ceo-no-brasil.html]]></loc><lastmod>2018-07-19T13:45:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-e-outras-doencas-cronicas.html]]></loc><lastmod>2018-07-19T14:11:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/discussoes-em-cardio-oncologia.html]]></loc><lastmod>2018-06-19T12:17:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/exame-de-proficiencia-em-oncologia-clinica.html]]></loc><lastmod>2018-05-27T03:59:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pancadas-na-cabeca.html]]></loc><lastmod>2018-05-27T03:39:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/imunoterapia-em-pauta.html]]></loc><lastmod>2018-05-23T21:53:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/metodos-e-bioestatistica-em-oncologia.html]]></loc><lastmod>2018-05-11T19:39:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/direitos-do-paciente-oncologico.html]]></loc><lastmod>2018-05-11T14:12:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/boehringer-e-ose-immunotherapeutics-anunciam-parceria.html]]></loc><lastmod>2018-04-23T23:12:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/premio-snola.html]]></loc><lastmod>2018-04-23T23:31:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-pancreas-e-vias-biliares.html]]></loc><lastmod>2018-04-24T01:04:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/avancos-no-tratamento-oncologico.html]]></loc><lastmod>2018-04-18T16:47:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/brasileiro-recebe-premio-no-sgo.html]]></loc><lastmod>2018-04-01T22:52:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/brasileiro-eleito-presidente-da-ahpba.html]]></loc><lastmod>2018-03-28T11:58:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/jornada-multidisciplinar-de-saude-do-medico.html]]></loc><lastmod>2018-03-16T15:19:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/rastreamento-e-tratamento-do-cancer-ginecologico.html]]></loc><lastmod>2018-03-07T16:22:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-e-sexualidade.html]]></loc><lastmod>2018-03-07T15:49:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncologia-de-precisao.html]]></loc><lastmod>2018-03-07T11:52:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/experiencia-internacional.html]]></loc><lastmod>2018-03-04T21:11:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/relacao-medico-paciente.html]]></loc><lastmod>2018-03-19T02:11:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/genomica-para-o-oncologista.html]]></loc><lastmod>2018-02-19T01:16:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/residente-do-hospital-do-cancer-mae-de-deus-recebe-premio-asco-idea.html]]></loc><lastmod>2018-02-18T21:18:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cuidado-pos-cancer.html]]></loc><lastmod>2018-02-19T13:21:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/multidisciplinaridade-no-cancer-colorretal.html]]></loc><lastmod>2018-02-19T16:01:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pos-graduacao-einstein.html]]></loc><lastmod>2018-01-15T10:47:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/programa-de-especializacao-em-tumores-neuroendocrinos-2018.html]]></loc><lastmod>2017-12-18T02:05:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/nucleo-de-oncologia-toracica.html]]></loc><lastmod>2017-12-17T19:27:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/palestra-sobre-cancer-de-pele.html]]></loc><lastmod>2017-12-11T18:34:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/aspectos-nutricionais-em-oncologia.html]]></loc><lastmod>2017-12-11T18:05:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/workshop-de-medicina-integrativa.html]]></loc><lastmod>2017-12-04T09:26:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cuidados-paliativos-um-olhar-sobre-a-pratica-e-as-necessidades-atuais.html]]></loc><lastmod>2017-11-27T18:11:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/nova-diretoria-da-abhh.html]]></loc><lastmod>2017-11-26T16:21:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hospital-de-cancer-de-barretos-inaugura-unidade-na-amazonia.html]]></loc><lastmod>2017-11-24T17:10:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/webmeeting-gbot-sequenciamento-genetico-e-diagnostico-molecular-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:27:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-prostata-em-pauta.html]]></loc><lastmod>2017-11-06T17:18:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/especial-novembro-azul.html]]></loc><lastmod>2017-11-06T13:01:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/gtg-tem-nova-diretoria.html]]></loc><lastmod>2017-10-30T03:52:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/programa-pd-point-oferece-testes-de-biomarcadores-no-cpnpc.html]]></loc><lastmod>2017-10-30T04:17:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/residencia-medica-em-mastologia-no-ibcc.html]]></loc><lastmod>2017-10-18T12:27:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/reuniao-cientifica-de-patologia-na-apm.html]]></loc><lastmod>2017-10-18T12:16:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/iii-simposio-de-humanizacao-do-icesp.html]]></loc><lastmod>2017-10-09T02:01:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/top-10-uro-oncologia.html]]></loc><lastmod>2017-10-09T02:02:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/fellow-de-pesquisa-clinica-em-barretos.html]]></loc><lastmod>2017-09-25T14:12:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/novo-diretor-medico-de-oncologia-clinica-e-hematologia-da-bp.html]]></loc><lastmod>2017-09-15T21:03:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/abordagem-do-cancer-colorretal.html]]></loc><lastmod>2017-10-09T01:59:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/atualizacao-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:29:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/iii-premio-de-inovacao.html]]></loc><lastmod>2017-08-28T18:38:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pos-asco-para-pacientes.html]]></loc><lastmod>2017-08-15T12:46:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pos-graduacao-em-oncologia-dermatologica.html]]></loc><lastmod>2017-07-20T19:23:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/clarissa-mathias-e-eleita-diretora-da-america-latina-da-iaslc.html]]></loc><lastmod>2017-07-24T04:45:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/webmeeting-gbot-imunoterapia-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:33:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/webmeeting-gtg-novidades-2017.html]]></loc><lastmod>2017-07-09T23:47:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/atualizacao-em-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2017-07-06T21:14:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-sobre-hpv-e-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2017-07-04T19:50:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pesquisa-clinica-em-cancer.html]]></loc><lastmod>2017-06-30T21:50:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-mama-avancado-em-pauta.html]]></loc><lastmod>2017-06-12T19:44:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/debate-sobre-reducao-de-danos-no-tabagismo.html]]></loc><lastmod>2017-06-05T18:07:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/o-papel-da-nutricao-no-combate-ao-cancer.html]]></loc><lastmod>2017-06-05T18:07:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/1-premio-ronaldo-ribeiro-de-pesquisa-clinica.html]]></loc><lastmod>2017-06-02T01:01:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hospital-leforte-inaugura-centro-avancado-em-cancer-de-tireoide.html]]></loc><lastmod>2017-05-31T21:17:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/o-futuro-do-sistema-cep-conep.html]]></loc><lastmod>2017-06-01T21:58:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/caminhada-de-conscientizacao-sobre-o-tumor-cerebral.html]]></loc><lastmod>2017-05-12T21:38:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/educacao-e-conscientizacao-sobre-o-tratamento-oncologico.html]]></loc><lastmod>2017-05-05T20:07:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/livro-retrata-bastidores-de-um-consultorio-oncologico.html]]></loc><lastmod>2017-05-05T20:13:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-cuidados-paliativos-para-nao-paliativistas.html]]></loc><lastmod>2017-05-11T21:40:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/apm-discute-os-limites-do-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2017-05-03T21:46:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/atualizacoes-sobre-cancer-colorretal.html]]></loc><lastmod>2017-04-11T12:26:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/odontologia-para-pacientes-oncologicos.html]]></loc><lastmod>2017-04-10T22:16:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/novas-tecnologias-no-tratamento-do-cancer.html]]></loc><lastmod>2017-04-03T18:56:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/barretos-inaugura-novo-centro-de-pesquisa.html]]></loc><lastmod>2017-03-22T19:37:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/video-alerta-sobre-os-riscos-dos-agrotoxicos.html]]></loc><lastmod>2017-03-22T20:56:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/workshop-discute-analise-de-risco-em-radioterapia.html]]></loc><lastmod>2017-03-09T19:46:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-mama-na-mulher-jovem.html]]></loc><lastmod>2017-03-07T16:17:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/saude-feminina.html]]></loc><lastmod>2017-03-07T11:59:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-sobre-cirurgia-de-cabeca-e-pescoco.html]]></loc><lastmod>2017-03-09T17:54:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncologia-para-nao-oncologistas.html]]></loc><lastmod>2017-02-13T15:47:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/terapias-de-suporte-como-auxilio-ao-tratamento.html]]></loc><lastmod>2017-02-03T11:25:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/bolsas-de-iniciacao-cientifica.html]]></loc><lastmod>2017-01-24T18:54:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/i-simposio-de-familia-e-cuidados-de-suporte.html]]></loc><lastmod>2017-01-24T18:25:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/transplante-de-medula-ossea-mitos-e-verdades.html]]></loc><lastmod>2017-01-19T15:59:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/sus-inicia-vacinacao-de-meninos-contra-hpv.html]]></loc><lastmod>2017-01-12T18:00:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/comunicacao-de-mas-noticias.html]]></loc><lastmod>2017-01-09T02:27:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pos-graduacao-em-oncologia.html]]></loc><lastmod>2016-12-27T15:24:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/gilberto-lopes-e-o-novo-editor-chefe-do-journal-of-global-oncology.html]]></loc><lastmod>2016-12-19T12:36:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/luiz-augusto-maltoni-jr-e-o-novo-diretor-executivo-da-fundacao-do-cancer.html]]></loc><lastmod>2016-12-08T17:14:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/inscricoes-abertas-para-pos-graduacao.html]]></loc><lastmod>2017-01-09T02:37:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/residencia-multiprofissional-em-uti-oncologica.html]]></loc><lastmod>2016-12-06T18:27:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/capsula-endoscopica-e-enteroscopia.html]]></loc><lastmod>2016-12-12T17:22:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/workshop-de-nutricao.html]]></loc><lastmod>2016-12-06T11:53:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/residencia-medica-em-transplante-de-medula-ossea.html]]></loc><lastmod>2017-01-09T02:37:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/focep-discute-entrada-do-brasil-no-ich.html]]></loc><lastmod>2016-11-25T03:06:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/diagnostico-de-leucemias-em-pauta-na-apm.html]]></loc><lastmod>2016-11-23T01:06:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/residencia-medica-em-porto-velho.html]]></loc><lastmod>2016-11-25T03:06:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/imunoterapia-e-biomarcadores-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:49:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/prevencao-do-cancer-de-prostata.html]]></loc><lastmod>2016-11-03T17:38:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ipilimumabe-recebe-o-premio-galien-usa.html]]></loc><lastmod>2016-11-02T17:49:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/treinamento-e-capacitacao-em-radioterapia.html]]></loc><lastmod>2016-10-14T14:09:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/daniel-forte-e-novo-presidente-da-ancp.html]]></loc><lastmod>2016-10-13T15:51:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-mama-conhecer-para-prevenir.html]]></loc><lastmod>2016-10-03T14:26:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-mastologia-para-ginecologistas.html]]></loc><lastmod>2016-10-03T13:19:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/sirio-libanes-inaugura-unidade-diagnostica-em-brasilia.html]]></loc><lastmod>2016-10-02T11:53:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/prova-de-titulo-em-cancerologia-cirurgica.html]]></loc><lastmod>2016-10-03T14:49:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/projeto-cura-arrecada-fundos-para-pesquisa.html]]></loc><lastmod>2016-10-03T14:31:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/congresso-todos-juntos-contra-o-cancer.html]]></loc><lastmod>2016-10-03T14:30:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cirurgia-reparadora-da-mama.html]]></loc><lastmod>2016-09-21T22:20:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/unidades-do-hospital-de-cancer-de-barretos-sao-credenciadas-pelo-sus.html]]></loc><lastmod>2016-09-14T22:13:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/forum-para-esclarecimentos-da-rdc-10-2015-anvisa.html]]></loc><lastmod>2016-09-16T20:08:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-prostata-localizado-no-idoso.html]]></loc><lastmod>2016-09-16T20:06:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/apm-promove-reuniao-cientifica-de-mastologia.html]]></loc><lastmod>2016-09-16T20:06:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/manejo-das-lesoes-impalpaveis-da-mama.html]]></loc><lastmod>2016-09-14T20:09:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/reuniao-na-apm-discute-psicologia-medica.html]]></loc><lastmod>2016-09-14T20:09:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/parceria-auxilia-no-diagnostico-precoce-do-cancer-de-boca.html]]></loc><lastmod>2016-09-12T02:26:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/uso-correto-de-medicamentos.html]]></loc><lastmod>2016-09-06T18:17:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-sobre-estomaterapia.html]]></loc><lastmod>2016-08-30T14:59:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/i-simposio-internacional-de-telemedicina-einstein.html]]></loc><lastmod>2016-08-26T03:39:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/2-encontro-ctcan-cancer-de-mama-e-ginecologico.html]]></loc><lastmod>2016-08-22T13:56:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hospital-moinhos-de-vento-inaugura-centro-de-oncologia.html]]></loc><lastmod>2016-08-26T03:41:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/inca-lanca-site-para-sobre-alimentacao-nutricao-e-prevencao-do-cancer.html]]></loc><lastmod>2016-08-26T03:40:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/encontro-discute-imunoterapia-em-oncologia.html]]></loc><lastmod>2016-08-26T03:40:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/novas-tecnologias-em-imagem-mamaria.html]]></loc><lastmod>2016-08-15T23:40:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/atualizacao-pos-asco-e-esmo-gi.html]]></loc><lastmod>2016-08-10T20:59:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/nova-unidade-do-hospital-alemao-oswaldo-cruz.html]]></loc><lastmod>2016-08-15T23:40:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pesquisa-avalia-conhecimento-da-populacao-sobre-o-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:53:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/tabagismo-nunca-mais.html]]></loc><lastmod>2016-08-30T17:24:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hospital-amaral-carvalho-realiza-cervicolp-jahu-2016.html]]></loc><lastmod>2016-08-08T00:19:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/tecnicos-do-ipen-retomam-atividades.html]]></loc><lastmod>2016-08-01T02:56:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/medicina-integrativa-em-foco.html]]></loc><lastmod>2016-07-28T20:02:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/paralisacao-compromete-fornecimento-de-material-para-medicina-nuclear.html]]></loc><lastmod>2016-07-28T20:01:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/inca-oferece-curso-de-atualizacao-em-boas-praticas-clinicas.html]]></loc><lastmod>2016-07-21T15:08:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/centro-de-saude-da-mulher.html]]></loc><lastmod>2016-07-21T15:07:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/qualidade-e-seguranca-do-paciente.html]]></loc><lastmod>2016-07-13T19:39:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/3-congresso-todos-juntos-contra-o-cancer.html]]></loc><lastmod>2016-07-13T18:38:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-basico-de-oncologia-no-hospital-amaral-carvalho.html]]></loc><lastmod>2016-07-13T19:55:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pre-congresso-da-sociedade-brasileira-de-biologia-celular.html]]></loc><lastmod>2016-07-08T21:07:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/1-masterclass-in-uniportal-vats.html]]></loc><lastmod>2016-07-08T20:48:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/nucleo-de-tratamento-da-dor-e-cuidados-integrais.html]]></loc><lastmod>2016-07-08T20:45:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/prevencao-e-diagnostico-precoce-do-cancer-infantil.html]]></loc><lastmod>2016-07-08T21:09:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-internacional-de-medicina-bucal.html]]></loc><lastmod>2016-07-08T21:10:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/gincana-virtual-de-oncologia-da-sboc.html]]></loc><lastmod>2016-07-04T14:50:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/novartis-oncology-conference-one.html]]></loc><lastmod>2016-07-08T16:06:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/usp-talks-discute-os-mitos-e-as-realidades-da-cura-do-cancer.html]]></loc><lastmod>2016-07-04T19:26:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-de-patologia-em-salvador.html]]></loc><lastmod>2016-06-27T01:41:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-sobre-tumores-osseos-em-porto-alegre.html]]></loc><lastmod>2016-06-27T00:33:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/x-curso-de-revisao-em-hematologia-e-hemoterapia.html]]></loc><lastmod>2016-06-27T00:33:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/abhh-promove-encontro-de-atualizacao.html]]></loc><lastmod>2016-06-20T03:13:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/1-jornada-de-dor-aguda-da-santa-casa-de-sp.html]]></loc><lastmod>2016-06-20T03:00:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/xxi-jornada-de-patologia-trato-gastrointestinal.html]]></loc><lastmod>2016-06-15T01:06:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/quimioterapia-e-tema-de-curso.html]]></loc><lastmod>2016-06-14T20:06:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/forum-big-data-em-saude.html]]></loc><lastmod>2016-06-14T14:25:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/a-importancia-da-nutricao-na-prevencao-e-tratamento-do-cancer.html]]></loc><lastmod>2016-06-03T13:02:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/instituto-de-prevencao-de-fernandopolis-encerra-atividades.html]]></loc><lastmod>2016-06-14T14:23:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/focep-discute-sistema-cep-conep.html]]></loc><lastmod>2016-06-14T14:24:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-discute-genomica-do-cancer.html]]></loc><lastmod>2016-06-12T23:53:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hemo-educa-llc-e-linfomas.html]]></loc><lastmod>2016-06-03T15:32:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/abbvie-anuncia-aquisicao-da-stemcentrx.html]]></loc><lastmod>2016-06-01T14:43:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cuidados-paliativos-para-nao-paliativistas.html]]></loc><lastmod>2016-06-01T14:45:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/um-novo-olhar-sobre-o-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:58:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/vi-forum-nacional-de-politicas-de-saude-em-oncologia.html]]></loc><lastmod>2016-05-09T16:52:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hemo-educa-leucemia-mieloide-cronica.html]]></loc><lastmod>2016-05-06T14:06:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/manual-de-cirurgia-segura-do-cbc.html]]></loc><lastmod>2016-05-23T15:15:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-discute-gestao-da-pesquisa-cientifica-no-brasil.html]]></loc><lastmod>2016-05-23T15:16:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-de-radiobiologia-no-hospital-de-cancer-de-barretos.html]]></loc><lastmod>2016-05-09T13:59:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/preservacao-da-fertilidade-em-pacientes-com-cancer-ginecologico.html]]></loc><lastmod>2016-05-19T14:48:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-discute-patologia-de-tumores-toracicos.html]]></loc><lastmod>2016-05-23T15:15:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/i-simposio-de-mastologia-sbm-e-inca.html]]></loc><lastmod>2016-05-09T13:58:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-de-imuno-oncologia-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:59:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/tireoide-e-tema-de-palestra-sobre-prevencao-no-hiae.html]]></loc><lastmod>2016-05-15T20:01:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/reuniao-discute-avancos-no-tratamento-do-cancer-de-testiculo.html]]></loc><lastmod>2016-05-06T14:07:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/manejo-das-lesoes-papiliferas-da-mama.html]]></loc><lastmod>2016-04-27T15:13:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/reuniao-de-urologia-oncologica-no-hcp.html]]></loc><lastmod>2016-04-27T15:08:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/sboc-realiza-simposio-brasileiro-de-imuno-oncologia.html]]></loc><lastmod>2016-04-24T14:10:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/seminario-aborda-relacao-entre-nutricao-e-oncologia.html]]></loc><lastmod>2016-04-27T14:41:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/reuniao-sobre-cancer-de-penis-no-hcp.html]]></loc><lastmod>2016-04-27T14:40:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/grupo-de-estudos-de-tumores-hereditarios-geth.html]]></loc><lastmod>2016-04-08T14:19:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/vi-simposio-internacional-de-oncologia-recife-detroit.html]]></loc><lastmod>2016-04-13T22:15:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/o-futuro-da-luta-contra-o-cancer-e-tema-de-palestra.html]]></loc><lastmod>2016-04-13T22:16:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/climaterio-na-paciente-com-cancer-de-mama-de-alto-risco.html]]></loc><lastmod>2016-04-05T02:31:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/workshop-sobre-cancer-de-prostata-na-oncomed-bh.html]]></loc><lastmod>2016-03-31T03:33:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-sobre-oncoginecologia-na-faculdade-de-medicina-de-petropolis.html]]></loc><lastmod>2016-03-24T17:42:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/prevencao-do-cancer-de-colo-de-utero.html]]></loc><lastmod>2016-03-31T03:10:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-multidisciplinar-em-nutricao.html]]></loc><lastmod>2016-03-31T03:11:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/mesa-redonda-discute-cancer-de-prostata-avancado.html]]></loc><lastmod>2016-03-20T09:48:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/dana-farber-e-grupo-oncoclinicas-ampliam-parceria-tecnico-cientifica.html]]></loc><lastmod>2016-03-15T01:00:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/mae-de-deus-anuncia-novo-hospital-do-cancer-em-porto-alegre.html]]></loc><lastmod>2016-03-10T20:23:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hospital-de-cancer-de-barretos-lanca-atlas-do-cancer.html]]></loc><lastmod>2016-03-10T19:28:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/primeira-reuniao-do-focep-em-2016.html]]></loc><lastmod>2016-03-10T19:29:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hospital-amaral-carvalho-inaugura-novo-espaco.html]]></loc><lastmod>2016-03-10T19:29:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/primeira-fabrica-varian-da-america-latina.html]]></loc><lastmod>2016-03-10T19:30:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hospital-de-barretos-lanca-pedra-fundamental-do-instituto-de-prevencao-em-campinas.html]]></loc><lastmod>2016-03-10T19:30:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/vencer-o-cancer-de-mama-e-tema-de-palestra.html]]></loc><lastmod>2016-03-08T21:04:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/exames-gratuitos-de-papanicolaou.html]]></loc><lastmod>2016-03-04T16:04:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/programa-de-especializacao-em-imagem-mamaria.html]]></loc><lastmod>2016-03-04T15:53:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pfizer-lanca-portal-para-profissionais-de-saude.html]]></loc><lastmod>2016-02-28T22:47:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/avancos-da-quimioterapia-neoadjuvante.html]]></loc><lastmod>2016-02-19T11:51:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/sbm-promove-curso-de-oncoplastica-mamaria-nos-eua.html]]></loc><lastmod>2016-01-20T11:16:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hospitais-brasileiros-recebem-selo-de-acreditacao.html]]></loc><lastmod>2016-01-07T21:04:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/palestra-aborda-calendario-da-saude.html]]></loc><lastmod>2016-02-18T16:19:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-de-endoscopia-digestiva.html]]></loc><lastmod>2016-01-21T03:19:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/1-emergencia-oncologica-do-rio-grande-do-sul.html]]></loc><lastmod>2015-12-14T00:22:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/dezembro-laranja-alerta-para-a-prevencao-do-cancer-da-pele.html]]></loc><lastmod>2015-11-30T03:15:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/primeiro-banco-publico-de-dados-genomico-do-brasil.html]]></loc><lastmod>2015-11-30T03:01:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/efeito-negativo-da-incidencia-de-doencas-cronicas-no-pib-brasileiro-ate-2030.html]]></loc><lastmod>2015-11-30T02:43:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/teste-diagnostico-baseado-em-sequenciamento-de-nova-geracao.html]]></loc><lastmod>2015-12-10T14:19:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/gbm-realiza-acao-de-prevencao-do-melanoma.html]]></loc><lastmod>2015-12-10T14:20:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/auro-del-giglio-assume-a-coordenacao-do-hcor-onco.html]]></loc><lastmod>2015-11-17T16:19:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/testes-geneticos-no-alto-risco-familiar.html]]></loc><lastmod>2015-11-16T20:08:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/livro-prevencao-do-cancer-ganha-2-edicao.html]]></loc><lastmod>2015-11-16T15:53:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/educacao-continuada.html]]></loc><lastmod>2015-11-09T12:38:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/icmd-realiza-simposio-de-melanoma.html]]></loc><lastmod>2015-11-05T01:00:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/brasileiro-recebe-o-asco-merit-award.html]]></loc><lastmod>2015-11-16T15:54:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/2-simposio-de-dor-oncologica-do-instituto-coi.html]]></loc><lastmod>2015-11-09T01:48:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/mastologia-para-ginecologistas.html]]></loc><lastmod>2015-11-03T16:25:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/caminhada-contra-o-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:07:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/focep-discute-questoes-apresentadas-4-encep.html]]></loc><lastmod>2015-11-16T15:55:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/reunioes-mensais-do-geth.html]]></loc><lastmod>2015-11-03T01:38:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/guia-da-sindrome-mielodisplasica.html]]></loc><lastmod>2015-10-27T12:50:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/vencer-o-cancer-de-mama.html]]></loc><lastmod>2015-10-15T18:48:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/1-curso-de-cancer-de-mama-do-instituto-coi-para-residentes.html]]></loc><lastmod>2015-10-11T17:21:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/novos-acessorios-de-radioterapia-no-hospital-mae-de-deus.html]]></loc><lastmod>2015-10-15T20:22:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/movimento-vaipormim-alerta-para-prevencao-do-cancer-de-intestino.html]]></loc><lastmod>2015-10-05T06:04:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/nenhuma-mulher-sem-mama.html]]></loc><lastmod>2015-10-05T14:38:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/campanha-virtual-em-prol-da-deteccao-precoce-do-cancer-de-mama.html]]></loc><lastmod>2015-10-25T19:29:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/campanha-juntos-somos-rosa.html]]></loc><lastmod>2015-10-05T14:36:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/endocrinoterapia-adjuvante-no-cancer-de-mama.html]]></loc><lastmod>2015-10-25T19:30:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pesquisa-com-pacientes-de-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2015-09-28T01:51:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/2-congresso-brasileiro-todos-juntos-contra-o-cancer.html]]></loc><lastmod>2015-10-16T22:52:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ii-summit-internacional-de-oncologia.html]]></loc><lastmod>2015-09-21T14:12:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/dor-em-cuidados-paliativos.html]]></loc><lastmod>2015-09-21T14:11:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/residencia-medica-do-hospital-mae-de-deus.html]]></loc><lastmod>2015-09-21T14:11:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/audiencia-publica-discute-combate-ao-cancer-colorretal.html]]></loc><lastmod>2015-09-16T19:01:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-discute-cancer-de-mama-masculino.html]]></loc><lastmod>2015-09-14T17:01:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-em-fisioterapia-oncologica.html]]></loc><lastmod>2015-09-10T18:25:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/palestra-sobre-genoma-do-cancer.html]]></loc><lastmod>2015-09-03T17:03:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/blau-farmaceutica-lanca-genericos-no-concan.html]]></loc><lastmod>2015-09-03T17:00:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hiae-inaugura-servico-de-teleoncologia.html]]></loc><lastmod>2015-09-02T12:48:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/lancamento-oncofertilidade-na-pratica-medica.html]]></loc><lastmod>2015-08-27T18:37:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/saude-da-mulher-e-tema-de-congresso.html]]></loc><lastmod>2015-08-27T17:26:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/acesso-a-tratamento-para-cancer-de-mama-avancado.html]]></loc><lastmod>2015-08-26T18:42:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/sbm-e-a-pesquisa-nacional-da-saude.html]]></loc><lastmod>2015-08-24T23:27:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/incidencia-de-cancer-colorretal-em-sp.html]]></loc><lastmod>2015-08-24T04:23:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-internacional-discute-pesquisa-e-tratamento-do-cancer.html]]></loc><lastmod>2015-08-20T18:58:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/centro-paulista-de-oncologia-amplia-equipe-medica.html]]></loc><lastmod>2015-08-18T19:52:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/encontro-em-belo-horizonte-discute-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:11:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/centro-internacional-de-referencia-em-imagem-oncologica.html]]></loc><lastmod>2015-08-13T17:59:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/reuniao-discute-prevencao-ao-tabagismo-e-cancer.html]]></loc><lastmod>2015-08-13T17:56:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/premio-empreenda-saude-reconhece-empreendedorismo-e-inovacao.html]]></loc><lastmod>2015-08-12T17:16:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-mama-avancado-e-tema-de-simposio.html]]></loc><lastmod>2015-08-09T22:12:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/premio-destaca-anticorpo-monoclonal-para-cancer-de-mama.html]]></loc><lastmod>2015-08-13T18:02:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-de-oncologia-discute-destaques-da-asco-2015.html]]></loc><lastmod>2015-08-12T14:31:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ensaios-clinicos-com-dispositivos-medicos.html]]></loc><lastmod>2015-08-05T16:02:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/trombose-em-pacientes-com-cancer.html]]></loc><lastmod>2015-07-20T01:44:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ans-prorroga-consulta-publica-do-rol-de-procedimentos.html]]></loc><lastmod>2015-08-12T14:25:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/premio-incentiva-conhecimento-em-prevencao-e-combate-ao-cancer.html]]></loc><lastmod>2015-08-12T14:26:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/anvisa-aprova-xofigo-para-cancer-de-prostata-resistente-a-castracao.html]]></loc><lastmod>2015-08-03T02:29:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/reconstrucao-mamaria-e-tema-de-encontro-em-bento-goncalves.html]]></loc><lastmod>2015-08-03T02:31:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/artigo-de-pesquisadores-brasileiros-e-premiado-como-melhor-do-ano-pelo-jnm.html]]></loc><lastmod>2015-07-20T02:26:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ans-tem-nova-diretora.html]]></loc><lastmod>2015-07-28T13:31:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/a-comunicacao-medico-paciente-no-tratamento-oncologico.html]]></loc><lastmod>2015-07-23T14:58:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/documento-reune-as-principais-dificuldades-na-oncologia-nacional.html]]></loc><lastmod>2015-07-28T13:32:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/mae-de-deus-oferece-servico-de-assistencia-domiciliar.html]]></loc><lastmod>2015-07-23T14:59:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/i-curso-de-biologia-do-cancer-para-jovens-cientistas.html]]></loc><lastmod>2015-07-20T02:25:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/anvisa-aprova-bevacizumabe-para-cancer-de-colo-do-utero-avancado.html]]></loc><lastmod>2015-07-07T19:22:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cpo-inaugura-nova-unidade-em-sao-paulo.html]]></loc><lastmod>2015-07-06T13:02:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/acreditacao-de-comites-de-etica-em-pesquisa.html]]></loc><lastmod>2015-07-06T16:04:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/inscricoes-abertas-para-o-19-congresso-da-sboc.html]]></loc><lastmod>2015-06-25T02:38:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/brasileiros-participam-de-estudo-inovador-em-cancer-de-prostata.html]]></loc><lastmod>2015-06-22T23:01:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/especialistas-debatem-as-novidades-apresentadas-na-asco.html]]></loc><lastmod>2015-06-22T22:56:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/um-novo-olhar-sobre-o-cancer-de-mama-metastatico.html]]></loc><lastmod>2015-06-18T14:48:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cpo-recebe-acreditacao-internacional.html]]></loc><lastmod>2015-06-16T14:33:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/grupo-coi-inaugura-unidade-em-botafogo.html]]></loc><lastmod>2015-06-16T14:18:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cartilha-virtual-de-cuidados-paliativos.html]]></loc><lastmod>2015-06-10T17:08:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/eleito-novo-presidente-da-sboc.html]]></loc><lastmod>2015-06-10T14:42:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/encontro-discute-cancer-colorretal.html]]></loc><lastmod>2015-06-09T16:58:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/composto-modificado-amplia-acao-antitumoral-em-melanoma.html]]></loc><lastmod>2015-05-25T01:25:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/diretrizes-para-expansao-da-medicina-nuclear.html]]></loc><lastmod>2015-05-25T01:22:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancerlinq-e-a-medicina-de-precisao.html]]></loc><lastmod>2015-05-25T01:16:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/unidade-movel-de-tomografia-produzida-no-brasil.html]]></loc><lastmod>2015-05-25T01:12:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/software-cria-mamografia-virtual-a-partir-da-tomossintese.html]]></loc><lastmod>2015-06-02T14:07:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/4-encontro-do-ii-simposio-interinstitucional-de-mastologia-sim.html]]></loc><lastmod>2015-06-02T14:08:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/feira-apresenta-novidades-na-area-da-saude.html]]></loc><lastmod>2015-05-18T18:31:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/participacao-brasileira-em-programa-de-qualidade-assistencial-em-harvard.html]]></loc><lastmod>2015-05-15T15:05:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/fda-aprova-teste-da-mutacao-kras-cobas-r-para-cancer-colorretal.html]]></loc><lastmod>2015-05-12T00:04:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/zykadia-e-aprovado-na-europa-para-cancer-de-pulmao-com-mutacao-alk.html]]></loc><lastmod>2020-04-24T19:16:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/colaboracao-cientifica-entre-sao-paulo-e-california.html]]></loc><lastmod>2015-05-07T22:43:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/discussao-sobre-pesquisa-clinica.html]]></loc><lastmod>2015-05-07T22:17:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/parceria-para-tratamento-do-cancer-na-zambia-e-mocambique.html]]></loc><lastmod>2015-05-07T22:11:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/construir-e-adaptar-modelos-de-patient-flow-e-patient-forecast.html]]></loc><lastmod>2015-05-04T03:52:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/expansao-da-medicina-nuclear-no-brasil.html]]></loc><lastmod>2015-05-04T03:54:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-discute-aplicacoes-do-pet-ct.html]]></loc><lastmod>2015-05-03T21:11:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hiae-inaugura-pronto-atendimento-oncologico.html]]></loc><lastmod>2015-04-28T01:07:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/o-sus-em-debate.html]]></loc><lastmod>2015-04-27T01:29:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/encontro-discute-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:16:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/nova-unidade-do-hospital-de-cancer-de-barretos.html]]></loc><lastmod>2015-04-27T01:30:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/novos-criterios-da-classificacao-mundial-de-linfomas.html]]></loc><lastmod>2015-04-27T01:31:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-discute-cuidado-paliativo.html]]></loc><lastmod>2015-04-27T01:31:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/anestesia-em-oncologia-no-12-copa.html]]></loc><lastmod>2015-04-24T17:54:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/mutirao-urologico-gratuito-em-campos-de-jordao.html]]></loc><lastmod>2015-04-22T21:29:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cirurgia-brasileira-e-destaque-em-programa-de-universidades-internacionais.html]]></loc><lastmod>2015-04-22T16:34:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/expansao-do-hospital-sirio-libanes.html]]></loc><lastmod>2015-04-24T15:14:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/3o-encontro-do-ii-simposio-interinstitucional-de-mastologia-sim.html]]></loc><lastmod>2015-05-25T18:39:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/uso-da-fisica-no-diagnostico-e-terapia-de-cancer.html]]></loc><lastmod>2015-04-22T16:40:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/encontro-discute-melanoma.html]]></loc><lastmod>2015-04-22T16:36:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/seminario-alianca-pesquisa-clinica-brasil.html]]></loc><lastmod>2015-04-13T02:42:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/medtronic-anuncia-aquisicao-da-covidien.html]]></loc><lastmod>2015-04-13T00:13:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ii-workshop-multidisciplinar-de-cancer-de-prostata.html]]></loc><lastmod>2015-04-10T17:54:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ii-encontro-multidisciplinar-de-cancer-de-tireoide.html]]></loc><lastmod>2015-03-30T19:25:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/encontro-internacional-do-instituto-coi.html]]></loc><lastmod>2015-04-14T03:01:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/2o-encontro-do-ii-simposio-interinstitucional-de-mastologia-sim.html]]></loc><lastmod>2015-05-25T18:44:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/carlos-gil-no-corpo-clinico-do-grupo-oncologia-d-or.html]]></loc><lastmod>2015-03-17T13:25:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/bevacizumabe-tem-patente-anulada.html]]></loc><lastmod>2015-03-15T00:52:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/4-congresso-mineiro-de-cirurgia-oncologica.html]]></loc><lastmod>2015-03-12T11:34:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/prevencao-do-cancer.html]]></loc><lastmod>2015-11-16T15:19:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/semana-municipal-de-informacao-e-divulgacao-da-pesquisa-clinica.html]]></loc><lastmod>2015-02-20T13:05:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cpo-amplia-corpo-clinico.html]]></loc><lastmod>2015-02-13T19:38:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/v-forum-de-politicas-de-saude-em-oncologia.html]]></loc><lastmod>2015-04-23T22:35:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/heparina-para-o-controle-de-metastases-cancerigenas.html]]></loc><lastmod>2015-03-02T13:45:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/novo-centro-de-tratamento-de-cancer-em-belo-horizonte.html]]></loc><lastmod>2015-02-04T21:25:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/lancamento-o-sonho-de-carmen.html]]></loc><lastmod>2015-01-29T13:16:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/prostate-cancer-debate-2015.html]]></loc><lastmod>2015-01-30T20:56:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/amgen-brasil-anuncia-novo-gerente-geral.html]]></loc><lastmod>2015-01-08T13:52:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-interinstitucional-de-mastologia-sim.html]]></loc><lastmod>2015-03-02T13:41:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/hospital-de-cancer-de-barretos-e-destaque-no-4-premio-melhores-hospitais.html]]></loc><lastmod>2014-12-18T22:23:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/pet-ct-e-incluido-no-sus.html]]></loc><lastmod>2014-12-17T15:38:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/livro-discute-acesso-a-medicamentos.html]]></loc><lastmod>2014-12-15T12:32:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/sabcs-2014.html]]></loc><lastmod>2014-12-09T20:29:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/livro-sobre-prevencao-e-tratamento-do-cancer-de-prostata.html]]></loc><lastmod>2014-11-24T18:09:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/1-ciclo-de-debates-regionais-sobre-cancer-de-mama-para-parlamentares.html]]></loc><lastmod>2015-03-25T18:00:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/2-jornada-mineira-do-cancer-de-mama.html]]></loc><lastmod>2014-11-24T15:58:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/talk-show-tira-duvidas-sobre-cancer.html]]></loc><lastmod>2014-11-24T15:52:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/atendimento-gratuito-para-rastreamento-de-cancer-colorretal.html]]></loc><lastmod>2014-11-24T15:43:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/sbu-cria-centros-de-referencia-no-trato-urinario.html]]></loc><lastmod>2014-11-24T15:37:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncologista-brasileiro-participa-de-encontro-da-oms.html]]></loc><lastmod>2014-11-17T13:12:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/salomaozoppi-diagnosticos-na-10-jornada-paulista-de-mastologia.html]]></loc><lastmod>2015-09-14T16:57:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/evento-discute-uso-da-hadronterapia-no-tratamento-do-cancer.html]]></loc><lastmod>2014-11-10T22:42:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/presenca-brasileira-em-encontro-internacional-de-cancer-ginecologico.html]]></loc><lastmod>2014-11-10T17:03:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/6-encontro-do-i-simposio-interinstitucional-de-mastologia.html]]></loc><lastmod>2014-11-12T20:10:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/bienal-internacional-de-oncologia.html]]></loc><lastmod>2014-11-06T03:21:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/fda-aprova-bortezomibe-em-linfoma-de-celulas-do-manto.html]]></loc><lastmod>2014-11-03T19:54:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/esporte-no-combate-ao-cancer-de-prostata.html]]></loc><lastmod>2014-11-03T18:15:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/congresso-nacional-sera-iluminado-de-azul.html]]></loc><lastmod>2014-11-06T03:24:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/icmd-recebe-medicos-colombianos-para-educacao-continuada-em-cancer.html]]></loc><lastmod>2014-11-04T17:59:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/blinatumomabe-terapia-inovadora-em-lla.html]]></loc><lastmod>2014-11-03T12:20:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/simposio-gastrointestinal.html]]></loc><lastmod>2014-11-10T13:54:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/18-congresso-de-ultrassonografia.html]]></loc><lastmod>2014-10-25T14:08:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-de-radioterapia-de-ultima-geracao-e-curso-de-braquiterapia-da-prostata.html]]></loc><lastmod>2014-10-22T16:14:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncogenetica-em-cancer-de-mama.html]]></loc><lastmod>2014-10-20T21:00:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/5-encontro-do-i-simposio-interinstitucional-de-mastologia.html]]></loc><lastmod>2014-10-15T16:28:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/roche-promove-3-edicao-do-chat-with-the-experts.html]]></loc><lastmod>2014-10-13T23:54:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/cancer-de-pulmao-pode-ficar-latente-por-20-anos.html]]></loc><lastmod>2020-04-24T19:20:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/bortezomibe-tem-nova-indicacao-em-linfoma-de-celulas-do-manto.html]]></loc><lastmod>2014-10-13T04:37:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/ricardo-caponero-fala-sobre-os-progressos-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2014-10-08T14:33:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/amgen-apresenta-pedido-de-comercializacao-da-terapia-oncolitica.html]]></loc><lastmod>2014-10-01T20:59:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/carreta-de-barretos-promove-mamografia-no-parque-do-ibirapuera.html]]></loc><lastmod>2014-10-01T23:56:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/orygen-tem-apoio-da-pfizer-em-biossimilares.html]]></loc><lastmod>2014-09-12T15:52:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/salomaozoppi-expande-capacidade-produtiva.html]]></loc><lastmod>2014-09-02T12:42:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/audiencia-publica-debate-falta-de-verba-e-baixa-qualidade-do-atendimento-no-sus.html]]></loc><lastmod>2014-08-27T16:52:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/curso-de-extensao-sobre-bioetica-no-fim-da-vida.html]]></loc><lastmod>2014-08-27T15:51:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/generico-do-bortezomibe-chega-ao-brasil-para-mieloma-multiplo.html]]></loc><lastmod>2014-08-27T19:13:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/sunitinibe-ativo-em-meningioma-refratario.html]]></loc><lastmod>2014-08-25T22:21:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/campanha-oncomed-bh-20-anos.html]]></loc><lastmod>2014-08-26T16:12:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/oncologia-molecular.html]]></loc><lastmod>2014-08-25T22:14:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/radar/i-simposio-do-servico-de-ginecologia-do-instituto-do-cancer-dr-arnaldo.html]]></loc><lastmod>2014-08-25T22:11:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/videos.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/video-ricardo-marques.html]]></loc><lastmod>2017-06-26T03:50:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/video-andrey.html]]></loc><lastmod>2017-06-26T21:42:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/cancer-de-pulmao-pequenas-celulas-cenario-atual-e-perspectivas.html]]></loc><lastmod>2020-04-24T18:36:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/adjuvancia-no-cancer-de-mama-her2-positivo.html]]></loc><lastmod>2017-05-29T01:22:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/tabacof-sales-younes.html]]></loc><lastmod>2020-04-24T18:37:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/tabacoff-sales-cruz.html]]></loc><lastmod>2020-04-24T18:37:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/bromberg-kaliks-corpa-ruiz.html]]></loc><lastmod>2017-05-15T02:19:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/bromberg-evento-eua.html]]></loc><lastmod>2017-05-15T14:08:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/video-gebrim.html]]></loc><lastmod>2017-05-15T14:08:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/stenio-zequi-video.html]]></loc><lastmod>2017-05-15T14:07:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/giselle-guedes-ponto-contraponto.html]]></loc><lastmod>2017-05-15T14:06:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/cancer-de-mama-na-mulher-jovem.html]]></loc><lastmod>2017-05-02T03:16:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/cancer-de-mama-na-pre-menopausa.html]]></loc><lastmod>2017-02-12T21:52:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/video-vania-hungria.html]]></loc><lastmod>2016-12-02T19:27:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/oncoplastica-no-cancer-de-mama.html]]></loc><lastmod>2016-12-02T19:20:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/testes-geneticos-para-o-cancer-de-mama.html]]></loc><lastmod>2016-10-17T19:06:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/novas-fronteiras-em-llc.html]]></loc><lastmod>2016-09-26T18:09:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/di-leo.html]]></loc><lastmod>2016-09-19T15:56:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/classificacao-molecular-do-cancer-colorretal.html]]></loc><lastmod>2016-08-29T05:15:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/abordagem-das-metastases-hepaticas-ressecaveis.html]]></loc><lastmod>2016-08-31T16:28:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/cancer-de-ovario.html]]></loc><lastmod>2017-05-15T14:05:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/neoplasias-mieloproliferativas.html]]></loc><lastmod>2017-05-15T14:04:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/uniportal-vats-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:54:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/linfoma-de-hodgkin.html]]></loc><lastmod>2017-05-15T14:03:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/leucemia-linfocitica-cronica.html]]></loc><lastmod>2017-05-15T14:02:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/neutropenia-febril.html]]></loc><lastmod>2016-07-19T20:19:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/controversias-o-que-fazer-na-suspeita-de-linfonodos-mediastinais.html]]></loc><lastmod>2016-04-11T15:02:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/destaques-do-congresso-da-sfbo.html]]></loc><lastmod>2016-07-04T00:04:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/entusiasmo-no-panorama-gastrointestinal.html]]></loc><lastmod>2016-03-14T04:26:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/axila-positiva-como-abordar.html]]></loc><lastmod>2017-05-15T14:01:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/o-linfoma-de-hodgkin.html]]></loc><lastmod>2017-05-15T14:01:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/exclusivo-abertura-do-3-simposio-internacional-do-grupo-oncoclinicas.html]]></loc><lastmod>2017-05-15T14:00:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/manejo-da-toxicidade-na-imunoterapia.html]]></loc><lastmod>2015-11-16T23:41:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/educacao-continuada-em-cancer-gastrointestinal.html]]></loc><lastmod>2015-11-16T01:28:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/i-consenso-brasileiro-em-cancer-de-prostata-avancado.html]]></loc><lastmod>2015-11-07T21:10:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/rastreamento-do-cancer-em-mamas-densas.html]]></loc><lastmod>2015-10-25T22:28:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/grupo-coi-promove-4-simposio-de-oncologia-toracica.html]]></loc><lastmod>2015-10-19T02:37:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/melanoma-qual-o-melhor-esquema-de-tratamento.html]]></loc><lastmod>2015-09-27T20:20:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/imunoterapia-e-destaque-em-congresso-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:10:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/sindrome-de-li-fraumeni.html]]></loc><lastmod>2015-09-08T01:52:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/concan-interdisciplinaridade-no-tratamento-do-cancer.html]]></loc><lastmod>2015-08-24T02:07:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/livro-aborda-a-delicada-relacao-medico-paciente.html]]></loc><lastmod>2015-07-27T00:47:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/farmacovigilancia-em-oncologia.html]]></loc><lastmod>2015-07-27T18:23:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/cirurgia-conservadora-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2015-07-07T23:38:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/sindrome-de-lynch-diagnostico-vigilancia-e-prevencao.html]]></loc><lastmod>2015-06-29T01:43:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/novos-criterios-para-a-classificacao-de-linfomas.html]]></loc><lastmod>2017-05-15T13:59:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/congresso-discute-desafios-para-o-cancer-oral.html]]></loc><lastmod>2015-05-20T21:55:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/metastases-cerebrais-dos-tumores-solidos.html]]></loc><lastmod>2015-05-11T05:37:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/novidades-em-neuro-oncologia.html]]></loc><lastmod>2015-04-21T22:51:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/cancer-e-hpv-epidemiologia-e-prevencao.html]]></loc><lastmod>2017-05-15T13:57:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/cancer-sexualidade-e-qualidade-de-vida.html]]></loc><lastmod>2015-03-24T22:06:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/comites-de-etica-marcam-presenca-em-evento-da-sbppc-em-sp.html]]></loc><lastmod>2017-05-15T13:56:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/desafios-e-perspectivas-da-pesquisa-clinica-brasileira.html]]></loc><lastmod>2015-03-23T19:54:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/sequencia-terapeutica-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2015-03-19T07:26:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/observacao-no-cancer-de-prostata-quando-como-e-para-quem.html]]></loc><lastmod>2015-03-19T07:20:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/gastos-no-tratamento-do-cancer-de-prostata-no-brasil.html]]></loc><lastmod>2015-03-19T07:19:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/adjuvancia-ou-neoadjuvancia-em-cancer-de-bexiga.html]]></loc><lastmod>2016-11-22T01:58:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/radioterapia-no-tratamento-do-cancer-de-prostata.html]]></loc><lastmod>2015-03-19T07:17:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/o-mapa-do-cancer-renal-na-america-latina.html]]></loc><lastmod>2015-03-09T21:37:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/novidades-da-asco-gu-sao-destaque-em-simposio-de-uro-oncologia.html]]></loc><lastmod>2017-05-15T13:55:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/educacao-continuada.html]]></loc><lastmod>2017-05-15T13:57:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/cancer-renal-e-sindromes-hereditarias.html]]></loc><lastmod>2017-05-15T13:55:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/criterios-moleculares-no-cancer-de-prostata.html]]></loc><lastmod>2017-05-15T13:54:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/evento-do-a-c-camargo-reune-grandes-nomes-em-sao-paulo.html]]></loc><lastmod>2017-05-15T13:54:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/cancer-hereditario-da-epidemiologia-a-clinica.html]]></loc><lastmod>2017-05-15T13:53:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/atualizacao-medica.html]]></loc><lastmod>2017-05-15T13:04:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/historia-do-cancer-no-brasil.html]]></loc><lastmod>2015-02-23T03:34:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/novembro-azul-em-pauta.html]]></loc><lastmod>2014-11-01T13:03:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/o-imperador-de-todos-os-males-uma-biografia-do-cancer.html]]></loc><lastmod>2014-05-31T00:03:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/polemica-na-triagem-do-cancer-de-mama.html]]></loc><lastmod>2014-05-30T21:01:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/multimidia/arquivo-de-videos/cancer-de-mama-em-homens.html]]></loc><lastmod>2015-09-16T22:32:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/edicoes-revista-index-onconews.html]]></loc><lastmod>2024-05-03T21:22:31+00:00</lastmod><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/noticias/edicoes-impressas.html]]></loc><lastmod>2024-05-03T21:21:41+00:00</lastmod><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/que-estrategias-podem-desintensificar-o-tratamento-em-pacientes-com-cancer-de-mama-her2-em-estagio-inicial.html]]></loc><lastmod>2021-02-28T21:08:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/medicina-integrativa-na-oncologia---quais-as-evidencias.html]]></loc><lastmod>2020-12-17T15:06:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/sabr-em-pacientes-com-cancer-de-pulmao-quando-como-e-para-quem.html]]></loc><lastmod>2020-11-03T02:55:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/microbiota-qual-o-impacto-clinico-no-cancer-colorretal.html]]></loc><lastmod>2020-11-03T00:32:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/apresentacao.html]]></loc><lastmod>2024-05-04T09:56:20+00:00</lastmod><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/normas-index-onconews.html]]></loc><lastmod>2020-04-20T22:29:17+00:00</lastmod><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/expediente-index-onconews.html]]></loc><lastmod>2020-04-20T22:29:17+00:00</lastmod><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-01-out-2018.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-01-out-2018/releitura-de-bokhman---quais-as-implicacoes-para-a-pratica-clinica-no-cancer-de-endometrio-pos-tcga-1.html]]></loc><lastmod>2020-04-23T20:08:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-01-out-2018/avancos-na-cirurgia-do-cancer-de-reto---o-que-ha-de-novo-1.html]]></loc><lastmod>2020-04-23T20:07:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-01-out-2018/preservacao-de-fertilidade-em-cancer-de-endometrio-como-e-para-quem.html]]></loc><lastmod>2020-04-23T20:06:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-01-out-2018/utilizacao-de-testes-genomicos-no-cancer-de-mama-qual-o-cenario-atual.html]]></loc><lastmod>2020-04-23T20:05:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-01-out-2018/terapia-endoscopica-no-tratamento-da-doenca-precoce-do-esofago-quando-como-e-para-quem.html]]></loc><lastmod>2020-04-23T20:04:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-01-out-2018/o-que-considerar-na-patologia-do-cancer-de-prostata.html]]></loc><lastmod>2020-04-23T20:02:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-01-out-2018/lma-como-diagnosticar-como-tratar.html]]></loc><lastmod>2020-04-23T19:59:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-01-out-2018/linfoma-difuso-de-grandes-celulas-b-onde-podemos-avancar.html]]></loc><lastmod>2020-04-23T20:01:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-01-out-2018/tne-do-trato-digestivo-como-eleger-a-melhor-sequencia-e-avaliar-a-resposta-terapeutica.html]]></loc><lastmod>2020-04-24T20:01:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-01-out-2018/radioterapia-paliativa-como-e-para-quem.html]]></loc><lastmod>2020-04-24T20:02:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-02-jan-2019.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-02-jan-2019/tratamento-do-cancer-do-colo-do-utero-avancado-como-transformar-um-paciente-unfit-em-fit.html]]></loc><lastmod>2020-04-23T20:09:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-02-jan-2019/como-avancar-na-prevencao-e-rastreamento-do-cancer-de-cabeca-e-pescoco-1.html]]></loc><lastmod>2020-04-23T20:12:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-02-jan-2019/qual-o-padrao-de-tratamento-adjuvante-no-cancer-das-vias-biliares.html]]></loc><lastmod>2020-04-23T20:15:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-02-jan-2019/qual-o-padrao-de-tratamento-com-quimioterapia-no-cancer-de-ovario-avancado-e-recidivado.html]]></loc><lastmod>2020-04-23T20:17:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-02-jan-2019/linfoma-de-hodgkin-quais-as-recomendacoes-para-diagnostico-e-tratamento.html]]></loc><lastmod>2020-04-20T22:29:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-02-jan-2019/como-promover-reabilitacao-e-fortalecimento-muscular-em-cancer-de-mama.html]]></loc><lastmod>2024-05-09T09:05:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-03-jun-2019.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-03-jun-2019/cirurgia-da-mama-apos-neoadjuvancia-o-que-considerar.html]]></loc><lastmod>2020-04-20T22:29:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-03-jun-2019/hipercalcemia-no-paciente-oncologico-como-reconhecer-como-tratar.html]]></loc><lastmod>2020-04-23T20:20:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-03-jun-2019/hipertensao-intracraniana-como-urgencia-oncologica-como-reconhecer-como-tratar.html]]></loc><lastmod>2020-04-23T20:21:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-03-jun-2019/adenocarcinoma-de-esofago-e-de-transicao-esofago-gastrica-o-que-mudou-com-o-tratamento-multimodal-e-as-novas-taticas-cirurgicas.html]]></loc><lastmod>2020-04-23T20:22:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-03-jun-2019/imagiologia-no-diagnostico-e-estadiamento-do-cancer-de-prostata-o-que-ha-de-novo-1.html]]></loc><lastmod>2024-07-08T14:33:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-04-nov-2019.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-04-nov-2019/imunoterapia-no-cancer-ginecologico-como-estamos.html]]></loc><lastmod>2020-08-23T20:54:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-04-nov-2019/diagnostico-e-tratamento-em-gliomas-qual-o-cenario-atual.html]]></loc><lastmod>2020-05-11T00:43:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-04-nov-2019/imunoterapia-na-oncologia-gastrointestinal-qual-o-cenario-atual.html]]></loc><lastmod>2021-02-12T16:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-i-numero-04-nov-2019/radioterapia-apos-neoadjuvancia---quando-indicar-apos-mastectomia.html]]></loc><lastmod>2020-05-11T00:38:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-ii-numero-06-fev-2021.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-ii-numero-06-fev-2021/como-garantir-a-fertilidade-durante-e-apos-o-tratamento-do-cancer.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-ii-numero-06-fev-2021/disbiose-microbiana-oral-e-cancer---quais-as-evidencias.html]]></loc><lastmod>2021-03-15T04:04:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-ii-numero-06-fev-2021/qual-o-papel-da-prostatectomia-no-tratamento-do-cancer-de-prostata-oligometastatico.html]]></loc><lastmod>2021-03-26T21:19:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-ii-numero-06-fev-2021/relacao-existente-entre-microbioma-e-ccr-revisao-e-meta-analise.html]]></loc><lastmod>2021-04-26T02:42:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-ii-numero-06-fev-2021/rastreamento-do-cancer-do-colo-do-utero-como-avancar.html]]></loc><lastmod>2021-10-19T16:33:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-ii-numero-06-fev-2021/neutropenia-no-paciente-oncologico-como-prevenir-como-tratar.html]]></loc><lastmod>2021-03-01T04:49:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-ii-numero-06-fev-2021/cirurgia-oncoplastica-novas-abordagens-o-que-sabemos.html]]></loc><lastmod>2021-03-01T04:50:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/revista-index-onconews/todas-edicoes-index-onconews/vol-ii-numero-06-fev-2021/terapia-primaria-no-cancer-de-mama-inicial-existe-consenso-sobre-a-melhor-abordagem.html]]></loc><lastmod>2021-03-03T15:34:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/osimertinibe-mostra-beneficio-no-snc-em-pacientes-com-cpcnp-localmente-avancado-egfrm.html]]></loc><lastmod>2025-05-05T00:02:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/osimertinibe-ganha-indicacao-no-cpcnp-irressecavel-com-mutacao-egfr-apos-quimiorradioterapia.html]]></loc><lastmod>2025-05-05T00:42:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/flaura-2-adicao-de-osimertinibe-a-quimioterapia-aumenta-slp-no-cancer-de-pulmao-avancado.html]]></loc><lastmod>2024-10-28T15:28:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/combinacao-de-tremelimumabe-durvalumabe-e-quimioterapia-e-aprovada-como-primeira-linha-no-cpcnpm.html]]></loc><lastmod>2024-09-11T18:52:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/enfortumabe-vedotina-muda-a-pratica-no-carcinoma-urotelial-localmente-avancado-ou-metastatico.html]]></loc><lastmod>2024-04-30T23:08:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/adaura-osimertinibe-adjuvante-aumenta-sobrevida-global-no-cpcnp.html]]></loc><lastmod>2024-04-30T23:09:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/empower-lung-3-resultados-de-longo-prazo-confirmam-beneficio-de-sobrevida-com-cemiplimabe-no-cancer-de-pulmao.html]]></loc><lastmod>2023-04-25T23:44:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/o-papel-dos-biomarcadores-no-tratamento-do-cancer-gastrico-avancado.html]]></loc><lastmod>2023-03-20T13:16:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/analises-de-subgrupo-de-trastuzumabe-deruxtecana-no-cancer-de-mama-her2-low-metastatico-e-ou-irressecavel.html]]></loc><lastmod>2023-01-19T00:17:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/dados-atualizados-de-t-dxd-em-comparacao-com-t-dm1-na-segunda-linha-de-cancer-de-mama-her2-positivo-metastatico-ou-irressecavel.html]]></loc><lastmod>2023-01-19T00:13:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/t-dxd-mostra-superioridade-em-comparacao-com-quimioterapia-em-pacientes-previamente-tratados-com-t-dm1-apos-segunda-linha-de-cancer-de-mama-her2-positivo-metastatico-ou-irressecavel.html]]></loc><lastmod>2023-01-19T00:31:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/ikema-analise-de-subgrupos-mostra-resultados-de-isatuximabe-no-mieloma-multiplo-recidivado.html]]></loc><lastmod>2022-12-22T18:40:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/esmo-i-o-cemiplimabe-em-combinacao-mostra-beneficio-de-sobrevida-global-no-cancer-de-pulmao.html]]></loc><lastmod>2022-12-21T16:28:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/empower-lung-1-cemiplimabe-mostra-resultados-de-longo-prazo-no-cancer-de-pulmao-de-celulas-nao-pequenas-avancado.html]]></loc><lastmod>2022-10-22T17:26:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/isatuximabe-mostra-significativo-beneficio-de-slp-no-mieloma-multiplo.html]]></loc><lastmod>2022-10-16T19:15:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/adaura-resultados-de-longo-prazo-confirmam-osimertinibe-adjuvante-como-padrao-de-tratamento-no-cpcnp.html]]></loc><lastmod>2022-10-10T19:37:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cmed-define-preco-de-venda-de-nova-opcao-no-tratamento-do-cancer-urotelial.html]]></loc><lastmod>2022-10-02T19:05:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/durvalumabe-confirma-beneficio-no-cppc-e-reduz-risco-de-progressao-em-snc.html]]></loc><lastmod>2022-08-04T01:42:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/anvisa-aprova-enfortumabe-vedotina-no-cancer-urotelial-avancado.html]]></loc><lastmod>2022-05-24T22:10:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/anvisa-aprova-cemiplimabe-no-cancer-de-pulmao.html]]></loc><lastmod>2022-05-23T19:56:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/trastuzumabe-deruxtecana-mostra-dados-de-qualidade-de-vida-e-beneficio-em-snc.html]]></loc><lastmod>2022-05-15T20:56:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cmed-define-preco-para-isatuximabe-no-tratamento-de-mieloma-multiplo.html]]></loc><lastmod>2021-11-19T19:15:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/ixazomibe-mostra-resultados-historicos-no-tratamento-do-mieloma-multiplo.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/diagnostico-e-tratamento-da-doenca-veno-oclusiva-hepatica.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/imunoterapia-mostra-resultados-de-longo-prazo-no-carcinoma-de-celulas-de-merkel-metastatico-sp-187.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/novas-fronteiras-no-tratamento-do-cancer-de-mama-her-2.html]]></loc><lastmod>2024-06-06T00:16:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/tpex-e-opcao-eficaz-e-segura-no-cancer-de-cabeca-e-pescoco-2.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/abemaciclibe-indicacoes-e-evidencias-na-oncologia-mamaria.html]]></loc><lastmod>2021-04-05T01:19:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cemiplimabe-mostra-beneficio-no-cec-metastatico.html]]></loc><lastmod>2024-06-05T23:53:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/novo-paradigma-no-tratamento-do-carcinoma-urotelial.html]]></loc><lastmod>2021-01-12T14:54:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/nova-opcao-de-primeira-linha-no-cancer-renal-avancado-2.html]]></loc><lastmod>2020-08-18T21:07:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/mulheres-em-risco-para-sindrome-de-cancer-de-mama-e-ovario-hereditario-conhecendo-o-lado-psicossocial.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/neoadjuvancia-em-cancer-de-mama-com-receptores-hormonais-positivos-e-her2-negativo-o-que-considerar-na-decisao-clinica.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/a-terapia-neoadjuvante-melhora-os-resultados-em-pacientes-com-cancer-de-pancreas-ressecavel.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/sindrome-da-compressao-medular-uma-breve-revisao.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/preservacao-de-fertilidade-em-cancer-de-endometrio-para-quem-e-como.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/sindrome-de-lise-tumoral-uma-breve-revisao.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/impacto-das-assinaturas-imunologicas-na-sobrevida-de-pacientes-com-glioblastomas.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/sequenciamento-de-cfdna-no-cancer-colorretal.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cirurgia-primaria-ou-qt-neoadjuvante-no-cancer-de-ovario.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/rastreamento-do-cancer-colorretal.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/primum-non-nocere-os-resultados-do-portec-3-e-gog-258.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cancer-de-pulmao-de-pequenas-celulas-novos-alvos-novas-perspectivas.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/o-papel-do-rechallenge-no-cpnpc.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/esofagectomia-de-resgate-status-atual-na-era-da-neoadjuvancia-cross-trial.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/anticorpos-anti-egfr-para-carcinomas-escamosos-de-pulmao---tarde-demais.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/subtipos-moleculares.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/interacoes-medicamentosas-em-cuidados-paliativos.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/tratamento-neoadjuvante-no-cancer-de-pulmao-localmente-avancado-estadio-iii-quando-e-como.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estrategias-para-vencer-a-resistencia-a-terapia-anti-her2.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/preservacao-da-fertilidade-e-cancer-de-ovario.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/ha-beneficio-da-quimioterapia-no-cancer-de-endometrio-precoce.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/imunoterapia-em-tumores-gastroesofagicos---cenario-atual-e-perspectivas-futuras.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/carcinoma-urotelial-de-bexiga-metastatico-tratamento-atual-e-novas-perspectivas.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/antiangiogenicos-no-cancer-epitelial-de-ovario.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/hepatocarcinoma-limitacoes-e-avancos-terapeuticos-na-doenca-metastatica.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cancer-de-pancreas---tratamento-da-doenca-localizada-passado-presente-e-futuro.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estimativa-de-mortes-prematuras-por-falta-de-acesso-a-terapia-anti-her2-para-cancer-de-mama-avancado-no-sistema-publico-de-saude-brasileiro.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/hipofracionamento-no-cancer-de-prostata.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/avaliacao-do-grau-histologico-pre-operatorio-no-cancer-de-endometrio.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cancer-de-mama-na-52-asco.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drenagem-pos-esvaziamento-axilar-no-cancer-de-mama.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/imaginologia-no-diagnostico-e-estadiamento-do-cancer-de-prostata.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/programa-de-prevencao-continua-do-melanoma.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/especialistas-brasileiros-e-os-destaques-da-ginecologia-oncologica.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cirurgia-minimamente-invasiva-em-gist-gastrico-limites-e-indicacoes.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/sgo-annual-meeting-sob-o-prisma-do-oncologista-clinico.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cancer-de-prostata-resistente-a-castracao-enzalutamida-e-abiraterona-pre-quimioterapia.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/review-prostata-qual-o-papel-da-radioterapia-na-doenca-localizada-ou-no-tumor-localmente-avancado.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/fatores-prognosticos-do-cancer-de-ovario-epitelial-recidivado.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/patologia-do-cancer-de-prostata.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/neoplasia-esofago-gastrica.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/carcinoma-de-nasofaringe-localmente-avancado.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/debates-no-manejo-de-tumores-neuroendocrinos.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/terapia-alvo-imunoterapia-e-cancer.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/avancos-no-tratamento-do-carcinoma-urotelial-de-bexiga-metastatico.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/transplante-autologo-de-celulas-tronco-hematopoeticas-em-mieloma-multiplo.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/linfoma-de-hodgkin.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/leucemia-mieloide-aguda.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/linfoma-difuso-de-grandes-celulas-b-tratamento-da-recaida.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/uma-visao-da-leucemia-promielocitica-aguda.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/tratamento-de-primeira-linha-no-mieloma-multiplo.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/fatores-de-prognostico-no-mieloma-multiplo.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/terapia-hormonal-adjuvante-em-carcinoma-epitelial-de-ovario.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/tratamento-adjuvante-do-cancer-de-colon-o-que-ja-sabemos-e-onde-queremos-chegar.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/alteracoes-geneticas-e-o-papel-das-novas-tecnologias-na-abordagem-do-mieloma-multiplo.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/diagnostico-e-tratamento-de-tumores-neuroendocrinos-do-trato-digestivo.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/imunoterapia-em-cancer-de-pulmao.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/radioterapia-no-tratamento-paliativo-do-cancer.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/reabilitacao-e-exercicios-de-fortalecimento-muscular-em-pacientes-operadas-por-cancer-de-mama.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/canceres-ginecologicos-novidades-do-congresso-europeu-2015.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/linfedema-secundario-ao-tratamento-oncologico.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/pos-asco-2015---ginecologia-oncologica.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/as-recomendacoes-de-st-gallen-no-cancer-de-mama-inicial.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cancer-oral-cenario-atual-desafios-e-perspectivas.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/incontinencia-urinaria-pos-prostatectomia.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/farmacovigilancia-na-oncologia-quais-as-recomendacoes.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/atualizacao-terapeutica-adenocarcinoma-de-esofago-e-de-transicao-esofago-gastrica---tratamento-multimodal-e-tatica-cirurgica.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/controversias-no-glioma-difuso-de-baixo-grau.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cancer-e-obesidade-qual-a-evidencia.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/a-fisioterapia-na-oncologia-e-o-valor-da-evidencia.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade-no-tratamento-de-adultos-com-cancer-como-abordar.html]]></loc><lastmod>2020-05-02T04:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-os-efeitos-catastroficos-da-cromotripsia-no-cancer.html]]></loc><lastmod>2026-01-15T13:54:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/acetilacao-e-autofagia-no-cancer-funcoes-e-potencial-terapeutico.html]]></loc><lastmod>2025-12-15T20:31:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-relacao-entre-disbiose-inflamacao-e-a-carcinogenese-do-cancer-colorretal.html]]></loc><lastmod>2025-12-05T14:17:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-splicing-alternativo-2.html]]></loc><lastmod>2025-11-26T11:05:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-interacao-entre-os-checkpoints-imunologicos-e-seus-ligantes.html]]></loc><lastmod>2025-11-18T02:44:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/simplificando-a-compreensao-da-epigenetica.html]]></loc><lastmod>2025-11-11T19:52:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-diferenca-entre-transicoes-e-transversoes-nas-mutacoes-de-dna.html]]></loc><lastmod>2025-11-03T17:14:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-papel-da-citrulinacao-de-proteinas-no-cancer.html]]></loc><lastmod>2025-10-27T12:58:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-proteina-her2-como-biomarcador-do-cancer-urotelial.html]]></loc><lastmod>2025-10-14T20:15:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/especial-nobel-de-medicina-2025.html]]></loc><lastmod>2025-10-07T13:18:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/modelos-de-ativacao-de-receptores-associados-a-tirosina-quinase.html]]></loc><lastmod>2025-10-02T12:18:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-bioinformatica-2.html]]></loc><lastmod>2025-09-25T02:28:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-papel-dos-exossomos-na-terapia-direcionada-contra-o-cancer.html]]></loc><lastmod>2025-09-15T18:28:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-tecnica-de-hibridizacao-in-situ-por-fluorescencia-fish.html]]></loc><lastmod>2025-09-08T00:03:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-as-adaptacoes-biologicas-das-celulas-malignas-a-hipoxia.html]]></loc><lastmod>2025-08-25T16:51:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-processo-de-transicao-epitelial-mesenquimal-tem.html]]></loc><lastmod>2025-08-14T20:47:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/revisitando-os-principais-mecanismos-epigeneticos-de-regulacao-genica.html]]></loc><lastmod>2025-08-01T21:19:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-como-as-celulas-car-t-exercem-a-necroptose-destruicao-das-celulas-tumorais.html]]></loc><lastmod>2025-07-23T17:09:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-os-exossomos-como-biomarcadores-tumorais-veiculos-e-alvos-terapeuticos.html]]></loc><lastmod>2025-07-16T18:24:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-baixa-positividade-de-her2-dos-canceres-em-geral.html]]></loc><lastmod>2025-07-10T19:10:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-ativacao-das-vias-jnk-e-nf-kb.html]]></loc><lastmod>2025-06-26T16:16:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-desregulacao-dos-mirna-no-cancer.html]]></loc><lastmod>2025-06-17T18:07:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-biomarcador-trop2-qcs.html]]></loc><lastmod>2025-06-09T14:12:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-as-areas-de-atuacao-de-cada-omica.html]]></loc><lastmod>2025-05-21T18:55:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-microbiota-intestinal-e-seu-papel-imunologico.html]]></loc><lastmod>2025-05-14T02:21:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-heterogeneidade-intratumoral-imune-e-sua-relacao-com-a-resposta-a-imunoterapia.html]]></loc><lastmod>2025-05-07T20:59:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-via-de-sinalizacao-pi3k-akt-mtor.html]]></loc><lastmod>2025-04-29T11:45:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-uso-da-tecnologia-de-celulas-unicas-na-oncologia-de-precisao.html]]></loc><lastmod>2025-04-16T21:37:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-as-diferencas-entre-o-dna-nuclear-e-o-dna-mitocondrial.html]]></loc><lastmod>2025-04-02T17:55:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-primeiro-atlas-metilomico.html]]></loc><lastmod>2025-03-14T19:16:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-hipoxia-tumoral-como-fator-de-instabilidade-genomica.html]]></loc><lastmod>2025-02-24T02:17:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-rna-de-interferencia-rnai-e-sua-regulacao-da-expressao-genica.html]]></loc><lastmod>2025-02-05T19:47:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-expansao-e-ativacao-de-celulas-nk-para-imunoterapia.html]]></loc><lastmod>2024-12-20T17:23:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-os-quatro-niveis-estruturais-de-uma-proteina.html]]></loc><lastmod>2024-12-12T19:49:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-modelo-de-dois-eventos-dos-genes-supressores-de-tumores.html]]></loc><lastmod>2024-12-03T12:58:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-apoptose.html]]></loc><lastmod>2024-11-21T10:31:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/uso-de-crispr-cas9-na-edicao-genomica-triagens-geneticas-e-modulacao-da-expressao-genica.html]]></loc><lastmod>2024-11-06T21:31:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-funcao-dos-primers-na-sintese-de-dna.html]]></loc><lastmod>2024-10-29T14:19:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-os-genes-do-sistema-hla.html]]></loc><lastmod>2024-10-03T18:34:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-reacao-em-cadeia-da-polimerase-pcr.html]]></loc><lastmod>2024-09-17T21:16:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/reclassificando-as-celulas-b-e-ressignificando-seu-papel-no-cancer.html]]></loc><lastmod>2024-09-03T21:18:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-cancer-de-mama-hereditario-alem-dos-genes-brca.html]]></loc><lastmod>2024-08-28T20:43:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/revisitando-o-panorama-genomico-do-cancer-colorretal.html]]></loc><lastmod>2024-08-19T21:48:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-as-mutacoes-por-insercoes-alu.html]]></loc><lastmod>2024-08-01T18:21:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-as-funcoes-do-gene-tp53.html]]></loc><lastmod>2024-06-28T21:18:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-os-conceitos-basicos-da-genomica-do-cancer.html]]></loc><lastmod>2024-06-18T16:50:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-risco-de-cancer-pela-metilacao-do-promotor-de-brca1.html]]></loc><lastmod>2024-06-05T21:15:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-os-oligonucleotideos-antisenso.html]]></loc><lastmod>2024-05-22T14:19:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-biópsia-líquida-por-ctdna.html]]></loc><lastmod>2024-05-14T17:49:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-splicing-alternativo.html]]></loc><lastmod>2025-11-25T17:51:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-os-mecanismos-de-ativacao-genica-sp-829.html]]></loc><lastmod>2024-05-14T23:02:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/celulas-dendriticas-imunidade-antitumoral-e-imunoterapia.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/translocacao-entre-os-cromossomos-8-e-14-c-myc-e-linfoma-de-burkitt.html]]></loc><lastmod>2024-03-26T16:06:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-os-rnas-circulares.html]]></loc><lastmod>2024-03-12T19:39:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/microbioma-e-resposta-tumoral-a-imunoterapia.html]]></loc><lastmod>2024-03-07T13:42:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-controle-da-expressao-genica-pelos-micrornas.html]]></loc><lastmod>2024-02-21T21:05:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-as-sondas-de-dna-e-suas-aplicacoes.html]]></loc><lastmod>2024-01-24T21:33:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/incidencia-de-variantes-genomicas-direcionadoras-de-tratamento-no-projeto-100-mil-genomas.html]]></loc><lastmod>2024-01-17T17:32:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-papel-oncogenico-da-hmga2.html]]></loc><lastmod>2023-11-24T11:36:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-genetica-populacional.html]]></loc><lastmod>2023-10-31T19:40:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/parg-e-seu-potencial-onco-terapeutico.html]]></loc><lastmod>2023-10-03T19:42:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-regulacao-da-longevidade-das-proteinas-pelo-sistema-ubiquitina-proteassoma.html]]></loc><lastmod>2023-09-26T12:11:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-como-modificacoes-do-mrna-regulam-a-sintese-proteica-o-modelo-da-disqueratose-congenita.html]]></loc><lastmod>2023-09-15T18:15:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-as-aneuploidias-e-seu-papel-na-carcinogenese.html]]></loc><lastmod>2023-09-05T12:49:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-controle-do-ciclo-celular-pelas-ciclinas.html]]></loc><lastmod>2023-08-17T23:40:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/novos-biomarcadores-baseados-em-neoantigenos-frameshift-avaliam-resposta-e-toxicidade-aos-inibidores-de-checkpoint-no-cancer-de-pulmao.html]]></loc><lastmod>2023-07-31T12:45:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/avaliacao-genetica-dos-ovulos-pre-fertilizacao-para-prevencao-de-sindromes-de-cancer-hereditario.html]]></loc><lastmod>2023-07-11T12:42:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-funcao-dos-genes-rad51b-rad51c-rad51d-xrcc2-na-recombinacao-homologa.html]]></loc><lastmod>2023-06-27T16:43:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/identificacao-de-portadoras-de-variantes-patogenicas-de-brca1-2-atraves-de-micrornas-circulantes.html]]></loc><lastmod>2023-06-16T14:43:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/e-correto-afirmar-que-as-mutacoes-sinonimas-sao-sempre-silenciosas-ou-benignas.html]]></loc><lastmod>2023-05-28T16:25:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/pangenoma-humano-uma-compreensao-mais-profunda-e-precisa-da-diversidade-genomica-mundial.html]]></loc><lastmod>2023-05-16T11:47:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/assinaturas-bioquimicas-de-controle-da-expressao-genica-identificadas-pelo-encode.html]]></loc><lastmod>2023-05-02T13:57:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/tecnologias-para-analise-do-perfil-molecular-tumoral-de-celula-unica.html]]></loc><lastmod>2023-04-18T13:16:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/efeitos-imunomodulatorios-do-oncogene-kras-e-seu-futuro-potencial-terapeutico.html]]></loc><lastmod>2023-03-31T16:49:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-genetica-reversa.html]]></loc><lastmod>2023-03-13T01:03:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-funcao-da-primase-e-do-primer-de-rna-na-sintese-de-dna.html]]></loc><lastmod>2023-02-15T15:15:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-as-variacoes-do-numero-de-copias-cnvs-do-nosso-genoma.html]]></loc><lastmod>2023-02-08T18:39:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-funcao-proofreading-da-dna-polimerase.html]]></loc><lastmod>2023-01-19T13:36:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/efeitos-imunossupressores-do-oncometabolito-d-2hg-em-tumores-com-mutacao-de-idh.html]]></loc><lastmod>2024-05-09T08:57:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/haveria-mais-algum-outro-gene-responsavel-pelo-cancer-de-mama-hereditario.html]]></loc><lastmod>2022-11-23T20:24:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/ensaio-logic-deteccao-de-alta-sensibilidade-da-mmr-d.html]]></loc><lastmod>2024-05-09T08:57:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/mutacoes-do-gene-rnf43-como-marcadores-de-sensibilidade-a-terapia-anti-braf-egfr-no-cancer-colorretal.html]]></loc><lastmod>2022-10-18T13:57:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/nova-classificacao-dos-meningiomas-baseada-em-marcadores-moleculares-e-suas-implicacoes-no-tratamento.html]]></loc><lastmod>2022-09-21T00:07:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-importancia-do-painel-germinativo-para-pacientes-com-cancer-de-pulmao.html]]></loc><lastmod>2022-08-24T21:50:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-relacao-da-metilacao-do-dna-com-o-cancer.html]]></loc><lastmod>2022-08-11T12:56:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/rna-mitocondrial-e-sua-correlacao-com-o-cancer-invasivo.html]]></loc><lastmod>2022-07-26T13:07:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-as-etapas-da-transcricao-e-da-traducao-genicas.html]]></loc><lastmod>2022-07-13T18:59:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-transposicao-genica-e-os-transposons.html]]></loc><lastmod>2022-06-29T18:50:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-via-keap1-nrf2-e-sua-funcao-no-cancer-de-pulmao.html]]></loc><lastmod>2022-06-17T16:53:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/funcao-das-enzimas-parp-e-toxicidade-hematologica-induzida-pelos-inibidores-de-parp-de-primeira-geracao.html]]></loc><lastmod>2022-05-24T13:30:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-as-inversoes-no-nosso-genoma.html]]></loc><lastmod>2022-05-17T18:25:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-as-mutacoes-de-reversao-do-gene-brca.html]]></loc><lastmod>2022-05-01T21:58:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-as-tecnologias-de-dna-recombinante.html]]></loc><lastmod>2022-04-11T12:28:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-genomica-dos-linfomas-double-hit-dhl.html]]></loc><lastmod>2022-04-04T00:31:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-acetilacao-de-histonas.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-diabody-um-anticorpo-dimerico-biespecifico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-bioinformatica.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-tecnologia-do-microarranjo-de-dna.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-via-de-transducao-de-sinais-de-um-gene.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/fda-reconhece-o-oncokb-como-o-primeiro-banco-de-dados-de-marcadores-tumorais.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-reacao-em-cadeia-da-polimerase.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-tecnica-fish.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-genoma-humano.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/gene-ambra1-autofagia-e-apoptose-celulares.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-codigo-genetico-universal-e-sua-leitura.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/mutacoes-de-insercao-do-exon-20-do-gene-egfr-no-cpcnp.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-transcricao-do-dna.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-os-polimorfismos-de-nucleotideo-unico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-funcao-dos-nucleossomos.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/rnas-nao-codificantes-longos.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-os-sistemas-de-reparo-do-dna.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-os-telomeros.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/sistemas-de-controle-de-ciclo-celular-sp-198.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-a-regulacao-da-expressao-genica.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/sequenciamento-genomico-de-celula-unica-em-oncologia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/gene-vhl-doenca-de-von-hippel-lindau-e-cancer-renal-secundario-sp-256.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/carga-mutacional-tumoral-e-sensibilidade-aos-inibidores-de-checkpoint.html]]></loc><lastmod>2021-04-20T13:54:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/rna-e-seus-subtipos-funcionais.html]]></loc><lastmod>2021-03-11T01:51:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/mutacoes-trk-xdfg-e-resistencia-aos-inibidores-trk.html]]></loc><lastmod>2021-03-10T16:54:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/tecnologias-de-sequenciamento-genetico-do-dna.html]]></loc><lastmod>2021-01-28T17:56:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/mutacao-de-sitio-splicing-do-exon-14-do-gene-met.html]]></loc><lastmod>2020-11-03T00:30:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/enzimas-apobec-no-mecanismo-de-edicao-do-mrna.html]]></loc><lastmod>2020-10-22T17:52:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-os-genes-dickkopf-dkk.html]]></loc><lastmod>2020-10-08T13:59:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/novas-variantes-geneticas-ligadas-ao-cancer-de-mama-masculino.html]]></loc><lastmod>2020-09-30T15:07:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/mutacoes-do-gene-errb2-como-novo-alvo-terapeutico.html]]></loc><lastmod>2020-08-24T22:35:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/nrg1-como-novo-alvo-terapeutico.html]]></loc><lastmod>2020-08-10T04:50:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/trop-2-como-novo-alvo-terapeutico.html]]></loc><lastmod>2020-07-27T00:50:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/como-funciona-a-vacina-de-oxford.html]]></loc><lastmod>2020-07-20T19:44:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/mutacoes-de-insercao-do-exon-20-do-egfr.html]]></loc><lastmod>2020-07-14T18:22:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/o-que-sao-pontuacoes-de-risco-poligenico.html]]></loc><lastmod>2020-07-02T19:54:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/mutacoes-cromossomicas.html]]></loc><lastmod>2020-05-25T01:35:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-o-gene-ret-e-suas-alteracoes.html]]></loc><lastmod>2020-05-18T20:08:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/os-gist-s-podem-ser-hereditarios.html]]></loc><lastmod>2020-05-07T22:44:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/entendendo-as-diferencas-entre-as-mutacoes-somaticas-direcionadoras-e-de-passagem.html]]></loc><lastmod>2020-04-25T01:44:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/a-genomica-de-precisao-como-ferramenta-para-a-identificacao-molecular-prognostica-da-covid-19.html]]></loc><lastmod>2020-04-13T23:17:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/a-importancia-da-epigenetica-em-tempos-de-covid-19.html]]></loc><lastmod>2020-03-22T15:50:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/como-se-caracteriza-a-sindrome-da-neoplasia-hereditaria-multilocus-minas.html]]></loc><lastmod>2020-04-13T23:18:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/o-que-sao-micro-rna-s-e-quais-as-suas-aplicacoes-na-genomica-do-cancer.html]]></loc><lastmod>2020-03-09T14:36:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/pcr-digital-em-gotas-dd-pcr.html]]></loc><lastmod>2020-01-31T16:24:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/splicing-e-mutacoes-no-sitio-de-splicing-o-que-sao.html]]></loc><lastmod>2020-02-09T23:47:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/como-classificamos-as-mutacoes-genicas-2.html]]></loc><lastmod>2020-01-14T14:17:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/perda-de-heterozigose-loh-o-que-e.html]]></loc><lastmod>2019-11-21T13:17:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/o-que-e-mosaicismo.html]]></loc><lastmod>2019-11-18T15:17:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/drops-de-genomica/o-conceito-de-hereditariedade.html]]></loc><lastmod>2019-11-08T23:18:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/hcor-inicia-recrutamento-de-pacientes-para-estudo-que-compara-crioablacao-com-cirurgia-no-cancer-de-mama-inicial.html]]></loc><lastmod>2025-06-27T20:27:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/pesquisa-brasileira-com-participacao-da-iarc-busca-aprimorar-conhecimentos-para-a-prevencao-do-cancer.html]]></loc><lastmod>2025-05-19T17:49:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/pesquisa-do-icesp-tem-foco-no-controle-da-dor-oncologica.html]]></loc><lastmod>2025-05-19T17:41:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/mirpanc-2-pesquisa-brasileira-com-biopsia-liquida-espera-aprimorar-o-tratamento-do-cancer-de-pancreas.html]]></loc><lastmod>2025-04-28T20:41:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/crioablacao-versus-cirurgia-de-mama-no-tratamento-local-do-cancer-de-mama-inicial.html]]></loc><lastmod>2025-04-02T16:08:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/padroes-de-tratamento-do-cancer-de-mama-rh-no-brasil.html]]></loc><lastmod>2025-04-02T15:43:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/antares-terapia-agnostica-em-tumores-raros.html]]></loc><lastmod>2025-02-03T14:32:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/pesquisa-do-icesp-avalia-prostatectomia-laparoscopica-parcial-para-cancer-de-prostata-de-risco-intermediario.html]]></loc><lastmod>2024-11-08T18:38:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/a-realidade-do-carcinoma-hepatocelular-no-brasil-bra-hep.html]]></loc><lastmod>2024-06-13T13:47:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/onco-genomas-brasil-mapeando-o-cancer-no-sistema-publico-de-saude.html]]></loc><lastmod>2024-06-13T13:59:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/madonna-caracterizacao-molecular-e-epidemiologica-do-cancer-endometrial-no-brasil.html]]></loc><lastmod>2024-06-13T13:46:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/estudo-brasileiro-de-mundo-real-avalia-t-dxd-no-tnbc-avancado.html]]></loc><lastmod>2024-02-02T13:36:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/cchoww-quimiorradiacao-e-quimioterapia-de-consolidacao-com-ou-sem-oxaliplatina-no-cancer-de-reto-distal-e-watch-and-wait.html]]></loc><lastmod>2022-08-16T19:12:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/estudo-de-mundo-real-deve-retratar-o-cenario-do-cancer-de-mama-rh-her2-no-brasil.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/brazilian-total-neoadjuvant-therapy-trial.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/microendoscopia-na-prevencao-do-cancer-cervical.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/qualidade-de-vida-apos-o-cancer-de-mama-desafios-e-perspectivas.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/pacific-brasil-inicia-recrutamento.html]]></loc><lastmod>2021-03-10T13:18:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/intervencao-mindfulness-em-pacientes-com-cancer-renal-metastatico.html]]></loc><lastmod>2021-01-28T20:59:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/c-post-pesquisa-com-cemiplimab-no-carcinoma-espinocelular-de-alto-risco-esta-aberta-a-participacao-brasileira.html]]></loc><lastmod>2020-10-19T03:02:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/estudo-brasileiro-discute-neoadjuvancia-e-sobrevida-no-cancer-retal.html]]></loc><lastmod>2020-07-16T14:46:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/explore-polimorfismo-e-farmacodinamica-no-cancer-de-prostata.html]]></loc><lastmod>2020-03-06T14:43:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/projeto-canopy-inicia-recrutamento-de-pacientes-com-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:51:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/sabr-imunoterapia-no-cancer-de-pulmao-inicial.html]]></loc><lastmod>2020-04-24T19:52:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/microbioma-e-infeccoes-respiratorias-na-oncohematologia.html]]></loc><lastmod>2020-03-02T02:11:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/estudo-multicentrico-avalia-anticorpo-droga-conjugado-no-cancer-de-mama-her2.html]]></loc><lastmod>2020-03-02T02:10:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/icesp-investiga-neoadjuvancia-no-cancer-de-prostata.html]]></loc><lastmod>2020-02-27T19:50:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/brasil-estuda-biomarcadores-no-cancer-de-prostata.html]]></loc><lastmod>2020-03-03T11:37:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/estudos-clinicos/carboplatina-neoadjuvante-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2020-03-03T11:36:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/incidencia-fatores-de-risco-e-mortalidade-por-fibrilacao-atrial-no-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/cancer-de-mama-e-risco-cardiovascular.html]]></loc><lastmod>2022-04-18T13:54:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/cancer-de-mama-e-fatores-de-risco-cardiometabolicos.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/pronounce-seguranca-cardiovascular-de-degarelix-versus-leuprolida-em-pacientes-com-cancer-de-prostata.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/impacto-do-diagnostico-de-cancer-nas-causas-e-resultados-de-pacientes-com-internacoes-cardiovasculares.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/toxicidade-cardiaca-e-ciclofosfamida-pos-transplante-alogenico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/saude-cardiaca-e-risco-de-cancer.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/seguranca-cardiaca-de-osimertinibe.html]]></loc><lastmod>2021-01-31T16:33:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/anticoagulantes-orais-diretos-em-pacientes-com-cancer-ativo.html]]></loc><lastmod>2020-11-24T16:25:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/terapia-hormonal-em-pacientes-idosas-com-cancer-de-mama-e-risco-cardiovascular.html]]></loc><lastmod>2020-10-04T18:34:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/disfuncao-miocardica-em-sobreviventes-de-cancer-de-mama-precoce.html]]></loc><lastmod>2020-08-23T23:01:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/estratificacao-de-risco-cardiovascular-em-pacientes-com-cancer.html]]></loc><lastmod>2020-07-26T17:51:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/covid-19-a-racionalizacao-dos-atendimentos-e-os-dilemas-medicos.html]]></loc><lastmod>2020-05-10T19:21:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/prevencao-de-tromboembolismo-venoso-na-clinica-ambulatorial-de-cancer.html]]></loc><lastmod>2020-04-12T18:34:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/atualizacao-cientifica/cardiotoxicidade/cardiotoxicidade-no-tratamento-do-cancer-de-mama-her2-como-reduzir.html]]></loc><lastmod>2020-03-18T14:22:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025.html]]></loc><lastmod>2025-01-21T21:32:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025.html]]></loc><lastmod>2025-01-21T21:33:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/breakwater-pesquisa-atinge-importante-endpoint-primario-no-cancer-colorretal-metastatico-braf-v600e.html]]></loc><lastmod>2025-01-29T12:30:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/checkmate-8hw-resultados-de-eficacia-projetam-nivo-ipi-como-potencial-tratamento-padrao-no-cancer-colorretal-metastatico-msi-h-dmmr.html]]></loc><lastmod>2025-03-28T12:23:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/bespoke-crc-analise-final-confirma-valor-prognostico-de-ctdna-no-cancer-colorretal.html]]></loc><lastmod>2025-01-25T21:14:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/calgb-swog-80702-papel-prognostico-e-preditivo-do-ctdna-no-cancer-de-colon-estagio-iii-tratado-com-celecoxib.html]]></loc><lastmod>2025-01-25T20:17:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/alascca-estudo-randomizado-confirma-que-aspirina-reduz-o-risco-de-recorrencia-do-cancer-colorretal.html]]></loc><lastmod>2025-02-02T18:31:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/cao-aro-aio-12-e-opra-analise-agrupada-reforca-beneficio-do-watch-and-wait-no-cancer-retal-localmente-avancado.html]]></loc><lastmod>2025-01-30T13:38:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/lapis-estudo-global-falha-mas-pode-influenciar-pesquisas-futuras-no-cancer-de-pancreas.html]]></loc><lastmod>2025-01-25T16:37:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/virus-oncolitico-e-promessa-no-cancer-de-esofago.html]]></loc><lastmod>2025-01-25T16:25:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/estudo-brasileiro-avalia-impacto-do-atraso-da-cirurgia-no-cancer-de-reto-localizado.html]]></loc><lastmod>2025-01-25T20:27:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/cap-ace-mostra-resultados-no-carcinoma-hepatocelular-irressecavel.html]]></loc><lastmod>2025-01-24T17:22:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/conquer-cancer-premia-pesquisadores-brasileiros-no-asco-gi-2025.html]]></loc><lastmod>2025-01-25T21:26:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/destiny-gastric03-atualiza-resultados-de-eficacia-e-seguranca.html]]></loc><lastmod>2025-01-23T19:39:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/solar-olaparibe-mostra-atividade-em-pacientes-com-adenocarcinoma-esofagogastrico-avancado.html]]></loc><lastmod>2025-01-23T19:41:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/estudo-avalia-valor-clinico-e-barreiras-ao-uso-de-novos-agentes-e-alvos-moleculares.html]]></loc><lastmod>2025-01-24T14:52:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/gaspar-estudo-analisa-caracteristicas-epidemiologicas-dos-tumores-de-estomago-e-pancreas-na-america-latina.html]]></loc><lastmod>2025-01-25T17:06:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/impacto-do-subtipo-difuso-de-lauren-no-prognostico-do-cancer-gastrico-localmente-avancado.html]]></loc><lastmod>2025-01-27T18:41:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/combinacao-de-everolimus-e-lanreotida-aumenta-slp-de-pacientes-com-tumores-neuroendocrinos-gastroenteropancreaticos.html]]></loc><lastmod>2025-01-26T22:38:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gi-2025/novo-teste-de-sangue-e-promessa-para-o-rastreamento-do-cancer-colorretal.html]]></loc><lastmod>2025-01-21T23:08:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025.html]]></loc><lastmod>2025-01-21T22:28:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/talapro-2-mostra-ganho-de-sg-com-talazoparibe-e-enzalutamida-no-cprcm.html]]></loc><lastmod>2025-02-15T17:38:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/epic-a-resultados-apoiam-cemiplimabe-qt-como-opcao-de-primeira-linha-no-cancer-de-penis-avancado.html]]></loc><lastmod>2025-02-14T23:53:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/cotrims-rplnd-mostra-altas-taxas-de-cura-no-seminoma-metastatico.html]]></loc><lastmod>2025-02-14T23:47:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/biomarcador-e-prognostico-do-beneficio-da-imunoterapia-adjuvante-no-rcc.html]]></loc><lastmod>2025-02-14T23:44:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/checkmate-9er-dados-de-longo-prazo-confirmam-eficacia-de-nivolumabe-cabozantinibe-no-rcc-avancado.html]]></loc><lastmod>2025-02-14T23:35:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/fksi-23-novo-questionario-de-qvrs-no-carcinoma-de-celulas-renais.html]]></loc><lastmod>2025-02-15T00:25:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/necrose-extensa-como-indicador-prognostico-no-rcc-metastatico-apos-ici.html]]></loc><lastmod>2025-02-14T23:17:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/adapt-bladder-avalia-combo-com-imunoterapia-no-cancer-de-bexiga.html]]></loc><lastmod>2025-02-14T15:16:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/forager-1-estudo-de-fase-1-apresenta-resultados-de-atividade-clinica.html]]></loc><lastmod>2025-02-14T15:15:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/combinacao-de-qt-com-durvalumabe-neoadjuvante-mostra-eficacia-no-carcinoma-urotelial-do-trato-superior-de-alto-risco.html]]></loc><lastmod>2025-02-17T16:53:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/pesquisa-brasileira-investiga-perfil-imunologico-e-inflamatorio-no-cancer-de-bexiga.html]]></loc><lastmod>2025-02-14T21:41:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/estudo-valida-pontuacao-portos-como-preditor-de-resposta-a-dose-da-radioterapia-no-cancer-de-prostata.html]]></loc><lastmod>2025-02-16T13:05:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/stampede-mostra-resultados-de-adesivos-de-estradiol-transdermico-arpis-no-cancer-de-prostata.html]]></loc><lastmod>2025-02-13T15:31:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/talapro-2-apresenta-resultados-finais-de-sobrevida-global-em-pacientes-com-hrr-deficiente.html]]></loc><lastmod>2025-02-14T14:09:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/capfish-3-dieta-rica-em-omega-3-e-pobre-em-omega-6-com-oleo-de-peixe-no-cancer-de-prostata-em-vigilancia-ativa.html]]></loc><lastmod>2025-02-13T18:57:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/enza-p-lupsma-mostra-resultados-da-combinacao-com-enzalutamida-no-cancer-de-prostata.html]]></loc><lastmod>2025-02-13T14:45:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/associacao-entre-terapia-de-privacao-androgenica-e-ira.html]]></loc><lastmod>2025-02-13T17:42:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/vision-177lu-psma-617-e-arpis-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2025-02-13T15:21:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-gu-2025/estudo-avalia-expansao-de-dose-de-mevrometostat-em-combinacao-com-enzalutamida-no-cprcm.html]]></loc><lastmod>2025-02-11T15:26:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025.html]]></loc><lastmod>2025-03-26T13:14:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/aegean-dados-relatados-pelos-pacientes-apoiam-qualidade-de-vida-com-durvalumabe-no-cpcnp.html]]></loc><lastmod>2025-04-03T13:02:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/laura-osimertinibe-continua-a-mostrar-tendencia-de-beneficio-de-sg.html]]></loc><lastmod>2025-03-28T17:00:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/pesquisadores-desenvolvem-escore-de-risco-para-prever-complexidade-cirurgica-no-cancer-de-pulmao.html]]></loc><lastmod>2025-03-28T16:49:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/estudo-valida-escore-de-malignidade-de-nodulo-pulmonar-definido-por-ia-na-previsao-do-risco-de-cancer-de-pulmao.html]]></loc><lastmod>2025-04-03T13:02:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/estudo-avalia-impacto-prognostico-de-sistema-de-classificacao-de-stas-no-adenocarcinoma-nao-mucinoso-invasivo-estagio-i.html]]></loc><lastmod>2025-03-28T09:59:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/lung-heart-impacto-da-dose-da-subestrutura-cardiaca-em-pacientes-com-cpcnp-em-estagio-inicial-tratados-com-sabr.html]]></loc><lastmod>2025-03-28T09:25:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/sakk-16-14-durvalumabe-perioperatorio-mostra-100-de-sg-em-5-anos-no-cpcnp-em-pacientes-com-pcr.html]]></loc><lastmod>2025-03-28T12:27:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/adriatic-durvalumabe-de-consolidacao-melhora-resultados-no-cppc-com-doenca-extensa.html]]></loc><lastmod>2025-03-28T21:38:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/ia-valor-preditivo-de-sobrevida-a-longo-prazo-no-cpcnp.html]]></loc><lastmod>2025-03-28T12:26:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/fenotipos-invasivos-e-metastaticos-em-tumores-neuroendocrinos-pulmonares.html]]></loc><lastmod>2025-03-28T12:29:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/status-socioeconomico-e-resultados-no-cancer-de-pulmao-uma-perspectiva-de-duas-decadas-no-brasil.html]]></loc><lastmod>2025-03-28T12:25:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/preditores-de-adesao-ao-tumor-board-multidisciplinar-de-tumores-em-pacientes-com-cpcnp-estagio-iii.html]]></loc><lastmod>2025-03-27T10:01:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/elcc-2025/savannah-eficacia-e-seguranca-de-savo-osi-no-cpcnp.html]]></loc><lastmod>2025-03-26T14:39:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/aacr-2025.html]]></loc><lastmod>2025-04-27T21:25:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/aacr-2025/mortalidade-por-cancer-de-mama-em-mulheres-de-20-a-49-anos-diminui-significativamente-entre-2010-e-2020.html]]></loc><lastmod>2025-04-29T15:23:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/aacr-2025/pesquisa-com-sobreviventes-mostra-diferencas-entre-homens-e-mulheres-na-fadiga-e-depressao-relacionadas-ao-cancer.html]]></loc><lastmod>2025-04-29T18:49:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/aacr-2025/pesquisa-de-barretos-aposta-na-biopsia-liquida-para-a-deteccao-precoce-do-cancer-de-pulmao.html]]></loc><lastmod>2025-05-05T11:50:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/aacr-2025/estudo-com-populacoes-hispanicas-latinas-mostra-importancia-da-caracterizacao-multiomica-do-cancer-colorretal.html]]></loc><lastmod>2025-04-29T01:38:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/aacr-2025/estudo-brasileiro-avalia-a-heterogeneidade-genetica-intratumoral-no-cancer-retal-localmente-avancado.html]]></loc><lastmod>2025-05-02T20:31:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/aacr-2025/avaliacao-prognostica-dos-desfechos-de-sobrevida-em-longo-prazo-do-cancer-de-mama.html]]></loc><lastmod>2025-04-28T15:02:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/aacr-2025/biopsia-liquida-pode-detectar-recorrencia-antes-de-exames-de-imagem-em-pacientes-com-cancer-colorretal-ressecavel.html]]></loc><lastmod>2025-04-29T16:42:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/aacr-2025/zoldonrasib-induz-respostas-objetivas-e-e-nova-promessa-no-cpcnp-kras-g12d.html]]></loc><lastmod>2025-04-27T21:54:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/aacr-2025/modelos-de-ia-podem-aprimorar-diagnostico-do-cancer-de-pele-nao-melanoma-em-ambientes-com-recursos-limitados.html]]></loc><lastmod>2025-04-27T21:52:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/aacr-2025/modelo-baseado-em-ia-pode-melhorar-a-deteccao-da-caquexia-do-cancer.html]]></loc><lastmod>2025-04-27T21:53:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/aacr-2025/rastreamento-de-variantes-germinativas-patogenicas-em-genes-de-predisposicao-ao-cancer-de-prostata.html]]></loc><lastmod>2025-05-01T14:09:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025.html]]></loc><lastmod>2025-05-22T18:43:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/estudo-brasileiro-avalia-a-prevalencia-de-disfuncao-sexual-entre-homens-com-cancer-antes-do-inicio-do-tratamento-sistemico.html]]></loc><lastmod>2025-06-13T12:46:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/camizestranto-pode-representar-novo-paradigma-na-terapia-endocrina-no-cancer-de-mama-hr-positivo.html]]></loc><lastmod>2025-06-02T20:58:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/cemiplimabe-e-a-primeira-terapia-sistemica-a-reduzir-recorrencia-do-cec-de-alto-risco.html]]></loc><lastmod>2025-06-02T20:57:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/destiny-breast06-analise-exploratoria-avalia-biomarcadores-de-t-dxd-vs-qt-no-cancer-de-mama-metastatico-hr-her2-low-ultralow.html]]></loc><lastmod>2025-06-02T20:55:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/destiny-gastric04-analise-primaria-de-eficacia-confirma-beneficio-de-t-dxd-no-cancer-gastrico-avancado.html]]></loc><lastmod>2025-06-02T20:59:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/tropion-lung02-datopotamab-deruxtecan-pembro-no-tratamento-de-primeira-linha-do-cpcnp-avancado.html]]></loc><lastmod>2025-06-03T13:17:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/komet-eficacia-e-seguranca-de-selumetinibe-em-adultos-com-neurofibromatose-tipo-1-e-neurofibroma-plexiforme-sintomatico-e-inoperavel.html]]></loc><lastmod>2025-06-03T19:04:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/neoadaura-osimertinibe-neoadjuvante-mostra-resultados-no-cpcnp-egfrm-ressecavel.html]]></loc><lastmod>2025-06-05T15:10:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/challenge-estudo-mostra-impacto-de-programa-estruturado-de-atividade-fisica-na-sobrevida-de-pacientes-com-cancer-de-colon.html]]></loc><lastmod>2025-06-04T19:02:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/estudo-investiga-entendimento-do-proprio-prognostico-em-idosos-com-cancer-metastatico.html]]></loc><lastmod>2025-06-01T17:27:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/incidencia-de-cancer-de-inicio-precoce-aumenta-219-no-brasil-em-20-anos.html]]></loc><lastmod>2025-05-31T18:36:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/estudo-do-icesp-mostra-eficacia-de-mfolfirinox-como-estrategia-de-resgate-no-ccrm.html]]></loc><lastmod>2025-05-31T14:41:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/asco-2025/inteligencia-artificial-pode-melhorar-a-precisao-na-identificacao-de-canceres-de-mama-her2-low-e-her2-ultralow.html]]></loc><lastmod>2025-05-22T21:07:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025.html]]></loc><lastmod>2025-10-17T15:18:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/estudo-revela-aumento-expressivo-da-incidencia-de-cancer-entre-indigenas-brasileiros.html]]></loc><lastmod>2025-10-20T16:37:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/paclilin-estudo-mostra-que-acupuntura-alivia-sintomas-de-neuropatia-induzida-por-paclitaxel-em-pacientes-com-cancer-de-mama-inicial.html]]></loc><lastmod>2025-10-20T13:45:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/estudo-brasileiro-mostra-que-a-quimioterapia-durante-a-gestacao-pode-ser-segura-em-casos-de-cancer-de-mama-metastatico.html]]></loc><lastmod>2025-10-20T13:08:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/tropion-breast02-dato-dxd-mostra-eficacia-na-primeira-linha-do-cancer-de-mama-triplo-negativo-metastatico-inelegivel-a-imunoterapia.html]]></loc><lastmod>2025-10-21T17:19:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/destiny-breast09-resultados-mostram-t-dxd-como-nova-opcao-de-tratamento-de-1l-no-cancer-de-mama-avancado-metastatico-her2.html]]></loc><lastmod>2025-10-19T16:01:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/adc-direcionado-ao-ta-muc1-mostra-atividade-clinica-precoce-e-perfil-de-seguranca-manejavel-em-tumores-solidos-avancados.html]]></loc><lastmod>2025-10-20T02:03:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/analise-final-do-estudo-destiny-crc02-atualiza-resultados-de-t-dxd-no-cancer-colorretal-metastatico-her2.html]]></loc><lastmod>2025-10-19T14:43:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/destiny-gastric04-dados-adicionais-confirmam-eficacia-de-t-dxd-no-cancer-gastrico.html]]></loc><lastmod>2025-10-19T12:23:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/rejoice-ovarian01-raludotatug-deruxtecan-e-promessa-no-cancer-de-ovario-resistente-a-platina.html]]></loc><lastmod>2025-10-20T19:09:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/trabalho-de-parto-e-amamentacao-aumentam-imunidade-das-celulas-t-cd8-mamarias-e-protegem-contra-o-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2025-10-21T01:13:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/ceralasertibe-combinado-a-manutencao-com-durvalumabe-mostra-sobrevida-promissora-em-pacientes-com-cpcp-em-estagio-extenso.html]]></loc><lastmod>2025-10-18T12:28:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/destiny-breast11-regime-com-t-dxd-thp-alcanca-maior-resposta-patologica-completa-e-menor-toxicidade-em-pacientes-com-cancer-de-mama-inicial-her2-de-alto-risco.html]]></loc><lastmod>2025-10-18T08:50:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/northstar-estudo-aponta-beneficio-da-adicao-da-terapia-local-de-consolidacao-a-osimertinibe-no-cpcnp-metastatico-com-mutacao-de-egfr.html]]></loc><lastmod>2025-10-17T17:22:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/tropion-pantumor03-estudo-aponta-eficacia-promissora-da-combinacao-dato-dxd-rilvegostomig-no-cancer-urotelial-avancado.html]]></loc><lastmod>2025-10-17T16:39:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/matterhorn-durvalumabe-reduz-risco-de-morte-em-22-no-cancer-gastrico-ressecavel-e-pode-mudar-padrao-de-tratamento.html]]></loc><lastmod>2025-10-17T16:17:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/positive-seguimento-de-5-anos-aponta-seguranca-da-interrupcao-temporaria-da-hormonioterapia-para-gravidez-em-pacientes-com-cancer-de-mama-rh.html]]></loc><lastmod>2025-10-17T15:17:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/esmo-2025/uma-nova-era-no-tratamento-do-cancer-de-mama-geracao-de-conjugados-anticorpo-medicamento-adcs-mostra-promessa-sem-precedentes-no-tratamento-da-doenca-inicial.html]]></loc><lastmod>2025-10-17T07:49:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/san-antonio-2025.html]]></loc><lastmod>2025-12-10T13:53:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/san-antonio-2025/enhance-acupuntura-pode-melhorar-dificuldades-cognitivas-percebidas-relacionadas-ao-cancer-de-mama.html]]></loc><lastmod>2025-12-15T20:39:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/san-antonio-2025/ferramenta-digital-melhora-qualidade-de-vida-de-jovens-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2025-12-12T12:19:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/san-antonio-2025/destiny-breast09-qualidade-de-vida-reforca-t-dxd-pertuzumabe-como-nova-opcao-de-1a-linha-no-cancer-de-mama-avancado-her2.html]]></loc><lastmod>2025-12-16T21:38:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/san-antonio-2025/regime-t-dxd-thp-neoadjuvante-confirma-perfil-de-seguranca-gerenciavel-no-cancer-de-mama-inicial-her2.html]]></loc><lastmod>2025-12-19T13:57:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/san-antonio-2025/omissao-da-biopsia-do-linfonodo-sentinela-e-segura-em-pacientes-selecionadas-com-cancer-de-mama-em-estagio-inicial.html]]></loc><lastmod>2025-12-11T15:40:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/san-antonio-2025/ressonancia-magnetica-pre-operatoria-nao-reduz-recorrencia-em-cancer-de-mama-inicial-hr-negativo.html]]></loc><lastmod>2025-12-11T11:36:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2025/san-antonio-2025/destiny-breast11-pacientes-relatam-melhor-tolerabilidade-e-funcionalidade-fisica-com-t-dxd-neoadjuvante-no-cancer-de-mama-inicial-her2-de-alto-risco.html]]></loc><lastmod>2025-12-10T14:13:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024.html]]></loc><lastmod>2024-01-16T19:32:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024.html]]></loc><lastmod>2024-01-16T19:40:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/matterhorn-flot-durvalumabe-no-cancer-gastrico-e-jeg.html]]></loc><lastmod>2024-05-06T01:39:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/escort-neo-qt-camrelizumabe-neo-no-carcinoma-espinocelular-de-esofago-ressecavel.html]]></loc><lastmod>2024-01-21T14:39:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/doc-f-seguido-de-docetaxel-versus-capox-mfolfox-7-em-tumores-gastricos-avancados.html]]></loc><lastmod>2024-01-21T14:26:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/uso-de-anti-hipertensivo-diarreia-grave-e-ou-enterocolite-induzida-por-capox-no-cancer-colorretal.html]]></loc><lastmod>2024-01-19T17:51:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/imunoterapia-quimioterapia-na-primeira-linha-do-cancer-de-esofago-avancado.html]]></loc><lastmod>2024-01-20T17:47:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/galaxy-ctdna-e-quimioterapia-adjuvante-no-cancer-colorretal.html]]></loc><lastmod>2024-01-18T20:10:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/estudo-japones-mostra-resultados-de-t-dxd-neoadjuvante-no-cancer-gastrico-ou-jeg.html]]></loc><lastmod>2024-01-18T12:36:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/relacao-plaquetas-linfocitos-e-neutrofilos-linfocitos-no-cancer-gastrico-avancado-tratado-com-imunoterapia.html]]></loc><lastmod>2024-01-22T19:20:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/estudo-de-fase-ii-avalia-ev-no-adenocarcinoma-pancreatico-avancado.html]]></loc><lastmod>2024-01-17T17:12:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/ctdna-pos-operatorio-no-cancer-de-colon-de-baixo-risco.html]]></loc><lastmod>2024-01-17T16:55:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/estudo-analisa-status-kras-g12c-e-cancer-colorretal-metastatico-na-populacao-brasileira.html]]></loc><lastmod>2024-01-19T15:51:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/estudo-descreve-epidemiologia-do-cancer-gastrico-e-do-cancer-pancreatico-na-america-latina.html]]></loc><lastmod>2024-01-18T19:12:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gi-2024/asco-gi-2024-anuncia-os-destaques-do-encontro-anual.html]]></loc><lastmod>2024-01-17T17:20:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024.html]]></loc><lastmod>2024-01-16T19:42:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/escalonamento-de-dose-de-rt-aumenta-a-sobrevida-no-cancer-de-prostata-de-alto-risco.html]]></loc><lastmod>2024-04-30T23:27:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/brcaaway-abiraterona-olaparibe-upfront-no-mcrpc-com-mutacoes-de-reparo-de-recombinacao-homologa.html]]></loc><lastmod>2024-01-29T16:21:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/paisagem-genomica-transcriptomica-e-imunologica-do-cancer-de-prostata-com-base-no-local-da-metastase.html]]></loc><lastmod>2024-01-31T21:07:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/diferencas-de-incidencia-e-mortalidade-do-cancer-de-prostata-em-paises-de-alta-e-baixa-renda.html]]></loc><lastmod>2024-02-04T03:26:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/septa-validacao-do-exame-stockholm3-em-uma-coorte-multietnica-para-deteccao-de-cancer-de-prostata.html]]></loc><lastmod>2024-02-03T01:41:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/unite-enfortumabe-vedotina-apos-manutencao-com-avelumabe-no-carcinoma-urotelial-avancado.html]]></loc><lastmod>2024-01-31T22:19:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/checkmate-67t-nivolumabe-subcutaneo-versus-intravenoso-no-cancer-renal-avancado-ou-metastatico.html]]></loc><lastmod>2024-01-28T15:09:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/combinacao-de-novos-agentes-hormonais-niveis-de-testosterona-e-leuprorrelina-no-cancer-de-prostata.html]]></loc><lastmod>2024-01-29T11:53:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/ciclofosfamida-oral-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2024-01-28T15:23:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/propel-olaparibe-abiraterona-no-mcrpc-com-mutacoes-de-reparo-de-recombinacao-homologa.html]]></loc><lastmod>2024-01-28T15:22:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/servico-remoto-aumentou-adesao-a-teste-multigenico-de-predisposicao-ao-cancer.html]]></loc><lastmod>2024-01-26T16:00:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/biopsia-transperineal-na-deteccao-do-cancer-de-prostata.html]]></loc><lastmod>2024-01-26T15:28:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-gu-2024/asco-gu-chega-a-vigesima-edicao.html]]></loc><lastmod>2024-01-19T17:52:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/elcc-2024.html]]></loc><lastmod>2024-03-19T19:32:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/elcc-2024/tropion-lung01-dato-dxd-mostra-eficacia-no-cpcnp-nao-escamoso.html]]></loc><lastmod>2024-04-30T23:19:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/elcc-2024/correlate-resultados-de-mundo-real-e-tratamento-pos-imuno-de-1l-no-cpcnp-metastatico.html]]></loc><lastmod>2024-03-22T16:45:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/elcc-2024/dieta-microbioma-e-resultados-clinicos-em-pacientes-com-cpcnp.html]]></loc><lastmod>2024-03-25T04:01:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/elcc-2024/pros-osimertinibe-melhora-qualidade-de-vida-no-cpcnp-avancado.html]]></loc><lastmod>2024-03-22T13:10:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/elcc-2024/pacientes-com-cancer-de-pulmao-rastreados-com-tc-de-baixas-doses-tem-maior-sobrevida.html]]></loc><lastmod>2024-03-25T04:03:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/elcc-2024/aegean-durvalumabe-perioperatorio-para-cpcnp-ressecavel.html]]></loc><lastmod>2024-03-22T13:08:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/elcc-2024/analise-descritiva-sobre-o-cancer-de-pulmao-de-celulas-pequenas-em-nunca-fumantes.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/elcc-2024/dados-preliminares-apoiam-o-perfil-de-seguranca-da-sequencia-dedalus.html]]></loc><lastmod>2024-03-22T12:46:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/elcc-2024/empower-lung-3-pros-de-cemiplimabe-qt-ipilimumabe-na-primeira-linha-do-cpcnp-avancado-sp-215.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/elcc-2024/rationale-315-tislelizumab-melhora-taxa-de-resposta-patologica-completa-no-cpcnp-ressecavel.html]]></loc><lastmod>2024-03-22T20:58:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/elcc-2024/ldrt-associada-a-durvalumabe-e-etoposideo-no-cppc-escamoso.html]]></loc><lastmod>2024-03-20T20:56:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024.html]]></loc><lastmod>2024-04-05T16:23:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024/assinaturas-mutacionais-revelam-novos-insights-sobre-o-cancer-colorretal-de-inicio-precoce.html]]></loc><lastmod>2024-05-06T01:43:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024/fragmentomas-de-cfdna-e-biomarcadores-de-proteinas-para-deteccao-precoce-do-cancer-de-ovario.html]]></loc><lastmod>2024-05-10T08:33:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024/vacina-personalizada-experimental-mostra-resultados-no-cancer-de-cabeca-e-pescoco-ressecado.html]]></loc><lastmod>2024-05-06T01:44:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024/expressao-de-microrna-no-carcinoma-mucoepidermoide-de-glandula-salivar.html]]></loc><lastmod>2024-05-06T01:50:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024/rnas-nao-codificantes-como-biomarcadores-para-deteccao-precoce-de-cancer-de-pulmao.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024/inibidor-de-parp-de-proxima-geracao-demonstra-beneficio-clinico.html]]></loc><lastmod>2024-05-03T14:27:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024/biopsia-liquida-baseada-em-exossomo-e-promessa-para-a-deteccao-precoce-do-cancer-de-pancreas.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024/teste-sanguineo-para-deteccao-precoce-mostra-resultados-na-aacr-2024.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/aacr-2024/envelhecimento-acelerado-pode-aumentar-o-risco-de-cancer-de-inicio-precoce-nas-geracoes-mais-jovens.html]]></loc><lastmod>2024-05-03T14:12:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-breast-2024.html]]></loc><lastmod>2024-05-16T20:52:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-breast-2024/panther-dose-densa-melhora-a-sobrevida-livre-de-recorrência.html]]></loc><lastmod>2024-05-17T12:57:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-breast-2024/tropion-breast01-confirma-segurança-de-dato-dxd-no-câncer-de-mama-hr-her2–.html]]></loc><lastmod>2024-05-17T12:34:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-breast-2024/natalee-dados-de-seguranca-sao-destaque-no-esmo-breast-cancer-2024.html]]></loc><lastmod>2024-05-17T20:21:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-breast-2024/t-dxd-e-rt-concomitante-no-cancer-de-mama-metastatico-her2-positivo.html]]></loc><lastmod>2024-05-17T12:16:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-breast-2024/destiny-breast04-mostra-benefício-de-t-dxd-versus-capecitabina-na-qualidade-de-vida.html]]></loc><lastmod>2024-05-17T11:47:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-breast-2024/tuxedo-2-dato-dxd-em-metástases-cerebrais-no-câncer-de-mama-triplo-negativo.html]]></loc><lastmod>2024-05-17T12:14:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-breast-2024/dolaf-olaparibe,-durvalumabe-e-fulvestranto-no-câncer-de-mama-avançado-er-her2.html]]></loc><lastmod>2024-05-16T21:48:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-breast-2024/atualização-do-questionário-eortc-de-qualidade-de-vida-em-pacientes-com-câncer-de-mama.html]]></loc><lastmod>2024-05-16T21:38:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-breast-2024/atividade-física,-saúde-sexual-e-sintomas-em-mulheres-com-câncer-de-mama-metastático.html]]></loc><lastmod>2024-05-16T21:19:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-breast-2024/destiny-breast02-mostra-resultados-atualizados-de-t-dxd.html]]></loc><lastmod>2024-05-16T21:20:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-breast-2024/retratamento-com-t-dxd-apos-doenca-pulmonar-intersticial-grau-1.html]]></loc><lastmod>2024-05-16T16:35:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024.html]]></loc><lastmod>2024-12-06T20:37:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/laura-osimertinibe-pode-mudar-o-padrao-no-cpcnp-localmente-avancado-egfrm.html]]></loc><lastmod>2024-06-03T15:07:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/adriatic-durvalumabe-apos-crt-melhora-sobrevida-no-cpcp-celulas-em-estagio-limitado.html]]></loc><lastmod>2024-06-03T15:04:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/analise-agrupada-amplia-evidencias-de-t-dxd-no-cancer-de-mama.html]]></loc><lastmod>2024-06-03T22:51:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/telessaude-pode-reduzir-impacto-ambiental-do-tratamento-do-cancer.html]]></loc><lastmod>2024-06-03T22:50:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/esopec-flot-perioperatorio-e-novo-padrao-de-tratamento-no-adenocarcinoma-de-esofago-ressecavel.html]]></loc><lastmod>2024-06-03T15:01:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/cuidados-paliativos-por-telessaude-sao-efetivos-entre-pacientes-com-cancer-de-pulmao-avancado.html]]></loc><lastmod>2024-06-03T14:55:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/adaura-doenca-molecular-residual-e-osimertinibe-adjuvante-no-cpcnp-estagio-ib-iiia-egfrm-ressecado.html]]></loc><lastmod>2024-06-03T15:24:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/atividade-antitumoral-de-dato-dxd-pembro-na-primeira-linha-do-cpcnp-avancado.html]]></loc><lastmod>2024-06-03T15:29:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/top-osimertinibe-mais-quimioterapia-no-cpcnp-com-mutacoes-egfr-e-tp53.html]]></loc><lastmod>2024-06-03T10:35:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/inteligencia-artificial-na-oncologia.html]]></loc><lastmod>2024-06-03T10:36:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/combinacao-de-cemiplimabe-e-vacina-isa101b-no-cancer-cervical-hpv16-recorrente-metastatico.html]]></loc><lastmod>2024-06-03T10:32:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/perfil-de-variantes-germinativas-associadas-ao-cancer-de-mama-no-brasil.html]]></loc><lastmod>2024-06-03T15:32:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/blossom-dose-de-80-mg-de-osimertinibe-e-eficaz-em-metastases-leptomeningeas-do-cpcnp.html]]></loc><lastmod>2024-06-03T10:33:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/coast-atualizacao-mostra-resultados-de-combinacoes-de-imunoterapia-no-cpcnp-irressecavel-estagio-iii.html]]></loc><lastmod>2024-06-03T06:48:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/laser-na-profilaxia-da-mucosite-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-06-03T23:48:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/epcore-nhl-2-epcoritamab-na-primeira-linha-e-em-manutencao-no-linfoma-folicular.html]]></loc><lastmod>2024-06-04T13:08:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/destiny-breast03-resultados-atualizados-reforcam-superioridade-de-t-dxd-versus-t-dm1.html]]></loc><lastmod>2024-06-04T21:40:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/caraco-omissao-da-linfadenectomia-na-citorreducao-de-intervalo-reduz-morbidade-no-ceo-avancado.html]]></loc><lastmod>2024-06-02T19:19:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/destiny-breast06-t-dxd-melhora-slp-em-pacientes-com-cancer-de-mama-hr-com-her2-low-e-ultralow.html]]></loc><lastmod>2024-06-02T14:17:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/transmet-estudo-randomizado-mostra-beneficio-do-transplante-de-figado-em-pacientes-com-metastases-hepaticas-irressecaveis.html]]></loc><lastmod>2024-06-02T14:16:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/aegean-durvalumabe-perioperatorio-no-cpcnp-ressecavel-n2.html]]></loc><lastmod>2024-06-02T19:17:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/orchestra-debulking-adicional-a-terapia-sistemica-paliativa-no-cancer-colorretal-com-metastases-em-multiplos-orgaos.html]]></loc><lastmod>2024-06-02T11:08:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/neo-olaparibe-neoadjuvante-no-cancer-de-ovario-seroso-de-alto-grau-recidivado-sensivel-a-platina.html]]></loc><lastmod>2024-06-02T19:18:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/epcoritamabe-e-opcao-de-tratamento-ambulatorial-pronta-para-uso-no-linfoma-folicular.html]]></loc><lastmod>2024-06-02T14:13:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/qt-adjuvante-apos-crt-nao-mostra-resultados-no-cancer-do-colo-do-utero-inicial-de-alto-risco-apos-histerectomia.html]]></loc><lastmod>2024-06-02T13:59:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/panorama-do-microbioma-intestinal-e-resposta-terapeutica-no-cancer-de-mama.html]]></loc><lastmod>2024-06-02T14:09:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/continuacao-de-icdk4-6-mostra-beneficios-no-cancer-de-mama-metastatico-rh-apos-progressao-da-doenca.html]]></loc><lastmod>2024-06-02T18:16:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/estudo-brasileiro-analisa-sobrevida-e-marcadores-prognosticos-no-cancer-de-penis.html]]></loc><lastmod>2024-06-02T14:01:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/destiny-lung02-analise-final-confirma-beneficio-de-t-dxd-no-cpcnp-metastatico-com-mutacao-her2.html]]></loc><lastmod>2024-06-03T10:28:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/ctdna-e-resultados-de-pacientes-com-mcprc-tratados-com-o-radioligante-177-lu.html]]></loc><lastmod>2024-06-01T22:37:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/destiny-breast07-t-dxd-pertuzumabe-no-cancer-de-mama-metastatico-her2-sem-tratamento-previo.html]]></loc><lastmod>2024-06-01T22:26:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/tropion-breast01-dados-relatados-pelos-pacientes-apoiam-dato-dxd-como-potencial-nova-opcao-terapeutica.html]]></loc><lastmod>2024-06-01T21:17:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/radioligante-177-lu-mostra-resultados-de-qualidade-de-vida-no-mcprc.html]]></loc><lastmod>2024-06-01T21:15:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/asc4first-estudo-mostra-que-asciminib-pode-mudar-o-paradigma-de-tratamento-na-lmc.html]]></loc><lastmod>2024-06-01T17:00:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/ribociclibe-reduz-o-risco-de-recorrencia-no-subgrupo-n0-de-cancer-de-mama-inicial-novos-dados-do-ensaio-natalee.html]]></loc><lastmod>2024-06-01T17:01:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/tabagismo-e-status-do-hpv-no-microambiente-imune-do-cancer-de-orofaringe.html]]></loc><lastmod>2024-06-02T18:12:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/ctdna-no-monitoramento-do-cancer-epidermoide-cervical-e-anal.html]]></loc><lastmod>2024-06-01T14:52:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/dosagem-inicial-de-tratamento-personalizado-em-idosos-com-cancer-avancado.html]]></loc><lastmod>2024-06-01T13:55:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/oncologistas-brasileiros-sao-premiados-no-asco-2024.html]]></loc><lastmod>2024-05-31T12:54:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/politica-de-rastreamento-e-diagnostico-do-cancer-de-pulmao-inicial-no-brasil.html]]></loc><lastmod>2024-05-31T19:06:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/tils-como-biomarcadores-de-resposta-no-tnbc.html]]></loc><lastmod>2024-05-31T13:11:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/perfil-imune-do-carcinoma-espinocelular-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-05-31T13:12:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/vigilancia-com-mri-de-corpo-inteiro-na-sindrome-de-li-fraumeni.html]]></loc><lastmod>2024-05-31T13:13:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/guarana-no-controle-de-fadiga-relacionada-ao-cancer.html]]></loc><lastmod>2024-05-31T13:15:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/oncologista-brasileira-recebe-o-premio-life-2024.html]]></loc><lastmod>2024-05-30T16:06:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/fertilidade-entre-jovens-sobreviventes-de-cancer-de-mama.html]]></loc><lastmod>2024-06-02T23:22:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/analise-retrospectiva-mostra-efeitos-da-vacinacao-contra-hpv-na-prevencao-do-cancer.html]]></loc><lastmod>2024-06-04T14:36:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/terapia-hormonal-com-estrogenio-pode-aumentar-o-risco-de-cancer-enquanto-combinacao-estrogenio-progesterona-reduz-o-risco.html]]></loc><lastmod>2024-06-03T02:39:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/asco-2024/a-arte-e-a-ciencia-do-tratamento-do-cancer-do-conforto-a-cura.html]]></loc><lastmod>2024-05-24T15:00:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/eha-2024.html]]></loc><lastmod>2024-06-19T19:00:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-gynaecological-2024.html]]></loc><lastmod>2024-06-19T22:04:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024.html]]></loc><lastmod>2024-08-27T22:21:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/destiny-lung03-monoterapia-com-t-dxd-no-cpcnp-com-superexpressao-de-her2-mostra-eficacia-e-seguranca.html]]></loc><lastmod>2024-09-13T13:17:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/estudo-avalia-processamento-de-linguagem-natural-para-deteccao-de-nodulos-pulmonares-incidentais.html]]></loc><lastmod>2024-09-10T15:27:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/tropion-lung01-mostra-resultados-de-dato-dxd-vs-docetaxel-no-cpcnp-avancado-ou-metastatico.html]]></loc><lastmod>2024-09-10T14:18:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/aegean-resultados-atualizados-mostram-eficacia-de-durvalumabe-perioperatorio-no-cpcnp-ressecavel.html]]></loc><lastmod>2024-09-09T11:43:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/pacific-brazil-estudo-atinge-principal-desfecho-primario.html]]></loc><lastmod>2024-09-09T11:43:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/adriatic-pros-reforcam-qualidade-de-vida-com-durvalumabe-de-consolidacao-no-cpcp-em-estagio-limitado.html]]></loc><lastmod>2024-09-09T11:45:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/neocoast-2-combinacao-de-durvalumabe-com-novos-agentes-melhora-resposta-patologica-no-cpcnp-ressecavel.html]]></loc><lastmod>2024-09-09T13:29:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/ideate-lung01-ifinatamab-deruxtecan-mostra-resposta-no-cancer-de-pulmao-de-celulas-pequenas-em-estagio-extenso-2.html]]></loc><lastmod>2024-09-08T09:59:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/pesquisa-global-da-iaslc-revela-progressos-e-barreiras-aos-testes-de-biomarcadores-no-cancer-de-pulmao.html]]></loc><lastmod>2024-09-07T19:37:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/flaura-2-atualiza-dados-sobre-mecanismos-de-resistencia-adquirida.html]]></loc><lastmod>2024-09-08T00:54:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/revisao-sistematica-compara-metodos-para-estadiamento-do-cpcnp.html]]></loc><lastmod>2024-09-07T13:25:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/flaura2-impacto-da-carga-tumoral-nos-resultados-de-primeira-linha-de-osimertinibe-qt-no-cpcnp-avancado-egfrm.html]]></loc><lastmod>2024-09-08T00:45:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/evidencias-de-mundo-real-apoiam-osimertinibe-como-primeira-linha-de-tratamento-no-cpcnp-avancado-com-mutacoes-incomuns-do-egfr.html]]></loc><lastmod>2024-09-07T12:18:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/desafios-e-futuro-do-cancer-de-pulmao-na-america-latina.html]]></loc><lastmod>2024-09-07T12:18:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/blosson-osimertinibe-mostra-eficacia-no-cpcnp-com-metastases-leptomeningeas-independentemente-do-status-da-mutacao-t-790m.html]]></loc><lastmod>2024-09-08T00:43:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/estudo-analisa-fatores-associados-a-deteccao-precoce-do-cancer-de-pulmao-no-brasil.html]]></loc><lastmod>2024-09-09T21:05:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/acesso-a-testes-moleculares-melhora-resultados-no-cpcnp-metastatico.html]]></loc><lastmod>2024-09-07T12:16:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/laura-osimertinibe-apresenta-dados-de-seguranca-e-confirma-beneficio-no-cpcnp-irressecavel-apos-qrt.html]]></loc><lastmod>2024-09-08T13:08:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/estudo-com-participacao-brasileira-mostra-que-tkis-melhoram-os-resultados-em-tets-avancados.html]]></loc><lastmod>2024-09-07T13:28:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/wclc-2024/wclc-2024-50-anos-de-colaboracao-internacional-na-pesquisa-do-cancer-de-pulmao-e-os-ultimos-avancos-na-oncologia-toracica.html]]></loc><lastmod>2024-08-28T16:20:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024.html]]></loc><lastmod>2024-08-27T22:45:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/piccolo-mirvetuximabe-soravtansina-mostra-resultados-no-cancer-de-ovario-recorrente-sensivel-a-platina-fra-alto.html]]></loc><lastmod>2024-09-18T22:53:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/estudo-avalia-atividade-de-abbv-400-novo-adc-direcionado-a-proteina-c-met-no-cpcnp-egfr-selvagem.html]]></loc><lastmod>2024-09-18T22:50:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/177lu-psma-mostra-eficacia-no-cancer-de-prostata-metastatico-hormonio-sensivel.html]]></loc><lastmod>2024-09-17T18:52:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/rome-pesquisa-confirma-valor-da-oncologia-personalizada.html]]></loc><lastmod>2024-09-17T18:19:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/estudo-mostra-eficacia-de-doses-mais-baixas-de-everolimus-em-tumores-neuroendocrinos-avancados.html]]></loc><lastmod>2024-09-17T02:16:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/estudo-brasileiro-avalia-caracteristicas-prognosticas-em-pacientes-com-cancer-de-pulmao-ps-ecog-2-4.html]]></loc><lastmod>2024-09-19T18:46:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/aegean-ctdna-durante-tratamento-neoadjuvante-resposta-patologica-e-sobrevida-livre-de-eventos-no-cpcnp-ressecavel.html]]></loc><lastmod>2024-09-16T15:28:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/gigapath-modelo-baseado-em-ia-promete-transformar-o-diagnostico-do-cancer.html]]></loc><lastmod>2024-09-16T10:54:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/no-cut-resultados-mostram-viabilidade-da-tnt-com-tratamento-nao-operatorio-no-cancer-retal-localmente-avancado.html]]></loc><lastmod>2024-09-16T11:41:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/himalaya-regime-stride-mostra-taxa-de-sg-em-5-anos-e-confirma-beneficio-no-carcinoma-hepatolecular.html]]></loc><lastmod>2024-09-16T11:10:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/microbiota-intestinal-como-biomarcador-para-lesao-pre-neoplasica-no-cancer-gastrico-no-amazonas.html]]></loc><lastmod>2024-09-16T10:55:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/laura-osimertinibe-mostra-novos-dados-de-eficacia-no-cpcnp-e-confirma-beneficio-no-snc.html]]></loc><lastmod>2024-09-16T10:42:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/mythos-trastuzumabe-deruxtecana-mostra-resultados-encorajadores-no-cancer-de-glandulas-salivares-her2.html]]></loc><lastmod>2024-09-15T11:40:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/tropion-pantumor03-apresenta-resultados-de-dato-dxd-no-cancer-ginecologico.html]]></loc><lastmod>2024-09-15T11:30:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/pesquisa-mostra-necessidade-de-avancar-na-profilaxia-de-nauseas-e-vomito-induzidos-por-quimioterapia.html]]></loc><lastmod>2024-09-15T11:41:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/enzalutamida-melhora-resultados-no-cancer-de-prostata-de-alto-risco-independentemente-do-corte-etario.html]]></loc><lastmod>2024-09-15T11:37:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/pesquisa-brasileira-analisa-adesao-de-pacientes-em-cuidados-paliativos-a-estudos-auto-relatados-pros.html]]></loc><lastmod>2024-09-15T11:42:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/pesquisa-brasileira-analisa-qualidade-de-vida-e-fatores-associados-em-pacientes-com-indicacao-de-quimioterapia.html]]></loc><lastmod>2024-09-15T11:36:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/nova-analise-do-tropion-lung01-confirma-beneficio-de-dato-dxd-vs-docetaxel-no-cpcnp-avancado-nao-escamoso.html]]></loc><lastmod>2024-09-14T11:10:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/parar-de-fumar-apos-o-diagnostico-melhora-a-sobrevida-e-reduz-o-risco-de-morte-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2024-09-14T11:08:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/pesquisa-brasileira-mostra-que-mulheres-negras-tem-risco-60-maior-de-mortalidade-por-cancer-de-mama.html]]></loc><lastmod>2024-09-14T11:06:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/destiny-gastric03-combinacao-de-t-dxd-e-pembro-mostra-beneficio-no-cancer-gastrico-gej-metastatico.html]]></loc><lastmod>2024-09-14T11:07:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/ipelife-estudo-avalia-impacto-do-extrato-de-cannabis-sativa-na-dor-e-qualidade-de-vida-em-pacientes-com-cancer-de-pulmao-metastatico.html]]></loc><lastmod>2024-09-14T15:17:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/esmo-2024-apresenta-resultados-da-primeira-vacina-terapeutica-para-glioblastoma.html]]></loc><lastmod>2024-09-13T18:46:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/icarus-breast01-eficacia-seguranca-e-analise-de-biomarcadores-de-her3-dxd-no-cancer-de-mama-avancado-hr-her2.html]]></loc><lastmod>2024-09-13T12:39:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/destinybreast-12-t-dxd-mostra-resultados-no-cancer-de-mama-metastatico-e-demonstra-beneficio-de-slp-no-snc.html]]></loc><lastmod>2024-09-13T09:58:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/adc-direcionado-a-b7-h4-mostra-resultados-iniciais-em-pacientes-com-tumores-solidos-avancados-ou-metastaticos.html]]></loc><lastmod>2024-09-13T12:50:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/netter-2-nova-analise-confirma-beneficio-de-177lu-dotatate-em-tumores-neuroendocrinos-gastroenteropancreaticos.html]]></loc><lastmod>2024-09-13T12:42:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-2024/estudos-fornecem-a-primeira-evidencia-de-que-a-amamentacao-apos-o-cancer-de-mama-e-segura.html]]></loc><lastmod>2024-09-11T09:19:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024.html]]></loc><lastmod>2024-12-06T20:36:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/inmind-adicao-de-tafasitamab-a-lenalidomida-e-rituximabe-melhora-resultados-no-linfoma-folicular-recidivante-ou-refratario.html]]></loc><lastmod>2024-12-10T16:11:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/resultados-e-perfil-de-toxicidade-em-pacientes-idosos-e-muito-idosos-com-linfoma-difuso-de-grandes-celulas-b.html]]></loc><lastmod>2024-12-10T02:52:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/desafios-na-predicao-do-risco-tromboembolico-na-leucemia-aguda.html]]></loc><lastmod>2024-12-09T16:29:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/estudo-avalia-envolvimento-do-sistema-nervoso-central-na-leucemia-linfoma-de-celulas-t-do-adulto-na-america-latina.html]]></loc><lastmod>2024-12-09T14:05:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/padronizacao-de-doenca-residual-minima-mensuravel-na-lma-usando-citometria-de-fluxo-multiparametrica.html]]></loc><lastmod>2024-12-09T14:33:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/novo-escore-prognostico-para-linfomas-de-celulas-t-maduras-e-de-celulas-nk-recidivantes-e-refratarios.html]]></loc><lastmod>2024-12-09T14:32:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/estudo-demonstra-valor-prognostico-do-numero-de-locais-extranodais-no-linfoma-de-celulas-t-periferico.html]]></loc><lastmod>2024-12-09T04:10:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/estudo-avalia-impacto-de-fatores-socioeconomicos-no-acesso-e-resultados-do-transplante-alogenico-para-leucemia-mieloide-aguda.html]]></loc><lastmod>2024-12-08T16:00:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/impacto-da-classificacao-da-oms-de-2022-na-leucemia-mieloide-cronica.html]]></loc><lastmod>2024-12-08T15:59:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/aumento-da-ingestao-de-fibras-melhora-sobrevida-global-apos-transplante-alogenico-de-celulas-hematopoieticas.html]]></loc><lastmod>2024-12-07T16:58:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/dieta-cetogenica-melhora-a-funcao-antitumoral-das-celulas-car-t-via-b-hidroxibutirato.html]]></loc><lastmod>2024-12-07T16:55:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/nutrivention-intervencao-dietetica-rica-em-fibras-pode-retardar-progressao-para-o-mieloma-multiplo.html]]></loc><lastmod>2024-12-07T16:57:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/ash-2024/associacao-entre-intensidade-do-tabagismo-mutacoes-geneticas-e-progressao-da-doenca-em-sindromes-mielodisplasicas.html]]></loc><lastmod>2024-12-07T16:59:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024.html]]></loc><lastmod>2024-12-09T20:26:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/maioria-dos-pacientes-com-cancer-de-mama-de-risco-intermediario-pode-evitar-irradiacao-da-parede-toracica-apos-mastectomia.html]]></loc><lastmod>2024-12-16T14:29:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/tamoxifeno-adjuvante-pode-reduzir-risco-de-recorrencia-em-pacientes-com-cdis-de-risco-favoravel-nao-submetidas-a-radioterapia.html]]></loc><lastmod>2024-12-16T04:11:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/portadores-de-mutacao-brca-com-historico-de-cancer-de-mama-de-inicio-precoce-podem-se-beneficiar-de-cirurgia-de-reducao-de-risco.html]]></loc><lastmod>2024-12-15T14:57:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/comet-monitoramento-ativo-e-uma-opcao-viavel-para-pacientes-selecionados-com-cdis-de-baixo-risco.html]]></loc><lastmod>2024-12-16T17:46:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/modelo-de-machine-learning-multimodal-mostra-eficacia-na-previsao-de-resposta-a-inibidores-de-cdk4-6-no-cancer-de-mama-hr-her2.html]]></loc><lastmod>2024-12-17T02:44:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/solti-valentine-analise-aponta-eficacia-e-seguranca-do-conjugado-direcionado-a-her3.html]]></loc><lastmod>2024-12-11T00:20:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/cirurgia-imediata-em-mulheres-70-diminui-pela-metade-a-taxa-de-morte-por-cancer-de-mama-apos-5-anos.html]]></loc><lastmod>2024-12-11T00:32:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/estudo-de-mundo-real-mostra-resultados-de-regimes-de-tratamento-pos-t-dxd-no-cancer-de-mama.html]]></loc><lastmod>2024-12-11T01:24:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/serie-de-casos-analisa-mulheres-com-cancer-de-mama-rh-e-implantes-hormonais.html]]></loc><lastmod>2024-12-11T01:26:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/europa-estudo-compara-terapia-adjuvante-e-apresenta-resultados-de-qualidade-de-vida-na-mulher-idosa.html]]></loc><lastmod>2024-12-10T16:34:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/ebctcg-analise-de-206-904-mulheres-mostra-associacao-entre-sobrepeso-e-obesidade-com-desfechos-clinicos-no-cancer-de-mama.html]]></loc><lastmod>2024-12-10T16:09:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/razao-neutrofilo-linfocito-pode-orientar-estrategias-neoadjuvantes-no-tnbc-inicial.html]]></loc><lastmod>2024-12-10T15:19:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/estudo-da-alliance-analisa-doenca-nodal-adicional-com-disseccao-axilar-no-cancer-de-mama-pos-nac.html]]></loc><lastmod>2024-12-11T12:45:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/pesquisa-mostra-o-impacto-da-covid-19-no-rastreamento-mamografico-no-brasil.html]]></loc><lastmod>2024-12-11T02:39:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/latina-breast-subanalise-descreve-intervalo-entre-o-diagnostico-e-o-primeiro-tratamento-do-cancer-de-mama-inicial-na-america-latina.html]]></loc><lastmod>2024-12-11T02:38:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/destiny-breast08-mostra-resultados-iniciais-de-combinacoes-de-t-dxd-no-cancer-de-mama-avancado-ou-metastatico-her2-low.html]]></loc><lastmod>2024-12-10T14:44:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/espectro-genetico-e-prevalencia-de-genes-hereditarios-de-cancer-de-mama-e-ovario-em-familias-cearenses.html]]></loc><lastmod>2024-12-10T14:35:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/supressao-ovariana-e-impacto-no-peso-corporal-em-mulheres-na-pre-menopausa-com-cancer-de-mama-luminal.html]]></loc><lastmod>2024-12-11T02:31:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/pesquisa-brasileira-descreve-resultados-de-pacientes-com-cancer-de-mama-triplo-negativo-de-acordo-com-a-raca.html]]></loc><lastmod>2024-12-11T02:22:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/tuxedo-4-t-dxd-pode-ser-nova-promessa-no-cancer-de-mama-her2-low-com-metastase-cerebral-ou-dlm.html]]></loc><lastmod>2024-12-10T12:58:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/analise-compara-atendimento-do-inca-com-medidas-de-qualidade-sugeridas-pela-asco.html]]></loc><lastmod>2024-12-10T12:55:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/pesquisa-descreve-padroes-de-local-de-morte-por-cancer-de-mama-no-brasil.html]]></loc><lastmod>2024-12-10T12:08:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/pro-pacientes-jovens-relatam-qualidade-de-vida-no-cancer-de-mama.html]]></loc><lastmod>2024-12-11T02:18:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/mulheres-pretas-tem-pior-qualidade-de-acesso-ao-diagnostico-e-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2024-12-10T11:47:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/inca-mostra-alto-indice-de-concordancia-nos-resultados-de-revisao-da-patologia.html]]></loc><lastmod>2024-12-11T01:31:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/destiny-breast12-t-dxd-preserva-qualidade-de-vida-e-funcao-neurologica-em-pacientes-com-e-sem-metastase-cerebral.html]]></loc><lastmod>2024-12-13T16:00:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/estudo-global-compara-concordancia-analitica-na-identificacao-do-cancer-de-mama-her2-low.html]]></loc><lastmod>2024-12-10T11:21:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/compass-combinacao-de-durva-dato-dxd-e-promessa-no-tnbc-metastatico.html]]></loc><lastmod>2024-12-11T02:12:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/icesp-mostra-resultados-da-quimioterapia-no-cancer-de-mama-lobular-invasivo.html]]></loc><lastmod>2024-12-11T02:09:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/pesquisa-multicentrica-mostra-que-combinacao-de-t-dxd-e-rt-concomitante-nao-aumenta-toxicidade-grave.html]]></loc><lastmod>2024-12-11T02:02:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/meta-analise-compara-cardiotoxicidade-com-terapias-anti-her2.html]]></loc><lastmod>2024-12-10T13:25:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/estudo-brasileiro-investiga-biomarcadores-preditivos-de-resposta-a-inibidores-de-cdk4-6-no-cancer-de-mama.html]]></loc><lastmod>2024-12-13T23:04:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/comparacao-mostra-discrepancias-entre-testes-genomicos-de-classificacao-de-risco-no-cancer-de-mama.html]]></loc><lastmod>2024-12-10T13:27:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/status-da-expressao-de-her2-pos-t-dxd-no-cancer-de-mama.html]]></loc><lastmod>2024-12-10T13:28:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/thummionco-telemonitoramento-facilita-a-identificacao-e-gestao-de-sintomas-em-pacientes-com-cancer.html]]></loc><lastmod>2024-12-11T01:17:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/san-antonio-2024/pesquisa-descreve-a-paisagem-molecular-do-cancer-de-mama-masculino-hr-her2.html]]></loc><lastmod>2024-12-10T13:30:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023.html]]></loc><lastmod>2023-01-19T14:11:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023.html]]></loc><lastmod>2023-03-27T13:35:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023/dados-de-mundo-real-do-uso-de-tkis-no-cpcnp-avancado-egfr-mutado.html]]></loc><lastmod>2023-04-01T23:12:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023/cemiplimab-na-primeira-linha-de-tratamento-do-cpcnp-localmente-avancado.html]]></loc><lastmod>2023-03-29T17:44:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023/poseidon-padroes-de-resposta-no-cpcnp-metastatico-apos-2-e-4-ciclos-de-quimioterapia-isolada-ou-com-durvalumabe---tremelimumabe.html]]></loc><lastmod>2023-03-29T17:57:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023/gemcitabina-cisplatina-versus-paclitaxel-carboplatina-em-pacientes-com-carcinoma-de-celulas-escamosas-de-pulmao-avancado.html]]></loc><lastmod>2023-03-29T17:57:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023/cemiplimabe-e-qualidade-de-vida-no-cpcnp.html]]></loc><lastmod>2023-03-31T19:17:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023/cemiplimabe-em-monoterapia-mostra-ganho-de-sobrevida-em-pacientes-com-cancer-de-pulmao-avancado-e-metastases-cerebrais.html]]></loc><lastmod>2023-03-30T19:13:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023/eventos-adversos-de-osimertinibe-e-terapia-de-consolidacao-local-no-cpcnpm-egfr-mutado.html]]></loc><lastmod>2023-03-29T17:53:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023/sequencia-de-tratamento-no-cpcnp-com-oligometastases-cerebrais-nao-afeta-sobrevida-global.html]]></loc><lastmod>2023-03-30T15:09:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/elcc-2023/elcc-2023-aponta-os-destaques-do-congresso-anual.html]]></loc><lastmod>2023-03-27T14:59:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023.html]]></loc><lastmod>2023-02-16T02:01:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/radiacao-de-toda-a-pelve-no-cancer-de-bexiga-musculo-invasivo.html]]></loc><lastmod>2023-03-01T14:11:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/programa-de-mindfulness-via-smartphone-e-qualidade-de-vida-para-pacientes-com-cancer-renal-metastatico.html]]></loc><lastmod>2023-02-28T19:08:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/prevalencia-de-mutacoes-no-gene-hrr-em-pacientes-com-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2023-02-28T12:53:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/resultados-falso-positivos-de-biopsias-de-lesoes-pirads-4-na-ressonancia-magnetica-multiparametrica-da-prostata.html]]></loc><lastmod>2024-07-08T14:21:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/lucab-cabazitaxel-e-lupsma-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2023-02-22T23:15:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/resultados-comparativos-de-pet-psma-no-cancer-de-prostata-recorrente.html]]></loc><lastmod>2023-02-17T14:16:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/estudo-brasileiro-apresenta-dados-de-pacientes-com-carcinoma-adrenocortical.html]]></loc><lastmod>2023-02-20T17:39:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/profilaxia-primaria-com-g-csf-em-pacientes-tratados-com-quimioterapia-durante-a-pandemia-de-covid-19.html]]></loc><lastmod>2023-02-16T20:53:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/radiomica-e-sobrevida-pos-nefrectomia-no-cancer-renal-de-celulas-claras.html]]></loc><lastmod>2023-02-16T18:56:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/desigualdades-na-assistencia-oncologica.html]]></loc><lastmod>2023-02-16T18:05:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/sbrt-ou-cirurgia-no-cancer-de-prostata-localizado.html]]></loc><lastmod>2023-02-26T16:56:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/p3bep-anzup-1302-estudo-internacional-compara-bep-padrao-com-regime-abreviado-em-tumores-de-celulas-germinativas.html]]></loc><lastmod>2023-02-16T16:37:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/terapias-de-primeira-linha-em-metastases-cerebrais-do-carcinoma-de-celulas-renais.html]]></loc><lastmod>2023-02-16T16:23:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/custo-efetividade-e-estrategias-de-vigilancia-no-cancer-testicular.html]]></loc><lastmod>2023-02-26T14:51:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/plasma-mir371-e-doenca-residual-minima-em-tumores-testiculares-de-celulas-germinativas.html]]></loc><lastmod>2023-02-16T16:18:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/perfil-genomico-do-cancer-de-penis.html]]></loc><lastmod>2023-02-16T16:27:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/pacientes-reportam-resultados-de-qualidade-de-vida-com-enfortumabe-vedotina-no-cancer-urotelial.html]]></loc><lastmod>2023-02-16T16:29:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gu-2023/icesp-mostra-resultados-de-transplante-autologo-em-pacientes-com-tumores-de-celulas-germinativas.html]]></loc><lastmod>2023-02-26T15:23:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023.html]]></loc><lastmod>2023-10-16T16:03:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/brasileiros-sao-premiados-pelo-melhor-poster-do-esmo-2023-em-cancer-de-pulmao.html]]></loc><lastmod>2023-10-25T21:20:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/estudo-agnostico-mostra-atividade-de-adcs-em-tumores-solidos-com-mutacoes-her2.html]]></loc><lastmod>2023-10-24T16:14:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/selpercatinib-mostra-ganho-de-slp-no-cpcnp-ret.html]]></loc><lastmod>2023-10-23T16:37:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/duo-e-nova-estrategia-no-cancer-de-endometrio-avancado.html]]></loc><lastmod>2023-10-26T19:18:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/dato-dxd-e-nova-opcao-no-cancer-de-mama-hr-her2.html]]></loc><lastmod>2023-10-24T14:45:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/tropionlung01-dato-dxd-mostra-beneficio-de-slp-no-cancer-de-pulmao-avancado.html]]></loc><lastmod>2023-10-23T16:58:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/pacific-6-mostra-resultados-de-eficacia-e-seguranca.html]]></loc><lastmod>2023-10-27T19:50:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/aegean-ctdna-e-resposta-patologica-no-tratamento-neoadjuvante-no-cpcnp-ressecavel.html]]></loc><lastmod>2023-10-24T15:46:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/rt-imunoterapia-e-nova-opcao-para-cpcnp-irressecavel-em-pacientes-frageis.html]]></loc><lastmod>2023-10-24T11:36:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/exposicao-a-poluentes-aumenta-o-risco-de-cancer-de-mama.html]]></loc><lastmod>2023-10-23T11:09:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/ngs-e-selecao-de-tratamento-no-cancer-pancreatico-avancado.html]]></loc><lastmod>2023-10-23T21:19:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/natalee-sobrevida-livre-de-doenca-invasiva-em-subgrupos-chave.html]]></loc><lastmod>2023-10-24T16:34:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/empower-lung-1-e-3-analise-de-subgrupos-confirma-beneficio-de-cemiplimabe-no-cpcnp-escamoso.html]]></loc><lastmod>2023-10-23T10:39:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/meta-analise-mostra-t-dxd-no-cancer-de-mama-her2-com-metastase-cerebral.html]]></loc><lastmod>2023-10-23T10:36:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/carmen-lc04-tusamitamabe-ravtansina-ramucirumabe-no-cpnpc-nao-escamoso-com-alta-expressao-de-ceacam5.html]]></loc><lastmod>2023-10-23T10:32:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/pesquisa-explora-tils-e-neoantigenos-no-tratamento-do-cancer.html]]></loc><lastmod>2023-10-23T21:59:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/tropion-lung07-dato-dxd-pembro-no-cpcnp-avancado-ou-metastatico.html]]></loc><lastmod>2023-10-23T10:27:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/novo-padrao-de-1l-no-carcinoma-medular-de-tireoide.html]]></loc><lastmod>2023-10-24T21:23:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/177lu-dotatate-mostra-resultados-em-tumores-neuroendocrinos-pancreaticos.html]]></loc><lastmod>2023-10-22T16:18:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/revisao-analisa-evidencias-do-mundo-real-e-impacto-na-oncologia.html]]></loc><lastmod>2023-10-22T11:42:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/estudo-mostra-a-epidemiologia-do-cancer-do-colo-do-utero-na-america-latina.html]]></loc><lastmod>2023-10-22T11:12:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/nemio-estrategia-neoadjuvante-e-promessa-no-cancer-de-bexiga-musculo-invasivo.html]]></loc><lastmod>2023-10-24T15:41:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/embark-qualidade-de-vida-com-enzalutamida-no-cancer-de-prostata-com-recorrencia-bioquimica.html]]></loc><lastmod>2023-10-23T15:59:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/gpt-4-como-ferramenta-de-suporte-clinico.html]]></loc><lastmod>2023-10-22T11:09:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/prevalencia-de-defeitos-de-reparo-de-dna-em-pacientes-com-cancer-de-prostata-avancado.html]]></loc><lastmod>2023-10-22T12:40:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/abbv-637-osimertinibe-osi-no-cpcnp-recidivado-ou-refratario-egfr-mutado.html]]></loc><lastmod>2023-10-22T16:12:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/til-mostra-resultados-no-melanoma-de-mucosa-avancado.html]]></loc><lastmod>2023-10-23T12:34:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/spotlight-resultados-atualizados-de-zolbetuximabe-no-cancer-gastrico-jeg-cldn18-2.html]]></loc><lastmod>2023-10-26T18:35:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/glow-zolbetuximabe-no-cancer-gastrico-ou-jeg-metastatico-her2-cldn18-2.html]]></loc><lastmod>2023-10-22T13:47:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/papillon-amivantamab-em-primeira-linha-no-cpcnp-avancado-com-mutacao-egfr.html]]></loc><lastmod>2023-10-24T12:20:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/qualidade-de-vida-com-ribociclibe-no-estudo-right-choice.html]]></loc><lastmod>2023-10-22T13:46:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/analise-agrupada-mostra-resposta-robusta-de-t-dxd-em-metastase-cerebral-do-cancer-de-mama.html]]></loc><lastmod>2023-10-21T22:38:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/nova-geracao-de-serds-orais-no-cancer-de-mama.html]]></loc><lastmod>2023-10-21T14:22:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/t-dxd-mostra-resultados-em-metastases-cerebrais-do-cancer-de-mama.html]]></loc><lastmod>2023-10-21T10:41:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/tremelimumab-paclitaxel-mostra-atividade-promissora-no-muc.html]]></loc><lastmod>2023-10-21T23:36:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/oncoclinicas-destaca-vantagem-economica-dos-cuidados-paliativos.html]]></loc><lastmod>2023-10-21T10:19:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/esmo-defende-direitos-financeiros-iguais-para-sobreviventes-de-cancer.html]]></loc><lastmod>2023-10-18T21:57:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/poluicao-aumenta-risco-de-cancer-de-mama.html]]></loc><lastmod>2023-10-22T01:39:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/esmo-2023-estudos-prometem-mudar-a-pratica-da-oncoginecologia.html]]></loc><lastmod>2023-10-17T21:27:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-2023/esmo-2023-destaca-o-uso-da-inteligencia-artificial-na-oncologia.html]]></loc><lastmod>2023-10-16T16:07:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023.html]]></loc><lastmod>2023-09-05T15:50:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/mutacoes-kras-incidencia-e-resultados-clinicos-no-cancer-de-pulmao-pedro-de-marchi.html]]></loc><lastmod>2023-09-26T12:10:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/pesquisadores-brasileiros-mostram-resultados-da-sbrt-no-wclc-2023.html]]></loc><lastmod>2023-09-14T22:06:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/aegean-durvalumabe-perioperatorio-no-cancer-de-pulmao.html]]></loc><lastmod>2023-09-14T13:01:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/talent-programa-nacional-de-triagem-de-cancer-de-pulmao-em-taiwan-mostra-bons-resultados.html]]></loc><lastmod>2023-09-12T15:42:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/valor-preditivo-dos-pros-na-sobrevida-no-cpcnp-avancado.html]]></loc><lastmod>2023-09-12T20:38:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/covid-19-e-impacto-no-cancer-de-pulmao-no-brasil.html]]></loc><lastmod>2023-09-11T00:20:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/analise-da-respiracao-exalada-e-promessa-na-deteccao-de-mesotelioma-pleural-maligno.html]]></loc><lastmod>2023-09-10T14:52:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/estigma-das-doencas-relacionadas-ao-tabagismo-e-uma-barreira-ao-cuidado.html]]></loc><lastmod>2023-09-15T18:29:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/ifinatamab-deruxtecana-em-pacientes-com-cppc-refratario.html]]></loc><lastmod>2023-09-10T12:31:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/illuminate-durvalumabe-tremelimumabe-e-qt-no-cpcnp-egfr-mutado-apos-progressao-a-inibidores-de-egfr.html]]></loc><lastmod>2023-09-11T02:42:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/hanse-criterios-de-elegibilidade-para-triagem-de-cancer-de-pulmao.html]]></loc><lastmod>2023-09-11T01:28:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/herthena-lung01-patritumab-deruxtecan-no-cpnpc-com-mutacao-de-egfr-apos-tki-egfr-e-quimioterapia.html]]></loc><lastmod>2023-09-12T23:16:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/tislelizumabe-mostra-beneficio-como-primeira-linha-no-es-sclc.html]]></loc><lastmod>2023-09-12T22:45:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/modelo-de-avaliacao-geriatrica-mostra-resultados-no-cancer-de-pulmao.html]]></loc><lastmod>2023-09-09T16:02:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/eortc-busca-consenso-sobre-ressecabilidade-no-cpcnp-em-estagio-iii.html]]></loc><lastmod>2023-09-15T20:55:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/fatores-que-influenciam-decisoes-de-tratamento-em-octogenarios-com-cpcnp.html]]></loc><lastmod>2023-09-09T14:28:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/estudo-de-mundo-real-descreve-mutacoes-erbb2-no-cancer-de-pulmao-na-america-latina.html]]></loc><lastmod>2023-09-09T14:08:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/cessacao-do-tabagismo-e-sobrevida-global-no-cancer-de-pulmao.html]]></loc><lastmod>2023-09-09T13:37:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/variacao-na-classificacao-do-mesotelioma-pleural.html]]></loc><lastmod>2023-09-09T13:33:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/estudo-identifica-necessidades-de-idosos-de-baixa-renda-com-cancer-de-pulmao.html]]></loc><lastmod>2023-09-09T13:17:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/criterios-de-rastreamento-para-cancer-de-pulmao-e-testes-moleculares.html]]></loc><lastmod>2023-09-09T12:57:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/dados-de-mundo-real-estimulam-pesquisa-e-apoiam-agencias-reguladoras.html]]></loc><lastmod>2023-09-15T21:14:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/estudo-estima-incidencia-global-do-cancer-de-pulmao.html]]></loc><lastmod>2023-09-09T11:53:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/wclc-2023/ablacao-pode-evitar-cirurgia-no-mesotelioma-pleural.html]]></loc><lastmod>2023-09-09T15:21:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023.html]]></loc><lastmod>2023-05-23T21:04:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/exio-programa-remoto-de-atividade-fisica-para-pacientes-em-tratamento-com-imunoterapia-no-brasil.html]]></loc><lastmod>2023-07-27T15:46:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/fatores-de-risco-para-cancer-e-exames-de-rastreamento-na-populacao-do-pantanal.html]]></loc><lastmod>2023-07-10T02:46:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/sequencia-terapeutica-em-pacientes-com-neoplasias-neuroendocrinas-avancadas.html]]></loc><lastmod>2023-06-07T13:55:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/avaliacao-prospectiva-da-utilidade-de-fdg-pet-concomitante-e-dota-pet-em-neoplasias-neuroendocrinas-gastroenteropancreaticas.html]]></loc><lastmod>2023-06-07T20:40:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/inibidores-de-parp-apos-quimioterapia-de-primeira-linha-no-cancer-de-ovario-com-recombinacao-homologa-proficiente.html]]></loc><lastmod>2023-06-07T15:16:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/prodige-23-resultados-de-longo-prazo-confirmam-beneficio-de-folfirinox-neoadjuvante-no-cancer-retal-localmente-avancado.html]]></loc><lastmod>2023-06-04T13:49:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/supressao-ovariana-com-agonista-de-gnrh-trimestral-versus-mensal-em-pacientes-pre-menopausadas-com-cancer-de-mama.html]]></loc><lastmod>2023-06-04T02:28:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/terapia-celular-com-obe-cel-mostra-eficacia-em-adultos-com-lla.html]]></loc><lastmod>2023-06-07T03:23:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/alliance-aponta-estrategias-para-aumentar-a-participacao-de-minorias-na-pesquisa-clinica.html]]></loc><lastmod>2023-06-03T18:07:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/swog-s1011-linfadenectomia-estendida-nao-demonstra-beneficio-no-cancer-urotelial-musculo-invasivo.html]]></loc><lastmod>2023-06-07T03:33:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/cemiplimabe-neoadjuvante-mostra-resultados-no-carcinoma-escamoso-de-cabeca-e-pescoco.html]]></loc><lastmod>2023-06-07T02:40:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/analise-agrupada-mostra-eficacia-e-seguranca-de-trastuzumabe-deruxtecana-em-mulheres-65-anos.html]]></loc><lastmod>2023-06-07T02:33:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/seguranca-e-eventos-adversos-da-cornea-de-tusamitamab-ravtansine-em-pacientes-com-tumores-solidos-avancados.html]]></loc><lastmod>2023-06-14T12:29:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/analise-final-de-sg-apoia-toripalimab-como-novo-padrao-no-cancer-de-nasofaringe-avancado.html]]></loc><lastmod>2023-06-03T17:13:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/tropion-lung02-datopotamab-deruxtecan-mais-pembrolizumabe-com-ou-sem-quimioterapia-de-platina-no-cpcnp-avancado.html]]></loc><lastmod>2023-06-03T02:01:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/right-choice-analise-de-subgrupo-dos-principais-parametros-de-eficacia-por-idade.html]]></loc><lastmod>2023-06-03T00:41:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/eficacia-e-seguranca-do-trastuzumabe-biossimilar-adjuvante-no-cancer-de-mama-her2.html]]></loc><lastmod>2023-06-06T01:30:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/trastuzumabe-deruxtecana-mostra-eficacia-e-seguranca-no-cancer-colorretal-metastatico-her2.html]]></loc><lastmod>2023-06-05T00:20:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/durvalumabe-mostra-beneficio-de-sobrevida-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2023-06-02T22:54:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/programa-nutricional-para-pacientes-com-cancer-de-prostata-em-terapia-de-privacao-androgenica.html]]></loc><lastmod>2023-06-05T00:19:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/medidas-de-qualidade-de-vida-relacionada-a-saude-no-carcinoma-de-celulas-renais.html]]></loc><lastmod>2023-06-04T23:37:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/biopsias-sucessivas-mostram-que-o-status-de-her2-e-dinamico-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2023-06-03T15:45:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/combinacao-de-enfortumabe-vedotina-pembrolizumabe-apresenta-resultados-de-longo-prazo-no-cancer-urotelial-avancado.html]]></loc><lastmod>2023-06-07T03:12:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/combinacao-de-fianlimab-cemiplimabe-mostra-alta-taxa-de-resposta-no-melanoma-avancado-apos-anti-pd-1-adjuvante.html]]></loc><lastmod>2023-06-02T14:48:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/destiny-breast04-eficacia-de-t-dxd-e-analise-de-biomarcadores-no-cancer-de-mama-her2-low.html]]></loc><lastmod>2023-06-02T14:38:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/oncotype-dx-e-expressao-de-her2-no-cancer-de-mama.html]]></loc><lastmod>2023-06-03T16:58:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/unicorn-osimertinibe-no-cpcnp-com-mutacoes-incomuns-de-egfr.html]]></loc><lastmod>2023-06-03T16:36:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/napoli-3-mostra-resultados-no-adenocarcinoma-ductal-pancreatico-metastatico.html]]></loc><lastmod>2023-06-12T12:47:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/her3-dxd-em-pacientes-com-cancer-de-mama-metastatico.html]]></loc><lastmod>2023-06-03T15:40:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/keynote-826-pembrolizumabe-associado-a-quimioterapia-melhora-sobrevida-no-cancer-de-colo-do-utero-avancado.html]]></loc><lastmod>2023-05-26T19:17:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/luspatercepte-mostra-resultados-na-sindrome-mielodisplasica.html]]></loc><lastmod>2023-05-25T21:16:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/reducao-do-sobrepeso-e-obesidade-no-cancer-de-mama.html]]></loc><lastmod>2023-05-25T21:01:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-2023/diploma-cirurgia-minimamente-invasiva-mostra-resultados-no-cancer-de-pancreas-ressecavel.html]]></loc><lastmod>2023-05-25T21:16:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023.html]]></loc><lastmod>2023-05-11T13:19:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/esmo-breast-cancer-e-a-inovacao-na-pesquisa-em-cancer-de-mama.html]]></loc><lastmod>2023-05-25T18:36:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/olaparibe-versus-capecitabina-no-cancer-de-mama-metastatico-com-mutacao-germinativa.html]]></loc><lastmod>2023-05-12T14:35:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/icarus-breast01-mostra-dados-de-patritumab-deruxtecan-no-cancer-de-mama.html]]></loc><lastmod>2023-05-22T14:47:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/cancer-de-mama-na-pre-menopausa-e-qualidade-de-vida.html]]></loc><lastmod>2023-05-13T14:51:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/revisao-sistematica-mostra-beneficio-dos-degradadores-seletivos-de-receptores-de-estrogenio-no-cancer-de-mama-avancado.html]]></loc><lastmod>2023-05-19T13:56:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/icesp-avalia-resultados-de-longo-prazo-da-imunoterapia-neoadjuvante-no-tnbc.html]]></loc><lastmod>2023-05-17T11:09:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/resistencia-ao-acetato-de-megestrol-no-cancer-de-mama-avancado-er.html]]></loc><lastmod>2023-05-11T21:46:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/acido-zoledronico-na-neoadjuvancia-do-cancer-de-mama-her2.html]]></loc><lastmod>2023-05-24T16:01:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/pacientes-do-ensaio-destiny-breast02-relatam-qualidade-de-vida-com-trastuzumabe-deruxtecana.html]]></loc><lastmod>2023-05-11T21:02:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/destiny-breast04-trastuzumabe-deruxtecana-apresenta-dados-de-seguranca.html]]></loc><lastmod>2023-05-17T17:34:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/emerald-pacientes-relatam-qualidade-de-vida-com-elacestrant.html]]></loc><lastmod>2023-05-11T20:53:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/datopotamab-deruxtecan-e-atividade-antitumoral-no-cancer-de-mama.html]]></loc><lastmod>2023-05-11T22:36:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/pacientes-reportam-estado-de-saude-e-qualidade-de-vida-com-t-dxd.html]]></loc><lastmod>2023-05-11T20:50:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/monaleesa-2-analise-de-subgrupo-mostra-beneficio-de-ribociclibe-em-pacientes-com-metastase-de-novo.html]]></loc><lastmod>2023-05-12T18:20:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/status-de-recombinacao-homologa-e-inibidores-de-parp-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2023-05-11T20:41:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/esmo-breast-2023/expressao-de-her2-e-resposta-a-her3-dxd.html]]></loc><lastmod>2023-05-11T20:39:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023.html]]></loc><lastmod>2023-04-14T19:57:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/genomica-baseada-em-plasma-como-preditor-de-resultados-no-estudo-savannah.html]]></loc><lastmod>2023-04-24T20:48:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/fatores-preditivos-de-recidiva-precoce-no-cpcnp-estagio-iii-irressecavel-tratado-com-durvalumabe-de-consolidacao-pos-quimiorradiacao.html]]></loc><lastmod>2023-04-25T12:52:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/status-do-hpv-e-perfil-epigenetico-da-saliva-em-uma-populacao-livre-de-cancer.html]]></loc><lastmod>2023-04-19T14:44:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/efeitos-imunomoduladores-de-ceralasertib-em-combinacao-com-durvalumabe-no-cpcnp.html]]></loc><lastmod>2023-04-25T16:58:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/alta-dose-de-exposicao-curta-de-osimertinibe-inibe-crescimento-de-organoides-de-cancer-colorretal-metastatico-derivados-do-paciente.html]]></loc><lastmod>2023-04-25T14:51:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/nacatrine-assinatura-genetica-preditiva-de-resposta-patologica-completa-em-pacientes-com-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2023-04-19T01:35:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/estudo-amplia-compreensao-sobre-metastases-cerebrais-no-carcinoma-de-celulas-renais.html]]></loc><lastmod>2023-04-24T15:18:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/innovatv-207-tisotumab-vedotin-no-carcinoma-espinocelular-de-cabeca-e-pescoco.html]]></loc><lastmod>2023-04-17T22:51:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/pesquisa-mostra-que-falta-conscientizacao-sobre-canceres-associados-ao-hpv.html]]></loc><lastmod>2023-04-17T12:38:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/medi1191-intratumoral-e-durvalumabe-em-tumores-solidos-avancados.html]]></loc><lastmod>2023-04-25T12:27:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/micrornas-e-potencial-metastatico-no-carcinoma-mucoepidermoide-de-glandula-salivar.html]]></loc><lastmod>2023-04-15T15:48:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/caracterizacao-do-viroma-em-diferentes-tipos-de-linfoma-nao-hodgkin.html]]></loc><lastmod>2023-04-15T15:25:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/inca-estuda-epigenetica-do-cancer-de-mama-em-mulheres-negras.html]]></loc><lastmod>2023-04-15T15:05:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/disparidades-no-cancer-de-esofago-no-brasil-do-diagnostico-ao-prognostico.html]]></loc><lastmod>2023-04-17T16:27:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/aacr-2023/trastuzumabe-deruxtecana-no-cancer-de-mama-redefinindo-o-status-her2.html]]></loc><lastmod>2023-04-14T20:01:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023.html]]></loc><lastmod>2023-12-08T20:36:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/pesquisa-brasileira-propoe-mudanca-no-tratamento-de-lma-em-pacientes-com-mau-prognostico.html]]></loc><lastmod>2024-02-02T17:37:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/desafios-para-a-integracao-dos-cuidados-paliativos-em-oncohematologia.html]]></loc><lastmod>2023-12-15T14:14:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/augment-101-revumenibe-mostra-resultados-na-leucemia-aguda-recidivante-refrataria.html]]></loc><lastmod>2023-12-17T18:34:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/analise-harmoniza-classificacoes-de-sindromes-mielodisplasicas-da-oms-e-icc-de-2022.html]]></loc><lastmod>2023-12-17T18:45:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/epcoritamab-mostra-resultados-no-linfoma-folicular-recidivante-refratario-dificil-de-tratar.html]]></loc><lastmod>2023-12-13T23:48:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/drm-e-preditivo-do-beneficio-do-transplante-na-lma-com-mutacao-npm1.html]]></loc><lastmod>2023-12-17T18:40:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/flair-ibrutinibe-venetoclax-e-novo-padrao-de-tratamento-para-leucemia-linfocitica-cronica.html]]></loc><lastmod>2023-12-13T19:45:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/car-t-cd19-produz-altas-taxas-de-resposta-em-linfoma-folicular-de-alto-risco.html]]></loc><lastmod>2023-12-11T11:10:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/infusao-de-30-minutos-de-isatuximabe-em-pacientes-com-mieloma-multiplo-recem-diagnosticado.html]]></loc><lastmod>2023-12-18T16:00:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/epidemiologia-dos-lpct-na-america-latina-caracteristicas-clinicas-e-resultados.html]]></loc><lastmod>2023-12-11T11:59:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/panorama-do-linfoma-primario-do-sistema-nervoso-central-na-america-latina.html]]></loc><lastmod>2023-12-10T11:39:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/combinacao-de-isatuximabe-e-cemiplimabe-mostra-eficacia-no-enktl-recidivado-ou-refratario.html]]></loc><lastmod>2023-12-17T20:51:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/ash-2023/eficacia-de-tratamentos-para-mieloma-multiplo-em-ensaios-controlados-versus-mundo-real.html]]></loc><lastmod>2023-12-10T22:55:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023.html]]></loc><lastmod>2023-12-04T22:40:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/t-dxd-com-anastrozol-ou-fulvestranto-mostra-atividade-e-seguranca-no-cancer-de-mama-her2-low.html]]></loc><lastmod>2023-12-14T16:41:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/impacto-dos-fatores-socioeconomicos-no-diagnostico-do-cancer-de-mama-na-america-latina.html]]></loc><lastmod>2023-12-14T16:53:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/estudo-de-mundo-real-mostra-resultados-do-regime-apt-no-brasil.html]]></loc><lastmod>2023-12-14T16:42:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/diferencas-de-sg-entre-her2-low-e-outros-subtipos-de-cancer-de-mama.html]]></loc><lastmod>2023-12-15T12:09:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/roset-sg-de-t-dxd-no-cancer-de-mama-her2-com-metastases-cerebrais-e-ou-leptomeningeas.html]]></loc><lastmod>2023-12-14T19:12:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/debbrah-t-dxd-mostra-resultados-no-cancer-de-mama-avancado-her2-ou-her2-low-e-carcinomatose-leptomeningea.html]]></loc><lastmod>2023-12-14T17:08:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/padroes-de-cancer-de-mama-por-genero-no-brasil.html]]></loc><lastmod>2023-12-14T16:55:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/determinantes-sociais-da-saude-desafiam-equidade-no-tratamento-do-cancer.html]]></loc><lastmod>2023-12-14T16:51:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/seguranca-e-tolerancia-da-terapia-por-ondas-de-choque-no-linfedema-secundario-ao-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2023-12-14T16:53:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/microbioma-intestinal-de-pacientes-com-cancer-de-mama-estagio-inicial-tratados-com-qt-neo.html]]></loc><lastmod>2023-12-14T16:52:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/status-her2-low-entre-pacientes-com-sindrome-de-li-fraumeni-e-cancer-de-mama.html]]></loc><lastmod>2023-12-14T16:52:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/capitello-291-pro-apoia-beneficio-de-capivacertib-no-cancer-de-mama-avancado.html]]></loc><lastmod>2023-12-14T16:51:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/tils-como-biomarcador-preditivo-de-recorrencia-no-carcinoma-ductal-in-situ-de-mama.html]]></loc><lastmod>2023-12-14T16:51:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/inseguranca-alimentar-e-determinantes-sociais-da-saude-no-cancer-de-mama.html]]></loc><lastmod>2023-12-14T16:50:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/qt-neo-e-omissao-de-irradiacao-nodal-regional-em-pacientes-com-cancer-de-mama-selecionados.html]]></loc><lastmod>2023-12-14T16:47:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/tuxedo-1-t-dxd-no-cancer-de-mama-her2-com-metastases-cerebrais.html]]></loc><lastmod>2023-12-14T16:46:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/hospital-perola-byington-mostra-evidencia-de-mundo-real.html]]></loc><lastmod>2023-12-14T16:48:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/oncocentro-analisa-a-qualidade-do-programa-de-rastreamento-do-cancer-de-mama-em-sp.html]]></loc><lastmod>2023-12-14T16:48:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/relacao-obesidade-cancer-e-destaque-no-san-antonio-breast-cancer.html]]></loc><lastmod>2023-12-14T16:39:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/plenaria-do-sabcs-r-2023-apresenta-avancos-recentes-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2023-12-14T16:38:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/san-antonio-2023/sabcs-23-discute-controversias-na-pesquisa-translacional.html]]></loc><lastmod>2023-12-14T16:37:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023.html]]></loc><lastmod>2023-01-19T14:13:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/tratamento-neoadjuvante-no-cancer-de-pancreas-ressecavel-e-resultados-da-doenca.html]]></loc><lastmod>2023-01-22T15:02:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/swog-1815-regime-gap-nao-mostra-beneficio-de-sobrevida-no-cancer-do-trato-biliar-avancado.html]]></loc><lastmod>2023-01-22T18:02:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/tumores-neuroendocrinos-do-apendice.html]]></loc><lastmod>2023-01-22T23:37:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/rationale-305-tislelizumabe-mais-quimioterapia-na-primeira-linha-do-adenocarcinoma-gastrico-jeg.html]]></loc><lastmod>2023-01-24T18:15:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/analise-compara-cross-magic-e-flot-no-adenocarcinoma-esofagico-ou-jeg.html]]></loc><lastmod>2023-01-23T01:21:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/topaz-1-uso-de-antibioticos-em-pacientes-com-cancer-do-trato-biliar-avancado.html]]></loc><lastmod>2023-01-22T14:56:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/mundo-real-analogo-de-somatostatina-em-tumores-neuroendocrinos-do-trato-digestivo.html]]></loc><lastmod>2023-01-22T13:43:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/sbrt-associada-a-sorafenibe-mostra-resultados-no-carcinoma-hepatocelular.html]]></loc><lastmod>2023-01-19T16:07:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/tremelimumabe-e-durvalumabe-no-adenocarcinoma-gastrico.html]]></loc><lastmod>2023-01-19T16:02:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/her2-low-no-cancer-gastrico-avancado.html]]></loc><lastmod>2023-01-19T19:00:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/quimiorradiacao-de-longa-duracao-versus-radioterapia-de-curta-duracao-no-cancer-de-reto.html]]></loc><lastmod>2023-01-19T19:01:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/biopsia-liquida-na-deteccao-de-doenca-residual-minima-no-cancer-colorretal.html]]></loc><lastmod>2023-01-19T15:30:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2023/asco-gi-2023/opera-boost-de-cxb-versus-boost-de-ebrt-como-modalidade-nao-cirurgica-no-cancer-retal.html]]></loc><lastmod>2023-01-20T15:06:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022.html]]></loc><lastmod>2022-01-15T14:51:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022.html]]></loc><lastmod>2022-01-15T14:54:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/eficacia-e-seguranca-da-nant-cancer-vaccine-no-cancer-de-pancreas.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/camilla-crc-cabozantinibe-e-durvalumabe-em-pacientes-com-cancer-colorretal-avancado-refratarios-a-quimioterapia.html]]></loc><lastmod>2022-01-24T16:54:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/checkmate-649-novos-dados-de-eficacia-e-seguranca-de-nivo-mais-quimio-na-oncologia-gi.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/keynote-590-resultados-de-longo-prazo-de-pembrolizumabe-na-primeira-linha-do-cancer-de-esofago-avancado.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/trybeca-1-ensaio-de-fase-iii-nao-atinge-endpoint-primario-mas-mostra-tendencia-de-sg.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/destiny-crc01-resultados-finais-de-trastuzumabe-deruxtecana-no-cancer-colorretal-metastatico-her2-positivo.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/destiny-gastric01-t-dxd-apresenta-analise-final-de-sobrevida-global-no-cancer-gastrico.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/nextstudy-qual-o-melhor-regime-neoadjuvante-no-cancer-de-esofago-avancado.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/doenca-residual-molecular-e-eficacia-da-quimioterapia-adjuvante-no-cancer-colorretal.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/biopsia-liquida-no-cancer-de-pancreas.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gi-2022/resultados-relatados-pelo-paciente-revelam-diminuicao-da-qualidade-de-vida-em-pacientes-e-sobreviventes-de-cancer-anal.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022.html]]></loc><lastmod>2022-01-15T14:55:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/pet-psma-e-pet-fdg-como-preditores-de-resposta-e-prognostico-de-lupsma-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/papel-da-nefrectomia-citorredutora-no-cancer-renal-metastatico-e-trombo-tumoral.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/caracterizacao-genomica-e-variantes-acionaveis-no-carcinoma-urotelial-localmente-avancado-ou-metastatico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/trastuzumabe-deruxtecana-e-nivolumabe-no-cancer-urotelial.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/tumores-intraescrotais-raros-em-um-centro-brasileiro-de-tratamento-de-cancer.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/programa-de-mindfulness-via-smartphone-para-pacientes-com-cancer-renal-metastatico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/enfortumab-vedotin-como-estrategia-neoadjuvante-no-cancer-de-bexiga.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/cabozantinibe-neoadjuvante-no-cancer-renal-avancado.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/ironman-registro-internacional-de-pacientes-com-cancer-de-prostata-avancado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/trophy-u-01-sacituzumab-govitecan-com-pembrolizumabe-no-carcinoma-urotelial-metastatico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/preditores-de-resposta-a-imuno-oncologicos-na-1l-do-cancer-renal.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/durvalumabe-e-olaparibe-no-cancer-urotelial.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/novo-score-de-risco-genetico-estratifica-risco-de-morte-por-cancer-de-prostata-ao-longo-da-vida-em-diversas-populacoes.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-gu-2022/asco-gu-2022-e-os-destaques-do-programa-cientifico-sp-461.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022.html]]></loc><lastmod>2022-12-09T22:23:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/fatores-de-risco-para-lesao-renal-aguda-em-pacientes-com-leucemia-e-linfoma-tratados-com-metotrexato-em-alta-dose.html]]></loc><lastmod>2022-12-19T14:55:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/cll2-give-analise-final-mostra-resultados-de-regime-triplo-no-llc-com-delecao-17p-mutacao-tp53-sem-tratamento-previo.html]]></loc><lastmod>2022-12-15T21:37:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/regime-triplet-avo-mostra-resultados-em-pacientes-com-llc-de-alto-risco-sem-tratamento-previo.html]]></loc><lastmod>2022-12-16T15:04:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/estudo-do-t-cell-brazil-project-e-selecionado-no-ash-2022.html]]></loc><lastmod>2022-12-18T11:49:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/ikema-isatuximabe-no-mieloma-multiplo.html]]></loc><lastmod>2022-12-13T00:42:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/estudo-finlandes-apresenta-teste-preditivo-de-resposta-ao-tratamento-na-lma.html]]></loc><lastmod>2022-12-13T00:26:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/etnia-e-participacao-na-pesquisa-clinica-em-dlbcl.html]]></loc><lastmod>2022-12-12T23:42:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/estudo-brasileiro-analisa-acesso-a-segunda-linha-na-llc.html]]></loc><lastmod>2022-12-12T23:23:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/venetoclax-aumenta-sobrevida-global-na-lma.html]]></loc><lastmod>2022-12-12T22:37:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/viale-a-confirma-beneficio-de-sg-de-longo-prazo-com-venetoclax-na-lma.html]]></loc><lastmod>2022-12-12T19:15:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/mundo-real-tempo-da-leucaferese-ate-a-infusao-em-pacientes-com-lbcl-tratados-com-axi-cel.html]]></loc><lastmod>2022-12-13T20:00:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/ibrutinibe-venetoclax-de-primeira-linha-em-pacientes-com-llc-apos-mrd-indetectavel.html]]></loc><lastmod>2022-12-15T17:09:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/follow-up-de-4-anos-de-venetoclax-e-ibrutinibe-em-primeira-linha-em-pacientes-com-llc.html]]></loc><lastmod>2022-12-14T16:11:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/estudo-brasileiro-mostra-resultados-de-isatuximabe-no-mieloma-multiplo-recidivado.html]]></loc><lastmod>2022-12-12T19:21:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/epcore-nhl-1-epcoritamab-e-qualidade-de-vida-em-pacientes-com-linfoma-de-grandes-celulas-b-recidivado-ou-refratario.html]]></loc><lastmod>2022-12-13T13:22:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/resposta-a-car-t-cells-e-volume-metabolico-tumoral.html]]></loc><lastmod>2022-12-11T12:46:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/icaria-isatuximabe-no-mieloma-multiplo.html]]></loc><lastmod>2022-12-10T17:05:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/neutrodiet-dieta-sem-restricoes-nao-aumenta-infeccoes-em-pacientes-apos-transplante-de-celulas-tronco.html]]></loc><lastmod>2022-12-12T15:57:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/ash-2022/o-que-esperar-do-ash-22.html]]></loc><lastmod>2022-12-09T22:30:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-breast-2022.html]]></loc><lastmod>2022-05-03T18:07:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-breast-2022/captacao-de-trastuzumabe-deruxtecana-e-maior-em-celulas-her2-low-do-que-em-celulas-her2-negativas.html]]></loc><lastmod>2022-05-17T15:31:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-breast-2022/begonia-combinacao-mostra-resultados-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2022-05-12T13:34:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-breast-2022/alpelisibe-apresenta-resultados-no-cancer-de-mama-avancado.html]]></loc><lastmod>2022-05-04T19:47:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-breast-2022/ribociclibe-mostra-resultados-de-mundo-real-e-confirma-beneficio-clinico.html]]></loc><lastmod>2022-05-04T19:36:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-breast-2022/trastuzumabe-deruxtecana-e-nivolumabe-em-pacientes-com-cancer-de-mama-avancado-expressando-her2.html]]></loc><lastmod>2022-05-03T19:48:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-breast-2022/estudo-brasileiro-analisa-toxicidade-financeira-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2022-05-03T18:30:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-breast-2022/patritumab-deruxtecan-her3-dxd-mostra-resultados-finais-do-estudo-solti-tot-her3.html]]></loc><lastmod>2022-05-03T18:16:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-breast-2022/destiny-breast03-pacientes-relatam-beneficio-de-qualidade-de-vida-com-trastuzumabe-deruxtecana.html]]></loc><lastmod>2022-05-09T11:45:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022.html]]></loc><lastmod>2022-12-06T18:06:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/podcast-bbn-onconews-especial-sabcs-2022.html]]></loc><lastmod>2022-12-11T21:37:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/resultados-preliminares-do-estudo-first-freezing-breast-cancer-in-brazil.html]]></loc><lastmod>2022-12-11T17:45:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/microbioma-intestinal-e-sobrevida-global-em-pacientes-com-cancer-de-mama-hr-tratados-com-eribulina-e-pembrolizumabe.html]]></loc><lastmod>2022-12-11T16:50:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/capecitabina-em-pacientes-com-metastases-de-cancer-de-mama-no-sistema-nervoso-central.html]]></loc><lastmod>2022-12-11T15:26:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/stic-ctc-contagem-de-ctcs-pode-melhorar-os-resultados-de-longo-prazo-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2022-12-09T22:19:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/sensibilidade-cutanea-na-quimioterapia-com-paclitaxel.html]]></loc><lastmod>2022-12-10T22:00:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/radioterapia-com-ultra-hipofracionamento-no-cancer-de-mama-inicial.html]]></loc><lastmod>2022-12-09T12:12:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/dato-dxd-no-cancer-de-mama-hr-her2-avancado.html]]></loc><lastmod>2022-12-14T18:22:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/destiny-breast04-analises-de-subgrupo-de-trastuzumabe-deruxtecana-no-cancer-de-mama-her2-low-metastatico-e-ou-irressecavel.html]]></loc><lastmod>2022-12-10T17:36:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/icesp-avalia-padroes-de-tratamento-do-idoso-com-cancer-de-mama-metastatico.html]]></loc><lastmod>2022-12-09T12:12:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/diferencas-clinicas-e-patologicas-entre-her2-low-e-outros-subtipos-de-cancer-de-mama.html]]></loc><lastmod>2022-12-09T12:12:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/disparidade-racial-no-microambiente-tumoral-pro-metastatico-em-mulheres-com-cancer-de-mama-residual-apos-qt-neoadjuvante.html]]></loc><lastmod>2022-12-07T17:24:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/avaliacao-do-breast-cancer-index-em-mulheres-na-pre-menopausa-com-cancer-de-mama-hr-em-estagio-inicial.html]]></loc><lastmod>2022-12-06T19:42:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/san-antonio-2022/swog-s1007-raca-e-resultados-clinicos-no-estudo-rxponder.html]]></loc><lastmod>2022-12-06T18:34:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022.html]]></loc><lastmod>2022-09-09T12:34:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/avaliacao-oncogeriatrica-e-disparidades-sociais-em-idosos-com-cancer.html]]></loc><lastmod>2022-10-04T13:20:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/internacoes-e-mortalidade-intra-hospitalar-em-pacientes-em-tratamento-quimioterapico.html]]></loc><lastmod>2022-09-19T21:04:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/fresco-2-eficacia-e-seguranca-de-fruquintinib-em-pacientes-com-cancer-colorretal-metastatico-refratario.html]]></loc><lastmod>2022-09-15T18:24:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/tuxedo-1-apresenta-analise-de-qualidade-de-vida.html]]></loc><lastmod>2022-09-15T23:50:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/receptor-androgenico-e-resposta-terapeutica-no-cancer-de-prostata-por-ctdna.html]]></loc><lastmod>2022-09-15T13:01:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/biomarcadores-e-selecao-terapeutica-no-cancer-de-prostata-de-novo.html]]></loc><lastmod>2022-09-15T12:41:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/arches-intensificacao-do-tratamento-com-enzalutamida-mostra-beneficio-no-cancer-de-prostata-metastatico-hormonio-sensivel.html]]></loc><lastmod>2022-09-15T12:22:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/enfortumabe-vedotina-pembro-no-cancer-urotelial-avancado.html]]></loc><lastmod>2022-09-15T12:11:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/durvalumabe-e-tremelimumabe-no-cancer-de-tireoide-avancado.html]]></loc><lastmod>2022-09-12T20:08:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/caracterizacao-de-pacientes-com-metastases-cerebrais-de-melanoma-uveal-metastatico.html]]></loc><lastmod>2022-09-12T19:57:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/estudo-avalia-qualidade-de-vida-no-cancer-de-orofaringe.html]]></loc><lastmod>2022-09-13T13:45:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/quimioterapia-adjuvante-em-dose-densa-mostra-beneficio-de-sobrevida-no-cancer-de-mama-linfonodo-positivo.html]]></loc><lastmod>2022-09-13T13:12:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/estudo-nao-apoia-anastrozol-estendido-no-cancer-de-mama-pos-menopausa.html]]></loc><lastmod>2022-09-13T13:07:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/hormonet-tamoxifeno-em-tumores-neuroendocrinos-positivos-para-receptores-de-estrogenio-progesterona.html]]></loc><lastmod>2022-09-11T21:21:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/trastuzumabe-deruxtecana-apresenta-novos-dados-no-cancer-de-pulmao-avancado.html]]></loc><lastmod>2022-09-14T16:52:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/sacituzumabe-govitecana-apresenta-resultados-de-qualidade-de-vida-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2022-09-11T19:32:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/destiny-breast04-mostra-resultados-de-qualidade-de-vida-relatados-pelos-pacientes.html]]></loc><lastmod>2022-09-11T19:25:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/desvendando-os-mecanismos-de-acao-e-resistencia-a-trastuzumabe-deruxtecana-t-dxd-analise-de-biomarcadores.html]]></loc><lastmod>2022-09-11T20:59:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/monaleesa-analise-exploratoria-agrupada-de-sobrevida-em-pacientes-com-cancer-de-mama-avancado-hr-her2-negativo-e-metastases-viscerais.html]]></loc><lastmod>2022-10-05T16:11:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/estudo-avalia-head-to-head-ribociclibe-e-palbociclibe-no-cancer-de-mama-avancado.html]]></loc><lastmod>2022-09-15T20:15:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/trastuzumabe-deruxtecana-atualiza-resultados-no-cancer-gastrico.html]]></loc><lastmod>2022-09-11T00:48:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/durvalumabe-confirma-beneficio-de-sobrevida-no-cancer-do-trato-biliar-avancado.html]]></loc><lastmod>2022-09-15T15:39:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/nova-formulacao-de-irinotecano-lipossomal-mostra-eficacia-e-seguranca-no-cancer-de-pancreas.html]]></loc><lastmod>2022-09-11T11:44:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/prevencao-deteccao-precoce-e-sustentabilidade-estao-entre-os-destaques-do-esmo-2022.html]]></loc><lastmod>2022-09-09T21:38:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/impacto-da-etiologia-viral-no-estudo-de-fase-iii-himalaya.html]]></loc><lastmod>2022-09-10T18:25:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/pesquisa-avalia-datopotamab-deruxtecan-em-pacientes-com-cancer-de-mama-metastatico-hr-her2-negativo.html]]></loc><lastmod>2022-09-14T14:21:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/perda-de-cdx2-e-alta-expressao-de-cox2-no-cancer-colorretal-estagio-iv.html]]></loc><lastmod>2022-09-09T13:33:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/validacao-do-haprog-ferramenta-prognostica-para-pacientes-ambulatoriais-com-cancer-avancado.html]]></loc><lastmod>2024-05-03T12:57:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-2022/perfil-lipidico-como-novo-marcador-diagnostico-em-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2022-09-09T20:53:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/wclc-2022.html]]></loc><lastmod>2022-08-08T13:11:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/wclc-2022/tropion-lung02-resultados-promissores-de-combinacao-com-datopotamab-deruxtecana-no-cpcnp-avancado.html]]></loc><lastmod>2022-08-15T21:02:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/wclc-2022/obstaculos-globais-a-triagem-do-cancer-de-pulmao.html]]></loc><lastmod>2022-08-11T21:13:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/wclc-2022/wclc-destaca-estrategia-de-cessacao-do-tabagismo-em-um-programa-de-triagem-de-cancer-de-pulmao.html]]></loc><lastmod>2022-08-09T11:52:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/wclc-2022/incidencia-timing-e-sobrevida-de-segundo-cancer-de-pulmao-primario-em-pacientes-no-nlst.html]]></loc><lastmod>2022-08-14T02:57:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/wclc-2022/validacao-prospectiva-de-especimes-citologicos-em-testes-geneticos-de-cancer-de-pulmao.html]]></loc><lastmod>2022-08-14T02:52:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/wclc-2022/disparidades-no-diagnostico-precoce-do-cancer-de-pulmao-entre-adultos-conforme-a-faixa-etaria.html]]></loc><lastmod>2022-08-09T13:02:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/wclc-2022/nelson-trial-demonstra-maior-sensibilidade-no-rastreamento-de-tumores-em-estagio-inicial.html]]></loc><lastmod>2022-08-08T13:21:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022.html]]></loc><lastmod>2022-06-29T19:37:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/avaliacao-geriatrica-como-ferramenta-complementar-em-pacientes-com-tumores-gastrointestinais.html]]></loc><lastmod>2022-07-03T23:55:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/sequenciamento-do-tratamento-de-pacientes-com-cancer-de-pancreas-avancado.html]]></loc><lastmod>2022-07-03T21:18:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/inibicao-de-braf-mek-e-pd-1-no-cancer-colorretal-brafv600e.html]]></loc><lastmod>2022-07-03T15:29:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/biopsia-liquida-e-desfecho-clinico-no-adenocarcinoma-de-apendice.html]]></loc><lastmod>2022-07-03T15:23:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/impacto-da-mutacao-braf-v600e-na-genomica-do-cancer-colorretal.html]]></loc><lastmod>2022-07-03T19:07:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/microbioma-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2022-07-03T13:32:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/radioterapia-com-iodo-131-no-colangiocarcinoma.html]]></loc><lastmod>2022-07-03T17:50:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/paradigm-panitumumabe-supera-bevacizumabe-no-cancer-colorretal.html]]></loc><lastmod>2022-07-03T23:21:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/novo-indice-de-fragilidade-prediz-resultados-de-curto-prazo-apos-esofagectomia-em-idosos.html]]></loc><lastmod>2022-06-30T15:31:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/expressao-concomitante-de-her2-e-pd-l1-no-cancer-gastrico-e-ou-adenocarcinoma-de-juncao-gastroesofagica-refratarios-a-trastuzumabe.html]]></loc><lastmod>2022-07-04T10:32:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/trastuzumabe-deruxtecana-mostra-beneficio-em-pacientes-frageis-com-cancer-gastrico-politratado.html]]></loc><lastmod>2022-06-30T13:14:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/folfiri-ou-folfox-na-segunda-linha-do-trato-biliar-avancado.html]]></loc><lastmod>2022-06-30T12:46:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/destiny-gastric04-t-dxd-no-cancer-gastrico-ou-de-juncao-gastroesofagica-her2-positivo-que-progrediu-ao-trastuzumabe.html]]></loc><lastmod>2022-07-03T23:50:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/fenotipo-brcaness-e-resposta-a-quimioterapia-a-base-de-platina-no-colangiocarcinoma-intra-hepatico.html]]></loc><lastmod>2022-06-29T20:26:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/esmo-gi-2022/impacto-da-covid-19-na-prestacao-de-cuidados-em-pacientes-com-cancer-anal.html]]></loc><lastmod>2022-06-29T20:11:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022.html]]></loc><lastmod>2022-05-01T18:55:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/tc-versus-avaliacao-de-sarcopenia-por-espectrometria-e-toxicidade-da-quimioterapia-no-cancer-de-mama-precoce.html]]></loc><lastmod>2022-06-21T17:59:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/mapeamento-imunologico-do-carcinoma-adenoide-cistico-e-alvos-terapeuticos-para-o-subtipo-solido-agressivo.html]]></loc><lastmod>2022-06-20T12:55:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/adesao-e-percepcao-da-importancia-das-medidas-de-protecao-anti-covid-19-entre-pacientes-com-cancer.html]]></loc><lastmod>2022-06-17T14:45:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/expressao-de-pd-l1-e-instabilidade-de-microssatelites-em-tumores-de-sitio-primario-desconhecido.html]]></loc><lastmod>2022-06-21T12:27:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/caracteristicas-clinicas-e-epidemiologicas-do-carcinoma-espinocelular-de-penis.html]]></loc><lastmod>2022-06-21T12:18:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/impacto-prognostico-da-metastase-ossea-em-pacientes-com-carcinoma-urotelial-metastatico.html]]></loc><lastmod>2022-06-13T21:16:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/caracteristicas-genomicas-e-imunofenotipicas-distintas-de-adenocarcinomas-de-pulmao-estagio-i-conforme-subtipo-histologico-predominante.html]]></loc><lastmod>2022-06-09T20:12:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/mecanismo-de-acao-da-nano-imunoterapia-oncotherad-no-cancer-de-bexiga-nao-musculo-invasivo-nao-responsivo-a-bcg.html]]></loc><lastmod>2022-06-08T16:37:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/biomarcador-mostra-valor-prognostico-e-prediz-resposta-a-quimioterapia-dose-densa.html]]></loc><lastmod>2022-06-07T12:12:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/strategic-1-multiplas-linhas-de-tratamento-no-cancer-colorretal-metastatico-irressecavel.html]]></loc><lastmod>2022-06-10T14:43:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/promessas-no-glioblastoma-apostam-na-imunoterapia.html]]></loc><lastmod>2022-06-13T13:24:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/star-trec-watch-and-wait-ou-cirurgia-transanal-apos-quimio-radioterapia-versus-excisao-total-do-mesorreto-no-cancer-de-reto-inicial.html]]></loc><lastmod>2022-06-07T17:48:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/optical-quimioterapia-perioperatoria-com-mfolfox6-ou-capox-no-cancer-de-colon-localmente-avancado.html]]></loc><lastmod>2022-06-07T14:22:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/herb-trial-trastuzumabe-deruxtecana-no-cancer-do-trato-biliar-irressecavel-ou-recorrente-com-expressao-her2.html]]></loc><lastmod>2022-06-05T22:44:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/conko-007-qt-de-inducao-seguida-de-quimiorradioterapia-ou-qt-isolada-no-cancer-de-pancreas-localmente-avancado-nao-ressecavel.html]]></loc><lastmod>2022-06-06T00:01:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/cuidados-paliativos-na-oncologia-toracica.html]]></loc><lastmod>2022-06-07T11:58:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/lu-psma-617-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2022-06-06T22:54:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/promessa-no-carcinoma-cistico-de-adenoide.html]]></loc><lastmod>2022-06-07T23:05:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/lupsma-versus-cabazitaxel-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2022-06-06T22:54:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/impacto-do-diagnostico-de-cancer-e-de-diferentes-terapias-sistemicas-na-resposta-imunologica-apos-a-vacinacao-contra-covid-19.html]]></loc><lastmod>2022-06-06T22:55:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/durvalumabe-e-imunorradioterapia-no-cancer-de-pulmao.html]]></loc><lastmod>2022-06-07T12:36:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/ixa-dara-mostra-resultados-no-mieloma-multiplo-recidivado.html]]></loc><lastmod>2022-06-06T03:29:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/destiny-breast03-atualiza-analise-de-seguranca.html]]></loc><lastmod>2022-06-04T18:16:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/sbrt-no-cancer-de-mama-oligometastatico-nao-aumenta-sobrevida.html]]></loc><lastmod>2022-06-04T18:15:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/alpelisibe-no-cancer-de-mama-avancado.html]]></loc><lastmod>2022-06-06T01:44:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/maintain-ribociclibe-mostra-beneficio-de-sobrevida-no-cancer-de-mama-metastatico-apos-progressao-a-cdk4-6i.html]]></loc><lastmod>2022-06-06T01:53:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/caspian-pacientes-relatam-dados-de-qualidade-de-vida.html]]></loc><lastmod>2022-06-04T18:23:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/vias-de-resposta-a-danos-no-dna-no-sarcoma-sinovial.html]]></loc><lastmod>2022-06-04T18:40:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/radioterapia-versus-quimiorradioterapia-no-carcinoma-nasofaringeo-de-risco-intermediario.html]]></loc><lastmod>2022-06-04T02:54:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/avelumabe-como-estrategia-neoadjuvante-no-cancer-de-bexiga-musculo-invasivo.html]]></loc><lastmod>2022-06-04T00:05:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/quimioimunoterapia-perioperatoria-com-durvalumabe-no-carcinoma-urotelial-musculo-invasivo.html]]></loc><lastmod>2022-06-04T00:02:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/enfortumabe-vedotina-no-carcinoma-urotelial.html]]></loc><lastmod>2022-06-04T00:00:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/estudo-prospectivo-avalia-o-desempenho-da-equacao-2021-ckd-epi-sem-coeficiente-racial-em-adultos-com-tumores-solidos.html]]></loc><lastmod>2022-06-03T23:22:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/calypso-estudo-com-novas-combinacoes-no-cancer-renal-nao-alcanca-endpoint-primario.html]]></loc><lastmod>2022-06-03T22:00:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/arches-enzalutamida-mostra-beneficio-na-populacao-idosa-com-cancer-de-prostata-metastatico-hormonio-sensivel.html]]></loc><lastmod>2022-06-05T20:40:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/concert-cisplatina-semanal-vs-tres-vezes-por-semana-no-carcinoma-de-celulas-escamosas-de-cabeca-e-pescoco-localmente-avancado.html]]></loc><lastmod>2022-06-04T03:11:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/analise-agrupada-da-fda-discute-primeira-linha-no-cancer-de-pulmao.html]]></loc><lastmod>2022-06-03T23:14:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/radioterapia-de-dose-reduzida-em-pacientes-selecionados-com-carcinoma-de-nasofaringe-estagio-iii-de-baixo-risco.html]]></loc><lastmod>2022-06-03T21:25:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/imunoterapia-status-kras-e-resposta-no-cancer-de-pulmao.html]]></loc><lastmod>2022-06-03T13:49:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/axi-cel-no-tratamento-do-linfoma-de-celulas-b-um-estudo-de-mundo-real.html]]></loc><lastmod>2022-06-09T14:50:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/letalidade-por-cancer-de-pulmao-no-sudeste-brasileiro-uma-analise-de-mundo-real.html]]></loc><lastmod>2022-06-03T16:24:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/desafios-globais-para-a-oncologia-de-precisao.html]]></loc><lastmod>2022-05-31T21:06:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/estudo-brasileiro-destaca-a-maior-serie-de-pacientes-com-sindrome-dos-alelos-da-neoplasia-hereditaria-multilocus.html]]></loc><lastmod>2022-05-30T18:23:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/15-anos-de-experiencia-de-um-servico-de-oncogenetica-no-nordeste-do-brasil.html]]></loc><lastmod>2022-06-02T15:18:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/superando-mecanismos-de-resistencia-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2022-05-26T22:32:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/estudo-brasileiro-mostra-resultados-de-terapia-alvo-no-cancer-de-pulmao.html]]></loc><lastmod>2022-06-02T20:40:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/mesotelioma-incidencia-e-mortalidade-no-brasil.html]]></loc><lastmod>2022-06-02T21:23:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/programa-de-avaliacao-geriatrica-em-pacientes-idosos-via-telemedicina.html]]></loc><lastmod>2022-05-31T20:16:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2022/asco-2022/zedora-trastuzumabe-biossimilar-mostra-novos-dados-de-seguranca-no-cancer-de-mama-her2.html]]></loc><lastmod>2022-06-06T12:57:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021.html]]></loc><lastmod>2021-01-15T16:25:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/elcc-2021.html]]></loc><lastmod>2021-03-26T12:32:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/elcc-2021/mutacoes-stk11-e-ou-keap1-e-resultados-em-pacientes-com-cpcnp-tratados-com-inibidores-de-checkpoint.html]]></loc><lastmod>2021-03-28T19:50:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/elcc-2021/aumento-da-incidencia-de-metastases-cerebrais-em-pacientes-com-cpcnp-estagio-iv-durante-a-pandemia.html]]></loc><lastmod>2021-03-28T19:52:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/elcc-2021/inibidor-de-krasg12c-mostra-atividade-no-cancer-de-pulmao-avancado.html]]></loc><lastmod>2021-03-26T13:30:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/aacr-2021.html]]></loc><lastmod>2021-04-10T15:53:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/aacr-2021/papel-das-polimerases-da-sintese-de-translesao-na-resistencia-a-temozolomida-em-celulas-de-glioma.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/aacr-2021/nivolumabe-neoadjuvante-mais-quimioterapia-aumenta-taxas-de-resposta-completa-no-cpnpc.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/aacr-2021/pacientes-com-cancer-de-ovario-tem-risco-aumentado-de-doenca-mental.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/aacr-2021/tils-nova-abordagem-mostra-promessa-em-melanoma.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/aacr-2021/estilo-de-vida-saudavel-pode-diminuir-risco-de-cancer-de-prostata-letal-em-homens-com-alto-risco-genetico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-breast-cancer-2021.html]]></loc><lastmod>2021-05-04T18:34:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021.html]]></loc><lastmod>2021-05-19T19:48:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/cemiplimabe-mostra-resultados-de-eficacia-e-seguranca-em-pacientes-imunossuprimidos.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/cemiplimabe-apresenta-analise-de-qualidade-de-vida-em-pacientes-com-carcinoma-basocelular-metastatico-sp-743.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/keynote-426-resultados-de-longo-prazo-carcinoma-renal-de-celulas-claras-avancado.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/asco-2021-estrategias-de-tratamento-no-cancer-de-reto-localmente-avancado.html]]></loc><lastmod>2022-05-13T18:17:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/ctdna-e-sobrevida-de-pacientes-tratados-com-imunoterapia-em-estudos-de-fase-inicial.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/cancer-e-covid-19---impacto-em-profissionais-da-oncologia-e-na-assistencia-ao-paciente.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/fire-4-5-mostra-resultados-no-cancer-colorretal-metastatico-com-mutacao-braf-v600e.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/futuro-do-desenho-de-estudos-clinicos.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/brasileira-recebe-o-global-oncology-young-invesigator-awards-2021.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/asco-2021-lu-psma-no-mcrpc-previamente-tratado.html]]></loc><lastmod>2022-05-13T18:10:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/arches-eficacia-de-enzalutamida-no-cancer-de-prostata-metastatico-hormonio-sensivel.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/javelin-merkel-200-dados-de-longo-prazo-de-sobrevida-global.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/inibidores-de-bomba-de-protons-e-antibioticos-em-pacientes-tratados-com-inibidores-de-checkpoint-imune-os-dados-do-icesp.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/uso-de-quimioterapia-no-final-da-vida-no-brasil.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/trastuzumabe-deruxtecan-mostra-atividade-e-taxa-de-resposta-em-metastases-de-snc-do-cancer-de-mama-her2.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/anti-pd-l1-neoadjuvante-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/duracao-de-tratamento-com-bevacizumabe-na-oncoginecologia.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/estudo-discute-seguimento-ideal-no-cancer-ginecologico.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/terapia-de-privacao-androgenica-e-sobrevida-em-pacientes-com-cancer-de-prostata-com-covid-19.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/sabr-nao-e-inferior-a-vats-no-tratamento-do-cancer-de-pulmao-inicial.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/javelin-bladder-100-manutencao-em-primeira-linha-no-carcinoma-urotelial-avancado---analise-de-subgrupos.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/destiny-gastric01-resultados-finais-de-sobrevida-global-sp-953.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/destiny-crc01-resultados-finais-de-trastuzumabe-deruxtecan-no-cancer-colorretal-metastatico-her2-positivo.html]]></loc><lastmod>2021-06-05T22:31:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/deeper-trial-folfoxiri-mais-cetuximabe-ou-bevacizumabe-na-primeira-linha-do-mcrc-ras-selvagem.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/isatuximabe-mostra-novos-resultados-no-mieloma-multiplo-recorrente.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/primeiro-trastuzumabe-biossimilar-brasileiro-atualiza-dados-de-seguranca.html]]></loc><lastmod>2021-06-05T21:45:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/cancer-e-covid-19-a-experiencia-de-9-centros-de-cancer-no-brasil.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/manutencao-com-capecitabina-prolonga-sobrevida-livre-de-progressao-no-cancer-de-nasofaringe-metastatico.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/nivo-quimio-neoadjuvante-no-cancer-de-pulmao-aumenta-resposta-patologica-completa-sp-724.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/paineis-multigenicos-no-cancer-de-endometrio.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/paisagem-genomica-do-cancer-de-prostata.html]]></loc><lastmod>2021-06-05T20:48:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/estudo-de-mundo-real-descreve-caracteristicas-clinicas-e-padroes-de-tratamento-em-metastases-cerebrais-do-cpcnp.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/swog-s1216-estudo-estabelece-novo-marco-de-sobrevida-no-cancer-de-prostata-metastatico-hormonio-sensivel.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/talazoparib-mostra-resultados-no-cancer-de-mama-germline-no-cenario-neoadjuvante.html]]></loc><lastmod>2021-06-05T19:50:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/estudo-brasileiro-discute-medicina-complementar-e-alternativa-no-tratamento-do-cancer.html]]></loc><lastmod>2021-06-04T16:15:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/begonia-estudo-mostra-dados-de-eficacia-e-seguranca-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/municipio-paulista-mostra-projeto-que-melhorou-acesso-ao-diagnostico-de-cancer-no-sistema-publico.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/begonia-combinacao-de-durvalumabe-com-datopotamab-deruxtecan-e-novo-braco-de-analise.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/ixazomibe-mostra-resultados-no-tratamento-do-mieloma-multiplo.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/terapia-ossea-no-cancer-de-prostata.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/amazona-iii-mostra-a-realidade-do-cancer-de-mama-na-mulher-idosa.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/empower-lung-1-cemiplimabe-mostra-beneficio-em-pacientes-com-metastases-cerebrais-do-cancer-de-pulmao.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/asco-2021-incidencia-e-tendencias-de-tumores-associados-ao-hpv.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/relativity-047-relatlimabe-mais-nivolumabe-no-melanoma-avancado.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-2021/asco-destaca-importancia-do-rastreamento-de-cancer-de-prostata-em-afro-americanos.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/bbcs-2021.html]]></loc><lastmod>2021-05-23T23:02:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/bbcs-2021/comunicacao-adesao-ao-tratamento-e-relacao-medico-paciente-sp-455.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/bbcs-2021/impacto-da-pandemia-no-diagnostico-do-cancer-de-mama-no-brasil.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/bbcs-2021/impacto-da-atividade-fisica-na-aptidao-e-composicao-corporal-apos-o-tratamento-de-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/bbcs-2021/associacao-de-cancer-de-mama-triplo-negativo-e-subexpressao-de-brca1.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021.html]]></loc><lastmod>2021-09-08T16:24:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/avana-quimiorradioterapia-pre-operatoria-e-avelumabe-no-cancer-de-reto-localmente-avancado.html]]></loc><lastmod>2021-07-05T02:04:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/estudo-de-fase-iii-nao-mostra-beneficio-de-napabucasin-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/microbioma-e-resultados-com-nivolumabe-no-cancer-gastrico-avancado.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/cancer-de-colon-e-antibioticos.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/a-variante-kras-g12c-na-oncologia-gi.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/octopus-dose-de-quimioterapia-adjuvante-e-sobrevida-em-obesos-com-cancer-colorretal.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/complicacoes-da-esofagectomia-de-resgate-no-cancer-de-esofago-avancado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/inibidor-da-bomba-de-protons-e-resposta-patologica-no-cancer-retal.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/folfox4-no-carcinoma-hepatocelular-avancado.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/imunoterapia-em-tumores-gi-um-estudo-de-mundo-real.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/cancer-de-pancreas-no-paciente-idoso-e-o-beneficio-da-quimioterapia-na-1-linha.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/trifluridina-tipiracil-mais-bevacizumabe-no-cancer-colorretal-metastatico-refratario-sp-221.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/quimiorradioterapia-neoadjuvante-e-resposta-imune-no-cancer-retal-localmente-avancado.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/sorafenibe-metformina-e-atorvastatina-no-carcinoma-hepatocelular-avancado.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-gi-2021/lenvatinibe-supera-sorafenibe-em-estudo-de-mundo-real-no-carcinoma-hepatocelular.html]]></loc><lastmod>2024-05-03T12:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021.html]]></loc><lastmod>2021-09-08T16:23:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/nova-promessa-no-cancer-de-ovario-seroso-de-baixo-grau.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/re-exposicao-a-inibidor-de-parp-no-cancer-de-ovario.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/checkmate-9kd-nivolumabe-rucaparibe-em-pacientes-com-mcrpc-virgens-de-quimioterapia-sp-881.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/kras-g12c-e-novo-alvo-terapeutico-no-cancer-colorretal.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/avelumabe-mostra-resultados-na-neoadjuvancia-do-cancer-de-bexiga.html]]></loc><lastmod>2021-09-21T23:52:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/esmo-2021-resultados-confirmam-eficacia-da-vacina-contra-covid-19-em-pacientes-com-cancer-sp-648.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/radioembolizacao-hepatica-com-itrio-90.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/conjugado-datopotamab-deruxtecan-e-nova-promessa-em-tumores-solidos.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/perfil-clinico-e-prognostico-do-cancer-de-mama-metastatico-com-pseudocirrose.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/destiny-breast12-cancer-de-mama-her2-e-metastases-cerebrais.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/checkmate-649-acompanhamento-de-longo-prazo-confirma-beneficio.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/destiny-breast01-atualiza-resultados-de-sobrevida-sp-369.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/impacto-de-biomarcadores-farmacodinamicos-em-ensaios-de-fase-i-em-imuno-oncologia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/pesquisadores-brasileiros-apresentam-resultados-de-nivolumabe-no-carcinoma-cutaneo-de-celulas-escamosas.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/destiny-breast09-avalia-trastuzumab-deruxtecan-no-cancer-de-mama-metastatico-her2-sp-423.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/icesp-aponta-aumento-de-mortalidade-por-cancer-de-mama-em-mulheres-jovens.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/trastuzumabe-deruxtecan-no-cancer-gastrico-ou-jeg-her2-avancado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/stent-endoscopico-no-cancer-gastroesofagico-sp-454.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/papel-prognostico-da-carcinomatose-meningea-no-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/cemiplimabe-mostra-resultados-de-qualidade-de-vida-no-cancer-cervical.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/novos-modelos-prognosticos-para-pacientes-ambulatoriais-com-cancer-avancado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/indice-de-massa-corporal-e-mudanca-de-peso-apos-tratamento-adjuvante-no-cancer-de-mama-precoce-her2.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/esmo-2021/impacto-da-pandemia-covid-19-em-pacientes-com-cabeca-e-cancer-de-pescoco-atendidos-em-centro-publico-de-cancer-sp-155.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/wclc-2021.html]]></loc><lastmod>2021-09-12T20:45:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021.html]]></loc><lastmod>2021-12-07T14:36:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/principais-estudos-em-cirurgia-no-sabcs-2021.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/destiny-breast11-nova-pesquisa-com-trastuzumabe-deruxtecana-no-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/trastuzumabe-deruxtecana-em-metastases-cerebrais-do-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/oncologia-de-precisao-no-sabcs-2021.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/trastuzumab-deruxtecan-como-agente-unico-no-cancer-de-mama-avancado.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/metanalise-compara-inibidores-de-aromatase-e-tamoxifeno-na-prevencao-da-recorrencia-do-cancer-de-mama-em-mulheres-na-pre-menopausa.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/resultados-de-mundo-real-de-ribocilibe-palbociclibe-e-abemaciclibe-no-cancer-de-mama-metastatico-rh.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/estudo-brasileiro-discute-abordagem-nao-cirurgica-no-cancer-de-mama-inicial-com-axila-negativa.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/monaleesa-2-analise-de-subgrupo-demonstra-resultados-de-sobrevida-global-por-local-metastatico.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/destiny-breast09-trastuzumab-deruxtecan-na-primeira-linha-do-cancer-de-mama-metastatico-her2.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/bylieve-eficacia-de-alpelisibe-no-cancer-de-mama-avancado-hr-her2-negativo-pik3ca-mutado-previamente-tratado-incluindo-cdki.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/cancer-de-mama-em-homens-caracteristicas-tendencias-e-resultados-no-estado-de-sao-paulo.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/analise-de-subgrupos-do-ensaio-monaleesa-3.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/entinostat-mostra-beneficio-de-sobrevida-no-cancer-de-mama-avancado-receptor-hormonal-positivo.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/datopotamab-deruxtecan-apresenta-resultados-promissores-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/z-endoxifeno-como-preditor-da-recorrencia-precoce-no-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/destiny-breast05-avalia-trastuzumab-deruxtecan-no-cancer-de-mama-de-alto-risco-pos-neoadjuvancia.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/assinatura-genomica-e-de-escalonamento-terapeutico-no-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/ace-breast-03-estudo-aberto-a-recrutamento-avalia-conjugado-de-ultima-geracao-no-cancer-de-mama-her2.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/bioitalee-ctdna-em-pacientes-com-cancer-de-mama-avancado-hr-her2-negativo-tratados-com-ribociclibe-e-letrozol-em-primeira-linha.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/funcao-sexual-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/san-antonio-2021/contraceptivos-orais-combinados-e-risco-de-cancer-de-mama.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021.html]]></loc><lastmod>2021-12-12T14:14:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/estudo-brasileiro-descreve-o-cenario-do-transplante-alogenico-em-adultos-com-leucemia-linfoblastica-aguda-no-brasil-sp-576.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/ponatinibe-em-combinacao-com-quimioterapia-de-alta-dose-na-leucemia-mieloide-cronica-de-fase-blastica.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/resultados-de-longo-prazo-confirmam-beneficio-de-asciminib-na-lmc-em-fase-cronica-sp-643.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/analise-comparativa-de-qualidade-de-vida-com-axi-cel-em-participantes-do-zuma-7.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/insure-analise-agrupada-de-pacientes-com-mieloma-multiplo-recorrente-refratario-tratados-com-ird.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/zuma1-analise-de-5-anos-mostra-sobrevida-livre-de-eventos-como-surrogate-de-sobrevida-global-sp-514.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/serie-brasileira-mostra-o-panorama-da-covid-19-em-pacientes-com-mieloma-multiplo-2.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/biopsia-liquida-no-linfoma-cerebral.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/zuma-1-corticosteroide-profilatico-reduz-eventos-graves-com-axi-cel.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/estudo-com-participacao-brasileira-mostra-resultados-no-ash-2021.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/ash-2021/isatuximabe-mostra-resultados-de-mundo-real.html]]></loc><lastmod>2024-05-03T12:12:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/sgo-2021.html]]></loc><lastmod>2021-03-21T22:39:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/sgo-2021/hipec-de-curta-duracao-no-cancer-de-ovario-avancado.html]]></loc><lastmod>2021-03-28T19:48:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/sgo-2021/combinacao-mostra-beneficio-de-sobrevida-no-cancer-endometrial-avancado.html]]></loc><lastmod>2021-03-24T00:47:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/sgo-2021/diu-hormonal-no-cancer-endometrial-inicial-ou-pre-cancer.html]]></loc><lastmod>2021-03-25T12:45:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/sgo-2021/solo1-olaparibe-de-manutencao-e-beneficio-de-slp-no-cancer-de-ovario-avancado-brca-mutado.html]]></loc><lastmod>2021-03-24T15:38:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/sgo-2021/ariel4-rucaparibe-demonstra-resultados-de-slp-no-cancer-de-ovario-com-mutacao-brca.html]]></loc><lastmod>2021-03-29T03:34:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021.html]]></loc><lastmod>2021-02-09T11:42:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/capitello-281-capivasertib-no-cphsm-com-deficiencia-de-pten.html]]></loc><lastmod>2021-02-16T19:57:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/abiraterona-no-cancer-de-prostata-metastatico-resistente-a-castracao-previamente-tratado-com-dietilestilbestrol.html]]></loc><lastmod>2021-02-13T19:31:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/meta-analise-em-rede-compara-eficacia-de-antiandrogenos-no-cprc-nao-metastatico.html]]></loc><lastmod>2021-02-14T19:29:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/qualidade-de-vida-em-pacientes-com-cancer-renal-tratados-com-lenvatinibe-e-everolimus.html]]></loc><lastmod>2021-02-12T20:11:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/imunoterapia-com-oncotherad-associado-ao-prp-no-cancer-de-bexiga-nao-musculo-invasivo.html]]></loc><lastmod>2021-02-12T18:58:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/checkmate-9er-resultados-por-histologia-sarcomatoide-e-acompanhamento-de-longo-prazo.html]]></loc><lastmod>2021-02-13T16:43:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/prosper-declinio-do-psa-em-pacientes-com-cancer-de-prostata-nao-metastatico.html]]></loc><lastmod>2021-02-12T00:19:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/analise-de-subgrupos-do-estudo-prosper.html]]></loc><lastmod>2021-02-14T20:27:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/enzalutamida-demonstra-resultados-em-analise-post-hoc-do-estudo-arches.html]]></loc><lastmod>2021-02-15T17:36:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/trisst-imagem-e-vigilancia-no-cancer-testicular.html]]></loc><lastmod>2021-02-11T15:35:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/spartan-analise-molecular-no-cancer-de-prostata.html]]></loc><lastmod>2021-02-15T01:56:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/perfil-genomico-e-oportunidades-terapeuticas-no-cancer-de-penis.html]]></loc><lastmod>2021-02-12T02:11:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/checkmate-274-adjuvancia-no-cancer-urotelial-musculo-invasivo.html]]></loc><lastmod>2021-02-09T12:25:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/queda-no-rastreamento-aumentou-incidencia-de-cancer-de-prostata-metastatico-nos-eua.html]]></loc><lastmod>2021-02-09T12:09:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gu-2021/asco-gu-2021-encontro-anual-apresenta-as-apostas-da-oncologia-geniturinaria.html]]></loc><lastmod>2021-02-09T20:55:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021.html]]></loc><lastmod>2021-01-15T16:26:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/polo-trial-apresenta-resultados-de-sobrevida-global.html]]></loc><lastmod>2021-01-19T00:26:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/terapias-eletromagneticas-no-carcinoma-hepatocelular.html]]></loc><lastmod>2021-01-18T13:19:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/alliance-a021501-mfolfirinox-neoadjuvante-no-adenocarcinoma-de-pancreas-com-resseccao-borderline.html]]></loc><lastmod>2021-01-19T13:47:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/cabozantinibe-e-nivolumabe-como-tratamento-neoadjuvante-no-chc-borderline.html]]></loc><lastmod>2021-01-17T13:46:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/neoadjuvancia-no-cancer-de-esofago-complicacoes-e-fatores-de-risco-perioperatorio.html]]></loc><lastmod>2021-01-15T19:10:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/microbioma-intestinal-e-eficacia-de-nivolumabe-no-cancer-gastrico.html]]></loc><lastmod>2021-01-15T19:01:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/quimioterapia-metronomica-oral-apos-quimiorradiacao-no-gej.html]]></loc><lastmod>2021-01-15T18:45:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/covid-19-e-o-impacto-na-oncologia-gi.html]]></loc><lastmod>2021-01-17T13:31:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/patritumab-deruxtecan-no-cancer-colorretal-avancado-previamente-tratado.html]]></loc><lastmod>2021-01-19T02:25:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2021/asco-gi-2021/asco-gi-2021-novos-paradigmas-controversias-e-evidencias.html]]></loc><lastmod>2021-01-17T21:00:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020.html]]></loc><lastmod>2020-04-20T14:47:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gi-2020.html]]></loc><lastmod>2020-04-20T14:34:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gi-2020/antiangiogenico-e-quimioterapia-perioperatoria-em-metastases-hepaticas-de-cancer-colorretal.html]]></loc><lastmod>2020-01-28T15:16:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gi-2020/tapur-novos-resultados-no-asco-gi-2020.html]]></loc><lastmod>2020-01-28T15:54:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gi-2020/gambit-trial-presenca-brasileira-no-asco-gi.html]]></loc><lastmod>2020-01-29T12:24:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gi-2020/radioterapia-estereotaxica-no-cancer-colorretal-oligometastatico.html]]></loc><lastmod>2020-01-28T15:38:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gi-2020/radioterapia-estereotaxica-em-tumores-gastrointestinais-oligometastaticos.html]]></loc><lastmod>2020-01-28T15:38:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gi-2020/combinacao-mostra-resultados-no-carcinoma-hepatocelular.html]]></loc><lastmod>2020-01-28T16:02:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gi-2020/celulas-tumorais-circulantes-e-prognostico-no-cancer-colorretal-metastatico.html]]></loc><lastmod>2020-01-24T14:58:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gi-2020/asco-gi-qualidade-de-vida-de-pacientes-com-cancer-colorretal-e-hepatico.html]]></loc><lastmod>2020-01-21T23:05:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gi-2020/asco-gi-mostra-perfil-sociodemografico-do-cancer-colorretal-em-adultos-jovens.html]]></loc><lastmod>2020-01-21T22:39:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020.html]]></loc><lastmod>2020-04-20T14:33:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/medo-de-recorrencia-entre-pacientes-e-sobreviventes-de-carcinoma-de-celulas-renais-localizado.html]]></loc><lastmod>2020-02-17T16:25:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/alteracoes-genomicas-na-via-da-ciclina-em-7-207-tumores-geniturinarios-nao-prostaticos.html]]></loc><lastmod>2020-02-17T16:24:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/sbrt-duplo-bloqueio-imune-no-cancer-renal.html]]></loc><lastmod>2020-02-16T00:41:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/sitravatinib-apresenta-resultados-iniciais.html]]></loc><lastmod>2020-02-17T21:47:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/escore-de-propensao-e-selecao-terapeutica-no-cancer-renal.html]]></loc><lastmod>2020-02-15T17:07:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/savolitinib-e-durvalumab-no-cancer-renal-papilar.html]]></loc><lastmod>2020-02-15T16:52:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/relacao-neutrofilo-linfocito-como-preditor-de-resultados-oncologicos-no-cancer-renal.html]]></loc><lastmod>2020-02-19T21:22:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/efeito-biologico-do-cbm588-em-combinacao-com-inibidores-de-checkpoint-no-ccrm.html]]></loc><lastmod>2020-02-15T22:46:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/radioterapia-adjuvante-apos-prostatectomia-radical-para-cancer-de-prostata.html]]></loc><lastmod>2020-02-21T12:54:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/enfortumab-vedotin-no-carcinoma-urotelial.html]]></loc><lastmod>2020-02-15T02:38:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/quimioterapia-em-dose-convencional-em-tumores-de-celulas-germinativas-recidivados.html]]></loc><lastmod>2020-02-14T22:44:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/estudo-frances-discute-quimioterapia-no-carcinoma-urotelial-musculo-invasivo.html]]></loc><lastmod>2020-02-15T01:10:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/dose-reduzida-de-bcg-intravesical-e-inferior-a-dose-padrao-no-cancer-de-bexiga.html]]></loc><lastmod>2020-02-15T02:39:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/desintensificacao-de-dose-no-seminoma-de-baixo-volume.html]]></loc><lastmod>2020-02-15T01:54:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/metastase-ossea-e-citopenias-no-cancer-de-prostata.html]]></loc><lastmod>2020-02-14T22:28:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/consorcio-internacional-atualiza-classificacao-prognostica-no-seminoma-avancado.html]]></loc><lastmod>2020-02-14T23:21:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/perfil-genomico-de-5356-tumores-de-prostata-descreve-alteracoes-na-via-da-ciclina.html]]></loc><lastmod>2020-02-13T20:53:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/auxilio-a-decisao-no-cancer-de-prostata.html]]></loc><lastmod>2020-02-18T23:21:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/classificador-genomico-prognostico-em-pacientes-com-cancer-de-prostata.html]]></loc><lastmod>2020-02-16T02:14:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/apalutamida-reduz-risco-de-progressao-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2020-02-13T21:05:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/biopsia-liquida-no-cancer-de-prostata-neuroendocrino.html]]></loc><lastmod>2020-02-14T00:26:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-gu-2020/cabozantinibe-atezolizumabe-no-cancer-de-prostata.html]]></loc><lastmod>2020-02-16T02:09:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/enets-2020.html]]></loc><lastmod>2020-04-20T14:32:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/enets-2020/enets-2020-estudos-avaliam-administracao-de-analogos-da-somatostatina.html]]></loc><lastmod>2020-03-13T22:01:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/enets-2020/analogos-de-somatostatina-na-hiperplasia-de-celulas-neuroendocrinas-pulmonares.html]]></loc><lastmod>2020-03-13T18:06:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/enets-2020/metnet-metformina-em-tumores-neuroendocrinos.html]]></loc><lastmod>2020-03-15T14:45:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/enets-2020/clarinet-forte-qualidade-de-vida-e-heterogeneidade-tumoral-em-tumores-neuroendocrinos-gastroenteropancreaticos.html]]></loc><lastmod>2020-11-11T20:06:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/aacr-2020.html]]></loc><lastmod>2020-04-28T21:11:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/aacr-2020/pesquisa-em-cancer-discute-consumo-do-tabaco-entre-jovens.html]]></loc><lastmod>2020-05-01T13:51:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/aacr-2020/biopsia-liquida-com-pcr-digital-em-gotas-para-decisao-terapeutica-em-tumores-solidos-avancados.html]]></loc><lastmod>2020-05-01T00:13:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/aacr-2020/biopsia-liquida-e-diagnostico-precoce.html]]></loc><lastmod>2020-05-01T00:10:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/aacr-2020/covid-19-e-cancer-a-experiencia-do-gustave-roussy.html]]></loc><lastmod>2020-04-28T23:26:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/aacr-2020/uso-continuo-de-terapias-alvo-aumenta-sobrevida-livre-de-progressao-no-melanoma-irressecavel.html]]></loc><lastmod>2020-04-28T22:05:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/aacr-2020/tratamento-de-pacientes-oncologicos-durante-a-pandemia-de-covid-19-na-china.html]]></loc><lastmod>2020-04-28T21:57:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020.html]]></loc><lastmod>2020-05-13T16:54:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/mindact-de-escalonamento-do-tratamento-adjuvante-no-cancer-de-mama.html]]></loc><lastmod>2020-09-28T21:02:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/extrapolacao-de-indicacao-e-intercambialidade-como-barreiras-ao-uso-de-biossimilares-no-brasil.html]]></loc><lastmod>2020-07-08T18:23:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/pcr-digital-em-gotas-e-perfil-genomico.html]]></loc><lastmod>2020-06-23T16:44:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/hero-privacao-androgenica-no-cancer-de-prostata.html]]></loc><lastmod>2020-06-16T17:25:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/estrategias-de-tratamento-no-cancer-de-mama.html]]></loc><lastmod>2020-06-08T20:14:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/avancos-e-controversias-no-panorama-gi.html]]></loc><lastmod>2020-06-08T20:01:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/enzalutamida-mostra-ganho-de-sobrevida-global-no-cancer-de-prostata.html]]></loc><lastmod>2020-06-04T17:03:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/analise-do-estudo-mindact.html]]></loc><lastmod>2020-06-04T18:25:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/trastuzumabe-deruxtecan-no-cancer-colorretal-metastatico-her2.html]]></loc><lastmod>2020-06-03T18:59:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/anti-pd-l1-na-neoplasia-trofoblastica-gestacional.html]]></loc><lastmod>2020-06-03T18:51:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/tv-onconews-oncologia-toracica.html]]></loc><lastmod>2020-06-08T20:44:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/radioterapia-no-asco-2020.html]]></loc><lastmod>2020-06-16T14:23:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/panda-trial-panitumumabe-em-idosos-com-cancer-colorretal-metastatico.html]]></loc><lastmod>2020-06-07T17:14:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/mindact-perfil-genomico-e-de-escalonamento-de-dose.html]]></loc><lastmod>2020-06-05T00:14:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/novo-agente-e-promessa-no-tratamento-de-gliomas.html]]></loc><lastmod>2020-06-03T19:21:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/nova-dose-de-imrt-melhora-disfagia-no-cancer-de-orofaringe.html]]></loc><lastmod>2020-06-03T19:14:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/medicina-alternativa-no-tratamento-do-cancer.html]]></loc><lastmod>2020-06-03T19:24:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/inibidor-seletivo-de-hif-2a-no-carcinoma-renal-da-doenca-von-hippel-lindau.html]]></loc><lastmod>2020-06-03T19:26:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/resultados-encorajadores-no-mesotelioma-pleural-maligno.html]]></loc><lastmod>2020-06-03T19:27:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/inibidor-de-fak-no-meningioma-recorrente.html]]></loc><lastmod>2020-06-03T19:29:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/iparp-em-monoterapia-no-cancer-de-mama.html]]></loc><lastmod>2020-06-03T19:30:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/inibidor-de-met-no-cancer-de-pulmao.html]]></loc><lastmod>2020-06-04T17:52:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/estrategias-de-reducao-de-dose-no-cancer-de-mama-her2.html]]></loc><lastmod>2020-06-03T22:32:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/caspian-novos-dados-de-durvalumabe-no-cppc.html]]></loc><lastmod>2020-06-03T20:44:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/calgb-swog-80702-inibidor-da-cox-2-nao-demonstra-reducao-do-risco-de-recorrencia-do-cancer-de-colon-estagio-iii.html]]></loc><lastmod>2020-06-07T19:48:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/inibidores-de-checkpoint-imune-no-cancer-de-pulmao-novas-combinacoes.html]]></loc><lastmod>2020-06-03T22:32:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/biopsia-liquida-e-valor-prognostico-no-cancer-de-prostata.html]]></loc><lastmod>2020-06-03T22:33:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/apalutamida-neoadjuvante-no-cancer-de-prostata-de-alto-risco.html]]></loc><lastmod>2020-06-03T22:33:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/beacon-crc-combinacao-de-terapias-alvo-no-cancer-colorretal-metastatico-braf-v600e.html]]></loc><lastmod>2020-06-09T18:54:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/neoadjuvancia-no-cancer-de-prostata-de-alto-risco.html]]></loc><lastmod>2020-06-03T22:33:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/novo-regime-no-carcinoma-hepatocelular-avancado.html]]></loc><lastmod>2020-06-03T19:17:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/soc1-sgog-ov2-cirurgia-citorredutora-secundaria-no-cancer-de-ovario-com-recorrencia-tardia.html]]></loc><lastmod>2020-06-08T13:46:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/jcog0603-mfolfox6-adjuvante-para-metastase-hepatica-de-cancer-colorretal.html]]></loc><lastmod>2020-06-08T13:40:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/resistencia-adquirida-a-terapia-anti-pd1-no-melanoma.html]]></loc><lastmod>2020-06-03T22:35:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/oncologista-brasileiro-recebe-o-young-investigator-award.html]]></loc><lastmod>2020-06-03T22:48:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/ecog-acrin-estudo-nao-mostra-beneficio-de-sobrevida.html]]></loc><lastmod>2020-06-05T12:33:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/imunoterapia-em-pacientes-com-neoplasia-trofoblastica-gestacional.html]]></loc><lastmod>2020-06-03T23:49:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/biopsia-do-linfonodo-sentinela-no-cancer-cervical-em-estagio-inicial.html]]></loc><lastmod>2020-06-03T19:20:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/cediranibe-em-combinacao-com-olaparibe-no-cancer-de-ovario-recorrente-platino-sensivel.html]]></loc><lastmod>2020-06-08T13:25:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/swog-s1505-quimioterapia-perioperatoria-no-cancer-de-pancreas-ressecavel.html]]></loc><lastmod>2020-06-03T19:23:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/estudo-brasileiro-discute-opcoes-de-tratamento-no-cancer-de-prostata-avancado.html]]></loc><lastmod>2020-06-03T22:46:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/papel-da-cirurgia-no-tratamento-do-cancer-de-mama-estadio-iv.html]]></loc><lastmod>2020-06-04T00:00:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/resultados-na-era-pos-pacific.html]]></loc><lastmod>2020-06-04T00:07:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/biomarcadores-preditivos-no-cancer-de-canal-anal-5-anos-de-seguimento.html]]></loc><lastmod>2020-06-04T00:17:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/estudo-do-mundo-real-confirma-seguranca-de-trastuzumabe-biossimilar.html]]></loc><lastmod>2020-06-04T00:17:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/estudo-brasileiro-destaca-vulnerabilidade-social-no-cancer-do-colo-do-utero.html]]></loc><lastmod>2020-06-04T00:16:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/obesidade-e-cancer-de-mama.html]]></loc><lastmod>2020-06-04T00:16:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/palb2-e-risco-de-cancer.html]]></loc><lastmod>2020-06-04T00:18:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/icesp-reporta-experiencia-com-cancer-de-mama-masculino.html]]></loc><lastmod>2020-06-04T00:20:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/cancer-de-pulmao-e-status-do-tabagismo-no-brasil.html]]></loc><lastmod>2020-06-04T00:21:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/impacto-economico-do-cancer-no-brasil.html]]></loc><lastmod>2020-06-04T00:23:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/unidades-moveis-na-triagem-do-cancer-do-colo-do-utero.html]]></loc><lastmod>2020-06-04T00:25:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/mutacoes-germinativas-no-cancer-de-pancreas.html]]></loc><lastmod>2020-06-04T00:26:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/barretos-mostra-experiencia-com-novos-agentes-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2020-06-04T00:27:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/conquer-cancer-premia-oncologistas-brasileiros-na-asco-2020.html]]></loc><lastmod>2020-06-04T00:31:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/asco-2020/oncologista-brasileiro-e-homenageado-pela-asco.html]]></loc><lastmod>2020-06-04T00:33:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020.html]]></loc><lastmod>2020-07-02T21:25:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/oncologista-brasileiro-recebe-o-young-investigator-award-no-esmo-gi-2020.html]]></loc><lastmod>2020-07-06T19:18:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/metformina-irinotecano-no-cancer-colorretal-refratario.html]]></loc><lastmod>2020-07-06T18:27:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/anchor-crc-terapia-tripla-no-tratamento-de-primeira-linha-do-cancer-colorretal-metastatico-brafv600e-mutado.html]]></loc><lastmod>2020-12-23T16:00:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/novo-tki-mostra-ganho-de-sobrevida-em-pacientes-de-gist-politratados.html]]></loc><lastmod>2020-07-12T19:23:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/beacon-crc-apresenta-dados-de-seguranca-e-recomendacoes-de-cuidados.html]]></loc><lastmod>2020-07-12T19:51:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/novos-regimes-no-carcinoma-hepatocelular-avancado.html]]></loc><lastmod>2020-07-03T14:01:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/tumores-neuroendocrinos-e-variantes-patogenicas.html]]></loc><lastmod>2020-07-03T17:13:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/colangiocarcinoma-pesquisa-mantem-apostas-na-genomica.html]]></loc><lastmod>2020-07-02T22:00:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/trastuzumabe-no-cancer-gastrico-com-expressao-her2-por-biopsia-liquida.html]]></loc><lastmod>2020-07-02T22:02:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/grupo-indiano-mostra-resultados-no-cancer-de-vesicula-biliar.html]]></loc><lastmod>2020-07-12T23:09:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/relacao-neutrofilos-linfocitos-e-prognostico-no-cancer-de-pancreas.html]]></loc><lastmod>2020-07-06T18:06:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-gi-2020/esmo-gi-e-os-destaques-da-oncologia-gastrointestinal.html]]></loc><lastmod>2020-07-02T22:05:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020.html]]></loc><lastmod>2020-09-14T12:22:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/solo1-resultados-de-longo-prazo-no-cancer-de-ovario-na-esmo-2020.html]]></loc><lastmod>2020-10-17T12:11:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/quimioterapia-de-resgate-apos-imunoterapia-em-pacientes-com-tumores-solidos-refratarios.html]]></loc><lastmod>2020-10-07T20:57:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/esmo-2020-avancos-no-cancer-urotelial.html]]></loc><lastmod>2020-10-14T22:26:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/inflamacao-sistemica-tecido-adiposo-intramuscular-e-prognostico-no-cancer-de-pulmao-avancado.html]]></loc><lastmod>2020-09-28T23:33:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/spartan-qualidade-de-vida-com-apalutamida-no-cancer-de-prostata-nao-metastatico.html]]></loc><lastmod>2020-09-23T21:19:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/p16-e-hpv-como-determinantes-prognosticos-no-cancer-de-orofaringe.html]]></loc><lastmod>2020-09-22T00:54:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/video-oncoginecologia-no-esmo-2020.html]]></loc><lastmod>2020-10-14T22:21:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/icon-8-quimioterapia-semanal-em-dose-densa-nao-melhora-sobrevida-no-cancer-epitelial-de-ovario.html]]></loc><lastmod>2020-09-21T22:09:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/integracao-de-cuidados-paliativos-e-assistencia-oncologica.html]]></loc><lastmod>2020-09-22T20:44:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/tumores-gastrointestinais-no-esmo-2020.html]]></loc><lastmod>2020-10-14T22:10:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/surrogates-em-estudos-pivotais-o-cenario-de-tumores-raros.html]]></loc><lastmod>2020-09-21T16:35:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/video-esmo-2020-nova-opcao-no-cancer-de-mama-triplo-negativo-metastatico.html]]></loc><lastmod>2020-10-14T22:10:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/5-fu-oxaliplatina-adjuvante-nao-mostra-beneficio-no-cancer-retal-avancado.html]]></loc><lastmod>2020-09-21T22:42:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/escat-recomendacoes-para-a-oncologia-de-precisao-no-esmo-2020.html]]></loc><lastmod>2020-10-14T22:15:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/til-e-valor-prognostico-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2020-09-21T01:39:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/radioterapia-no-esmo-2020-virtual-congress.html]]></loc><lastmod>2020-10-14T22:12:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/aspectos-clinicos-e-epidemiologicos-de-pacientes-com-cancer-e-covid-19.html]]></loc><lastmod>2020-09-20T19:02:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/metnet-metformina-em-pacientes-com-tumores-neuroendocrinos-bem-diferenciados.html]]></loc><lastmod>2020-09-20T18:57:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/escat-e-alvos-moleculares-licoes-para-a-oncologia-de-precisao.html]]></loc><lastmod>2020-09-21T04:46:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/viabilidade-de-uma-avaliacao-geriatrica-de-design-realista-em-uma-unidade-ambulatorial-de-oncologia.html]]></loc><lastmod>2020-09-20T17:19:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/caspian-analisa-beneficio-clinico-de-longo-prazo-e-fatores-prognosticos-no-cancer-de-pulmao.html]]></loc><lastmod>2020-09-24T15:11:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/cancer-e-covid-19-avancos-e-perspectivas-no-esmo-2020.html]]></loc><lastmod>2020-10-14T22:10:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/solo1-resultados-de-longo-prazo-confirmam-beneficio-de-olaparibe-no-cancer-de-ovario.html]]></loc><lastmod>2020-09-21T00:05:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/video-esmo-2020-adaura-e-o-osimertinibe-no-controle-da-recorrencia-em-snc.html]]></loc><lastmod>2020-10-14T21:40:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/esmo-2020-checkmate-9er-primeira-linha-no-cancer-renal-metastatico.html]]></loc><lastmod>2020-10-14T21:32:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/resultados-de-pacientes-com-cancer-anal-metastatico-e-infeccao-por-hiv.html]]></loc><lastmod>2020-09-19T18:29:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/clarinet-forte-resultados-mostram-beneficio-de-sobrevida-livre-de-progressao-em-tumores-neuroendocrinos.html]]></loc><lastmod>2020-11-27T15:08:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/covid-19-e-cancer-em-destaque-no-esmo-2020.html]]></loc><lastmod>2020-09-21T04:42:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/impacto-da-covid-19-na-assistencia-oncologica.html]]></loc><lastmod>2020-09-14T15:30:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/esmo-2020/esmo-crescimento-da-carga-de-trabalho-em-oncologia.html]]></loc><lastmod>2020-10-02T18:41:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/astro-2020.html]]></loc><lastmod>2020-10-26T18:07:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/astro-2020/parcer-novo-padrao-de-rt-adjuvante-no-cancer-do-colo-do-utero.html]]></loc><lastmod>2020-10-28T17:17:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/astro-2020/pet-no-planejamento-da-radioterapia-aumenta-sobrevida-no-cancer-de-prostata-recorrente.html]]></loc><lastmod>2020-10-27T14:52:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/astro-2020/radiocirurgia-com-arcoterapia-volumetrica-modulada-para-multiplas-metastases-cerebrais.html]]></loc><lastmod>2020-11-16T16:39:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/astro-2020/radioterapia-estereotatica-e-reducao-da-dor-no-tratamento-de-metastases-da-coluna.html]]></loc><lastmod>2020-10-26T19:21:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/astro-2020/radiocirurgia-estereotaxica-e-declinio-cognitivo-em-pacientes-com-multiplas-metastases-cerebrais.html]]></loc><lastmod>2020-10-26T18:09:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/estro-2020.html]]></loc><lastmod>2020-12-02T14:17:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020.html]]></loc><lastmod>2020-12-08T18:32:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/i-spy-2-biomarcadores-de-resposta-a-durva-olaparibe.html]]></loc><lastmod>2020-12-12T13:45:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/video-sabcs-2020-e-os-avancos-no-cancer-de-mama.html]]></loc><lastmod>2020-12-13T00:41:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/her2-low-prevalencia-e-impacto-na-resposta-a-quimioterapia-neoadjuvante.html]]></loc><lastmod>2020-12-10T20:35:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/tendencias-da-mortalidade-por-cancer-de-mama-no-brasil.html]]></loc><lastmod>2020-12-10T18:42:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/cancer-de-mama-e-sindrome-de-li-fraumeni.html]]></loc><lastmod>2020-12-10T01:42:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/trastuzumabe-deruxtecano-no-cancer-de-mama-hr-her2-low.html]]></loc><lastmod>2020-12-10T14:20:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/sabcs-hospital-da-usp-mostra-impacto-da-covid-no-tratamento-do-cancer-de-mama.html]]></loc><lastmod>2020-12-11T15:39:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/analise-baseada-em-inteligencia-artificial-promete-refinar-a-classificacao-her2.html]]></loc><lastmod>2020-12-10T02:27:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/video-bylieve-e-a-eficacia-de-alpelisibe-no-cancer-de-mama-avancado-com-mutacao-pik3ca.html]]></loc><lastmod>2020-12-13T00:24:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/prime-radioterapia-adjuvante-na-paciente-idosa-e-resultados-de-sobrevida.html]]></loc><lastmod>2020-12-09T15:06:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/meta-analise-mostra-dados-de-fertilidade-em-sobreviventes-de-cancer.html]]></loc><lastmod>2020-12-09T14:40:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/estudo-brasileiro-mostra-caracterizacao-genomica-do-cancer-de-mama-masculino.html]]></loc><lastmod>2020-12-09T13:46:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/sabcs-trastuzumabe-deruxtecan-mostra-resultados-da-combinacao-com-nivolumabe.html]]></loc><lastmod>2020-12-11T17:00:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/destiny-breast-05-avalia-trastuzumabe-deruxtecan-em-pacientes-de-alto-risco.html]]></loc><lastmod>2020-12-10T01:59:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/celulas-tumorais-circulantes-valor-preditivo-e-prognostico.html]]></loc><lastmod>2020-12-10T02:39:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/dados-atualizados-do-monaleesa-7-reforcam-beneficio-de-ribociclibe-no-cancer-de-mama-avancado.html]]></loc><lastmod>2020-12-13T00:12:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/insonia-e-qualidade-de-vida-no-cancer-de-mama.html]]></loc><lastmod>2020-12-09T11:23:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/selecao-de-pacientes-e-terapia-endocrina-no-cancer-de-mama.html]]></loc><lastmod>2020-12-09T11:17:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/san-antonio-2020/lipofilling-e-seguranca-oncologica-apos-cirurgia-de-cancer-de-mama.html]]></loc><lastmod>2020-12-09T16:10:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/wclc-2020.html]]></loc><lastmod>2024-05-24T15:24:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/wclc-2020/mundo-real-radioterapia-estereotatica-em-pulmao.html]]></loc><lastmod>2024-05-24T15:28:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/wclc-2020/sobrevida-livre-de-doenca-com-osimertinibe-adjuvante-no-cpcnp.html]]></loc><lastmod>2024-05-24T15:28:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/wclc-2020/talent-eficacia-da-triagem-em-nao-fumantes-de-alto-risco-para-cancer-de-pulmao.html]]></loc><lastmod>2024-05-24T15:28:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2020/wclc-2020/imunoterapia-mostra-resultados-promissores-no-mesotelioma-recidivado.html]]></loc><lastmod>2024-05-24T15:28:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019.html]]></loc><lastmod>2020-04-20T14:58:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/astro-2019.html]]></loc><lastmod>2020-04-20T14:40:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia.html]]></loc><lastmod>2020-04-20T14:36:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/novas-perspectivas-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2019-11-05T20:07:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/inibidores-de-parp-no-tratamento-do-cancer-epitelial-de-ovario.html]]></loc><lastmod>2019-11-04T22:54:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/implicacoes-da-classificacao-da-oms-2017-no-tratamento-dos-tumores-neuroendocrinos-grau-3.html]]></loc><lastmod>2019-10-31T20:35:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/o-papel-do-tecido-na-era-da-biopsia-liquida.html]]></loc><lastmod>2019-10-30T19:13:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/qualidade-de-vida-e-cancer-ginecologico.html]]></loc><lastmod>2019-10-31T13:34:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/inteligencia-artificial-em-radio-oncologia.html]]></loc><lastmod>2019-10-29T21:40:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/cancer-de-prostata-desafios-da-doenca-oligometastatica.html]]></loc><lastmod>2019-10-29T14:05:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/cirurgia-no-cancer-de-colo-uterino-inicial.html]]></loc><lastmod>2019-10-31T12:53:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/biomarcadores-genomicos-agnosticos.html]]></loc><lastmod>2019-10-28T21:03:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/novidades-em-terapia-adjuvante-para-pacientes-com-cpnpc-e-doenca-inicial.html]]></loc><lastmod>2019-10-28T21:06:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/resultados-ineditos-em-radioterapia-hipofracionada-de-leito-prostatico-sao-apresentados-na-ii-semana-de-oncologia.html]]></loc><lastmod>2019-10-28T21:11:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/controversos-no-adenocarcinoma-de-esofago-localmente-avancado.html]]></loc><lastmod>2019-10-28T21:13:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/clarissa-mathias-assume-a-presidencia-da-sboc.html]]></loc><lastmod>2019-10-28T21:04:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/quando-indicar-a-quimioterapia-neoadjuvante-ao-inves-da-cirurgia-upfront.html]]></loc><lastmod>2019-10-28T20:52:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ii-semana-brasileira-da-oncologia/mastectomia-profilatica-em-paciente-brca-quais-os-beneficios-riscos-e-desfechos.html]]></loc><lastmod>2019-10-29T22:48:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ash-2019.html]]></loc><lastmod>2020-04-20T14:36:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ash-2019/car-t-reduz-utilizacao-de-servicos-de-saude-em-pacientes-idosos.html]]></loc><lastmod>2019-12-10T00:46:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ash-2019/eficacia-do-transplante-autologo-em-idosos-com-mieloma-multiplo.html]]></loc><lastmod>2019-12-10T00:37:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ash-2019/ash-2019-experiencia-institucional-enfrenta-barreiras-de-acesso.html]]></loc><lastmod>2019-12-10T00:22:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ash-2019/criterios-de-funcao-renal-podem-excluem-minorias-de-ensaios-clinicos.html]]></loc><lastmod>2019-12-10T00:17:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ash-2019/ash-2019-disparidades-socioeconomicas-em-ensaios-clinicos.html]]></loc><lastmod>2019-12-10T00:13:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/ash-2019/ash-2019-destaques-da-oncohematologia.html]]></loc><lastmod>2019-12-06T15:52:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019.html]]></loc><lastmod>2020-04-20T14:36:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/esmo-2019-mostra-avancos-na-pesquisa-em-cancer.html]]></loc><lastmod>2019-10-28T19:03:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/novo-paradigma-na-oncoginecologia.html]]></loc><lastmod>2019-10-28T18:18:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/progressos-na-oncologia-mamaria.html]]></loc><lastmod>2019-10-28T17:43:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/evidencias-e-controversias-no-panorama-gu.html]]></loc><lastmod>2019-10-28T16:25:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/perspectivas-no-cancer-gastrointestinal.html]]></loc><lastmod>2019-10-28T16:25:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/promessas-na-oncologia-toracica.html]]></loc><lastmod>2019-10-28T14:52:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/risco-de-quedas-e-fraturas-em-pacientes-com-cancer-de-prostata-tratados-com-novos-agentes-hormonais.html]]></loc><lastmod>2019-10-07T20:52:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/esmo-2019-estudo-brasileiro-discute-quimioterapia-no-osteossarcoma.html]]></loc><lastmod>2019-10-07T12:33:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/risco-de-pacientes-com-melanoma-cutaneo-por-variantes-no-gene-stat3.html]]></loc><lastmod>2019-10-04T19:07:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/sequenciamento-de-proxima-geracao-nos-carcinomas-gastrointestinais-nao-colorretais-metastaticos.html]]></loc><lastmod>2019-10-13T21:54:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/infeccoes-oportunistas-em-pacientes-com-tumores-neuroendocrinos-tratados-com-everolimus.html]]></loc><lastmod>2019-10-13T18:25:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/resposta-completa-apos-quimiorradioterapia-em-pacientes-com-cancer-anal-com-e-sem-infeccao-pelo-hiv.html]]></loc><lastmod>2019-10-17T15:57:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/oncologia-mamaria-mostra-novidades-importantes.html]]></loc><lastmod>2019-09-30T23:50:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/video-william-e-thiago.html]]></loc><lastmod>2019-09-30T23:34:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/video-gilberto-gelatti-e-santini.html]]></loc><lastmod>2019-09-30T23:35:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/profound-apresenta-resultados-no-cancer-de-prostata-avancado.html]]></loc><lastmod>2019-09-30T22:18:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/imunoterapia-em-mesotelioma-pleural-maligno.html]]></loc><lastmod>2019-09-30T17:12:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/capecitabina-adjuvante-no-tnbc.html]]></loc><lastmod>2019-09-30T08:03:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/emf-como-estrategia-paliativa.html]]></loc><lastmod>2019-09-30T16:57:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/video-rachel.html]]></loc><lastmod>2019-09-29T17:37:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/video-angelica-e-miguel-abreu.html]]></loc><lastmod>2019-10-01T15:41:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/video-virgilio-e-renata.html]]></loc><lastmod>2019-09-29T22:28:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/estudo-brasileiro-discute-recorrencia-no-cancer-de-mama.html]]></loc><lastmod>2019-10-22T23:40:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/nova-opcao-no-cancer-de-ovario.html]]></loc><lastmod>2019-09-29T13:28:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/citocinas-salivares-e-apoptose-das-celulas-da-mucosa-oral-em-transplantados-de-celulas-hematopoieticas.html]]></loc><lastmod>2019-09-29T09:20:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/expressao-de-parkina-apex1-e-bcl2l1-em-diferentes-subtipos-de-cancer-de-mama.html]]></loc><lastmod>2019-09-29T08:57:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/perfil-de-dna-no-cancer-primario-oculto.html]]></loc><lastmod>2019-09-28T13:55:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/video-pulmao.html]]></loc><lastmod>2020-04-24T17:08:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/video-gineco.html]]></loc><lastmod>2020-04-23T16:03:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/highlights-do-panorama-gi.html]]></loc><lastmod>2019-09-28T05:27:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/promessas-no-colangiocarcinoma.html]]></loc><lastmod>2019-09-28T05:35:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/anti-pd-l1-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:08:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/ascend-7-ceritinibe-mostra-eficacia-em-metastases-cerebrais.html]]></loc><lastmod>2019-09-28T07:59:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/classificacao-eano-esmo-de-metastases-leptomeningeas-e-implicacoes-prognosticas.html]]></loc><lastmod>2019-09-28T07:55:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-2019/esmo-2019-debate-custo-e-valor-no-tratamento-do-cancer.html]]></loc><lastmod>2019-09-27T06:55:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019.html]]></loc><lastmod>2020-04-20T14:36:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/trastuzumabe-biossimilar-com-pertuzumabe-na-doenca-her2.html]]></loc><lastmod>2019-12-14T03:49:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/video-jose-casali-e-dirce-carraro.html]]></loc><lastmod>2019-12-14T04:57:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/video-felipe-ades-e-mayana.html]]></loc><lastmod>2019-12-14T04:59:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/terapia-hormonal-e-impacto-na-incidencia-do-cancer-de-mama.html]]></loc><lastmod>2019-12-13T23:49:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/ctdna-pode-prever-risco-de-recorrencia-do-cancer-de-mama.html]]></loc><lastmod>2019-12-13T15:40:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/amazona-iii-descreve-a-prevalencia-do-cancer-de-mama-hereditario.html]]></loc><lastmod>2019-12-13T23:11:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/anastrozol-e-reducao-do-risco-de-cancer-de-mama.html]]></loc><lastmod>2019-12-12T19:28:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/cancer-de-mama-em-jovens-uma-coorte-brasileira.html]]></loc><lastmod>2019-12-12T19:36:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/irradiacao-parcial-e-prevencao-da-recorrencia-no-cancer-de-mama.html]]></loc><lastmod>2019-12-12T16:22:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/imunoterapia-novos-dados-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2019-12-12T16:10:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/novo-anti-her2-margetuximab-apresenta-resultados-no-sabcs-2019.html]]></loc><lastmod>2019-12-12T01:19:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/estudo-brasileiro-e-as-licoes-do-acosog-z0011.html]]></loc><lastmod>2019-12-13T13:47:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/biopsia-estereotaxica-a-vacuo-mostra-resultados-em-pacientes-brasileiros.html]]></loc><lastmod>2019-12-11T20:15:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/cancer-de-mama-25-anos-depois-do-acidente-com-cesio-137.html]]></loc><lastmod>2019-12-12T19:42:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/ribociclibe-apresenta-dados-de-qualidade-de-vida-no-sabcs-2019.html]]></loc><lastmod>2019-12-11T20:28:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/analise-de-mundo-real-do-trastuzumabe-biossimiliar.html]]></loc><lastmod>2019-12-12T15:55:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/san-antonio-2019/taxas-de-mastectomia-como-estamos.html]]></loc><lastmod>2019-12-11T20:54:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/wclc-2019.html]]></loc><lastmod>2020-04-20T14:40:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-quality-care-symposium.html]]></loc><lastmod>2020-04-20T14:40:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/zodiac-summit-uro-onco-2019.html]]></loc><lastmod>2020-04-20T14:40:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/zodiac-summit-uro-onco-2019/summit-uro-onco-2019-aposta-no-carater-multidisciplinar.html]]></loc><lastmod>2019-07-18T00:58:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/zodiac-summit-uro-onco-2019/avancos-no-tratamento-cirurgico-da-hpb.html]]></loc><lastmod>2019-07-18T00:59:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/zodiac-summit-uro-onco-2019/recorrencia-bioquimica-no-cancer-de-prostata---evidencias-e-desafios.html]]></loc><lastmod>2019-07-18T01:06:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/zodiac-summit-uro-onco-2019/linha-do-tempo-a-privacao-androgenica-no-cancer-de-prostata.html]]></loc><lastmod>2019-07-18T01:27:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gi-2019.html]]></loc><lastmod>2020-04-20T14:36:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gi-2019/tumores-colorretais-no-asco-gi-2019.html]]></loc><lastmod>2019-03-19T17:57:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gi-2019/hipec-adjuvante-no-cancer-de-colon-com-alto-risco-de-metastases-peritoneais.html]]></loc><lastmod>2019-01-21T01:42:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gi-2019/quimioterapia-adjuvante-no-cancer-de-colon-estadio-iii-de-alto-risco.html]]></loc><lastmod>2019-01-18T18:14:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gi-2019/o-perfil-do-cancer-na-populacao-muito-idosa.html]]></loc><lastmod>2019-01-17T22:32:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gi-2019/andecaliximab-na-primeira-linha-de-tratamento-do-adenocarcinoma-gastrico-ou-de-juncao-gastroesofagica.html]]></loc><lastmod>2019-01-17T16:28:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gi-2019/incidencia-de-metastase-pulmonar-em-pacientes-com-adenocarcinoma-colorretal.html]]></loc><lastmod>2019-01-19T12:50:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019.html]]></loc><lastmod>2020-04-20T14:36:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/video-laurence-albiges-e-fabio-schutz.html]]></loc><lastmod>2019-02-19T13:47:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/combinacao-de-imunoterapia-mostra-dados-de-longo-prazo-na-1-linha-do-cancer-renal.html]]></loc><lastmod>2019-02-17T03:43:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/analise-de-subgrupo-do-estudo-javelin-renal-101.html]]></loc><lastmod>2019-02-17T03:42:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/reducao-tumoral-e-sobrevida-no-estudo-meteor.html]]></loc><lastmod>2019-02-17T01:38:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/tkis-no-cancer-renal-do-idoso.html]]></loc><lastmod>2019-02-17T01:32:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/imunoterapia-expectativa-de-cura-e-realidade.html]]></loc><lastmod>2019-02-18T16:47:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/imunoterapia-perfil-genomico-e-desfechos-no-cancer-renal.html]]></loc><lastmod>2019-02-17T01:20:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/imunoterapia-no-carcinoma-renal-de-celulas-nao-claras.html]]></loc><lastmod>2019-02-17T01:00:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/calypso-seguranca-e-eficacia-do-savolitinibe-e-durvalumabe-no-cancer-renal-papilar-metastatico.html]]></loc><lastmod>2019-03-01T19:12:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/tivo-3-tivozanib-versus-sorafenibe-no-carcinoma-de-celulas-renais-avancado-refratario.html]]></loc><lastmod>2019-02-17T01:09:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/video-vinicius-carrera-e-ignacio-duran.html]]></loc><lastmod>2019-02-19T13:56:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/quimiorradioterapia-sequencial-no-cancer-de-bexiga-pos-cistectomia-radical.html]]></loc><lastmod>2019-02-16T03:31:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/primetest-disseccao-de-linfonodos-retroperitoneais-no-seminoma-estadio-ii-a-b-sem-tratamento-adjuvante.html]]></loc><lastmod>2019-02-16T02:25:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/ribociclibe-em-pacientes-com-teratoma-irressecavel.html]]></loc><lastmod>2019-02-16T02:17:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/ramucirumabe-no-carcinoma-urotelial-refratario-a-platina.html]]></loc><lastmod>2019-02-16T02:09:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/coach-quimioterapia-em-pacientes-com-cancer-urotelial-nao-elegiveis-a-cisplatina.html]]></loc><lastmod>2019-02-16T02:02:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/marcadores-preditivos-no-cancer-de-bexiga-de-alto-risco.html]]></loc><lastmod>2019-02-16T01:14:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/pet-psma-na-recorrencia-bioquimica-do-cancer-de-prostata.html]]></loc><lastmod>2019-02-16T03:31:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/expressao-de-pd-l1-no-cancer-de-penis.html]]></loc><lastmod>2019-02-16T01:52:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/video-carvalhal-e-fay.html]]></loc><lastmod>2019-02-15T19:15:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/video-carlos-dzik-e-fernando-nunes.html]]></loc><lastmod>2019-03-21T15:12:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/video-eduardo-zucca-e-lucas-nogueira.html]]></loc><lastmod>2019-02-15T08:50:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/video-andrey-soares-e-fernando-maluf.html]]></loc><lastmod>2019-02-15T17:50:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/video-salvajoli-e-reis.html]]></loc><lastmod>2019-02-15T08:50:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-gu-2019/video-fizazi.html]]></loc><lastmod>2019-02-15T09:02:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-sitc-2019.html]]></loc><lastmod>2020-04-20T14:36:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/esmo-gi-2019.html]]></loc><lastmod>2020-04-20T14:40:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019.html]]></loc><lastmod>2020-04-20T14:36:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/cirurgia-melhora-sobrevida-em-pacientes-com-cancer-de-mama-her2-estadio-iv.html]]></loc><lastmod>2019-04-03T14:11:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/imunoterapia-dados-agrupados-mostram-ganho-de-sobrevida-no-cpnpc.html]]></loc><lastmod>2019-04-03T14:12:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/oncotarget-mostra-resultados-no-aacr-2019.html]]></loc><lastmod>2019-04-02T20:02:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/perfil-imunogenomico-no-cpnpc.html]]></loc><lastmod>2019-04-02T20:04:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/cancer-de-cabeca-e-pescoco-os-destaques-da-aacr-2019.html]]></loc><lastmod>2019-04-02T20:06:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/aacr-2019-destaques-e-perspectivas.html]]></loc><lastmod>2019-04-02T20:08:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/aacr-2019-estudo-brasileiro-investiga-saliva-como-biomarcador-do-cancer-oral.html]]></loc><lastmod>2019-04-02T11:59:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/assinaturas-prognosticas-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2019-04-02T11:50:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/pesquisa-brasileira-discute-estrategias-no-cancer-de-mama.html]]></loc><lastmod>2019-04-02T11:41:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/baixas-taxas-de-vacinacao-contra-hpv-em-adultos-com-alto-risco-de-infeccao-por-hiv.html]]></loc><lastmod>2019-04-03T13:02:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/vacina-preventiva-mostra-resultados-no-modelo-pre-clinico-da-sindrome-de-lynch.html]]></loc><lastmod>2019-04-01T20:24:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/aacr-2019/terapia-car-t-cell-dirigida-a-mesotelina-mostra-atividade-promissora-em-tumores-solidos-avancados.html]]></loc><lastmod>2019-03-31T15:23:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019.html]]></loc><lastmod>2020-04-20T14:36:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/asco-2019-e-os-caminhos-do-tratamento-oncologico.html]]></loc><lastmod>2019-06-30T03:32:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/evidencias-e-perspectivas-na-oncologia-mamaria.html]]></loc><lastmod>2019-06-30T03:12:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/panorama-gu-mostra-avancos-com-impacto-clinico.html]]></loc><lastmod>2019-06-30T03:13:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/oncologia-toracica-reconfigura-padrao-terapeutico.html]]></loc><lastmod>2019-06-30T03:13:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/entusiasmo-na-oncoginecologia.html]]></loc><lastmod>2019-06-30T03:14:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/dilemas-e-promessas-no-panorama-gi.html]]></loc><lastmod>2019-06-30T03:15:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/novo-padrao-no-tratamento-do-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2019-06-30T03:09:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/highlights-em-melanoma.html]]></loc><lastmod>2019-06-30T03:30:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/quem-e-o-paciente-de-alto-custo-no-tratamento-oncologico.html]]></loc><lastmod>2019-06-25T13:24:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/rivaroxabana-reduz-o-tev-em-pacientes-ambulatoriais-ambulatoriais-com-cancer-de-pancreas.html]]></loc><lastmod>2019-11-28T14:15:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/panorama-gu-as-licoes-da-asco.html]]></loc><lastmod>2019-06-04T04:10:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/cirurgia-oncologica-na-asco-2019.html]]></loc><lastmod>2019-06-05T22:23:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/estrategias-no-cpnpc-metastatico.html]]></loc><lastmod>2019-06-04T04:04:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/avancos-no-cancer-de-mama-inicial.html]]></loc><lastmod>2019-06-04T03:58:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/novidades-na-ginecologia-oncologica.html]]></loc><lastmod>2019-06-04T03:52:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/neuro-onco-o-que-ha-de-novo.html]]></loc><lastmod>2019-06-04T03:48:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/asco-destaca-avancos-no-cancer-renal-metastatico.html]]></loc><lastmod>2019-06-04T04:23:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/avelumabe-anti-pd-l1-no-cancer-endometrial.html]]></loc><lastmod>2019-08-27T15:07:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/imuno-oncologia-no-cancer-esofagogastrico.html]]></loc><lastmod>2019-06-13T02:41:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/solo-3-e-destaque-em-apresentacao-oral.html]]></loc><lastmod>2019-06-11T21:56:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/analise-molecular-e-resultados-clinicos-no-glioma-anaplasico.html]]></loc><lastmod>2019-06-03T22:53:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/biopsia-liquida-por-digital-droplet-pcr-dd-pcr-para-decisao-terapeutica-em-tumores-solidos-avancados.html]]></loc><lastmod>2019-06-12T12:25:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/oncogenomica-e-biomarcadores.html]]></loc><lastmod>2020-06-02T14:00:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/gi-nao-colorretal-avancos-e-controversias.html]]></loc><lastmod>2020-06-02T13:53:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/heritage-1-biossimilar-registrado-no-brasil-mostra-dados-de-seguranca-e-eficacia.html]]></loc><lastmod>2019-06-03T17:07:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/monaleesa-7-analise-de-expressao-genica-e-tema-de-poster-discussion-na-asco-2019.html]]></loc><lastmod>2019-06-07T12:39:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/trastuzumabe-biossimilar-aprovado-no-brasil-mostra-na-asco-resultados-de-pos-comercializacao.html]]></loc><lastmod>2019-06-04T04:38:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/inibidores-de-braf-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:12:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/oncologista-brasileira-coordena-comite-internacional-da-asco.html]]></loc><lastmod>2019-06-12T22:33:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/nab-paclitaxel-na-adjuvancia-do-cancer-de-pancreas.html]]></loc><lastmod>2019-06-02T03:17:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/os-highlights-de-cancer-de-colon.html]]></loc><lastmod>2019-06-02T03:33:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/oncologia-toracica-promessas-e-desafios.html]]></loc><lastmod>2019-06-02T03:32:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/imunoterapia-mostra-resultados-de-5-anos-no-cpnpc.html]]></loc><lastmod>2019-06-02T04:05:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/lideranca-medica-na-america-latina.html]]></loc><lastmod>2019-06-02T04:21:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/biopsia-liquida-e-valor-prognostico-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2019-06-02T23:04:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/sequencia-de-tratamento-neoadjuvante-e-desfecho-clinico-no-cancer-de-mama.html]]></loc><lastmod>2019-06-02T20:49:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/video-aline-e-thiago.html]]></loc><lastmod>2019-06-01T18:38:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/heterogeneidade-do-psma-e-defeitos-de-reparo-do-dna-no-cancer-de-prostata.html]]></loc><lastmod>2019-06-01T06:15:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/cancer-de-glandulas-salivares-her2-amplificado-basket-trial-fase-ii.html]]></loc><lastmod>2019-06-01T06:14:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/qualidade-de-vida-no-cancer-de-prostata-nao-metastatico-resistente-a-castracao.html]]></loc><lastmod>2019-06-01T03:09:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/asco-2019-estudo-brasileiro-analisa-zika-virus-no-glioblastoma.html]]></loc><lastmod>2019-05-22T20:40:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/lei-dos-60-inteligencia-artificial-e-acesso-ao-tratamento-oncologico.html]]></loc><lastmod>2019-05-23T12:59:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/meta-analise-avalia-inibidores-de-ciclinas-no-cancer-de-mama-receptor-hormonal.html]]></loc><lastmod>2019-05-30T23:39:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/eficacia-da-lenalidomida-em-individuos-de-alto-risco-para-o-mieloma-multiplo.html]]></loc><lastmod>2019-05-20T03:26:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/match-alteracoes-moleculares-acionaveis-em-tumores-pediatricos.html]]></loc><lastmod>2019-05-16T12:04:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/entrectinib-em-criancas-e-adolescentes-com-cancer-do-snc-e-tumores-com-fusoes-de-genes-especificos.html]]></loc><lastmod>2019-05-20T03:29:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/dieta-com-baixo-teor-de-gordura-reduz-o-risco-de-morte-por-cancer-de-mama-em-mulheres-na-pos-menopausa.html]]></loc><lastmod>2019-05-20T03:32:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/quimioterapia-em-baixa-dose-e-efetiva-em-pacientes-idosos-e-frageis-com-cancer-gastroesofagico.html]]></loc><lastmod>2019-05-21T23:24:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2019/asco-2019/asco-2019-destaques-do-encontro-anual.html]]></loc><lastmod>2019-04-22T02:27:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018.html]]></loc><lastmod>2019-05-26T21:42:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gu-2018.html]]></loc><lastmod>2019-05-26T21:50:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gu-2018/pout-quimioterapia-perioperatoria-versus-vigilancia-no-cancer-urotelial-do-trato-superior.html]]></loc><lastmod>2018-06-16T05:13:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gu-2018/radioterapia-guiada-por-imagem-diaria-versus-semanal-no-cancer-de-prostata.html]]></loc><lastmod>2018-02-19T00:39:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gu-2018/olaparibe-e-durvalumabe-no-cancer-de-prostata-metastatico-resistente-a-castracao.html]]></loc><lastmod>2018-02-20T11:40:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gu-2018/falcon-impacto-do-pet-ct-com-18f-fluciclovina-no-manejo-clinico-do-cancer-de-prostata-com-recidiva-bioquimica.html]]></loc><lastmod>2018-02-15T12:43:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gu-2018/estudo-mostra-resultados-promissores-no-carcinoma-renal-avancado.html]]></loc><lastmod>2018-02-15T12:44:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gu-2018/novo-modelo-prediz-sobrevida-de-pacientes-com-cancer-de-bexiga-em-tratamento-com-imunoterapia.html]]></loc><lastmod>2018-02-23T20:55:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gu-2018/imunoterapia-em-primeira-linha-no-cancer-renal.html]]></loc><lastmod>2018-02-15T12:51:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/sgo-2018.html]]></loc><lastmod>2019-05-26T21:49:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018.html]]></loc><lastmod>2019-05-26T21:49:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/mudanca-de-paradigma-2.html]]></loc><lastmod>2019-06-25T14:43:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/novas-abordagens-em-tumores-geniturinarios.html]]></loc><lastmod>2018-07-10T07:09:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/novos-rumos-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2018-07-10T05:13:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/destaques-da-oncoginecologia.html]]></loc><lastmod>2018-07-10T04:11:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/cenario-de-consolidacao.html]]></loc><lastmod>2018-07-10T03:28:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/licoes-para-evitar-o-overtreatment.html]]></loc><lastmod>2018-07-10T02:51:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/avancos-e-incertezas-na-oncologia-toracica.html]]></loc><lastmod>2018-07-10T07:15:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/prosper-analises-de-qualidade-de-vida.html]]></loc><lastmod>2018-07-25T12:13:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/controversias-em-cancer-de-mama.html]]></loc><lastmod>2018-06-16T05:11:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/mudanca-de-paradigma.html]]></loc><lastmod>2018-06-14T19:43:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/destaques-em-cancer-colorretal.html]]></loc><lastmod>2018-06-12T13:44:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/cancer-de-pulmao-na-asco-2018.html]]></loc><lastmod>2020-04-24T19:48:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/panorama-do-cancer-de-prostata.html]]></loc><lastmod>2018-06-11T03:50:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/atualizacao-em-melanoma.html]]></loc><lastmod>2018-06-11T01:56:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/imunoterapia-no-cancer-de-mama.html]]></loc><lastmod>2018-06-11T01:52:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/perspectivas-da-genomica.html]]></loc><lastmod>2018-06-11T01:52:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/radioterapia-em-cancer-de-mama-e-pancreas.html]]></loc><lastmod>2018-06-10T22:51:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/realgido-eficacia-e-seguranca-em-estudo-de-mundo-real.html]]></loc><lastmod>2024-06-13T11:57:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/diagnostico-de-sarcomas-em-cenarios-de-recursos-limitados.html]]></loc><lastmod>2018-06-10T21:33:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/asco-2018-highlights-em-tumores-gastrointestinais.html]]></loc><lastmod>2018-06-06T18:32:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/quimiorradioterapia-pre-operatoria-no-cancer-de-pancreas.html]]></loc><lastmod>2018-06-10T23:07:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/mfolfirinox-mostra-ganho-de-sobrevida-no-cancer-de-pancreas.html]]></loc><lastmod>2018-06-06T18:33:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/asco-mostra-promessas-de-anti-fgfr-no-cancer-urotelial.html]]></loc><lastmod>2018-06-11T03:37:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/hipec-nao-mostra-beneficio-de-sobrevida-no-cancer-colorretal.html]]></loc><lastmod>2018-06-06T21:23:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/carmena-terapia-alvo-vs-nefrectomia-no-cancer-renal-metastatico.html]]></loc><lastmod>2018-06-04T08:16:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/highlights-em-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2018-06-04T08:12:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/estudo-brasileiro-em-poster-discussion.html]]></loc><lastmod>2018-06-04T08:13:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/avancos-em-tumores-gastricos-e-de-juncao-gastroesofagica.html]]></loc><lastmod>2018-06-04T07:49:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/destaques-da-sessao-oral-gu-nao-prostata.html]]></loc><lastmod>2018-06-04T07:36:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/onco-ginecologia-em-pauta.html]]></loc><lastmod>2018-06-04T07:31:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/biopsia-liquida-no-diagnostico-do-cancer-de-pulmao-inicial-2.html]]></loc><lastmod>2020-04-24T17:19:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/radioterapia-avancos-e-controversias-na-asco-2018.html]]></loc><lastmod>2018-06-04T03:26:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/neosamba-impacto-da-sequencia-de-tratamento-no-cancer-de-mama.html]]></loc><lastmod>2018-06-04T00:56:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/tailorx-teste-genomico-e-gestao-de-risco-no-cancer-de-mama.html]]></loc><lastmod>2018-06-04T19:04:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/imunoterapia-mostra-novos-resultados-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:20:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/carmena-novo-paradigma-no-cancer-renal.html]]></loc><lastmod>2018-06-03T12:32:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/o-que-esperar-das-novas-terapias-para-cancer-gastrico-e-jeg.html]]></loc><lastmod>2018-06-02T20:27:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/pesquisa-global-no-cancer-de-mama-como-avancar.html]]></loc><lastmod>2018-06-02T18:03:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/custo-e-valor-exemplo-brasileiro-na-asco.html]]></loc><lastmod>2018-06-02T17:44:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/marcadores-genomicos-na-sindrome-de-lynch.html]]></loc><lastmod>2018-06-04T13:47:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/biopsia-liquida-no-diagnostico-do-cancer-de-pulmao-inicial.html]]></loc><lastmod>2020-04-24T17:20:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/taselisib-toxicidade-desafia-eficacia-no-cancer-de-mama-avancado.html]]></loc><lastmod>2018-06-02T16:51:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/raca-e-sobrevida-global-no-cancer-de-prostata.html]]></loc><lastmod>2018-06-04T03:16:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/abi-race-diferencas-raciais-e-resposta-a-hormonioterapia.html]]></loc><lastmod>2018-06-04T03:19:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/disparidades-de-genero-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2018-06-01T18:12:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/comunicacao-medico-paciente-na-oncogeriatria.html]]></loc><lastmod>2018-06-01T18:12:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/custos-de-saude-contrastes-e-desafios.html]]></loc><lastmod>2018-06-02T20:44:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/estudo-evita-mostra-desafios-na-prevencao-do-cancer-cervical-no-brasil.html]]></loc><lastmod>2018-06-01T21:39:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/o-que-esperar-da-asco-2018.html]]></loc><lastmod>2018-06-01T21:42:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/persephone-tratamento-mais-curto-com-trastuzumabe-no-cancer-de-mama-her2.html]]></loc><lastmod>2019-04-19T19:20:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/estudo-identifica-menor-expressao-de-pd-l1-no-cpnpc-no-brasil.html]]></loc><lastmod>2020-04-24T17:21:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/ressonancia-magnetica-multiparametrica-e-valor-preditivo-no-cancer-de-prostata.html]]></loc><lastmod>2018-06-01T22:00:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/custo-efetividade-de-testes-geneticos-abrangentes-no-cancer-de-pulmao-avancado.html]]></loc><lastmod>2020-04-24T17:21:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/maioria-dos-fumantes-pesados-nao-sao-rastreados-para-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T17:22:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/tecnologia-para-controle-de-sintomas-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2018-06-01T21:45:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/acupuntura-e-terapia-comportamental-cognitiva-no-tratamento-da-insonia-em-sobreviventes-de-cancer.html]]></loc><lastmod>2018-06-01T21:44:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-2018/asco-2018-destaques-do-encontro-anual.html]]></loc><lastmod>2018-06-01T21:58:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro.html]]></loc><lastmod>2019-05-26T21:50:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/congresso-franco-brasileiro-chega-a-10-edicao.html]]></loc><lastmod>2018-09-21T06:11:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/biomarcadores-no-cancer-de-prostata.html]]></loc><lastmod>2018-09-25T13:46:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/como-a-biologia-molecular-pode-ajudar-na-conducao-do-tratamento-ha-marcadores-para-auxiliar-na-decisao-terapeutica.html]]></loc><lastmod>2018-09-21T04:21:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/qual-o-melhor-regime-de-conversao-em-cancer-colorretal-metastatico-para-figado.html]]></loc><lastmod>2018-09-21T04:09:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/tratamento-sistemico-isolado-e-meningite-carcinomatosa-no-cancer-de-mama.html]]></loc><lastmod>2018-09-21T03:06:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/quimioterapia-adjuvante-nos-tumores-periampulares---o-que-fazer.html]]></loc><lastmod>2018-09-21T02:52:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/tratamento-sistemico-no-cancer-de-colo-de-utero.html]]></loc><lastmod>2018-09-21T02:38:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/melanoma-avancado-qual-a-melhor-abordagem.html]]></loc><lastmod>2018-09-21T02:29:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/uso-racional-do-diagnostico-oncogenetico.html]]></loc><lastmod>2018-09-21T02:14:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/tratamento-do-mieloma-multiplo-recidivado-ou-refratario-novas-opcoes-no-brasil.html]]></loc><lastmod>2018-09-21T02:01:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/linfoma-folicular-o-que-ha-de-novo.html]]></loc><lastmod>2018-09-21T01:48:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/1-simposio-do-grupo-brasileiro-de-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2018-09-21T13:14:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/a-medicina-de-precisao-no-cancer-de-pulmao.html]]></loc><lastmod>2018-09-21T01:30:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/cancer-e-microbiota-intestinal.html]]></loc><lastmod>2018-09-21T01:26:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/novas-perspectivas-no-cancer-de-pulmao-inicial.html]]></loc><lastmod>2020-04-24T19:59:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/os-desafios-da-prevencao-do-cancer-de-boca.html]]></loc><lastmod>2020-04-23T20:34:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/x-congresso-franco-brasileiro/video-casali-e-murad.html]]></loc><lastmod>2018-09-21T06:16:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018.html]]></loc><lastmod>2019-05-26T21:50:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/video-murad-2-carga-mutacional-e-cpnpc.html]]></loc><lastmod>2018-11-05T18:30:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/quimiorradioterapia-pos-18-fdg-pet-ct-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2018-10-30T04:11:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/eficacia-e-seguranca-do-sorafenibe-em-idosos-com-carcinoma-hepatocelular.html]]></loc><lastmod>2018-10-30T02:45:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/destaques-em-tumores-colorretais-na-esmo-2018.html]]></loc><lastmod>2018-10-29T17:56:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/oncologia-toracica-as-licoes-da-esmo-2018.html]]></loc><lastmod>2018-10-27T13:14:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/imunoterapia-na-pratica-clinica.html]]></loc><lastmod>2018-10-23T02:16:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/cancer-de-pulmao-neoadjuvancia-na-doenca-inicial.html]]></loc><lastmod>2018-10-23T21:12:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/carcinoma-espinocelular-anal-localizado-e-infeccao-por-hiv.html]]></loc><lastmod>2018-10-23T01:37:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/quimioterapia-de-inducao-no-cancer-de-esofago-localmente-avancado.html]]></loc><lastmod>2018-10-23T01:20:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/abordagem-cirurgica-no-cancer-de-mama.html]]></loc><lastmod>2018-10-23T01:03:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/a-abordagem-axilar-minima-leva-a-perda-de-fatores-prognosticos-no-cancer-de-mama.html]]></loc><lastmod>2018-10-23T00:56:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/quimioterapia-de-inducao-mais-quimiorradioterapia-com-aspirina-no-cancer-de-reto.html]]></loc><lastmod>2018-10-25T23:47:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/quimioterapia-neoadjuvante-e-cirurgia-radical-versus-quimiorradiacao-no-cancer-de-colo-uterino.html]]></loc><lastmod>2018-10-30T02:30:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/fadiga-em-pacientes-tratados-com-olaparibe.html]]></loc><lastmod>2018-10-30T01:58:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/getug-12-dados-atualizados-no-cancer-de-prostata-localizado.html]]></loc><lastmod>2018-10-22T22:30:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/video-cancer-renal-na-esmo-2018-o-que-ha-de-novo.html]]></loc><lastmod>2018-10-22T15:47:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/video-destaques-em-cancer-de-prostata.html]]></loc><lastmod>2018-10-22T06:51:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/video-imunoterapia-no-cancer-de-mama.html]]></loc><lastmod>2018-10-22T06:50:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/video-panorama-gi-nao-colorretal-na-esmo-2018.html]]></loc><lastmod>2018-10-21T20:39:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/destaques-da-oncoginecologia.html]]></loc><lastmod>2018-10-21T22:12:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/video-cancer-de-bexiga-na-esmo-2018.html]]></loc><lastmod>2018-10-21T15:59:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/neoadjuvancia-na-oncologia-toracica.html]]></loc><lastmod>2018-10-21T20:53:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/metastase-cerebral-em-pacientes-com-cancer-de-ovario.html]]></loc><lastmod>2018-10-21T09:58:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/barreiras-limitam-participacao-de-adolescentes-e-jovens-na-pesquisa-em-cancer.html]]></loc><lastmod>2018-10-21T21:59:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/cancer-e-atividade-fisica.html]]></loc><lastmod>2018-10-21T21:30:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/franca-identifica-barreiras-para-o-rastreamento-populacional.html]]></loc><lastmod>2018-10-21T21:04:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/evita-qualidade-de-vida-de-pacientes-com-cancer-de-colo-do-utero-recem-diagnosticados-no-brasil.html]]></loc><lastmod>2018-10-20T21:43:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/video-highlights-em-cancer-de-mama.html]]></loc><lastmod>2018-10-21T05:20:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/video-pesquisa-translacional-na-esmo-2018.html]]></loc><lastmod>2018-10-20T22:35:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/esmo-2018-discute-cancer-e-fertilidade.html]]></loc><lastmod>2018-10-21T22:37:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/atualizacao-em-cancer-de-prostata.html]]></loc><lastmod>2024-05-04T20:09:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/biossimilares-falta-educacao-medica.html]]></loc><lastmod>2018-10-20T20:25:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/w4o-pede-igualdade-de-genero-na-oncologia.html]]></loc><lastmod>2018-10-18T12:39:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/pacientes-com-cancer-de-mama-e-o-twitter.html]]></loc><lastmod>2018-10-15T02:04:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/uso-de-medicina-integrativa-e-complementar-em-pacientes-com-sarcoma.html]]></loc><lastmod>2018-10-10T20:33:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/esmo-2018/expansao-da-oferta-de-terapias-alvo-para-o-cancer-avancado-nos-estados-unidos.html]]></loc><lastmod>2018-10-09T13:58:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/hemo-2018.html]]></loc><lastmod>2019-05-26T21:51:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/hemo-2018/atualizacao-em-linfomas-cutaneos.html]]></loc><lastmod>2019-01-21T12:31:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/hemo-2018/tratamento-da-mielofibrose-de-risco-intermediario-e-de-alto-risco.html]]></loc><lastmod>2018-11-04T21:11:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/hemo-2018/llc-doenca-residual-minima-e-resposta-terapeutica.html]]></loc><lastmod>2018-11-04T21:08:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/hemo-2018/hot-topics-em-transplante-de-medula-ossea.html]]></loc><lastmod>2018-11-04T21:04:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/hemo-2018/avancos-no-tratamento-do-mieloma-multiplo.html]]></loc><lastmod>2018-11-04T21:01:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/hemo-2018/tratamento-de-infeccoes-no-paciente-com-mieloma.html]]></loc><lastmod>2018-11-04T20:57:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018.html]]></loc><lastmod>2019-05-26T21:51:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/novo-conceito-em-llc.html]]></loc><lastmod>2019-01-21T12:29:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/eventos-adversos-tardios-da-car-t-cells-anti-cd19.html]]></loc><lastmod>2019-01-21T11:48:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/modelo-personalizado-melhora-precisao-do-prognostico-para-sindromes-mielodisplasicas.html]]></loc><lastmod>2018-12-04T12:02:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/ash-2018-resultados-e-perspectivas.html]]></loc><lastmod>2018-12-04T03:05:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/lmc-grupo-brasileiro-apresenta-resultados-na-ash-2018.html]]></loc><lastmod>2018-12-04T01:09:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/rastreamento-genetico-rapido-mostra-viabilidade-da-medicina-de-precisao-para-leucemia-mieloide-aguda.html]]></loc><lastmod>2018-12-04T00:35:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/atualizacao-em-leucemias-agudas.html]]></loc><lastmod>2018-12-03T19:59:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/mieloma-multiplo-ash-destaca-resultados-do-anti-cd-38-na-primeira-linha.html]]></loc><lastmod>2018-12-03T23:17:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/ash-2018-promessas-no-linfoma-difuso-de-grandes-celulas.html]]></loc><lastmod>2018-12-03T12:59:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/impacto-prognostico-de-mutacoes-nras-e-kras-na-mielofibrose.html]]></loc><lastmod>2018-12-02T21:04:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/ash-2018/llc-o-que-muda-na-primeira-linha.html]]></loc><lastmod>2018-12-02T17:17:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018.html]]></loc><lastmod>2019-05-26T21:51:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/autoestima-e-qualidade-de-vida-em-pacientes-com-cancer-de-mama.html]]></loc><lastmod>2019-01-30T11:38:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/dexrazoxano-para-cardioprotecao-em-pacientes-com-cancer-de-mama-tratados-com-antraciclinas.html]]></loc><lastmod>2019-03-06T21:44:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/infusao-de-quimio-neoadjuvante-homolateral-ao-cancer-de-mama-e-risco-de-linfedema.html]]></loc><lastmod>2019-02-04T14:13:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/navegacao-da-paciente-com-cancer-de-mama-no-rio-de-janeiro.html]]></loc><lastmod>2019-01-30T11:43:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/pesquisa-do-linfonodo-pos-qt-neoadjuvante-no-cancer-de-mama.html]]></loc><lastmod>2018-12-11T22:28:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/neoadjuvancia-hormonal-no-cancer-de-mama.html]]></loc><lastmod>2018-12-11T22:30:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/posteres-brasileiros-em-foco.html]]></loc><lastmod>2019-01-14T18:44:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/metanalise-do-ebctcg-e-os-destaques-da-radioterapia-no-sabcs-2018.html]]></loc><lastmod>2018-12-11T22:32:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/cirurgia-e-qualidade-de-vida-na-mulher-jovem-com-cancer-de-mama.html]]></loc><lastmod>2018-12-11T16:54:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/oxibutinina-no-controle-de-fogachos-em-sobreviventes-do-cancer-de-mama.html]]></loc><lastmod>2018-12-11T16:55:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/sabcs-2018-10-anos-do-estudo-amaro.html]]></loc><lastmod>2018-12-10T12:07:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/hormonioterapia-no-cancer-de-mama.html]]></loc><lastmod>2018-12-08T15:41:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/amazona-iii---brasil-apresenta-resultados-no-sabcs2018.html]]></loc><lastmod>2018-12-12T20:11:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/imunoterapia-no-cancer-de-mama-triplo-negativo-e-novidades-do-sabcs-2018.html]]></loc><lastmod>2018-12-07T22:43:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/destaques-de-radioterapia.html]]></loc><lastmod>2018-12-10T22:38:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/san-antonio-2018/atraso-na-quimioterapia-adjuvante-associado-a-piores-desfechos-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2018-12-07T04:16:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gi-2018.html]]></loc><lastmod>2019-05-26T21:49:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gi-2018/checkmate-142-nivo-ipi-no-cancer-colorretal-metastatico-com-deficiencia-no-mismatch-repair-e-alta-instabilidade-de-microsatelites.html]]></loc><lastmod>2018-02-19T04:53:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gi-2018/scot-lateralidade-tumoral-e-influencia-da-duracao-da-quimioterapia-na-sobrevida-livre-de-doenca.html]]></loc><lastmod>2018-02-19T04:54:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gi-2018/reverce-sequencia-ideal-de-tratamento-com-regorafenibe-e-cetuximabe-no-cancer-colorretal-metastatico-previamente-tratado.html]]></loc><lastmod>2018-02-19T04:55:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gi-2018/celestial-cabozantinibe-no-carcinoma-hepatocelular-avancado.html]]></loc><lastmod>2018-01-22T01:50:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gi-2018/folfox-adjuvante-no-cancer-de-colon-estadio-iii.html]]></loc><lastmod>2018-01-21T23:39:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2018/asco-gi-2018/keynote-224-pembrolizumabe-em-pacientes-com-carcinoma-hepatocelular-avancado-previamente-tratado.html]]></loc><lastmod>2018-02-19T04:57:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017.html]]></loc><lastmod>2019-05-26T21:42:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/ash-2017.html]]></loc><lastmod>2019-05-26T21:47:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/ash-2017/mieloma-multiplo-em-foco.html]]></loc><lastmod>2018-11-04T16:37:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/ash-2017/murano-mostra-dados-em-llc.html]]></loc><lastmod>2017-12-17T19:37:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/ash-2017/alcyone-mostra-resultados-no-mieloma-multiplo.html]]></loc><lastmod>2017-12-18T02:06:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/ash-2017/combinacao-de-terapias-alvo-e-promessa-na-leucemia-linfocitica-cronica.html]]></loc><lastmod>2017-12-17T17:34:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/ash-2017/combinacao-de-drogas-alvo-reduz-o-risco-de-falha-no-tratamento-de-primeira-linha-no-linfoma-de-hodgkin-avancado.html]]></loc><lastmod>2017-12-17T17:36:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/ash-2017/mogamulizumab-mostra-resultados-no-linfoma-cutaneo-de-celulas-t-pre-tratado.html]]></loc><lastmod>2017-12-20T22:28:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/ash-2017/ash-2017-e-os-destaques-da-oncohematologia.html]]></loc><lastmod>2017-12-17T19:34:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gu-2017.html]]></loc><lastmod>2019-05-26T21:45:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gu-2017/asco-gu-vigilancia-ativa-no-cancer-renal.html]]></loc><lastmod>2017-08-22T17:55:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gu-2017/destaques-do-panorama-geniturinario.html]]></loc><lastmod>2017-03-21T12:41:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gu-2017/asco-gu-os-estudos-que-marcaram-o-programa-cientifico.html]]></loc><lastmod>2017-02-21T14:19:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gu-2017/biopsia-liquida-e-avaliacao-genomica-no-cancer-renal.html]]></loc><lastmod>2017-02-21T17:38:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gu-2017/quimioterapia-e-recorrencia-no-cancer-de-testiculo-de-alto-risco.html]]></loc><lastmod>2017-02-19T16:04:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gu-2017/uso-de-antibioticos-pode-reduzir-eficacia-da-imunoterapia.html]]></loc><lastmod>2017-02-21T14:20:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gu-2017/asco-gu-resposta-duradoura-apos-a-interrupcao-da-imunoterapia-no-cancer-renal-avancado.html]]></loc><lastmod>2017-02-21T17:28:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gi-2017.html]]></loc><lastmod>2019-05-26T21:48:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gi-2017/destaques-da-asco-gi-2017.html]]></loc><lastmod>2017-03-17T18:11:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gi-2017/gemox-adjuvante-no-cancer-do-trato-biliar-localizado.html]]></loc><lastmod>2017-02-21T14:24:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gi-2017/checkmate-040-nivolumabe-como-monoterapia-no-carcinoma-hepatocelular-avancado.html]]></loc><lastmod>2017-02-21T17:02:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gi-2017/cabozantinibe-em-tumores-neuroendocrinos-carcinoides-pancreaticos.html]]></loc><lastmod>2017-02-21T16:14:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gi-2017/atividade-fisica-e-sobrevida-no-cancer-colorretal-avancado.html]]></loc><lastmod>2017-02-21T14:24:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gi-2017/pet-scan-e-avaliacao-de-resposta-ao-tratamento-do-cancer-de-esofago.html]]></loc><lastmod>2017-02-21T14:24:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-gi-2017/asco-gi-abordagem-watch-and-wait-no-cancer-de-reto.html]]></loc><lastmod>2017-02-21T15:54:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017.html]]></loc><lastmod>2019-05-26T21:46:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/estrategias-no-tratamento-de-tumores-ginecologicos.html]]></loc><lastmod>2017-08-07T07:03:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/analise-neuro-onco.html]]></loc><lastmod>2017-07-05T21:30:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/uro-oncologia-mantem-entusiasmo.html]]></loc><lastmod>2017-07-04T20:50:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/panorama-gu-na-asco-2017.html]]></loc><lastmod>2017-07-04T20:51:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/analise-gtg.html]]></loc><lastmod>2017-07-01T19:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/cabeca-e-pescoco.html]]></loc><lastmod>2017-06-26T17:04:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/oncologista-brasileiro-recebe-o-idea-award-2017.html]]></loc><lastmod>2017-06-20T21:12:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/imunoterapia-para-o-mesotelioma-maligno-de-pleura.html]]></loc><lastmod>2017-06-12T16:53:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/estudo-da-asco-chama-a-atencao-para-o-cancer-e-a-saude-ocupacional.html]]></loc><lastmod>2017-06-13T20:35:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/kamilla-tdm-1-no-cancer-de-mama-her2.html]]></loc><lastmod>2017-06-14T21:45:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/oncogenetica-no-cancer-de-ovario-platino-resistente.html]]></loc><lastmod>2017-06-12T13:44:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/imunoterapia-no-cancer-de-celulas-renais-metastatico.html]]></loc><lastmod>2017-06-12T15:21:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/andre-fay.html]]></loc><lastmod>2017-06-16T23:11:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/conquer-fear-abordagem-ajuda-a-reduzir-medo-da-recidiva.html]]></loc><lastmod>2017-06-12T15:08:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/pedro-nazareth-aguiar.html]]></loc><lastmod>2017-06-13T22:22:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/estudo-mostra-ganho-de-sobrevida-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2017-06-12T14:02:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/video-buzaid-resumo-da-sessao-oral-de-melanoma.html]]></loc><lastmod>2017-06-12T20:15:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/video-11-mutacoes-hereditarias-em-genes-que-afetam-o-reparo-do-dna.html]]></loc><lastmod>2017-06-08T16:31:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/video-12-nivolumabe-neoadjuvante-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:35:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/terapia-car-t-mostra-dados-iniciais-de-remissao-no-mieloma-multiplo.html]]></loc><lastmod>2017-06-06T19:16:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/felipe-prodocimo-lestingi.html]]></loc><lastmod>2018-05-02T14:46:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/video-8-sessao-plenaria-olaparibe-mono-x-quimioterapia-em-cancer-de-mama-her2-metastatico-e-mutacao-germinativa-dos-genes-brca.html]]></loc><lastmod>2017-06-12T17:18:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/imunoterapia-no-cancer-de-pulmao-seguranca-e-toxicidade.html]]></loc><lastmod>2020-04-24T18:35:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/presenca-brasileira-na-asco-2017.html]]></loc><lastmod>2017-06-19T00:25:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/video-10-sessao-plenaria-cancer-de-prostata---terapia-de-privacao-de-androgenio-com-abiraterona-prednisona-versus-placebo.html]]></loc><lastmod>2017-06-12T14:57:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/fernando-maluf-o-papel-da-cirurgia-nos-pacientes-em-que-a-doenca-retornou.html]]></loc><lastmod>2017-06-12T20:01:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/video-9-sessao-plenaria-cancer-colorretal---3-ou-6-meses-com-a-oxaliplatina.html]]></loc><lastmod>2017-06-16T18:19:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/raphael-brandao.html]]></loc><lastmod>2017-06-12T15:48:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/profiler-importancia-do-teste-genomico-para-a-medicina-de-precisao.html]]></loc><lastmod>2017-06-12T00:30:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/inibidor-de-parp-no-cancer-de-mama-metastatico-brca-mutado.html]]></loc><lastmod>2017-06-12T17:20:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/fernando-maluf-estudo-sobre-cirurgia-para-cancer-de-ovario.html]]></loc><lastmod>2017-06-12T20:01:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/kaliks-testes-moleculares-para-identificar-alvos-terapeuticos.html]]></loc><lastmod>2017-06-08T21:44:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/teste-genomico-de-rotina-e-viavel-mas-beneficia-apenas-um-subgrupo-de-pacientes.html]]></loc><lastmod>2017-06-03T19:28:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/intervencao-psicologica-alivia-distress-em-pacientes-com-cancer-avancado.html]]></loc><lastmod>2017-06-12T15:15:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/prevencao-e-gestao-do-cancer-um-desafio-global.html]]></loc><lastmod>2017-06-12T14:38:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/asco-discute-nova-classificacao-para-tumores-linfoides.html]]></loc><lastmod>2017-05-29T00:44:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/imuno-oncologia-no-cancer-gastrico.html]]></loc><lastmod>2017-05-29T00:45:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/aphinity---duplo-bloqueio-her2-na-adjuvancia.html]]></loc><lastmod>2017-06-12T17:24:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/asco-discute-prevencao-e-promocao-da-saude.html]]></loc><lastmod>2017-05-29T00:46:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/asco-2017/presenca-brasileira-na-asco.html]]></loc><lastmod>2017-06-12T14:42:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/retrospectiva-2017.html]]></loc><lastmod>2019-05-26T21:47:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/retrospectiva-2017/cancer-de-mama-em-pauta.html]]></loc><lastmod>2018-02-19T04:50:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/retrospectiva-2017/cuidados-paliativos-em-foco.html]]></loc><lastmod>2018-02-04T22:15:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/retrospectiva-2017/mudancas-na-pratica-clinica.html]]></loc><lastmod>2018-01-21T20:40:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/retrospectiva-2017/gtg-destaca-os-top-3-no-panorama-gi.html]]></loc><lastmod>2018-01-09T16:18:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/retrospectiva-2017/oncologia-toracica-o-ano-em-review.html]]></loc><lastmod>2017-12-18T02:56:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/retrospectiva-2017/promessas-e-controversias-da-neuro-oncologia.html]]></loc><lastmod>2017-12-18T03:02:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/retrospectiva-2017/ginecologia-oncologica-em-pauta.html]]></loc><lastmod>2017-12-18T02:50:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/retrospectiva-2017/avancos-no-tratamento-do-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2017-12-18T03:02:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/retrospectiva-2017/mudancas-no-cancer-de-prostata-hormonio-sensivel.html]]></loc><lastmod>2017-12-18T11:22:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/retrospectiva-2017/uma-nova-era-no-carcinoma-urotelial.html]]></loc><lastmod>2017-12-18T11:23:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/san-antonio-2017.html]]></loc><lastmod>2019-05-26T21:47:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/san-antonio-2017/inibidores-de-ciclinas-apresentam-novas-evidencias-no-sabcs.html]]></loc><lastmod>2017-12-14T19:08:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/san-antonio-2017/panacea-terapia-anti-her2-e-anti-pd-1-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2017-12-15T01:16:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/san-antonio-2017/biopsia-liquida-na-avaliacao-de-risco-de-recorrencia.html]]></loc><lastmod>2017-12-17T15:17:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/san-antonio-2017/sold-duracao-ideal-da-adjuvancia-no-cancer-de-mama-her2.html]]></loc><lastmod>2018-11-12T15:41:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/san-antonio-2017/controle-de-peso-e-risco-de-cancer-de-mama.html]]></loc><lastmod>2017-12-12T19:19:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/san-antonio-2017/embraca-mostra-resultados-de-eficacia-e-seguranca.html]]></loc><lastmod>2018-11-12T15:42:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/san-antonio-2017/abcsg-16-discute-estender-terapia-endocrina-adjuvante.html]]></loc><lastmod>2017-12-11T16:04:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/san-antonio-2017/acupuntura-no-controle-de-sintomas.html]]></loc><lastmod>2017-12-13T21:39:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/san-antonio-2017/meta-analise-discute-intensidade-da-dose-na-quimioterapia-adjuvante.html]]></loc><lastmod>2017-12-11T01:19:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/san-antonio-2017/nsabp-b-47-apresenta-dados-em-san-antonio.html]]></loc><lastmod>2018-11-12T15:40:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/san-antonio-2017/brasileiros-participam-da-conferencia-de-san-antonio.html]]></loc><lastmod>2017-12-11T01:22:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017.html]]></loc><lastmod>2019-05-26T21:46:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/oncologista-brasileiro-e-selecionado-como-um-dos-futuros-lideres-da-esmo.html]]></loc><lastmod>2017-10-01T23:50:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/highlights-em-onco-ginecologia-da-esmo-2017.html]]></loc><lastmod>2017-10-19T12:15:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/abiraterona-ou-docetaxel-no-cancer-de-prostata-avancado-hormonio-sensivel-estudo-head-to-head.html]]></loc><lastmod>2017-09-15T19:28:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/esmo-debate-biossimilares-na-oncologia.html]]></loc><lastmod>2017-09-26T22:17:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/lorelei-taselisib-no-cancer-de-mama-receptor-hormonal.html]]></loc><lastmod>2017-09-18T02:42:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/cancer-de-pulmao-na-esmo-2017.html]]></loc><lastmod>2020-04-24T17:31:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/eficacia-e-seguranca-do-nivolumabe-e-pos-nivolumabe-no-cpnpc-experiencia-do-programa-frances-de-acesso-expandido-eap.html]]></loc><lastmod>2017-09-17T16:42:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/estudo-oak-eficacia-do-atezolizumab-em-subgrupos-de-pacientes-com-cpnpc-pd-l1.html]]></loc><lastmod>2017-09-26T22:18:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/pneumonite-induzida-por-radioterapia-antes-do-uso-do-nivolumabe-e-risco-de-doenca-pulmonar-intersticial.html]]></loc><lastmod>2017-09-17T14:53:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/mutacoes-driver-e-de-resistencia-por-ngs-em-celulas-tumorais-do-liquor-em-metastases-leptomeningeas.html]]></loc><lastmod>2017-09-17T14:48:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/nab-paclitaxel-vs-durvalumabe-no-cpnpc-avancado-previamente-tratado.html]]></loc><lastmod>2017-09-17T14:44:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/duracao-do-tratamento-e-nivolumabe-em-pacientes-com-cpnpc-metastatico-previamente-tratado.html]]></loc><lastmod>2017-09-17T14:38:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/impacto-psicossocial-da-quimioterapia.html]]></loc><lastmod>2017-09-11T21:11:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/cuidados-paliativos-na-assistencia-oncologica.html]]></loc><lastmod>2017-09-11T17:41:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/rucaparib-no-cancer-de-ovario-recorrente.html]]></loc><lastmod>2017-09-17T01:37:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/pembrolizumabe-no-cancer-gastrico-metastatico-pre-tratado.html]]></loc><lastmod>2017-09-11T17:43:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/sequenciamento-de-dna-e-novas-indicacoes-de-medicamentos-para-tumores-raros.html]]></loc><lastmod>2017-09-11T17:44:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/esmo-2017-estudo-avalia-uso-excessivo-de-testes-de-marcadores-tumorais-em-cuidados-primarios-e-secundarios.html]]></loc><lastmod>2017-09-11T17:45:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/esmo-atualiza-escala-de-magnitude-de-beneficio-clinico.html]]></loc><lastmod>2017-09-11T17:45:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2017/esmo-2017/esmo-2017-tomografia-computadorizada-no-seguimento-pos-operatorio-de-cpnpc.html]]></loc><lastmod>2017-09-12T20:27:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016.html]]></loc><lastmod>2017-06-28T18:34:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gu-2016.html]]></loc><lastmod>2017-06-28T18:42:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gu-2016/uso-regular-de-aspirina-e-diminuicao-do-risco-de-cancer-de-prostata.html]]></loc><lastmod>2016-01-18T02:54:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gu-2016/estatinas-e-abiraterona-em-cancer-de-prostata.html]]></loc><lastmod>2016-01-18T02:14:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gu-2016/asco-gu-estrategias-de-hormonioterapia-em-cancer-de-prostata.html]]></loc><lastmod>2016-01-18T02:17:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gu-2016/assinatura-de-resistencia-a-terapia-de-privacao-androgenica-adt-para-prever-falha-no-tratamento-hormonal-adjuvante.html]]></loc><lastmod>2016-01-18T02:26:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gu-2016/2016-genitourinary-cancers-symposium.html]]></loc><lastmod>2016-01-18T02:27:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gu-2016/aspirina-e-cancer-de-prostata.html]]></loc><lastmod>2016-01-18T04:09:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gu-2016/asco-gu-biopsia-liquida-e-selecao-terapeutica-em-cancer-de-prostata.html]]></loc><lastmod>2016-01-18T02:15:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gi-2016.html]]></loc><lastmod>2017-06-28T18:42:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gi-2016/asco-gi-poucas-surpresas.html]]></loc><lastmod>2016-02-21T23:15:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gi-2016/asco-gi-netter-1.html]]></loc><lastmod>2016-02-21T23:15:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gi-2016/asco-gi-custo-e-acesso-na-assistencia-oncologica.html]]></loc><lastmod>2016-02-01T01:21:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gi-2016/asco-gi-recomendacoes-para-selecao-molecular-em-cancer-colorretal.html]]></loc><lastmod>2016-02-21T21:20:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gi-2016/netter-1-mostra-resultados-em-tumores-neuroendocrinos.html]]></loc><lastmod>2016-01-31T23:23:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gi-2016/asco-gi-e-os-destaques-do-panorama-gastrointestinal.html]]></loc><lastmod>2016-02-21T21:28:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-gi-2016/asco-gi-destaques-em-cancer-retal.html]]></loc><lastmod>2016-02-01T01:19:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/elcc-2016.html]]></loc><lastmod>2017-06-28T18:41:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/elcc-2016/biopsia-liquida-e-selecao-terapeutica-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:02:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/elcc-2016/necitumumab-associado-a-quimioterapia-em-cancer-de-pulmao-egfr.html]]></loc><lastmod>2020-04-24T19:01:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/elcc-2016/anti-egfr-de-terceira-geracao-na-primeira-linha-de-cpnpc.html]]></loc><lastmod>2016-05-09T20:08:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/elcc-2016/elcc-2016-pleurectomia-estendida-tem-indicacao-em-idosos.html]]></loc><lastmod>2016-05-03T22:26:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/elcc-2016/atualizacoes-dos-estudos-checkmate-063-e-017-confirmam-eficacia-do-nivolumabe-em-cpnpc-escamosas-avancado-refratario-a-platina.html]]></loc><lastmod>2016-05-03T22:11:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/aacr-2016.html]]></loc><lastmod>2017-06-28T18:41:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/aacr-2016/postergar-a-radioterapia-aumenta-risco-de-tumores-da-mama-ipsilateral-em-mulheres-com-cdis.html]]></loc><lastmod>2016-08-17T19:56:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/aacr-2016/pembrolizumab-mostra-resposta-duradoura-m-carcinoma-de-celulas-de-merkel-avancado.html]]></loc><lastmod>2016-05-04T19:20:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/aacr-2016/nutricao-e-cancer-novas-evidencias.html]]></loc><lastmod>2016-05-04T19:14:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/aacr-2016/palbociclib-no-cancer-de-mama-inicial.html]]></loc><lastmod>2016-05-04T19:17:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/aacr-2016/antiangiogenico-em-llc.html]]></loc><lastmod>2016-05-04T19:04:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016.html]]></loc><lastmod>2017-06-28T18:40:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/impacto-na-pratica-clinica.html]]></loc><lastmod>2016-11-15T17:17:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/keynote-021-imunoterapia-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:48:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/monaleesa2-ribociclib-no-cancer-de-mama-avancado.html]]></loc><lastmod>2016-10-28T13:39:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/checkmate-141-imunoterapia-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2016-10-14T00:10:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/cabozantinibe-na-primeira-linha-do-cancer-renal.html]]></loc><lastmod>2016-10-11T15:40:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/keynote-024-imunoterapia-na-primeira-linha-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:51:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/esmo-ipilimumabe-adjuvante-no-melanoma-de-alto-risco-estadio-iii.html]]></loc><lastmod>2016-10-10T04:20:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/cancer-de-cabeca-e-pescoco-e-subestimado-na-franca.html]]></loc><lastmod>2016-10-09T22:19:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/europa-enfrenta-desigualdade-no-acesso-a-imunoterapia-no-tratamento-do-melanoma.html]]></loc><lastmod>2016-10-09T22:20:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/segmentacao-do-receptor-de-estrogenio-melhora-sobrevida-livre-de-progressao-no-cancer-de-mama-avancado.html]]></loc><lastmod>2016-10-09T22:21:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/esmo-imunoterapia-neoadjuvante-no-cancer-de-pulmao-inicial.html]]></loc><lastmod>2020-04-24T18:51:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/esmo-congresso-europeu-destaca-rastreamento-e-prevencao-do-cancer.html]]></loc><lastmod>2016-10-09T22:21:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/baixo-indice-de-notificacao-de-eventos-adversos-em-estudos-de-terapias-alvo-e-imunoterapia.html]]></loc><lastmod>2016-10-09T22:22:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/esmo-2016/impacto-das-funcoes-cognitivas-na-adesao-as-terapias-orais.html]]></loc><lastmod>2016-10-09T22:22:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016.html]]></loc><lastmod>2017-06-28T18:40:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/dialogo-de-experts-igor-morbeck-e-karim-fizazi.html]]></loc><lastmod>2016-11-27T21:46:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/imunoterapia-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2016-11-27T21:57:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/rodrigo-santa-cruz.html]]></loc><lastmod>2016-11-27T21:54:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/riad-younes.html]]></loc><lastmod>2020-04-24T18:48:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/axel-lecesne.html]]></loc><lastmod>2016-11-27T21:55:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/martine-piccart.html]]></loc><lastmod>2016-11-28T01:27:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/graziela-zibetti-dal-molin.html]]></loc><lastmod>2016-11-27T20:41:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/gustavo-zucca-matthes.html]]></loc><lastmod>2016-11-22T02:05:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/ricardo-sales-dos-santos.html]]></loc><lastmod>2020-04-24T19:31:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/andre-marcio-murad.html]]></loc><lastmod>2016-11-28T01:25:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/oncogenetica-diagnostico-e-avaliacao-de-risco.html]]></loc><lastmod>2016-12-15T13:53:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/ix-congresso-franco-brasileiro-de-oncologia.html]]></loc><lastmod>2016-11-17T18:17:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/presente-e-futuro-do-tratamento-do-cancer-gastrico-avancado.html]]></loc><lastmod>2016-11-16T20:16:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/novos-agentes-no-tratamento-sistemico-do-cancer-de-cervix-metastatico-ou-recorrente.html]]></loc><lastmod>2016-11-11T05:23:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/o-cancer-hereditario-na-america-do-sul.html]]></loc><lastmod>2016-11-11T05:24:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/terapia-adjuvante-em-adenocarcinoma-do-reto.html]]></loc><lastmod>2016-11-16T12:56:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/franco-brasileiro-2016/propulmao-resultados-do-programa-de-rastreamento-em-sao-paulo.html]]></loc><lastmod>2020-04-24T18:49:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016.html]]></loc><lastmod>2017-06-28T18:40:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/asco-2016-centralidade-no-paciente.html]]></loc><lastmod>2016-08-15T05:23:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/xix-destaques-onco-acontece-em-sao-paulo.html]]></loc><lastmod>2016-08-15T05:24:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/biopsia-liquida-confirma-precisao-em-analise-de-larga-escala.html]]></loc><lastmod>2017-05-12T22:08:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/cancer-de-prostata-na-asco-2016.html]]></loc><lastmod>2016-06-20T19:25:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/estudo-fast-imab362-em-cancer-gastrico-avancado.html]]></loc><lastmod>2016-06-20T15:04:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/tumores-gastrintestinais-na-asco-2016.html]]></loc><lastmod>2016-06-20T14:58:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/panorama-geniturinario-na-asco-2016.html]]></loc><lastmod>2016-08-15T05:24:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/principais-topicos-em-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2016-06-20T15:06:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/cancer-de-pulmao-na-asco-2016.html]]></loc><lastmod>2020-04-24T18:57:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/novo-adc-em-cancer-de-pulmao-pequenas-celulas.html]]></loc><lastmod>2020-04-24T18:58:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/imunoterapia-em-cancer-renal.html]]></loc><lastmod>2017-05-12T22:07:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/destaques-em-oncoginecologia-na-asco-2016.html]]></loc><lastmod>2016-06-20T11:12:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/checkmate-032-apresenta-resultados-promissores-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:57:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/novo-anticorpo-em-cancer-gastrico-avancado.html]]></loc><lastmod>2016-06-10T21:47:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/asco-reforca-importancia-de-cuidados-paliativos.html]]></loc><lastmod>2016-06-14T14:53:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/mypathway-medicina-de-precisao-pode-expandir-opcoes-terapeuticas.html]]></loc><lastmod>2016-06-05T20:46:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/checkmate-012-nivolumabe-ipilimumabe-na-primeira-linha-de-cpnpc-avancado.html]]></loc><lastmod>2016-06-12T14:12:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/projeto-incentiva-pesquisa-genomica-em-cancer-de-mama.html]]></loc><lastmod>2016-06-05T02:25:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/catnon-quimioterapia-adjuvante-em-glioma-anaplasico.html]]></loc><lastmod>2016-06-06T14:30:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/novos-dados-da-quimioterapia-intraperitoneal-no-cancer-de-ovario.html]]></loc><lastmod>2016-06-04T20:32:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/heritage-trastuzumabe-biossimilar-mostra-resultados-no-cancer-de-mama-her2.html]]></loc><lastmod>2016-06-07T18:06:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/nemo-binimetinib-no-melanoma-metastatico-avancado-nras-mutado.html]]></loc><lastmod>2016-06-02T20:59:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/novo-padrao-de-cuidados-em-lma-de-alto-risco.html]]></loc><lastmod>2016-06-02T15:59:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/paloma-2-palbociclib-no-cancer-de-mama-avancado-er-her2.html]]></loc><lastmod>2016-06-12T21:38:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/checkmate-141-nivolumabe-no-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2016-06-02T16:01:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/imunoterapia-continua-em-destaque.html]]></loc><lastmod>2017-05-15T14:32:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/tace-2-sorafenibe-nao-mostra-resultados-no-carcinoma-hepatocelular.html]]></loc><lastmod>2016-06-02T16:02:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/asco-2016-grupo-europeu-confirma-beneficio-do-transplante-autologo-em-mieloma-multiplo.html]]></loc><lastmod>2016-06-02T16:03:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/asco-2016-estudo-castor-daratumumab-em-mm-recidivado-ou-refratario.html]]></loc><lastmod>2016-06-05T23:50:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/asco-2016-keynote-001-pembrolizumabe-no-melanoma-metastatico.html]]></loc><lastmod>2016-06-02T21:07:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/asco-2016-medicina-de-precisao-em-estudos-clinicos-de-fase-i.html]]></loc><lastmod>2016-06-02T16:05:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/asco-2016/cuidados-paliativos-melhoram-qualidade-de-vida-de-familiares-e-cuidadores.html]]></loc><lastmod>2016-06-02T16:05:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas.html]]></loc><lastmod>2017-06-28T18:41:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/grupo-oncoclinicas-promove-encontro-de-atualizacao.html]]></loc><lastmod>2016-12-06T13:33:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/painel-de-especialistas.html]]></loc><lastmod>2016-12-06T14:16:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/cancer-de-mama-atualizacao-em-radioterapia-da-axila.html]]></loc><lastmod>2016-12-06T14:20:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/biomarcadores-no-cancer-de-prostata.html]]></loc><lastmod>2016-12-12T01:24:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/limites-da-nefrectomia.html]]></loc><lastmod>2016-12-07T13:19:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/controversias-e-evidencias-no-rastreamento-do-cancer-de-prostata.html]]></loc><lastmod>2016-12-06T14:30:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/carlo-greco.html]]></loc><lastmod>2016-12-06T17:24:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/novas-fronteiras.html]]></loc><lastmod>2020-04-24T18:47:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/tabagismo-e-carga-de-morte-por-cancer.html]]></loc><lastmod>2017-01-30T20:28:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/neoadjuvancia-no-cancer-de-pulmao-onde-estamos.html]]></loc><lastmod>2020-04-24T18:46:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/progressos-no-tratamento-do-melanoma.html]]></loc><lastmod>2016-12-06T17:25:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/selecao-molecular.html]]></loc><lastmod>2016-12-06T17:25:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/inibidores-de-checkpoint-no-melanoma-avancado.html]]></loc><lastmod>2016-12-06T14:13:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/linfomas-foliculares.html]]></loc><lastmod>2016-12-06T17:26:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/jairo-sobrinho.html]]></loc><lastmod>2016-12-06T17:26:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/como-eu-trato-linfoma-de-hodgkin.html]]></loc><lastmod>2016-12-06T14:47:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/4-simposio-oncoclinicas/mario-giannakis.html]]></loc><lastmod>2016-12-06T17:27:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/ash-2016.html]]></loc><lastmod>2017-06-28T18:38:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/ash-2016/avancos-e-desafios-da-oncohematologia.html]]></loc><lastmod>2016-12-22T13:51:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/ash-2016/transplante-autologo-em-mieloma-multiplo.html]]></loc><lastmod>2016-12-16T13:01:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/ash-2016/stamina-intervencoes-adicionais-nao-trazem-beneficios-no-mieloma-multiplo.html]]></loc><lastmod>2016-12-14T19:53:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/ash-2016/alcanza-brentuximabe-vedotin-em-linfoma-cutaneo-de-celulas-t-cd30.html]]></loc><lastmod>2016-12-12T00:58:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/ash-2016/terapia-combinada-para-pacientes-com-leucemia-mieloide-aguda.html]]></loc><lastmod>2016-12-12T00:59:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/ash-2016/terapia-car-t-na-ash-2016.html]]></loc><lastmod>2016-12-12T00:59:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/ash-2016/hed-to-head-gallium-mostra-superioridade-do-novo-anti-cd-20.html]]></loc><lastmod>2016-12-12T01:44:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/san-antonio-2016.html]]></loc><lastmod>2017-06-28T18:39:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/san-antonio-2016/nsapb-b52-e-belle-3-os-resultados-de-san-antonio.html]]></loc><lastmod>2016-12-20T18:07:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/san-antonio-2016/inibidor-de-aromatase-neoadjuvante-no-cancer-de-mama-hr-her2.html]]></loc><lastmod>2016-12-12T00:53:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/san-antonio-2016/sintomas-da-menopausa-e-adesao-ao-tamoxifeno.html]]></loc><lastmod>2016-12-12T00:53:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/san-antonio-2016/ibandronato-e-terapia-hormonal-no-cancer-de-mama-na-pos-menopausa.html]]></loc><lastmod>2016-12-12T00:54:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/san-antonio-2016/inibidores-de-aromatase-e-funcao-endotelial.html]]></loc><lastmod>2016-12-12T00:54:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/san-antonio-2016/belle-3-inibidor-de-pi3k-mostra-eficacia-no-cancer-de-mama-avancado-hr.html]]></loc><lastmod>2016-12-12T00:54:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/san-antonio-2016/abemaciclib-neoadjuvante-no-cancer-de-mama-inicial.html]]></loc><lastmod>2016-12-12T00:55:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/san-antonio-2016/sequenciamento-genomico-do-cancer-de-mama-metastatico-resistente-ao-tratamento.html]]></loc><lastmod>2016-12-12T00:56:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/san-antonio-2016/adicionar-veliparib-a-quimioterapia-melhora-taxas-de-resposta-no-cancer-de-mama-brca-mutado.html]]></loc><lastmod>2016-12-12T00:57:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/mundial-de-pulmao-2016.html]]></loc><lastmod>2017-06-28T18:39:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/mundial-de-pulmao-2016/ascend-4-mostra-ceritinib-na-primeira-linha-em-cpnpc-alk.html]]></loc><lastmod>2016-12-12T04:28:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/mundial-de-pulmao-2016/aura3-confirmando-as-expectativas.html]]></loc><lastmod>2016-12-12T02:54:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/mundial-de-pulmao-2016/keynote-024-qualidade-de-vida-no-tratamento-do-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:43:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/mundial-de-pulmao-2016/oak-atezolizumab-mostra-resultados-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:43:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/mundial-de-pulmao-2016/nivolumab-mostra-promessa-no-tratamento-do-mesotelioma.html]]></loc><lastmod>2016-12-12T00:56:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/mundial-de-pulmao-2016/imuno-histoquimica-pd-l1-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:44:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/mundial-de-pulmao-2016/ibuprofeno-e-risco-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:44:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/mundial-de-pulmao-2016/atlantic-mostra-resultados-de-pd-l1-em-pacientes-politratados.html]]></loc><lastmod>2016-12-12T00:57:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/mundial-de-pulmao-2016/aura3-tkis-de-segunda-geracao-no-cancer-de-pulmao-avancado.html]]></loc><lastmod>2020-04-24T18:45:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/mundial-de-pulmao-2016/wclc-2016-luta-anti-tabaco-e-desafio-global.html]]></loc><lastmod>2016-12-12T00:58:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2016/mundial-de-pulmao-2016/participacao-brasileira-na-conferencia-mundial-de-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T18:47:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015.html]]></loc><lastmod>2016-05-20T15:13:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gu-2015.html]]></loc><lastmod>2016-05-20T15:17:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gu-2015/receptor-de-androgenio-e-resposta-a-taxanos.html]]></loc><lastmod>2015-03-04T19:57:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gu-2015/aumento-do-cancer-de-prostata-de-alto-risco-entre-2011-e-2013.html]]></loc><lastmod>2015-03-04T19:35:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gu-2015/vigilancia-ativa-no-cancer-de-prostata-de-risco-intermediario-associada-a-diminuicao-da-sobrevida.html]]></loc><lastmod>2015-03-04T19:29:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gu-2015/cancer-de-testiculo-e-risco-de-cancer-de-prostata.html]]></loc><lastmod>2015-03-23T01:41:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gu-2015/ascende-rt-braqui-de-baixas-doses-mostra-superioridade.html]]></loc><lastmod>2015-03-02T14:01:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gu-2015/estatinas-no-cancer-de-prostata-hormonio-sensivel.html]]></loc><lastmod>2015-03-02T03:16:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gu-2015/cancer-renal-e-obesidade.html]]></loc><lastmod>2015-03-02T11:27:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/18-jornada-uropatologia.html]]></loc><lastmod>2016-05-20T15:17:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/18-jornada-uropatologia/jornada-de-uropatologia-reune-grandes-nomes-em-sao-paulo.html]]></loc><lastmod>2015-03-16T03:49:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/18-jornada-uropatologia/criterios-moleculares-no-cancer-de-prostata.html]]></loc><lastmod>2015-03-16T03:46:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/18-jornada-uropatologia/cancer-renal-e-sindromes-hereditarias.html]]></loc><lastmod>2015-03-16T03:46:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/18-jornada-uropatologia/educacao-continuada.html]]></loc><lastmod>2015-03-16T03:46:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/6-congresso-uro-oncologia.html]]></loc><lastmod>2016-05-20T15:18:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/6-congresso-uro-oncologia/sequencia-terapeutica-no-cancer-de-prostata-metastatico.html]]></loc><lastmod>2015-03-19T07:23:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/6-congresso-uro-oncologia/observacao-no-cancer-de-prostata-quando-como-e-para-quem.html]]></loc><lastmod>2015-03-19T07:20:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/6-congresso-uro-oncologia/peculiaridades-do-cancer-de-prostata-no-brasil.html]]></loc><lastmod>2015-03-19T07:19:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/6-congresso-uro-oncologia/adjuvancia-ou-neoadjuvancia-em-cancer-de-bexiga.html]]></loc><lastmod>2015-03-19T07:16:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/6-congresso-uro-oncologia/radioterapia-no-tratamento-do-cancer-de-prostata.html]]></loc><lastmod>2015-03-19T07:13:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/1-simposio-gtg.html]]></loc><lastmod>2016-05-20T15:18:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/1-simposio-gtg/simposio-discute-avancos-e-controversias-em-tumores-gastrointestinais.html]]></loc><lastmod>2015-03-30T04:25:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/1-simposio-gtg/atualizacao-em-gist.html]]></loc><lastmod>2015-04-06T15:25:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/1-simposio-gtg/controversias-a-visao-de-especialistas.html]]></loc><lastmod>2015-03-30T03:08:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/1-simposio-gtg/hcc-metastatico-o-que-ha-de-novo.html]]></loc><lastmod>2015-03-30T04:10:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/1-simposio-gtg/classificacao-molecular-no-cancer-colorretal.html]]></loc><lastmod>2015-03-30T03:07:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/1-simposio-gtg/endpoints-como-interpretar.html]]></loc><lastmod>2015-03-30T03:40:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/1-simposio-gtg/cancer-hereditario-da-epidemiologia-a-clinica.html]]></loc><lastmod>2015-03-30T03:15:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/oncoplastica-2015.html]]></loc><lastmod>2016-05-20T15:19:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/oncoplastica-2015/jornada-de-oncoplastia-2015.html]]></loc><lastmod>2015-04-13T15:13:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/oncoplastica-2015/rastreamento-mamografia-aos-40-anos.html]]></loc><lastmod>2015-04-13T15:26:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/oncoplastica-2015/cirurgia-redutora-de-risco-quando-considerar.html]]></loc><lastmod>2015-04-13T16:09:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/oncoplastica-2015/reconstrucao-oncoplastica-pos-mastectomia.html]]></loc><lastmod>2015-04-13T15:27:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/oncoplastica-2015/cirurgia-conservadora-e-oncoplastica.html]]></loc><lastmod>2015-04-14T21:57:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/oncoplastica-2015/dialogo-multidisciplinar-e-decisao-cirurgica.html]]></loc><lastmod>2015-04-13T16:02:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/oncoplastica-2015/margens-cirurgicas-no-cancer-de-mama.html]]></loc><lastmod>2015-04-14T02:59:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/oncoplastica-2015/evolucao-na-abordagem-axilar.html]]></loc><lastmod>2015-04-14T03:01:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/oncoplastica-2015/criterios-para-a-mastectomia-profilatica.html]]></loc><lastmod>2015-04-14T03:01:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/oncoplastica-2015/incidencia-do-cancer-de-mama.html]]></loc><lastmod>2015-04-14T03:02:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/iv-congresso-neuro-oncologia.html]]></loc><lastmod>2016-05-20T15:19:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/iv-congresso-neuro-oncologia/novidades-no-tratamento-de-tumores-cerebrais.html]]></loc><lastmod>2015-05-11T23:05:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/iv-congresso-neuro-oncologia/tratamento-sistemico-no-glioma-de-baixo-grau.html]]></loc><lastmod>2015-05-25T12:28:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/iv-congresso-neuro-oncologia/metastases-cerebrais-dos-tumores-solidos.html]]></loc><lastmod>2015-05-11T23:06:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/iv-congresso-neuro-oncologia/avancos-no-tratamento-dos-gliomas-de-alto-grau.html]]></loc><lastmod>2015-05-11T23:08:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/iv-congresso-neuro-oncologia/imunoterapia-em-tumores-cerebrais.html]]></loc><lastmod>2015-05-11T23:09:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/iv-congresso-neuro-oncologia/bevacizumabe-no-cancer-cerebral.html]]></loc><lastmod>2015-05-11T23:09:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/iv-congresso-neuro-oncologia/destaques-do-iv-congresso-internacional-de-neuro-oncologia.html]]></loc><lastmod>2015-05-11T23:10:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/iv-congresso-neuro-oncologia/cirurgia-em-bloco-versus-piecemeal.html]]></loc><lastmod>2015-05-11T23:10:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015.html]]></loc><lastmod>2016-05-20T15:17:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/cancer-de-mama-e-as-novidades-de-chicago.html]]></loc><lastmod>2015-06-03T06:16:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/stampede-e-os-destaques-do-painel-geniturinario.html]]></loc><lastmod>2016-11-16T00:55:02+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/checkmate-067-mostra-resultados-no-tratamento-do-melanoma.html]]></loc><lastmod>2015-06-02T20:00:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/paloma-3-no-cancer-de-mama-estrogenio-receptor-positivo.html]]></loc><lastmod>2015-06-02T12:16:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/apresentacoes-mais-relevantes-sobre-cancer-colorretal.html]]></loc><lastmod>2015-06-03T04:11:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/destaques-em-cancer-geniturinario.html]]></loc><lastmod>2015-06-03T03:07:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/atividade-fisica-e-cancer-de-ovario.html]]></loc><lastmod>2015-06-02T12:27:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/relacao-entre-cancer-e-bebidas-alcoolicas.html]]></loc><lastmod>2015-06-02T12:24:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/tumores-gastrointestinais.html]]></loc><lastmod>2015-06-07T22:15:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/metastases-cerebrais-wbrt-srs-nao-aumenta-sobrevida.html]]></loc><lastmod>2015-06-02T20:31:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/combi-d-e-o-melanoma-metastatico.html]]></loc><lastmod>2020-04-24T20:34:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/esvaziamento-cervical-eletivo-aumenta-sobrevida-no-cancer-oral.html]]></loc><lastmod>2015-06-02T20:14:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/estudos-mais-relevantes-sobre-melanoma.html]]></loc><lastmod>2020-04-24T20:34:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/reposicao-hormonal-com-estrogeno-em-mulheres-negras.html]]></loc><lastmod>2015-06-02T12:08:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/imunoterapia-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:14:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/uso-de-estatina-pode-dimunir-mortalidade-por-cancer.html]]></loc><lastmod>2015-06-01T22:38:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/rindopepimut-associado-a-bevacizumabe-para-glioblastoma-recidivado.html]]></loc><lastmod>2020-04-24T20:38:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/helios-ibrutinib-mostra-beneficios-na-llc-recidivada.html]]></loc><lastmod>2015-06-01T20:32:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/atividade-fisica-beneficia-mulheres-com-cancer-de-mama.html]]></loc><lastmod>2015-05-31T18:03:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/daratumumab-resultados-promissores-em-mieloma-multiplo.html]]></loc><lastmod>2015-06-03T04:47:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/marcador-preve-resposta-ao-anti-pd1-em-varios-tipos-de-cancer.html]]></loc><lastmod>2015-05-30T13:47:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/asco-2015-pembrolizumab-em-cancer-de-cabeca-e-pescoco---keynote-012.html]]></loc><lastmod>2015-06-03T06:57:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/nivolumab-aumenta-sobrevida-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:14:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/asco-2015-nivolumab-mostra-promessa-em-cancer-de-figado-avancado.html]]></loc><lastmod>2015-05-30T23:28:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/cancer-de-cabeca-e-pescoco-na-asco-2015.html]]></loc><lastmod>2017-05-15T14:30:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/rilomet-1-rilotumumabe-em-primeira-linha-no-adenocarcinoma-gastrico-met-positivo.html]]></loc><lastmod>2015-05-25T15:30:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/keynote-012-pd-l1-em-cancer-gastrico.html]]></loc><lastmod>2015-05-25T15:30:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/fowarc-quimioterapia-e-radioterapia-neoadjuvante-em-cancer-de-reto.html]]></loc><lastmod>2015-05-25T15:30:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/lista-de-medicamentos-da-oms-a-acesso-ao-tratamento-na-asco-2015.html]]></loc><lastmod>2015-05-25T15:31:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/gadolin-mostra-obinutuzumab-em-linfoma-nao-hodgkin.html]]></loc><lastmod>2020-04-24T20:15:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/neratinibe-no-cancer-de-mama-her2-positivo.html]]></loc><lastmod>2015-05-25T15:38:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/paloma-3-mostra-resultados-na-asco-2015.html]]></loc><lastmod>2015-05-25T15:33:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/promessas-na-oncohematologia.html]]></loc><lastmod>2015-05-25T15:38:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-2015/checkmate-017-e-checkmate-057.html]]></loc><lastmod>2015-05-25T15:39:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/5-congresso-oncologia-oral.html]]></loc><lastmod>2016-05-20T15:20:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/5-congresso-oncologia-oral/desafios-no-manejo-do-cancer-oral.html]]></loc><lastmod>2015-07-19T20:22:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/5-congresso-oncologia-oral/diagnostico-precoce-em-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2015-07-14T14:23:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/5-congresso-oncologia-oral/educacao-medica-para-o-diagnostico-precoce.html]]></loc><lastmod>2015-07-15T13:36:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/5-congresso-oncologia-oral/quimioprevencao-em-cancer-de-cavidade-oral.html]]></loc><lastmod>2015-07-13T02:42:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/5-congresso-oncologia-oral/a-imunoterapia-no-cancer-oral.html]]></loc><lastmod>2015-07-13T02:45:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015.html]]></loc><lastmod>2016-05-20T15:20:40+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/da-imunoterapia-ao-desafio-do-acesso.html]]></loc><lastmod>2015-10-08T19:27:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/nova-opcao-de-imunoterapia-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:09:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/checkmate-057-imunoterapia-em-cancer-de-pulmao-e-destaque-na-esmo-2015.html]]></loc><lastmod>2020-04-24T19:09:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/aspirina-aumenta-sobrevida-em-cancer-gastrointestinal.html]]></loc><lastmod>2015-09-28T13:00:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/checkmate-025-nivolumab-melhora-a-sobrevida-global-em-pacientes-com-cancer-renal-avancado.html]]></loc><lastmod>2015-09-28T02:44:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/eurocare-5-europa-expoe-desigualdades-no-tratamento-do-cancer.html]]></loc><lastmod>2015-09-27T21:22:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/selecao-genetica-de-metastases-cerebrais-pode-revelar-novos-alvos.html]]></loc><lastmod>2015-09-30T13:35:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/netter-1-cancer-raro-responde-excepcionalmente-bem-a-novo-tratamento.html]]></loc><lastmod>2015-09-29T14:39:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/eurecca-tratamento-de-idosos-com-cancer-de-mama-varia-entre-os-paises-da-europa.html]]></loc><lastmod>2015-09-29T14:41:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/ecc2015-diferencas-geneticas-no-cancer-de-mama-recidivado.html]]></loc><lastmod>2015-09-29T14:36:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/cirurgia-esta-associada-com-beneficio-de-sobrevida-em-pacientes-com-cancer-de-cabeca-e-pescoco.html]]></loc><lastmod>2015-09-29T14:35:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/combater-o-deficit-global-em-radioterapia-pode-salvar-milhoes-de-vidas-e-impulsionar-a-economia-dos-paises-mais-pobres.html]]></loc><lastmod>2015-09-29T14:36:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/esmo-ecc-2015/cancer-colorretal-em-jovens-e-idosos.html]]></loc><lastmod>2015-09-29T14:33:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas.html]]></loc><lastmod>2016-05-20T15:20:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/padrao-ouro.html]]></loc><lastmod>2016-01-05T13:31:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/cancer-de-mama-avancos-e-desafios.html]]></loc><lastmod>2015-12-07T02:02:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/hormonioterapia-no-cancer-de-mama-metastatico.html]]></loc><lastmod>2015-12-06T22:31:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/desafios-e-controversias-em-cancer-de-mama.html]]></loc><lastmod>2015-12-06T22:31:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/promessas-da-genomica.html]]></loc><lastmod>2015-12-08T15:17:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/quimioterapia-no-cancer-de-mama-rh.html]]></loc><lastmod>2015-12-06T22:45:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/novas-estrategias-no-tratamento-do-cancer-de-prostata.html]]></loc><lastmod>2015-12-06T22:38:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/rastreamento-e-gestao-de-risco-em-cancer-de-prostata.html]]></loc><lastmod>2016-02-04T14:10:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/medicina-nuclear-no-estadiamento-do-cancer-de-prostata.html]]></loc><lastmod>2015-12-06T22:35:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/terapias-minimamente-invasivas-no-cancer-de-prostata-localizado.html]]></loc><lastmod>2015-12-06T22:48:31+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/linfadenectomia-na-recidiva-bioquimica.html]]></loc><lastmod>2015-12-06T22:34:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/cancer-de-bexiga-promessas-e-desafios.html]]></loc><lastmod>2015-12-06T22:30:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/mesotelioma-cenario-atual-e-perspectivas.html]]></loc><lastmod>2015-12-06T22:36:52+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/imunoterapia-em-cancer-de-pulmao-a-proxima-fronteira.html]]></loc><lastmod>2020-04-24T19:07:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/imuno-oncologia.html]]></loc><lastmod>2015-12-06T22:29:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/mutacoes-detectaveis-em-cancer-de-pulmao-perspectivas-e-evidencias.html]]></loc><lastmod>2020-04-24T19:06:29+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/o-estado-da-arte-no-tratamento-do-cancer-de-colon.html]]></loc><lastmod>2015-12-06T22:40:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/o-papel-da-cirurgia-na-progressao-do-cancer-de-colon.html]]></loc><lastmod>2016-01-04T23:29:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/tumores-neuroendocrinos-do-pancreas.html]]></loc><lastmod>2015-12-06T23:12:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/novos-paradigmas-no-tratamento-do-melanoma.html]]></loc><lastmod>2020-04-24T20:23:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/linfonodo-sentinela-positivo-em-melanoma-seguimento-ja-e-uma-alternativa-em-esvaziamento.html]]></loc><lastmod>2015-12-06T22:35:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/terapia-sistemica-no-melanoma-braf-mutado.html]]></loc><lastmod>2015-12-06T22:47:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/3-simposio-oncoclinicas/perspectivas-futuras-da-oncogenetica-em-melanoma.html]]></loc><lastmod>2020-04-24T20:24:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015.html]]></loc><lastmod>2016-05-20T15:24:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/57-ash-nova-geracao-de-agentes-em-mieloma-multiplo.html]]></loc><lastmod>2016-01-05T18:16:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/ash-2015-venetoclax-mostra-promessa-em-leucemia-linfocitica-cronica.html]]></loc><lastmod>2015-12-22T01:46:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/pesquisadora-comenta-destaques-da-ash-2015.html]]></loc><lastmod>2015-12-19T14:03:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/ash-2015-terapia-combinada-com-idelalisib-em-leucemia-linfocitica-cronica.html]]></loc><lastmod>2016-01-05T13:57:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/ash-2015-keynote-023-investiga-pembrolizumab-em-combinacao-no-mieloma-multiplo-recidivado-refratario.html]]></loc><lastmod>2016-01-05T13:57:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/ash-2015-terapia-alvo-e-eficaz-para-mieloma-multiplo-de-dificil-tratamento.html]]></loc><lastmod>2016-01-05T13:58:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/ash-2015-terapias-alvo-na-primeira-linha-em-pacientes-com-leucemia-linfocitica-cronica.html]]></loc><lastmod>2016-01-05T13:58:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/ash-2015-evidencias-para-o-primeiro-tratamento-oral-para-mieloma-multiplo-recidivado-e-ou-resistente.html]]></loc><lastmod>2016-01-05T13:58:57+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/ash-2015-varfarina-no-tratamento-de-longo-prazo-da-trombose-associada-ao-cancer.html]]></loc><lastmod>2016-01-05T13:59:24+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/ash-2015-anticoagulacao-na-trombocitopenia-em-pacientes-com-cancer.html]]></loc><lastmod>2016-01-05T13:59:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/ash-2015-celulas-t-em-canceres-hematologicos-resistentes-ao-tratamento.html]]></loc><lastmod>2016-11-28T17:27:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/ash-2015/ash-2015-terapia-alvo-melhora-sobrevida-na-leucemia-mieloide-aguda.html]]></loc><lastmod>2016-11-28T17:26:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015.html]]></loc><lastmod>2017-06-28T18:52:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015/painel-de-experts---2015-san-antonio-breast-cancer-symposium.html]]></loc><lastmod>2016-04-11T01:49:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015/terapia-de-conservacao-da-mama-tem-impacto-na-sobrevida.html]]></loc><lastmod>2015-12-21T20:57:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015/mastectomia-mais-reconstrucao-tem-maiores-taxas-de-complicacao-e-custos.html]]></loc><lastmod>2015-12-20T15:11:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015/sabcs-2015-geparsixto-carboplatina-neoadjuvante-no-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2016-01-05T18:21:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015/sabcs-2015-th3resa-mostra-resultados-finais-em-san-antonio.html]]></loc><lastmod>2016-01-06T00:13:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015/sabcs-2015-ibis-ii-anastrozol-ou-tamoxifeno-no-cdis.html]]></loc><lastmod>2016-01-06T00:17:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015/terapia-de-conservacao-da-mama-na-doenca-inicial.html]]></loc><lastmod>2016-01-06T00:17:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015/sabcs-2015-mutacoes-no-gene-esr1-associadas-com-pior-sobrevida-geral.html]]></loc><lastmod>2016-01-06T00:18:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015/sabcs-2015-apobec3b-enzima-pode-guiar-resistencia-ao-tamoxifeno.html]]></loc><lastmod>2016-01-05T14:04:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015/sabcs-2015-mulheres-com-cancer-de-mama-luminal-a-nao-se-beneficiam-da-quimioterapia-adjuvante.html]]></loc><lastmod>2016-01-05T14:04:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/san-antonio-2015/sabcs-2015-denosumab-mostra-novos-dados-em-san-antonio.html]]></loc><lastmod>2015-12-19T14:04:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gi-2015.html]]></loc><lastmod>2016-05-20T15:16:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gi-2015/vitamina-d-associada-ao-aumento-da-sobrevida-em-cancer-colorretal-avancado.html]]></loc><lastmod>2015-01-19T01:59:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gi-2015/preservacao-de-orgao-no-cancer-retal.html]]></loc><lastmod>2015-01-19T02:05:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gi-2015/reach-ramucirumabe-em-segunda-linha-no-carcinoma-hepatocelular-avancado.html]]></loc><lastmod>2015-01-19T01:40:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gi-2015/keynote-012-expressao-do-pd-l1-em-cancer-gastrico-avancado-tratado-com-pembrolizumabe.html]]></loc><lastmod>2015-03-23T17:31:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gi-2015/image-1-imm-101-com-gemcitabina-demonstra-vantagem-de-sobrevida-no-cancer-de-pancreas.html]]></loc><lastmod>2015-01-19T02:03:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2015/asco-gi-2015/valor-diagnostico-do-teste-im2-pknorastreamento-de-lesoes-colorretais-malignas.html]]></loc><lastmod>2015-02-04T18:16:50+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014.html]]></loc><lastmod>2016-05-20T15:13:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/san-antonio-2014.html]]></loc><lastmod>2016-05-20T15:16:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/san-antonio-2014/ibis-i-resultados-confirmam-beneficio-do-tamoxifeno.html]]></loc><lastmod>2014-12-21T20:47:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/san-antonio-2014/bolero-1-mostra-resultados-finais-de-sobrevida-livre-de-progressao.html]]></loc><lastmod>2014-12-21T23:04:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/san-antonio-2014/ingestao-de-gordura-e-mortalidade-em-cancer-de-mama.html]]></loc><lastmod>2014-12-12T18:29:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/san-antonio-2014/first-anastrozol-superior-ao-fulvestrano.html]]></loc><lastmod>2014-12-12T18:21:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/san-antonio-2014/ibis-i-tamoxifeno-reduz-taxas-de-cancer-de-mama-em-mulheres-de-alto-risco.html]]></loc><lastmod>2014-12-12T01:17:13+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/san-antonio-2014/bevacizumabe-neoadjuvante-em-cancer-de-mama-triplo-negativo.html]]></loc><lastmod>2014-12-12T01:13:16+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/san-antonio-2014/ice-capecitabina-em-monoterapia-em-idosos-com-cancer-de-mama-inicial.html]]></loc><lastmod>2014-12-12T01:09:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/san-antonio-2014/sabcs-2014-e-a-pesquisa-em-cancer-de-mama.html]]></loc><lastmod>2014-12-10T19:58:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/san-antonio-2014/celulas-imunes-e-cancer-de-mama-her2-positivo.html]]></loc><lastmod>2014-12-11T01:16:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/san-antonio-2014/pembrolizumabe-em-cancer-de-mama-avancado-triplo-negativo.html]]></loc><lastmod>2014-12-15T15:01:26+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gi-2014.html]]></loc><lastmod>2016-05-20T15:22:04+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gi-2014/asco-gi-avanca-em-areas-criticas.html]]></loc><lastmod>2014-05-05T03:14:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gi-2014/tratamento-sistemico-do-adenocarcinoma-de-pancreas.html]]></loc><lastmod>2014-05-05T03:25:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gi-2014/erradicacao-do-h-pylori-e-a-chave-para-eliminar-o-cancer-gastrico.html]]></loc><lastmod>2014-03-12T19:40:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gi-2014/rainbow-mostra-ramucirumab-no-gej-avancado.html]]></loc><lastmod>2014-03-12T18:32:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gu-2014.html]]></loc><lastmod>2016-05-20T15:22:28+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gu-2014/10-edicao-do-simposio-gu-tem-publico-recorde.html]]></loc><lastmod>2014-03-12T19:26:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gu-2014/cancer-de-penis-uretra-e-testiculos.html]]></loc><lastmod>2014-03-12T19:25:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gu-2014/os-cinco-maiores-avancos-em-rcc.html]]></loc><lastmod>2014-05-05T12:31:33+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gu-2014/cancer-urotelial-o-que-ha-de-novo.html]]></loc><lastmod>2014-03-12T19:15:11+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gu-2014/drogas-asi-em-pacientes-hipertensos-com-rccm.html]]></loc><lastmod>2014-03-12T19:12:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gu-2014/drogas-alvo-no-rccm-axitinibe-ou-sorafenibe.html]]></loc><lastmod>2014-03-12T19:06:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-gu-2014/orteronel-nao-aumenta-sobrevida-global-no-cprcm.html]]></loc><lastmod>2014-03-12T19:04:44+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/elcc-2014.html]]></loc><lastmod>2016-05-20T15:21:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/elcc-2014/4-elcc-destaca-imunoterapia-no-tratamento-do-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:23:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/elcc-2014/assinatura-de-mirna-no-plasma-de-fumantes.html]]></loc><lastmod>2014-04-15T15:33:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/elcc-2014/terapia-em-adenocarcinoma-de-pulmao-com-fusao-ret.html]]></loc><lastmod>2020-04-24T19:23:00+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/elcc-2014/pacientes-reportam-qualidade-de-vida.html]]></loc><lastmod>2014-05-05T12:45:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/elcc-2014/disfuncao-sexual-em-pacientes-com-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:24:07+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/elcc-2014/quimioterapia-baseada-em-platina-em-pacientes-nsclc-performance-status-2.html]]></loc><lastmod>2014-04-21T04:16:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/elcc-2014/terapia-de-resgate-com-paclitaxel-e-bevacizumabe.html]]></loc><lastmod>2014-04-15T15:46:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/elcc-2014/associacao-da-expressao-pd-l1-com-a-sobrevida-em-mesotelioma.html]]></loc><lastmod>2014-04-16T17:07:22+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/elcc-2014/estudo-de-fase-i-avalia-inibidor-de-quinase-de-3-geracao.html]]></loc><lastmod>2014-04-16T17:08:59+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/estro-33.html]]></loc><lastmod>2016-05-20T15:21:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/estro-33/hormonioterapia-mais-radioterapia-no-cancer-de-prostata-localizado.html]]></loc><lastmod>2014-05-05T12:51:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/estro-33/radioterapia-em-cancer-de-mama-amplia-risco-de-um-segundo-cancer.html]]></loc><lastmod>2014-06-21T05:54:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/estro-33/papel-prognostico-do-hpv-depende-do-sitio-do-tumor.html]]></loc><lastmod>2017-05-15T14:35:18+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/estro-33/braquiterapia-no-cancer-de-prostata.html]]></loc><lastmod>2014-04-21T04:18:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/estro-33/avancos-e-promessas-da-radioterapia.html]]></loc><lastmod>2014-04-16T17:35:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014.html]]></loc><lastmod>2016-05-20T15:22:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/asco-50-anos-de-avancos.html]]></loc><lastmod>2014-07-22T00:32:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/resultados-do-altto-nao-confirmam-eficacia-da-dupla-terapia-anti-her2-em-cancer-de-mama-estadio-inicial.html]]></loc><lastmod>2014-06-09T03:21:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/alsympca-confirma-seguranca-do-ra-223.html]]></loc><lastmod>2014-06-09T02:39:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/panorama-1-mostra-resultados-em-mieloma-multiplo.html]]></loc><lastmod>2014-06-05T03:56:20+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/bevacizumabe-ou-cetuximabe-com-folfox-ou-folfiri-no-cancer-colorretal.html]]></loc><lastmod>2014-06-05T04:04:48+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/momento-promissor-para-a-imunoterapia-em-melanoma.html]]></loc><lastmod>2014-09-09T20:44:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/prevail-confirma-beneficios-da-enzalutamida-no-cprcm.html]]></loc><lastmod>2014-06-06T22:51:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/optmize-2-e-o-zolendronato-em-metastases-osseas-do-cancer-de-mama.html]]></loc><lastmod>2014-06-06T16:10:32+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/descontinuacao-de-estatinas-em-pacientes-terminais-pode-melhorar-a-qualidade-de-vida.html]]></loc><lastmod>2014-06-01T23:56:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/cuidados-paliativos-para-o-cuidador---estudo-enable-iii.html]]></loc><lastmod>2014-06-09T01:39:35+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/radiacao-de-menor-dose-para-pacientes-com-cancer-de-cabeca-e-pescoco-hpv-positivo.html]]></loc><lastmod>2014-06-01T23:46:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/preservacao-da-fertilidade---estudo-poems.html]]></loc><lastmod>2014-06-05T04:42:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/cediranib-mais-olaparib-no-cancer-de-ovario-recorrente.html]]></loc><lastmod>2014-06-01T23:57:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/estudo-select---levantinib-para-cancer-diferenciado-de-tireoide.html]]></loc><lastmod>2014-06-02T05:30:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/ibrutinib-para-leucemia-linfocitica-cronica-estudo-resonate.html]]></loc><lastmod>2016-03-11T21:04:43+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/ramucirumab-mais-docetaxel-em-cpnpc---estudo-revel.html]]></loc><lastmod>2014-06-10T18:08:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/selecao-terapeutica-e-alvos-moleculares.html]]></loc><lastmod>2014-05-31T13:59:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/o-que-e-noticia-na-asco-2014.html]]></loc><lastmod>2014-06-07T16:08:51+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/asco-2014-estrategias-de-privacao-hormonal-em-cancer-de-prostata.html]]></loc><lastmod>2014-05-31T13:55:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/asco-2014-drogas-alvo-no-cancer-de-pulmao-nao-pequenas-celulas.html]]></loc><lastmod>2020-04-24T19:22:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/asco-2014-inovacoes-no-tratamento-da-sinovite-vilonodular-pigmentada.html]]></loc><lastmod>2015-02-03T21:51:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/asco-2014-obesidade-e-cancer-de-mama.html]]></loc><lastmod>2014-05-31T01:03:41+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/asco-2014/destaques-da-asco-2014.html]]></loc><lastmod>2014-05-30T20:41:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/56-astro.html]]></loc><lastmod>2016-05-20T15:23:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/56-astro/56-astro-e-a-radioterapia-no-tratamento-do-cancer.html]]></loc><lastmod>2014-09-30T18:58:36+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/56-astro/quimioterapia-seguida-de-radioterapia-estereotaxica-ablativa-rea-pode-ser-opcao-de-tratamento-promissora-para-pacientes-com-cancer-de-pancreas-avancado.html]]></loc><lastmod>2014-09-27T14:57:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/56-astro/tratamentos-agressivos-mostram-aumento-de-sobrevida-no-cancer-de-pulmao-de-baixo-risco.html]]></loc><lastmod>2020-04-24T19:20:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/56-astro/56-astro-mostra-os-destaques-da-radioterapia.html]]></loc><lastmod>2014-09-16T20:11:27+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/56-astro/rtog-0236-radioterapia-estereotaxica-em-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:21:55+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/56-astro/radioterapia-mostra-beneficios-no-cancer-de-endometrio-de-alto-risco.html]]></loc><lastmod>2014-09-16T19:30:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/56-astro/radioterapia-privacao-androgenica-e-qualidade-de-vida-no-cancer-de-prostata.html]]></loc><lastmod>2014-09-16T19:14:58+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/56-astro/radioterapia-hipofracionada-e-qualidade-de-vida-no-cancer-de-prostata.html]]></loc><lastmod>2014-09-16T19:09:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014.html]]></loc><lastmod>2016-05-20T15:23:39+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/esmo-2014.html]]></loc><lastmod>2014-10-02T04:13:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/novos-dados-no-tratamento-do-cancer-colorretal-metastatico.html]]></loc><lastmod>2014-10-02T04:12:46+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/estudos-franceses-avaliam-beneficios-do-rastreamento-de-cancer-colorretal.html]]></loc><lastmod>2014-10-02T03:24:08+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/tratamento-do-cancer-em-gestantes-nao-impacta-qualidade-de-vida-dos-bebes-apos-o-nascimento.html]]></loc><lastmod>2014-10-01T23:13:01+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/cobrim-mostra-novos-dados-do-tratamento-combinado-para-melanoma.html]]></loc><lastmod>2014-09-30T03:35:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/nivolumab-mostra-sinais-de-taxa-de-resposta-superior-em-comparacao-com-a-quimioterapia-padrao-em-pacientes-com-melanoma-avancado.html]]></loc><lastmod>2014-10-02T22:59:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/pembrolizumabe-no-cancer-gastrico-avancado.html]]></loc><lastmod>2014-10-02T04:27:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/crizotinibe-mostra-acao-em-cpnpc-com-mutacao-ros1.html]]></loc><lastmod>2014-09-29T03:57:30+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/bevacizumabe-em-primeira-linha-no-cancer-cervical-avancado.html]]></loc><lastmod>2014-09-29T04:35:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/estudos-de-fase-iii-em-cuidados-de-suporte.html]]></loc><lastmod>2014-09-28T22:31:49+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/terapia-alvo-em-melanoma-e-destaque-da-esmo-2014.html]]></loc><lastmod>2014-09-28T22:06:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/esmo-2014/magrit-decepciona-em-cpnpc.html]]></loc><lastmod>2014-09-28T22:03:05+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/franco-brasileiro-2014.html]]></loc><lastmod>2016-05-20T15:15:14+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/franco-brasileiro-2014/viii-franco-brasileiro-de-oncologia.html]]></loc><lastmod>2014-10-13T00:15:06+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/franco-brasileiro-2014/cancer-de-pancreas-avancado.html]]></loc><lastmod>2014-10-13T13:50:25+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/franco-brasileiro-2014/selecao-molecular-no-cancer-de-pulmao.html]]></loc><lastmod>2020-04-24T19:20:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/franco-brasileiro-2014/simposio-satelite-destaca-abiraterona-no-cancer-de-prostata.html]]></loc><lastmod>2014-10-13T03:10:17+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/franco-brasileiro-2014/tratamento-sistemico-do-cancer-de-ovario.html]]></loc><lastmod>2014-10-11T16:09:23+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/franco-brasileiro-2014/smb-promove-curso-de-oncoplastia.html]]></loc><lastmod>2014-10-11T16:45:37+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/franco-brasileiro-2014/bms-destaca-a-experiencia-brasileira-com-acesso-expandido-para-ipilimumabe.html]]></loc><lastmod>2014-10-13T03:14:47+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/franco-brasileiro-2014/premiacao-tem-tripla-homenagem.html]]></loc><lastmod>2014-10-11T16:59:21+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/hemo-2014.html]]></loc><lastmod>2016-05-20T15:23:56+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/hemo-2014/florianopolis-recebe-4-3-mil-congressistas.html]]></loc><lastmod>2014-11-15T23:01:19+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/hemo-2014/linfoma-de-hodgkin-em-novos-tempos.html]]></loc><lastmod>2014-11-15T22:59:38+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/hemo-2014/mieloma-multiplo-o-que-ha-de-novo.html]]></loc><lastmod>2014-11-15T22:59:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/hemo-2014/resonate-avancos-no-tratamento-da-llc.html]]></loc><lastmod>2014-11-15T22:53:53+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/hemo-2014/llc-e-a-importancia-da-selecao-terapeutica.html]]></loc><lastmod>2014-11-15T22:51:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/hemo-2014/grupo-brasileiro-de-mieloma-multiplo-na-hemo-2014.html]]></loc><lastmod>2014-11-15T22:43:12+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/hemo-2014/novos-inibidores-de-quinase-em-lmc.html]]></loc><lastmod>2014-11-15T22:41:15+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/hemo-2014/4-forum-educacional-das-instituicoes-de-apoio-a-pacientes.html]]></loc><lastmod>2014-11-15T22:05:03+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/ash-2014.html]]></loc><lastmod>2016-05-20T15:15:54+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/ash-2014/56-ash-e-as-novidades-da-oncohematologia-mundial.html]]></loc><lastmod>2014-12-10T12:25:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/ash-2014/dasision-analise-final-apresentada-na-ash.html]]></loc><lastmod>2014-12-08T23:36:34+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/ash-2014/ash-traz-novas-solucoes-para-linfoma-e-mieloma-multiplo.html]]></loc><lastmod>2014-12-08T21:23:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/ash-2014/cll-10-analise-final-apresentada-na-56-ash.html]]></loc><lastmod>2014-12-08T00:51:42+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/ash-2014/soraml-sorafenibe-versus-placebo-em-adicao-a-terapia-padrao.html]]></loc><lastmod>2014-12-09T00:57:10+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/ash-2014/aethera-brentuximabe-vedotin-em-linfoma-de-hodgkin.html]]></loc><lastmod>2014-12-08T00:57:09+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2014/ash-2014/daratumumab-mostra-resultados-preliminares-em-mm.html]]></loc><lastmod>2014-12-08T01:05:45+00:00</lastmod><changefreq>never</changefreq><priority>0.5</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/coberturasespeciais/2024/esmo-gi-2024.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/pesquisa-e-navegacao-por-assunto.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/pesquisa-e-navegacao-por-assunto/mama.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/pesquisa-e-navegacao-por-assunto/pulmao.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/pesquisa-e-navegacao-por-assunto/geniturinario.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/pesquisa-e-navegacao-por-assunto/gastrointestinal.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/pesquisa-e-navegacao-por-assunto/oncoginecologia.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/pesquisa-e-navegacao-por-assunto/cabeca-e-pescoco.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/pesquisa-e-navegacao-por-assunto/oncohematologia.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/pesquisa-e-navegacao-por-assunto/pele.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/pesquisa-e-navegacao-por-assunto/onconeurologia.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/pesquisa-e-navegacao-por-assunto/oncogenética.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/pesquisa-e-navegacao-por-assunto/radio-oncologia.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url><url><loc><![CDATA[https://www.onconews.com.br/site/buscar.html]]></loc><changefreq>daily</changefreq><priority>1</priority></url></urlset>